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SHORT COMMUmCATION 
Tracing the fate of oxygien consumed during phagocytosis 
by human neutrophils with ^^Oj 
A. W. S E G A L , J . C L A R K * A N D A. C . A L L I S O N 
Clinical Research Centre. Harrow. Middlesex. U.K. and 
'MRC Cyclotron Unit. Hammersmith Hospital, London 
{Received 3 March 1978; accepied 22 June 1978) 
Summary 
1. The metabolism of oxygen by phagocytosing 
neutrophils was traced by using ''Oj. 
2. The isotope did not exchange with the 
incubation medium or cells to an appreciable extent 
and unmetabolized oxygen was readily eluted by 
gassing the cell suspension. 
3. The polarographic measurements of oxygen 
consumption closely paralleled the recovery of 
metabolized '^O^. 
4. Almost all the metabolized " 0 , was con-
verted into water, both in the presence and absence 
of K C N , supporting the concept that the oxygen 
consumed by neutrophils is converted into H^O,. It 
is unlikely that an appreciable proportion of this 
oxygen is incorporated into the organic com-
position of the cell or of the ingested micro-
organism. 
Key words: granulocytes, hydrogen peroxide, 
leucocytes, oxygen, phagocytosis, radioactive 
• gases. 
Introduction 
The oxygen consumption of neutrophil poly-
morphonuclear leucocytes (neutrophils) increases 
with phagocytosis (Baldridge & Gerard, 1933). 
This is not due to mitochondrial respiration, as it 
is not inhibited by either cyanide (Sbarra & 
Karnovsky, 1959) or other inhibitors of mito-
chondrial cytochromes, and it is important for the 
bactericidal function of these cells (Mandell, 1974). 
Correspondence: Dr A. W. Segal, Clinical Research 
Centre, Watford Road, Harrow, Middlesex, HAl 3UJ, 
U.K. 
Hydrogen peroxide, a possible substrate fo.-
the myeloperoxide-halide microbicidal sysierr. 
(Klebanoff, 1975) is produced as this oxygen is 
consumed, but (Iyer. Islam & Quastel, 1961: 
Homan-Miiller, Weening & Roos, 1975) it is not 
known what proportion of the oxygen is reduced lo 
H2O2 and how much enters the organic com-
position of the ingested organism or of the cei! 
itself The methods for the measurement of H;0-. 
including '"COj release from ['"Clformate and 
peroxidation of various substrates, are non-specifi: 
and may require high concentrations of cyanide e: 
azide to prevent endogenous degradation of HjO-. 
The effect of these inhibitors on other cell functions 
and enzyme systems is unknown. Specific analysis 
of H2O2 by measuring the Oj regenerated by a.-, 
excess of catalase (EC 1.11.1.6) gives only a small 
percentage recovery of the oxygen, and the fate of 
most of the oxygen remains unexplained (Homan-
Miiller el ai, 1975; Zatti, Rossi & Patriarca. 
1968). Aldehydes (Jacobs, Paul, Strauss & Sbarra. 
1970) and oxidized lipids (Gutteridge, Lamport 
Dormandy, 1976) have antibacterial activity, and 
the ingestion by neutrophils of particles containing 
hnoleic acid generates malonaldehyde (Stossei. 
Mason & Smith, 1974). This suggests that the 
oxygen not otherwise accounted for might b-e 
incorporated into lipids in the cell, possibly 
producing a bactericidal agent, or into the ingested 
micro-organism. 
We have studied the extent to which the 
metabolized oxygen is incorporated into the 
organic composition of the engulfing cell, or 
engulfed micro-organism, and how much even-
tually forms water, by using the short-lived isotope 
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Materials and methods 
A. W. Segal, J. Clark and A. C.Allison 
Neutrophils were purified from human blood by the 
technique of Boyum (1968) and suspended in 
Hanks balanced salt solution (2-5 x lOVml). An 
aliquot of the cell suspension (1-0 ml) was stirred 
rapidly in the chamber of a platinum oxygen 
electrode (Rank) at 37°C and to this was added 
1 -0 ml of Hanks solution which had been gassed 
for 4 min with a mixture of '^Oj + (20:80, v/v; 
1-2 mCi) (Clark & Buckingham, 1975). 
Phagocytosis was stimulated by the addition of 1 x 
10'" latex particles coated with human IgG (0-81 
nm diameter) or 1 x 10'" serum opsonized, heat-
killed staphylococci (Oxford strain) in 100 /il of 
Hanks solution. Oxygen consumption was 
measured polarographically for 4-6 min, after 
which the cell suspension was removed, the 
incubation chamber washed with 1-0 ml of 
phosphate-buffered saline [sodium phosphate (8 
mmol/1 of sodium chloride solution (154 mmoJ/1), 
pH 7-2) and the mixture was centrifuged at 8000 g 
for 30 s in an Eppendorf 3200 centrifuge. The 
pellets were washed twice with 1-5 ml of phosphate-
bufTered saline. The supernatants were pooled 
and gassed for 2 min with to remove unmetab-
olized '^Oj. Radioactivity in the cell pellets and 
gassed supernatants was measured in a well-type 
gamma counter and compared with that in an 
aliquot of the '^ O -^gassed medium. Experiments 
were also performed with heat-killed cells (95°C for 
4 min) ^ d in the presence of K C N (5 mmol/1). 
Lactate dehydrogenase (EC 1.1.1.27) activity 
was assayed (Davies, Page & Allison, 1974) in 
the cell pellet and supernatant medium of cells 
processed in an identical manner. 
In four other experiments (four studies) 5 x 10' 
neutrophils in 4 ml of Hanks solution were 
incubated at 37°C with latex particles and '^Oj for 
2 min. The cell suspension was then gently heated 
under vacuum and a sample of distilled water was 
collected in a liquid nitrogen trap. Aliquots of the 
incubation mixture and distillate were weighed and 
the radioactivity was measured. 
Results 
Unmetabolized "Oj was completely removed from 
the medium by gassing it with Nj. The neutrophils 
demonstrated a burst of oxygen consumption after 
the addition of particles to the cell suspension, 
which was enhanced by the presence of K C N 
(Table 1). The proportion of the oxygen in the 
chamber that was consumed as measured by 
polarography was very similar to the proportion of 
radioactivity that was recovered. Almost all the 
radioactivity was in the aqueous medium and very 
little remained in the cells. In two control studies, 
16 and 17% of the cellular lactate dehydrogenase, 
a marker of cell viability (Davies et ai, 1974), was 
released into the medium. The specific radio-
activity of the water distilled from an incubation 
mixture of phagocytosing cells was 91-6, 101-4. 
87-6 and 113-4% in four studies (mean value 
98-5%). 
T A B L E 1. Oxygen consumption by human neutrophils and ihe subsequent 
distribution o/v'^Oj in the cells and incubation medium 
Oxygen was consumed by neutrophils at a rate of 0 05 fmol min"' cell"' before 
the addition of bacteria and latex particles, which did not consume oxygen by 
themselves. Results are shown for two studies in each category except for the 
single study on the cells that were killed by heating at 95°C for 4 min. 
Incubation Oxygen consumption 
conditions (polarographic measurement) 
"Oj radioactivity 
recovered (%) 
Rate 
(fmol min"' cell"') 
Proportion 
consumed 
(%) 
Cell 
pellet 
Supernaiani Total 
Viable cells + 0-59 54 3-5 52-3 55-8 
latex particles 0-51 51 2-5 46-5 49-0 
Viable cells + 104 76 1-3 780 79-3 
latex particles + 100 76 4-1 68-4 72-5 
K C N ( 4 mmol/1) 
Viable cells + 0-86 57 3-5 511 54-6 
dead bacteria 0-66 26 1-7 25-8 27-5 
Dead cells + 0 0 1-3 3-3 4-6 
latex particles 
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Discussion 
'^Oi does not rapidly exchange with oxygen of 
water and could therefore be used to determine the 
fate of the oxygen in the striking burst of oxygen 
consumption that accompanies phagocytosis. Al-
most all the metabolized oxygen was found to enter 
the suspending medium. This was not due to 
damage to the cells as only a small proportion of 
the cytoplasmic marker enzyme lactate dehydro-
genase (Segal & Peters, 1977) was released from 
the cells during the studies. The '^Oj was shown to 
enter the water itself, as opposed to being present 
as a soluble metabolite, as its specific radioactivity 
in water distilled from the incubation mixture was 
very similar to that in the original cell suspension. 
The '^62 was not metaboUzed to water by mito-
chondrial respiration, as its consumption was not 
inhibited by K C N , nor was its exchange with the 
Oj simply accelerated by cellular components, as it 
did not occur in the "resence of dead cells. Very 
little (less than 4%) if any, of the oxygen that is 
consumed becomes incorporated into the organic 
structure of neutrophils or ingested bacteria. 
The current concept that all the oxygen con-
sumed in association with phagocytosis forms 
HjOj (Klebanoff, 1975; Homan-Muller et a/., 
1975; Iyer et ai, 1961) appears correct. The low 
recovery of HjOj previously observed, which 
accounted for less than 10% of the oxygen 
consumed, probably results from further metabol-
ism of I ^ O j by myeloperoxidase (EC 1.11.1.17) as 
HjOj accumulates in myeloperoxidase-deficient 
neutrophils (Klebanoff & Pincus, 1971) and as the 
recovery of HjO^ amounts to 50-70% of the 
oxygen consumed in the presence of cyanide and 
azide (Homan-Miiller et a/., 1975), which inhibit this 
enzyme. Cyanide appears to enhance oxygen 
consumption under the conditions in which the 
present studies were conducted because it is basic 
and buffers the acid produced by phagocytosing 
cells (Sbarra & Karnovsky, 1959). 
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The Interpretation of Thallium-201 Cardiac 
Scintigrams 
Studies in Experimental Ischemic Heart Disease in Dogs 
A . P . SELWYN, E. W E L M A N , T . A . P R A T T , J . CLARK, C. M C A R T H U R , A N D 
J.P. L A V E N D K R 
S U M M A R Y Twenty-one anesthetized and thoracotamized dogs were studied. Scintigrams of the heart 
were recorded using a continuous in fus ion of k ryp ton-81m into the aortic sinuses as well as intravenous 
injections of thaliium-201. A gamma camera l inked to a d ig i ta l computer was used to record the 
myocardial distr ibution of these tracers. The d i s t r i bu t ion of - " 'T l was s imi la r to that of ^'"'Kr when 
myocardia l blood f low was normal (seven dogs). I n 14 dogs, the lef t anter ior descending coronary 
ar tery (LAD) was narrowed to produce a regional decrease in myocardial blood f low. Blood f low 
changes were measured wi th an electromagnetic f lowprohe . When the epicardial ECG was normal in 
seven dogs, the ' " 'T l scintigram showed no regional decreases in ac t iv i ty when the tracer was delivered 
af ter L A D narrowing. In contrast, a decrease in the ac t iv i ty of " '" 'Kr was observed in the region 
supplied by the LAD. When the decrease in blood f l o w was associated w i t h ECG signs of ischemia in 
seven dogs, both ^'"'Kr and -*"T1 scint igrams showed decreased activ'ity in the ischemic area. The 
cardiac d is t r ibut ion of "°'T1 was de termined i n f i v e dogs whi l e myocardial blood f low and mei;'bo!ism 
were nurnial . L.AD narrowing then produced 24 hours of severe myocardial ischemia. The d i s t r i l j u t io i i 
of cieatine kinase activity in the le f t ventr ic le ( U / m g D N A ) was s imilar to the dis t r ibut ion of " '"Tl 
(counts /mg DN.^^), /• = 0.8.!; P = < 0.001. These studies suggest that ' " ' T l scint igraphy of the heart can 
demonstrate decreases in regional myocard ia l per fus ion only when metabolism is disturbed. 
' r H . A L L l U M - 2 0 1 is being widely investigated and used to 
image the heart in the a.NSe.ssmeni of patients w i t h cd 'O-
na iy ar tery d i s e a s e . F o l l o w i n g a peripheral venous in-
j e c i i o i i , t in ; I'cgional cli.strihution of this radionuclide in 
t h e heart has been useil to obtain i n f o i i n a t i o n about 
myocard ia l ischemia and infarc t ion. ' ' " ' " T l cardiac scin-
t igrams arc rei)orled as demonslraling abnormali t ies of 
regional niyocardial perfusion.' Exper imental research 
has suggested a close relationship between the d i s t r ibu-
tion of " " " ' r i in the heart and regional myocardia l blood 
i low." These e.x|)erimenis have made certain assumptions 
about the energy-de|)en(lent cell membrane extract ion of 
the imiicator , ' •" The purpose of (his s tudy was to test 
whcthei- " " " r i scintigrams of the heart can provide an 
assessment of changes in regional myocardial perfusion. 
T h e relative importance of coronary blood How and myo-
cardial n\etabolie processes in the in te rpre ta t ion of ' " ' T l 
cardiac scintigrams is discu.ssed. 
.Methods 
' l \venty-one mongrel dogs weighing between 32 and 51 
kg were anesthetized wi th intravenous sodium thiopen-
tal (Pento t l ia l , 16 mg/kg) . .•\nesthesia was mainta ined by 
the intermitt(?rit .-'itravenous injection of pentabarbi ta l 
I 'Vuin l i l t ; ( ' . i rdiov.- i .srul j t i t t c s t a r ch U n i t , IX'p.TrtineTlI u f f i . n i i o l o g v , 
III l - i l i l , I t oya ! t'f).^li:r.Kiii:\U' M(; ( l i ( : : l l .Sctujot, I . o lu loM, 
t)r. .A. !'. 
M K C C v r l 
l l n c l a i u t 
A(l{ir(.-.";s for ii_-|»riiil 
l\ny;ll i'{>.';li:r;i(tii.ii(; N' 
iii;l-civuil Si'llU'ili!" 
l-.svn, Car<iiov;i.scul;ir tte.'^ L'arcli ttiiil., 
. l.i,ntl.,:i, \\'V2 OILS, l.ji^land. 
lor j(i;t>liraUon .Jamiarv t!l, t!)7.S. 
(Saggital, 2 mg/kg) . Respiration was maintained via a 
cuf fed endotracheal tube w i th a mechanical xonti lator . A 
l e f t thoracotomy was performed and the heart supported 
in a pericardial crarlle. reversible snare was placed 
around the le f t anter ior tiescending coronary ar tery 
( L A D ) approximately 2 cm f r o m where this ve.=.sel 
emerges f r o m under the l e f t atrial appendage. Th i s snare 
consisted of 4 silk strands pulled through an H-cni length 
of 3 f rench cardiac catheter tubing. 
A n electromagnetic (low probe ( c m f j of suitable ?i?.e 
was positioned around the L A D immediately pro.xima! to 
the snare. M o s t commonly a 3- to 5-mni probe was u.sed. 
Pulsatile regional coronary f low was recordefl by con-
necting tlse probe to a Systems Klectronic i"oi .Modi'.ine 
f lowmete r (type 275). T h i s has a carrier frequency of ifc'o 
H / . and the response is nominal ly Hat (less than 3 dB 
down) to 80 Hz. Phasic and mean tracings wore recorded 
on a mul t ichannel ins t rument (Hewlet t Packard 77S.S-A). 
A t the end of the experiments, calibration was carried ou t 
by ty ing o f f a l l the branches of the left coronary ar te ry 
except the one of interest and perfusing the artery w i t h 
the dog's own blood w i t h a constant infusion pump, ' i 'he 
accuracy of the probe and f lowmeter was tested dur;ng 
each cal ibrat ion by repeatedly measuring 20 values for 
f l o w between 10 and 150 n i l / m i n . I ' he probe showe'i a 
.systematic and random error of less than 5% when com-
pared to the pump and absolute measurement.. The aii-
solutc measurements were made by taking l imed collec-
tions into tarerl gla.ss containers and v.eighing. The d i -
crotic notch on an arter ial |)ressure wave v.'a.s usefi as 'he 
2SS 011 u:, U1 , A • r 10 N R E .S E A R C H V O L . No , 2, A i f:i;,ST iw: 
beginning of diastolic coronary flow. Planimetry wa.s u,sed 
to calculate area.s under the phasic tracings and the 
ca l ibra t ion data were used to calculate mean and phasic 
regional coronary How ( n i l / m i n ) . 
Epicardial electrocardiographic (EGG) complexes were 
recorded, using a saline-soaked cotton wick electrode 
attached to the chest lead of a Hewlet t Packard 7788A 
EGG ampl i f ie r ( in |}ut impedance, 50 .M 9.).~ The stan-
dardizat ion used throughout was L m m = 1 n iV, 
A 7 f rench cardiac catheter was in.serted into the infe-
r ior vena cava via a r ight femora! venotomy. A specially 
designed no, 3 f rench catheter was inserted via a lef t 
femoral a r te r io tomy and sealed in the aortic sinuses. 
" ' " ' K r svas cont inuously eluted in 57c> dextrose f r o m il,s 
cyclotron-produced parent com|)ound rubidiuni-81 held 
in a i)Ortable generator,"'"'"'Kr (7-10 m C i / m i n ) was deliv-
ered into the aortic sinuses at a constant rate of between 
5 and 10 m l / m i n of 5% dextrose. 
Each dog was positioned so t h a i the chest was w i t h i n 
the f ield of a gamma camera (Toshiba CC.^ 202). A digi ta l 
computer was used to record the total and regional activ-
i t y o f any gamma emissions f r o m the heart as ( juan l i t a t ive 
h igh spatial resolution images (Del t ron-Nova 1220), 
T h r o u g h o u t these experiments a high resolution coll i -
mator (parallel holes) was used (Toshiba R D H 606), The 
overal l resolution of coll imator and camera wa,s 7 m m for 
" ' " ' K r and 17 m m for ' " ' T l . Th i s was determined by 
calculat ing the f u l l - w i d t h half-measure f rom a line source 
posit ioned w i t h i n the left \ entricular cavity of an asystolic 
dog heart. T h e source was -5 cm f rom the camera face. 
.Seven dogs were studied while control regional coro-
nary flow var ied by less than ± 5?o and ihe epicardial 
EGG showed no abnormalities. " ' ' "Kr cardiac scintigrams 
were recorded by coUectmg 250,000 counts in .^ 0 seconds 
w i t h the camera detection window at 190 keV ± 20%. T h e 
epicardial EGG complexes were recorded f r o m eight po-
sit ions w i t h i n the area supplied by the L A D . ' The camera 
detect ion window was changed to 80 keV ± 209;.. and 1 
niGi of tha l l ium-201 (Duphar) was given as a single 
in t ravenous in jec t ion . A f t e r 10 minutes, quant i ta t ive - " ' T l 
scintigrams of the heart were recorded by the computer 
and Polaroid f i l m by collecting 250,000 counts. 
T h e L A D was then completely occluded in five of these 
seven dogs. T h e per icardium and chest were drained and 
closed and the anesthesia continued to 24 hours. T h e 
chest was opened and each heart surrounded w i t h 
crushed ice. T h e hearts were excised and washed w i t h 
sucrose so lu t ion (0.25 mol / l i t e r ) . T h e r ig l i t a t r ium and 
ventr icle , l e f t a t r i um, pulmonary artery, and aorta were 
removed by dissection. A n incision along the junc t ion 
between the interventr icular septum and the posterior 
free wal l o f the le f t ventricle (LV) allowed the .specimen 
to be laid f l a t on a cooled Perspex surface. T h e specimen 
was held in place by a metal gr id. Th is divided the 
e|)icardial L V surface into 1 cm" regions. The outl ine of 
the L V specimen, the epicardial coronary vessels, the 
snare, electrode positions and the area of discoloration 
were marked on a Perspex sheet held over the gr id and 
specimen. 
T h e fo l lowing procedures were carried out at 4 ° C , U p 
to 30 tissue samples (0,3 to 0,5 g) of the f u l l thickness of 
the specimen were taken f rom sites in the veiurici:!,':r 
muscle supplied by the L A D , lef t c ircumflex coro:::-• ,• 
ar tery, and r i gh t coronary artery. T h e position of e: 
.sample site was noted wi th reference to the overlaid grid. 
T h e tissue samples were i>laced in tared tube.~ a j id 
weighed, Homogcnizal ion was then carried out in iO 
vo lume sucrose (0,25 mol / l i t e r ) containing mercapioeth-
anol (10" ' m o l / l i t e r ) wi th a Polytron homogenizer bv 3 
X 5 sec at set t ing 5, A sample (0,5 ml) of each homogenate 
was removed for determination of D N A , The remainiiis 
homogenate was centrifuged at 600 g for 10 minute? ;•• 
sediment the nticlci , myofibri ls , and membrane h.-. 
ments. Samples of the post-nuclear supernaiant exirr. 
were taken fo r the assay of creatine kinase ( C K ) activii ; . 
These samples woie first diluted 1 in 500 vol /vo i wit:-, 
sucrose-mercaptoelhanol solulion, 
D N A was measured by the method described by P..--
ters;'' C K ac t iv i ty was a,s.sayed in a Cecil S|)CCirophoto:v,-
eter by the method of Oliver, '" using the modificatio;-..-
described by Hearse," The CK act ivi ty in unii.- i:..-. 
m i l l i l i t e r was then calcidated and expressed i)er mi!:;^r:- -
of D N A , 
Samples (0.2 ml) of the po.=i-nuclear supernata:ii u 
t iac t f r o m each homogenate were placed in coJ:ui:',-' 
tubes. T h e " " ' T l act ivi ty (80 keV gamma emi.ssir,.-,.<i 
each sample was measured in an automated well v mi- : 
(Nuclear Entei |"jrise). Th is result was then expires.;- i 
m i l l i g r am of D.N .A a.nd compared to the region;;! dc:..-;i; . 
of C K activ i ty , using a linear regression analysis. 
.A constant in f i i s ion of ' ' ' " 'Kr was delivered to ih ; : ::~<r 
sinuses in an addit ional seven dogs, linages oi the ::•• 
cardial d i s t r i bu t ion of this tracer were recorded i . ' . • 
lecting 250,000 counts on Polaroid film and on the '::g::.. 
computer , f j t i r i n g ihis t ime heart rate, blood pr-j=.-urT 
and regional coronary How were stable and the epi^.irdi;:. 
rOCG showed no S-T segment or T wave change.- i hrr 
L A D vvas then narrowed so a; to reduce me^n rci'.."':'.. 
coronary f low by between 35'/c and 60%, The " ' K r '.^ni:,-. 
sc int igrams were recorded again and a continuous ihei.-: 
was made that, there were no changes in the epicsrc:; 
EGG. A f t e r 7 minutes, the gamma camera dei->:ti' 
w indow was changed to 80 ke\ ' ± 20% and the k,-,:>-
in fus ion stopped. One mCi of " ' ' T l was given i i . ' . . " ' , • . 
nously and, a f te r 10 minutes, i.mages of the .myocirdi. t . 
d i s t r i bu t ion o f ' " ' " T l were recorded on Polaroid fil.- a:'." 
the d ig i ta l computer by collecting 250,000 counts. .Aftc; 
this, * ' " ' K r scintigrams were recorded again. 
K r v j i t o n - S l m cardiac scintigrams were recorded i h r 
seven remaining dogs while regional coronary flo---. Cr.-. 
epicardial EGG, heart rate, and blood pressure wt.-e a. 
stable. T h e L A D snare was tightened unt i l mea.i corona: 
f low was reduced by between 35% and 60%. Th:= v.a-
achieved by at taching the four strands of the snari to -
screw clamp and turning slowly un t i l mean regiont! cor-
onary fiow was diminished as required and the ' ' " K : 
scint igrams showed a regional defect. The sc 'ew clamt: 
was held stable by attachment to the chest "Aall. Eac'r 
exper iment proceeded when the f lowprobe and repona. 
ac t i v i t y of * ' " K r showed a stable decrease w i t h varia'.ion.-
of < ± 7%, I n each dog of this group, the epicardia! ECC-
complexes in the area supplied by the L A D sh jwei 
• r H A L l J U : v l - 2 ( ) l C A K O i A C SC\iS^\^^C.RA^\^S/S^•llvr„ cl (it. 
changes wi th in 60 seconds. Kry]) ton-81m cardiac scint i-
grams were recorded as described above and the energy 
detection window of the camera was changed to 80 keV 
± 20%. Seven minutes after L A D narrowing, I mCi of 
" " ' T l was given intravenously and images recorded af ter 
10 minutes. 
A f t e r each experiment the quant i ta t ive images of the 
heart obtained wi th " ' " ' K r were displayed on tlie com-
puter osciUiscope visual display t i n i t w i t h i n a 04 x G4 
mat r ix of squares. The whole image was then enclosed 
w i t h i n .seven rectangular areas of interest. The ac t iv i ty 
(in counts per minute) in each area was expressed as a 
rat io of the total myocardial act ivi ty . The '" '"Tl catdiac 
scint igram f r o m the same experiment was then disii layed 
w i t h i n the .same areas of interest tmd the corresponding 
seven ratios calculated. Throughou t each experiment care 
was taken that the or ientat ion between the heart and the 
gamma camera did not change. The dogs were held in 
posi t ion throughout each ex[)orinient and the images on 
the visual display were checked to ensure that they had 
not moved w i t h i n the I i 4 X G-1 rnat.i ix t luring the course of 
each experiment. 
N o computer processing, image enhancement, or back-
grot ind subtraction techniques were used. 
A t the end of each experiment the snared L A D was 
selectively injectet l v^ith 5 ml of patent blue 5 dye, and 
the area of myocardium stained by the dis t r ibut ion of 
tha t ve.ssel was dissected out and weighed.'"' 
T h e experimental [iroceduro for each group of do,gs is 
summarized in I 'able 1. Paired /-tests ivere used to com-
pare the regional myocardial d is t r ibut ion of " ' " 'K r and 
"°'T1. Linear regression analysis was used to compare the 
regional myocardial d is t r ibut ion of creatine kinase .activ-
i ty and " " T l . 
Results 
•^ Fhe regional myocardial d is t r ibut ion o f ' ' " ' K r was sim-
ilar to that of ' " ' T l in the cardiac scintigrams f r o m those 
experiment-s w i t h no L A D stenosis and normal ei i icardial 
ECG complexes (Fig. 1, a and c). The ratios demonstrated 
that there were no signiilcant differences in the relative 
myocardial d i s t i i bu t ion of the two indicators (Fig. Ic ) . 
Paired /-tests showed P = > 0.50. 
In all the experiments the percentage decreases in the 
regional myocardial ac t iv i ty o f ' " ' " ' K r produced by L.AD 
narrowing were closely related to the percentage de-
creases in regional coronary f low using the How probe ( r 
= 0 . 9 1 , P = < 0.001, ; i = 21 observations, linear regre-ssion 
analysis). 
'Fwenty-four hours after L A D occlusion, the regional 
myocardial d i s t r ibu t ion of C K act ivi ty showed marked 
decreases in the area aftected by the L.AD occlusion. The 
ac t iv i ty in the affected areas was 0.5G ± 0.0R2 U / m g D N A 
and in the unaffected areas i t was 1.30 ± 0.13 U / m g DN.A 
(mean ± S D ) . T h e regional myocardial act ivi ty o f ""'T! in 
remote regions of the heart unafl'ecled by the L.AD .s.-are 
was treated as 100% in each dog. The percentage oecroase 
in the regional mvocardial act ivi tv of ' at each .-iie 
was calculated (rom the measured act ivi ty w ; ;h in : h r 
region affected I jy the L.AD snare. T h e relationshir. be-
tween the regional myocardial decrease in the f.ctiv.-.ie-; 
of C K and -'""Fl was Y = 0.918X -r 8.45, = 0.;-.3. P = < 
0.001, '! = so myocardial samples. 
In seven of the 21 dogs. L A D narrowing produced i :c-.\'. 
in coronary blood How of 37-56'c (mean = -.b''K ''!•.•_-
cpicardial F]CG showed no changes and the "ica." 
dis t r ibu t ion of " ' " 'K r demonstrated regional dc'.re.:-..--;- \:. 
ac t iv i ty in the area supplied by the snared ve£;c-l ~\i 
2a). 'Fho ratios in Figure 2b demonstrate the c;-:ang-H v\ 
the t l i s t r ibut ion of this isotope when regional :oro.'.-=ry 
How was diminishef i . The ' " ' T l cardiac scintigTf.ms i m i 
the ratios shown in Figure 2, a and b, did not de;r. jn.-'..-aie 
any regional defect when this isotope was delivc-.-ed •.•.hi!-r 
the L.AD was narrowed in these seven dogs. 
I n seven dogs the L.AFJ was narrowed unt i l r . - . - a r . or-
onary How decreased by 35-GO"' (mean = 5'. . •. . 
T A B I J E 1 Groups of Dogs and Experiments using 'Vliallium-201 Scintigrap/iv 
L A D now-
( i n ! / [ i l i n l i" "' '"I\r iinaf,'e 
l%i)icar(iia! 
' i-.cc; 
Mean role 
{ t i c a c s / n i i n l T 
BP 
(iiini t It;): 
I'liailiuiii.-"); C K 10 • 1'. 
ima{;r* i c i : . . : , ; 
Group 1 (n = 7) 
Control 
53 ± 5.0 No regional 
defect 
Isoelectric .S-T 
segment 
123 ±14 .0 93 ± V.ll No defecis 
24 hr after LAD 
narrowed 
Y = O.SlS.x -
r = 0.S3. P < 0.0 ; 
Group 2 (/! = 7) 
Control 
48 ± 7.0 No regional 
delect 
Isoelectric S-T 
segment 
128 ± 12.0 95 ± 5.U 
After LAD 
narrowed 
2<1 ± 9.0 Regional 
defect 
Isoelectric .S-T 
segment 
121 ± 17.0 No regional 
defecls 
Group 3 in = 7) 
Control 
52 ± 8,0 No regional 
defect 
Isoelectric S-T 
segment 
118 ± 15.0 99 ± 4.0 
After LAD 
narrowed 
26 ± 11.0 Regional 
defect 
S-T elevation, 
S-T depression 
Both >2 mm 
120 ± 18.0 Regional 
defect 
* Measured by elecLromagnetic flowineter. 
t M e a n ± SD. 
X L i n e a r regression analysis: C K U / n i g O N A and Lhallium-201 counLs /mg D N A . 
C I R C U L A T I O N R I : : S K A R C i l V O L , - l . ! , No, 2, A I I ( ; I ; , S T ifjT.s 
LHD snare 
C ' ^ D 
l - l < : r K K ! o ; Scu,t,gran,s of ,hc heart u.^iag -"Kr a..,! -^77 arc > / , o , r „ , 77,c rc;.a,nal nn„ra../,al d:s,r,ln,-.„ „/,/„..,. ..„ 
s:„ular n„cn Ua, roronar. nra.!alu,n u-as ,nu„l. The " 77 uua,, ,s </,.n, n ,,, a: ,hc--Kr una,, shau n o c 77,- ' ' AV „,„ 
snn„i,ra,ns ,n ,acl, experu„„U u:crc ,/iculcd ,nlo i,.v area, of .ntc c.t an th, nsaal d,.<pUn- unit. The r-slationslup i,„„ r-r,, : 
areas and Ac card.ac anatomy ,houn. dr In each experimcU. the "^Kr and '"Ti ,n„.,e.- u.rc pa.iUaned a . t L tia-
uicas 01 intcrcsl. Ihe rata,, o/ tl,e regional lo the total ciclieily in er 
(Usiribulion of the tracers i<:as similar. 
caeh areii s/ion: inl/t iinag lhal llie regional i 
ei j icardia l ECCl showed planer S-T segment depression 
( < 2 mm) and T wave inversion in two, and characteristic 
.S-T segment elevation ( < 2 mm) in the other five. The 
" ' ' " K r cardiac .scintigrams and the ratios of the myocardial 
d i s t r i l i u t i on o f ' ' ' ' " K r showed a regional decrease in activ-
i ty af ter L A D narrowing (Fig, 3, a and b). The " ' "T l 
cardiac scintigrams and the ratios of ac t iv i ty in these dogs 
showed a corresponding regional decrease in activity (Fig. 
3, a and b). 
The segments of myocard ium supplied by the snared 
L A D weighed between 29 and 43 g. 
T h e results are summarized in Table 1. 
Discus-sion 
In these experiments regional coronary flov.- in .: 
snared vessel was measured wi th the electro.^-iagn-." 
probe and changes in regional myocardial perfusion v--
observed by imaging the steady rate equi l ibr ium of k,-y 
ton-81m in the heart,''^^ Dur ing a continuous infusio,', 
" " " K r into the aortic sinuses, a proport ion of this tr?,: 
reaches the coronary circulat ion. Th i s inert and fr'r-r 
d i f fu s ing indicator has a hal f - l i fe (.13 sec, decay consif.: 
3 .2 /min) that is faster than normal and reduced va!.-
for the turnover of myocardial flow per unit volu:ne. T : 
T F ! A I , l . l l l M - 2 ( i l C.VHFMAC .S(;iN'FiaR.AiV!.S/.Sc/((;v;i vl a/. 
steady state e tp i i l i b r ium of " ' " 'Kr in the myocardial water 
space in these circumstances depends mostly on ar r iva l 
of the tracer by blood f low and the constant radioactive 
decay. The " ' ' " K r myocardia l signal w i l l arise mostly f r o m 
the extracellular f l u i d space and myocardial tissues. 'Fhe 
shor t ha l f - l i fe w i l l prevent washout of the tracer f r o m 
being i m p o r t a n t . " 
T h e results showed tha t when coronary f low was not 
obstructed, the regional myocardial d i s t r ibu t ion o f ' ^ ' " ' K r 
and - " ' T l were similar, using images recorded w i t h a 
gamma camera. However, when regional perfusion wa.s 
d iminished as shown by the How probe and " ' " 'K r scint i-
grams, the " ' " T l images of the heart did not demonstrate 
the regional decrease in perfusion while the KCG was 
normal . When the L A D narrowing and decreases in myo-
cardial perfus ion were accompanied by epicardial ECG 
evidence of some cellular abnormali ty , the "'"'11 scint i -
grams demonstrated regional decreases in ac t iv i ty corre-
sponding to the defects seen in the " ' " 'K r images. 'Fhe 
regional decreases in myocardial perfusion in these ex-
periments may or may not be accompanied by manifes-
tat ions of tissue ischemia, 'Fhis w i l l depend on the avail-
able col lateral blood f low and metabolic demand ( M V O j ) 
at the titne of L A D narrowing. 
'Fhe regional myocardial depletion of C K ac l iv i iv h.is 
been used to assess ischemic damage after coronary oc-
clusion. ' ' 'These experiments showed that the d is t r ibu t ion 
and severity of the myocardial depletion of ' " " 'F l and CK 
act iv i ty 24 hours after L A D occlusion were similar. 'Fhis 
sug.gested tha t in these circimistances ' " ' T l was acting .i.-. 
a tisstie marker of ischemic damage. 
'Fhe affected regions of myocardium were positioned 
on the edge of the images o f ' ' ' " ' K r and ""''Fl act ivi ty . 'Fbe 
segments of tissue affected by the coronar.y narrowing 
were dissected and weighed. The use of patent blue 5 dye 
overestimates the size of the ischemic area; however, this 
technique was used in an a t tempt to ensure that the area? 
of interest were big enough to resolve as defects tisina 
••"'Tl and ' " ' "Kr . 
Strauss et al.^ and others have used experimenta.i 
models to show that the regional dis t r ibut ion of '"'1"1 in 
the l ieart is related to myocardial blood flow. 'Fhose 
exj ier imcnts d id not separate the energy-dependent cel-
lular mechanisms that dominate the extraction of ihi= 
tracer f r o m the blood. Poe"" has shown that (he propori ior . 
of ^ ' K and related compounds extracted by the mv.x-ar-
d ium is inversely related to blood flow. 'Buja et a!. ' 'na\-
shown that ischemic myocardiuin has a l imi ted ab i l i t y i -
i.?s I 
...-••"3 / I 
' i / / 
Ti 
. . J 
n • I doqs. 
X %• 
9 
• ^''^Kf bclore LAD naffowinq. 
o ^'^Kr alter LAO naffov.inq. 
d 1 1 -
• Tl qiven after LAD narrowiitq. 
1 1 • 1 
FtGUKt; 2 The myocardial distribution of'^Kr is shown before (a) and after (b) partial occlusion of the LAD. The regmna! def. 
in acliuily thai appears was not accompanied by epicardial ECG changes. The -"'Tl scintigrams showed no such defect in octii. 
(c). d: The ratios showing the regional actiuity of'^Kr demonstrate the loss of activity in the area supplied by the l.AD. Thi ra:. 
for '""Tl show a normal distribution when the epicardial ECO was normal. Paired l-tests showed thai the change in the rcgiu:. 
myocardial distribution of""Kr were significant (P = < 0.01} and the changes in '"'Tl were not (P = < 0.20) for areas I and 2. 
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/ i i f i; I 
' " ' 
y . "''"Vt Lel-jfr L'.D .-.irr .-. - ; 
••••* o i - , . ; , lAIl.-.-i.-.--..- • 
d 1 1 1 1 
FiCUHF, 3 The myocardial distribution of^''^Kr is slioiin before (a) and after (h) partial oeelusior, o; l..-\0. The rc^'.on 
in activity that appeared was accompanied by epicardial ECC ciianges in the.'ie dogs. The ' Tl cardiac scintigrams sluji. -.d i: 
defect in activity (e). d: The ratios showing the regional aelieity •)/ •"""K'r demonslniles the i-y-s of aeiiv.i: in the area --rpp. 
narrowed L.-\D. The ratios for -'"'fl shoiecd a similar regional loss in activity (compare to Figure lb). Paired t tests siv ;. • 
changes in the regional myocardial distribution of ""'Kr and '"'"77 were significant (I' = < (•'.')/) for arras I and 2. 
take up ' " ' "T l , and this is followed by a redistr ibut ion of 
the indicator resulting f r o m rediffusion and recirculation 
and also collateral flow, Hami l t on et a l . ' ' have demon-
s t ra ted tha t ischemic bu t not infarcted myocardium can 
take up '^" 'Tl dur ing the complex kinetics of this tracer 
t h a t fol lows the in i t i a l d i s t r ibu t ion of an intravenous 
in jec t ion . 
T h e work of Ado lph et a l . " supports the view that 
reversibly hypoxic myocard ium has a l imi ted capacity for 
™'TI uptake. Cl inical research comparing * ' T 1 scintigra-
phy and the ECG testing dur ing exercise does not always 
show ™'T1 defects w i t h regional EGG abnormalities. '" 
T h i s exper imental model w i l l tend to oversimplify the 
c l in ica l s i tua t ion in man, bu t the specific techniques of 
^ ' " K r scint igraphy and graded coronary occlusion have 
been used to demonstrate a single principle in the u.se of 
I n patients w i t h segmental r igid coronary artery ste-
nosis and func t iona l disturbances of regional myocardial 
perfusion, ^ " ' T l scintigrams w i l l demonstrate defects in 
a c t i v i t y on s t r e s s . H o w e v e r , the results of this study 
w o u l d suggest tha t ™'TI cardiac scintigraphy may not 
detect regional decreases in myocardial perfusion due to 
coronary ar tery disease u n t i l these have progre.ssed suf-
ficiently to d is turb myocardial metabolism at rest or 
du r ing stress. 
In conclusion, '" '"Tl cardiac scintigrams coulc n ' . ' . ' . - i - : ' 
experimental decreases in regio:^al myocardia! p - .-: 
alone in these experiments. Tlit.- myocardial c:.-:ti.- . 
of this indicator did demonstrate decreases in r-:;;.':' 
myocardial [jerfusion when these were acco::.pai -<i 
disturbances of the epicardial !.-!ectrocardiogram 
findings re(|uire fur ther exp-;-r::nenis that i jk -.• " 
cellular mechanisms o f ' ^ ' " T l uptake and may be :r;|:- • 
t an t in the interpretation of cardiac .scintigrairis b;- '.s'.r.-. 
this tracer in man. 
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_ [ ' ^ F ] - L and DL-FLUOROAKYL AMINO ACIDS. PRESENT STATUS. 
R.W. Goulding and J.C.Clark. 
4^RC C y c l o t r o n U n i t , Hammer,smith H o s p i t a l , Ducane Road, London V,'12 OHS, UK. 
Alt h o u g h these compounds have been a v a i l a b l e s i n c e 1970 {1—h) they have 
not y e t given s u c c e s s f u l r e s u l t s as pancreas imaging agents i n man. On t;"e 
o t h e r hand they have not been d e f i n i t e l y r e j e c t e d . The m a t e r i a l s p r e v i o u s l y 
prepared c o u l d liave c o n t a i n e d l a b e l l e d i m p u r i t i e s and were o r i g i n a l l y mace 
a t r e l a t i v e l y low s p e c i f i c r a d i o a c t i v i t i e s . Also the comments o f r e f (5) 
c o n c e r n i n g t h e i n s t a b i l i t y o f d e r i v i t i v e s o f DOPA should be noted. The 
r e c e n t v i s u a l i s a t i o n o f the pancreas i n man u s i n g [ " C j - v a l i n e ( 6 ) and the 
o p p o r t u n i t i e s opened up by the p -camera encourage f u r t h e r work w i t h the 
'^F-amino a c i d s . We c o n s i d e r t h a t as many as p o s s i b l e o f "che amino a c i d s 
should be a v a i l a b l e f o r the user. 
A r e - e v a l u a t i o n o f the p r e p a r a t i o n and use o f these compounds has been 
tmdertaken. The key i n t e r m e d i a t e s were the p r o t e c t e d lormamido, I l l ( a - d ) 
o r acetamido, I l l C e - j ) , malonic e s t e r s ( 6 ) . The p r o t e c t e d ^ ^ F - l a b e l l e d 
compounds ( I I I ) were o b t a i n e d by thermal decompositioi". o f the correspond"l:..; 
diazonium f l u o r o b o r a t e s ( I I ) . Because o f chemical and p:!7sical d i i f e r e n c e j 
between the v a r i o u s compounds ( I I I ) a v a r i e t y o f methods o f decompositio.-. 
and subsequent d e - p r o t e c t i o n ( 7 ) vjere needed. 
' ^ F - l a b e l l i n p ; o f the diazonium f l u o r o b o r a t e s ( I ) : 
R N ; B F : RN,^  B'V: - ^ f ^ ^ ^ R'«F + N , . 8 ^ 3 
I ( a - j ) neon i K a - j ) "0-200 n K ^ . j )^ 359/„ 
The a r y l diazoniuiri f l u o r o b o r a t e s ( I ) were l a b e l l e d 
Imps/Tar 
-65% 
. .^0.^ a .a .ucj .a .eu uy :-.e"cerogeneous 
exchange between '*F/neon(80 p s i ) and the o r g a n i c s o l i d (I3mg) d i s p e r s e d i : " . 
a f i l t e r element, a 3.5cm diameter GFD d i s c ( F i g 1) i n the r e c i r c u l a t o r y 
t a r g e t system(7,8). The e f f e c t o f a d d i t i v e s i n the t a r g e t gas was i n v e s t i -
gated. With pure neon, or neon c o n t a i n i n g oxygen (15%) or n i t r o g e n (15%), 
about hfdd o f the f l u o r i n e - l 8 produced was trapped on the f i l t e r d i s c . Whe:'. 
neon c o n t a i n i n g hydrogen (15%) was used, v i r t u a l l y a l l fne f l u o r i n e - l 8 
produced remained on t h e g l a s s w a l l s ( 8 ) o f the t a r g e t vessel. These r e s u l t s 
suggest t h a t the species NO'% o r 02'*F may be the c a r r i e r s o f f l u o r i n e - l 8 
between the t a r g e t v e s s e l and the f i l t e r element, but t h i s idea can be 
c r i t i c i s e d . 
18 
Decomposition o f the F-diazonium f l u o r o b o r a t e s ( I I ) : 
A v a r i e t y o f methods were i n v e s t i g a t e d f o r t h i s stage. Speed ajid ease o f 
p u r i f i c a t i o n and o f h a n d l i n g o f the pr o d u c t ( I I I ) were d e s i r e d . I t was not 
p o s s i b l e t o use a s i n g l e method f o r a l l cases ( a - j ) . Decomposition by 
h e a t i n g alone ("dry") had the advantage t h a t the crude product c o u l d be 
taken up i n a v o l a t i l e s o l v e n t f o r subsequent p u r i f i c a t i o n by p r e p a r a t i v e 
TLC, LC o r GLC. The p r e v i o u s l y d e s c r i b e d i n e r t s o l v e n t ( t e t r a l i n ) decorapos-
i t i o n ( 9 ) s u f f e r e d from s e v e r a l d isadvantages and so was not used. 
When the f l u o r o - e s t e r was s u f f i c i e n t l y v o l a t i l e , I I I ( a — d , i , j ) i t was 
f e a s i b l e t o p u r i f y ( I I I ) by vacuum s u b l i m a t i o n or GLC. Vacuum s u b l i m a t i o n 
d i d n o t prove t o be u s e f u l because the s u b l i m a t e s t i l l c o ntained many 
i m p u r i t i e s . On the o t h e r hand GLC u s i n g a 5 f t X - l i n column o f 3% OVl o r QFl 
a t 200°C gave a pure p r o d u c t ( F i g 2) t h a t was r e a d i l y t r a pped a t the 
chromatograph o u t l e t . I t was even p o s s i b l e t o i n j e c t the '^F-diazonium f l u o r o 
146 Symposium Abstracts 
- b o r a t e i n acetone d i r e c t l y i n t o the i n j e c t o r o f the clii'omatograph ( g l a s s 
column e s s e n t i a l ) . 
FLUORO-ESTERS I l K a - i ) . 
.COOEt 
NHCOR 
COOEt 1 — OH. 
.COOEt 
NHCOR 
COOEt (xo); 
COOEt 
NHCOMe 
COOEt 
l l l ( a - d ) 
N' 
X IKCe- -h) I lK: 
( a ) p - F ( b ) r a - r , R 
( c ) p - F (d)m-F, R 
P r o t e c t e d forms o f 
f l u o r o p h e n y l a l a n i n e s 
V(a p-F, b m-F). 
Ro u t i n e Procedure 
H . 
Me. 
(e)5-F ( f ) 6 - F , R = H . 
(g)5-F (h)6-F, R = Me. 
X = Ac. P r o t e c t e d forms 
o f f l u o r o t r y p t o p h a n s 
V(e 5-F, f 6-F). 
t-Me 
3 
( i ) 3 - F , X 
(3)5-F, X 
Pr o t e c t e d forms o f 
f l u o r o - t y r o s i n e V ( i ) , 
fluoro-DOPA V ( j ) . 
(n = 1) 
The dry decomposition was alv;ays used. The GFD-disc 
w i t h "'F-diazonium f l u o r o b o r a t e was plac e d between two s t a i n l e s s s t e e l d i s c s 
(5 X 1cm) p r e h e a t e d t o 150°C (170°C f o r i n d o l e s ) and l e f t l o r 7!r,in. The 
crude p r o d u c t s I I l ( e — h ) were e x t r a c t e d i n t o c h l o r o f o r m and p u r i f i e d by 
p r e p a r a t i v e TLC on a 5 XlOcm " a n a l y t i c a l " s i l i c a g e l p l a t e e l i ; t e c w i t h 
c h l o r o f o r m , e t h y l a c e t a t e (5- 1 - v o l s ) , Rp-^O.? ( F i g jO. The crude products 
I I I ( a — d , i , j ) were p u r i f i e d by p r e p a r a t i v e GIC as des c r i b e d above, t p c—10 
min ( F i g 2). 
H y d r o l y s i s o f ^ ^F - F l u o r o - e s t e r s ( I I I ) i n c l u d i n g enzjTne r e s o l u t i o n . 
HjOVOH A c y l - e s t e r 
i n ( a - j ) 
Acylamino-acid 
I f f ( a - j ) 
H 3 O * 
enzyme 
Free 
y(a,b, 
y(a,b. 
•-~ir.o-acia 
;,:,i,j...DL) 
:.f...L) 
The a c e t y l e s t e r s I I l ( c , d , g , h ) gave the J ^ - a c e t y l - D L - a j r d n o a c i d s ( I I ' ) by .rrtild 
h y d r o l y s i s (Method 1. I n g,h X^K a l s o ) . These i n t e r m e d i a t e s were s t e r e o -
s e l e c t i v e l y c o n v e r t e d t o the f r e e L-amino a c i d s V(a,b,e,f) using an ami.no 
a c y l a s e ex A s p e r g i l l u s O r izae, K i n d l y s u p p l i e d by Dr I . Chibata (Method 2) 
(9,10). Cleavage o f t h e a c e t y l e s t e r s I I I ( c , d , i , 3 ) w i t h ii-7% F3r gave the DL-
amino a c i d s y ( a , b , i , j ) *(Method 3). Compounds I l l ( a , b , e , f ) c o n t a i n i n g the 
l a b i l e F l - f o r m y l group are r e p o r t e d t o g i v e t h e DL-amino a c i d s d i r e c t l y by 
Method 1 (2) b u t a n a l y s i s o f the p r o d u c t s on t h e B i o g e l column i n d i c a t e d 
t h a t t h i s h y d r o l y s i s was incomplete, even n e g l i g a b l e i n 30min. [ ' ( i , 3 X^H). 
Method 1 d i d not work f o r compounds I I I ( i , 3 ) because o f the great s t a b i l i t y 
o f t h e 0-methyl g r o u p ( s ) . A more l a b i l e p r o t e c t i n g group i s r e q u i r e d . The 
0 - i s o p r o p y l e t h e r s would be s u i t a b l e b ut the s y n t h e t i c probleir.s are g r e a t . 
R o u t i n e Procedure : Method 1. The f l u o r o - e s t e r I I l ( a , b , e , f ) was r e f l u x e d 
w i t h 0.3N-NaOH C+OOiil) f o r 20min, and a f t e r t h e a d d i t i o n o f 2i\'-HCl (75^il) 
r e f l u x e d a f u r t h e r 15min. The f i n a l s o l u t i o n was a d j u s t e d t o pH 7-
Method 2. The enzyme i^vag, as s u p p l i e d ) was made up i n water (200)il) w i t h 
sodium a c e t a t e (7mg) and a c t i v a t e d by t h e a d d i t i o n o f Co''''^ (50ul o f O.OOOIK 
CoCl^). The enzyme s o l u t i o n was in c u b a t e d w i t h t h e a c y l amino a c i d s o l u t i o n 
f o r 20min. The L-amino a c i d was i s o l a t e d as below. 
Method 3.The f l u o r o - e s t e r I I I ( c , d , i , j ) was r e f l u x e d w i t h 't7^-HBr (200ul) f o r 
h^min. The r e s u l t i n g s o l u t i o n was d i l u t e d 5 - f o l d w i t h water and passed 
t h r o u g h a 7 X 1cm column o f A m b e r l i t e IR'+B(OH~). 
P u r i f i c a t i o n . The f i n a l s o l u t i o n (0.5—1.0ml) was passed through a 30 X 1 
(10 X 1 f o r t r y p t o p h a n ) cm. column o f B i o g e l P2 (200-^lOOmesh) e l u t e d w i t h 
d e - i o n i s e d water a t 0.3ml/min (amino a c i d tR-^30min, F i g ^ t ) . 
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FIGURES 
F i g 1 : '^F-exchange v e s s e l used i n 
r e c i r c u l a t o r y neon t a r g e t system. 
(Ref 8 - complete system). 
F i g 2 : P u r i f i c a t i o n o f f l u o r o - e s t e r 
I l l ( j ) by p r e p a r a t i v e GK;. (See t e x t ) . 
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INCORPORATION OF FLUORINE-18 IN PERHALO COMPOUNDS USING THE 20l.'e(d .a ) l Q r 
REACTION 
A.J. Palmer, J.C. C l a r k , P.L. Horlock and P.D. Buckingham. 
HRC C y c l o t r o n U n i t , Hammersmith H o s p i t a l , Ducane Road, London W12 OHS, UK. 
The r e c o i l c h e m i s t r y o f f l u o r i n e - I 8 and simple o r g a n i c s u b s t r a t e s has been 
e x t e n s i v e l y s t u d i e d , mainly a t low r a d i a t i o n dose u s i n g the l^ F ( ( ^ , n ) l S F 
and •'-'^F(n, 2n) l ^ F r e a c t i o n s ( 1 ) . A v a r i e t y o f gaseous i n o r g a n i c 
f l u o r i n a t i n p agents have been l a b e l l e d w i t h h i g h l e v e l s o f r a d i o a c t i v i t y 
u s i n g the 20),|g(£i^ (j)18p r e a c t i o n , v.'here due t o the h i g h r a d i a t i o n doses 
encountered t h e e f f e c t s o f r a d i a t i o n chemical r e a c t i o n s would be expected 
t o predominate ( 2 - 5 ) . Sulphur h e x a f l u o r i d e and s e v e r a l halomethanes ( I - V ) 
have now been l a b e l l e d i n h i g h a c t i v i t i e s by the bombardment o f 0.3-2% 
m i x t u r e s o f an a p p r o p r i a t e s u b s t r a t e i n neon w i t h i4MeV deuterons. This 
work was undertaken i n o r d e r t o make some o f the compounds a v a i l a b l e f o r 
pharmacodynamic s t u d i e s . I n a d d i t i o n s u l p h u r h e x a f l u o r i d e - l ^ F i s o f 
i n t e r e s t f o r t h e study o f r e g i o n a l pulmonary d i f f u s i o n . 
The t a r g e t was a c y l i n d r i c a l aluminium v e s s e l U5 cm long by 6 cm diameter 
w i t h a 4 X 2 cm beam e n t r y window o f 0.050 mm s t a i n l e s s s t e e l . A 
c y l i n d r i c a l copper l i n e r e l e c t r o p l a t e d i n t e r n a l l y w i t h s i l v e r t o a t h i c k -
ness o f 0.1 mm was i n t r o d u c e d v i a the detachable b a c k p l a t e . A f t e r evacua-
t i o n t o a pressure o f l O " ^ mm Hg the t a r g e t was f i l l e d w i t h CP. grade neon 
and the s u b s t r a t e (0.5 - 4 m moles) t o a pressure o f 3.5 Kgf.cm"^. 
F o l l o w i n g i r r a d i a t i o n t h e gaseous p r o d u c t s were analysed by r a d i o - g a s 
chromatography on a 1.55 m x 5.25 mm column o f 80-100 mesh Porapak-Q u s i n g 
a c a r r i e r gas f l o w r a t e o f 20 ml m i n ~ l . The gaseous c o n t e n t s o f the 
t a r g e t were vented t o a t r a p a t -196° a t a f l o v ; r a t e o f 50-100 ~:1 min"! 
and the e x t r a c t e d r a d i o a c t i v i t y measured. 
The r e s u l t s o b t a i n e d f o r s u l p h u r h e x a f l u o r i d e and compounds i n the s e r i e s 
CCl4_j^ F^ (n = 1 t o 4) as s u b s t r a t e s are g i v e n i n Table 1. The r a d i o -
chemical y i e l d s were c a l c u l a t e d u s i n g p r e v i o u s l y r e p o r t e d data f o r the 
2 % e ( d , a ) l 8 F r e a c t i o n (.6,7), With s u l p h u r h e x a f l u o r i d e l a b e l l i n g o f the 
s u b s t r a t e was t h e predominant r e a c t i o n and t h e two major gaseous i m p u r i t i e s 
were s u l p h u r y l f l u o r i d e - ^ ^ F and t h i o n y l f l u o r i d e - l ^ F ( i d e n t i f i e d by g l c -
mass s p e c t r o m e t r y ) a r i s i n g from the presence o f t r a c e s o f oxygen i n CP. 
neon. A c r y o g e n i c p u r i f i c a t i o n system f o r s u l p h u r h e x a f l u o r i d e - ^ ^ F has 
been developed. 
S i m i l a r l y , l a b e l l i n g o f the s u b s t r a t e i n h i g h a c t i v i t y was a l s o observed i n 
t h e case o f t e t r a f l u o r o m e t h a n e ( V ) . I n t h i s case t r a c e s o f l ^ F - l a b e l l e d 
h e x a f l u o r o ethane and o c t a f l u o r o p r o p a n e were d e t e c t e d (by glc-mass 
s p e c t r o m e t r y ) t o g e t h e r w i t h o t h e r u n i d e n t i f i e d i m p a r i t i e s . With 
t e t r a c h l o r o m e t h a n e ( I ) and t h e c h l o r o f l u o r o m e t h a n e s ( I I , I I I , IV) P f o r 
C l and f o r F replacement r e a c t i o n s were observed, p r o d u c t s o t h e r than 
t h e major one being o t h e r c h l o r o f l u o r o m e t h a n e s w i t h minor amounts o f 
u n i d e n t i f i e d m a t e r i a l . Mass peaks on a n a l y t i c a l g l c were observed f o r a l l 
t h e i d e n t i f i e d l a b e l l e d p r o d u c t s . The s i l v e r p l a t e d t a r g e t l i n e r was 
e s s e n t i a l i n o r d e r t o o b t a i n t h e p r o d u c t s i n t h e y i e l d s r e p o r t e d h e r e , 
i n d i c a t i n g t h a t chemical processes a t the l i n e r s u r f a c e are i m p o r t a n t . 
Bombardments w i t h t h e s e s u b s t r a t e s r e s u l t i n chemical d e p o s i t s on t h e 
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Of.^O.'I^stionaires sent out to Destitutes known to be operating accelerators, replys were received relating 
rJl "^'^tY^dual accelerators a l l of whidi had a program for radionucUde production. The naj o r i t y of the non-
ccomercially operated accelerators were seen to be concentrating t h e i r e f f o r t s on producing radionuclides which' 
were not fenerally available from the 9 coranercially operated accelerators. Notable exceptions however were 
™ :!; • ^  °^ problesns encountered i n the use of these accelerators for large scale radionucUde production w i l l be discussed. 
[Accelerator, radionuclide production] 
Introduction 
There are at least 55 accelerators engaged i n 
radionuclide production at the present time.' Their 
energies range from the 6 MeV deuterons of the A l l i s -
Chalmers classical cyclotrons i n St. Louis and Boston 
to the 800 MeV protons of the linear accelerator at 
Los AlamDs. However, the majority (19) of these accel-
erators are isochronous cyclotrons with a proton energy 
between 20 and 30 MeV. Table 2 gives a more detailed 
breakdown of the d i s t r i b u t i o n . In order to get an up 
to date picture o f the extent of radionuclide production 
progranmes of these accelerators, two of my colleagues 
r e c s i t l y sent out a questional re to more than 60 i n s t i -
tutes VxioMi to be operating accelerators. 48 replies 
were received r e l a t i n g to the 55 accelerators mentioned 
above. Ihfortunately, no information was received from 
E. Europe. S. Africa, or S. America. The results are 
sunnarized i n Table 1. Part A comprises the "non-
comnercial" accelerators (40 cyclotrons and 2 Linacs 
and l i s t s f o r each of those radionuclides (a) which are 
currently being produced at least once a wed^, (b) those 
which are produced less frequently, and (c) those which 
are expected to be i n production by 1980. Part B of 
the table l i s t s the world's 9 cannercially operated 
cyclotrons and t h e i r products. 
In order to discuss seme aspects of these accelera-
tor operations that my be of interest the present gath-
ering, i t i s useful to divide them i n t o roughly four 
energy ranges namely 100-800 ^ teV. 50-100 MeV, 20-50 Mev, 
(including the large group at 20-30 MeV), and those up 
to 20 MeV proton energies. I w i l l avoid any reference 
to cost effectiveness and d j e l l only on some of the 
p r a c t i c a l i t i e s of radionuclide production with each 
group, where possible mentioning some unique aspects. 
Accelerators With Proton Energies of 100-800 MeV 
Five accelerators with a large scale radionuclide 
production potential exist i n the Western Ubrld. Tuo 
are linear accelerators, the 200 IfeV i n j e c t o r f or Che 
alternating gradient synchrotron at Brookhaven^ and 
Che 800 MeV giant at the Los Alamos meson physics 
f a c i l i t y . The remaining 3 are cyclotrons and include 
the very large isochronous cyclotron at Vancouver^ at 
500 MeV, and two separated sector cyclotrons at Bloom-
ington, Indiana' (20CMeV) and Vi l l i g e n , Switzerland'. 
(590 MeV). A l l these accelerators r e l y heavily on spal-
l a t i o n reactions f o r radionuclide production. This i s 
a f i e l d which i s probably much more familiar to some of 
our participants Chan myself so I hope my interpretation 
of Che problems stand up to t h e i r c r i t i c i s m . The term 
spallation seems to cover a coo^jlex series of nuclear 
events when incident nucleons with energies i n excess of 
100 MeV interact with a target, including knock-on cas-
cade, evaporation, fragmencation and for s u f f i c i e n t l y 
higji Z materials, f i s s i o n processes. In addition, 
secondary nuclear reactions can occur between emitted 
particles and other target nuclei. Thus one can expect 
the formation, to a greater or lesser extent, of every 
elanent from Z + 2 or 3 above the target to E =1. Ac 
800 MeV three d i s t i n c t regions can be seen i f the for -
mation cross sections are plotted against mass nurber. 
In Che case of a bisnuth target a peak A = 180 to 200 
can be i d e n t i f i e d due to spallation products near the 
Carget mass, a fi s s i o n product peak betveai A = 60 and 
140. and a fragmentation continuum below A = 40. 
To the radionuclide production chanist this can 
only mean formidable radiochemical recovery and decon-
Caminacion problems. However, ic misc be f a i r l y s e l f -
evidaric chac several radionuclides of that Z w i l l be 
present i n the product. For example."Sr (c^25 day) 
i s of interest i n the medical f i e l d as a source of 
radiogenic °'Rb ( t % 1.25 min). a B emiccer of pocential 
value i n emission tomographic studies of heart and ki d -
ney function. The most effective means of production 
i s v i a spallation of a moly bdenun target using 800 MeV 
protons at LAMPF.° A l l samples of "^Sr however, contain 
sig n i f i c a n t amornts of °*Sr ( t % = 65d) so chat great 
care must be exercised when designing and operating a 
radionuclide generator'''"'" for the in vivo use of 
'^ Rb as a strontium leakage could result in unacceptable 
'*Sr burdens i n Che bone. Fortunately, systems have 
been perfected for t h i s use so that h i ^ levels of "Pb 
can be available due to this fortunate radiogaiic rela-
tionship. 
The production of high p u r i t y ' ^ ' l ( t % = 13h) and 
" ' T l ( t % = 73h) are further exain)les of radiogenic 
purificacion and w i l l be refered Co below. 
Acceleracors With Procon Ehergies of 50-100 MeV 
There are around 10 acceleracors, a l l cyclocrons. 
i n Chis group and alirosc a l l o r i g i n a l l y dedicaced to 
nuclear physics work. However, chey have now turned 
some of cheir accentions Co Che produccion of medically 
useful radionuclides and are recovering some of cheir 
operacing coses by doing so. 
' ^ ' I seons to be by far the most popular radio-
nuclide to produce, and several ingenious and highly 
effective target systems have been devised and perfect-
ed t o produce i t v i a the "'I(p.5n)'^'Xe t % ^ 2.1h - " l 
reaction. The relevant nuclear data have recentTy been 
reviewed by STOCKLIN AND QAIM. The various chemical 
: t e c Nucf ar Cross Sections for Technology, J L Fowler and CH Johnson Eds 
National Bureau of Standards (US) Special Publication 594 (1980) 458-
463 
forms of iodine used include CHjIz,"' mixtures 
thereof,'^ and N a l . " In addition the use of l i q u i d 
Cs and the "'Cs(p,2p9n)'Xe reaction has been pro-
posed when protons of variable energy are being dumped!'' 
At the Crocker cyclotron, (UC Davis) an elegant target 
system centred around a stainless steel vessel con-
tai n i n g mDlten Nal is maintained at 650°C by a combin-
a t i o n of beam pcs<;er and a controlled helium flow. 
The '^ 'Xe is removed from the target by the helium and 
transported to a remote laboratory where i t is recover-
ed and p u r i f i e d cryogenically prior to allowing i t s 
decay to ' ^ ' l . Several inportant factors such as t a r -
get thickness and Nal density during i r r a d i a t i o n had 
to be carefully studied before the routine target was 
perfected. In the use of methylene iodide, O l j l a , at 
at the variable energy cyclotron at Harwell, U.K., 
d i f f e r e n t problems arose. Here the aim was to c i r -
culate t±ie organic l i q u i d through a t i t a n i u n target 
c e l l and recover the Xe using a gas/liquid scrubber. 
Early experience shewed t±iat extensive r a d i o l y t i c 
polymerisation of the CH2I2 to a thick o i l occured at 
high beam currents making i t impossible to puro i t 
around the c i r c u i t . Hovever, the application of a 
classical radiation chemist's radical scavenger, mol-
ecular iodine I2, not only solved the polymerisation 
problem but also increased the iodine content of the 
target mixture. Ihe target systsn has now been in 
routine use for about 3 years satisfying SCHE of the 
demand f o r ' I i n the U.K. 
Accelerators With Proton Energies of 20-50 bfeV 
This gro-jp includes a l l the ccnmercially operated 
cyclotrons and perhaps mentioi of seme of the problens 
encountered here vrould be of interest. The major log-
i s t i c problan i s that the accelerator produced pro-
duct nust be available on a routine scheduled basis. 
Thus a conmercial operator would expect his accelerator 
to be dedicated to radionuclide production and be ready 
for action at a l l times. He may even have more than 
one accelerator! He w i l l also be keen to make the very 
best use of the beam available from his particular 
accelerator. 
Vhen a charged particle beam interacts with a t a r -
get the principle method of energy loss i s by ionisa-
t i o n ; only about one particle i n a thousand produce 
a nuclear reaction and Che rest of the energy appears 
as heat and here l i e s the najor problem for the high 
current target designer. The internal beam of the 
cyclotron, where the higjiest intensities are usually 
available, has a radial d i s t r i b u t i o n that i s approx-
i m t e l y triangular with the high i n t m s i t y towards the 
centre of the machine. I f a target plate is placed at 
a tangent to the beam the resultant beam pattern w i l l 
be spread over a larger area. I f the plate is then 
either angled to the tangent or bent to a radius 
s l i ^ t l y larger than the beam radius a s t i l l larger 
spread can be obtained. The msre the beam can be 
spread out the lower the power density (Wcm"'). The 
power density i n the unspread beam of a t y p i c a l pro-
duction cyclotron compares well with those found i n the 
arc welding f i e l d , being t y p i c a l l y 15-50KWcm"2; thermal 
damage to targets i s therefore an ever present hazard. 
The beam dimensions of the f l a t f i e l d or classical 
cyclotron, few of whidi renain i n the radionuclide 
production f i e l d , have internal beams of between ISnm 
X 5 ™ (Hannersmith 4 5 " ) " and 70™ X 6nni (ORNL 86").^° 
A t y p i c a l isochronous cyclotron might have a beam of 
^aas X 1.5™. ^' Thus beam pcuer d i n s i t i e s i n excess 
of 50 KWon'^are easily achieved. Ihe peak power den-
s i t y that can be handled by normal water cooling i s 
about 3KWan"^  so that i t can be seen that i f the f u l l 
output potential of the more recently introduced 
ccnnercial isochronous cyclotron i s to be achieved, 
beam spreading techniques are of prime importance. 
One manufacturer offers a beam interactive spreader 
that uses RF driven deflector plates above and below 
the c i r c u l a t i n g beam close to the f i n a l r a d i u s I n 
other cases the users have-found that rotating^''"' or 
o s c i l l a t i n g the target has helped provide the necessary 
power density reduction. Ihe use of thin targets in 
th i s f i e l d i s not usually practicable. However, the 
use of enriched isotopic targets can often give rise to 
a higher i n t r i n s i c y i e l d together with a reduced in t e r -
fering impurity. The producticii of ^"'Tl with protons 
of up to 28 MeV being a typical exanple. ^  ^  Of course 
the use of highly enriched target materials is expen-
sive, so high efficiency recovery procedures have to be 
devised. Often radionuclides of the target material 
are also made making target recovery and refabrication 
more d i f f i c u l t . 
Target fabrication includes a l l the normal metal-
l u r g i c a l techniques. A typical target would consist of 
copper or other h i ^ thermal conductivity backing of the 
shape nost suited to the beam spreading c r i t e r i a out-
lined above, with a t h i n layer (typically 0.050 - O.hmi) 
of the desired target material deposited and securely 
fixed i n a thermal sense onto i t s surface. Techinques 
such as electrodeposition, flame spraying, chemical 
vapour deposition, vacurm evaporation, soldering, braz-
ing, casting andspot welding finding application, dep-
ending on the properties of the specific target material. 
Many of the non conmproial accelerators in this 
group do not have provision for internal targets and 
re l y on the extracted or external beam for radionuclide 
production. Although somewhat less e f f i c i e n t the ex-
ternal arrangement does allow nuch more scope for target 
thichness selection and thus the opportmity to optimi.se 
a p a r t i c u l a r nuclear reaction to minimize impurity. The 
direc t production of ' ^ ' l via the '^'T:e(p,2n)'"I re-
action i s a good exanple. Several groups have applied 
themselves to t h i s problen and have fomd that by using 
a t h i n highly enriched (927.) '^ 'Te target and carefully 
selected proton energy the ' ^ " " I inpurity due to 
'^'T:e(p,n)'^''I can be suppressed to beloi>' IX at end 
of boiibarcfaent ( E O B ) . H o w e v e r , as the half 
live s of ' ^ ^ I and ' ^ ' " I are 13.3h and 4.3d respectively 
the level increases quite rapidly with time. 
Cne further advantage of the external beam is that 
gaseous and l i q u i d targets can be irradiated. These are 
usually considered impracticable for internal beam i r -
r a d i ation due to the severe space restrictions imposed 
i n the t y p i c a l modem cyclotron's accelerating region. 
.; The production of "Rb ( t ^ 4.5h) has achieved com-
mercial status using an external beam and is used in 
the i n c r e a s i n g l y p opular "Ki™ ( t ^ l 3 s ) radio-
nuclide gaierator. Krypton-81m has found widespread use 
i n nuclear medicine organ flow studies. Once again 
due to the radiogenic nature of the desired product, 
"Kr™, the presence of other Rb radionuclides in the 
generator i s i n practice of no importance. Thus the 
most favourable route to large scale production of "Rb 
is v i a the Kr(p,xn)°'Rb r e a c t i o n s . " ' ^ ' " ' Protons 
of 20 MeV upwards have been found Co be useful here, 
however the use of enriched "I'x is essential for the 
lower ffiergies.' ^ Several approaches have been described 
f o r the recovery of the Rb from the target walls after 
i r r a d i a t i o n but the most popular seems Co be the use 
of a rotating target l i n e r which can conveniaitly be 
washed with water. " Ihe Rb is then s i m l y bound to a 
small c o l i i m of cation exchanger. "Kr^may be re-
covered continously during c l i n i c a l use in the gas phase, 
for lung v e n t i l a t i o n assessment, by passing humidified 
a i r through the colunn or alternatively, in a solution 
suitable for infusion for blood flow investigations, by 
passing isotonic dextrose through the co l i r a i . ^ ' ' ' " 
Accelerators With Proton Energies Up To 20 MeV 
Here external beams and gas targets seem Co be che 
order of day and Che mosc ooononly produced radionuclid-
es are ' 'N (c%= 10 min). ''C (t%=20 min). '^ 0 (t%= 2 
min) and ' 'F (t%= 110 rain) . They are almost invariably 
descined for incorporacion inco biomolecules or varying 
conplexicy for use i n anission ccraographic studies, 
description of which is beyond the scope of chis pres-
entation. However, there are several features of Che 
produccion of these radionuclides i n a chemical form 
d i r e c t l y applicable to these syntheses that may be of 
interest. N may readily be produced as "NDs"- by t i e 
"0 (p,o)'^N reaction using a water target,'" a simple 
reduction reaction yielding high specific a c t i v i t y 
"NH3. In recent studies "C produced v i a the ''''N 
(p,a)"C reactions has been incorporated into brain 
receptor selective drugs." Here the najor aim i s to 
exclude ' ^C from the target system so that the synthesis 
should result i n very high specific a c t i v i t y biomole-
cules t y p i c a l l y Q.5-lCi/pM or better. This i s quite a 
challenging problem and has led workers into designing 
gas targets to standards usually only found i n the u l t r a 
higb vacuum f i e l d . The target gas has also received 
careful attention to raiiove traces of CO2 and hydro-
carbons. One group in the f i e l d has observed an i n -
creasing reluctance of che "QDj co escape from Che 
carget possibly dte to selective adsorption sices 
trapping the desired product rather than being satur-
ated w i t h the undesired '^COj. This i s probably a gross 
o v e r - s i n p l i f i c a t i o n of events and much work s t i l l seems 
to be necessary before an approach to the theoretical 
specific a c t i v i t y of "C i s achieved. 
In the case of ''O specific a c t i v i t y has not yet 
received much attention but the chanical form i n which 
may be recovered, after the ''•N(d,n)'*0 reaction 
i n Cargec gsses of differenc coinposicions. has been 
s u p e r f i c i a l l y studied.'S'^' The '*0 atom produced here 
i s a highly reactive species and has been seen to react 
with a variecy of subscraces including che Carget gas 
N2. Radiacion chemical effects can also be seen which 
a l t e r the i n i t i a l produce conposicion as evidenced by 
scudies ac differenc beam currencs (beam d i s t r i b u t i o n 
raraining sensibly constant). 
Turning to "F we f i n d chat both the r e a c t i v i t y of 
the nucleogenic atom and specific a c t i v i t y are the 
problaos confronting the cargec chemise. I f recovery 
of ' °F as a malecular Fz i s desired for some synthetic 
purpose, the addition of carrier F; to the Ne Cargec 
gas (^ °Ne (d,a)"F) i s essential as i s careful attention 
Co carget vessel oonscruccion macerials and cechniques' ° 
I f recovery as H"F i s desired che addition of Hz to the 
Ne target gas can under favourable circunstances y i e l d 
a high recovery of '°F as HF without the addition of 
carrier''' which i s of value as i n the "C case f o r the 
synthesis of receptors specific radiolabelled drugs. 
The Place Of Nuclear Data In This Field 
I t must be ob-zious that f o r the generation of any 
radionuclide adequate nuclear data for the prediction 
of yields of both the desired product and any impurities 
are essential. Most of the accelerator groups engaged 
i n t h i s f i e l d have when necessary attempted an exten-
sion or improvement of the existing cross section data 
to s u i t t h e i r requiranents. Often, however, i t i s not 
the nuclear physics that i s the l i m i t i n g factor. 
Problems of designing a target that w i l l work r e l i a b l y 
at the desired beam intensity and produce a recoverable 
product often sean to make the fine d e t a i l sometimes 
quoted i n nuclear data of l i t t l e practical consequence. 
Perhaps to put this into better perspective consider 
a gas N2 target f o r the production of "C. A calcula-
ted y i e l d from che excellent cross section data a v a i l -
able i s seen i n practice only to hold i f carrier ''C 
is present and irradiations are carried out at low beam 
currents. As the current is increased the ' 'C product-
iocL.'jersus beam current becomes grossly non-linear due 
to a variety of effects which are as yet l i t t l e under-
stood ,>'""' 
Factors involved may be simply thennal or induced 
plasnH effects in the beam path boch reducing che 
number of cargec nuclei in che beam path and also per-
haps increasing the mean free path of the product 
nucleus, enabling i t to react wich che cargec walls 
(e.g. "F and h i ^ specific a c t i v i t y "C). Rjrther 
study i s going to be essential before problans such as 
these are to be resolved. 
Hcwever, Che produccion of radionuclides wich an 
acceleracor is a challenging incerdisciplinary and 
mill c i d i s c i p l i n a r y f i e l d and the contributions of the 
Markers i n the cross section f i e l d are gra t e f u l l y 
ackncwledged. 
REFERENCES 
1. D.J. Silvster and S.L. Vacers in Proceedings of che 
Second InCernacional Synposium on Radiophanmceuti-
cals. March 19-22, 1979, Seaccle. Washington USA. 
To be published by The Society of Nuclear Medicine. 
N.Y. 
2. L.G. Stang, J. Labelled Qipds. Radiopharm. 
13, 240. (1977). 
3. H.A. O'Brien (Jr.) P.M. Grant and A.E. Ogard .Prog. 
Nucl. bfed. 4 , 93-99. (1978) 
4. I b i d 16-22 
5. B.D. Pate i b i d 61-62. 
6. D.L. Friesel and W. Smith i b i d 63-71. 
7. E. loepfe, I . Huzar and F. Hegedeus. J.Labelled 
Cmpds. Radiophaim. 13. 241, (1977). 
8. P.M. Grant, M. Kahn and H.A. O'Brien J. Inorg. Nuci. 
Chan. 37, 413-417, (1975) 
9. P.M. Grant, B.R. Erdal and H.A. O'Brien. J.Nucl. >tec. 
16, 300-304, (1975) 
10. Y.Yano, P. Chu and T.F. Buriinger J. Nucl. Med. 
18, 46-50. (1977). 
11. Y.Yano, T.F. Budinger. G. Chiang et. a l . J. Nucl. 
Med.. 20, 961-966, (1979). 
12. G. Stocklin and S.M. Qaim Proceedings of Intema-
onal Conference on Neutron Physics and Nuclear Ceta 
f o r Reactors and other applied purposes. Harwell 
U.K. 25-29 Sept. 1978. Publ. by Her hfajesties Sta-
tionary Office ISBN 92-64-01870-0 
13. J. Godart, J.L. Barat, A. Menthe et. a l . Inc. J. 
Appl. Rad. Isotopes 28, 967-969 (1977). 
14. A. Schimuel, F.M. Kaspersen and L. Lindner. I n t . J. 
Appl. Rad. Isotopes 30, 63-64, (1979) 
15a)J.G. Cuningjiame. B. Morris. A.L.Nichols et. a l . I n t . 
J. Appl. Rad. Isotopes 27. 597-603, (1976). 
b)J.G. Cuninghane. J.I.S. H i l l , A.L. Nichols ec. a l . 
The Produccion of Iodine-123 on che Harwell \'ariabie 
Energy Cyclotron: AERE Reporc 9087, (1978) 
16.M.C. Lagunas-Solar. J.A. Jungerman. N.F Peek and C. 
Bennet. J. Labelled. Cpds. Radiopharm. 16. 224-225. 
(1979) 
17a). J.W. Blue, R. Leonard, S.Jha, and V.J. Sodd 
Prog. Nucl. Med. 4. 53-60. (1978) 
b). J.W. Blue, D.L.Friesel. D.C. U u and J. Labelled 
Ctapds. Radiopharm. 16. 101-102 (1979). 
18. M.C. Lagunas-Solar Prog.Nucl. Med. 4. 118-128. (1975) 
19. D.D. Vonberg, L.C. Baker. P.D. Buckin^iam ec.al. 
Proceedings of a Conference on The Uses of Cyclocrtns 
i n Chemistry Metallurgy and Biology do. 258-269. 
Publ. Butterworrhs (1970) ISBN 0408 70029 7 
20. J. A. Martin, R.S. Livingston, R. Murray and M.Rac:-U--. 
Nucleonics 13, 28. (1955). 
21. J.L. Need. IEEE Trans. Nucl. Sci. NS-26. 2236, (1979) 
22 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34. 
35. 
36. 
37. 
38. 
39. 
40. 
41. 
42. 
The Cyclotron Corporation. Berkeley, Ca. 
M.F. Finlan Proceedings of 5th European Meeting 
of Radioisotope Producers, Athens pp. 119. Ministry 
of Culture and Science Greek Atomic Energy Conmis-
sion (1974) 
N.N. Krashov, P.P. Qnitryev, et. a l . Proceedings of 
a conference on The Uses of Cyclotrons i n Chemistry 
tfetallurgy and Biology pp 159-167. Ed. C.B. 
Amphlett. Butterworths (1970) ISBN 0 408 70029 7. 
J.A. Campbell. R.D. Finn, and P.M. Smith J. 
Labelled Qnpds. Radiopharm. 13, 437, (1977). 
E. Acerbi, C. B i r a t t a r i et. alT I n t . J. Appl. Rad. 
Isotopes 26, 741-747 (1975) 
R. Van Den Bosch, J.J. M. De Goeij e t . a l ^ .ibid,28, 
255-261. (1977) ~ 
K. Knodo. R. M. Laniirecht and A.P. Volf i b i d , 28, 
395-401 (1977) 
J.C. Clark, P.L. Horlock and I.A. Watson, Badiochem 
Radioanal. Letts. 25, 245-253, (1976). 
C l i n i c a l and Experimental Applications of Krypton-
Sim. J.P. Lavmder Ed. B r i t . J. Radiol. Special 
Report No.15 London, (1978) 
•J.C. Clark, R.D. Finn, e t . a l . 9th Inc. Hot Atcm 
Syn^josium Blacksburg Va. Sept. 18-23. 1977 
(abstract) 
J. Lamb et. C l i n i c a l and Experimental Applications 
of Krypton-81 m. J.P. lavender Ed.,Brit.J.Radiol. 
Special Report No. 15, London (1978) 
T.J. Ruth, R.M. Lambrecht, A.P. Wolf and M.L. 
Thakur, J. Labelled Qnpds. Radiopharm. 16, 210-
211, (1979) 
R.S. Tilbury, J.R. D^hl and S.J. Marano. J. 
Labelled Qipds. Radiopharm. 13, 208, (1977). 
K.A. Lathrop, P.V. Harper, B.H. Rich et. a l . 
Radiopharmaceuticals and Labelled Compounds 
Vol.1, pp. 471-481, IAEA Viama (1973) Sn/PUB/344 
G. Berger, M. Maziere, D.Coraar et. a l . I n t . J. 
Appl. Rad. Lsotopes 30. 393-399, (1979) 
G. Berger, M. Maziere, J. Sastre and D. Ccmar. 
Carrier-free "C formaldehyde": An approach 
Submitted to J. Labelled Qnpds. Radiopharm. 
J.C. Clark and P.D. Buckingham pp 122-170 Short 
Lived Radioacti-ve Gases for Cl i n i c a l Use Butter-
worths, London 1975. ISBN 0 407 39770 1 
H. V. Ruiz and A.P. Wolf J. Labelled Qnpds. Radio-
pharm. 15. 185-189. (1978). 
T.J. Ruth and A.P. Vblf. IEEE Trans. Nucl. Sci. 
NS-26, 1710-1712, (1979) 
T.J. Tewson, M.J. Welch and M.E. Saichle, J. 
Nucl. Med. 19, 1339-1345, (1978). 
M. Cselka, 37E. Gindler and A.M. Friednan, I n t . 
J. Appl. Rad. Isotopes. 28, 804-805, (1977) 
TABLE 2 
Proton &iergy MgV N° of Accelerators 
up to 10 4 
10 - 20 6 20 - 30 19 
30 - 40 3 
4 0 - 5 0 6 
50 - 60 4 
60 - 70 3 
70 - 80 3 
80 - 100 0 
100 - 200 2 
200 - 800 3 
T A R 1 F 1R 
ACCELERATORS FOR RADIONUCLIDE PRODUCTIDN 
B. QJtCRCIAIXY OPERAIED CYCLOTRONS 
Firm 
Location Machine Type 
Person Supplying Information 
Radionuclides Produced 
JAPAN 
Nihan tedi-Physics 
Takarazuka, tiyogo 
Dr. Masaaki Hazue 
F-18, Ga-67, Rb-81, I n - I l l , I -
NETHERLANDS 
Mallinckrodt (formerly 
Duphar) 
Petten, N. tolled 
No Information Given 
TCC CS-30 
123, Tl-201 
Philips 
(28 MeV protons) 
UNITED KPOXM 
The Radiochemical Centre 
Amersham 
Dr. M. Finlan 
Philips 
(27 MeV protons) 
Ga-67, I n - I l l , Cb-57, As-73, 74. Au-195, Be-7. Bi-206 
207, Co-56, Fe-55, ^ h-52,54, Ti-44, V-48 
mrm) STATES 
Medi-Ph-ysics 
Dr. A. Fleischer 
( i ) Arlington Heights, 111 
Rb-81, 1-123, Tl-201 
Scanditronix .^-40 
( i i ) Elneryville, Calif. TCC CS-22 
Ga-67, Rb-81, I n - I l l , 1-123, Tl-201 
( i i i ) South P l a i n f i e l d , N.J.TCC CS-22 
Ga-67, Rb-81, 1-123 
New England Nuclear 
North B i l l e r i c a , Mass. 
Dr. J. Need 
( i ) TCC CS-22 
( i i ) TCC CS-30 
( i i i ) TCC CS-30 
( i ) Co-57, Ga-67, Cd-109, I n - I l l 
( i i ) Ge-68, Au-195, Tl-201 
(iU)Ge-68, Au-195, Tl-201 
TABI£ LA ACCELERATORS FDR RADICNUCLIDE PBDOJCriON: 
DECEMBER 1978 
A. NCM-COmERCIAL ACCELERATORS 
Location Machine Type 
I n s t i t u t e Time Spent on Radio-
Person Supplying Informacion nuclide Produccion 
^Radionuclides Produced 
BELGIIM 
Qienc Universicy CCK-Mev 520 
Inscicute f o r Nuclear Scudies 
Dr. C. VandecasCeele 8 hr/wk 
Rb/Kr-81, N-13, (C-U) 
Liege l i i i v e r s i t y COl-MeV 520 
Cyclocron Research Cencre 
Dr. M.A. GuillaunK 25 hr/wk 
C-11, N-13, 0-15, F-18,. K-43, Rb/Kr-81. Se-73 
Ga-67, I n - U l 
Louvain-la-Neuve Uhiversicy CGR-tfeV 930 
Nuclear Chemistry Laboratory 
Dr. M. Cogneau 15 hr/wk 
Fe-52. 1-123. Mg-28. Ac-211, (Tl-201) 
CANADA 
Vancouver, B. C. 
TRIUMF 
Dr. B.D. Pace 
TCC CP-42 
and 
TRUlff 500-MeV 
1-123, (C-U, N-13. 0-15. F-18. Fe-52, Se-77m. 
G i ^ , Ge-68, Cd-109, I n - I l l , Xe-127. Tl-201) 
Winnipeg 
I h i v e r s i t y of Manitoba 
Dr. M.I. Gusdal 
1-123. Rb/Kr-81. Rb-84 
Fmjm 
Turku 
Abo Academy 
Dr. M. Brenner 
(50 MeV protons) 
Techsnabexport, USSR 
(20 f^eV protons) 
16 hr/wk 
C-11. F-18. Rb/Kr-81, 0-15, K-43, Fe-52. Br-77, 
Tl-197-202. Re-181. Bi-206. (1-123) 
FRANCE 
Orsay 
Service ffospitalier Fred. 
J o l i o t 
Dr. D. Canar 
C-11, N-13, 0-15, F-18. K-43. Ru-97. Ge-68. Bi-206. 
(Rb/Kr-81) 
COl-MeV 520 
30 hr/wk 
CTSMAN FEDERAL REPUBLIC 
Essen TCC CV-28 
Uhiversity C l i n i c 
Dr H.J. Machulla (507.) 
C-11, F-18. 1-123, (N-13, 0-15) 
Heidelberg AEG-Compact 
Inst. F. Nukleanredizin,DKFZ 
Dr. F. Helus 
N-13, F-18. Rb/Kr-81, 1-121. 1-123. Hg-197m. 0-L5. 
Fe-52. Cu-61. Zn-62. Ru-97, Tl-201, (C-11) 
Julich 
Inst. f. Chemie 1, KFA 
Dr. G. Scocklin 
(1) TCC CV-28 
24 hr/wk 
C-11, F-18, P-30, Cr-48, Br-77. 1-123, Cl-34m, 
Tl-201, Pb-203, (ncre F-18. and Cr-48) 
(2) "Julie" 
(45 IfeV protons) 
12 hr/wk 
Mg-28. 1-123. -every two weeks. Br-76.77 
Karlsruhe Isochronous 
Kemforschungszentrum (26 MeV protons) 
Dr. H. Schweickert 5 hr/wk 
1-123 (500mCi/wk). (double 1-123. Rb/Kr-81) 
INDIA 
Calcutta V.E.C. 
(60 MeV protons) 
Dr. R.S. Mani (Bhabha 
Atomic Res. Cencre. Trcnbay) 
(K-43, Fe-52, Ga-67, I n - U l , 1-123, Tl-201) 
ITALY 
Milan Universicy 
Cyclocron Laboratory 
Dr. C. B i r a t t a r i 
A.V.F. 
(45 MeV nrocons) 
10-15 hr/wk 
Rb/Kr-81, 1-123, Tl-201, V-48. As-71-74, Cd-107-
109, Hg-197, Pb-203. Bi-205-206 
JAPAN 
Chiba CQl-MeV 930 
Nacl. Insc. of Radiological 
Sciences 
Dr. T. Hiramoco 12 hr/wk 
C-11. N-13. 0-15. F-18. Ti-45. Fe-52, Br-77, 1-123 
Saicama 
Insc. Phys. Chem. Research (18 MeV protons) 
Sciences 
Dr. T. Nozaki 5 hr/wk 
F-18, Mg-28, K-43, Fe-52, Br-77 
Sendai CGR-MeV 680 
Tohofcu Universicy 
Dr. S. htorica 
(F-18, Br-77) 
Tokyo University 
Inst, of Medical Science 
Dr. Akira I t o 
F-18, Ti-44, Co-56. 1-123 
30-40 hr/wk(planned) 
TCC CS-30 
2 hr/wk 
NETHERLANDS 
Eindhoven 
University of Technology 
Dr. R.L.P. van den Bosch 
Br-77. 1-123. Fe-55. Sr-87m. Cd-109. (Fe-52. 
Rb/Kr-81 
AVE 
(30 f^eV protons) 
8 hr/wk 
NEl'HERLANDS Cont. 
Groningen thi^versity 
Inst, of fyuclear Physics 
Dr. W. Vaalburg 
C-U, N-13, Co-55, 0-15. 
HF197 
AW 
(65 MeV protons) 
7 hr/wk 
Fe-52, Rb/Kr-81, 1-123. 
SWITZERLAND 
Vi l l i g e n 
Natl. Inst. 
Dr. I . Huszar 
VEC (72 MeV protons) 
f o r Nuclear Research and 
Ring Accelerator 
(590 MeV protons) 
3-4 hr/wk 
I n - I l l , 1-123, (Xe-127) 
UNTTED KINGDCM 
Birmingham University 
Dept. of Physics 
Prof. J. H. Fremlin 
Rb/Kr-81, 1-123, Ma-22, Po-208, (daily Rb/Kr-81) 
Edinburgh TCC CS-30 
M.R.C. Western General 
Hospital 
Mr. T. Saxton 
Fixed-frequency 
(10 MeV protons) 
20 hr/wk 
(0-15, N-13, C-U, Rb/Kr-81) 
Harwell 
Chem. Division AERE 
Mr. J. G. Cuninghame 
1-123, S-38, Nb-92m, Rh-99m, Pu-236, Pu-237 
(Tl-201) 
London 
M.R.C. HanmersnrLth Hospital 
Mr. I.A. Watson 
C-11, N-13, 0-15, 
1-123, Cu-61, 
(K-38) 
VEC 
(58 MeV protons) 
12 hr/wk 
Classical 45" 
(8 ffeV protons) 
37 hr/wk 
F-18, K-43. Rb/Kr-81, Fe-52, 
Zn-62, Br-77, Ru-97, Cs-129, Pb-203, 
UNTTED STATES OF AMERICA 
Bloomington 
Indiana I h i v . Cyclotron 
F a c i l i t y 
Dr. D. L. Friesel 
1-123 
Boston 
Mass. General Hospital 
Dr. G. L. Brownell 
C-U. N-13, F-18, 0-15 
Brookha'ven National Lab. 
Upton Long Island, N.Y. 
Dr. A.P. Wolf 
Separated sector VEC 
(200 MeV protons) 
(under 1%) 
Allis-Qialmers 
(6 MeV deuterons) 
40 hr/wk 
Isochronous 60" 
(36 ffeV protons) 
40-50 hr/wk 
C-11, N-13, 0-15, F-18, K-38, m-51, ^ fa-52, 
Rb/fa:-81, t-L23, A t - m , Ne-lS, Cl-^4m, Fe-55, 
Br-76, Br-77, Se-97m. Tc-92, Os-191, Au-195m, 
Pb-203 
Brookhawm National Lab. 
Upton Long Island, N.Y. 
Dr. Louis Stang 
KLIP (Lin. Acc.) 
(200 MeV protons) 
145 hr/week 
I1g-28, Fe/hh-52, Ga-67, Rb/Kr-81, Ru-97, 1-123, 
Ge-68, Cd-109, Sn-113, Te-U8, Xe/I-122, Xe-127, 
W-178 
Chicago Ihi-versit;/ TCC CS-15 
Franklin McLean Mem. Res. 
In s t i t u t e 10 hr/wk 
Dr. P.V. Harper 
C-11, N-13, 0-15, F-18, Mn-51 
Cleveland, Ohio 
NASA 
Dr. J.W. Blue 
C-11, Tl-201 
Davis, California 
Crocker Nuclear Lab. 
Dr. M.C. Lagunas-Solar 
1-123, Tl-201, N-U, Co-55. 
Los Alamos, New Mexico 
CP. Anderson Meson Phys. 
F a c i l i t y 
Dr. H. A. O'Brien 
Fe/^ t1-52. Br/Se-77. Sr/Rb-82. 
Ge-68, Se-72, 1-123, Xe-125 
VEC 
(45 MeV protons) 
3 hr/wk 
VEC 
(66 MeV protons) 
20-35 hr/wk 
Rh-lOlm 
LAMPF (Lin. Acc.) 
(800 tfeV protons) 
168 hr/wk 
Hf/Lu-172, (Cu-67. 
Los Angeles, California 
U.C.L.A. School of Medicine 
Dr. N.S. MacDonald 
C-11, N-13, F-18. Zn/Cu-62, 
TCC CS-22 
50 hr/wk 
Cu-64. Rb/Kr-81. 0-15, 
Cd-107, I n - I l l , 1-123 
Miami Beach, Florida 
Mount Sinai Medical Center 
Mr. J.E. Beaver 
TCC CS-30 
(27 MeV protons) 
100 hr/wk 
Rb/Kr-81, Ga-ei. I n - I l l . Tl-201, C-11, 0-15. (N-i3) 
Michigan 
State University Cyclotron 
Laboratory 
Dr. P.S. M i l l e r 
C-11, N-13 
New York, N.Y. 
Sloan Ketteming I n s t i t u t e 
Dr. R.S. Tilbury 
C-11, N-13, 0-15, F-18. K-38. 
'TEC 
(50 MeV protons) 
av. 6 hr/wk 
TCC CS-15 
20 hr/wk 
Fe-52, Se-73 
Oak Ridge, Tennessee 
O.R.N.L. 
Dr. S. W. MDsko 
No Data Given 
Sc. Louis, Missouri 
Washington Uni-versicy 
Dr. M.J. Welch 
C-11, N-13, 0-15. F-18 
do 
Br-77, Kr-77, Rb/Kr-81 
do 
N-13, F-18) 
Isochronous CyclotrcT: 
(55 MeV protons) 
27. 
(1) Allis-Qialmers 
(6 MeV deuterons) 
(2) 52" Cyclotron 
(30 MeV V ) 
12 hr/wk 
(3) TCC CS-15 
Sector-Focusing Cycl. 
(65 MeV protons) 
(C-11, 
Washington, D.C. 
Naval Research Laboratory 
Dr. R. 0. Bondelid 
C-11, F-18, 1-123 
•* Radionuclides produced Routinely at lease once a 
week; underlined. 
I r r e g u l a r l y or in future; in parenthesis. 
46 A M E R I C A N A C A D E M Y O F N E U R O L O G Y Scient i f ic Program Abstract Form 
Please check your choice 
Type of presentation: Projection r:eeds: 
• either platform or poiter presentation 0 2 x 2 slides 
• poster preseritation or>ly QOmm movie 
Hplatform presentation only DlOmin movie 
Title of paper: Measurement of Regional Cerebral Blood Flow (rCBF) by Positron 
Emission Tomography Using -'•-'0-Water — Va l i d a t i o n of an I n Vivo 
Autoradiographic Paradigm. 
Pfesenler's n a m e and mailinj? address: Myron D. Ginsberg, M.D. 
Department of Neurology (D4-5) 
University of Miami School of Medicine 
P.O. Box 016960 
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T y p e 200-word, tlouble-spaced abstract here: 
V-Jater l a b e l l e d with the positron-emitting radionuclide ''"^O (T !^  
L23 sec.) i s i d e a l for positron-emission tomographic (PET) studies of 
:CBF i n man, owing to i t s ease of sy n t h e s i s and low p a t i e n t radiation ex-
posure . "'•^ 02 was prepared by the (p,pn) nuclear r e a c t i o n on "'"^02 and 
vas r e a c t e d with H2 on a platinum c a t a l y s t to y i e l d •'•^O-v^ater. In phys-
i o l o g i c a l l y monitored V/istar r a t s anesthetized with n i t r o u s oxide, we 
f i r s t employed i n d i c a t o r f r a c t i o n a t i o n to compare rCBF using •'•^0-water 
I 14 
land simultaneously administered C-iodoantipyrine (I/iP) . Agreement be-
tween t r a c e r s was e x c e l l e n t (hemispheral rCBF 1.96 + 0.17 ml/gm/min. v/ith 
•"•^O-water; 1.89 + 0.16 with •'''^ C-IAP; c o r r e l a t i o n c o e f f i c i e n t 0.999; 
range of PCO2 44-73 t o r r ) . I n other experiments simulating human PET 
s t u d i e s , c r a n i a l r a d i o a c t i v i t y was recorded from r a t s with a p a i r of 
co l l i m a t e d bismuth germahate c r y s t a l s i n a coincidence c i r c u i t during 
a 60-sec. modified ramp intravenous i n f u s i o n of "'•^0-water. An operation 
a l equation v/as derived from which CBF was r e a d i l y c a l c u l a t e d by an i t e r 
a t i v e method from the integrated c r a n i a l a c t i v i t y . CBF values computed 
by t h i s i n v i v o s t r a t e g y agreed c l o s e l y v;ith values obtained by d i r e c t 
assay of b r a i n a c t i v i t y ( i n vivo method, 1.65 +^  0.19 ml/gm/min; d i r e c t 
method, 1.76 + 0.23). Integrated c e r e b r a l a c t i v i t y followed CBF we l l 
even a t high flow r a t e s . T h i s method promises< ease and exactitude i n 
human measurements of rCBF by emission tomography, and image x e s o l u t i o n 
may be optimized inasmuch as the method does not require repeated, d i s -
c r e t e measurements of c r a n i a l clearance. 
If accctited. i; 'S unil^nlood that ihii m.itcrial (1) fias not Iwn nor will b<? publish>->l or jue-Sfnt<:<I cl«r"hfrp 
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Measurements of regional ventilation using nitrogen-13 and 
krypton-81m in mechanically ventilated dogs 
R N Arnot, J C Clark, A N Herringt, M K Chakrabarti and M K SykesJ 
Depar tmen t s o f Med ica l Physics and Anaesthet ics and the Medica l Research Counc i l 
C y c l o t r o n U n i t , H a m m e r s m i t h H o s p i t a l , L o n d o n W 1 2 OHS, England 
Received 23 February 1 9 8 1 . in final f o r m 28 July 1981 
Abstract. " N J and " ' K r ™ were used to measure changes in u p p e r / l o w e r ( u / L ) ratios of 
regional ven t i l a t i on in supine anaesthet ised dogs mechanical ly vent i la ted al d i f f e r en t t ida l 
vo lumes and the results c o m p a r e d . Ana lys i s o f the slopes of the ' • ' N ; washout curves 
indica ted that u / L specific v e n t i l a t i o n was less than un i ty at low t idal volumes and decreased 
as t ida l v o l u m e increased. u / L t o t a l v e n t i l a t i o n , measured using the specific ven t i l a t ion 
results and est imat ions of re la t ive l u n g v o l u m e using ' ^ N , . also decreased w i t h increase m 
t ida l v o l u m e . Pre fe ren t ia l d i s t r i b u t i o n of ven t i l a t i on to dependent lung regions thus 
increased w i ; h t idal v o l u m e despi te the oppos ing hydrostat ic forces f r o m the abdomen . 
Reg iona l count densi ty d i s t r i b u t i o n s in " " K r " " images of the lungs were analysed. A t high 
specific ven t i l a t ion rates, c o r r e c t i o n o f " ' K r " ' count densi ty is requi red in order to obta]n 
correct regional ven t i l a t i on i n f o r m a t i o n . T h e specific ven t i l a t ion rates in this series were 
such that the uncorrected u / L coun t rat ios o f K r ' " increased as t idal vo lume increased in 
contrast to the decrease in u / L t o t a l v e n t i l a t i o n recorded by the ' - ^ N , m e t h o d . W h e n 
correct ions using the ' " " N J specif ic v e n t i l a t i o n results were appl ied , the changes in u L 
' * ' K r ' " count ratios w i t h t ida l v o l u m e showed a s imi lar t rend to the changes in to ta l 
ven t i l a t i on measured w i t h ' ' ^ N j . Sources of e r ro r in the t w o techniques are b r i e f ly discussed. 
1. Introduction 
The use of a gamma camera to obtain '^ N2 washout curves in the whole lung has been 
found to give washout rates in good agreement with those obtained using expired air 
concentration curves, and in fair relationship with those obtained using measured lung 
volumes and tidal volumes (Arnot et al 1978). Since the shapes of washout curves are 
not affected by different gamma camera sensitivities to radioactivity in different regions, 
relative regional washout rates and changes in distribution may be expected to be 
measured correctly with ' ' ' N J , and if measurements of the relative volumes in the 
regions under consideration are also made, then values of the relative regional total 
ventilation may also be obtained. In this study, changes in relative regional washout 
rate, volume and total ventilation due to variation in tidal volume were measured with 
'^Nj and a gamma camera in immobile anaesthetised dogs mechanically ventilated 
under reproducible conditions. 
Krypton-81m was administered to the dogs under the same ventilatory conditions 
and the results of analysing regional count densities in gamma camera images were 
compared with the '^Nj total ventilation results. When the gas ^'Kr™ (half-life 13 s) is 
breathed continuously, radioactive equilibrium in the lungs is obtained, the amount of 
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radioactivity present in a lung region (and the count density recorded from that region) 
depending on the relationship between the concentration inhaled, the ventilation to the 
region and the " ' K r " decay constant. In humans, the relative count densities can be 
used to detect underventilated regions of lung (Fazio and Jones 1975). It is a 
convenient technique, the gas being obtained by continuous elution of a generator and 
images being accumulated during tidal breathing so that respiratory manoeuvres such 
as breath holding are unnecessary. Gamma camera detection of its radiation is efficient 
and its short half-life minimises radiation dose and disposal problems. Means of 
quantifying regional ventilation using *"Kr'" were suggested by Jones (1978), a cor-
rection to count densities being required at high ventilation rates. In this study the 
possibility of obtaining useful quantitative or qualitative information from ' " K r " 
images without such a correction was investigated. Corrections to count densities were 
also applied so that estimations of regional ventilation could be compared with the ' ' N , 
results to test the validity of the theory underlying the *"Kr'" technique. 
2. Methods 
The studies were performed on five dogs of varying breeds weighing 21-33 kg. The 
animals were anaesthetised with thiopentone 20-30 mg kg"' and anaesthesia was 
maintained with pentobarbitone given in divided doses of 60-120 mg throughout the 
experiment. A 10 mm cuffed endotracheal tube was passed under direct vision and 
ventilation controlled mechanically. Apnoea was maintained with 6-8 mg incremenis 
of pancuronium bromide. The animals lay in the supine position in a shallow trougii 
which supported the spine but did not prevent thoracic expansion, and their forelegs 
were held gently extended so that the gamma camera could be placed close to the right 
lateral thoracic wall. 500-1000 ml of Ringer's lactate solution was infused during the 
6-8 h of the experiment and arterial pressure was monitored from a line in the aorta. 
2.1. The ventilator 
The ventilator consisted of a powerful electric motor which drove a camshaft via a 
variable speed gearbox. The camshaft was fitted with cams which could be positioned 
under a spring-loaded cam follower. The latter drove one end of a rocker arm, the other 
end of which was attached to the positive-pressure bellows. The tidal volume was 
adjusted by altering the position of the pivot on the rocker arm and the geometry was so 
designed that the bellows emptied completely at each stroke regardless of the tidal 
volume. The cams were cut to produce a constant inspiratory flow pattern. The bellows 
were connnected to a pressure-operated non-rebreathing valve (Sykes 1969) with a 
90 cm length of 11 mm i d plastic tubing. Expired gas volumes were measured either 
with a dry gas meter (accuracy ± 2 % of the reading) or a dry bellows spirometer which 
recorded tidal volumes with an accuracy of ± 2 0 ml. The ventilator circuit was appro-
priately screened to prevent stray radiation from affecting the gamma camera. 
2.2. The '^Nj circuit 
'^ N2 was generated in the M R C Cyclotron Unit (Clark and Buckingham 1975) and 
piped to the experimental laboratory where it was dispensed. The ventilator circuit was 
arranged as shown in figure 1. The ventilator controls were first adjusted whilst the dog 
was being ventilated with the non-rebreathing circuit and measurements of expired 
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Figure 1. V e n t i l a t i o n ci rcui t f o r ' " " N J measurements . T h e en la rged sections of the three-way taps indicate the 
closed c i rcui t ( rebrea th ing) and open c i rcu i t (washou t ) pos i t ions . 
volume and airway pressure were made. The circuit was then closed by turning both 
taps during inspiration and the flow of oxygen into the circuit was adjusted to match the 
dog's oxygen consumption. When conditions were stable, 520-740 MBq (14-20 mCi) 
of '"'N2 contained in 4-6 ml of gas were injected into the circuit and allowed to 
equilibrate throughout the lungs and ventilator circuit for 4 min. The ventilator circuit 
was then switched to non-rebreathing by turning both taps during an inspiration and the 
nitrogen washout followed for a period of ten minutes. 
2.3. The *"Kr circuit 
^'Kr"" (half-life 13 s) is produced continuously by passing air through a cation exchange 
column to which the parent radionuclide ^'Rb is bound (Clark. Horlock and Watson 
1976). T h e ^ ' R b is produced by bombarding sodium bromide with alpha particles in the 
M R C Cyclotron at Hammersmith Hospital and has a half-life of 4.6 h. 
One of the problems in using the ^'Kr"" technique is thai variations in inspired 
radioactivity concentration may result from differences in transit times through the 
ventilator circuit. To minimise errors from this source, the circuit shown in figure 2 was 
developed. The ^'Kr"" was eluted from the krypton generator by a stream of humidified 
air and mixed with an additional supply of air to create a total gas flow of 12-13 1 min"'. 
This flow was directed into a reservoir bag, situated close to the non-rebreathing vah e. 
Volume adjustment 
' K r " 
Gas meter 
J 1 volve Airway -z; 
pressure 
E-T tube 
ebreathing 
Figure 2 . Venti lat ion circuit for ^'Kr™ measurements. 
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aspirated into the bellows via the short, 11 mm bore inspiratory tube and then driven 
directly through the non-rebreathing valve to the lungs. The resulting inspired concen-
tration measured just before the non-rebreathing valve was constant to within ± 5 % . 
The radioactive gas flow rate to the reservoir bag was adjusted to match the highest 
minute volume used, and at lesser tidal volumes the excess gas was exhausted to the 
outside of the building from a blow-off valve situated on the bag mount. 
2.4. Recording of radioactivity distribution 
The gamma camera was fitted with a high-energy collimator and aligned so ihai it 
viewed the whole of the lateral aspect of the right lung, the face of the collimator being 
positioned 2 - 5 cm from the chest wall at its nearest point. Images obtained using the 
1 9 0 keV gamma radiation of'*'Kr'" and the 5 11 keV annihilation radiation of '•'Ni were 
recorded on magnetic tape for computer processing (Vernon and Glass 1 9 7 1 ) . For '" 'N, 
measurements, data were recorded during the last 3 0 s of rebreathing to provide a 
measurement of regional lung volume, and during JO min of washout. Recording of 
'*'Kr'" gamma camera data began after radioactive equilibrium in the lungs was reached 
and was continued until a total of 2 0 0 0 0 0 counts from the whole lung had been 
accumulated. The maximum count rate in all studies was kept below 7 0 0 0 counts s"' in 
order to avoid the need to correct for gamma camera dead time. 
2.5. Analysis of data 
Corrections for non-uniformity of camera response were made and regions were 
selected for analysis as shown in figure 3 . '"'N2 equilibrium count rates and washout 
A n t e r i o r 
H e a d -
1.1 - . . - - « L L l , i . 
I.LLr.l.. .l l .Ll.LI.H.1 1 I 
I I LLLLI I l .LI .LI .Ll 
'1 i I i / I / I \ I I I i 
' ' / / I 1 I I LLLLLLl 1 
/ ' / I I I l.LLu — - . . ' - " l . L I 
/ / I I I LLLL-.>-Ht«"" — L I 
/ 1 1 1 L I . L L L l . - - t l l » " " l . l 
LLi l i i i a i i i i n -
1 i-Ll.L 
L L l . H . t L L . . - t l l « i « J l # . . | 
- L I . 
I 1 I .LLI .Lt-LLHM.r i | | | |HRHB*liaN< 
LLLLLLLLLL1.I.I.LI Li LLI.Ll.L 
. * / 1 i I I LLI.LLLi '<« ' - -"-*«-«-- '" '<t««l 
, . / / / r 1 1 11.1.LLI.LLf'•--•••-•<•'••'»• 
. , . / / t i l l 1 l . l .LLL""< ' ' "LI 
. . . . / / / [ 1 1 I I .Lt.Ll.LI-l 
. . , / ' / I 1 1 1 Ll .LI 
. , . / ' / 1 1 1 1 I.I 
. . . / ' I I I 
• * • • • « • « « • • • • < 
" • • ' • • • • • • • • • I 
, i , .-ii>,>-iiiflai 
LLI.-i 
•••>••«< ••nam «••••••# 
I t M - L L l ' 
l a u i t L i ' 
• ••"•LL1 ' 
.1 . l . l .L l .LL-"^> ' "«"-" '*" - -*- ' ' i ' "L t .LLI 
1 1 1 1 LLI.LUL"H-.-"«--LULl.LLI.H 
' / / l i l t LLLLLLLLLLJ 1 I ' 
. . / / / / / / 1 1 1 1 / / / , 
Figure 3 . C o m p u t e r p r in t -ou t showing d i s t r i b u t i o n o f r a d i o a c t i v i t y over r ight la teral aspect of dog's ihora.x. 
T h e d o g was supine w i t h the head on the l e f t . T h e rectangles used f o r analysis are o u t l i n e d . 
curves and * ' K r " accumulated counts were derived from the two horizontal slices which 
embraced the upper and lower zones of the lung field. Further analyses of "'Kr™ counts 
were performed on the caudal sections of these rectangles and on smaller areas of high 
count rates centrally placed in each zone, but no significant differences were found 
between the results derived from these areas and those derived from the large 
rectangles. For each animal, identical areas were used for all analyses. The areas were 
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chosen using the radioactivity pattern obtained at the highest tidal volume in order to 
allow for lung movement and so to ensure as far as possible that the same lung tissue was 
contained within each area at all stages of the respiratory cycle at all tidal volumes. 
Regional '^Nj washout curves were analysed into two exponential components 
using a computer programme (Herman, Shahn and Weiss 1 9 6 2 ) and the average 
washout rate (a s~') was derived from the intercepts (A, and ^ 2) and slopes (a , and a^) 
of the fast and slow components: 
Specific ventilation (V/V) was calculated for each region using the expression V/V = 
60(5 min '. The ' • ' N J regional count rates at equilibrium were used to calculate relative 
regional lung volumes ( V ) . Relative regional ventilation (V) was calculated by 
multiplying relative regional specific ventilation {V/V) by relative regional volume. 
All results for " N J and for ^'Kr"" counts were expressed as the ratio of the value in 
the upper zone to that in the lower zone, normalised to the value obtained at the 
minimum tidal volume. 
The upper/lower * 'Kr '" count ratios were used to obtain an estimation of relative 
regional ventilation ratios using the lung model described by Jones (1978). This 
assumes a continuous passage of "'Kr"" through the lungs such that at radioactive 
equilibrium, in each region, 
Rate of inflow of radioactivity = Rate of outflow of radioactivity 
Vc = A{V/V + X) 
where V'= ventilation to region, c = concentration inspired, assumed the same to all 
regions, A = radioactivity present in region, V/V = fractional rate at which radioac-
tivity is lost from region due to ventilation, A = fractional rate at which radioactivity is 
lost due to ' ' 'Kr'" radioactive decay. 
Thus 
A=Vx-^-^ . ( l i 
(V/V) + \ 
The radio of radioactivity present in two regions 1 and 2 is given by 
A , ^ V , J V / V h + X 
Aj -.(V/Vji + A 
and the ratio of counts detected in the two regions in a given time is given by 
C , J , V , J V / V h + K 
C2 52^2 ( V / V ) , + A 
where 5, and 52 are instrument sensitivity factors for regions 1 and 2 . When ratios in 
the same regions are normalised to the value obtained under one physiological 
condition, the sensitivity factor S1/S2 cancels out. Thus, normalised values for V / ^ 2 
are obtainable from normalised count ratios if the absolute values of V/ V are known or 
if these are all so small in comparison with A that the last fraction of equation (3) reduces 
to unity. In the latter situation, *"Kr"' activity present at equilibrium is proportional to 
lung ventilation, which is the basis for the widespread clinical use of '"Kr"' (Fazio and 
Jones 1975). In this study, V/V was not small in comparison with A and the values of 
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V/V obtained using '^Nj were used to calculate normalised values of upper/lower V 
ratios from the normalised upper/lower '^'Kr"' count ratios, using equation (3) rear-
ranged. 
2.6. Protocols 
2.6.1. Effect of tidal volume. The regional distribution of ventilation was measured at a 
number of tidal volumes from 300-1300 ml whilst the inspiratory: expiratory time ratio 
was maintained at 1:2 for four dogs and at 1:4 for one dog, at a frequency of 15 breaths 
per minute. 
2.6.2. Additional *"Kr'" experiments. Some experiments were carried out to investi-
gate the effect of the inhalation of *"Kr"' of non-constant concentration on relative 
regional count rates. 
(i) Tracheal sampling. In one of the dogs, a continuous sample of gas was obtained 
from a catheter placed with its tip at the carina. The gas was sampled by a thin bore tube 
at a rate of 500 ml min"' and passed through a coil of the same tubing in a well counter, 
whose output was fed to a multiscaler for graphing by computer. 
(ii) In another dog, images of the distribution of boluses of radioactivity delivered to 
the trachea at two different times in the inspiratory phase were obtained. A 50 ml 
syringe, driven by compressed CO2 and a solenoid valve that was activated by switching 
controlled by the ventilator cam, was used to elute the generator and drive a highly 
concentrated bolus of *"Kr'" to the tip of a tube situated in the trachea. The bolus was 
delivered in 0.2 s at either the beginning or in the middle of the inspiratory phase, 
during every tenth breath. The cam switching also controlled recording of data from the 
gamma camera, data being recorded only while boluses were being delivered during 
every tenth inspiration. Thus only the initial distribution of each bolus was recorded 
since clearance by decay and ventilation took place between recordings. 
3. Results 
Figure 4 shows the variation in upper/lower zone relative regional lung volume ( V ) 
derived from '^Nj equilibrium count rates, relative regional specific ventilation {V/V) 
derived from the '^ N2 average washout rate a, and relative regional ventilation ( V ) 
obtained by multiplying relative regional specific ventilation by relative regional 
volume. Three of the dogs showed some decrease in relative regional lung volume with 
increase in tidal volume, while in two dogs relative volume remained constant ( I and 3). 
Two of the dogs (2 and 4) showed a progressive and marked decrease in upper/lower 
( U / L ) zone ratio of regional specific and total ventilation as tidal volume was increased. 
In the other three dogs there were variable changes up to a tidal volume of about 
700 ml, but above this tidal volume there was a decrease in the U/L ratio of regional 
specific and total ventilation. The absolute value of U/L specific ventilation was always 
less than unity. Values of specific ventilation increased with tidal volume from about 
2 min"' to about 7 min"' in the lower region and from about 1.5 to 4.5 min"' in the 
upper region, the greater increase in the lower region producing the decrease in 
upper/lower ratio. 
The ^'Kr"" U/L count ratios are shown in figure 5. In four out of the five dogs the U/L 
ratio increased with tidal volume whilst there was little change in the remaining animal. 
Thus a decrease in U/L ventilation ratio of 10-30% as demonstrated by '^N, measure-
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Figure 4 . ' "^Ni measurements of u p p e r / l o w e r r eg iona l v o l u m e ( V ) . specific ven t i l a t ion tV.'V) and tota l 
ven t i l a t i on (V') at var ious t ida l vo lumes ( V y ) . T h e values are no rma l i sed to the ratios obta ined at the lowest 
t ida l v o l u m e 
ments was associated with an increase in u/u '^'Kr'" count ratio of up to 25%. When the 
normalised '^'Kr'" U/L count ratios were corrected using '^N, specific ventilation values, 
the resultant normalised U/L ventilation ratios showed similar trends to those obtained 
using '"^N, alone except in the case of Dog 1 whose very high count ratios are 
under-corrected (figure 6). The corrected ^"Kr"' results were ( 7 ± S D 6)% greater than 
the '^Nj results (n = 21). 
Figure 7 shows the variation with time of the concentration of'""'Kr"' in the trachea of 
a dog ventilated at an inspiratory: expiratory ratio of 1 :4 at difl'erent tidal volumes. At 
high tidal volume (figure 7(c)), the ^'KT"" concentration in the dead space gas was much 
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Figure 5. U p p e r / l o w e r ratios o f reg iona l " ' K r ' " coun ts at va r ious t i d a l vo lumes . The values are normal ised to 
the r a t i o o b t a i n e d at the lowest t ida l v o l u m e . 
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higher than at low or medium tidal volumes (figures 7(a) and (b)), but the dead space gas 
constituted a smaller fraction of the total volume inspired since the increase in 
anatomical dead space is not linearly related to the increase in tidal volume (Shepard ei 
al 1957). The effect of the relative concentration and volume of the dead space gas on 
the distribution of radioactivity depends on whether there is preferential distribution of 
the dead space gas to certain areas of the lungs and whether the distribution varies with 
tidal volume. The results of investigating these factors are as follows. 
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Figure 7 . Rad ioac t i v i t y of * " K r " ' in gas sampled f r o m trachea at three t i d a l vo lumes : ( o ) low. (fe) m e d i u m , (c) 
h i g h . T h e p r o p o r t i o n s of dead space and a lveolar gas were es t imated f r o m separate measurements of 
a n a t o m i c a l dead space made by the single b r ea th F o w l e r t echn ique . 
Table 1 shows the results obtained on the dog to which boluses of '''Kr"' were 
administered to the trachea during the initial and middle part of the inspiratory phase. 
The u/L distribution of the initial boluses did not vary significantly with tidal volume in 
either the thirds of the lungs or in the smaller caudal regions. The U/L ratio of 
distribution of the middle boluses was lower than that of the initial boluses. The 
distributions of th(. initial and middle boluses are representative of the distributions of 
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Table 1. Upper / l ower ratios of distribution of " ' K r " boluses administered to trachea 
during initial and middle 0.2 s of inspiratory phase. T h e regions e.xamined were the 
non-dependent and dependent large rectangles shown in figure 3 and the caudal areas of 
these rectangles. 
1/3 lungs Caudal regions 
Tida l Initial Middle Initial Middle 
volume boluses boluses boluses boluses 
300 0.84 0.48 0.75 0.46 
600 0.82 0.73 0.73 0.66 
900 0.82 0.60 0.76 0.55 
1200 0.84 0.58 0.77 0.51 
dead space gas and gas entering at the mouth respectively. These results indicate that 
the fraction of the dead space gas distr ibuted to the upper regions was greater than the 
fraction of the middle part of the breath dis t r ibuted to those regions, but the dead space 
distr ibution d id not vary wi th t idal volume. O n the other hand, the distribution of the 
middle part of the breath did change wi th t idal volume, in keeping with the finding of 
variations in venti lat ion d is t r ibut ion in the dogs when using ' ' N , . 
4. Discussion 
A l l five dogs showed a reduction in U / L rat io of venti lat ion at high tidal volumes though 
results were variable in three of the dogs at intermediate tidal volumes. In two of the 
dogs the decrease in U / L rat io was due solely to a reduction in the U / L ratio of V/ V bui 
in the remaining three animals there was also a reduction in the U / L ratio of V. 
Kanekoetal (1966) and M i l i c - E m i l i et at (1966) showed that at functional residual 
capacity ( F R C ) the volume of the non-dependent alveoli is greater than those in the 
dependent zones. This variat ion in regional lung volume results f rom the vertical 
gradient of pleural pressure which results in a greater transpulmonary pressure 
difference in non-dependent zones. Since the volume-pressure curve of the lung is 
non-linear, this gradient of pleural pressure also results in regional differences in 
ventilation dur ing spontaneous breathing, the lower alveoli situated on the steeper part 
of the volume-pressure curve receiving more venti lat ion than the upper alveoli dur ing 
inspiration f r o m F R C . 
During mechanical vent i la t ion the respiratory muscles are paralysed so that the 
distr ibution of vent i lat ion is modi f ied by external pressures acting on the chest wall . In 
the supine subject the abdominal contents create a hydrostatic pressure gradient which 
acts maximally on the dependent port ions of the diaphragm. This reduces regional lung 
volume in the dependent port ions of the lung and also causes ventilation lo be 
redistributed away f r o m the dependent lung zones. When tidal volume is increased 
f r o m 300 m l to 1200 m l the peak inf la t ion pressure increases f rom appro.ximately S cm 
H 2 O to 25-30 cm H 2 O . The resulting increase in end-inspiratory transpulmonary 
pressure probably shifts the non-dependent alveoli onto the flatter port ion of the 
volume-pressure curve, and so tends to increase the propor t ion of ventilation dis-
tr ibuted to the dependent zones (Froese and Bryan 1974). 
In the present experiments an increase in t idal volume resulted in a small re la t i \e 
increase in dependent zone regional lung volume in three of the dogs. The simplest 
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explanation for these changes is that F R C increased progressively with tidal volume. 
Because of the shape of the volume-pressure curve this would have resulted in a 
relatively greater increase in the volume of dependent alveoli . Closed circuit helium 
F R C measurements made on these animals earlier in the day revealed that F R C increased 
by 100-300 ml when tidal volumes increased f r o m 300-1200 ml . It seems likely that 
this change was due to inadequate t ime fo r the lung to empty at the high tidal volumes 
since subsequent experiments have demonstrated that the increase is not observed 
when the closed circuit hel ium apparatus is connected to the endotracheal tube 15 s 
after the latter has been opened to atmosphere. 
4.1. Nitrogen-13: error considerations 
" N 2 has been used in studies of both normal and abnormal lungs using collimated 
scinti l lat ion counters (Rosenzweig et al 1970) and gamma cameras (Ronchetti el at 
1975b, Ewan ef a/ 1975, Nosi l er a/ 1976). Some sources of error in the measurement 
technique may be considered in relat ion to their possible effect on the measurement of 
change in regional vent i la t ion. The advantage of ' ' ^Nj over other inert gases such as 
'^^Xe is its lower solubil i ty in blood and tissue: this reduces the magnitude of two 
sources of error, namely washout of radioact ivi ty f r o m tissue into the lungs, and the 
presence of radioactivity in the chest wal l (Matthews and Dol lery 1965. Ronchetti el al 
1975a). Al though small, both sources of error warrant fur ther consideration. Dur ing 
washout, radioactivity which has accumulated in the tissues and blood passes f rom the 
b lood into the alveoli and so slows the washout curve. Examinat ion of data obtained on 
dogs has shown that this error slows the washout rate by 1-2% (Rhodes et al 1980). 
Radioactivity in the chest wal l is detected wi th high efficiency by the gamma camera 
since the chest wall is close to the crystal. The radioactivity remaining during the last 
part of the washout recording was regarded as tissue background and subtracted f r o m 
the recorded count rates, but any previous local tissue components would have been 
included in the data recorded and wou ld have caused an under-estimation of the true 
washout rate. Comparison of gamma camera results wi th results obtained f r o m 
simultaneous expired gas concentration curves indicated that a chest wall correction of 
5% is probably applicable to washout rates recorded wi th a gamma camera (Arnot el al 
1978). However, both these factors are of negligible importance when the results are 
expressed in terms of normalised U / L ratios since both regions of lung are equally 
affected. 
A th i rd factor which may lead to an error is the determinat ion of specific ventilation 
by equating it directly to the washout rates defined by smooth curves fitted to ventilation 
data. Vent i la t ion is a discontinuous process and this should be taken into account when 
calculating specific venti lat ion f r o m the parameters of smooth washout curves (Briscoe 
and Cournand 1959). The effects of the d i f ferent methods of calculating specific 
vent i lat ion have been investigated. The differences are less than 5% at low washout 
rates (such as are found in resting humans), but increase wi th increasing washout rates. 
However , the effect on the measurement of changes in relative regional ventilation is 
small . In this series, changes in U / L ratios, calculated by taking the discontinuous nature 
of venti lat ion into account, d i f fered by a max imum of 8% f r o m the values determined 
by direct use of '^N2 washout rates. This difference occurred at the highest t idal 
volumes used, the difference usually being only 1-3%. Calculation by this method d id 
not affect the direction of change of U / L ra t io in any dog at any tidal volume. 
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A fou r th source of error, regional variations in the distr ibut ion of the dead space gas, 
may also affect regional washout curves because the proportions of dead space gas (i.e. 
alveolar gas) and fresh gas entering the alveoli may vary. The experiments on the 
dis t r ibut ion of dead space gas were carried out only once, and can only relate to supine 
anaesthetised dogs, but the relevance of such informat ion to ventilation measurements 
is wor th consideration. 
A t the end of expirat ion, the dead space is f i l led wi th gas f r o m the alveoli. The 
composit ion of this gas varies throughout the lung depending on regionsl V/V, but in 
the ma jo r airways the gas contains mixed contributions f r o m all lung regions. Dur ing 
inspiration, this gas may be distr ibuted in a non-un i fo rm fashion, so altering the fraction 
of radioactivity re-inhaled by each region of the lung. This would distort the relation-
ship between regional washout curves. For example, if the whole of the dead space gas 
were delivered to one particular region while the rest of the lungs received only fresh 
inactive gas dur ing inspirat ion, then the washout f r om that region would be slowed 
down. However, it can be argued that if all the dead space gas (high P C O 2 , low P O 2 gas) 
is redistributed to a particular region, then the effective ventilation to that region is 
decreased, and it is proper for this to be reflected in a slower washout measurement. 
Thus the effect of the inspiration of radioactive dead space gas on '"'N2 measurements is 
in the correct direction though it cannot be assessed quantitatively. The effect is l ikely 
to be greater in the dog than the human since the anatomical dead space after intubation 
is about 1 ml k g " ' in the human and 4 m l kg ' in the dog (Severinghaus and Stupfel 
1955). A n y variation in dead space dis t r ibut ion wi th tidal volume could therefore affect 
the values of changes measured as well as of individual clearance rates. In our 
experiment on the dis t r ibut ion of d i f ferent parts of the breath, the labelled gas in the 
dead space was distributed more to the upper part of the lungs than labelled gas entering 
half way through the inspiratory period, but the distr ibut ion did not alter with tidal 
volume. I f the dis t r ibut ion was unchanged in the other dogs in the series, the effect of 
the dis t r ibut ion of dead space radioactivi ty on the measured changes in relative regional 
venti lat ion must have been min imal . 
4.2. Krypton-Sim: assessment of technique and error considerations 
As may be seen f r o m equation (1), when ^ 'Kr"" of a constant concentration c is breathed 
continuously unt i l radioactive equ i l ib r ium is reached, the amount of ^'Kr"" present in a 
lung region ( A ) is propor t ional to the vent i lat ion in the region (V) provided specific 
venti lat ion (V/V) is small in comparison wi th the *"Kr" ' decay constant A (Fazio and 
Jones 1975). The value of A is 3.2 m i n " ' and figure 8, in which V / [ ( V / V ) + 3.2] is 
plot ted against V, shows how ^ ' K r ' " equ i l ib r ium radioactivity varies with ventilation for 
human and dog lungs of volumes 2.5 1 and 1.01 respectively. It is seen that the 
relationship between equ i l ib r ium radioact ivi ty and venti lat ion is closely linear for 
values of V/V up to the normal adult human value of 1.5 m i n ~ ' ( V = 3.75 1 m i n " ' in 
humans, 1.5 1 m i n " ' in dogs). A t higher values of V/V, A increases more slowly wi th V 
unt i l it reaches a max imum value which reflects lung volume alone. The effect on results 
obtained when comparing count densities in regions wi th increasing V/V can be seen 
by reference to figure 8. A t points P and Q, the ratio of ventilation is 2.5/5 = 0.5, and 
t h e r a t i o o f activity is 0.5 x 1.44 = 0.72 ( f r o m equation (2); V/V = V since V = 1 on this 
curve). A t points R and S, the rat io of vent i lat ion is st i l l 0.5 (6 /12) but the rat io of 
activity is 0.5 x 1.65 = 0.83. Thus each single activity ratio (or count ratio if sensitivity 
factors are similar; equation (3)) gives, in this case, a correct qualitative indication of 
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Figure 8. Theore l i ca l curves showing how Kr"" equil ibrium radioacl ivi iy varies wi ih ventilation for an adult 
human (i-RC 2.5 litres) and 25 kg dog ( F R C 1.0 litres). When V / V is less than 1.5 min ' the relationship is 
relatively linear. At higher values of V/V the method becomes less sensitive and the relationship non-linear. 
relative venti lat ion (e.g. V'p< Vq), but comparison of the two activity ratios gives an 
incorrect indication of the relat ion between the two ventilation ratios owing to the 
d i f f e r i n g absolute values of V/V. T h e regional V / V values found in this series were 
such that while the U / L venti lat ion ratios decreased, the normalised U / L count ratios 
remained constant or increased. The difference between activity ratios and ventilation 
ratios is not inconsiderable even at clearance rates found in human lungs. It may be 
calculated that in assessing changes in regional dis t r ibut ion of venti lat ion when specific 
vent i la t ion ranges f r o m well below normal to normal , the difference between changes in 
act ivi ty ratios and changes in vent i la t ion ratios can be of the order of 10%, while if 
specific venti lat ion ranges f r o m normal values to those found after exercise then such 
differences can be more than 2 5 % . The use of **'Kr"' alone for accurate measurements 
is therefore very l imited. 
Thus to obtain quantitative in fo rma t ion on venti lat ion f r o m **'Kr"' images at high 
specific venti lat ion rates, addit ional i n fo rma t ion on washout rates is required (Jones 
1978). The correlation that was f o u n d in this series between '^ 'K" ' measurements and 
' ^ N j measurements showed that agreement between theory and practice is obtained 
using a gamma camera and data analysis as described when changes in relative regional 
vent i la t ion are measured. Comparison of th i s^ 'Kr"" theory based on a continuous f low 
model of the lungs with that obtained on a discrete breath model has been carried out by 
the authors and is shortly to be reported. Using data f r o m this study, the differences 
between the results calculated by the two methods were small. Several sources of error 
in the technique may be briefly ment ioned. 
The first is the effect of redis tr ibut ion of dead space gas. The radioactivity in dead 
space gas closely parallels that expired f r o m the alveoli connected to the dead space, but 
the rat io between inspired and alveolar act ivi ty is dependent on alveolar V / V. Thus at 
low t ida l volumes (figure 7(a) the concentrat ion in dead space gas is about 40% of the 
inspired concentration but at high t idal volumes (f igure 7(c)) it is 7 0 % of the inspired 
concentrat ion. Regional radioactivity w i l l therefore depend on regional V / V and on 
the p ropor t ion of dead space gas in the alveolar inspirate. Similar to the effect of dead 
space inhalat ion on '^N2 measurements, a h igh p ropor t ion of dead space low concen-
t ra t ion ^ 'Kr"" distributed to a region reflects less effective venti laton in the region, so 
that the effect is again in the correct d i rect ion but di f f icul t to assess. The experiment 
w i t h boluses showed that the dead space gas appears to constitute a greater proport ion 
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of the ventilation to the upper lobes than to the lower lobes, but since the U / L 
distr ibut ion does not vary wi th t idal volume, there is l ikely to be little effect on the 
measured change in count ratios. Other factors which could affect count ratios are the 
inclusion of the tracheal gas volume in the lower of the two rectangles subjected to 
analysis, movement of lung tissue between the computat ion areas caused by expansion 
of the thorax, variation in the radioact ivi ty concentration of the inspired gas and 
accumulation of counts before equ i l i b r ium is fu l ly established. Errors in the " ' K r ' " 
technique have been considered in more detai l for a future report, and it is apparent that 
their overall effect would be to cause a small increase in the measured normalised count 
ratios. 
5. Conclusion 
Inherent errors in the ' ^ N j technique are unlikely to cause significant errors when 
measuring changes in relative regional vent i la t ion . When corrected for regional specific 
venti lat ion, *"Kr'" equi l ibr ium count ratios indicate similar changes in relative regional 
venti lat ion to those measured by the " N j technique. This supports the theoretical 
analysis of the " 'Kr"" technique. W i t h o u t correction, ' ' ' K r ' " count ratios can give a 
qualitative indication of the relative regional venti lat ion in a single image if geometrical 
differences between the regions are small , but when comparing different images, 
changes in relative regional venti lat ion may be accompanied by no change in the " ' K r " ' 
count ratios or by a change in the opposite direct ion, depending on the values of specific 
ventilation involved. Similarly, changes in ^ ' K r " ' count ratios may occur when there is 
no change in ventilation ratio. The value of ' " K r " ' lies in those situations where it can be 
used alone, when specific venti lat ion always remains low in comparison with the 
radioactive decay rate of " 'Kr"" . 
It was found that increasing tidal volume in mechanically ventilated supine dogs 
results in a decrease in the upper / lower ratio of specific ventilation, regional lung 
volume and regional total vent i la t ion. 
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Resume 
Mesure de la ventilation regionale chez le chien ventile artificiellement a l aide d'azote 13 et de krypton 81m. 
Nous avons utilise, pour mesurer les modifications des rapports haut/bas (H/B) de ventilation regionale chez 
des chiens anesthesies, en decubitus dorsal, ventiles artificiellemeni a differenls v olumes inspiratoires. Ic ' '.N'; 
et le ^'Kr™, et nous avons compare les resultats obtenus. L'analyse des courbes de washout du '^Ni indique 
que la ventilation specifique H / B est inferieure a 1 a de faibles volumes inspiratoires ei diminue quand le 
volume inspiratoire augmente. L a distribution preferentielle de la ventilation aux difTerentes regions du 
poumon augmente avec le volume inspiratoire malgre les forces hydrosiatiques opposees provenant de 
I'abdomen. Nous avons analyse la distribution de densile de comptage regionale sur les images pulmonaires 
obtenues avec le " K r " . A de hauts taux de ventilation specifique, il est necessaire d'efTectuer une correction 
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de la densite de comptage pour obtenir des informations correctes sur la ventilation regionale. Les taux de 
ventilation specifique dans cette serie sont tels que Ton observe une augmentation des rapports de complage 
H/B non corriges pour le ' ' K r " " avec le volume inspiratoire, au lieu d'unc diminution des rapports de 
ventilation totale H/B enregistres avec le '^N2. Q u a n d les corrections utilisant la ventilation specifique du 
'•'N2 sont appliquees, les modifications des rapports de comptage H/B avec le " ' K r " ' en fonction du volume 
inspiratoire montrent une evolution similaire a celles de la ventilation totale mesurees par le '•^N2. Nous 
discutons brievement les sources d'erreur des deux methodes. 
Zusammenfassung 
Messungen der regionalen Ventilation mit StickstofT-13 und Krypton-81m bci mechanisch bealmcten 
Hunden. 
U m Anderungen der Verhaltnisse zwischen oberer und unterer regionaler Ventilation (O/U-Verha l tn i s s e ) 
mit Hilfe von " N und " ' K r ' " messen zu konnen, wurden narkolisierte Hunde bci verschiedenen Atem-
volumina mechanisch beatmet und die Ergebnisse verglichen. Die Analyse der ' ^ N,-.'\uswaschkurven zeigt. 
dap die O/U-spezi f ische Ventilation bei wachsendem A t e m v o l u m e n sinkt. Die O / U - t o i a l e Ventilation, die 
man erhalt aus den Ergebnissen der spezifischen Venti lat ion und aus Abschatzungen des relativen Lungen-
volumens mit ' " " N J , sinkt ebenfalls mit wachsendem A t e m v o l u m e n . Die Vertci lung der Ventilation in 
verschiedenen Lungenabschnitlen wachst mit dem Atemvo lumen , trotz der enigegengeseizien hydro-
statischen Krafte des Abdomens. Regionale Dichtevertei lungen in " 'Kr'^-Bi ldern der Lunge wurden 
analysiert. Bei hohen spezifischen Ventilationsraten ist eine Kor r e kt ur der " ' K r " ' Zahlratendichte erforder-
lich, um richtige Informationen iiber die regionale Venti lat ion zu erhalten. Die spezifischen Veniilaiions-
raten waren in dieser Serie so, dap die nicht korrigierten O / U - V e r h a l t n i s s e von '"'Kr'" mil wachsendem 
Atemvolumen ebenfalls wuchsen, ganz im Gegensatz cum Abfa l l bei der O / U - i o l a l e n Ventilation, auf-
genommen mit der '""Nj-Methode. Korr ig ier l man die Zahlraten mit Hilfe der Ergebnisse der ' ' N j -
spezifischen Ventilation, so zeigen die Anderrungen der O / U - Z a h l r a t e n v e r h a l t n i s s e mit dem Atem>.olumen 
bei " ' K r " einen ahnlichen T r e n d wie die Anderungen bei der totalen Ventilation mil ' N; . Die 
Fehlerquellen beider Techniken werden kurz diskutiert. 
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' ^ Sr has now been produced by the spallation o f Molybdenum by protons o f up to 
800 MeV. The radiochemical recovery o f strontium is described together with a description 
of the analytical techniques used to estimate recovered yields o f the various radionuclides 
generated. A radionuclide generator is described for the rapid recovery o f ' ^ R b , the 1.25 
min half-life decay product o f " S r . A n outiine is given o f the quality control procedure 
adopted to ensure that the " Rb is suitable fo r clinical use. 
Introduction 
The preparation of radiopharmaceuticals from radionucHde generator systems is 
well established in nuclear medicine practice. For exampe ' ' ' " T c (T = 6 h), sepa-
rated from its parent "Mo (T = 66 h), using an alumina column chromatographic 
technique, is now used in the majority of routine nuclear medicine diagnostic proce-
dures. The attraction of generator produced radionucUdes in medicine is the ability to 
have materials of short half-life readily, available at sites remote from the production 
facility. The use of short half-life tracers usually leads to a significantly reduced 
radiation dose to the subject without compromising the statistical quahty of the 
clinical data acquired. 
Recently an increasing emphasis has been placed on the use of positron emitt-
ing short hved radionuclides as a result of the development of the technique of 
positron emission tomography,* a radionuclide counterpart of the x-ray transmission 
tomographic technique developed by EMI.^ The latter provides information on tis-
sue density whilst the radionucUde technique has the potential to provide informa-
tion on tissue function. Many of the short lived positron emitting radionucUdes 
for example '^O (T = 2.03 m), *^N (T = 9.96 m), and ' ' C (T = 20.3 m) have 
to be made by a cyclotron at, or very close to the site of use. However there are 
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some that are in principle available from radionuclide generator systems. These are 
*«Ge (T = 287 d)/^«Ga ( T = 68 m)^ *'Zn ( T = 9.13 h) /"Cu (T = 9.76 m)" 
and *^Sr ( T = 25 d)/^^Rb ( T = 75 sf and is the chemical development of the 
last that is the subject of this paper. Earlier attempts at producing a medically . 
acceptable *^Sr/^^Rb generator used a single column containing an organic ion 
exchange material e.g. Bio-Rex-70 or Chelex 100.^ "'' At tracer levels these materials 
performed reasonably satisfactorily; however, when applied to a more pracrical 
situation where much larger amounts of parent radionuclide were being loaded 
onto the generator, typically 100—200 mCi, these organic materials proved to be 
unsuitable as they were unstable with respect to the high radiation dose that they 
received during the six to eight weeks usable life of a generator. Discolouration of 
these materials occurred overnight when loaded with only 20-30 mCi of parent, 
and retention of the parent, a very important factor in medical applications, was 
reduced. 
Recent work by YANO et al. at Berkeley,*'^ suggested that basic alumina, an 
inorganic ion exchange material could be used. The long term radio-resistance of 
alumina is borne out by its use in medicine for ^ ' T C " " generators and the separa-
tion of fission products. 
Materials and methods 
Production and purification of ^^Sr 
*^Sr is produced in Curie quantities at the Los Alamos Meson Physics Facility 
(LAMPF) by irradiating a thick Mo target with 300-600 iiA of up to 800 MeV 
protons for a duration period of 1-2 weeks.'° Spallation of the Mo nuclei 
results not only in the desired ^^Sr product, but also in a wide variety of pri-
marily neutron deficient isotopes spanning the elemental range from Tc to H. 
A post- bombardment radiochemical separation procedure must therefore isolate 
radiostrontium (*Sr) from numerous other species, and must also do so reason-
ably quantitatively. Because of the intense radiation levels of LAMPF- irradiated 
targets (typically ~ 10'' R/hr at 1 cm), the radiochemistry must be performed 
remotely in a suitable hot cell. 
There are currently two related procedures for the recovery of *^Sr that are 
implemented in LASL's radiochemistry hot cells. Because of the non-specificity of 
spallation as an isotope production mechanism, other useful nuclides (such as ^ ^ Br, 
**Zr and *^Y) are also produced in a Mo target, and procedures for their, isola-
tion have been developed as well. The choice of the particular ^^Sr separation 
scheme is dependent upon the need for these attendant isotopes. The schemes 
are shown in Figs 1 and 2. 
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Fig. 2. L A S L combined M o - ' ' Sr, " Br hot cell proced ure 
If Zr and/or Y are desired as nuclear physics targets or for safeguards ex-
ZTT'^^r^'^^'T" '^^ P '^^ ^y '^-60 g in weight) is dissolved wtth 
unstabd^ed 30% H , 0 , . The resulting molybdic acid solution is passed through a 
strong acid cation exchange column (Bio-Rad AG50-X4), where cationic species 
J. Radioanal. Chem. 64 (1981) 
. 17* 259 
p. L . HORLOCK et al . : THE PREPARATION OF A RUBIDIUM-82 
are adsorbed while bulk peroxymolybdates and other anions are not. The cations 
are then eluted with 6M HCl, the medium adjusted to 9M HCl, and the solution 
passed through a strong base anion exchange column (Bio-Rad AG1-X4). Anionic 
chloro-complexes of *Co, *Fe, *Zn and other contaminants are retained on this 
resin, and *Sr and other cations of interest remain in the eluate. This solutiori' 
is then evaporated to near-dryness and the pH adjusted to 0-1 by the addition 
of 0.1 M HCl. Solvent extraction with a mixture of HDEHP [bis-(2-ethylhexyl) 
orthophosphoric acid], acetylacetone and toluene follows. The organic phase 
extracts any *Y, *Zr, *Nb and Al (from target cladding materials) present, 
while *Sr and *Rb reside in the aqueous phase. The aqueous solution is adjusted 
to a pH > 10 by the addition of 50% NaOH, and the fluid is passed through a 
chelating ion exchange column (Bio-Rad Chelex-100). The *Sr is adsorbed by 
the resin, whUe *Rb is found in the effluent and subsequent wash. Lastly, tl:e 
purified *Sr is eluted from this column with 0.5M HCl. This final solution con-
tains primarily ®^Sr and *^Sr (as an isotopic impurity), with small quantities 
of *Co and *Mn often observable as well. 
If on the other hand, ^^Br is desired for radiopharmaceutical research, in the 
interests of speed and volume reduction the Mo target is dissolved in a mixture 
of cone. HNO3 and H3P04. The ''"'Br is isolated via subsequent distillation, pre-
precipitation, and ion exchange technique, and *Sr remains in the strongly acidic 
dissolurion medium along with other product and target species. This solution is 
then diluted with equal volumes of water and 2,4-dioxane and passed through the 
strongly acidic cation column to adsorb *Sr and other cations. Follov/ing elution 
with 6M HCl, the *Sr is processed as described above in the H2O2 dissolution 
procedure. 
JUass separator studies of the radionuclidic purity of ^^Sr 
The NPL mass separator was used to investigate the levels of possible strontium 
radionuclide impurities in ^^Sr (containing high levels of *^Sr.) Of particular in-
terest were the long-hved pure /3-emitters ^^Sr and '°Sr which could not be assay-
ed by 7-ray spectrometry. 
The NPL mass separator has a linear separation of 15 mm between successive 
mass numbers at mass number 80 and an enrichment factor of better than 2000. 
^^Sr/*^Rb solution was loaded into a graphite crucible together with strontium 
chloride carrier (20 mg) and the solution was evaporated to dryness. The crucible 
was placed in the mass separator ion source and heated to a temperature of 
1000 °K. Positive ions were extracted at 50 kV, focussed, and mass separation 
was achieved in a 90° sector magnet with a magnetic flux of 0.6 tesla. Mass num-
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bers 80 to 90 were collected on a strip of thin aluminium foO. An autoradiograph 
of this foil is shown in Fig. 3. The foil was cut into sections corresponding to 
mass numbers 82, 85, 89 and 90. The activities of the strontium-82 and stron-
tium-85 were assayed using a calibrated intrinsic germanium detector by counting, 
respectively, annihilation quanta and 514 keV 7-rays. The strontium-89 and stron-
tium-90 were assayed in a low background anti-coincidence slnelded 47r|3 proportional 
counter. The radionuclidic purity of all samples was checked by 7-ray spectrometry. 
Preparation and loading of the radionuclide generator 
In an attempt to make use of the better features of the previously reported 
generator systems based on basic AI2O3 or Chelex-100 we chose to test a dual 
column system. The primary generator column is a 5 cm x 1 cm diameter Perspex 
tube filled with Whatman chromatographic grade basic alumina supported by sin-
tered polyethylene (Fisons, Loughborough) discs at top and bottom, the alumina 
being washed exhaustively prior to assembly to remove fmes. The second column 
is a 2 cm X 1 cm diameter Perspex tube of the same design containing Bio-Rad 
Chelex-100 (200-400 mesh preconditioned with 1.8% NaCl at pH 10), and per-
forms a final chemical purification on the primary column eluate, Fig. 4. Both 
columns are provided with threaded ports that can be cormected using 1/16" 
o.d. 1/32" i.d. flanged PTFE tube and 1/4" x 28 TPI screws (Altex fittings, 
Anachem, Luton). 
The ^^Sr solufion in 0.5M HCl is adjusted to pH 9-10 using 3M NaOH and 
loaded onto the AI2O3 column using a peristaltic pump at 1 ml min"'. The 
column is then washed with 200 ml of 1.8% NaCl at pH 9-10 to remove any 
poorly adsorbed activities. Typically more than 99% of the *^Sr and ^^Sr is 
retained on the column. A sample of eluate is taken to assess the *Sr breakthrough 
or leakage from the primary column using a calibrated Ge/Li spectrometer, the 
Chelex column is then connected and further samples are taken on flow to assess 
*Sr breakthrough for the complete assembly at flow rates of up to 18 ml min"'. 
Elution efficiency measurements on a ~ 5 ^Ci test generator were made by 
direct observaUon of the change in the intensity of the 777 keV line of ^^Rb 
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from the equilibrium value to its steady state value during elution at 4.4, 12 and 
18 ml • miri"'. A low geometry Ge/Li spectrometer was used to view the generator 
columns whilst the effluent was transferred to a well shielded position. 
To make the column effluent suitable for human administration it is neces-
sary to adjust the pH 6.5-7.5 and reduce the NaCl concentration to 0.9% which 
is isotonic with blood. This is achieved by mixing the column output flow with 
acidified water for injection/HCl pH 2-4 at an equal flow rate. The mixed solu-
tion is then passed through a sterilizing filter having a pore size of 0.22 fjsn 
and low dead vol (~0.3 ml) (Millipore, SLG0250S) to remove any bacterial con-
tamination. In vitro tests for pyrogens are carried out using the Limulus test 
(Pyrogent-Mallincrodt). Additional in vivo pyrogen tests are carried out on random 
batches of eluate using rabbits. 
Results 
Combined data from Ge/Li spectroscopy and beta and gamma counting of a 
mass separated sample are shown in Table 1. The radiochemical impurities, ^^Co, 
*'*Rb and present the starting material as shipped from LASL are eliminat-
ed during the AI2O3 column loading procedure. The ^ '^^ ^Sr breakthrough has 
never been found to exceed 250 pCi • mf^ and Fig. 5 shows values measured 
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100 h -
New generator 
10 12 V, 16 18 20 
Session No. 
Fig. 5. Generator stability 
con-
Table 1 
Example assay o f " Sr batch shipped 19th December, 1979. 
Reference date 18th December, 1979. 
Nuclide Half-life Activi ty, mCi 
• ' S r 25 d 130 
" S r 65 d 36 
" S r 50.5 d 0.66 
' ° S r 28.5 y 0.01 
8 7 Y 80 h 0.47 
' • C o ' 71 d 0.33 
' * R b 33 d 0.14 
f a <?' 
prior to clinical use of three recently prepared generators. The elution efficiency 
was found to be 66, 49, 14 percent at 18, 12, 4.4 ml min'' respectively, these 
flow rates being found convenient in our clinical situation. 
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Discussion 
Material suitable for ^^Sr radionuclide generator preparation can be separated 
from the spallogenic mixture of products found in the proton irradiated molyb-
denum target. The resulting generator described here represents a significant 
improvement in ^^^^^Sr retention whilst some elution efficiency is sacrificed. 
However, we have chosen to use the generator for steady state infusion studies 
where the flow rate is of necessity much lower than reported by other workers. 
As strontium radionuclides are well known to concentrate in the bone it is im-
perative that the generator is carefully monitored before each clinical use. The 
calculated radiation doses to the skeleton of a 70 kg man from 1 microcurie 
of «^Sr/^^Rb, «^Sr and ' ° S r / ' ° Y are 71.1, 7.6, 5900 mrads,'' thus the search 
for pure beta emitting radionucHdic impurities using the cumbersome technique 
of mass separation is amply justified. The assay of ^^Sr and ®^Sr by Ge/Li 
spectrometry leaves much to be desired as the 514 keV line of *^Sr is not fully 
resolved from the 511 keV annihilation line. In addition values for the abundance 
of the 777 keV line of ®^Rb show wide variations in the hterature (9-13%)'^''^ 
making the proportional subtraction of the 511 from the combined 511 +514 
peak imprecise. This problem is accentuated by the poor statistics encountered with 
assay breakthrough samples containing typically 2 nCi. Thus in the present work 
^^'^^Sr breakthrough values are consistenfly overestimated as no allowance is 
made for the presence of both ^^Rb annihilation photons in the 514/511 com-
bined peak. Attempts are being made to improve this situation using mass 
separated *^Sr samples. 
We are indebted to the United States Department of Energy for their support in this col-
laborative programme. The enthusiasm from our clinical colleagues Drs. A. P. S E L W Y N and 
R. M. A L L A N has been a great encouragement. We would like to thank M. J. K E N S E T T 
for his contribution in carrying out the routine gamma-ray spectrometry 
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Radiation-Induced Defects as Illustrated 
by the ^^Rb-^^^'Kr Target System 
R O N A L D F I N N , M A N H A R V O R A , T H O M A S B O O T H E , 
J A M E S C A M P B E L L , S T U R M C A R R O L L and J O H N C L A R K * 
Cyclotron Facility. Baumritter Institute of Nuclear Medicine. Mount Sinai Medical Center. 
Miami Beach. F L 33140, U.S.A. 
{Reci'iied 16 September 19811 
The preparation of cyclotron-produced radionuclides for incorporation into clincally useful diagnostic 
agents requires special attention to quality control determinations. O f particular concern is the paucity 
of data on the toxicity of those chemical contaminants produced within the target during the bombard-
ment and subsequent radiation cooling as well as those arising from materials used in the handling and 
construction of targets. A l Mounl Sinai Cyclotron Facility, a krypton-rubidium targeiry system has 
been in use for five years. Consequently we shall use this largetry and generator system as an illustration 
of the problems created when such unexpected chemical moieties are encountered. The chemical species 
apparently formed by radiolytic processes as well as their elTects on the chemical processing of the 
diagnostic agent are presented. 
Introduction 
THROUGHOUT the past decade there has been a signifi-
cant increase in the utilization of short-lived radioac-
tive gases having clinical applications. One such gas 
which has been of particular interest to the Nuclear 
Medicine Department of Mount Sinai Medical Center 
is the generator-produced krypton-81m ( t i = l 3 s ) 
used to study pulmonary ventilation functions. 
Furthermore, the parent radionuclide of krypton-81m, 
rubidium-81 ( I j = 4.58 h). having metabolic similarity 
to potassium, is also expected to show diagnostic 
potential, 
Rubidium-81 was prepared by utilizing several 
nuclear reactions upon a variety of targets.""'" The 
^^Kr(p, 2n)"Rb reaction on natural krypton gas has 
been utilized by the Mount Sinai Cyclotron Facility 
for several years.'"" This study illustrates that 
although the chemical effects resulting from the 
nuclear transformation are of particular interest, one 
must also appreciate the synthetic potential of the 
cyclotron beam as a powerful tool capable of catalyz-
ing reactions and thus inducing preparation of a var-
iety of reactive species. 
The currently used rubidium-krypton targetry sys-
tem dramatically emphasizes the necessity of antici-
pating the formation of such chemical contaminants 
and the importance of devising appropriate quality 
control procedures to assess the purity of the short-
lived radiopharmaceuticals produced. 
Nuclear Reociions (or the Preparation 
of RuDidium-81 
• V i s i t i n g Scientist from M R C Cyclotron Unit, H a m -
mersmith Hospital, London, England. 
^ B r t o . Z n l Rb 
Kr I d, nl Rb 
= ' B r l ^ H e . 3 n l ° 'Rb 
Kr( d, 3nl Rb 
Kr ( p, 2n 1 Rb 
FIG. 1. 
iVlaterials and Methods 
Rubidium target and processing 
The rubidium-81 radionuclide is prepared on the 
Mount Sinai Medical Center Cyclotron (Cyclotron 
Corp. CS-30) by using a thick-targei containing 
research-grade krypton gas (Matheson. East Ruther-
ford, New Jersey). The externa) target assembly is a 
modification of a fluorine-18 target system"" which 
facilitates the remote recovery of the rubidium radio-
nuclides. Employing a mean l5-;tA beam current, the 
measured yield of rubidium-81 is 4.4 mCi/|iAh. .-^pari 
from rubidium-81 other concurrently produced radio-
isotopes of rubidium do not interfere with the clinical 
usefulness of the generator as none decay lo radio-
krypton. The target system is diagrammed in Fig. 1. 
Following bombardment of the natural krypton with 
26 MeV protons, the rubidium moieties deposited on 
the walls of a stainless steel, electrically rotated liner 
are dissolved in distilled water which is introduced 
onto the liner by means of a remotely operated pneu-
matic syringe. After rotation of the liner to effect dis-
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F I G . 2. Target and recovery system fo r the prepara t ion o f 
k r y p t o n - 8 1 m generators using the * ' K r ( p . 2 n ) " Rb reac-
t i o n . (1) A l u m i n u m beam m o u n t i n g flange: (2) E N 5 8 B 
stainless steel beam entry windows (0.001 in . in thickness) 
and insu la to r ; (3) Stainless steel l iner ; (4) Borosi l icate glass 
r o d ; (5) Ro ta t i ona l dr ive assembly; (6) Stainless steel water 
co l l ec t ion tube ; (7) A l u m i n u m target back plate. 
solution of the rubidium species, the aqueous solution 
is forced from the target through a cation exchange 
resin (AG50X8. 100-200 mesh, H"). Typically. 4 0 m C i 
of rubidium-81 are loaded onto the generator and an 
elution efficiency of 90°„ of krypton-8l/ii achieved 
using humidified air. The target gas is retained within 
the target and removed every two months for routine 
target maintenance. During the course of this work, 
target gas analyses for nitrogen and oxygen were per-
formed by conventional gas chromatography and 
mass spectrometry. 
Gases and protons 
Historically, the noble gases have been used as 
moderators in gas phase hot-atom chemical investiga-
tions in an attempt to differentiate hot reactions from 
thermal and secondary radiolytic efl"ects." How-
ever, the assumption that noble gases are chemically 
unreactive may not be completely valid" '^ when con-
sidering these gases in an environment of energetic 
charged particles. Minute concentrations of impuri-
ties, e.g. nitrogen and oxygen, have been found to 
profoundly alter the ionization properties of noble 
gases."" 
The effects of radiation on both water and air are 
well d o c u m e n t e d . " R a d i a t i o n induced reac-
tions caused by charged panicles are dependent upon 
the average energy expended per ion pair formed. For 
the noble gases the value of energy ion pair is depen-
dent upon the concentration of impurities."" '-' 
Radiolysis of mixtures of nitrogen, oxygen and 
water vapor produces active species such as ions, 
atoms and excited molecules which react to produce 
such species as N O . N O j , N , 0 . N j O , and O , as 
final products."'-'" " " " ' 
H , 0 . H , , H , O j . H. O H . H O , 
-I- O 2 •—• NO. N 2 O . N O , . ( N , O j . 
Chemical coniaminanls 
When considering the fabrication of a cyclotron 
target, the stability of various components toward 
their surroundings; temperature considerations: and 
resistance to radiation damage without chemical or 
structural alteration are of prime importance. Deter-
ioration and loss of material due to chemical erosion 
may be termed corrosion, which generally occurs 
through the interaction of the processes of dissolution 
and oxidation. In operation the rubidium-krypton 
target system described in this work possesses all the 
necessary conditions for galvanic-induced corrosion. 
Electrical contact between dissimilar materials and 
the presence of oxygen and other ions may be 
expected to greatly accelerate the corrosion effects. 
Stress points and composition galvanic cells are a 
consequence of this target's fabrication. The necessity 
for rotation of the liner coupled with the machining of 
parts from dissimilar metals results in internally 
stressed components. The presence of such stressed 
areas often significantly accelerates the chemical 
deterioration of the component. 
Results and Discussion 
Although the largetry-processine system was 
designed as a closed-loop operation, the introduction 
of water to dissolve the rubidium moieties from the 
walls of the stainless steel liner allows gaseous impuri-
ties (primarily oxygen and nitrogen) to accumulate in 
the target gas. The use of dissimilar metals such as the 
casement of aluminum, stainless steel inner liner and 
copper guide ring in the construction of the target, 
coupled with the water solvent containing ionic spe-
cies in the target leads to galvanic corrosion. Both 
aluminum and iron serve as the anode as indicated in 
the target photographs. 
H P L C analysis of the solution which remains 
within the target until routine maintenance is per-
formed, has indicated the presence of nitrate and 
nitrite ions. Determinations of nitrate and nitrite ion 
concentrations have been performed by high pressure 
liquid chromatography using a Partisil S.AX 
column."'' Furthermore, wet chemical analysis using 
diphenylamine has been employed for confirmation of 
nitrate ions.'"' The maximum concentration of these 
r 
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ions has been recorded al 1.2mg/rnl and 0.06 mg/ml 
respectively, although variability in this determination 
is dependent upon target operating conditions. It 
should be noted that the efficiency of absorption of 
the rubidium radionuclides on the generator resin 
support has been shown to be a function of the pH of 
the target water. Data obtained in experiments study-
ing this efficiency of absorption as a function of time 
of target operation were too variable to allow quanti-
tation of the nitrate concentration. However, with 
continued operation it was noted that the pH of the 
aqueous phase residing within the target became 
strongly acidic and the concentration of nitrate ions 
increased to a maximum with time. The combined 
oxygen and nitrogen content of the target gas was 
determined to be nearly 17% immediately prior to 
maintenance. In addition a slight turbidity was noted 
in the residual aqueous solution with time elapse. F i l -
tration of the aqueous solution prior to the loading of 
the generator column caused slight adsorption of 
rubidium moities. Chemical testing confirmed the 
presence of aluminium. Possible chemical forms for 
this precipitate include AlO (OH) and A U O H I j . 
No attempt has been made to diagnose all the poss-
ible reaction schemes that could be occurring in this 
system. However, if one considers the anodic nature 
and amphoteric character of aluminum, the possi-
bility of formation of oxides of nitrogen; the presence 
of water vapor; and the generation of heat from the 
bombardment of the target gas with energetic pro-
tons; products such as nitric acid, A U O H j j or 
A I O ( O H ) are readily rationalized. 
Conclusions 
A cyclotron adjunct to a large medical center can 
be an extremely useful tool in the armamentarium for 
basic biomedical research and clincal applications. 
However, intrinsic complications related to the cyclo-
tron beam and targetry can arise. The impact of ener-
getic charged particles upon any target system usually 
leads to a complex mixture of chemical species. These 
excited molecules and ions formed by the radiation 
are in most systems chemically unstable and are 
rapidly converted to neutral molecules. The radiation 
and hot-atom chemical results coupled with the lack 
of toxicity data on such chemical contaminants pro-
duced or introduced into the cyclotron targetry pro-
cessing system must be anticipated and if the specific 
has a toxic potential, removed. As evidenced by the 
continued operation of the krypton-rubidium target 
system, the inert nature of the fabrication materials 
can be misleading. Products formed can contribute to 
target deterioration and chemical processing difficul-
ties such as generator breakthrough or parent radio-
nuclide adsorption on precipitated galvanic products 
with and/or within the target itself 
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E x p e r i m e n l s w e r e u n d e r l c k e n u s i n g r u b i d i u m - 8 2 a n d p c s i l i o n l o m o y i ^ p h y 
l o e x a m i n e t h e r e l a t i o n b c l w e e n m y o c a i d i a l p e r f u s i o n and c a l i o n up ' .ake 
d u r i n g a c u t e I s c h e m i a , R u b i d i u m - 3 2 w a s r ep ' ^a tod ly e l u l e d ( rorn a 
s t r o n l i u m - 8 2 - r u b i d i u m - 8 2 g e n e r a t o r . In six dogs e m i s s i o n l o n i o g t a r r . s 
w e r e u s e d t o m e a s u r e t h e d e l i v e r e d a r l o t i a l a n d n i y o c a t d i a l c o n c i n l i a-
l i o n s a l res t a n d a f t e r c o r o n a r y s t enos i s , s t ress a n d i s c h e m i a . There v-.'-s 
a poo r o v e r a l l l e l a l i o n b e l v . ' o e n r e g i o n a l m y o c a r d i a l u p l a k e and f!: w 
m e a s u r e d b y m i c r o s p h e r e s a n d a l a r g e i n d i v i d u a l v a r i a b i l i l y . E x l r a c i i o n 
of r u b i d i u m - 8 2 w a s i nve r se ly r e l a t e d lo ( low. Sig.ni ' icanI r eg iona l r e d u c l i o n 
of c a t i o n u p t a k e w a s d e t e c t e d in t h e t o m o g r a m s v /hen r e g i o n a l f l o w d e -
c r e a s e d b y m o r e t h a n 35 p e r c e n t . Th i s r e d u c l i o n v/as s i gn i l i c an ' l y g r e a l e r 
w h e n i s c h e m i a w a s p r e s e n t . A s m a l l bu t s i g n i f i c a r i l d e c r e a s e ( 3 3 . 0 i 9 . 1 
p e r c e n t , m e a n db s t a n d a r d d e v i a t i o n ) in the m y o c a r d i a l u p t a k e of r u b i d -
i u m - 8 2 w a s d e l e c t e d o n l y w h e n ( l o w w a s i n c r e a s e d by rtiOre i h a n 1 2 0 
p e r c e n t i n r e l a t i o n t o a c o n t r o l a r e a a f l e r a d m i n i s l r a t i o n of d y p i r i d a -
m o l e . 
The t e c h n i q u e u s i n g t u b i d u m - 8 2 a n d t o m o g r a p h y w a s a p p l i e d in f i v e 
v o l u n t e e r s o n d f i v e p a t i e n t s w i t h a n g i n a p e c t o r i s a n d c o r o n a r y a r t e r y 
d i sease . M y o c a r d i a l ( o m o g r a m s r e c o r d e d at res t a n d a f t e r e x e r c i s e in t h e 
v o l u n t e e r s s h o w e d h o m o g e n e o u s u p t a k e of c a l i o n in r e p r o d u c i b l e a n d 
r e p e a l a b l e s c a n s . In c o n t r a s t , t h e p a t i e n t s w i t h c o r o n a r y a r t e r y d i s e a s e 
s h o w e d a n a b s o l u t e m e a n d e c r e a s e of 3 6 ± 14 p e r c e n t i n r e g i o n a l 
m y o c a r d i a l u p t a k e of r u b i d i u m - 8 2 a f l e r e x e r c i s e . T h e s e a b n o r m a l i l i e s 
pe r s i s t ed in s e r i a l t o m o g r a m s fo r m o r e I h a n 20 m i n u t e s a f l e r the s y m p t o m s 
a n d e l e c t r o c a r d i o g r a p h i c s i g n s of i s c h e m i a . 
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R a d i o a c t i v e ca t ion .? a re w i d e l y u s e d t o i i n ; i j ; e t h e m v i r c a r d i u i n . ' T h e 
t n a j o r p r o b l e m s i n c l u d e t h e i n a b i l i t y l o m e a s u r e i h e aUsivUiU- r e g i o n a l 
m y o c a r d i a l u p t a k e i n r e l a t i o n t o t h e i n j e t t e d drrse or a r t e r i a l c r i n c f r n -
t r a t i o n . I n a d d i l i o n , t h e \ a r i a b l e t i s s u e a l t e n u a t i c r n a n d in(.-(TK i e n l d e -
l e c l i o n o f l o w o r h i g h e n e r g y e m i s s i o n s h i n d e r q t i a n l i l a t i o n . T h e l o n g 
h a l f - l i f e o f L h a l l i u m - 2 0 1 m a k e s s e r i a l s t u d i e s d i f f i c i i l l , a n d n o t e i i i ' i i g h 
is k n o w n a b o u t t h e r e l a l . i ve i m p o r t a n c e o f t h e e f f e c t s o f f l o w , e x l r o c t i i i n 
a n d mass w i t h i n t h e i n y o c a r d i u n i . ^ 
T h i s p a p e r d e s c r i b e s t h e use of a si roo t i u rn -82 ru l ) i r i i i in i - . '<2 s^i-iH-rau..: 
f o r t h e i n t e r i n i U e n l e l i i l i o n o f r i i l r i d i u m - 8 2 i n s a l i n e s ( ' l u l i r j n . T h e 
p h y s i c a l a n d b i o l o g i c p r n p e r l i e s o f ( h i s I r a c c r ( h a l f l i f t - T S s e r ^ . n r ; ; 
511 k e V c o i n c i d e n c e p l i n l o r i s ) w i t h i n i s i t r o n t n n i n g r a p h y I r t r g c l y c . e r -
c o n i e v a r i a b l e a l l e n u a l i c ' i i a n d ( l e r m i l ripc.-isiireiin.-iil n f r c g i i ' i i a l m y o -
c a r d i a l t i p t a k e ( i f t h e i.:al i o n . T h e s h o r t h a l f - l i f e is ; V ) j l i ' i l ( - ( ! i n sr r i s l i f . -
iTKpgrams p e r m i t t i n g e a c h s u h j e r l t o be used as h i s n w n (- . . •nlrol . .A r e f -
e rence mcr.Tsure o f H o w has b e e n u s e d i n e x j . r e r i m e r i t s t o e>:i>riirt- t h e 
r t - l a l u r n bet wr-e i i r i ; g i i ' i i a l n n ' r t c a r d t a l c ; i l r^pn u p t a k e i m d j>erf ' . iS)i 'n. v. j t h 
a n d w i t h o u t i s c h e m i a . T h e c l i n i c a l a p | i l i c a l i o n r . f t h i s m e t h . . d is f i e m -
o n s l r a t e d i n p a t i e n t s . 
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Methods 
P r c i i a r a t i o n o f t h e gonoraWrr : The- i i a n n l , s ( r o n t i u m - 8 2 
is p rdduced at (he Cli i i l<in P. .•\nd(.T.';c.n McM.n Physics f a c i l i t y 
M t he Los A l a m o s S c i e n t i f i c L a l j o r a l o r y , N e w M c x i f o . T h e 
j j a r c n l m a t e r i a l con ta ins as a p r o d u c t i o n eon l^ i tn inan t 
s t ront ium-8.5 ( l i a l M i f e 65 days) in s i f jn i f i can t . qua j i t i t i e s . T h e 
s t r o n t i u m isotopes are I x a m d (o an a l u m i n a c o l u m n , w h i c h 
has a h igh a f f i n i t y for s t r o n t i u m at. high p H (9 to 10), h u t a low 
a f f i n i t y for r u b i d i u m and sod ium. R u b i d i u m - 8 2 can be e lu t ed 
c o n t i n u o u s l y f r o m the generator by 1.8 percent sod ium c h l o -
ri«ie at. p H 10 a t f l o w ra («s up to 30 m l / m i n . " ' - ' ' A n equal f l o w 
o f a c i d i f i e d walx-r fo r in jec t ion is added to adjus t the infusat^e 
t o 0.9 pe rcen t s o d i u m ch lor ide a t j ) H 7 to 8. T h e i n f u s a l e was 
s t e r i l i zed hy t e r m i n a l f i l t r a t i o n ( M i l l i p o r e .SLG02.i.0.'), 0.22 
inn). T h e j .uoduct has been shown to be pyrogen- f ree by i n 
v i v o r a b b i t t e s t ing (Consu l lox , L o n d o n ) . T h e c l u l i o n o f 
s t r o n t i u m isotoj ies is low and an up | ie r l i m i t o f 1 ijCI per 
l i t e r " ' o f s( r o n t i u i n - 8 2 and strontium-.S.5 has been set.. T h e 
ca lcu la t ed rad ia l ion dos t to t lu - skc-lelon o f a 70 kg man f r o m 
1 fiCi o f St ron(ium-8.5 and s t r o n t i u m ,S2- r u l i i d i u m 82 is 7.6 
and 71.1 mrads , rcspect.ively. 
T h e f j u t j ^u t o f iJie s tr( int ium-82- rul^irIium-<S2 generator (10 
n i l / m i n o f n o r m a l sal ine so lu t ion) was p u m p e d over a c a l i -
b r a t e d de tec tor ( B i c r o n l . r>M2/2P, O R T E C ) . T h e a c t i v i t y 
s t ab i l i zed w i t h i n 90 seconds and var ied by ±b p e n ent fo r 40 
m i n u t e s o f observa t ion . T h e b r e a k t h r o u g h of s t r ( i n t i u m - S 2 
a n d s t r o n l i u m - 8 5 was less t h a n C I O / j Q i / l i t e r . 
T h e o r e t i c a l c o n s i d t r a t i o n s ; R u b i d i u m - 8 2 has a h a l f - l i f e 
o f 78 seconds. D u r i n g a con t inuous in t r avenous i n f u s i o n o f 
cons tan t a c t i v i t y a rad ioac t ive e q u i l i b r i u m is achieved i n t h e 
a r t e r i a l b lood o w i n g t o rap id decay o f t.he isotope in the sys-
t e m i c b lood poo l . T h e a r te r ia l concen t r a t i on of r u b i d i u i n - 8 2 
at e q u i l i b r i u m re | jresents the i n p u t concen l ra l ion t o the 
co rona ry c i r c u l a t i o n and m y o c a r d i u m . T h e a c t i v i t y o f r u -
b i d i u m - 8 2 in the m y o c a r d i u m w i l l also reach an e q u i l i b r i u m 
because of the const^int i npu t and rap id decay of rv ib id ium-82 . 
' f h e r e l a t i o n between the a r te r ia l and myoca rd i a l concen-
t r a t i o n s is d e t e r m i n e d by the conservat ion o f energy ( t h a t is, 
r a d i o a c t i v i t y ) o f r u b i d i u m - 8 2 : 
I n p u t = o u t p u t - I - decay of r u b i d i u m - 8 2 : 
Therefc i re , the expression is: 
E X F X Ca = F X C V -1^  X A T , (1) 
w h e r e E = e x t r a c t i o n o f r u b i d i u m - 8 2 f r o m b lood i n t o t issue, 
F = b lood f l o w t o (he m y o c a r d i u m , Ca = a r t e r i a l a c t i v i t y o f 
r u b i d i u m - 8 2 , C V = venous ac t iv i ty o f r u b i d i u m - 8 2 , X = decay 
c o n s t a n t fo r r u b i d i u m - 8 2 and A t = a c t i v i t y o f r u b i d i u m - 8 2 
i n t h e t i s sues .Tf we d i v i d e th i s expression by v o l u m e ( V ) 
t h e n , 
E . S . C . (2) 
w h e r e C l now represents the tissue a c t i v i t y o f r u b i d i u m - 8 2 
a n d p = the p a r t i t i o n c o e f f i c i e n t fo r r u b i d i u m - 8 2 a n d , 
hence, 
p C t = C V . 
T h i s equa t ion can be rearranged: 
C t = E . ^ . C a (3) 
Once r u h i d i u m - 8 2 , l ike p o l ^ s s i u m , is t aken up i n t o m y o -
cardia l cells the tu rnover de te rmin ing release (40 minu tes a n d 
hours ) is s low i n r e l a t i on t o (he r a p i d decay (78 seconds) . 
T h e r e f o r e , i n ; i g n i f i c a n t quan t i t i e s o f r u b i d i u m - 8 2 w i l l be 
washed out o f the m y o c a r d i u m in the act ive f o r m and t he re -
f o r e p ( F A ' ) is smal l i n relat ion to X. 
Ct 
E . - . C a 
Ca can be measured f r o m the (^jmographic e c j u i l i b r i u m scan. 
Ct can be measured f r o m the t omograp l i i c wasl i f tu t scan. X is 
cons tan t and therefore the above expression can be used to 
ca lcula te E - ( F A ' ) in each regitpii of the m y o c a r d i u m : 
X ^ - F ^ 
^ C a ~ ' ' v 
( 5 ) 
A n i m a l S t u d i e s 
E x p e r i m e n t a l p r e p a r a t i o n ; ,Six mongre l dogs (we igh t 20 
t o 3.5 kg) were anesthetized using in t ravenous t h i o p e n t o n e 
s o d i u m (12 m g A g body we igh t ) . Anesthesia was main t -a in rd 
using | ) tn l aba rb i tone (2 m g A g ) i n t e r m i t t e n t l y a j i d respira t ion 
WHS maint.ained w i t h a cu f f ed endotracheal tube and H a r v a r d 
ven(,ila(or. Portex tub ing and three-way taps were filled w i t h 
hepar in ized .saline soluticm (1,000 l U / l i t e r ) and inse r t ed by 
way o f the f emora l ar tery and f emora l vein i n t o the thorac ic 
af^rta and i n f e r i o r vena cava. I n four dogs (he a r t e r i a l blcK.'d 
was c o n s t a n d y withdra\H"n f r o m the f emora ! a r t e ry , [)um;*»rd 
over a ca l ib ra t ed detector ( B i c r o n 1.D.M2/2P, O R T E C ) end 
t h e n r e tu rned to the f emora l ve in . T h e level o f a c t i v i t y mea-
surei l by the detector was recorded on a s t r i p char t before , 
d u r i n g and af ter infus ion of rubidium-S2 in to a per iphera l vein 
f o r 10 minu te s . 
A le f t thoraco tomy was per formed and the heart suppo.'-icd 
in a pe r i ca rd i a l cradle. A plast ic c u f f and wedge device was 
pos i t i oned a r o u n d the m i d pf»rt ion o f the l e f t a n t e r i o r de-
scending coronary artery in order lo produce a graded deer.. .-..^ 
i n l u m i n a l d iameter . P r t i x ima l tct th is a 3 or 4 m m diamc ' .e : 
f l o w probe (Systems Elec t ronic , SE) was pos i t i t 'ned arC'U.nd 
the l e f t an te r io r descending coronary a r te ry . Pul.satile and 
mean coronary f l o w were recorded using a f lowmeter t S E '27.51. 
T h e l inear response of the probe was checked and m e c b a n i i a i 
occlusions o f the l e f t anterior descending coronary a r te ry ss^tt 
made t o ensure a le.ss than 5 percent d r i f t in zero level 
t h r o u g h o u t the s tudy. T h e probe was ca l ibra ted in - s i t u a; the 
end o f the exper iments . F low in m l / m i n was ca lcula ted usinE 
t h e mean f l o w t rac ing and ca l ib ra t ion data . 
A 7 F rench catheter was inserted t h r o u g h a pu r se - s i r i n i : 
su tu re i n t o the l e f t a t r i u m and pacing wires were s t i t c h e d to 
the l e f t a t r i a l appendage. A o r t i c and le f t a t r i a l pressures l i c 
m m H g ) were measured using P 23 d B S t a t h a m t ransducers 
and devices ampl i f i e r s . T h e epicardial e lec t rocardiogram v.as 
recorded us ing a saline-soaked co t ton electrode (1 m m = 1 
m V ) . Pressures, e lec t rocardiographic and f l o w d a u we re re-
corded on a m u l t i c h a n n e l s t r i p chart recorder (Devices ) . 
Arterial blood samples were taken i n t e r m i i t e n l l y for 
measurement o f par t ia l pre.ssure of carbon d ioxide and ox'>f:en 
p H , h e m o g l o b i n and acid base balance. 
P o s i t r o n emiss ion t r a n s a x i a l tomograph .v : I!ach dog ^ss 
pos i t i oned w i t h i n a hexagonal r ing o f s o d i u m iodide cr>~ials 
organized f o r de tec t ion of coincidence r ad i a t i on ( E C . A T p.-o-
duced by O R T E C ) . A m i d l e f t ven t r i cu la r pos i t ion w £ 5 se-
lected for serial transa.xial emission tomography. The posiii-. 'rj 
was f i x e d in r e l a t ion to the detectors by a laser beam. 
A n ex t e rna l r i n g source o f ge rman ium-68 was po5iti".--7<i 
be tween the detectors and the ana tomic pos i t ion chose.n :'or 
Iran.saxial tomography. Transmission scans were collected :o; 
la ter a t t e n u a t i o n cor rec t ion of emission data.* R u b i d i u n j - : " 2 
(15 to 18 m C i / m i n ) was e lu ted in 10 m l / m i n o f 0.9 percent 
s o d i u m ch lo r ide so lu t ion and infused in t ravenous ly .^ Serial 
ar ter ia l blocxJ samples were collected and c<iunts/ml measvrec 
i n a c a l i b r a t ed w e l l counter . A t e q u i l i b r i u m of a c t i v i t y in the 
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a r t e r i a l b l o o d , the K C A T recorded coincidence events fcrr 120 
seci 'uds ( e r i u i l i b r i u i i i scans). T h e i n f u s i o n was s lup i i ed and 
t o m o g r a p h i c da ta were again recorded al between 30 and l.')0 
seconds a f t e r the r u b i d i u m - 8 2 inf i i s i r rn ( m y o c a r d i a l scans). 
E n i i s s i o n da ta were corrected for attenu,-3tion and recon-
s t r u c t e d b y c o m p u t e r i n t o images w i t h i n a 100 by 100 m a t r i x 
o f p i x e l s . 
The inslruiiicnl has a rcsoluli<in uj 1.4 cm and a .v/ice 
t h / c f c r i c w of 1.6 cm. Week ly cal ibra t ions using phnnUrms and 
k n o w n a c t i v i t y arc used to ensure l i n e a r i t y and st.ahle sensi-
t i v i t y . A week ly c a l i b r a t i o n fac tor is ca lcu la ted in order to 
r e la* t E C A T counts to wel l counter c o u n t s / m l per s. 
P r o i o c o l of t h e E x p e r i m e n t s 
P h a s e 1: E q u i l i b r i u m and myoca rd i a l scans, e lec t romag-
n e t i c c o r o n a r y f l o w , ep ica rd ia l e l ec t roca rd iog ram, l e f t a t r i a l 
pressure and aort ic pressure were all recorded du r ing a cont ro l 
p e r i o d w i t h o u t in t e rven t ions . T h r e e a r t e r i a l b lood samples 
were d r a w n d u r i n g the e q u i l i b r i u m scaits and i h r e e t o e igh t 
s amples were d r a w n d u r i n g the e q u i l i b r i u m scans and three 
l o e igh t samples were d rawn dur ing the m y i c a r d i a l srans, and 
a c t i v i t y ( c o u n t s / m l per s) i n each sample was nu-asur td i n a 
w e l l coun te r . T w o t o f i v e m i l l i o n microspheres (7 l o ]b fi), 
l a b e l e d w i t h 30 fiCi o f iodine-125 (3.M C o m p a n y ) , were sus-
pended i n no rma! saline strUilion, mixed , agi ta ted and i t i jec led 
i n t o the l e f t a t r i u m . A t i m e d ar ter ia l sample was collected f o r 
t h e l a t e r c a l c u l a t i o n o f mYrK:ardlal b lood f l o w . 
P h a s e 2 : T h e screw device was used t o decrease t he d i a m -
eter o f the l e f t an ter ior descending coronary a r te ry . T h i s was 
done u n t i l rest ing f l o w was decreased by 10 to 15 percent and 
r e a c t i v e h y p e r e m i a abol ished. Care was t h e n t a k e n t l i a t no 
f l u c t u a t i o n s or decreases in f l o w greater t h a n 15 percent oc-
c u r r e d . Obse rva t ions were recorded to be sure tha t the l e f t 
a t r i a l pressure d i d not increase pr irgressively or s i g n i f i c a n t l y 
above the con t ro l values (5.0 ± 3.0 m m H g before stenrrsis, 5.5 
± 2.2 a f t e r s tenosis) . T h e regional ep ica rd ia l e lec t rocard io-
g r a m s were recorded t o ensure tha t no s i g n i f i c a n t changes 
o c c u r r e d i n the S-T segment (depression or e levat ion greater 
t h a n 1 m r n ) , i n the Q R S w i d t h or the r h y t h m . T h i s evidence 
was used t o ensure t h a t the stenosis alone d i d no t cause re-
g i o n a l m y o c a r d i a l ischemia. L e f t a t r i a l pac ing was tised t o 
increase the hea r t rate by 20 to 25 percent f o r 15 minu te s . 
E q u i l i b r i u m and m y o c a r d i a l scans p lus a l l the observa t ions 
l i s t e d i n phase 1 were recorded. C e r i u m - 1 4 1 - l a b e l e d m i c r o -
spheres were used. 
P h a s e 3: A f t e r 30 minu te s o f recovery a f t e r phase 2, t he 
e l ec t roca rd iog ram and l e f t a t r i a l pressure were used to de tec t 
evidence o f myocard ia l ischemia. I f no i.schemia was found the 
l e f t an t e r i o r descending ar ter ia l stenosis was checked and the 
h e a r t ra te increased b y 70 to 80 percent f o r 10 t o 14 m i n u t e s . 
E q u i l i b r i u m and m y o c a r d i a l scans plus a l l the observa t ions 
l i s t e d i n phase 1 were recorded. . ? t r on t i um-85 - ) abe l ed m i -
crospheres were used. 
P h a s e 4 : A f t e r 30 minu tes o f recovery a f t e r pacing, a check 
was again made f o r evidence o f regional m y o c a r d i a l ischemia. 
I f none was f o u n d , the cr i t ical left anter ior descending ar te r ia l 
s tenosis was checked and then 0.3 m g / k g per m i n o f d i p y -
r i d a m o l e was i n f u s e d in t ravenous ly f o r 10 m i n u t e s . T h i s was 
used t o p r o d u c e a 5 to 10 percent decrease i n mean aor t i c 
pressure. T h i s in t e rven t ion was u.sed in an a t t empt to produce 
c o r o n a r y v a s o d i l a t i o n , increases in p e r f u s i o n trt areas una f -
f e c t e d b y t h e co ronary stenosis and t h e r e f o r e regional d i f -
ferences i n f l o w i n the l e f t vent r ic le . T h e e f f ec t s o f the d r u g 
on f l o w were measured w i t h the labeled microspheres . E q u i -
l i b r i u m and myoca rd i a l scans plus the observalioi-is l is ted f o r 
phase 1 were repea led . Scandii im-'16 - labeled microspheres 
were used. 
W e l l c o u n t i n g o f b l o o d samples : , - \ l l l i lonH s-Tiuples were 
d r a w n i n t o t.arred tubes and weighed. T h e t ime f r i ' i n w i t h -
dra\val to comple t ion o f well crrunting was rf-ctirfl<-d and ust-d 
f o r decay correct ion . T h e number o f count s/s per ml was cal-
ci r la ted using a ca l ib ra ted detector . 
P o s t m o r t e m d i s s e c t i o n o f t h e h e a r t : A t the end o f each 
exper ivnen l t h e laser l i gh t was \rsed l o m a r k the t rack o f the 
t ransax ia l slice on the heart seen by the detectors. T h e or-
i e n t a t i o n o f t he hear t and slice w i t h i n the r ing was recorded 
i n re la t ion t o the f i e l d o f view, laser, vent r icu la r ana tomy and 
ep ica rd ia l co rona ry arteries. T h i s procedure a l lowed later 
compar i son o f eight regions o f vei-i tr ici j lar m y o c a r d i u m w i t h : 
e igh t regions i n the emission tomograph ic scans. Ca l cu l a t i on 
o f regional myoca rd i a l f l o w for each area ( m l / g per m i n ) was 
made by n i u l l i p i c birr j isy, wel l coont i i tg w i t h sef ia ra t ion of 
. energy levels e m i t t e d by the four inicrospbere label? and the 
reference a r t e r i a l wi t l id r . t \ va l . ^ 
C a l c u l a t i o n s M a d e F r o m P o s i t r o n T o m o g r a p h y 
Tornograi . ihic images wr-re reci-rrlt-d r.n ;15 m m f i l m and i n -
spected by three observers, ' t he t i M i i o g r a p h i c d i s t r i h u i i o n of 
a c t i v i t y is recorded v\-i l t j in a 100 by RtO m a t r i x of pixels , arid 
a p r i n t o u t o f th i s image p r m idesa mat r ix d i s | i l ay r.if 20 by 20 
numbers , each represent ing a mean i . f 25 | ) i \ e l s . T h e d i m . n-
sion ( i n mrn) for each pixel is gi'-'en fi.'r each scan. T w o ir ide-
penden t observers calculated the dala . The peak count in the 
m a t r i x was i d e n t i f i e d and a l l counts of .50 p e n ent or more iti 
the peak value were enclosed, thus i d e n t i f y i n g the to.m.-igram 
of the myocard ium. T h e favorable myocardium l o ha< k t r o u n c 
r a t i o a l lowed e igh t regions to he i den t i f i ed in the t o m o g r a m 
w i t h the spatial o r i e n U l i o n recorded as described eaj l ier , thus 
alUrwing regional compar i son w i t h microsphere data. 
M y o c a r d i a l s c a n s : T h e mean of fc'Ur peak counts in each 
o f 1 he e ight areas o f interest was calculated. Counts/s per g o:' 
tissue were ca lcula ted f r o m the ca l ib ra t ion factor r e l a t i n g 
E C A T counts to wel l <-ounter equivalents. Crtrrecl if'ns fc'r the 
p a r t i a l v o l u m e e f f e c t were made using measureinents o f v.al! 
th ickness t aken f r o m the dissected slice o f inviK-ardium. T h e 
v.all th ickness ( i n m m ) in each region v.as used to select £ 
systematic cor rec t ion factor der ived f r o m publ ished phanlfTT; 
s tudies. Because w a l l th ickness is under the resolut ion o f the 
detector t h i s fac to r , w i t h ca l i b r a t i on , al lows f u l l count rate 
recovery f r o m the tissue. The ac t iv i ty in each area was cor-
rected for decay back to the end of the rubidium-S2 infus ion . 
E i j u i l i b r i u m scans: T h e |ieak counts over the left ven i r i c lc 
were used to calculate counts/s per m l . These values were 
compared w i t h the counts/s per m l obta ined f r o m the corre-
spond ing a r t e r i a l b lood samples taken s imul taneous ly . 
The arterial and myocardial cunccntraiions u-ere related 
as shown: 
X 0.693/78 X W / l , 
Regional m y o c a r d i a l (coiints/s per g) 
A r t e r i a l a c t i v i t y (counls /s per ml ) 
where 0.683/78 represents the tu rnove r o f r u h i d i u m - S 2 due 
to decay. T h i s calculat ion provides a f rac t ion representing the 
up take o f r u b i d i u m - 8 2 in each region of the m y o c a r d i u m in 
r e l a t i on t o t h e de l ivered a r t e r i a l activ ' i ty presented w the 
hear t , t h a t is, a f r a c t i o n for ex t rac t ion X f l o w / m g per rain. 
S t a t i s t i c a l a n a l y s i s : T h e six dogs s tud ied p rov ided the 
f o l l o w i n g comparisons between regional myocardia l flov.- anc 
ca t ion up take : (1) C o n t r o l , six compari.=ons; (2) stenosis plus 
pac ing , six compar i sons ; (3) stenosis plus r a p i d pacing, f o u r 
compar isons ; and (4) stenosis plus d i p y r i d a m o l e , fou r com-
parisons. Pa i red ( t.e,sts and l inear regression analvsis were 
used t o c o m p a r e t h e f o l l o w i n g measurements: (1) a n e r i a ! 
a c t i v i t y (counts/s per g) al e q u i l i b r i u m measured f r o m E C A T 
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T A B L E I 
Hemodynamic C h a n g e s in E a c h Stage of the Dog Exper iments 
Heart rale 
(beals/min) 
Mean aortic 
pressure (mm Hg) 
Mean left atrial 
pressure (mm Hg) 
^ Electrocardiogram' 
Number of 
comparisons 
between rubidium-82 
_ uptake and flow 
Phase 1 
Control 
F ^ s e 2 
Pacing 1 
Phase 3 
Pacing 2 
Phase 4 
Dipyridamole 
120 ± 15 1 150 ± 10.0 195 ± 24.0 124 ± 17.0 
101 ± 7.0 97 ± 10.0 93 ± 11.4 94 ± 12.3 
5.5 ± 2.2 4.5 ± 2.6 10.5 ± 6.0 7.6 ± 4.1 
Normal in 
6 dogs 
6 
Normal in 
5 dogs and 
positive in 1 
6 
Positive in 
4 dogs 
4 
Norntal in 
3 dogs and. 
positive in 1 
4 
• A positive electrocardiographic response was S-T depression greater than 1 mm below the T-P segment at 20 ms after the end of the ORS 
complex. 
FIGURE 1. The transmission scan (1) 
stwws l t« fieart, lungs and chest within 
a transaxial slice of a dog. This is used 
to correct emission scans for tissue 
attenuation. The equilibrium scan (2) is 
recorded during rubidium-82 infusion 
arxf shows ttie activity in lf>e ventricles 
and aorta which is used lo calculate 
delivered concentration. The myocar-
dial scan (3) records tissue activity in 
the free wall (FW) of the left ventricle 
and tfte interventricular septuin(s). This 
tomogram was recorded at 30 to 150 
seconds after cessation of the intra-
venous infusion of rubidium-82 and 
shows ttie free wall and apex (A) of tlie 
left ventricle and ttie intervenliicular 
septum. The earlier arterial concen-
tration plus the myocardial concentra-
tion allows nDeasurements of regional 
myocardial uptake of the cation. 
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a n d f r o m t h e bl iKrd samples , and (2) t he regi i - i .a l myo< a r d i a l 
u p t a k e o f r u h i d i u m - 8 2 and regional myii< a r d i a l f l o w i n each 
o f t h e e ight regions o f intere,st i n each phase o f t he experi-
ments . 
Patient Studies 
N o r m a l v o l u n t e e r s : F ive vo lun tee r s w i t h no de tec tab le 
evidence o f heart disease were posi t ioned i n the E C A T c a m e r a 
a n d an 18 gauge needle was placed i n an an t ecub i t a l vein . T h e 
s t r o n t i u m - 8 2 - r u b i d i u m - 8 2 generator and t u b i n g were p r e -
p a r e d us ing aseptic t e c h n i q u e and the i n f u s a t e was f i l t e r e d 
( M i l l e T ; 0.22 ^ , M i l l e p o r e S A ) . T r a n s m i s s i o n scans were re-
co rded fo r la ter a t t e n u a t i o n co r r ec t i on o f emiss ion da t a . 
E q u i l i b r i u m scans were recorded (120 seconds) when one h a n k 
o f de tec tors showed cons tan t a c t i v i t y on a l inear d i g i t a l r a t « 
me te r . M y o c a r d i a l scans were recorded be tween 30 a n d 150 
seconds a f t e r cessation o f the I n f u s i o n . E q u i l i b r i u m a n d 
myix-ard ia l scans were p e r f o r m e d w i t h each stibject at rtrst and 
again at 0, 10 and 20 m i n u t e s a f t e r a s y m p t o m l i m i t e d m a x i -
m a l exercise test p e r f o r m e d s r i j i ine us ing a b icyc le er-
goiTieter. 
P a t i e n t s w i t h c o r o n a r y a r t e r y disease: F ive p a t i e n t s 
( f o u r male and one female , aged .36 to 65 years) were selected 
f o r s t u d y . These pa t i en t s a l l had e x e r t i o n a l angina a t least 
FIGURE 2. TLiese serial lorTX>grams were recorded during (our ptiases 
of the same dog experiment shown in Figure 1. Ttiere was a uniform 
regional myocardial uptake of rubidium-82 during the control period 
with critical coronary stenosis but no sti ess (phase 1). Atrial pacing (116 
lo 150 beats/min) with no ischemia (ptiase 2) produced insignificant 
differences in the regional myocardial uptake of rubidium-82. Rapid 
atrial pacing (120 to 190 tieats/min) with evidence ot iscL»emia (phase 
3) produced a decrease in regional myocardial uptake ot rubidiurT)-82 
arid microsphere flow. Although dipyridamole (phase A) produced a 
2.2:1 difterence in regional myocardial blood flow between pcsl-slenotic 
and remote areas there were no iscLiemia and no obvious regional 
differences in uptake of rubidiurTV-82. 
<in<e d a i l y (class II . New Y o r k Hear t .As.^ociation). A l l f i v e 
pa t i en t s had s ign i f ican t S -T sr-gincnl depression and chesl 
p a i n d u r i n g a p<rsilive exercise test and the work load achieved 
ranged f r o m 1 l ,0f)0 to 21.000 joules d u r i n g (he test. Four o f 
the f ive pat ients I i d ihree vessel coronary ar tery disease and 
one had two vessel di-case on angi iKardingraphy. Each patient 
was positi<rned in the E C A T c a m e r a . E q u i l i b r i u m and inyo-
c^irdial scans were rr-corded at rest as descrilied for the he-i l thy 
volunteers . Each ])a(len( then pe r fo rmed a s y m p t o m - l i m i t e d 
g raded exercise test w i t h use o f a b icycle ergonieter and con-
t i n u o u s e lec t rocard iographic m o n i t o r i n g . E q u i l i b r i u m and 
myocard ia l scans were pe r fo rmed at 0 ,10 and 20 minutes after 
exercise. 
M mode echocardiography was used to measure the 
th ickness o f the in t e rven t r i r ular s ep tum and the free wa l l of 
the le f t ventricle. These niea-ures were used fur pa r t i a l volume 
c o r r e c t i o j i of emission data.^ 
Results 
A n i m a l S t u d i e s 
riiiring the six experiments the partial pressure of 
oxygen ranged between 90 and 110 mm Mg, the partiaJ 
pressure of carbon dioxide between .30 and 46 mm Hg 
and the pH between 7.38 and 7.40. Table I shows the 
changes in heart rate, bl<K>d pressure, left atrial pressure 
and electrocardif)gram during the four phases of the 
experiments in six dogs. 
A r t e r i a l blood radioactivity: The activity detected 
in 10 ml/min of normal saline solutirm continuously 
eluted from the stroiitiuin-82 Rubidium-82 generator 
showed that w ithin 2.0 minutes an equilibrium of ac-
tivity was achieved (at 5 to 16 mCi min) and was 
maintained for 7 minutes (w ithin ± 3 . 0 percent). Simi-
larly, the activity detected in 30 ml/min of arterial blood 
during a peripheral intravenous infusion reached 
eijuilibrium within 4 minutes. During the next 6 min-
utes of infusion (here was ± 4 . 0 percent variability and 
a small systematic decrease in activity ranging from 5 
to 6 percent. When the peripheral intravenous infusion 
of ruh)dium-82 was stopped, the arterial activity began 
to decrease within 10 seconds and decreased below 25 
perceilt of peak activity within 30 secfjnds in all the 
experiments. 
E q u i l i b r i u m scans: Figure 1 shows an example of the 
tomograms recorded during the constant infusion of 
rubidium-82. The heart to background ratio of activity 
was 4.0 ± 1.3:1 (mean ± deviation). T h e peak activity 
in the scan was calculated (counts/ml per s) and then 
used as the arterial concentration of rubidium-82 at 
equilibrium. There was a significant relation between 
the arterial activity measured by the camera and the 
simultaneous measurement of activity made using bl(K>d 
samples and well counting (Y = X0.85 + 828.0, corre-
lation coefficient [r] = 0.90, probability (p) = <0.0(ll. 
n = 19). This measure was made without partial vrjiume 
effect because of the size of the cavity and of tht 
heart. 
Myocardia l scans: Figure 2 shows an example of the 
myoc ardial scans recorded during control conditii-ns as 
well as a sequence of images recorded from a single ex-
periment showing the regional myocardial distribution 
of rubidium-82 in tomograms during the control perit)d 
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FIGURE 3. Wilh crilical slenosis 
and no slress or ischtemia (ptiase 1) 
Ihe regional myocardial distribulion 
o l uibidium-82 (upper graph) is 
similar to IK-jt ol flow (lower graph). 
Relalion between legional myo-
cardial p.';rlusion and uptake of ru-
bidium-82. Crilical slenosis wilh 
pacing but no evidence of ischemia 
(phase 2) produced regional ine-
qualities of blood flow bul no sig-
nificant inequalities of regional 
myocardial uptake of rubidium-82. 
Crilical slenosis with rapid pacing 
and ischemia (pfiase 3} produced 
signific^jinl changrjs in both regional 
myocL-. dial uptake of rubidium-82 
and flow. Critical stenosis and di-
pyridamole (no evidence of isch-
emia) (phase 4) produced large 
dillerences in regional myocardial 
blood flow with only a minor difler-
ence in the regionat myocardial 
uptake of rubidium-82. 
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(with critical stenosis ti.'itli(iut. stress), during crilical 
stenosis and pacing, during critical stenosis with rapid 
pacing and during stenf)sis with dipyridamole. Figure 
3 shows the regional myocardial uptake of rubidium-82 
in each of the eight areas of interest, at each stageofone 
expc-riinent. T h i s figure also shows (he measurements 
of regional myocardial perfusion in the eight areas 
during each phase of the same experiment. Table II 
shows the changes in regional myocardial uptake of 
rubidium-82 and blood flow for all the experiments 
taken from a normal area (three segments selected in-
dependently by each observer as unaffected) and an 
affected area (two segments selected independently by 
each observer as being changed by the stenosis of the left 
anterior descending coronary artery and stress). 
Figure 4 shows the relation between (he regional 
myocardial uptake of rubidium-82 and regional myo-
cardial blood flow in the normal and affected areas in 
the six dogs. This significant relation shows that in each 
experiment any given change in regional myocardial 
perfusion is accompanied by a smaller change in the 
regional myocardial uptake of rubidium-82. 
Human Studies 
Figure 6 shows examples of equilibrium and myo-
cardial scans recorded from a healthy subject. The heart 
to background ratio of activity was 3.5 ± 0.4:1. Figure 
6 shows a sequence of scans recorded before and after 
supine exercise in a healthy volunteer. T h i s shows a 
homogeneous distribution of cation uptake throughout. 
During exercise the heart rate increased from a mean 
of 72/mm to 170/mm and the volunteers achieved a 
work load of 24,000 to 32,000 joule.s. There was homo-
geneous regional myocardial uptake of rubidium-82 
before and after exercise in the five healthy subjects. 
T h e areas of interest were selected independently by the 
observers as described for the ex|:ieriiriental seci ion. .-^ .n 
analysis of variance showed a significanl 16 ± -i.O j'i ."-
cent increase in rubidium-S2 upl^ike with no significi.Tt 
differences between regions (coefficient of vari.-nce = 
5.2 ± 0.90 percent). During exercise in the jjalienls v-.v.h 
coronary artery disense the mean hi art rau- incrtva-rd 
TABLE II 
Values (or the Regional Myocardial tJptake ol Rubidiu.m-c2 
and F low Wi th C r i l i c a l Slenosis, Pac ing, Fast Pacing and 
A f l e r Dipyr idamole 
Phase 1 Phase 2 Phase 3 Phase 4 
(conUol) (pacing 1) (pacing 2) (dipyriJirr-.:^-
Normal Area 
Tomogram 
Regional 0.54 0.62 0.64 0.72 
myocardial ± 0 . 0 8 ±0 .10 ± 0 . 1 4 ± 0 12-
uptake ol (n = 6) (n = 4) (n = 4) (n = 4) 
rubidium-82 
Microsptieres 
Regional 0.89 1.20 0.99 1.92 
myocardial ± 0 . 3 0 ± 0 . 4 0 ± 0 . 2 0 ± 0 . 4 6 -
perfusion (n = 6) (n = 4) (n = 4) (n = 4) 
(ml/g per 
min) 
Adecled Area 
Tomogram 
Regional 0.59 0.52 0.37 0.66 
myocardial ± 0 . 1 0 ± 0 . 0 7 ± 0 . 1 1 - ±0 .21 
uplal^e o( (n = 6) (n = 4) (n = 4) (n = 4j 
rubidium-82 
Microspheres 
(Regional 0.88 0.85 0.39 0.75 
myocardial ± 0 . 3 2 ±0 .31 d 0.13- ± 0 50 
perfusion (n = 6) (n = 4) (n = 4) in = 4; 
(ml/g per 
min) 
* Value significanlly ditlerent (p = <0.01) from the •.;:lue r-?CCr JT<: 
during phase 1 (control). 
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2 0 . 4 Dog No. 1 
• 2 
xO.20 * 0.37 
p = < 0 . 0 1 
0.5 1.0 1.5 2.0 
Microspheres - Myocardial flow ml/gm/mln. 
2.5 
FIGURE 4. In six dogs the reliilion be;.veen Ihe 
regional rnyocardi.'jl upt,ii>.e of rubidium-82 and 
flow sliows a limiied rrikilior ckirige in tracer 
uptake ICK any cl->:'5e in f l c wi'h wide- iridividval 
vai iat:ility. Ttie ^iynificrinl n-,Jiiclions in reg'or:;jl 
myocrtiritiil uptrtke c l ri«liid:,jrn v. :ih d»-fcC!< in to-
niogrnrriS OCCuricd only wl.-;'.'l a reg'-:>r,al myo-
Crtid;al rfdi'Clion ol tlow v.;;s a c c o n - i t e d by 
evi'lence of isch.-m;,; {syml.ols tncio-.-.-i by cir-
cles). 
Equilibrium Scan .:Wypc&rdia!;$<an->^ 
FIGURE 5. Patient studies T>* 
transmission scan (1) sho-vs tt»e 
heart, lungs a.-y) chest wall in a 
left venificular arid tiansexia! slic* 
The c-:;uii;briom scan (2) d j i r ^ ru-
bidiunv82 infusion provides 
arterial cc-.cen;ralion A; 3C to 15: 
secorids after infusion the myo-
cardial scan (3) shiO»-s the f^ *-e wat 
(FW) of left ventricle arxf s^pluo: 
(S) The free wall ol the t i ^ ven-
tricle (RV) is faint bol can 
seen. 
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FIGURE 6. Serial tomograms were recorded before (upper left) and after 
(upper right) exercise in a healthy volunteer. Exercise was associated 
with a small (16 ± 4.0 percent) but significani increase in the regional 
myocardial uptake of rubidium-82. No change in distribution of rubid-
ium-82 occurred except (or the region of the mitral orifice which is 
particularly affected by any changes in geon-ielry. Ttie lower scans (post) 
were delayed scans after exercise. 
from 78 to 141 beats/min and all five patients com-
plained of angina pectoris, which limited the exercise. 
They achieved a work load of 11,000 to 21,000 joules 
during the test. All the patients showed an obvious re-
gional abnormality of rubidium-82 uptake in the to-
mograms recorded aft«r exercise. 
Figure 7 shoios a sequence of scans recorded from a 
representative patient. The tomograms recorded after 
exercise show-ed an obvious decrease in regional myo-
cardial uptake of rubidiura-82. The regional myocardial 
uptake of rubidium-82 in the affected segment de-
creased from 0.56 ± 0,07 to 0.32 ± 0.10 fractional uptake 
of rubidium-82. Th is regional decrease in uptake of 
rubidiuni-82 lessened; however, at 20 minutes after 
exercise there was still a significant regional decrease 
at 0.47 ± 0.04 (p = <0.01). The calculated radiation dose 
to each patient was less than 1 rad and no complications 
were encountered. 
Discussion 
Radionuclide techniques using cations (thallium-201, 
for example) have found clinical application in detection 
of t ransient regional myocardial ischemia and coronary 
artery disease. However, the inability of these tech-
niques to quantify events in each region of the myo-
cardium and ambiguities about the effects of flow- and 
me1.abolism have hindered interpretation of the re-
sults.'--® Our experiments show that the delivered ar-
FIGURE 7. Serial (omograms recorded from a patient with angira 
pectoris. Recovery bom exercise (3, 28 and 38 min post exercise |EX)) 
was associated with a severe regional defect in uptake of rubidiufr^S 
compared to control. The defect in this catkw scan occurred no! be-
cause of increased uptake in unaffected areas but because of an al>. 
solute decrease in cation uptake in the affected area. 
terial concentration of rubidium-82 can be measured 
in tomograms during intravenous infusion. Thirty to 150 
seconds after infusion it is possible to record tomograms 
of the regional myocardial concentration of rubidium-
82. These tomograms are of adequate physical quality 
even though the arterial concentration is approximately 
5 to 20 percent of peak activity at this time. T h e blood 
pool represents 5 to 15 percent of the volume of the 
myocardium within the tomogram. T h e conlaminatioo 
of the myocardial activity by arterial-activity (less than 
20 percent of peak activity in 5 to 15 percent of the to-
mogram) is not enough to interfere with the adequate 
physical quality of the data. T h i s is supported by the 
high myocardium to background ratio of activity. 
Re la t ion between myocard ia l f low and uptake 
and extract ion of rubidium-82: Our experiments hav^ 
confirmed in vivo the inverse relation between myo-
cardial flow and extraction of rubidium-82. Although 
the initial distribution of the cation o<cursthroij;jh flow, 
the camera detects the mass of intramyocardial tracer. 
Therefore flow, residence time, extracted fraction, 
fractional escape and metabolism are all important 
vi riables that affect the information.'"" Any alleratiois 
in flow were accompanied by much smaller changes in 
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uptake of rubi(liuin-82. T h e relations among flow, cx-
tr;ictiuii and ui.itake .ilso sbowr-d 1b;U changes in uptflke 
of rul)iili\iin-82 will not clearly indicate increases in flow 
unless (bc.se are extreme (more than 120 percent). In -
creases in How were produci-d by different mechanisms 
using atrial (lacing and dipyridainole. The different, 
physiologic effects may in iheniselves affect ration 
ujjtake; however, in these ex|)erinients t.he removal of 
pacing or dipyridamole data does not change the rela-
tion lK:tween flow and uptake. Similarly, decreases in 
inyocardial perfiision between 35 and 50 percent 
(without evidence of ischemia) are accompanied by only 
small decre.'ises in uptake of rubidium-82. When de-
creases in regional myocardial perfusion were accom-
panied by evidence of istbcinia the uptake of ruliid-
ium-.82 w.-^ s severely and aVifoluloly decreased below^ the 
control level. Although the relation between uptake of 
ril)idium-S2 and How is weak and variable the technique 
ap]iears to resptmd and consistently indicates the 
presence of actite transient regional myocardial isch-
emia. T h e stcady-s(ate adniinistralion of (r.'ice quan-
tities of nibidium-82 produces no isotope effect and the 
uptake into the myocardium is governed by the same 
jjliysiology that determines vijitakc after a bolus injec-
tion (that is, How, extraction, myocardial pool). 
T o m o g r a p h i c dc lce f ion of rubidium-82: T h e use 
of rubidiuin-82 carries the advantages of the 511 keV 
coincidence photons, tomographic detection, delivered 
arterial concentration and an absolute measure of re-
gional myocardial uptake of the cation. The short 
half-life (tV2 = T8 seconds) allows serial slAidies in the 
same subject. All of these features permit measurement 
and interpretation of directional changes in events in 
each region of the myocardium. 
T h e signal is a mean of events over 2 minutes and 
requires expensive equipment. In all forms of external 
nuclear imaging the detector loses sensitivity as the 
object decreases in size (the partial volume effect).'' T h e 
import<<nce of object size in recovery of activity from the 
heart is shown in these experiments. T h e measurement 
of wall thickness in the dog experiinents and echocar-
diographic studies in the pat ients are bolh iinperfect but 
necess.qry attempts to correct for partial volume effects 
when trying to qiiantitate events in the myocardium. 
P a t i e n t s w i l h a n g i n a pectoris: T h e technique in 
patients has provided information about the regional 
myocardial uptake of rubidium-82 in tomograms of the 
heart. Repeatable studies using each patient as his or 
her own control were possible because of the short 
half-life of the radionuclide. Spatial resolution, repro-
ducibility and homogeneous cation uptake are shown 
in the norma! subjects. T h e work performed during 
exercise probably produced marked increases in myo-
cardial (perfusion. However, these were accompanied by 
a small (16.0 ± 4.0 percent) increase in uptake of ru-
bidium-82. T h i s result is similar lo and supports (he 
experimen(,al findings. T h e |ia(ients all bad angina 
[lectoris, a [xisitive electrocardiographic exercise test 
and (iironary artery disease; they all showed regional 
myocardial defects in Ihe tomograms after exercise. 
Measurements of regional myocardial uptake of tracer 
showed that (hesc defects did not occur because of an 
increase in tracer uptake in normal areas. All the to-
mograms afler exercise showed one region with an ab-
solute decrease in cation uptake. These abnormal 
changes recovered slowly and returned to control level 
only after 20 minutes in four of the patienLs. T h e dog 
experiments suggest that these absolute decreases in 
regional myocardial cation uptake are likely to be due 
to a significant reduction in regional myocardial per-
ftision and ischemia. Neverlheless, the scans record ihe 
regional myocardial uptake of the cation and cannot 
dissect ou( the separate effects of How and mel,aboli.=m. 
T h e serial scans showed that the rc-giimal myocardial 
disturbance lasted longer than the symptoms .-md 
elect.rocardlogra|)hic signs of ischemia. 
C l i n i c a l implications: Patients with coronary arier\' 
disease are thought to have transient dis(urbance= <:•;' 
regional myocardial perfusion and meljibolism. The 
resultant regional ischemia is probably an imporian-
cause of morbidity and mortality. T h e deiection of 
transient ischemia and its causes is an important goal, 
and a variety of techniques are available. 
The stron(iuni-82 ruhidium-82 geiieralor is |.iijr;.;!.'c 
and provides safe quantities of rubidium-S2 fur pe-
ripheral intraveniH:s infusion. Wilh positron tomogra-
phy the arterial and myocardial activities can be mea-
sured for calculation of absolute regional myocardii-
uptake of rubiditim-82 in tomograms of adeqijate 
physical quality. The short half-life of the tracer perinili 
serial studies to assess changing pathophysiology. .Al-
though t.he relation between myocardial uptake of ru-
bidium-82 and flow is weak the technique is suitable fo.-
detection of acute transient regional myocardiaJ 
ischemia. The slrontium-82-rubidium-82 generato.r c&i; 
be used without a cyclotron. This means that the ad-
vantages of positron tomography can be used clinically 
w^ilhout the expense of an on-sile cycloiron. 
Our preliminary results in patients wilh angina pec-
toris have shown that abnormalities (that is. defect;' 
appear in cation scans not because of increased tr icc: 
uptake in norma! areas bul because of an absolute de-
crease in uptake in an affected area of myf-c-ardiiim. 
These ischemic lesions persist for much longer than pain 
or the electrocardiogram sviggests. This informaiic.-; 
may help to characterize and elucidate; acute myoca.rdiii 
ischemia in patients with angina and coronary aneo" 
disease. 
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THEKMAl. CHARACTERISTICS OF THE RELEASE OF FLUORINE-18 FROM AN INCONEL-600 
GAS TARGET . 
J . C . C l a r k and F . O b e r d o r f e r . 
Medical Research Counc i1 ,Cyc lo tron Unit,Hammers(nith Hospital .London W12. 
Severa l publ ica t ions dea l ing with no c a r r i e r added syntheses of 
radiopharmaceut ica l s conta in ing f l u o r i n e have made only b r i e f mention of the 
methods by wliich the "anhydrous n o - c a r r i e r - a d d e d HF-18" was prepared(1 ,2 ) . A 
p a t e n t ( 3 ) r e f e r s to the recovery of F-18 i n an unspec i f i ed chemical form 
a f t e r deuteron i r r a d i a t i o n of a n e o n - f i l l e d n icke l target i s followed by a 
hydrogen purge w h i l s t heating to 900 C. I n c o n e l ( 4 ) , Monel(5) and copper(6) 
have a l so been proposed as c o n s t r u c t i o n a l m a t e r i a l s for neon targets to be 
operated in the anhydrous n o - c a r r i e r - a d d e d mode. The target ( in terna l 
dimensions 162x50mm) used in t h i s study was f a b r i c a t e d from Inconel-600 
us ing the tungsten-arc i n e r t gas welding process ( T . I . G . ) and Inconel f i l l e r 
metal 8 2 ( 7 ) . The w a l l s were po l i shed using s i l i c o n carbide paper and water 
as a l u b r i c a n t . Heating was achieved using a 1.25KW ceramic knuckle band 
h e a t e r on the target barre l and a 0.35KW annular ring heater on the window 
f l a n g e . With the ceramic f i b r e lagging (as shown in F i g . l ) condit ions of 
minimal temperature gradients were demonsratated on the inner surface of the 
t a r g e t by thennocouple scanning . A 25mm diameter 0.050mm thick Inconel-625 
e n t r y window was sealed to the t a r g e t vesse l using a 3mni square sec t ion 
s o f t copper r i n g . Before f i l l i n g wi th targe t qas ( f ix tures the target was 
t r e a t e d in two a l t e r n a t i v e ways. 
a) Target heated to 5 0 0 t under a neon flow of I00m1/min and allowed to cool 
i s o b a r i c a l l y . 
b) Target heated to 500"^ under a hydrogen flow of 100ml/min and allowed to 
cool i s o b a r i c a l l y . 
Hydrogen concentrat ions were v a r i e d between 10 and 20 volumes % in neon and 
t a r g e t f i l l i n g pressures were t y p i c a l l y 200psig . I r r a d i a t i o n s were c a r r i e d 
out with 16MeV deuterons for approximately Iviamp.h. at 2 to 3pamp. A f t e r 
i r r a d i a t i o n the target was removed from the cyc lo tron to a hot c e l l where 
the targe t gas was re l eased through a potassium carbonate trap with no 
observed loss of F-18 . Valve V4 F i g . l was removed and a 1/8 inch PTFE tube 
toge ther with a PTFE c o i l t rap were connected to the target o u t l e t . Dry 
oxygen-free hydrogen was then passed through the target at a flow rate of 
250ml/min w h i l s t the t a r g e t .was heated to a prese lec ted maximum temperature 
of 700"^. The PTFE o u t l e t connection was held at below 150°C by forced a i r 
c o o l i n g and the PTFE c o i l cooled to - 7 8 ° C . As shown in F i g . 2 the re lease of « F-18 s t a r t s between 80°C and 140 "^ C when the target was pretreated with hydrogen and between 200 °C and 400°C when the target was pretreated with 
neon. The recovery p r o f i l e a l s o s t r o n g l y depends on the neon to hydrogen 
r a t i o i n the i r r a d i a t e d m i x t u r e ; the s t a r t i n g temperature decreases with 
i n c r e a s i n g amounts of hydrogen. This i s p o s s i b l y due to d i r e c t formation of 
HF-18 during the i r r a d i a t i o n . The decrease in the recovery temperature 
fi observed a f t e r hydrogen pretreatment i s probably the resu l t of HF-18 
format ion at the hydrogen-saturated Inconel w a l l . Another important 
o b s e r v a t i o n , which may lead to a b e t t e r understanding of the chemical 
proces se s and k i n e t i c s of F-18 removal from a target w a l l , r e f e r s to the 
s i t u a t i o n of low hydrogen concentra t ion in the target gas and the 
pretreatment with neon (run 5 F i g 2 b ) . Here temperatures in excess of S O C C 
were reached before any F-18 was recovered. Thus the temperature must be 
r e l a t e d to the a c t i v a t i o n temperature f o r the thermal desorption of the 
f l u o r i n e atoms from the targe t w a l l ; these r e a c t i v e f l u o r i n e atoms then 
combine wi th the hydrogen purge gas to form HF-18. 
i 
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F i g u r e _1 
(1) Pallddiutn c a t a l y s t (Engelhard "Deoxo Model-D") 150x25fnm . ( 2 ) Magnesiutn 
p e r c h l o r a t e 150x25fiifii. (3) Copper trap -196*'C. (4) Inconel target vessel with 
h e a t e r s and thermocouples T l and T2 f o r temperature control and monitoring. 
(5 ) PTFE trap 400x3mm 00 c o i l - 7 8 ° C . (6) Potassium carbonate trap ( f o r 
checks on the e f f i c i e n c y of t rap 5. (7) Temperature c o n t r o l l e r . (8) Shielded 
r e - e n t r a n t i o n i s a t i o n chamber. (9) DC A m p l i f i e r . (10) Thermocouple 
c o n d i t i o n i n g a m p l i f i e r . (11), Dual channel recorder . (12) l o n i s a t i o n chambe'-
p o l a r i s i n g supply. 
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These pre l iminary r e s u l t s from e x t r a c t i o n s tud ies of F-18 from the target 
system descr ibed could be in terpre ted in terms of model c a l c u l a t i o n s for 
heterogenous f l u o r i n e atom reac t ions on metal s u r f a c e s ( 8 ) . Further problems 
r e l a t i n g to the k i n e t i c s of adsorption and desorpt ion processes of f l u o r i n e 
atoms highly d i lu ted in an i n e r t medium are p r e s e n t l y under i n v e s t i g a t i o n at 
The German Cancer Research Center using a model based on the Langmuir-Rideal 
mechanism(9). This model agrees very wel l with our observations on the 
removal of F-18 from the targe t w a l l s . We suggest that the fol lowing 
r e a c t i o n s give r i s e to observat ions descr ibed here . 
I ) F-18 + HH = H F - I 8 + H . 
I I ) ADSORBED F-18 + DISSOLVED HH = DESORBED HF-18 . 
I I I ) ADSORBED F-18 + (T>400 C) = DESORBED F-18 + HH = HF-18 + H. 
(1 
(2 
(3 
(4 
(5 
(6 
(7 
(8 
(9 
Tewson T . J . , W e l c h M.J . and R a i c h l e M . E . , J . Nucl . Med.,19,1339 (1978). 
Tewson T .J . ,Maeda M. and Welch M . J . , J . L a b e l . Cmpds. Radiophami. 18, 
21 (1981) . ~ 
Winchell H . S . et a l . , U . S . Patent 3981769 (1976) . 
Wolf A.P.. , Personal communication. 
Welch M.J.^Personal communication. 
Dahl J . R . et a l . , J . Label Cmpds. Radiopharm. ,18,34 ( 1981). 
P u b l i c a t i o n s 3489 (1973) and 3591 (1978), 
 a l . , J , 
"Wiggin welding products". 
Henry Wiggin and C o . L t d . 
Jumper E . J . , U l t e e C . J . and Dorko E . A . , J . Phys. Chem. Si.41 ( 1980). 
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Figure 2a . Target pretreated with hydrogen at 500"^C. Runs 1 and 2 15 
volumes % hydrogen in neon. 
F igure 2b. 
Target pretreated with neon at 500^C. Runs 3 and 4 15 volumes % hydrogen in 
neon. Run 5 <10 volumes % hydrogen in neon. 
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Rate of uptake of carbon monoxide at different 
inspired concentrations in humans 
H A Z E L A. J O N E S , J . C . C L A R K , E . E . D A V I E S , R. E . F O R S T E R , 
A N D J . M. B. H U G H E S 
Department of Medicine, Royal Postgraduate Medical School, Medical Research Council 
Cyclotron Unit, Hammersmith Hospital, London W12 0HS, United Kingdom: and 
Department of Physiology, University of Pennsylvania, Philadelphia. Pennsylvania 19104 
JoNKs, H A Z E L A., J . C. C L A R K , E . E . D A V I E S , R . E . F O K S T E R , 
A N D J . M . B . H U G H E S . Rate of uptake of carbon monoxide at 
different inspired concentrations m humans. J . Appl. Physiol.: 
Respirat Environ. Exercise Physiol. 52(11: 109-113, 1982.—The 
rate of uptake of carbon monoxide (CO) in the lungs of normal 
subjects was measured at inspired concentrations of <1, 300, 
and 3,000 ppm « 0 . 0 0 0 1 - 0 . 3 % ) using radioactive CO ("CO). In 
nine subjects the rale of uptake was monitored at the mouth 
during rebreathing. At inspired CO concentrations of approxi-
mately 1, 300, and 3,000 ppm and a mean alveolar Oj fraction 
of 0.15. the mean lung diffusing capacity was 25.8, 26.4, and 25..! 
ml-min"'-Torr"' , re.spectively. In seven subjects the mea.sure-
ments were repeated after a period of 0. breathing, giving a 
mean alveolar Oj fraction of 0.78. The calculated membrane 
diffusing capacity was 31.9, 33.7, and 32.0 ml• min"' -Torr ' ' at 
<1, 300, and 3,000 ppm inspired CO. We conclude that there is 
no difference in the rate of uptake of CO over the range of 
concentrations studied in these experiments. No evidence for 
the presence of a facilitated transport system for CO in the 
normal human lung was found. 
lung diffusing capacity for CO; membrane diffusion for CO; 
facilitated transport; radioactive C O ; rebreathing techniques 
C A R B O N M O N O X I D E (CO) is generally considered to dif-
fuse across the pulmonary membrane between alveolar 
gas and capillary blood and across the pla'cental mem-
brane between maternal and fetal capillary blood at a 
rate proportional to the difference in partial pressure of 
CO. However, variations in the proportionality constant 
(the diffusing capacity) have led various authors to pro-
pose facilitated transport of C O in the placenta of sheep 
and dogs (1, 5, 7). Following Longmuir et al. (9), Gurtner 
and Burns (6) have suggested that cytochrome P^ .^ ) may 
act as a carrier for O2 and CO in the placenta. 
A similar mechanism has been proposed for the lung 
(2, 12) and evidence for the presence of such a system in 
dogs and sheep has been put forward on the basis of a 
differential rate of uptake of CO with varying inspired 
concentrations. If the transfer of CO is purely passive, 
the rate of uptake will be independent of initial concen-
tration, but if the transfer is facilitated by any means, for 
example by a cytochrome carrier, the rate of uptake will 
be higher at low concentrations than at concentrations 
high enough to saturate the carrier mechanism (9). 
Recently, confirmation of the claim that pulmonary 
0161-7567/82/0O0O-0O00$01.25 Copyright © 1982 the American Physiological Society 
diffusing capacity varies systematically with the inspired 
concentration of CO has been sought using isotopic lech-
niques (8, 13). Meyer et al. (13) used the stable isoiooe;. 
'"C'^O and ' ' C ' O and a mass specirometer, and ue used 
the radioactive isotopes, "C"'0 and '"'C'''0. In neiihc-
siudy was any dependence on inspired concentr£-.ior. 
found. In this paper, we report a further series of ."le,;-
surements in which the membrane diffusing capaciiy to:' 
CO has been measured in addition 1 0 the pulmo.ii:"-
diffusing capacity, over a 3.000-fold range of CO cor.:-:::-
tration. 
M E T H O D S 
The rate of uptake of CO was studied by a rebreaihi;.; 
method in nine normal male subjects, whose anthi.•>.>.-
metric data are shown in Table I . .'Ml gave info.'.T.r 
consent; the maximum radiation dose to each subjec: •" 
mrads) had been approved by (he Health Services Dr>".-
sion of the Department of Health and Social .SecL.-;;;. 
We were able to make measurements at very low cor.ce.".-
trations, less than 1 ppm by the u.se of "C-labeled CO 3. 
positron (/?*) emitting isotope oi CO with a half-lire •.: 
20 min. The " C O was produced in the Medical Reseircr. 
Council cyclotron, London, using an N , target i3i. T h -
" C O was free from stable CO and had no radioe-ici. e 
contaminants. The "CO was dispensed into a syringe 
stable N2. The concentration at this low level was .Tiei-
sured as less than 1 ppm using an Ecolyser C O anaiyze: 
(Energetics Science). Monitoring was carried out on 2 
gas radiochromatograph to ensure that no radioa.tive 
contaminants were present. 
The P'^ emissions from this isotope were detected '-.ur.z 
the apparatus shown in Fig. 1. This detector consii-:.? 
a plastic scintillator 2 x 2 x 0.4 cm' in a thin light-V:zh: 
stainless steel envelope that projects into the rehTea'.nir.z 
apparatus at the same point as the tip of a sampling Ime 
from a mass spectrometer (Centronics MGA 200). Tr:.r 
plastic scintiUator emits light when bombarded by ao;i-
trons. The light is converted into an electronic signa.^  ar:C 
amplified in a photomultiplier tube. Counts proponwr:*. 
to the amount of "CO present are relayed to a compu-e: 
(Digico ^l 16) simultaneously with signals of flow a r c 
volume. The respon.se of the detector was linear weC 
beyond ranges of count rates achieved. These signal; a.-ie 
all delayed to synchronize with signals coming from ih-^ 
110 
mass spectrometer, which lag the other signals due to 
transit time down the sample line. The rebreathing ap-
paratus is shown in Fig. 2. This consists of a 1-liter bag 
in a bottle connected via a pneumotachograph to a wet 
spirometer for the measurement of flow and volume. The 
test gas consisted of 10% He, 10% SFs, and 30% O2 in Ar 
with either no C O , 0.03% C O , or 0.3% CO. The "CO at a 
concentration of <1 ppm was added to all these mixtures 
to give total C O concentrations of <1, 300, and 3,000 
ppm. T h e bag was filled with 0.65 liter of one of the test 
gas mixtures. The subject was switched into the rebreath-
ing system at end expiration and asked to empty and fill 
the bag completely 15 times at a rate of 1 breath/s, set 
by a metronome. During the rebreathing maneuver the 
concentrations of all gases, No, 0>, Ar, CO2, He, and SFe 
measured in the mass spectrometer and " C O monitored 
by the fi*-detector were sampled 50 times/s together 
with signals of flow and volume. The computer printed 
out the time and volume of each breath, followed by the 
flow-weighted mean concentrations of all the gases for 
each inspiration. Paired measurements were made at 
inspired C O concentrations of <1, 300, and 3,000 ppm in 
random order. In seven subjects three additional mea-
surements, one at each inspired concentration, were 
made after an initial period of breathing 100% O2 for 5 
min. 
T A B L E 1. Anthropometric data for the subjects 
Subj Age. yr Hi. m 
Wt, kg 
VC. li-
ters 
(liTPSI 
F E V , . 
liters 
(BTPS) 
Smoking History 
S C 33 1.68 74 4.3 3.7 Exsmoker 
MH 44 1.69 63.5 5.0 3.9 Nonsmoker 
AS 30 1.85 82 5.6 5.0 Smoker 
RC 23 1.83 68 5.5 4.3 Nonsmoker 
MT 30 1.81 75 5.8 4.6 Nonsmoker 
LN 29 1.63 57.6 3.9 3.4 Pipe smoker 
ED 44 1.77 85 4.6 3.3 Pipe smoker 
EE 40 1.85 75 6.3 5.4 Nonsmoker 
RA 31 1.73 71 4.6 3.5 Nonsmoker 
V C , vital capacity; F K V . forced expired volume at 1 s. 
• J O N E S E T A L . 
The rate of uptake of CO (Kco) was calculated as the 
exponential slope of the fall in radioactiviij' in the gas 
sampled at the mouth once the initial mixing phase had 
passed, as shown by the equilibration of the He and SF,;. 
The diffusing capacity ( D L C O ) in ml min~' Torr"' was 
calculated as (Kco x Vs x 60 x 0.826)/713, where Kco 
is the rate constant for CO uptake (s"'), Vs the system 
volume, i.e., the end-expiratory volume plus the bag 
volume in mJ ( B T P S ) calculated from insoluble gas dilu-' 
plastic scintillator 
electronics 
mass spectrometer "2 
A 
He 
photomultiplier tube 
P counts CO ^ I 
flow 
volume 
F I G . 1. Diagram of detector used for monitoring " C O . showing its 
position relative to other detection systems and computer. Circle 
represents cross section of lube (2.5 cm I D ) connecting mouthpiece to 
rebreathing bag. 
to mass 
spectrometer pressure 
transducer 
Fleisch 
pneumotachograph spirometer Ftc. 2. Diagram of whole rebreathing 
apparatus. 
calibrated 
syringe 
gas supply 
containing 
10% He, 10% SF, 
E F F E C T O F I N S P I R E D C O N C E N T R A T I O N O N C O U P T A K E 
100-r 
50 J 
E 
E 
x 
E 
10-^ 
8 _ _ . £ » _ _ » _ . o _ . o - - 0 - - " - - D - F I G . 3. Seniilogarithmic plot of breaih by-breath He (•) . SFtt (o). and "C0(:1) concentrations (as percent of 
maximum) against time, in subject SC. rebreathinz a 
high (3,000 ppml C O mixture. " C O values at low con-
centration ( i l have been added for comparison. Insolu-
ble gas dilution was identical for both measuremenu 
- I — 
10 
Time (sec) 
15 
tion, 60 the conversion from s to min, 0.826 the conversion 
from B T P S to S T P D , and 713 the barometric pressure 
minus water vapor pressure. 
The membrane diffusing capacity (Dm) and the cap-
illary blood volume (Vc) were calculated graphically from 
the relationship described by Roughton and Forster (14) 
. D L ^ D m ' ^ W ^ 
6, the rate of reaction of CO with hemoglobin, was 
calculated from the mean alveolar O2 concentration dur-
ing the post-mixing part of the rebreathe, measured by 
the mass spectrometer. 
^ = (« + /?• Pco,) / [Hb]-( l - S c c o ) 
a 
We followed Cotes (4) in using values of 0.34 and 0.006 
for the coefficients a and fi. Pco, is the mean partial 
pressure of O2 in the plasma of the alveolar capillaries, 
[Hb] is the hemoglobin concentration as a fraction of 
normal, and Scco the mean fractional saturation of he-
moglobin with C O (11). 
The backpressure of " C O was measured by repeating 
the rebreathing maneuver with a bag filled with air 
immediately after the final measurement. 
R E S U L T S 
Figure 3 shows data obtained in one subject (SC) 
rebreathing high and low concentrations of C O after air 
breathing. After five breaths mixing has been established 
T A B L E 2. Vs, Kco, and DLI-O for all subjects 
at high, medium, and low inspired CO concentration.-
.ApproMiiiit!,' lii.-;pired Contentration. ppni 
Subj 
3.0(X) 30(1 <l -l.i'hl <l :j(M 
VslBTPSl. liter.'; A'co. -
Du i. ml-rrnn • 
Torr 
S C 2.99 2.94 2.99 10.12 10.05 10.18 20.92 20.53 21 ; :• 
MH 3.95 4.10 4.19 8.91 S.S7 8.76 24..52 24.75 25 •. 
AS 4.64 4.85 4.92 8.-42 8.72 8.52 27.21 29.4 • 29 ; . 
RC 4.26 4.14 4.36 10.77 11.8S 11.65 31.88 .35.10 35 -
MT 4.43 4.47 4.45 9.91 11.05 8.61 .30.47 34.20 26 
LN 3.64 3.68 3.41 7.43 7.21 7.49 18.66 18.2f 17.7" 
ED 4.11 3.55 3.82 8.07 8.66 7.04 23.07 21.40 i8.'> 
EE 5.68 6.39 6.23 7.69 6.73 6.84 30.29 29.77 29..;-:' 
RA 3.31 3.61 3.49 11.02 9.49 10.03 25.18 23.80 24.';' 
Mean 4.11 4.20 4.21 9.15 9.16 8.79 25.80 26.36 •lb.:: 
Values are means of 2 measurements, 
0.15. Vs . system volume i.e.. bag plus end 
rate constant for C O uptake; Di.,-,). pulirn 
. Mean alveolar 0 . fractio.'; is 
-expiratory lung volume; A'-:.o. 
onary diffusing capacity. 
as shown by the constant He and SFe concentrations; the 
uptake of C O is monoexponential after this point. For all 
subjects the regression coefficients of the 75 calculated 
slopes were never less than 0.687 with a mean of 0.9-59 
± 0.062 (SD). The accumulated data for all the studies is 
shown in Table 2. Each number is the mean of I K T O 
measurements made at each inspired concentration. .\ 
two-tailed paired t test of significance was carried out on 
the individual values between the high and medium 
concentrations and the high and low concentrations, 
yielding P values of .0.51 and 0.55, respectively. For all 
. JONKS E T A L . 
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T A B L E 3. DLCO, Dm, and Vc for 7 subjects 
at high, medium, and low CO concentrations 
<1 10 
< 0.0001 0.001 
r 
100 
0.01 
alveo]3r CO concentration 
F I G . 4. Lung diffusing capacity for C O ( D L C C ) at different alveolar 
concentrations. E a c h point represents a single measurement, and all 
are plotted as fraction of mean of two measurements a l highest inspired 
concentration. No concentration-linked difference is apparent. 
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F I G . 5. Graphic analysis of Dm and Vc. 1 / D L is plotted against \/6 
for high (•), medium (o), and low (A) inspired concentrations. High 
values for 1/8 were obtained by O2 breathing. Intercept on y-axis 
represents 1 /Dm and slope of lines 1/Vc. 
subjects the individual values for D L C O are plotted 
against the calculated initial alveolar concentration for 
C O (Fig. 4). T h e points are all shown as a fraction of the 
mean D L C O at the highest concentration. Thus values 
greater than 1.0 would indicate an increased C O uptake. 
Despite the expanded scale there appears to be no such 
increase at the intermediate or low levels. 
Figure 5 shows the graphical analysis for D m and Vc 
on one subject (AS); 1 /Dm obtained from the intercepts 
on the jy-axis did not vary with concentration, nor did 
1/Vc obtained from the slopes of the lines. The results 
for D m and V c are shown in Table 3. A two-tailed paired 
t test of significance gave P values of 0.25 for D m between 
high and medium and 0.95 between high and low concen-
trations. T h e individual results for D m at differing alveo-
lar, C O concentrations are shown in Fig. 6, each point 
—1 
100 
O.Oi 
alveolar CO concentration 
F I G . 6. .Membrane diffusing capacii\' ( 0 m l for C O at different al -
veolar concentration.^. Each point repre.serus a ..single measurement 
fraction of that at highest inspired concentration. 
being plotted as the fraction of the value at the highest 
C O concentration. There appears to be no influence of 
C O on the membrane diffusion as all points at the me-
dium and low concentrations lie around the line of unity. 
D I S C U S S I O N 
The use of radiolabeled " C O enabled us to measure 
C O uptake accurately at very low concentrations. T h e 
C O backpressure poses a significant problem in experi-
ments not using tracers of C O , but no backpressure of 
" C O was detected at any time. 
The rate of uptake of C O is influenced by the state of 
inflation of the lung (10). The variation in the lung 
volumes at which our measurements were made, shown 
in Table 2, was not large enough nor in the appropriate 
range of the vital capacity to affect the results. 
The rate of uptake during air breathing is also depend-
ent on the capillary blood volume. The studies carried 
out after O2 breathing were designed specifically to study 
the properties of the alveolar membrane in which the 
proposed carrier resides. At high O2 levels the OVc term 
is reduced fourfold and the Dm term dominates. Under 
these conditions C O uptake was again not dependent on 
inspired concentration. 
I t is possible that there may be a carrier present in 
E F F E C T O F I N S P I R E D C O N C E N T R A T I O N O N C O U P T A K E 
human lungs whose O2 half saturation pressure (PM) is 
at a C O concentration that we did not study. Even were 
this so, we would have expected to find a slightly in-
creased uptake for at least one of the concentrations 
studied, as the influence of a carrier should be apparent 
up to 10 times above its P.50 concentration and below it 
to a lesser extent (12). 
T h e presence of a carrier for C O and O2 in the placenta 
has been suggested (1, 7); in this situation, where diffu-
sion distances are significant, there is at least a physio-
logical role for a carrier to enable the fetus to obtain an 
adequate supply of O2. In contrast, the diffusion distances 
across the alveolar membrane in the lung are extremelv 
small, approximately 1.7 t^M (15). In certain diseases the 
membrane does become thickened, but these conditions 
are relatively rare and the thickening usually occurs at a 
late stage in the disease process. Thus the evoluiionaiy 
pressure required to develop a facilitated transport sys-
tem in the lung is not strong. 
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Quantitative measurement of intrapulmonary 
and extrapulmonary right-to-left shunt 
H A Z E L A. J O N E S , J . R. S T R A D L I N G , J . C . C L A R K , 
E . E . D A V I E S , A N D A. R O Z K O V E C 
Department of Medicine, Royal Postgraduate Medical School; 
and M. R. C. Cyclotron Unit, London W12 OHS, United Kingdom 
J O N E S , H A Z E L A., J . R. S T R A D L I N G , J . C . C L A R K , E . E . 
D A V I E S , A N D A. R O Z K O V E C . Quantitative measurement of in-
trapulmonary and extrapulmonary righl-to-left shunt. J . Appl. 
Physiol.: Respirat. Environ. Exercise Physiol. 54(5): 1434-1438, 
1983.—We have developed a new technique that enables the 
shunting of blood from the right to the left side of the circulation 
to be partitioned into a cardiac and a lung component. The 
effects of recirculation are minimal, and the method does not 
require on-line data analysis. Quantitative estimates of these 
components have been made in two normal dogs and in five 
patients with raised puhnonary arterial pressures, some of 
whom were known to have a patent foramen ovale. The results 
were compcired with oxygen shunt measured during air breath-
ing. A poorly soluble gas, nitrogen, radiolabelled with '^ N in 
solution is injected first into a central vein whUe matched 
samples of blood are drawn from the pulmonary artery and the 
aorta. A second solution containing '^ N is injected into the right 
ventricle and sampled from the aorta only. Standardized 
gamma-counting techniques were used to analyze both the 
injected radioactivity and the radioactivity in the samples. 
These two measurements enable us to calculate the total right-
to-left shunt, the pulmonary shunt, an,d by subtraction the 
extrapulmonary cardiac shunt. 
pulmonary shunt; cardiac shunt; nitrogen-13; oxygen shunt 
T H E Q U A N T I T A T I O N A N D A N A L Y S I S of shunting through 
the lungs and through the heart, as well as ventilation-
perfusion (V /Q) mismatching, are important if bne is to 
study the effects of potentially beneficial vasodilator 
drugs in patients with raised pulmonary arterial pres-
sures, particularly if they have associated foramen ovale. 
T h e importance of this differentiation has been recog-
nized for many years (12, 16), and several techniques 
based on the Pick principle have been tried. These in-
clude the oxygen method (1) and the use of poorly soluble 
gases that are virtually eliminated from the blood on 
passage through the lungs (4, 8,18). However, in patients 
who are shunting blood from right to left, none of these 
methods can differentiate cardiac from lung shunts, 
which may result from atelectasis or new vessels formed 
in response to high pulmonary arterial pressures that 
bypass gas-exchanging areas (2). Low V / Q areas in the 
lung will interfere with all methods to a varying extent. 
We have developed and tested a new technique that 
not only differentiates between cardiac and intrapulmo-
nary shunting of blood but allows quantitative measiire-
ments of each to be made. This enables the effective site 
of action of various drugs that affect total shunting in 
patients with raised pulmonary arterial pressures to be 
determined. 
T H E O R Y 
A diagrammatic representation of the system to be 
studied is shown in Fig. 1. This system consists of an 
input (I) and an output (0). Blood flow is in the direction 
shown by the arrows. 
Blood entering at 1 can reach 0 by three possible 
routes. Let x be the fraction of blood shunted through 
the heart from right to left and y be the fraction of blood 
shunted through the lungs. This includes any areas of 
atelectasis and any new vessel formation. Thus 1 - .r -
y will be the fraction of blood that passes through the 
gas-exchanging area of the lung and will completely lose 
a totally insoluble gas tracer. 
Consider an injection of A' molecules of insoluble tracer 
at A. Let F be the fraction of blood leaving 0 and 
returning at 1, i.e., the fractional recirculation. Therefore 
I . F - O . 
Let C be the number of tracer molecules detected. -At 
sampling site 1 
C i A = K(N + I A ) 1 7 ] 
where K is the proportionality constant of tracer detec-
tion. And at sampling site 2 
C2A = K(N+U){x -4- y) 
Therefore 
C 2 A / C , , X -i- y 
1434 
where or -t- _y is the fractional heart and lung shunt 
independent of recirculation. 
Now consider an injection of N molecules of insoluble 
tracer at B. Input counts are not measurable in this case, 
and therefore C I B is not relevant. 
I B = F - 0 B 
C2B = K-0B = K(N-y-^\n(x +y)) (2) 
O B = I B / F 
0161-7567/83/0000-0000$01.50 C o p y r i g h t © 1983 the American Physiological Society 
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HEART 
F I G . L Heart and lung system; 3 theoretical pathways by which 
blood can pass from the right to the left side of the circulation are 
shown. Sites of injection (A and B) and sampling (1 and 2) for the 
measurement of shunts are also shown. 
Therefore 
IB/F= N-y + IB(X + y) 
ls{x + y - l / F ) = ~N.y 
1 / F - x - y 
substituting for I B in Eq. 2 
N-y(x + y) 
C2B = K{N.y + 
l / F - x - y , 
Similarly for injection at A 
I A = ^ ' - 0 A 
C2;. = K-0^ = K-(N+IK)(X + y); 
O A = I A / - F 
IJF=(N +W(x + y) 
I A ( X + y - 1 / F ) = -N{x + y) 
N(x + y) 
" 1 / F - x - y 
substituting for I A in Eq. I 
dividing Eq. 3 by Eq. 4 
[3] 
C 2 B / C l A — 
N-y + 
l / F - x - y 
N-y{x + y) 
(4) 
l / F - x - y 
K{N + 
N(x + y) 
l / F - x - y 
= y 
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where y is the fractional lung shunt independent of 
recirculation. (Note that the fractional recirculation ( F ) 
must be the same for injection at A and at B.)' 
The use of a gas with very low but finite solubility such 
as nitrogen (blood-gas partition coefficient = 0.015) 
means that the intrapuLmonary retention is dependent 
on V/(^ distribution as well as true shunt, retention being 
X/X + V/<^ (6). Thus a "shunt" of 1.48% will be measured 
in a lung with a V / Q of 1.0 due to the solubility. The 
lower the V / Q of the unit, the greater will be the reten-
tion of nitrogen, such that the retention will be 2.9% for 
a V / q of 0.5, 4.8% for a V / q of 0.3, 13.0% for a V / Q of 
0.1, and so on. 
The use of a single gas does not allow the differentia-
tion of the measured intrapulmonary shunt into V / Q 
distribution and pure anatomic shunt, but differentiation 
of the intrapulrnonary and extrapulmonary component is 
unaffected by V / Q . 
M E T H O D S 
Dog studies. Two greyhound dogs were anesthetized 
with iv thiopental sodium (5 mg/kg body wt iv) and 
pentobarbital sodium (3-6 mg-kg"'• h"'). Catheters were 
placed under fluoroscopy in the inferior vena cava and 
right ventricle for injection of solution and in the main 
pulmonary artery and the aorta for withdrawal of blood. 
Repeat measurements of shunt were made with our new-
technique. 
Patient studies. Four patients with primary pulmonar* 
hypertension, confirmed by previous cardiac catheteri-
zation and pulmonary angiography, underwent repeal 
catheterization to study the effects of two drugs, prosta-
cyclin and nifedipine. All patients gave their informed 
consent, and the study was approved by the Hammer-
smith Hospital Ethics Committee. Two of the patient; 
were thought to have patent foramen ovale. None of the 
patients were in right heart failure at the time of the 
study, and there was no clinical indication of tricuspid 
regurgitation. Pressures measured in the right atrium 
were independent of the presence or absence of the 
catheter across the tricuspid valve, making catheter-ii!-
duced regurgitation unlikely. Catheters were placed u.'.-
der fluoroscopic control into the aorta, the right ventricle, 
and the pulmonary artery via the femoral approach. .-^  
long line was inserted via an antecubital vessel into a 
central vein. 
Measurement of shunt by our method were made at 
the end of a control period and in three cases at the end 
of an infusion of either prostacyclin into the pulmonaiy 
artery or after nifedipine sublingually, in a dose sufficient 
to lower pulmonary or systemic arterial pressure by at 
least 10 Torr. Just before these shunt measuremenTS, 
paired 5-ml samples of systemic and pulmonary arterial 
blood were drawn over a 5-min period, during which time 
all expired gas was collected. Total expired volume was 
measured through a gas meter, and oxygen and carbon 
dioxide concentrations were analyzed by a mass spec-
trometer (Centronic 200 M C A ) . The blood samples wa-e 
immediately placed in ice and were always analj'Zcd 
within 30 min of withdrawal, to minimize the effect of 
oxygen metabolism by the blood on partial pressure of 
oxygen. The data enabled us to calculate the cardiac 
1436 J O N E S E T A L . 
output and oxygen shunt using the alveolar air equation 
(15). Saturations and gas tensions in the blood sample 
were measured on an oximeter ( I L CO-oximeter 282) and 
gas analyzer ( I L 613). 
Methodology. Nitrogen radiolabelled with " N was pre-
pared in the M . R . C . cyclotron at Hammersmith Hospital 
by deuteron irradiation of carbon dioxide (3). This iso-
tope of nitrogen emits positrons and has a half-life of 10 
min. Solutions of approximately 1 mCi " N in 10 ml 
isotonic saline were prepared for each injection by dis-
solving 0.1-0.2 ml of the gas in isotonic saline by vigorous 
shaking. T h e solution was then sterilized by millipore 
filtration, which also removed any undissolved microbub-
bles of gas. Al l counting of radioactivity was carried out 
using a two-position jig over a N a l / T l scintillation 
counter (Fig. 2), which was situated in a room remote 
from the patient to avoid interference from exhaled ra-
dioactivity. Room background was counted at intervals 
with and without the removable lead filter in position. 
Al l counts were corrected for room background, radio-
active decay, and decay occurring during the counting 
time (3). 
E a c h measurement consisted of two parts that were 
identical, apart from the site of injection and the number 
of samples withdrawn. Two 30-ml syringes were con-
nected to the pulmonary arterial and aortic catheters via 
manometer tubing (0.2 cm I D , 60 cm long). The whole 
system was flushed with heparinized saline and was 
bubble free. The syringes were placed in a dual-charmel 
matched withdrawal pump (Harvard Apparatus model 
2206). Withdrawal of blood was started, and 1 mCi of '^N 
in 10 ml isotonic saline was injected into the central vein 
over 5-10 s, followed by immediate withdrawal of 10 ml 
fluid into the same syringe, so that the residual activity 
ead shield 
electronics 
removable lead (liter 
Nal/Tl 
scintillation 
crystal 
photo-
multiplier 
tube 
FIG. 2. Two-position jig used for all measurements of radioactivity. 
Posit ion 1 is used for counting radioactivity in syringes containing 
injection and residue and position 2 for counting radioactivity in sy-
ringes containing pulmonary arterial and aortic samples. 
in the injection catheter could be counted. Both the 
initial and residual '^N were counted with the sjTinge 
mounted in position 1 on the jig and with the lead filter 
in position to attenuate the radioactivity reaching the 
detector (Fig. 2). The same volume of fluid in each 
measurement ensured identical counting geometry. The 
blood withdrawal was continued at a steady rate of 0.5 
ml/s until a 30-ml sample had been collected in each 
syringe. The second part of the measurement was made 
approximately 5 min later by injecting the '^N solution 
into the right ventricle and sampUng from the aorta only. 
Again initial and residual activities were counted in the 
injection syringe. Aortic blood was sampled in a manner 
identical to that for the first part of the measurement. 
All blood samples were counted with the 30-ml syringes 
containing 30 ml of fluid mounted in position 2 on the jig 
and with the lead filter removed, because the radioactiv-
ity in the samples was lower than that injected due to 
dilution with blood and also, in the case of the aortic 
sample, loss of '^N to the lung gas. Counting times were 
adjusted to give a low statistical counting error. After 
counting the radioactivity of all samples the blood was 
returned to the patient. 
The total shunt and the intrapuhnonary shunt were 
calculated from the equations derived in T H E O R Y . A S 
described in M E T H O D S , blood was withdrawn from the 
pulmonary artery, because we wanted to be absolutely 
sure of a mixed venous sample. This dous not a;Mect the 
application of T H E O R Y , because an iuen;.i'..>v sample 
would be obtained after injection at A (Fig. 1) whether 
the blood was withdrawn from position 1 or in the pul-
monary artery. Thus C I A was measured as counts in the 
pulmonary arterial sample, and C2A and C J B were meas-
ured as counts in the two aortic samples. Thus fractional 
total shunt = C 2 A / C I A . Because the injected activity ( A ' ) 
was not the same for injections at A and B, the ratio of 
the injected counts was calculated to give the appropriate 
CiA for the injection at B 
injected counts = initial - residual counts in s>Tinge 
N counts injected at A gives C I A counts. Thus A'* counts 
injected at A would give CIA-N*/N counts. Therefore 
the CiA term must be multiplied by A ' V A ' for calculation 
of intrapulmonary shunt, where N* are the counts in-
jected at B 
fractional intrapulmonary shunt = C>B-N/CtA-N' 
R E S U L T S 
Dog studies. The measurements of "N shunting are 
shown in Table 1 both as the total measured shunt and 
as intrapulmonary shunt in the two dogs. The shunt 
T A B L E 1. shunt measurements in dogs 
Dog 
No. 
A B C 
Total IP E P Total IP E P Total IP E P 
1 
2 
2.0 
2.1 
2.2 
1.9 
- 0 . 2 
-t-0.2 
3.2 
4.0 
2.7 
3.5 
-1-0.5 
-1-0.5 4.4 4.1 +0.3 
A , B , and C are repeat measurements separated orJy by time; I P , 
intrapulmonary; E P , extrapulmonary. Tota l shunt (as percent of total 
blood flow) differentiated into intra- and extrapulmonary components. 
I N T R A - AND E X T R A P U L M O N A R Y SHUNT M E A S U R E M E N T 
T A B L E 2. Oxygen and ^^N shunt measurements before 
and after administration of vasodilator drug 
Patient 
A B 
0 , 
shunt 
"N shunt O2 
shunt 
"N shunt 
Total IP E P Total IP E P 
JH 21.4 13.9 9.6 4.3 26.6 22.0 8.6 13.4 
MW 44.7 66.0 1.4 64.6 
SH 4.7 2.4 2.2 0.2 9.2 3.7 4.0 - 0 . 3 
DJ 6.2 1.6 1.7 -0 .1 10.2 1.7 1.7 0 
Values expressed as percent of total blood flow. A, before vasodilator 
drug; B, after vasodilator drug; IP, intrapulmonary; E P , extrapulmo-
nary. 
measurements give increasing values with time. The 
intrapulmonary and total values of shunt for each paired 
measurement give an indication of the precision of the 
technique, because no cardiac shunting was suspected in 
these animals. 
Patient studies. T h e measurements of '^N shunt are 
shown in Table 2 and compared with those for oxygen 
shunt before and after the admirustration of prostacyclin 
or nifedipine. When the " N shunt is differentiated into 
intra- and extrapulmonary components, two of the pa-
tients iJH and MW) show that a significant amount of 
the shunt is through the heart, whereas the remaining 
patients exhibit purely intrapulmonary shunting. The 
measured intrapulmonary shunt comprises both ana-
tomic shunt and areas of very low V / Q . 
After the administration of the drug to three of the 
patients, no change in '^N shunt was demonstrated in 
patient DJ, shunting through the lungs was increased in 
SH, and shunting through the heart increased in JH. 
D I S C U S S I O N 
All presently available methods for measuring shunting 
of blood are subject to various limitations. The oxygen 
method, which compares oxygen content in mixed venous 
and arterial blood, if carried out during air breathing, 
tends to overestimate shunting due to areas of low V / Q 
(7). The use of a gas with very low solubility minimizes 
this effect. Oxygen breathing can minimize the influence 
of these areas (1) but may affect the shunt (5, 11), 
changing V / Q itself by reducing hypoxic vasoconstriction 
or by creating areas of atelectasis due to the washout of 
nitrogen from poorly ventilated areas, fdready prone to 
collapse. The oxygen measurement of shunt also includes 
any right-to-left shunting both through the heart and 
through lung vessels that bypass gas-exchanging units. 
T h e advantage of the oxygen method is that it is a 
steady-state method and therefore not subject to inac-
curacies due to recirculation. 
T h e double-indicator dilution techniques, which com-
pare the passage of an insoluble with a soluble tracer 
through the system, are not steady-state methods knd 
hence have additional limitations. The magnitude of the 
effect of low V / Q areas on the measurement of pulmo-
nary shunt depends on the solubility of the "insoluble" 
tracer used. SFe, ""Kr, Xe, and tritium have all been used 
(8,10,13,14,17) and their retention in blood as a function 
of lung volume described (4). Probably a more important 
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limitation of this technique is the effect of recirculation 
on the data. Copley et al. (4) avoided the problem in 
their animsd preparation by not allowing the recirculated 
blood to enter the system during the shunt measurement. 
Other authors have terminated measurement before the 
downslope of the soluble tracer ciu-ve deviated from a 
monoexponential (8, 10, 13) or used the Hamilton mon-
oexponential extrapolation (9) to analyze the soluble 
tracer curve (14). The use of these methods assumes that 
the transit time is the same through all pathways. This 
cannot be true, especially when there is a right-to-left 
conununication through the heart. Transit times through 
intrapulmonary shunts are also likely to affect this anal-
ysis, albeit to a lesser extent. 
Our technique combines the use of a low-solubility gas, 
'^N, which has a blood gas partition coefficient of 0.015, 
with a method that is independent of recirculation. The 
solubility of is such that only very low V / Q will 
contribute significantly to the measured shunt, the reten-
tion of gas being X/X + V / Q (6), where X is the blood gas 
partition coefficient. Thus will be equally partitioned 
between blood and gas at a V / Q of 0.015, and a homo-
geneous lung with a V / Q of 1 will give a '^N shunt of 
1.48%. Farhi's equation (6) is, however, based on steady-
state conditions. A true single-pass bolus technique 
would lead to problems of resorption of gas with high 
specific activity from areas with a low V / Q as pointed 
out by Copley et al. (4). Our technique is not truly steady 
state, nor is it a discrete bolus, because the injection 
takes place over 5-10 s and recirculation is included in 
the input signal. The fact that the time-activity profile in 
blood reaching the lung is not absolutely flat may lead to 
a small error; this is, however, minimized by the use of a 
gas of very low solubility, such as nitrogen. V / Q distri-
bution within the lungs of our patients, which may well 
be affected by the drugs administered, will affect the 
intrapuLmonary retention of '^N and hence our measure-
ment of intrapulmonary shunt. However, in no way does 
V / Q distribution or resorption of gas affect our ability to 
distinguish between the intra- and extrapulmonary com-
ponents of gas retention. 
The measurements in both dogs show '^N shunt in-
creasing with time. Because the dogs were anesthetized 
and supine, it is probable that areas of atelectasis and 
very low V / Q developed and caused increased '^N shunt-
ing through the lungs. 
Measurements of oxygen shunt are influenced to a 
greater extent by low V / Q areas than are those of '"'N 
shunt, and the values we obtained for oxygen shunt were 
higher in all but one of our patients {MW, Table 1). We 
are unable to explain this discrepancy, but because the 
measurements were made at different times and under 
different conditions the most probable reason is that the 
shunt was variable through the heart. Although the 
oxygen shunt measured closest in time to the '^N shunt 
was only 45%, a measurement made later in the study 
was 59%. The measurement of oxygen shunt is made with 
the patient breathing on a mouthpiece for 5 min, which 
may alter both breathing pattern and body position. 
Certainly the patient is aware that the measurement is 
being made, whereas he is not during the '^N measure-
ment. Pulmonary arterial pressures are extremely Labile 
in these patients, and this may contribute to the differ-
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ences between the two methods. 
As the measurement collects blood over a long sam-
pHng time, our sample will include recirculated blood. If 
a shunt is present, this blood will contain radioactivity. 
This does not affect the calculation of either the total 
shunt or the intrapuLmonary shunt as shown in T H E O R Y . 
T h e only possible error that the recirculation could in-
troduce would be radioactivity returning to the pulmo-
nary Eirterial but not to the aortic sample. This is unlikely 
to be a significant error, because the time-activity profile 
will be slurred on recirculation due to the vastly different 
transit times through the systemic circulation. 
T h e presence of tricuspid regurgitation would affect 
the measurement of the intrapulmonary shunt by allow-
ing some of the injected radioactivity to flow back into 
the right atrium and thence across a foramen ovale. The 
appropriate pressure measurements made in all patients 
before the start of the study (see M E T H O D S ) eliminates 
the possibility of this phenomenon. 
Patient JH (Table 2) is a good example of the use of 
this technique to study the effects of a vasodilator drug. 
T h e total measured '^N shunt is 14% in the control 
situation; 9% of this is through the lungs and the rest 
through the heart. After the administration of the drug 
the shunting through the lungs was not altered, and it 
was purely the cardiac component of the shunt that was 
increased. This explains the other observations made at 
the time: although the drug increased cardiac output and 
decreased pulmonary arterial pressure, the patient's hy-
poxemia worsened. This is not surprising, because we 
were able to demonstrate that the fraction of blood 
supphed to the gas-exchanging units in the lungs did not 
increase. 
This technique for the measurement and differentia-
tion of shunts can of course be used with gases other 
than the cyclotron-produced '^N used here. Any gas with 
a sufficiently low solubility is suitable, provided that its 
concentration can be detected with accuracy by sonie 
method. Gas chromatography, for example, using SFe 
would be ideal, because this gas is even less soluble than 
nitrogen. ^^SFe, which has a half-life of 86 days, could 
also be used in conjunction with the widely available 
liquid scintillation detectors for '"C. Radioactive tracers 
used in this way provide extremely accurate estimates of 
blood levels with a low radiation dose to the patient. 
In summary, we believe that we have developed a 
potentially useful technique that can be used to study 
the effects of various drugs in patients, with puhnonarv' 
hypertension. This technique involves the injection of a 
low-solubOity tracer into a central vein and the right 
ventricle and the withdrawal of blood through catheters 
that have been introduced into the aorta, right ventricle, 
and pulmonary artery for other routine investigations, 
such as injections of drugs and measurements of pressure. 
The technique can be used with widely available detec-
tion systems. 
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Ra(dioassay Problems Associale(d with the 
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The short-lived positron emiiiinc radionuclide '-Rh (/,, 1.27 min) is conveniently available fron-. c 
'-Sr"-Rh generator system. The parent nuclide ((,, 25.5d) produced from the spallation of mcl>bdcnuir., 
has associated with it varyinf; quantities of other long-lived strontium radionuclides, namely '"Sr. '"Sr and 
*Sr. It is important therefore in the clinical use of such material that the levels of strontium radionuclidc-
being administered to patients is carefully assayed and controlled. The problems associaied with these 
measurements arc discussed with special reference to the radiation dose received by the patient and ih-
problems in resolving overlapping peaks with different FWH.Ms. 
Introduction 
Slroniium-82 (/,,; 25.5d)'" can be used as a source of 
!he shori-li\'ed posilron eminer ^ Rb (/,; 76.4s)'" in a 
generator s y s t e m . S u c h a generator is being exten-
sively used at Hammersmith Hospiial for myocardial 
studies in patients and experimental animals using the 
positron emission computerised axial tomograph 
( P E C A T ) " " ' These studies involve a continuous in-
fusion of the generaior eluaie which in some cases 
amounts to a total of aboul 1500 ml of solution. As 
ii IS important lo determine accuraiely the radiation 
dose to the palieni from this infusion, great care has 
to be taken in assaying the generaior. In particular 
the long-lived strontium radionuclides which accu-
mulate in bone and have a long effective half-life'"' 
may be present due to breakthrough from the gener-
ator columns. 
Materials and Methods 
The ^'Sr used in these studies was produced by the 
irradiation of molybdenum with 800 MeV protons at 
the Los Alamos Meson Physics facility, where exten-
sive processing was carried out concentrating the 
strontium radionuclides, and subsequenl decay prod-
ucts."- However, by the time the processed '^Sr 
solution was delivered to the U.K., only the longer-
lived strontium radionuclides remained, namely *^Sr, 
*-Sr (f, _, 64.8d). ''"Sr { / , 50 .5d) and *Sr - 28.5yrl. 
The clinical generaior assemhK which has been 
described in detail elsewhere."'" consisted of two 
perspex columns in series. The primarv column 
(5 X 1 cm diameter) was filled with Whaiman chro-
matographic grade basic alumina supported on sin-
tered polyethylene. The second smaller column 
(2 X 1 cm diameter) contained Bio-Rad Chelex-lOO 
(200-400 mesh, preconditioned wiih 1.8':„ NaCl at 
pH 10) which performed a final chemical puniication 
of the primary column eluate. 
The solution of "'Sr obtained from Los Alamos in 
0.5 M H C l was adjusted to pH 9-10, loaded onto the 
A L O - column, and washed with > 200 ml of 1.8"^ ^ 
NaCI at p H 9 - I O to remove the poorly absorbed 
radionuclides (e.g. -*Co. ""Rb. " Y . etc). A l this stage 
more than 99% of the '"Sr was retained by the 
column 
Clinically useful '-Rb was obtained from the col-
umn by elulion with 1.8% NaCI solution, which was 
subsequently adjusted for pH and NaCI concen-
tration by mixing the output flow with acidified water 
for injection. The final solution (pH 6.5-7.5) in 0.9*:o 
NaCI was then passed through a sterilising filter 
before being infused. 
Because of the possible breakthrough from the 
column of strontium radionuclides il was extremely 
important thai the exact quantity of each in the 
infused solution could be determined. From y-ray 
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analysis. '-Sr was readily delectable by its 514 keV 
emission line, though as it will be shown this proved 
difiicull 10 assay, as u was not completely resolved 
from the annihilation radiation. As the presence of 
the pure /i-emitiers "Sr and *Sr was a distinct 
possibility. II uas decided lo subject a portion of the 
*-Sr Slock soluiion lo mass-separation and a! the 
same time to independently check the level of "Sr. 
Raiiioas.suy 
On receipt of the ''Sr radioacti*iiy in the U . K . . 
sources were prepared for counting and examined 
using a Ge(L i ) deiecior (See Fig 1) and a 4096 
multichannel analyser. The radioassay for *"Sr was 
performed by integrating '.he 777 keV photopeak. 
Using a n absolute intensity of 13.6%."" '^ ' excellent 
agreement ( + 0.5'',.l with the Los Alamos assay was 
obtained foi the total '•'Si aciivny delivered. 
Though (he 514 keV line of "Si was detected with 
Ihe Medical Research Council ( M R C ) Ge(Li ) de-
tector it was not possible to resolve it completer, 
from the annihilation radiation of'^'Rb (see Fig. Zi. 
and in early batches the "Sr was assayed by a simple 
subtraclion technique (using peak areas) and by z 
gross analysis v^hen the '-Sr had completely decayed 
After correcting these values for decay, there was an 
inexplicable diiTercnce with the Los Alamos dais 
which had been obtained from computerised analyses 
of Ge(Li ) v-ra\ spectra using a derivative of ihe 
G A M A N ' A L programme.'"" 
Further studies at Hammersmith, resulted in zn 
assay procedure thai could resolve the 511 and 
" S r / " R b - " S . 
511 / 5 I 4 KeV 
P a X - roys 
2 0 5 0 1 5 5 0 
Cnonnei no. 
Fig. 2. r - R a y spectrum of spallogenic produced «'Sr (0.493 keVch"' ) . 
Radioassjy problems ussi^ ciylcd w i i h ihc c l i n i c a l use of a radioiiuchdc g c n c r a k M 
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9 S C 1050 1150 1 2 5 0 1350 K 5 0 1550 1650 
Channel no . 
Subtraction » p « c t f J . T , . *^ 5f Onl^ 
Channel n o . 
Fig. 3. Specirum stripping technique for the resolution of the 511.514 keV lines. 
514 keV lines by a ' 'Rb y-ray specirum stripping 
technique, which was made possible by the use of a 
Nuclear Data (ND-66) analyser system. The method 
is illustrated in Fig. 3, and the results for a number 
of different batches of ^ "Sr are summarised in Table I. 
During the <levelopment of the spectrum strip 
procedure it became clear that even greater care than 
normal had to be taken in standardising all the 
parameters affecting the Ge(Li) detector efficiency. In 
particular, as Ihe endpoint energies of the emitted 
positrons from ' 'Rb are so high (up lo 3.35 MeV) a 
relatively thick absorber (e.g. 2.14 g cm"-of Al) was 
required in an attempt to annihilate the positrons 
within the fixed geometry of the source. However this 
thickness of annihilator material had a significant 
effect on the overall detection efficiency of the y-rays, 
amounting to =r20% reduction for the detection of 
the annihilation radiation.'"' 
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Table i. Relative "Sr conicni in various batches of spall-
tigeiiit produced ^ Sr {c iMTcctcd \o the date (if Cdl ibrai i ( in) 
'•'Rb spectrum 
Ci.AM.AN.-M. value strip analysis 
(Lo^ .Mamosl ( l lammcrsniilhi 
L A N L number 
and 
calibration date 
SR - J r i w i 
Ma: . 'N! 
SR ~5S"-(" 
4..\iii; '.^ 1 
SR 7K(.ic4C-
2(1 A u e . SI 
ISd' 
vvil- . !'.- r. -.-
| ( | S V - u 
I l L T V .-J - -5 
id.s.i' - I . 
uhcrc n ~ A 
{n number of Individual measurcmenlsl 
When this effect was taken into account the a n n i -
hilation radiation could be used lo assay for the 
''-Sr''^'Rb equilibrium using ihc published positron 
brLinching. ratio of 96".,."" '" Howe'.cr ihc \aluc oh-
lL:inf(.i u;;> ii; C;-';iL;reC"lL'!"i: \^ilh ih;; ;ls^;:^ \;;U:i-
calculated using ihc 777 keV line. If ihe adoption of 
I ."^  6"„ for the 777 keV line is torreci ihcn the posilron 
branching ralio measured during ihis series of experi-
ments would appear to be closer lo 75";, (74.4 + 5.2"„ 
where n = i ) than lo the literature value of 96'!,,. 
Ma.'is-sepal atioi: 
Samples from two batches of Los Alamos material 
were subjected lo mass-separation al the National 
Physical Laboratory. ( N P L ) and details of the 
method have been published elsewhere."" The im-
portance of using this procedure was thai it was 
possible 10 radioassay separately for *-Sr. ''"Sr and the 
/?-emitlers ""Sr and '"Sr. using pure samiplcs available 
only by this method. "'Sr and *^Sr were assayed using 
the .MRC Ge(Li) detector, while ''Sr and '^•Sr,"'^' 
were assayed in a low background anli-coincidence 
shielded 47!/l proportional counler"*' at ihe N P L . The 
results of these experiments are given in Table 2. 
Discussion 
Before any determinations were made of the dose 
incurred by the patients in these clinical studies, il 
was importanl to have reliable measurements as lo 
the exact quantities of thev radionuclides involved. 
The activity of the '^Sr/'-Rb equilibrium was 
measured using the Ge(Li ) detector and integrating 
Ihe 777 keV pholopeak using an adopted abundance 
figure of 13.6%."'"-'' Assuming a constant flow in-
fusion of *'Rb into the patient and basing calcu-
lations on the M I R D Tables for radiation dose at a 
steady state."'" then ihc radiation dose lo the patient 
was calculated to be 1.9 x 10 ' G y (19 mrad)m;p. ' 
to the myocardium. .V5 \ 1 0 G y (.15 mrad)min to 
the renal coricx and 0.2 x 10" G>-(2 mradlmin" to 
l i i c u h i i l c body, for a ' 'Rb ccncriitoi giviiis WH-z 
(1(1..^  mCiimii! ai a steady slate eluiion. This is .noi 
regarded :i.s excessive lor the clinical inrorma;..in 
which 1-. oh;aincd.''''' However, it appears frorti ou; 
measurements lhat Ihc adopted value for ihe posilron 
branching ratio for ^'Sr may be in error by as much 
as 20"„. If this is confirmed by further experiment.''"' 
it could mean an increase in the calculated radia::on 
dose 10 the patient. 
.\n additional source of patient radiation dose 
arose - . i : : the hrcakihrouch of stroniiun-
nucliJc-- l i ^ ' i : : !!u- ciiiiica! generator. The tola! CL^n-
l i l \ of stroniiuir, radioactivity leached from a tyr--.;3l 
column inio a hire of ini'used solution was foun; to 
be only 20 Bq (0.54 nCi)ml' \ thus makmg '.he 
separate assa> lor ''"Sr and '''Sr a difiiculi task 
In addition, there appeared to be a discrepanc;. m 
the *'Sr-''-Sr activity ratio (see Tables 1. 2) as caku-
laied using the " G A M A N A L " assay for ^*Sr with ".he 
spectrum-strip and mass-separator values. In order io 
find a reason for this difference, a study was mac; i i 
the NPL of a similar computerised v-ra> ana:.;:s 
programme to GAM.AN.'kL which was capabk of 
resolving overlapping y-rays of similar energy. The 
GAMAN. 'XL programme does this by making •jie 
reasonable assumption thai the peak widths of i:nes 
which are only .i keV apart are comparable, i.e -Jie 
values for the full w-idth al half the maxirr.jm 
(FWH.M) are virtually equal.'"" 
Houevcr. in ihc case of the annihilation radi£-on 
the P W H M of the y-ray is much wider than "Jie 
corresponding nuclear emitted photons becausr of 
Doppler broadening as the posilron is brough; lo 
rest.'•''•' This increase in peak widlh is a function of 
both annihilatot material and of positron energy ^ 
In the case of the annihilation radiation from the ••;r> 
energetic '"Rb positrons, this increase in wjith 
measured with the M R C Ge(Li) detector amouDted 
to a factor of 1.6 of the 514 keV widlh when alimi-
nium annihilators were used (See Fig. 4). 
When this information was incorporated into 'jie 
computerised y-ray analysis programme, il becime 
clear that unless proper account was taken for •jie 
Tabic Examination of spallogenic produced '"Sr after mass-separation (activity relaiive to 
''Sr at the dale of calibration.! 
G A M A N A L 
value for '-Sr 
Mass-separated samples 
L A N L number and *'Sr "Sr '«'Sr;'«Y 
Notes calibration date (Los Alamos) Ge(Li) assay Anfl counter 
SR,'6.'<764 
18 Dec. -79 
180% - - W % :i0.5"„ <o.or;v Results refiecl 
preliminary 
nature of study 
SR./74299C 165% 10.1% 1.85% 0.018% 
31 Mar. 'El 
Radi(i:issay p r o h l c m s a . s s o c i j i c d w i i h t h e c l i n i c i i l u s e o f it n u l i o n i k l i d c i i c n c r L i l m 7.t 
5ia k e V 
514 KeV 
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r i r s i chonnel 
n onolysis 
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A B C D 
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Cticnnel no. 
Fig. 4. Resoluiion companson of the 5 l l . ' 5 l4ke \ ' line> 
showing increased peak width of ihe 511 keV annihiiaiion 
radiation. 
increased peak width of the 511 keV line, then its 
integration was underestimated and the 514 keV line 
overestimated by as much as 75% (See Table 3). 
After these corrections were '- made to the 
G A M . ' ^ N A L figures for the "'Sr content in the '"Sr 
batches, it was found that all the analytical methods 
gave approximately the same ratio (i.e. 106':„ at the 
time of calibration). 
l.lsing this figur.,' ;uul \ 1 M ! S C f o r "Sr and '*'Sr '"'S' 
from Tabic 2. t h e itiuil r : i d i : i i i o i i dose lo the bono 
tissue due to the brcakihrcugh of s t r c M i i i u n i radio-
nuclide.- frtini t h e _L'eiHT:iii.ir i i i n c been calcuhileti : in( l 
iippciir in Tiiblc J 1 lu-.,c \ : i l u e s w e r e delcrniin.,\l f n 
ihe ii.i..!s l i i e t i i>- . : . : ; i - , ' i ! '> v i i i t p . i^ v HiLici ,•; . 
iiiui cieaiK s h u u thai l i i e i i K i ; i ' r i l \ of ili-j radi::ii,'!i 
d i - - e :a]-c>- I ' l - . i i i i liic ' Si " Rb euiiiiibntini. ,.\i ;lu- eiui 
of the geiicraii'i • l i l e ' l a p p i n . v Mill d;ly^ f r i M i i tiie 
Ci:iibr;iii(>i) d i i i c l t h e p K i p o r l i o n o f ihe lonuci-li\ed 
Slrontium radionuclides incrciises but ""Sr remains 
the predominant source oi' radiation dose. 
Conclu.sion 
Tiu-'^S: iVoni I A!.:;><.->- :- n- . : L L-\;en<i\el;. u - e , : 
11"; .: ' Kb ijciic!.:;,•: !\'; iiiuii::iitii.ii - - l i i i i i o u-i-ij: ii,e 
PHC'.XT and t h e i C s u l i s :ire \er\ eiicouraginj; The 
r;id:aii(>ii dose lo i h c p.iticnl ii.i^ been caicuUiied aiui 
is not regarded as excessive for the clinical informa-
tion ivhich is obtained 
Various analyiical approaches have been made to 
estimate the proportion of other stroniium radio-
nuclides present, a mass separation technique being 
necessary for the assa> of '"Sr and *Sr The 
various adopted methods employed for the measure-
ment of the '~Sr content all give a value of around 
106",, at the lime of calibration, and these are out-
lined belou-
(a) .Measuring the "Sr when all of the ""Sr had 
decayed and correcting this data for decay to obtain 
a value at the Los .Alamos dale of calibration. 
(b) Using a simple subtraction technique to correct 
the ctiunis in the 511 514 kc\ ' lines for the '"Sr 
comribution using the published literature values for 
the 777 ke\'' 51 1 ke\' ratio, A measurement with cen-
eraior eiuied "^'Rb has shown this ratio lo be 1:0.0914 
(13.6"„ for 777 keV and 148.8% for 511 keV y +). 
(cl Mass separating samples and individually 
measuring the collector foils of diffe.'-ent mass num-
ber. 
(d) Using a specirum strip method with the aid of 
multichannel analyser that can store and retrieve the 
spectra of separated •'^ •Rb. 
(e) By examination of the '•Sr/*'''Sr spectra using a 
computer programme which indicated that a discrep-
ancy in the "^Sr ^-Sr ratio could be explained by the 
Table 3. Quantiiative analysis for the resoluiion of the 511 '514 lines from 
the L A N L ''Sr Batch SR.78684C 
Number of channels 
used for analysis 
(0.497 k e V c h " ' ) * 
Ratio of integrated counts for 511.'514 
Similar peak widths Adiusied peak widihs 
511 511" 3.25 kcV 
514 2.5keV ( F W H M l 514 2.01 keV*"^ ' 
40 ( A ) 1.22 2.50 
4 5 ( B ) 1.22 — 
50 ( C ) 1.22 — 
6 0 ( D ) 1.21 2.33 
• See Fig. 4. 
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Measurement of Cerebral Blood Flow Using Bolus 
Inhalation of and Positron Emission Tomography: 
Description of the Method and Its Comparison with the 
C'^O^ Continuous Inhalation Method 
Iwao Kanno, Adriaan A. Lammertsma, Jon D. Heather, Jeremy M. Gibbs, 
Christopher G. Rhodes, John C . Clark, and Terry Jones 
MRC Cyclotron Unit, Hammersmith Hospital. London. Lni;lanil 
Summary: This article describes a rapid method for the 
regional measurement of cerebral blood flow using a 
single breath of and positron emission tomography. 
The technique is based on the bolus distribution principle 
and utilises a reference table for the calculation of flow. 
Seven subjects were studied using both this method and 
the C'^O, continuous inhalation stendy-«tate technique. 
The single-breath method gave How values 20% hi<;her 
than those obtained using the steady-state meliioc. A 
simulation study was performed in an attempt to define 
the reasons for the difference between the two tech-
niques. Estimations were made of identified sources of 
error in the measurement of regional cerebral blood How 
using the single-breath technique and compared with re-
sults fiom a similar >:|ud\ previousK described f.)r the 
steady-su.ie technique. Ht.uever. further comparative 
studies wii' be necessary in s itisficti rily e.xp'ain the dif-
ferei cc be. ween bo'.h '.ccl.niques. Key W ords: Conim-
uous in!u( :itiun oi C O . — I'ositror emission tomog-
raphy—Regional cerebral blood llow —Single-breath in-
halation of C'^O,. 
The search continues for improved methods for 
measuring regional cerebral blood flow (rCBF) 
using techniques based on positron emission to-
mography (PET). Flow measurements are required 
to interpret the results of metabolic studies and in 
particular to define supply-demand relationships 
within cerebral tissue. In addition, a rapid means 
for measuring rCBF is needed. This would not only 
reduce the time scale of combined cerebral f l ow-
metabolism studies but is essential for studying the 
transient cerebral vascular response to vasody-
namic, chemical, and neurophysiological stimula-
tion. The more common techniques developed to 
date for measuring rCBF with PET are the " K r 
clearance method described by Yamamoto et al. 
(1977), the C'^Oj continuous inhalation technique 
developed by Frackowiak et al. (1980), the Hj'^O 
Address correspondence and reprints to Dr. Kanno at Division 
of Radiology, Research Insiitute of 5rain and Blood Vessels. 6-
10 Senshu-Kuboia-Machi, Akila City, Akita 010 Japan. 
Abbreviations used: C B F , Cerebral blood flow; C V , coeffi-
cient of variation; CRT, cathode ray tube; PET, positron emis-
sion tomography; rCBF, regional cerebral blood flow. 
clearance method reported by Huang el al. (1982). 
the ramp intravenous Hj'^O infusion technique of 
Ginsberg et al. (1982). and the intravenous H;'^0 
bolus injection technique (Herscovitch et al., 1983; 
Raiclile et al.. 1983) initially developed by Raichle 
et al. (1981). The ste.idy-state and clearance lech-
mq'ies require a cond.tion of steady brain function 
during a scan period of several minutes. Hence 
these mer.hods arc unsuitable for monitoring rapid 
chani:es in cerebral v.tscular function. 
This article describes a method for the rapid mea-
surement of rCBF using PET and a systemic arterial 
bolus of Hi'^O produced by a single-breath inhala-
tion of C ' O T . The measurement used is based on 
the bolus distribution principle (Landau el al.. 
1955). The method developed in this study differs 
from that described in previous publications 
(Raichle et al., 1981; Ginsberg et al., 1982; Her-
scovitch et al., 1983; Raichle et al., 1983) in two 
respects. First, in our study a single breath of C'-Q; 
was used. Raichle and co-workers (Raichle et al.. 
1981,1983; Herscovitch et al., 1983) employed an 
intravenous bolus injection of Hj '^O, while Gins-
224 
C'^Oy SINGLE-BREATH BLOOD FLOW MEASUREMENTS 225 
berg et al. (1982) made use of a ramp infusion of 
Hi'^O. Second, in contrast to the previous studies 
fiJw values were calculated using a reference table, 
a technique initially described by Kanno and 
Lassen (1979). 
The uptake approach has been adopted since dif-
ficulties arise when attempting to use the tissue 
clearance of Hj'^O to measure flow following sys-
temic administration of tracers. These problems 
arise because the concentration of the recirculating 
Hj '^O rapidly reaches that of the Hj '^O in the 
tissue, at which time the recorded signal contains 
little or no flow information. In the study reported 
here, the bolus inhalation uptake technique was 
compared directly with the continuous inha-
lation steady-state method (Frackowiak et al . , 
1980). 
T H E O R Y 
The relationship between the time course of the 
arterial concentration of a diffusible radioactive 
tracer, a(i) (in fxCi/ml), the cerebral blood flow 
(CBF) per unit volume, / (in ml/ml/min), and the 
concentration of the tracer per unit volume of brain 
tissue, b(t) (in nCi/ml), is given by the convolution 
integral: 
hU) = r/a(^)e-'^'^'*'-^'</s 
^ 
a(/)*/e-^'" 
(1) 
where k = Jlk, X is the equilibrium partition coef-
ficient of the tracer between the tissue and the 
blood (ml/ml), the asterisk denotes the convolution 
integral, and s is the time variable of integration. 
Integration of both sides of Eq. 1 between /, and 
t2 gives 
f'2 ['2 
bit) dt = \ a{t)*ke 
-ki dt (2) 
When C'^Oj is administered as a single breath, 
the '^O atoms exchange almost instantaneously 
with the oxygen of the water molecules in the lung 
under the influence of carbonic anhydrase (West 
and Dollery, 1962). With the use of W-^^^O as the in 
vivo tracer, Eq. 1 can be solved by measuring a(t) 
and b(t) [corrected for the radioactive decay of '^ O 
. ^ ' / . ~ 2.1 min)]. In the application of this model it 
^^^^ partition coefficient for water 
^ ^ ^ l g . . ^ n > t y - Values of i'Mt) dt can be ob-
^ " ^ ^ ^ S H M the integral concentration of 
HT'^O in the brain with a positron emission tomo-
graph. 
The component /^ ^^ (^r) dt of Eq. 2 corresponds 
to the pixel value of the reconstructed tomogram 
obtained by the PET scanner during the period be-
tween r, and This assumes that the time integral 
of the tomogram is given by the time integration of 
the projection data (Tsui and Budinger, 1978). 
Continuous monitoring of the arterial blood con-
centration, usifig a detection system calibrated 
against the pixel response of the PET scanner, pro-
vides values of a(t). Hence, values for the right-
hand side of Eq. 2 can be calculated by inserting 
values for k between 0.01 and 2.00 in steps of 0.01. 
This provides a reference table with which the re-
gionally measured pixel values (i.e., the left-hand 
side of Eq. 2) can be compared to determine the 
actual k values and hence the rCBF (Fig. I). This 
approach is in essence the ""early picture'" method 
described by Kanno and Lassen (1979), which has 
been modified to scale the integral in absolute units. 
METHOD 
The subject, while positioned wjihin the PET scanner, 
exhaled to functional residual capacity and then inhaled 
I L of air containing between 70 and 100 mCi of C^O, 
through a mouthpiece. This was followed up to end ex-
piration with room air. The 1-L anaesthetic bag con-
taining the radioactive gas was surrounded by a 5-mm-
k-value (mln 
FIG. 1. Graphic representation of the reference table for the 
C'^Oj single-breath bolus distribution method. The curve 
represents the relation between pixel counts (ordinate) and 
C B F (abscissa). The pixel value was calculated by Eq. 2 using 
the arterial blood concentration curve measured by "beta 
counting" the continuously withdrawn arterial blood. The 
absolute arterial concentration was measured with a well 
counter calibrated against the positron emission tomo-
graphic scanner. 
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thick acrylic cylinder which absorbed the emitted posi-
trons, thus protecting the skin and eyes. 
Selection of the period of integration requires special 
consideration in order to optimise the signal (How-related 
counts)-lo-noise (tissue volume-related counts) ratio. 
Given the time course of the tracer in the tissue and the 
mechanical speed and sensitivity of the P E T scanner 
used, this period was taken to be approximately 1.5 min 
starting 5 s after inhalation. Although ideally a shorter 
scanning time would probably be better, this could not 
be explored with the present re lat ive ly insensit ive 
system. From statistical studies (Lammertsma et a l . , 
1982), it was concluded that a reduction in count density 
would result in a large reduction in statistical precision. 
A fine-gauge catheter was inserted into the radial artery 
at the beginning of the study and connected to manometer 
tubing (1.6 mm i.d.) which had been coiled on the surface 
of a plastic scintillator. This allowed the concentration of 
Hj '^O in the arterial blood to be measured by "beta 
counting" while being sampled using a constant-with-
drawal pump. The tube length from the catheter to the 
coil was approximately 60 cm, and the speed of the pump 
(Harvard Apparatus Model 2206) was set at a constant-
withdrawal rate of 10 ml/min. After recording the blood 
activity for 4 - 5 min, the tube was disconnected and an 
arterial blood sample withdrawn into a syringe. At this 
time the blood concentration was reasonably steady (Fig. 
2). The concentration of this sample was measured with 
a well counter that had been calibrated against the P E T 
scanner as cps/ml in relation to cps/pixel. This sample, 
with an appropriate decay correction, in turn was used 
to scale the arterial curve in absolute units. The disper-
sion in the tube was measured experimentally using ve-
nous blood mixed with H,'^0. The tube dispersion func-
tion d(t) obtained was used to correct the right-hand side 
of E q . 2 (see the Appendix). 
The plastic scintillator used for the (J-ray detection was = 
a Nuclear Enterprises type 102A, 3 mm thick and 20 mm 
in diameter. This detector has a high sensitivity for reg-
istering positrons but a low response to 51 l-keV annihi-
lation photons. A lower energy discrimination threshold 
was used to reject the low energy continuum of scattered 
photons that emerged from the subject and penetrated the 
detector shielding. Only about 2 cm of lead was needed 
for the primary shielding around the detector. The anerial 
blood time activity data were recorded in l-s intervals on 
a multichannel analyser (Hewlett-Packard model 4096). 
The P E T system used for the study was the whole-bod\' 
E C A T II ( E G & G Ortec). For these investigations, me-
dium-resolution shadow shields and the medium-resolu-
tion scan mode were used (Phelps el al. , 1978; Williams 
et al . , 1979). This provides a sensitivity of 12 x 10" cps 
(iCi/ml for a 20-cm-diameter uniform pool of activity. The 
scanner has a spatial resolution of 17 mm full width ai 
half maximum in both the transverse and axial directions. 
A net scan time for data acquisition was set to 70 s. How-
200-^ 
150-^ 
100-
> 
I— 
< 
50H 
Head Concentration Curve 
i 
\ 
Arterial Biood Concentration Curve 
TIME (mm) 
F I G . 2. Time course of the radioactivity concentration of the arterial blood and the head following a single breath o f C ^ O j . 
Both curves were corrected for the decay of '^O (T,,^  = 2.1 min). The arterial curve shows a steep rise and fall and then a steady 
level of recirculating activity. The head curve shows a very slow clearance, illustrating the difficulty in applying conventional 
clearance analysis techniques. 
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ever, this took a total of 90 s because of mechanical mo-
tion between different scan positions. The scan was 
started 5 s after the end of the single breath of C ' - O , . In 
addition to recording the arterial detector counts, the 
multichannel analyser also recorded the whole slice count 
rale from the P E T scanner. An additional channel in this 
analyser was used to record the time at which the P E T 
scan commenced. In this way the starting points of the 
head and blood data could be superimposed. Figure 2 
shows a typical example of the arterial curve and P E T 
true coincidence events (totals minus randoms). The total 
number of counts accumulated with the above procedure 
varied between 0.8 and 1.0 million per plane. In calcu-
lating r C B F , a pixel size of 2.5 x 2.5 mm- was used on 
the cathode ray tube ( C R T ) display and 7.5 x 7.5 mm-
on the matrix printout. In addition to the scan a 
transmission scan was performed using an external ^ Ge 
ring source. The data from this scan were used to correct 
for attenuation in the C O , scan. 
Subjects 
Single-breath C ' O , r C B F studies were carried out on 
three cerebral infarct patients, one brain tumour patient, 
and three normal volunteers. In all cases, they were fol-
lowed immediately with the conventional steady-state 
C'^Oj r C B F study. The two measurements of r C B F were 
performed on the same anatomical plane. A total of nine 
planes in seven subjects were measured. Four planes 
were studied at a level of 4.5 cm above the orbitomeatal 
line (OM + 4.5 cm), two at C M -I- 6.0 cm, two al O M 
+ 6.5 cm, and one at O M -i- 7.0 cm (Table 1). 
Analysis of errors 
There are several possible factors which determine the 
accuracy of the C'^O, single-breath technique: (1) the use 
of an incorrect value of the partition coefficient for water; 
(2) the limited extraction of water in a single pass, re-
sulting in nonextracted intravascular (venous) H , ' ' 0 : (3) 
the contribution of activity contained within the arterial 
blood; (4) the inhomogeneity of tissue within the resolved 
volume; and (5) the imposed statistical error. There arc 
also possible technical errors that arise from (6) an in-
accurate cross-calibration between the P E T scanner and 
the well counter; (7) a nonlinearity of the count rates 
(deadtime) of the P E T scanner; (8) an inaccurate correc-
tion for the dispersion of tracer within the tubing through 
which the arterial blood is withdrawn; and (9) misalign-
ment, with respect to time, of the P E T data and the re-
corded arterial curve. Of these factors, the first five in-
trinsic problems of the method were evaluated by simu-
lation. The other factors will not be discussed here, since 
they can be avoided by careful selection of the instru-
mentation used and the design of the studies. 
Simulation 
In the simulation, the right-hand side of E q . 2 was ex-
panded to include the terms involving the partition coef-
ficient (X), the extraction fraction of water (£"), and the 
fractions of the total volume occupied by the arterial (V.J 
and venous [VJ blood and the tissue (l^,): 
A i f ) = j'HV, + V,y\)£.7n(/)*(' 
-I- \\.{\ - Bail) + V.jiiDl </' (."'I 
where \\. + V^^ + = \ and £' = I - p ( w h e r e /'S 
is the permeability-surface area product). Each of the 
three itemised sources of error were evaluated by con-
sidering the difference in the values of r C B F obtained 
using both E q . 2 and 3. These comparisons were carried 
out separately by keeping two of the three parameters. 
X, Vj . and E. constant and equal to the values used in 
E q . 2. 
The effect of the partition coefficient of the water ( \) 
was examined imder the condition that V.^ = 0. \ \ = 0. 
and £ = 1: 
T A B L E 1. Cerebral blond flow (CBF) sH(die.<: measured by the C'O, aingle-hreaih (SB) ineihod and die C " 0 , 
continuous inhalation (sieady-siaie. SSj ineihod 
Study 
no. Subject 
Age 
(years) 
Whole plane C B F 
Conical 
tissue C B F 
Level" Diagnosis 
Periventricular 
tissue C B F 
SB* SS' SB* SS^ SB* SS' 
40..^ M.O 41.2 35.2 29.4 22.8 
51.8 41.1 54.7 43.1 32.1 28.3 
49.6 35.3 53.1 36.6 24.3 20.6 
42.8 32.5 55.5 41.1 23.0 17.7 
40.4 41.7 42.9 46.3 32.0 30.3 
51.0 38.4 58.8 50.7 31.9 23.4 
32.7 30.7 39.1 37.9 17.8 16.2 
42.9 40.9 46.8 44.9 32.1 30.6 
48.8 34.4 .50.4 36.5 32.0 23.1 
G . K . 58 4.5 
v . o . 33 4.5 
T . J . 41 4.5 
T . J . 41 6.5 
l . K . 35 4.5 
I . K . 35 6.5 
J . M . 54 7.0 
K . K . 33 6.0 
A . G . 52 6.0 
Carotid 
stenosis 
MCA 
stenosis 
Normal 
Normal 
Normal 
Normal 
Microglioma 
Normal 
Bilateral 
carotid 
stenosis 
^ i ^ ^ n t : ; : ' ; ; ; : ' ^ ! ^ ' ' " - .he orb.tomeatal I 
^ " ^ V m i n bl u^ e C'3o' '^"g .^'-breath method, 
g ^ ^ y m e C'^Oj contmuous inhalation 
ine. 
method. 
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A ( f ) '.fa 
J I, 
(4) 
A{f) was used as a value in the "look-up"' reference 
table based on E q . 2 to obtain a calculated (: value (A:,). 
This value was then converted to flow using the relation-
ship = Kk^. The partition coefficient X was varied from 
0.8 to 1.1 in steps of 0.05. 
The effect of limited extraction of the water in the cap-
illary was examined under the condition that X = I and 
I / , = 0: 
A { f ) = '[EaU)*fe-^' + V'.d - E)a{i)] di 
'i 
= '[{I - e''''''')a{l)*fe''' + V^e'''^''^ail)\di (5) 
Similariy. Aif) in E q . 5 was used as a value in the look-
up reference table based on E q . 2. However, instead of 
the extraction fraction £ , the ^5 product was varied from 
PS = 100 ml/100 g/min to infinity. The calculation was 
carried out for two values of the venous fraction IV',.). 
0.05 and 0.10, respectively. 
The contribution of the anerial blood volume was eval-
uated assuming \ = 1 and £ = I . The fraction of the 
tissue volume occupied by arterial blood was varied from 
0 to 5% in 1% steps. 
A i f ) V^)a{l)*fe''' + V./i{i)\ dt (6) 
Aif) in E q . 6 was used as a value in the look-up ref-
erence table for E q . 2. 
The effect of inhomogeneity of the tissues was evalu-
ated using a compartment model which consisted of var-
ious mixtures of pure grey and pure white matter within 
a single image element: 
A = W^Aif^) + W,Aif,) (7) 
where / , and / , are the fiows of each component and W, 
and W, are the weighting factors such that IV, + W, = 
I. The flows determined for the summed value given by 
E q . 7 were compared with the mean flow ij'). calculated 
as / = W,/ , -1- W / , . The ratio of W, to W, was varied 
from 0 to I in steps of 0.05. The flows of each component 
were taken to be 70 and 20 ml/100 g/min. 
The statistical error in the computation of How can be 
determined from the statistical error in the original pixel 
counts. This approach was previously examined for the 
steady-state C O , study (Lammertsma et al . , 1982) and 
is also applicable for the single-bolus technique. This pro-
cedure assumes that changes in the distribution of radio-
activity during the scan do not influence the statistical 
error of the tomogram. From the statistical error in the 
accumulated pixel value, the corresponding error in How 
can be determined using E q . 2 and appropriate values 
for k. 
R E S U L T S 
From the total of nine planes studied it was not 
possible to obtain mean flow values for both pure 
grey and white matter because, for the grey, the OM 
+ 4.5 cm needed to be recorded and, for the white. 
OM -1- 6 - OM -I- 7 cm. Hence, mean hemispheric 
cerebral blood flow (CBF) values in each plane 
were considered representative of flow for the 
present study comparing the two methods. Where 
possible, mean CBF values for the cortical tissue, 
the periventricular tissue, and the whole plane were 
extracted. Mean CBF values were obtained by firsi 
calculating rCBF per pixel and then taking the av-
erage. Comparisons between the single-breath and 
the steady-state techniques are shown individually 
in Table 1 and summarised in Table 2. In calculating 
the mean CBF for the cortical tissue, the d a i i 
within the frontal and occipital poles were excluded 
to avoid unknown contributions from the anerial 
and venous blood. For the cortical and the penver.-
tricular tissue, the single-breath technique gave 
values for CBF 18.9 and 19.5% higher than ihoie 
obtained using the steady-slate technique The 
mean values for the entire planes showed the fo-.-
lowing relation between the two methods; 
.19 CBFss + 3.85 ml/100 ml r.in 
r = 0.90 (p < 0.001) i M 
CBFsB = 
where CBF^g is the CBF with the sincle-rrea:n 
technique and CBFgs is the CBF with the f.ead;.-
state technique (Fig. 3). A statistical test on the 
slope of this relation in comparison to 1 (the '.ine cA 
identity) showed that the two methods were dif-
ferent, with a significance level of 0.005. 
The rCBF data were further analysed by r.oiti.- e 
profiles from the printout matrices for rCBF. Fcr 
each plane, CBF profiles were plotted as cortic.il 
strips for each plane for both the left and righ: hemi-
spheres (Fig. 4, top left). Each point of the proF.'e 
is the mean of pairs of adjacent matri.x ele-ien:,-. 
each element corresponding to an area 7.5 •< ~.5 
mm-. The left and right profiles obtained fn:m tne 
single-breath and the steady-state techniques were 
superimposed on the same drawing. Similarly rCBF 
profiles along the coronal lines and the sagifiii Wn-^i 
were obtained for the two methods (Fig. 4. left a.Tid 
top right). By comparing corresponding pixel valu e^s 
along the profile, correlation coefficients bitween 
the single-breath and the steady-state methocs uere 
calculated for each profile (Table 3). For the :ortical 
profile data, 8 of the 18 profiles gave a correlatBon 
of >0.8 for both hemispheres. In the coroial cu:\A 
sagittal profiles, of 36 data sets only 2 had a cicr-
relation of <0.8. One reason for such differences 
between the cortical contour and the coroial-s.-ig-
ittal line was that the former was very sensxive lo 
the misalignment in repositioning the head in ::he 
J Cereb Blood Flow Melabol. Vol. 4. No. 2, 1984 
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T A B L E 2. Comparison of mean cerebral blood flow by 
both C " 0 , methods 
S 
d 
s 
n 
e 
i l 
d 
r-
Region Single-breath Steady-stale Ratio 
Whole plane 44.52 36.56 1.220 
Cortical tissue 49.17 41.36 1.189 
Periventricular tissue 28.29 23.67 1.195 
two studies. However, these CBF profiles were of 
use in identifying systematic differences between 
the two techniques rather than in the direct visual 
comparison of rCBF images (Fig. 5). 
The results from the simulation of the systematic 
errors are shown in Figs. 6-9. These figures indi-
cate that the errors move in directions similar to 
those in the steady-state method (Lammerlsma et 
al., 1981a), but in general the range of the error is 
seen to be smaller. Using a 5% increase in the par-
tition coefficient gave flow values I and 3.5% higher 
at flow rates of 20 and 70 ml/100 ml/min, respec-
tively (Fig. 6). By varying the value of the PS 
product, the effect of limited water extraction was 
seen for low PS products (Fig. 7). With increasing 
venous blood volume, the effect was reduced. The 
contribution of the arterial blood volume to the flow 
signal was almost constant over the wide range of 
flow values considered and was almost proportional 
to the blood volume fraction itself. An arterial frac-
60 
50 
y 30 
r= 20 
• / 
/ a 
n 
C P / O Q 3 
O / 
/ 
O/^ Y = 1.192 X + 3.852 
/ 
/ O 
• Mean Cortical Tissue 
oMean Periventricular Tissue 
tion of 5% resulted in an approximate 5% overes-
timation of fiow (Fig. 8). An underestimation of 
mean tissue fiow results when mixtures of grey and 
white matter reside within a resolution element 
(Fig. 9). This effect was found to be smaller than 
with the steady-state technique. When considering 
a grey matter flow of 70 ml/100 ml/min and a white 
matter flow of 20 ml/100 ml/min, a maximum un-
derestimation of 9% occurred for a white/grey ratio 
of 0.4. 
Statistical errors were evaluated using the pixel 
value of the plane and referring to the experimental 
statistical response data of Lammertsma et al. 
(1982). In the present single-breath C'^O, study, 
typical count densities were 3,000 and 1,500 counts 
per pixel for the cortical tissues and periventricular 
tissues, respectively. Relating these count densities 
to those in Fig. 2 of the Lammertsma article showed 
that the corresponding coefficients of variation 
(CVs) were 4.4-4.7%. From these pixel CVs. the 
corresponding flow CVs were obtained from the 
count-flow relationship shown in Fig. I . 
DISCUSSION 
The single-breath C'^Oi procedure is an attrac-
tive means for pulse-labelling the arterial blood wiih 
H , " 0 . The instantaneous shifi of the '"0 from the 
gas phase to HjO in the lung (West and Dollery. 
1962) means that the protraction of an intravenous 
bolus of H,'^© that results from transit through the 
right side of the heart is avoided. In addition, ra-
diochemical sterility problems associated with pro-
ducing Hj'^O for i.v. injection are avoided. 
The general systematic administration of H^'^G 
results in a high level of recirculation such that tra-
ditional "washout" or ""clearance" measurements 
are difficult. The tracer rapidly redistributes be-
tween the high and low flow tissue with the flow 
T A B L E 3 . Correlation coefficients between the iwo 
C'^02 methods In the CBF profiles 
Cortical 
contour Coronal line 
Saggiial 
line 
^ ° 20 30 iiO 50 
(ml/ lOOg/mln) 
^1§?l»iJf-P^J ^^'"^^ measured by the C ' ^ o , 
®'^'^ig^^?.S*?ady-state (abscissa) methods ^^^^ll*??)"®-^"' 9'°t>al regions SlriBSP** ^'^^ perlventric-
aOg'^WMerit work. 
:!>iuuy 
no. Left Right Anterior Posterior Left Righi 
1 0.47 0.83 0.95 0.96 0.72 0.94 
2 0.67 0.89 0.96 0.84 0.82 0.94 
3 0.65 0.67 0.91 0.87 0.85 0.81 
4 0.84 0.48 0.89 0.96 0.84 0.92 
5 0.55 0.52 0.86 0.87 0.93 0.77 
6 0.73 0.85 0.85 0.98 0.87 0.81 
7 0.87 0.89 0.95 0.88 0.92 0.% 
8 0.74 0.77 0.85 0.97 0.87 0.94 
9 0.93 0.96 0.95 0.89 0.94 0.81 
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F I G . 4. C o m p a r i s o n s of the C B F profiles (study no. 7) c' 
the c o r t i c a l c o n t o u r s ( a b o v e left), the c o r o n a l (A = 
posterior, B = frontal) l ines (left) and the sagittal lines 
(above right) for both methods. Solid l ines represent C B -
values m e a s u r e d by the single-breath method and d a s h e : 
lines those m e a s u r e d by the steady-state method. E a c " 
point represents the mean value for two adjacent pixe:s 
in the printout perpendicu lar to the direction of the pro-
file. 
L e f t R i g h t 
information in the tissue signal rapidly becoming 
attenuated. We therefore adapted the bolus distri-
bution principle using only the early uptake phase 
(Landau et al., 1955) rather than the clearance anal-
ysis using the whole kinetics (Huang et al.. 1982^. 
The tracer model used for the analysis was based 
on the early picture method described by Kanno 
and Lassen (1979). This technique has been modi-
y Cereb Blood Flow Melabol. Vol. 4. No. 2. 1984 
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O H + 4 . 5 
+ 6 . 5 
F I G . 5. Cerebra l blood flow im-
a g e s m e a s u r e d at the level of 
the o r b i t o m e a l a l l ine (OM) + 
4.5 cm (top) and O M -• 6.5 c m 
(bottom) by the C ' ^ O j s ing le -
breath m e t h o d (right) a n d the 
C ' ^ O j steady-state method (left) 
in the s a m e patient. 
fied to deal with absolute tissue uptakes. It is dif-
ferent from procedures in previous reports (Raichic 
etal.. 1981,1983; Ginsberg et al., 1982; Herscovitch 
et al., 1983) in the way the tracer is administered 
of 
les 
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F I G . 6. E r r o r s due to an incorrect partition coeff ic ient eval-
uated by s imulat ion studies. T h e s ingle-breath C B F value (/"=) 
(ordinate) a n d the given (true) C B F value { f ) ( absc i s sa ) are 
plotted for varying partition coeff ic ients from 0.85 to 1.10 in 
increments of 0.05. 
and in the computational algorithm based on a ref-
erence table. 
0 . 10 
0 . 0 5 
flOO 
300 
f 
50 
(ml/ lOOml/min) 
F I G . 7. E r r o r s due to the l imited e x t r a c t i o n of water , a s -
suming the partition coefficient is 1 and the arterial blood 
volume is 0. The true C B F (/) Is given on the a b s c i s s a a n d 
the C B F calculated from the reference table iF) on the or-
d inate . T h e e x t r a c t i o n of water (5) is re lated to the per-
meability surface area product (PS) according to £ = 1 -
e ''^"'. The value of P S was varied from 100 ml/100 g/min to 
infinity. Two values of venous blood volume (V,) were used: 
5% (dashed lines) and 10% (solid lines). 
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FIG. 8. E r r o r s due to the contribution of the arterial blood 
vo lume, f ix ing other parameters , i.e., the partit ion coeff i -
cient is 1 and the extraction of water is 1. T h e true C B F (/) 
is given on the a b s c i s s a and the C B F ca lcu la ted from the 
reference table ( f ) on the ordinate. T h e fraction of the ar-
terial blood volume (p) was varied from 0 to 0.2 in increments 
of 0.05. 
Comparison with the steady-state method 
In the present study we observed a significantly 
(p < 0.005) higher value of rCBF using the single-
breath method than with the steady-state method. 
One reason for the difference might be that the 
single-breath procedure requires more cooperation, 
and hence the subjects are more aroused than in the 
steady-state study. In addition, a breath hold, even 
as short as 10 s, immediately after C'^02 inhalation 
might increase P a C O , . These states of arousal and 
the possible elevation of P^COj would tend to in-
crease the CBF. In practice the breath hold is not 
necessary, since most of the inspired C'^Oj ex-
changes instantaneously with the'water pool. 
It is doubtful, however, if these reasons could 
fully explain why the rCBF values were 20% higher 
than those obtained by the single-breath method. 
This was the main motivation in carrying out a sim-
ulation study for evaluating systematic errors. This 
analysis showed that most systematic errors were 
in the same direction as, but smaller than, those of 
the steady-state method. Only the overestimation 
due to the presence of arterial activity is higher in 
the single-breath method, the overestimation in the 
steady-state technique normally being negligible 
(Lammertsma and Jones, 1983). 
In particular, the underestimation of mean flow 
due to the inhomogeneity of components in a res-
olution element was much lower than that in the 
J Cereb Blood Flow Meiabol. Vot. 4. No. 2, 1984 
Mixture r o t i o of wfi i te /grcv (%l 
F I G . 9 . Underest imation of C B F due to the mixture ol i- ihorr-
ogeneous t i ssues in the s a m e pixel. The simulation C'jrve is 
given by E q . 7 in the text, where / , = 70 ml/100 ml min a s 
grey matter flow and = 20 ml/100 ml/min as white maite-
flow. T h e a b s c i s s a gives the white/grey ratio. The ordinaie 
represents the difference between the weighted mecn a r c 
that ca lculated from the reference table. 
steady-state method (Lammertsma et al.. 1981i). .A 
9% underestimation at maximum was half ihai of 
the steady-stale method. This possibly explains pan 
of the overestimation of rCBF by the single-breath 
method in comparison with the steady-state tech-
nique. 
An incorrect partition coefficient was sho'--n -.o 
induce the same effect as in the steady-siaee 
method. Limited extraction of water resulted in le>f 
undereslimation than in the steady-state meihoc. 
The results of the simulation indicate that the ob-
served higher values for How in the single-breaJi 
method imply an undereslimation in the siead;--
siaie method. More experimenial clinical i".jdie.~ 
are necessary to establish this point. 
Limitations of the PET device 
It is clear from the reported experience u!:h the 
ECAT II body PET scanner that the sensitivity of 
this generation of machines (12 kcps/ixCi/ml) is not 
optimal for transit studies of this nature. The seo-
sitivity and mechanical movement should be such 
that data can be collected over a shorter time 
window of about 40 s following inhalation, during 
which the tissue activity reaches maximum (see 
Fig. 2). This would significantly improve the flo 
signal contained within the emitted data. 
Arterial sampling 
The dispersion of blood within the sampling tube 
was found to be insignificant in the present n^ethod. 
In the simulation, the distortion of Eq. A2 in the 
Appendix caused less than a 2.5% overeslimation 
of flow at flow values greater than 20 ml/iOO ml 
min. An alternative approach would be to ntonitior 
i 
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the lung or left ventricular activity externally, as-
suming that this signal would be proportional lo the 
arterial concentration. Such a possibility awaits 
"time of fl ight" techniques for measuring intratho-
racic activity lo avoid the chest wall contribution. 
APPENDIX 
Measurement and correction for dispersion in the 
arterial blood sampling tube 
The dispersion effect of the sampling lube on the 
arterial blood time-activity curve was experimen-
tally measured under the same conditions as those 
used for the rCBF studies. A mixture of 20 ml of 
heparinised blood containing 4 mCi Hj'^O was pre-
pared. The catheter, sampling tube, and beta de-
tector were set up as for the human studies. The 
lines were initially filled with saline. The tip of the 
catheter was submerged in inactive blood, and the 
withdrawal pump was switched on. The catheter tip 
was moved into the active blood after —30 s. The 
count rate of the beta detector was recorded using 
the multichannel analyser. From the build-up phase 
of the recorded curve, the response function to the 
step input was determined. We defined the disper-
sion function d(t) as the time derivative of this func-
tion. Four experimental determinations of d[t) gave 
d(t) = 24.7^^^"' + 0.82e-^' (A l ) 
where dit) was normalised such that pf^d(t)ldt = 1. 
Correction for d(t) in this calculation of Eq. 2 was 
possible mathematically using the Laplace trans-
form. The following terms were employed: 
W^e -k\i - W,e-
a(t)*d(i)' 
-ki 
Dispersion function; dU) 
Measured arterial curve: g{t) 
Tissue impulse response; /?(/) = ke 
A(S), D(S), G(5), and H{S): Laplace transforms 
of a{t), d(t), g(t), and /?(/), respectively 
Using these expressions, a{t)*ke~'" in the integral 
of the right-hand side of Eq. 2 can be rewritten and 
solved as follows: 
a(l)*h{t) = Z'[A(SmS)] 
G{s)H{S) 
D{S) 
PigW + ?>28(t)*h(t) + ^^g(t)*r(t) 
+ ^,g(t)*h(t)*r{t) (A2) 
Where r{t) = ae"'; a = k^k^KW^ + W,); (3, = k! 
( W I + W^)- 32 = {k,lkj)l{W, + Wj) - (3,; Pj 
~K 34 = 1 - (A - A:, - k2)li,W^ + W,); and^"' 
•"^presents the inverse Laplace transform. Equation 
A2 was used with Eq. 2 in calculating the reference 
table. This calculation does not enhance the statis-
tical noise, unlike the usual deconvolution of d{t) 
from gU). 
Finally a simulation study was carried out to eval-
uate the effect of such a dispersion on the CBF. If 
we ignore the dispersion in Eq. 2, that is, treat the 
measured g(t) as the true arterial curve a{i), the 
integral on the right-hand side of Eq. 2 will decrease 
more for low values of k. However, it was found 
that the overestimations of CBF caused by this de-
crease in the reference table value were quite small, 
2.5 and 1.5% at flows of 20 and 70 ml/100 ml/min, 
respectively. Thus, the error caused by the disper-
sion of the sampling lube, even if neglected, was 
revealed to be a minor factor. 
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1. Introduction 
Two basic detector configurations have been employed in in vivo positron emission 
tomography. One consists of a ring or polygon of detectors for the imaging of pre-
selected slices of the body. Examples of this are the EG&G Ortec ECAT II (Phelps 
et al 1978), a single plane device employing a hexagon of 66 Nal detectors, and 
PETT V I , the design of Ter-Pogossian et al (1982) which consists of four rings each 
of 72 CsF detectors simultaneously yielding seven tomographic sections. The second 
type consists of opposed planar detectors which provide images of a larger section of 
the body from which desired planes may be subsequently selected at will. The Anger 
camera system described by Muehllehner et al (1976) and the device using two arrays 
of 127 Nal detectors devised by Burnham and Brownell (1972) are examples in this 
category. 
The ability of planar detector systems to image a larger section of the body 
potentially enables more efficient use to be made of scanning time and administered 
dose. However, the limited field of view even of current Anger cameras and the high 
cost of significantly increasing their size has prompted the development of cheaper 
large-area devices such as those employing multiwire proportional chambers ( .MWPCI. 
Detectors of this design for positron imaging have been described by Jeavons ei al 
(1980) and Bateman et al (1980). The latter has been employed to investigate blood 
flow using the continuous inhalation of C '^Oj , a technique in routine use at the Medical 
Research Council Cyclotron Unit employing an EG&G Ortec ECAT II (Frackowiak 
et al 1980, Hopkins et al 1983). The radioactive gases are produced on line in the 
cyclotron. The positron camera used has an intrinsic spatial resolution of 6 mm (FWH.M ) 
(Bateman ei al 1980) but, as will be discussed below, the effective resolution for the 
images presented was lower than this due to relatively poor contrast and statistics. 
Tomographic devices designed to image transaxial slices through the body minimise 
scattered radiation by collimation. For area devices a much greater proportion of 
scattered radiation contributes to the image but the positron camera used in this study 
has been designed to be relatively insensitive to photons of energy less than 511 keV 
(Ott et al 1983), which is the opposite of the case for the Anger camera. Scatter 
§ Present address: Department of Surgery, St Thomas ' Hospital , London S . E . I , England 
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874 T J Spinks el al 
contributes a broadcast (very low spatial frequency) background in the image and 
although this reduces contrast, imaging ability is retained in the form of unscatiered 
events. For preliminary studies it was considered that imaging of the limbs, where 
scattering is as low as possible and sensitivity is important, would be more appropriate. 
This paper describes a study of blood flow in the feet of patients suffering from diabetes 
to investigate the extent of necrotic areas. The camera, with its associated computing, 
display facilities and gas rig, was built into a mobile container for convenient transfer 
lo the Hammersmith Hospital site, with its source of isotopes from the MRC Cyclotron. 
This system was found to operate very satisfactorily. 
2. Materials and methods 
2.1. Positron camera 
The positron camera consisted of two opposed detectors counting in coincidence with 
a resolving time of 52 ns. Each detector was made up of a stack of 20 multiwire 
proportional chambers (Bateman et al 1980). The x-y coordinaies of each event were 
determined by signals from mutually orthogonal lead (cathode) strips and the particular 
(anode) wire plane triggered specified the z coordinate (essential to avoid parallax 
errors in image reconstruction due to the finite detector depth). 
The active area of each detector was 30x30 cm" although a limit was placed on 
the angle that recorded rays could make with ihe 2-axis to ensure uniform detec-
tion efficiency over a volume of 1 5 x l 5 x l 5 c m ^ in the centre of the field of view. 
This procedure was essential for the implementation of the deconvolution procedure 
(Townsend et at 1978). 
The intrinsic spatial resolution was measured by the use of line sources of ""Na, 
contained in steel tubes of diameter 1 mm and length 50 mm, placed in the centre of 
the field of view. The reconstruction showed a F W H M of 6 mm (Bateman et al 1980). 
For an acceptable signal-to-noise ratio in imaging the activity distribution in patients, 
the rate limit is about 2000 C P S in the fast coincidence rate, half of which are accepted 
in the image. This matched well with the direct data acquisition rate on to magnetic tape. 
The part of the body to be imaged was placed centrally between the detectors, 
whose centres were separated by 43 cm (figure 1). Since the uptake of activity in these 
Planes 
Detector 
1 
Detector 
2 
Figure 1. Approximate relationship between patient's foot, imaged planes and detectors (plan view). Spacing 
between planes = 4 cm. 
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studies was not confined to the region to be imaged, the detectors had to be shielded. 
If N, is the 'singles' counting rate, assumed the same for each detector, and t the 
coincidence resolving time, then the random coincidence rate is given by A / J t . This 
squared dependence emphasises the importance of reducing the gamma-ray 'back-
ground' outside the field of view of the detectors. Each was therefore shielded around 
the sides and back with 5 cm thick lead bricks and additional shielding was placed 
around the pipes carrying radioactive gases from the cyclotron. 
2.2. Data collection and processing 
Steady-state images were obtained from continuous inhalation of C'^Oj. The label is 
transferred to H j ' ^O in the lungs enabling regional tissue blood flow to be determined. 
For steady state inhalation of C'^02 we can apply the equation (Frackowiak etal 1980): 
FC = 
F 
(1) 
(since input of activity equals output), where F is the blood flow (ml min"'), C the 
arterial concentration of labelled water ( M B q m l " ' ) , Q the activity in tissue volume 
V (MBq), and A the decay constant of (0.336 min^'). 
Arterial sampling was not carried out on the patients in this study so that absolute 
measurement of blood flow was not possible. However, from work using the Ortec 
ECAT I I (Hopkins et al 1983) average blood flow per unit volume (F / V) in diseased 
and normal resting legs of 16 patients with ulceration or liposclerosis was found to be 
0.073 and 0.011 m l m P ' min"' respectively. In both cases, F/V is small compared 
with A and equation (1) can be approximated to 
0 = FC/A (2) 
that is, activity is proportional to flow. 
Patients wore a light, disposable plastic mask through which C'^02 diluted with 
air, was breathed; gas was defivered at a rate of 500 ml min"' with a specific activity 
of 0.5 MBq mr'. Data accumulation was begun after an equilibrium period of 6 ± I min 
(from the start of inhalation) when a steady count rate had been achieved. The mean 
counting time was 474 ± 4 3 s and was limited both by the dose received by the patients 
and their ability to remain still. The dose equivalent received by the lungs (the critical 
organ) was 16 mSv and the data rate corresponded to a steady state activity of 
3 ±0 .5 MBq in the field of view. 
Prior to data accumulation, the following quantities were measured: (i) total 'singles' 
counting rate in each detector, (ii) total fast coincidence events, (iii) 'good' coincidence 
events actually contributing to the image, and (iv) accidental events associated with 
categories (ii) and (iii). Accidental coincidences were measured by delaying the signals 
from one detector relative to those from the other. For patients in this study 3.0 ± 0.1 x 
10' coincidence events contributed to the image of which 25% were accidental 
coincidences. 
In the manner described above (section 2.1) x, y and z coordinates were attributed 
to each coincidence event and images were obtained by back projection. Raw images 
were obtained by forming histograms on the intersections of the positron decay vectors 
with {x-y) planes (parallel to the detector planes) whose position and spacing were 
chosen by the operator. Images were firstly smoothed and deconvoluted (filtered) 
with the point response function to enhance the contrast. Each of these planes contained 
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a 'blurred' contribution from activity outside the plane and a mathematical technique 
was applied to subtract this 'out-of-focus' contribution (Townsend et al 1978). In 
these preliminary studies no correction for tissue attenuation was applied. Five x-y 
planes were reconstructed for each scan, one mid-way between the detectors and two 
equally spaced 4 cm either side. The position and spacing of the planes could be 
selected retrospectively. The computer used was an LSI 11-23 with 256 kbytes of 
main memory and associated rigid disc, floppy disc and magnetic tape drives. The 
positron camera operated under computer control at all times, data being taken into 
memory on an event-by-event basis into a buffer store which, when full , was normally 
written directly to magnetic tape. For fast image processing an Analogic AP-400 array 
processor was utilised to carry out the Fourier transform calculations and operated at 
a rate of about two seconds per plane. 
2.3. Description of patients 
Two male patients suffering from diabetes who had developed gangrene of the feet 
were scanned prior to surgery. The procedure was approved by the research ethical 
committee of the Royal Postgraduate Medical School and the United Kingdom 
Administration of Radioactive Substances Advisory Committee. Both patients gave 
informed consent. Patient No 1 had gangrene in the fourth toe of the right fool which 
extended some way back into the foot (figure 2(a)). Patient No 2 had gangrene in 
the big toe of the left foot (figure 3(a)). 
ia) ib) 
Figure 2. ( a ) Planes 1 to 4 for patient No 1 filtered and processed by the 
method of Townsend el al (1978) to remove off-plane 'blurring' (necrotic 
region shown arrowed) , (b) Planes 1 to 4 for patient No 1 filtered but 
unprocessed. 
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ia) ib) 
Figure 3. ( a I Planes 1 to 4 for patient No 2 Tillered and processed, ih) 
i Planes 1 to 4 for patient No 2 filtered and unprocessed. 
3. Results 
The approximate relation between the imaged planes and the patient's foot is given 
in figure 1. Figure 2(a) shows C'-'O^ (steady-stale) images for patient No 1 which 
were filtered and processed using the algorithm of Townsend ei al (1978). The region 
displayed extends from toes lo ankle (for both patients). A necrotic region is clearly 
visible in plane 3 (arrowed) and the progressive focusing of this structure is apparent 
for successive planes (plane 5 is omitted because this region is not clearly displayed— 
similar to plane 2). Flow in the right side of the foot and in the unaffected toes is 
approximately twice that in the left side. The maximum flow (3.5 times the average 
for the whole foot in plane 3) occurs immediately above the gangrenous region. Figure 
2{b) shows, for comparison, the images before subtraction of off-plane 'blurring'. 
Planes 1 to 4 for patient 2 are shown in figure 3(a). In this case plane 4 gives the 
clearest demonstration of the gangrenous big toe (again arrowed). As in the case of 
patient No 1, there is a region of relatively high flow in the adjacent toes and even 
higher flow in the region just above the necrotic area (2.4 times the average). During 
subsequent surgery the latter was found to be the site of an abscess. Figure ?yib) 
similarly shows the unprocessed images. 
4. Discussion 
The Mwpc camera used in this study has successfully delineated regions of impaired 
blood flow using the steady state C'^ ^02 inhalation technique with an acceptable 
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radiation dose and scanning period. The scans on both diabetic patients studied, shown 
in figures 2 (a ) and 3 (a ) , demonstrate the s t r iking way in which different structures 
are focused by moving f r o m plane to plane. Areas o f impaired blood flow (arrowed) 
are obvious f r o m figures 2{b) and 3{b) before subtraction of off-plane 'b lur r ing ' but 
are made clearer after subtraction (figures 2 (a ) and 3 (a ) ) . Mean counts per pixel in 
these areas were reduced f r o m 30% of the image maximum values to less than 5% 
by this process. This corresponded well w i th known areas f r o m which the blood supply 
had been cut off , although the filtering process introduced a more mottled appearance 
in the background where maximum pixel counts on average rose f r o m 12% to 15% 
of the image maximum. However, the quali tat ive rather than quantitative nature of 
the images should be emphasised at this stage. The cut-off frequency (Fc, expressed 
as harmonics of the 30 cm field) on the low pass filter must of ten be set to give lower 
spatial resolution than the 'physical' resolution of the system (corresponding approxi-
mately to F c = 15) due to poor contrast and statistics. For the images presented, a 
cut-off value of 10 was used, which corresponds to a spatial resolution of 12-14 mm 
( F W H M ) . If a value of f c = 15 were chosen, potentially more detail could be observed 
but noise oscillations would increase and there would be a danger of introducing 
confusing artefacts (Bateman et al 1982). 
Designs of single and multiple-slice transaxial positron tomographs recently 
described (Burnham et al 1983, H o f f m a n el al 1983) have intrinsic spatial resolutions 
comparable with that of the positron camera employed in this study. However, the 
col l imation inherent in these devices leads to relatively inefficient use being made of 
emitted rays because of the small solid angle of collection. The positron camera has 
a much wider angle of acceptance and al though this is inevitably associated wi th a 
greater number of Compton scatter coincidence counts, its sensitivity to scattered 
radiation is reduced relative to the pr imary 511 keV gamma rays. Scatter (and 
accidental) fast coincidence events generate long range tails in the point response 
[unction but these are approximately constant in shape and can be modelled wi th 
reasonable accuracy. For instance, in a study of thyroid uptake this was carried out 
by placing a point source next to the section of the patient's body to be scanned 
(Bateman et al 1982). In the present study, the contrast in the object was lower than 
fo r the thyroid uptake studies and the point spread funct ion was not modelled as 
accurately but the clear demarcation of relatively small necrotic regions is apparent. 
Addi t iona l advantages of the camera are ( i) the possibility of retrospectively 
selecting multiple slices through a relatively large section of the body and (ii) the 
potential of construction at a relatively much smaller cost than that of an Anger camera 
of comparable size. 
In addi t ion to the assessment of the appropriate method of image processing, an 
accurately quantitative analysis wi l l only be feasible when arterial sampling is carried 
out and correction fo r gamma ray attenuation applied. In this particular study, the 
problem of attenuation is less important because of the relatively small regional 
variation in the thickness of the foot (a correct ion of 35% would correspond to 3 cm 
of tissue, taking m to be 0.1 cm""'). The accurate and simply-applied attenuation 
correction procedure, employing a r ing source, in transaxial positron tomography 
(Huang etal 1979) is essential for accurate quanti ta t ion of radionuclide concentrations. 
A comparable procedure is not yet available f o r the positron camera and some work 
is needed to implement one. The fu tu re requirements of the system, apart f r o m 
attenuation correction are: ( i) larger area detectors, ( i i ) a greater detector efficiency 
(a factor of 2 increase appears to be technically possible which would give a factor of 
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4 in sensitivity) and ( i i i ) at least two orthogonal views to improve the stereo informat ion 
at low spatial frequencies. 
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The Remotely-controlled Preparation of a 
'C-Labelled Radiopharmaceutical—[1-"C]Acetate * 
V I C T O R W. P I K E , PETER L. H O R L O C K , C Y R I L B R O W N and 
J O H N C. C L A R K 
Medical Research Council Cyclotron Unit, Hammersmith Hospital, Ducane Road. London W12 OHS. 
U.K. 
(Rvcdved 30 October 1983) 
Remotely-controlled apparatus is described Cor the preparation o f the radiopharmaceutical, (l-"C)aceiaie. 
from cyclotron-produced ("CJcarbon dioxide according to established radiochemistry. This apparatus 
features a multi-ported reaction vessel (fitted with an electrical stirrer), twelve solenoid valves (to direct 
fluid flows and hydraulically-powered syringes), one hydraulic oil pump and one heated water-bath (all 
operated at 24 V d.c). These components are controlled either with a rotary-switch or with an '.Apple 
11" iTticrocompuler acting through a digital output card. An important advantage of the use of this 
apparatus over the use of manually-controlled apparatus is that it results in a much reduced radiation 
dose to the operator. Moreover it has been shown that |l-"Cjacetate can be prepared much more efficiently 
with the remolely-conlrolled apparatus than with corresponding manually-controlled apparatus. Thus the 
overall efficiencies (radiochemical yields uncorrected for decay) for the conversion of |"C|carbon dio.vidc 
into (l-"C]acetate for injection are 24 + 8, 39 + 7 and 47 + 8% for manual, remote rotary-switch and 
remote microcomputer control, respectively. The high efficiency and consistent performance of the 
remotely-controlled apparatus have been found to permit useful flexibility in the design of clinical 
experiments with [l-"C)aceiate and positron emission tomography. 
Introduction 
With the development of the quantitative technique 
of positron emission tomography,'" radio-
pharmaceuticals labelled with short-lived positron-
emitting radionuclides, such as (f,,., = 10 min), "C 
(/i,.2 = 20.4 min) and " F ((,,2 = 110 min), have become 
increasingly important for the non-in.vasive in-
vestigation of physiological function and disease. In 
order to supply such radiopharmaceuticals regularly 
for clinical studies, efficient, reliable and safe prepara-
tive procedures are required. 
Within our Unit [l-"C)acetate has proved a valu-
able radiopharmaceutical for the study of human 
myocardial metabolism.'^" Originally, the required 
doses of [l-"C]acetate were prepared via the carbo-
nation of methylmagnesium bromide with cyclotron-
produced ["CJcarbon dioxide in a well-established 
procedure that uses manually-controlled apparatus.'^' 
Though this apparatus performs reliably, regular use 
of the apparatus exposes its operator to significant 
radiation; the average finger dose per preparation is 
7mSv (0.7 rem). In order to be able to prepare 
• For a preliminary report of this work see. Pike V. W., 
Horlock P. L., Brown C. and Clark J. C. Nud. Med. 
Commun. (abstr.) 4, 149 (1983). 
[l-"C]acetate more regularly and in greater safely ue 
set out to achieve remote control of all the operations 
involved in the established preparation.'-' Here we 
report on the apparatus we have developed and 
compare its performance to thai of the corresponding 
manually-controlled apparatus. 
Experimental and Results 
Preparation of methytmagnesium bromide 
Solutions of methylmagnesium bromide (<(/. 
1.0 M ) in diethyl ether were prepared and stored as 
described previously."'' 
Production of [^^C]carbon dioxide 
["CJCarbon dioxide was produced on the Medical 
Research Council cyclotron at Hammersmith Hospi-
tal by the "'N(p, a)"C nuclear reaction, using essen-
tially the method described by Clark and Buck-
ingham.'"' Nitrogen at 100 kN m~ - acted both as the 
bombarded substance and as the sweep gas for the 
target. The ["C]carbon dioxide was continuously 
trapped from the sweep gas (flow rate = 
80-100 mL m i n ' ' ) in a stainless steel tube 
(5 cm X 7 mm i.d.) that was filled with molecular 
sieve (4A, 60-80 mesh; B.D.H. Chemicals Ltd) and 
contained within an ionisation chamber. Bombard-
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Scheme 1. Apparatus for the remotely-controlled preparation of ll-"Claccl;iie. I—electrical stirrer: 
2—pressure gauge (Budenberg): 3—solenoid valves (a-d and j - l , sub-mlniaturc: Production Techniques 
Ltd. e-f, Joucomatic. i , Skinner); 4—magnesium perchlorale trap: 5—syringe with glass barrel and Teflon 
plunger ( lOmL; Hamihon): 6—cylinder (double acting, stroke I I cm, Scovill. Scliradcr Fluid Division): 
7—oil flow restrictor: 8—self-sealing couplings (Swagelok Ltd): 9—soda lime trap; IO~poppet valve 
(opening pressure l . B c N m " ' : Nupro); II—syringe with glass barrel and Tellon plunger (I .OmL: 
Hamilton); 12—glass vessel (capacity l 5 m L ) with multi-ported Tefllon lop, (Sovirel SVL .iO joint l : 
13—tap (Pharmaseai K75, KHS International): 14—glass reaction vessel (capacity. l 5 m L ) fitted with 
Teflon multi-ported top (Sovirel SVL 42 Joint): 15—filter (0.22 / /m, Mille.x FS, Millipore Corporation): 
16—electrically-heated water bath; 17—lead wall (5 cm thick): 18—lead glass window. Connection tubes 
are Teflon (3 or 0.15mm o.d.) with screw fittings (Alte.x Beckman Ltd) and Hanged ends. 
ment of nitrogen with protons (7.6 MeV, 40-50/J A ) 
for 40-60 min usually gave 9-13 GBq (250-350 mCt) 
of trapped ["Qcarbon dioxide at the end of bom-
bardment. The trapped ["Cjcarbon dioxide was dis-
pensed when required by heating the column of 
molecular sieve to 220°C and then passing nitro-
gen through the column at about 20mLmin '. 
Generally 80-90% of the trapped radioactivity was 
released into the nitrogen stream within 1-2 min. 
Remotely-controlled preparation o/[l-"C]ace/afe 
Apparatus (Scheme 1) was built to enable 
[l-"C]acetate solutions to be prepared remotely for 
clinical use, according to the sequence of operations 
listed in Table 1. These operations achieve the radio-
chemistry shown in Scheme 2, which is exactly that 
reported'^' previously. Many features of the appara-
tus are not readily apparent from Scheme 1 or Table 
1 and are therefore described below. 
(a) Hydraulics. Hydraulics are used to drive two 
double-acting cylinders, each linked to the piston of 
an adapted gas-tight syringe, so enabling solutions to 
be added to or withdrawn from the reaction vessel 
(Scheme 1). 
The hydraulic system is powered by a "Minipack" 
oil pump (Smiths Hydraulics Industries Ltd). A 
pressure-relief valve limits the pressure in ihe hydrau-
lic circuit to ca. 1 M N m v Oscillations in oil pres-
sure and in flow are damped by means of an air 
reservoir (volume. 100 tnL). These components are 
housed in a box that is fitted with a cooling fan and 
situated remote from the main apparatus (Scheme I ) . 
Oil lines (6.35 mm, o.d.) leading lo and from the box 
are connected to the main apparatus via two self-
sealing couplings. These enable the hydraulic pump-
ing system to be easily disconnected and. in principle, 
to be used to power syringes in other apparatus. No 
re-bleeding of the hydraulic system is necessary after 
breaking the self-sealing couplings. 
The direction of syringe movement is controlled by 
solenoid valves (Table 1, Scheme I ) . The rate of 
withdrawal of liquid from the reaclion vessel into 
each syringe was set by pre-adjustmenl of a flow 
restrictor at one port of each hydraulic cylinder 
(Scheme 1) to give a linear motion of 0.5 cm s' '. This 
slow linear motion enables an aqueous phase to be 
withdrawn slowly and precisely from ihe boitom of 
any two-phase system within the reaction vessel, via 
an appropriate dip-tube (Scheme I ) . (Preliminary 
investigations indicated that such precise control 
would not be easy to achieve with pneumatically-
powered syringes). 
(b) Electrics. A 24 Vd.c. supply is used to power 
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Table I . Detai ls o f operations in the microcomputer-control led preparation of ( l - " C ] a c e t a l e and their relationstiips 
to ro lary-swi lch positions in the rotary-swilcl i -controlled preparat ion 
Corresponding 
Solenoid valves D u r a t i o n rotary-swnch 
Operat ion energised' '"^  (s) position 
f-lusti wi ih dry N , - 6 0 0 -
L o a d reagent' (O.O.S M M c M g B r in i ; t ,0 ; 4.0 i n L ) j - 6 0 -
Standby - 3 0 0 - o i r 
( " C l C a r b o n a l i o n ' ( w i t h " C O , / N , ; at 2 0 m L m i n " ' ) j 120 1 
A d d acid'* (6 M H C I O.S m L ) j . k, h 20 2 
Phase separation j . k, h 30 2 
Wi thdraw acid* a, k, g - 3 0 - 3 
A d d N a H C O , s o l n ' « (0.9';„ w,v: 10.0 m L ) d, r, j , h 60 4 
Phase separation d, f, J , h 30 4 
W i t h d r a w aq. | l - " C | A c O " soln' a, d, e - 3 0 - 5 
Trans fer aq. ( l - " C ) A c O " soln- r. i 20 6 
Remove ether at 60-C' ' b, i 300 7 
Dispense aq. [ l - " C | A c O * soin' b. 1 60 8 
'Va lve nomenclature .corresponds to that in Scheme I . 
' 'Two-port solenoid valves are open when energised. 
' T h e de-energised configurations of three-port solenoid valves are shown in Scheme I . 
- D u r a t i o n controlled by operator from microcomputer keyboard. 
'Reagent loaded through a hydrophobic hiter (Mil lex F G . Mill ipore C o r p o r a t i o n ) connected to the manual valve (no. 
13 in Scheme 1). which is thereafter kept closed. 
'Electrical stirrer operates automatical ly in microcomputer-control led preparation. 
^Hydraul ic oil pump operates automatical ly in inicrocomputer-conirol led preparation. 
"Waier-balh is maintained at 60 C -
' N , supply is pre-set lo 5 0 k N m " - . 
the electrical stirrer, 12 solenoid valves, electrical 
heater and hydraulic oil pump. 
(c) Remote-control of apparatii.s. (i) By rotary-
switch. Originally a rotary-switch (comprised of 14 
banks of l-pole-l2-way switches and with 8 position 
control) was used to control the radiosynthesis. Each 
position of the rotary-switch energises a particular set 
of solenoid valves and corresponds to either one or 
two operations (Table 1). Separate toggle switches 
were used to control the electrical stirrer and to allow 
syringe movement to be started and stopped during 
phase separations (roiary-swiich positions 3 and 5; 
Table I ) . The timing of all operations was controlled 
by the operator to match as nearly as possible the 
durations shown in Table I . 
(ii) By microcomputer control. Subsequently a 
microcomputer ("Apple 11 europlus"; Apple Com-
puter Inc.) was programtrted* in "Applesoft BASIC" 
to control and time operations (Table 1) in the 
radiosynthesis via an interface (digital output card; 
M C Computers) with the electrical components of 
the apparatus. The digital output card fits into any 
one of option slots 1-6 within the microcomputer. 
* The computer programme is available from the authors 
on request. 
is powered from a +5 V power rail and gives output 
via a 40-way ribbon cable supplied with the card. 
With microcomputer control of the apparatus the 
preparation of [l-"C]acetale requires only two oper-
ator interventions, each to control syringe movement 
during the withdrawal of an aqueous phase from the 
reaction vessel. Each removal of an aqueous phase is 
monitored visually through the lead glass window 
(Scheme 1) and syringe movement (stop, forward and 
reverse) controlled frotn the microcomputer key-
board. Aqueous phase withdrawals are the only 
operations not having programmed durations 
(Table I ) . 
Performance of the remotely-controlled apparatus 
Measurements (from the National Radiological 
Protection Board) show that the average finger dose 
received by an operator of the manual apparatus'"' 
during one preparation of [l-"C]acetate is ca. 1 mSv 
(0.7 rem), whereas during one rotary-switch or 
microcomputer-controlled preparation an operator 
receives a finger dose of <2niSv (0.2 rem). 
The efficiency ofthe apparatus under rotary-switch 
control and under microcomputer control was com-
pared to that of the manually-controlled apparatus 
previously described.'^' Parameters measured were 
2min, RT 
CO;,i- MeMgBr 
in eirier under N , 
Me COOMqBr 
6M HCI 
Me'^COOH 
oqucous 
Scheme 2. The radiosynthesis of [i-"Clacetate from cyclotron-produced ["Qcarbon dioxide. 
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T a b l e 2. Radiochemica l yields, preparation times, and ef ikiencies for the preparation of 
Rad iochemica l Preparat ion Elliciency^ of 
C o n t r o l o f No. o f yield' o r | l - " C j A c O " l ime preparation 
preparation studies (mean + SD)",', (ni in) (mean ± SD)" . , 
M a n u a l .15 48 ± 16 20 24 r , S 
Rotary- swi l ch 10 6 0 + 10 I2..S 39 ± 7 
Microcomputer 8 70 ± 11 1 1.5 4 7 + 8 
'Decay-correc led and based on the activity of " C O , dispensed inio M e M g t i r / E i - 0 . 
'Non-decay-correc ied radiochemical yield of | l - " C | A c O ' from " C O . . 
T h e data for manual control were obtained using the apparatus described in Ref. 2 
the decay-corrected radiochemical yield of 
[l-"C]acetate from the ["CJcarbon dioxide dispensed 
and the preparation time. Several preparations were 
examined for each form of control (Table I). From 
the measured parameters the average overall 
efticiency (the non-decay corrected yield) and its 
standard deviation were calculated for each method 
of preparation (Table 2) 
Solutions of [l-"C)acetate, prepared in the 
remotely-controlled apparatus, were all found to be 
>96% radiochemically pure by the chromatographic 
methods described previously,''' and to have phys-
iologically acceptable pH (pH 7-8) and tonicity. All 
randomly selected preparations passed independent 
(Safepharm Ltd) tests for apyrogeniciiy (the rabbit 
pyrogen test) and sterility. 
The apparatus is very reliable; no failures have 
been recorded in 40 production runs. 
Discussion 
The development of the remotely-controlled appa-
ratus described in this paper achieved its main objec-
tive, a drastic reduction in the finger dose received by 
the chemist during a single preparation of 
[l-"C]acetate. This achievement permits any one 
operator to prepare (l-"C]acetate more regularly 
than previously. 
A bonus arising from the adaptation of the prepa-
ration of [l-"C]acetate from manual to remote con-
trol is the much increased efficiency of the prepara-
tion (Table 2); indeed the microcomputer-controlled 
preparation is nearly twice as efficient as the 
manually-controlled preparation previously 
reported'^' (Table 2). Two factors contribute almost 
equally to the increased efficiencies of each of the 
remotely-controlled preparations, their greater radio-
chemical yields and their reduced preparation times 
(Table 2). The increased radiochemical yields are not 
the result of any formal change in radiochemislry or 
protocol, since great care was taken to reproduce the 
already optimised radiochemistry and protocol of the 
manual preparation;*^' they are the result of the more 
reproducible precision with which each stage of the 
preparation is performed under remote control. Re-
mote control reduces the preparation time consid-
erably because many operations (e.g. valve-
switching), which must be performed sequentially 
under manual control, are performed simullaneously 
and insianlly under remote control. The liming of 
operations under microcomputer control is some-
what more precise than under rotary-switch control 
and this is reflected in the slightly shorter preparation 
time and in its very small standard deviation (12s. 
/; = 8). 
Overall, microcoiiipuier-conlrol was found to be 
more efficient than rotary-swiich control (Table 2). 
This benefit need nol he at great expense: in principle, 
a dedicated microprocessor could act as a cheap 
substitute for the microcomputer. Nevertheless, we 
found the microcomputer to be very convenient for 
the initial development of programmed control and 
to have the further advantage ofenabling graphics to 
be used to monitor the radiosynihcsis. 
In practice, the average yield of (l-"C|acetate 
obtained for injection from the remotely-controlled 
apparatus was 5.2CBq (141 mCi) under micro-
computer control and 4.3 GBq ( l l 7 m C i ) under 
rotary-switch control. It is known that a dose of 
about 370 MBq (lOmCi) of [l-"C)acetaie must be 
administered to a patient in order to obtain good 
images of myocardium and meaningful quantitative 
data by means of positron emission tomography.''' 
The production of greater than 3.3 GBq (90 mCi) of 
[l-"Clacetaie makes it possible to administer two 
doses of (l-"Claceiate. each of about 370 MBq 
(lOmCi), up to at least 60 min (i.e. 2-3 half-lives of 
"C) apart. This possibility has been e.vploiied in the 
study of transient myocardial ischemia.''-'' Thus, for 
example, information on the myocardium may be 
gained with the patient al rest from the first dose of 
[l-"C]acetate and wiih the patient at exercise from 
the second dose. That remote control enables 
[l-"C]acetate to be produced ruminely in activities 
exceeding 3.3 GBq (90 mCi) therefore permits greater 
flexibility in the design of clinical experiments and 
enables more information to be gained from each 
study. 
We are aware that the activity of (l-"C]acetaie thai 
could be prepared in a modern cyclotron facility, 
where high energy (<•<(. 20 MeV) protons are avail-
able, is many times higher than that reported here, 
because much higher activities (74-110 GBq; 2-3 Ci) 
of ["C]carbon dioxide could be produced. (Only 
7.6 MeV protons are presently available within our 
Unit). Even so the use of high initial radioactivity 
Remote-controlled preparation of [l-"C]acetate 627 
would also make the use of remotely-controlled 
apparatus, similar to that reported here, very de-
sirable if not essential in order to limit radiation 
exposure to personnel. 
Remotely-controlled procedures, of diverse soph-
istication, have been reported for the preparation of 
several radiopharmaceuticals that are widely applied 
in positron emission tomography, including 
[l-"C)palmitate,'^' 2-deoxy-2-['*F]nuoro-D-glucose,"*' 
(l-"C]2-deoxy-D-glucose,'" L-[S-methyl-"C\meih-
ionine,'*'and 3-["C]methyl-D-glucose.'" Though these 
procedures are generally claimed lo be reliable and to 
reduce radiation doses to personnel, a detailed com-
parison between a manually-controlled procedure 
and a corresponding remotely-controlled procedure 
has not been made hitherto. This study clearly dem-
onstrates that the adaptation of procedures for the 
labelling of radiopharmaceuticals with short-lived 
positron-emitting radionuclides ('-"N, "C and '"F) 
from manual to remote control can provide several 
benefits besides the desired reduction in radiation 
exposure to personnel. These benefits include reduced 
preparation time, increased yield, greater re-
producibility and consequently more flexibility in the 
design of clinical experiments. The approaches we 
have taken towards the design and construction of 
the remotely-controlled apparatus reported here 
could equally well be applied to the remote control of 
the preparations of other radiopharmaceuticals that 
require similar operations. Important examples are 
the preparations of [l-"C]palmitate''"" and D , L - 3 -
methyl-[l-"C]heptadecanoate."" 
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An i n c r e a s e i n dopamine r e c e p t o r d e n s i t y a s s e s s e d by s p i p e r o n e 
b i n d i n g has been f o u n d i n p o s t - m o r t e m b r a i n s o f s c h i z o p h r e n i c p a t i e n t s 
(1), t h u s s u p p o r t i n g t h e h y p o t h e s i s t h a t s c h i z o p h r e n i a m i g h t be r e l a t e d 
t o a d i s t u r b a n c e i n t h e p o s t s y n a p t i c d o p a m i n e r g i c r e c e p t o r ( 2 ) . To t e s t 
t h i s h y p o t h e s i s i n v i v o , we u s e d t h e b u t y r o p h e n o n e d e r i v a t i v e 3 - [ ^ ^ C ] -
• • e t h y l s p i p s ' ^ o n s and p o s i t r o n e m i s s i o n t o m o g r a p h y t o measure dopamine 
f e c e p t o r b i n d i n g i n s c h i z o p h r e n i c p a t i e n t s and n o r m a l c o n t r o l s . I n t h e 
s t r i a t u m t h i s t r a c e r i s m a i n l y b o u n d t o D2 d o p a m i n e r e c e p t o r s whereas 
a c t i v i t y i n t h e c o r t e x i s t h o u g h t t o r e f l e c t b i n d i n g t o S2 s e r o t o n i n 
i ^ c e p t o r s (3,^)-
P a t i e n t s and M e t h o d s 
T w e l v e n o r m a l v o l u n t e e r s , 7 f e m a l e s and 5 m a l e s , r a n g i n g i n age f r o m 
20-64 y e a r s (mean 45 ± 17) and f i v e s c h i z o p h r e n i c p a t i e n t s , 2 f e m a l e s and 
3 m a l e s , i n t h e age r a n g e f r o m 2 1 - 6 3 y e a r s (mean 37 ± I6) were s t u d i e d . 
I l l p a t i e n t s f u l f i l l e d t h e p r e s e n t - s t a t e e x a m i n a t i o n c r i t e r i a f o r t h e 
d i a g n o s i s o f s c h i z o p h r e n i a . F o u r o f t h e f i v e s c h i z o p h r e n i c p a t i e n t s were 
f r e s h l y d i a g n o s e d , had n e v e r r e c e i v e d n e u r o l e p t i c m e d i c a t i o n and 
d i s p l a y e d p o s i t i v e p s y c h o t i c symptoms a t t h e t i m e o f t h e s c a n . One male 
p a t i e n t aged 21 had had a p s y c h o t i c e p i s o d e one y e a r p r i o r t o t h e s t u d y 
and had t h e n r e c e i v e d n e u r o l e p t i c s f o r s e v e r a l m o n t h s . A t t h e t i m e o f 
the s c a n , he had been d r u g - f r e e f o r 6 m o n t h s and was s y m p t o m - f r e e . 
As f o u r o f t h e s c h i z o p h r e n i c p a t i e n t s were u n d e r t h e age o f 40 ( 2 1 -
37, mean 30 ± 7 ) t h e m a i n p o i n t s - o f c o m p a r i s o n were made be tween them and 
the s i x n o r m a l s i n t h i s age g r o u p ( 2 0 - 3 8 , mean 29 ± 7 ) -
Scans were p e r f o r m e d on a s i n g l e p l a n e SCAT I I s c a n n e r . 2 . 5 - 1 9 mCi 
o f 3 - [ ^ ^ C ] m e t h y l s p i p e r o n e w e r e i n j e c t e d i n t r a v e n o u s l y . The t o t a l amount 
o f m e t h y l s p i p e r o n e i n j e c t e d r a n g e d f r o m 0 . 0 3 - 0 . 1 4 mg i n t h e p a t i e n t g r o u p 
and 0 .02-0 .13 mg i n t h e c o n t r o l g r o u p . I n most s t u d i e s , i m m e d i a t e l y 
i f t e r I n j e c t i o n a s e r i e s o f c o n s e c u t i v e s cans was i n i t i a t e d a l t e r n a t i n g 
between 2 p l a n e s 2 . 5 and 4 . 5 - 5 c m a b o v e and p a r a l l e l t o t h e O M - l i n e . 
l > « p e n d i n g on t h e amount o f a c t i v i t y , s u b j e c t s were s c a n n e d f o r 6 5 - 8 5 
• I n u t e s a f t e r i n j e c t i o n . I n t w o s c h i z o p h r e n i c p a t i e n t s and one n o r m a l 
f o l t m t e e r o n l y one s c a n n i n g c y c l e o f 2 p l a n e s was p e r f o r m e d a t 60 
U n u t e s . 
R e g i o n s o f i n t e r e s t w e r e t a k e n f r o m t h e c e r e b e l l u m i n t h e -i-2.5cm 
p l a n e and t h e s t r i a t u m and c e r e b r a l c o r t e x i n t h e - F 4 . 5 / + 5 . 0 c m p l a n e . 
I n t e g r a t e d c e r e b e l l a r v a l u e s w e r e t a k e n a t t i m e s c o r r e s p o n d i n g t o t h e 
- « i d s c a n t i m e s o f t h e s t r i a t a l p l a n e . S t r i a t u m / c e r e b e l l u m and 
' « O r t e x / c e r e b e l l u m r a t i o s c o u l d t h e n be c a l c u l a t e d and p l o t t e d a g a i n s t 
The r a t i o a t 60 m i n u t e s was used t o compare p a t i e n t and c o n t r o l 
J r o u p s . 
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R e s u l t s 
The s t r i a t u m / c e r e b e l l u t n r a t i o s and c o r t e x / c e r e b e l l u m r a t i o s 
i n c r e a s e d l i n e a r l y w i t h t i m e ; r a t i o s a t 60 m i n u t e s a f t e r i n j e c t i o n showed 
a n a g e - d e p e n d e n t d e c l i n e as has been o b s e r v e d by o t h e r i n v e s t i g a t o r s ( 5 ) . 
R a t i o s o f t h e s c h i z o p h r e n i c p a t i e n t s were n o t s i g n i f i c a n t l y d i f f e r e n t 
f r o m n o r m a l c o n t r o l s , w h e t h e r p a t i e n t and c o n t r o l g r o u p s were c o n s i d e r e d 
as a w h o l e o r w h e t h e r o n l y t h e u n d e r 10 age g r o u p was l o o k e d a t . 
C o n t r o l s S c h i z o p h r e n i c s 
R a t i o a l l <age 140 a l l <age 40 
n = 12 n 6 n = 5 n = 4 
s t r i a t u m / 3 .14 ± 0 . 6 1 3 . 5 7 ± 0 45 3-29 ± 0 30 3 .24 ± 0 33 
c e r e b e l l u m 
c o r t e x / 1.60 ± 0 . 2 1 1.73 ± 0 15 1.64 ± 0 12 1.60 ± 0 10 
c e r e b e l l u m 
As a c o r r e l a t i o n was f o u n d be tween r a t i o s and t h e t o t a l amount o f 
m e t h y l s p i p e r o n e i n j e c t e d ( 6 ) r a t i o s were a l s o c o r r e c t e d t o a common 
i n j e c t e d dose o f O . O I m g . T h e r e were a g a i n no d i f f e r e n c e s be tween p a t i e n t 
a n d c o n t r o l g r o u p s . 
C o n c l u s i o n s 
The d a t a a v a i l a b l e do n o t s u p p o r t t h e h y p o t h e s i s o f dopamine 
r e c e p t o r s u p e r s e n s i t i v i t y i n s c h i z o p h r e n i a . H o w e v e r , t h e l i n e a r i n c r e a s e 
i n r a t i o s means t h a t s p e c i f i c b i n d i n g has n o t r e a c h e d e q u i l i b r i u m ^ i n t h e 
s c a n n i n g p e r i o d whose l e n g t h i s d i c t a t e d by t h e h a l f - l i f e o f t h e 11 C-
l a b e l ( t 1/2 = 2 0 m i n ) . I t i s t h e r e f o r e p o s s i b l e t h a t t h e two g r o u p s 
d i f f e r i n s t r i a t a l r e c e p t o r d e n s i t y b u t , e s p e c i a l l y i f d i f f e r e n c e s a r e 
o n l y s m a l l , a l o n g e r l i v e d l a b e l w i l l be n e c e s s a r y t o t e s t t h i s 
h y p o t h e s i s ( e . g . ' ^ p - ^ ^ t h a t 1/2 o f 110 m i n ) . 
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Brain dopamine metabolism in patients with 
Parkinson's disease measured with positron emission 
tomography 
K L L E E N D E R S , * A J P A L M E R , * N Q U I N N , t JC C L A R K , * G F I R N A U , J 
E S G A R N E T T , t C N A H M I A S , t T J O N E S , * C D M A R S D E N t 
From the Cyclotron Unit. Hammersmith Hospital.* Institute of Psychiatry and King's College Hospital Medical 
School.^ London UK and McMasier University Medical Center. Hamilton, Ontario. Canada% 
SUMMARY L - [ ' ^ F ] fluorodopa was admin i s t e red in trace a m o u n t s in t ravenous ly to heal thy c o n t r o l 
subjects and to pat ients w i t h Pa rk inson ' s disease. Stinatal u p t a k e o f r ad ioac t iv i ty was measured 
using p o s i t r o n emission t o m o g r a p h y . T h e capaci ty o f the s t i i a t u m to re ta in tracer was severely 
i m p a i r e d in pat ients c o m p a r e d to con t ro l s . T h i s m a y reflect a r e d u c t i o n o f s t r ia tal dopamine storage 
i n Pa rk inson ' s disease. Patients s h o w i n g the " o n / o f f " p h e n o m e n o n had an even greater decrease o f 
s t r ia ta l storage capaci ty . 
Positron emission tomography (PET) is a scanning 
technique which allows measurement in absolute 
units o f the regional concentration o f positron emit-
ting isotopes in the brain or other organs.' When 
these isotopes are attached to suitable tracers and 
inhaled or injected intravenously it is possible lo 
explore their fate by measuring the uptake o f radio-
activity over lime in an organ such as the brain. 
Recently a method has been developed to label an 
analogue of levodopa (6-L-fluorodopa) wi th the posi-
tron emitt ing isotope fluorine-18." This tracer can be 
used to study regional dopamine metabolism in brain 
in vivo by measuring tomographically the accumu-
lated radioactivity with PET.^"^ 
We have applied this method to a group o f healthy 
control subjects and to patients wi th Parkinson's dis-
ease. Because o f severe loss o f nigrostriatal dopami-
nergic neurons that characterises Parkinson's disease, 
the dopamine content in striatum o f these patients is 
markedly diminished.* The aim of the present study 
was to investigate storage capacity for dopamine in 
striatum of healthy individuals and subjects wi th Par-
kinson's disease. 
Methods 
Tracer 
The isotope fluorine-18 (half life 110 min) was produced in 
Address for reprint requests: Dr K L Leenders, MRC Cyclotron Unit, 
Hammersmith Hospilal, Du Cane Road, London WI2 OHS. UK. 
Received 21 May 1985 and in revised form 6 September 1985. 
Accepted 10 Septcmljer 1985 
the MRC cyclotron at the Hammersmith Hospilal. London. 
Labelled L-['*F] fluorodopa was prepared according to the 
technique of Fimau et al^ (but without the final stage of 
separation of isomers). Therefore a mixture of 2-. 5- and 
6-L-['*F] fluorodopa was used. The relative isomeric pro-
portions were 35, 5 and 60% respectively. TTie radioactivity, 
2-6 mCi, was associated with 8-10 mg L-fluorodopa. The 
estimated mean specific activity was 103 0 + 22-9 
mCi/mmol. This mixture was injected intravenously in a vol-
ume of 10 ml over two minutes using a constant infusion 
Harvard pump. 
Construction of arterial curve 
A Teflon (gauge 21) cannula was inserted into one radial 
artery, and 3 ml blood samples were taken at 20 second 
intervals during the first three minutes following tracer injec-
tion, and then every 30 to 60 seconds for a further seven 
minutes. Arterial sampling times were then gradually spaced 
out via 5 and 10, to 20 minute intervals. Usually a total of 25 
samples were taken. The samples were spun and the concen-
tration of isotopes in plasma was measured in a well-counter 
cross calibrated with the tomograph. 
Scanning technique 
The positron emission tomograph used was the ECAT-II 
(EG & G Ortec). This is a whole body single slice machine 
with a spatial resolution of 17 mm x 17 mm FWHM (full 
width half maximum) and a slice thickness of 16 mm 
( E W n M ) . ' Serial scans were started in most subjects about 
one hour after the tracer had been given. Some subjects were 
scanned from the moment at which tracer was injected. 
Owing lo the slow uptake of the tracer by brain tissue, the 
relatively small volume of the striatum and the relatively low 
sensitivity of our scanner, 10 minute scans were needed to 
obtain sufficient counts to reconstruct one tomographic 
image. Only one cross-section was scanned (5 cm above and 
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Fig I L-['^F]fluorodopa uptake in a cross-section through both striata of the brain of a normal volunteer (a). The image is a 
.'summation of all the scans (after correction for attenuation) between 100 and 220 min after administration of the tracer. In 
this and following illustrations the top of the image indicates the front of the brain, viewed from above, (b I illustrates how the 
regions of interest were positioned on each image (see text for explanation). 
parallel to the orbito-meatal line) at the level of the body of 
the striatum. The same transaxial tomographic plane was 
measured in a sequence of consecutive 10 minute scans for 
approximately two hours. A transmission scan, using an 
external ring source (Germanium 68/Gallium 68), was used 
to correct the measured emission data for tissue attenuation. 
After data collection the images were reconstructed using 
standard computer processing for all of the 10 minute scans 
(fig la). The picture element (pixel) response within each 
reconstructed tomographic image relates directly to the 
regional concentration of fluorine-18 in the tissue examined, 
and was corrected for physical decay from the time of injec-
tion. This procedure allowed us to follow the changes in 
concentration of radioactivity over time in the striatal region 
and in regions of the surrounding brain. 
Data analysis 
The tissue concentration of fluorine-18 in both striata and 
surrounding brain were obtained from regions of interest 
(ROIs) defined on the images of the emission scans. An 
example is given in fig lb . The left and right striatal ROIs 
were obtained by summating all sequential images and 
determining a circular area (49 pixels; each pixel is 2-5 mm 
X 2 5 mm) containing the maximum concentration of iso-
tope. Striatal ROIs thus determined were placed on each 10 
minute scan separately to obtain the time course of radio-
activity. The average value from left and right striatum in 
any one slice was taken as the "striatal value". The "sur-
rounding brain value" was obtained as follows. A large ROI 
was placed on the image of the transmission scan just inside 
the rim representing the junction of skull and brain. This 
large ROI was then used to determine the outer border of the 
brain in each 10 minute emission scan. Two oval ROIs (radii 
8 and 9, totalling 223 pixels) which completely encircled the 
two centrally located striatal regions with high activity were 
then subtracted from this large ROI to obtain the 
"surrounding brain value" (fig lb). From the "striatal" and 
"surrounding brain" values a ratio was obtained for each 10 
minute scan. 
Patients and normal controls 
Six healthy volunteers and 12 patients with Parkinson's dis-
ease were studied (table 1). The patients were divided into 
two groups. The first group comprised seven patients who 
had had the disease for only a relatively short time ("early" 
patients). Three of these patients were on regular treatment 
with a stable and sustained therapeutic response: their medi-
cation was stopped one day before the PET scan. The other 
four patients in this group had not been treated. The second 
group comprised five patients who had had the disease for 
longer, were more severely disabled, and whose response to 
levodopa treatment fluctuated ("on/oflT' patients). Al l of the 
second group were taking levodopa, but their response to 
treatment was variable. Throughout each day they had 
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Table 1 Clinical and scan data of normal controls and patients with Parkinson's disease 
Sex Age (yr) ''FDopa 
mCilkg 10' ' 
Disease duration "OnlOff" 
lyri 
Total disability 
score* 
Usual drugs 
(daily doseI'i 
Time off drugs 
before scan 
Controls 
M 42 215 
M 32 3-48 
M 65 308 
F 30 610 
F 64 11 05 
M 23 7-79 
Mean 42-7 5-61 
± SD + 18-0 ± 3-39 
Group 1% 
M 71 3-44 1 400 Levodopa (500 mg) 24 hrs 
M 62 5-50 5 530 l^vodopa (600 mg) 
M 64 5-66 
orphenadrine (50 mg) 24 hrs 
6 450 Levodopa (600 mg) 24 hrs 
M 32 4-83 2-5 255 Nil 
M 46 5-59 3 255 Nil 
M 76 3-82 3 710 Nil 
F 74 9-62 ~> 850 Nil 
Mean 60-7 5-49 3-2 493 
± SD ± 16-2 ± 2 0 2 ±1-7 ± 224 
Group 11^ 
M 68 10 + 1245 l-evodopa (500 mg) 
bromocriptine (22-5 mg) 
M 61 900 10 + 
selegiline (5 mg) 12 hrs 
735 Levodopa (400 mg), pergolide 
M 47 706 
(20 mg) 24 hrs 
8 + 750 t^vodopa (600 mg) 12 hrs 
M 41 5-82 12 + 450 l^vodopa (400 mg) 
M 42 5-35 
orphenadrinc (400 mg) 24 hrs 
7 + 1845 Levedopa (900 mg) 24 hrs 
Mean 51 8 6-81 9-4 1005 
± SD ± 121 ±63 + 20 + 550 
•Maximum disability score on N Y U scale is 2000. 
tLevodopa dosage taken in combination with peripheral decarboxylase inhibitor. 
JGroup I patients comprise those with eariy disease or showing sustained response to levodopa therapy. 
§Group 11 comprises "on/off" patients. 
Control 
periods of mobility (often with dyskinesias) alternating with 
periods of immobility. Such swings from mobility to immo-
bility generally were related to the time at which levodopa 
was taken. Drugs were stopped the night before the PET 
scan in three "on/ofl'" patients, but two could only tolerate 
a few hours without treatment. Each control subject and 
patient received 75 mg carbidopa orally about 30 minutes 
before the tracer was injected. Just before the patients were 
scanned they were examined and rated according to the New 
York University disability scale.' The two groups of patients 
did not difler in respect of age or administered dose of tracer 
(table 1). However, patients in group I I had suR'ered from 
the disease three times as long as those in group I (p < 0001) 
and were more disabled (p < 0 05). 
Written informed consent was obtained from each patient 
and healthy control. The project was approved by the 
Research Ethics Committee of the Hammersmith Hospital 
and the Maudsley Hospital, and permission for use of the 
isotope was obtained from the UK Administration of 
Radioactive Substances Advisory Committee. 
Results 
Figure 2 illustrates the time course o f activity in stri-
a tum and surrounding brain in a control subject and 
an " o n / o f f ' patient. From 70 minutes onwards stri-
Potient 
W 180 20 60 100 1^0 K ) 
Time (minutes) 
Fig 2 Striatal (A), surrounding brain (B) and arterial 
plasma (C) activity al 10 min intervals after /--["/] 
fluorodopa administration in a control subject and a paiieni 
with Parkinson's disease, expressed as a percentage of the 
arterial plasma peak activity. For clarity the striatal and 
surrounding brain values have been multiplied by a factor of 10. 
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Fig 3 Left hand panels (a,b, c) show sequences of 10 min scans from 70 to 170 min. (a) a normal control, the comast between striatal 
uptake of L-'^Ffluorodopa and that of surrounding brain increases constantly with lime, (b) a patient with "early" Parkinsons disease: the 
contrast between uptake of the tracer in striatum and surrounding brain also is obvious, although the images are noisier owing to lower count 
rates, and there is little increase in contrast over lime, (c) a case of Parkinson's disease showing the "onjoff" phenomenon: the contrast 
between striatum and surrounding brain is hardly visible and Ihe image reconstruction is very noisy owing to the low count rates. Right hand 
panel shows ihe ratios of activity in striatum to that in surrounding brain, for (A) normal subjects (n = 6) (top), (B) patients with "early" 
Parkinson's disease (n = 7) (middle), and (C) Parkinsonian patients with the "onjojf'phenomenon (n = 5) (bottom). 
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Fluorodopa 
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Fig 4 The average ratios of radioactivity (striatum versus 
surrounding brain), plotted at intervals of 20 min, are shown 
for (A ) normal subjects (n = 6), (B) patients with "early" 
Parkinson's disease (n = 7), and (C) Parkinsonian patients 
with the "onloff'phenomenon (n = 5). Means ± SD are 
shown. 
alal activity in the control subjects decreased only 
slightly ( f rom 8-7% of arterial peak plasma value at 
70 min to 8 0% at 180 min); activity in surrounding 
brain decreased more rapidly ( f r o m 5-8% at 70 min to 
3-9% at 180 min) . In the patients striatal activity f o l -
lowed the pattern of surrounding brain activity (stri-
atal activity fell f rom 5-7% to 4 1 % , and surrounding 
brain activity f r o m 4-6% to 3-3%, between 70 and 170 
min) . The time course o f the decline in surrounding 
brain activity was similar in controls and patients. 
The peak of this activity in those subjects whose scans 
were started immediately after administration o f the 
tracer occurred in controls at 28-8 ± 5-3 m i n (n = 3) 
and in patients at 29-3 ± 0 min (n = 2) after injec-
t ion . The percentage decline o f activity in sur-
rounding brain f rom about 2 to 3 hours after adminis-
t ra t ion in those subjects who were scanned in that 
time period was 15-9 ± 2-0 (n = 3) and 15-7 >f 2-9 
(n = 7) in controls and patients respectively. 
Table 2 A verage ratios o / [L- ' *F] Fluorodopa uptake in 
striatum versus surrounding brain from ICQ to 200 min after 
administration in patients with Parkinson's disease 
Stable response patients "OnlOff" patients 
Mean 
±SD 
1-58 
1-49 
1-43 
1-47 
1-38 
1-61 
1-34 
1-47 
+ 010 
1-35 
1-29 
1-22 
1-42 
1-33 
1-32 
-fO-07 
p < 0 02* 
The ratio o f activity in striatum compared to sur-
rounding brain increased steadily over time in the 
normal subjects (fig 3a) for at least 120 min after 
injection o f t h e tracer. Thereafter the ratio continued 
to increase, but the overall absolute count rates were 
extremely low by then, because o f physical decay of 
the isotope, and only two subjects were studied at this 
time. 
In contrast all Parkinsonian patients showed a 
lower ratio o f activity for each time point after admin-
istration o f the tracer (fig 3b, c). The variability o f 
L-( F ) Flourodopa in patients 
with Parkinsons disease 
1-60-1 
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•Student's / test. 
Fig 5 The mean ratio of radioactivity (striatum versits 
surrounding brain) for each patient between 100 and 200 min 
after administration of L-['^F\ fluorodopa. The bars indicate 
means and standard deviations. The "onjoff" group of 
patients diff'ered significantly from the group of patients with 
a stable response to treatment. Two sample Student's t test 
(v = 10: t = 2-84: p < 0 02). 
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this ratio in the patient group was considerably larger 
than in the control subjects. This may have reflected 
the lower overall absolute activity in the striatum of 
patients, particularly towards the later part o f the 
study, when the absolute count rates o f isotope 
became very low. 
Averaged ratios at 20 minute intervals for each 
group o f subjects arc shown in fig 4. The average ratio 
in the control subjects progressively increased 
• throughout ihc period of study. In contrast, in the 
patient groups the average ratio platcaucd about 100 
min after isoiopc udminislralion. In the group of 
patients with "early" disease, the ralios were not 
different whether the patients were treated or not. The 
ralios for patients with the "on/ofT" phenomenon 
were consisicntl\ lower than those for patients with 
"ear ly" disease. 
For each palicnl the average ratio (of all available 
ralios between 100 and 200 minutes after adminis-
trat ion o f the tracer) was calculated (table 2). 
"On.ofT" patients had a lower mean ratio compared 
with "ear ly" patients (fig 5). 
Discussion 
This study confirms previous reports-'"-'^ that 
accumulation o f radioactivity alter administration o f 
fluorine-18 labelled levodopa takes place preferen-
tially in the striatum of healthy controls and in 
patients wi th Parkinson's disease. By observing the 
time course of this uptake, we found a striking 
difference between controls and patients. 
PET can only dcicrminc the concentration of posi-
t ron emitt ing isotopes in a certain volume of tissue. 
The detected radioactivity (in this study fluorine-18) 
may arise f rom L - [ ' * F ] fiuorodopa itself or one o f its 
metabolic products, notably fluorinaied dopamine 
( D A ) , homovanillic acid ( H V A ) . .^.4-dihydroxy 
phenylacetic acid (DOPAC) or •, 3-methoxy. 
4-hydroxy-phenylalanine (3-OM-dopa). The accumu-
lation o f the isotope is greatest in striatum, which has 
the highest concentration o f native dopamine and 
related anabolic and catabolic enzymes. Fluorodopa 
has been shown to behave biochemically like 
levodopa and fluorodopamine is stored in the slri-
a t u m . ' ^ " " Further, in primates much o f t h e striatal 
radioactivity measured an hour after injection o f 
L-C'F] fluorodopa is due to ['**F]-fluorodopamine. 
H o m e ei a/ '- have shown in rats pretreated with 
carbidopa that L - [ ' * C ] dopa accumulated in striatal 
tissue mainly in the form of dopamine; dopa. H V A 
and D O P A C together constituted a small fraction o f 
tissue radioactivity f rom I to 4 hours after intra-
venous administration. 3-OM-dopa rose slowly but 
steadily in arterial plasma, was capable o f passing the 
blood brain barrier, and accounted for a considerable 
fraction of brain tissue activity. However. 
3-OM-dopa was distributed uniformly throughout 
the brain. Furthermore, lesions of substantia nigra 
markedly reduced striatal acii\ ity fol lowing adminis-
tration of L-C^C] dopa, Hef i i et a/' ' reported that 
lesioning of substantia nigra and medial forebrain 
bundle in rats reduced dopamine concentration by 
95% compared lo the unlesioned coniralaicral side, 
and also demonstrated that dopamine formation 
f r o m exogenous levodopa in striatum occurs mainly, 
but not exclusively, within dopaminergic nerve termi-
nals. The clinical effects o f levodopa administered in 
pharmacological doses are exerted only after it is 
decarboxylated to dopamine within the striatum. 
Reserpine depletes intraneuronal vesicular storage 
sites of dopamine and other monoarhines, and pre-
treatment of rats with reserpine decreased striatal 
activity after L-( ' ' 'C] dopa administration by 48% at 
two hours.'* This reserpine effect has also been dem-
onstrated in monkey brain after L - [ ' * F ] fluorodopa.-* 
On the basis of these animal experiments we believe 
that the initial activity seen in the human striatum is 
an indication of its capacity to convert L - [ " F ] 
fluorodopa to L- [ '*F] fluorodopamine. The absolute 
concentration o f tracer in striatum of normal human 
controls reached a plateau between 30 and 45 min. 
and thereafter decreased slightly.' * The ratio o f activ-
ity between striatum and surrounding brain con-
tinued to rise steadily f rom 0 ^ hours after injection 
of the tracer in normal controls. This was due to a 
greater decrease of activity in surrounding brain 
rather than to an increase of activity in striatum. Our 
study therefore indicates that activity derived from 
L - [ ' * F ] fluorodopa is retained in human striatum for 
up to four hours after injection. This suggests that the 
activity seen in striatum throughout the major part of 
the period after injection o f L- [ ' *F ] fluorodopa repre-
sents stored L - [ ' * F ] fluorodopamine. 
In contrast to normal subjects, patients wi th Par-
kinson's disease showed a different time course of stri-
atal activity after injection of labelled L-fluorodopa. 
The ratio o f striatal to surrounding brain activity 
failed to rise after about 100 min f r o m the injection, 
indicating that the net accumulation o f activity within 
the striatal and surrounding brain tissue occurred at 
the same rate. The relative failure o f Parkinsonian 
patients to selectively retain the tracer in the striatum 
suggests inability to store L-fluorodopamine. due to 
loss o f nigroslriatal dopamine terminals. 
Patients with longstanding disease and fluctuating 
"on/oflT" clinical response to levodopa treatment had 
a significantly lower "storage capacity" compared 
wi th "early" patients, either untreated or showing 
sustained clinical response. The ratio o f acti%-iiy 
between striatum and surrounding brain f rom about 
100 min onwards was consistently lower in the youn-
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ger group o f " o n / o f f ' patients than in the older group 
o f "ear iy" patients. This finding, together with the 
tight pattern o f striatum to surrounding brain ratios 
wi th in the control group despite wide age variations, 
would imply that these ratios are not age dependant. 
Reches and Fahn '^ and Gervas ei a/'^ found in 
rats that 3-OM-dopa inhibits striatal uptake o f 
levodopa in a dose-dependant manner. The difference 
in striatal uptake o f the tracer between our three 
groups o f human subjects could conceivably be due to 
circulating 3-OM-dopa. This would be expected to be 
present in higher concentrations in the " o n - o f f ' than 
"early" patients, and in patients than controls, as they 
had used higher pharmacological doses o f levodopa 
and peripheral decarboxylase inhibi tor before the 
PET scans were peformed. However, i f 3-OM-dopa is 
indeed capable o f impairing transfer o f levodopa 
across the blood-brain barrier in man, this should 
only affect overall levodopa uptake into brain, and 
not the ratio o f levodopa concentration between stri-
a tum and surrounding brain. We have recently dem-
onstrated (Leenders et al, unpublished observation) 
that the intravenous administration o f a mixture o f 
amino acids, although inhibit ing uptake o f injected 
L - [ ' ' F ] fluorodopa into brain, has no efliect on the 
ratio o f striatal to surrounding brain radioactivity. In 
keeping wi th this observation, the four previously 
untreated Parkinsonian patients in this study showed 
the same ratio o f activity between striatum and sur-
rounding brain as the three who showed a sustained 
response to levodopa therapy. 
Elsewhere" we have suggested that the devel-
opment o f " o n / o f f ' fluctuations in patients with Par-
kinson's disease on chronic levodopa therapy is due 
to progressive loss o f the capacity to store dopamine 
in the striatum. Our results provide further evidence 
that as Parkinson's disease progresses, there is indeed 
a continuing decline o f striatal storage capacity for 
dopamine. Patients in an advanced stage o f the dis-
ease are therefore less capable o f maintaining a con-
stant dopamine pool in striatal tissue, and levels o f 
striatal dopamine thus became more closely 
dependent upon the rate at which levodopa is deliv-
ered to striatum at any given time. A constant and 
sufficiently high level o f plasma levodopa as provided 
by continuous intravenous infusion has been shown 
lo abolish clinical fluctuations in patients wi th severe 
swings on oral t he r apy .^ ° "^^ I t has been proposed 
that such infusions may owe their success to their 
abi l i ty to compensate fo r a lack o f storage capacity 
f o r striatal dopamine. 
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POSITRONS FROM GENERATORS 
J.C. CLARK 
I n t h e l a t e 1950s when what we now know as n u c l e a r m e d i c i n e 
was i n i t s i n f a n c y t h e d e t e c t i o n o f human b r a i n tumours by 
r a d i o i s o t o p e s c a n n i n g was b e i n g p i o n e e r e d by a team a t Massa-
c h u s e t t s G e n e r a l H o s p i t a l l e a d by Gordon B r o w n e l l ( 1 ) . They had 
chosen, f o r r e a s o n s t h a t a r e now p r o b a b l y much more w i d e l y 
a p p r e c i a t e d , t o make use o f t h e h i g h degree o f s p a t i a l r e s o l u -
t i o n a c h i e v a b l e when t h e two t i m e c o i n c i d e n t 180° c o r r e l a t e d 
gamma r a y s (due t o p o s i t r o n a n n i h i l a t i o n s ) were d e t e c t e d e x t e r n -
a l t o t h e s u b j e c t w i t h a p a i r o f s c i n t i l l a t i o n c o u n t e r s e l e c -
74 
t r o n i c a l l y s e t i n t i m e c o i n c i d e n c e . The r a d i o n u c l i d e s As 
6 4 
(17.7d) and Cu (12.7h) were t h e o n l y p o s i t r o n e m i t t e r s commer-
c i a l l y a v a i l a b l e a t t h e t i m e and t h e i r s u p p l y was n o t w i t h o u t 
problems. S e v e r a l n u c l e a r r e s e a r c h g r o u p s , p a r t i c u l a r l y t h o s e 
a t t h e Oak Ridge and Brookhaven N a t i o n a l L a b o r a t o r i e s , began t c 
l o o k f o r a l t e r n a t i v e p o s i t r o n e m i t t i n g r a d i o n u c l i d e s . A t t e n t i o r . 
was drawn t o s e v e r a l n u c l e a r r e l a t i o n s h i p s i n v o l v i n g l o n g o r 
medium h a l f - l i f e p a r e n t s and s h o r t - l i v e d p o s i t r o n e m i t t i n g 
d a u g h t e r s . Such r e l a t i o n s h i p s i m m e d i a t e l y o f f e r e d t h e p o s s i b i l -
i t y o f a p o s i t r o n g e n e r a t o r system w i t h a s h e l f l i f e b e i n g t h a . 
o f t h e p a r e n t . The f i r s t g e n e r a t o r o f t h i s k i n d , d e s c r i b e d by 
Gleason as a " P o s i t r o n Cow" i n 1960 ( 2 ) , was based on t h e 
Ge^^ (271d)/Ga^® (68 min) p a r e n t d a u g h t e r r e l a t i o n s h i p . 
Over t h e y e a r s o t h e r p o s i t r o n g e n e r a t o r systems have been 
s t u d i e d , some o f w h i c h a r e shown i n t a b l e 1. 
W i t h o u t d o u b t t h e two most e x h a u s t i v e l y s t u d i e d and c l i n i c -
82 82 68 68 a l l y used p o s i t r o n g e n e r a t o r s a r e Sr /Rb and Ge /Ga and 
t h i s r e v i e w w i l l c o n c e n t r a t e most o f i t s a t t e n t i o n on them. 
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S r ^ ^ (25 d)/Rb^^ (75 s) 
82 
The f i r s t Rb g e n e r a t o r was d e s c r i b e d by Yano and Anger i n 
1968 ( 3 ) . I t was based on t h e weakly a c i d i c c a t i o n exchange 
r e s i n BIOREX 70 and ammonium a c e t a t e as t h e e l u a n t . 
Over the i n t e r v e n i n g y e a r s o t h e r i o n exchange m a t e r i a l s and 
e l u a n t c o m b i n a t i o n s have been s t u d i e d ( 4 - 1 2 ) . Some o f these a r e 
l i s t e d f o r q u i c k r e f e r e n c e i n t a b l e 2. 
The e a r l y o r g a n i c r e s i n g e n e r a t o r s s u f f e r e d f r o m t h e f o l l o w -
i n g m a j o r drawbacks. A l t h o u g h t h e i r p e r f o r m a n c e a t low l e v e l s 
8 2 
o f Sr seemed q u i t e good, r a d i a t i o n damage a t h i g h p a r e n t 
l o a d i n g s caused breakdown o f t h e r e s i n w h i c h l e d t o a s e r i o u s 
d e g r a d a t i o n i n t h e i r p e r f o r m a n c e . I n p a r t i c u l a r t h e Sr b r e a k -
t h r o u g h i n c r e a s e d . I n a d d i t i o n t h e e l u a n t s s e l e c t e d f o r these 
e a r l y systems were g e n e r a l l y t h e p r e f e r r e d s o l u t i o n t o t h e 
c h e m i c a l p r o b lem and r a r e l y a c c e p t a b l e as an i n f u s a t e i n man, 
e.g. NH^Cl ( 1 3 ) . The use o f i n o r g a n i c i o n exchange m a t e r i a l s t o 
s u c c e s s f u l l y overcome t h e r a d i a t i o n damage problems a s s o c i a t e d 
w i t h o r g a n i c i o n e x c h angers has been known f o r many y e a r s . The 
most commonly e n c o u n t e r e d example i n r a d i o p h a r m a c y i s t h e 
99 99m 
Mo /Tc c h r o m a t o g r a p h i c a l u m i n a r a d i o n u c l i d e g e n e r a t o r w h i c h 
i s c o n v e n i e n t l y e l u t e d w i t h p h y s i o l o g i c a l s a l i n e (0.9% N a C l ) . 
The search f o r an i n o r g a n i c i o n exchange m a t e r i a l f o r use i n 
8 2 82 
t h e Sr /Rb g e n e r a t o r was s t i m u l a t e d by two o t h e r f a c t o r s , 
namely t h e upsurge i n p o s i t r o n e m i s s i o n t o m o g r a p h i c c a p a b i l i t y 
u s i n g t h e r i n g d e t e c t o r a p p r o a c h (14,15) and t h e com m i s s i o n i n g 
o f t h e beam dump t a r g e t s t a t i o n s a t t h e l a r g e l i n e a r a c c e l e r a -
t o r s a t Los Alamos, LAMPF ( 1 6 ) , and Brookhaven, BLIP ( 1 7 ) , 
w h i c h were d e m o n s t r a t e d t o be c a p a b l e o f making hundreds of 
8 2 
m i l l i c u r i e s o f t h e p a r e n t Sr ( 1 8 ) . 
Two r e p o r t s on t h e s t u d y o f p o t e n t i a l c a n d i d a t e s i n i n o r g a n i c 
i o n exchangers by B r i h a y e e t a l (19) and N e i r i n x e t a l (20) 
c o n c l u d e d t h a t t i n d i o x i d e s h o u l d f o r m t h e b a s i s o f an a c c e p t -
a b l e g e n e r a t o r . They and o t h e r g r oups have moved on t o t e s t 
t h i s h y p o t h e s i s w i t h t h e r e s u l t t h a t a l m o s t a l l c l i n i c a l s t u d i e s 
8 2 
u s i n g Rb r e l y on t h e SnO^/0.9i NaCl system. Only t h e Donner 
L a b o r a t o r y g r o u p i n B e r k e l e y , C a l i f o r n i a , appear t o be p e r s i s t -
i n g w i t h t h e AI2O2 g e n e r a t o r ( 4 , 2 1 ) . A t Hammersmith we employed 
71 
TABLE I I I 
DISTRIBUTION COEFFICIENTS (Kd) OF S r ( I I ) and Rb(I) 
( T r i s buffer/HCl solutions room temperature 12 h e q u i l i b r a t i o n ) 
Data shown f o r pH - 1 
Adsorbant S r ( I l ) Rb(I) S r ( I I ) / R b ( I ) 
"Oxtain" • 
( o - t i n dioxide) 20000 1 20000 
Basic AI2O2 3980 25 160 
Titanium Vanadate 3I6OO 39800 0.8 
"Polyan M" • 
(Polyantimonic acid) 2800 320 9 
Antimony (V) 
hexacyanoferrate ( I I ) 7550 110 72 
Ref: Brihaye C., Guillaume M. and Cognau M. Radiochem.Radioanal.Lett., _48_, 
157-16H, (1981), 
• Applied Research Laboratories (see page 4 ) . 
t h e Al^0.^/^.8% NaCl pH 9 - 10 system t o g e t h e r w i t h a Chelex-100 
s a f e t y t r a p column (5) u n t i l we t o o t r a n s f e r r e d t o t h e Sn0 2/ 
0.9% NaCl pH 6.5 - 7 system. 
T a b l e 3 anci 4 summarize t h e B r i h a y e anc3 N e i r i n x d a t a r e s p e c -
t i v e l y . A l t h o u g h n o t a c q u i r e d i n e x a c t l y t h e same way, t h e d a t a 
a r e c o m p a r a b l e . I t i s c l e a r f r o m t h i s d a t a why Sn02 i s now most 
f a v o u r e d . However a c o m p l i c a t i o n a r i s e s . T i n d i o x i d e e x i s t s i n 
a t l e a s t two d i f f e r e n t f o r m s , a and B, d e p e n d i n g upon i t s method 
o f p r e p a r a t i o n (22) and t h e s e e x h i b i t , d i f f e r e n t a d s o r p t i o n 
c h a r a c t e r i s t i c s f o r b o t h a n i o n s and c a t i o n s . F o r t u i t i o u s l y , 
B r i h a y e and N e i r i n x b o t h c a r r i e d o u t t h e i r d i s t r i b u t i o n s t u d i e s 
u s i n g t h e a f o r m f r o m t h e same m a n u f a c t u r e r ( O x t a i n A p p l i e d 
72 
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R e s e a r c h , J o d o i g n e , B e l g i u m ) . The 6 f o r m a v a i l a b l e f r o m a d i f f e r -
e n t s u p p l i e r ( F a r m i l a t i a C a r l o Erba, M i l a n , I t a l y ) , i s q u i t e 
8 2 8 2 
u n s u i t a b l e - f o r t h e p r e p a r a t i o n o f a Sr /Rb g e n e r a t o r (23) . 
8 2 
The p e r f o r m a n c e o f a t y p i c a l SnO^Rb g e n e r a t o r i s d e s c r i b e d 
i n d e t a i l by Gennaro e t a l ( 6 ) . 
I n o u r e a r l y e x p e r i e n c e s w i t h t h e Sn02/0.9% NaCl system we 
r e t a i n e d t h e c o n c e p t o f a Chelex-100 s a f e t y column w o r k i n g on 
8 2 
t h e a s s u m p t i o n t h a t i f an added s a f e t y f a c t o r on t h e Sr b r e a k -
t h r o u g h c o u l d be a c h i e v e d w i t h a r e p l a c e a b l e Chelex-100 column 
o p e r a t i n g i n a low r a d i a t i o n dose s i t u a t i o n , some advantages 
c o u l d be g a i n e d . I t t u r n e d o u t however t h a t t h e r a d i o c h e m i c a l 
p u r i t y improvements were t o t a l l y o u t b a l a n c e d by t h e i n a b i l i t y 
t o m a i n t a i n t h e g e n e r a t o r system s t e r i l e when a Chelex column 
was i n c o r p o r a t e d i n t o i t . I t was f o u n d t h a t Sn0_ even when 
8 2 
l o a d e d w i t h Sr c o u l d be s t e r i l i z e d u s i n g i s o t o n i c sodium hypo-
c h l o r i t e ( M i l t o n ) whereas a l l a t t e m p t s e i t h e r c h e m i c a l l y or by 
Y i r r a d i a t i o n t o s t e r i l i z e Chelex-100 r e s u l t e d i n a severe 
d e g r a d a t i o n o f i t s a b i l i t y t o r e t a i n s t r o n t i u m . 
The p r o b l e m s o f m a i n t a i n i n g a g e n e r a t o r o f t h i s t y p e i n t h e 
c l i n i c a l s i t u a t i o n b e a r some e x a m i n a t i o n i n t h e c o n t e x t of 
a c h i e v i n g a good p h a r m a c e u t i c a l p r a c t i c e and r e c o r d i n g o f 
q u a l i t y c o n t r o l d a t a . The main c o n s i d e r a t i o n s a r e t h e f o l l o w i n g : 
1. The l o n g p h y s i c a l and b i o l o g i c a l h a l f - l i f e o f t h e p a r e n t 
8 2 8 5 Sr w h i c h i s a l w a y s accompanied by Sr (65d) u s u a l l y i n a t 
l e a s t e q u a l p r o p o r t i o n s ( 1 8 , 5 ) . T h i s f a c t o r demands an 
8 2 
e x t r e m e l y h i g h l e v e l o f s c r u t i n y o f t e s t e l u a t e s f o r Sr 
8 5 
and Sr b r e a k t h r o u g h , b e f o r e and a f t e r each c l i n i c a l s e s s i o n 
(24) . 
2. As t h e g e n e r a t o r systems a r e a l m o s t a l w a y s used i n an i n f u s i o n 
mode and t h e p o t e n t i a l f o r l a r g e volume i n f u s i o n s e x i s t s , 
t h e e l u a n t must be p h y s i o l o g i c a l l y a c c e p t a b l e , e s p e c i a l l y i n 
t h e case o f c a r d i a c s t u d i e s and be m a i n t a i n e d s t e r i l e and 
a p y r o g e n i c . T e s t s f o r p y r o g e n i c i t y can be a c h i e v e d q u i c k l y 
i n house ( " P y r o g e n t " , Byk M a l l i n c k r o d t ) b u t s t e r i l i t y and 
r a b b i t p y r o g e n t e s t s c a n n o t and t h e use o f membrane f i l t e r s 
f o r t e r m i n a l s t e r i l i z a t i o n i s n o t w i t h o u t i t s problems. I t 
i s a p p a r e n t t h a t whenever t h e e l u a n t r e s e r v o i r i s changed, 
74 
( i n o u r case c o m m e r c i a l l y produced bags o f i s o t o n i c s a l i n e f o r 
i n j e c t i o n a r e e m p l o y e d ) , t h e r e i s a r i s k o f i n f e c t i n g t h e 
g e n e r a t o r as i t i s q u i t e i m p r a c t i c a l t o c a r r y o u t t h i s change 
i n a s t e r i l e e n v i r o n m e n t . As i s u s u a l l y t h e c a s e , i f something 
can go wrong, e v e n t u a l l y i t w i l l , r e s u l t i n g i n our g e n e r a t o r 
o c c a s i o n a l l y f a i l i n g t o s t a n d t h e t e s t s f o r s t e r i l i t y and i n e v i t -
a b l y p y r o g e n i c i t y . However s i n c e we i n t r o d u c e d t h e i s o t o n i c 
h y p o c h l o r i t e t r e a t m e n t between c l i n i c a l s e s s i o n s f o l l o w e d by an 
e x h a u s t i v e wash w i t h s t e r i l e i s o t o n i c s a l i n e , we have not en-
c o u n t e r e d s t e r i l i t y o r p yrogen p r o b l e m s . 
I n c o n c l u s i o n , i t i s f a i r t o say t h a t c l i n i c a l l y a c c e p t a b l e 
systems a r e now w e l l e s t a b l i s h e d and t h o s e c l i n i c a l r e s e a r c h e r s 
8 2 
who have had t h e o p p o r t u n i t y t o c a r r y o u t s t u d i e s w i t h Rb are 
w i t h o u t e x c e p t i o n h i g h l y e n t h u s i a s t i c . The c o m m e r c i a l p o t e n t i a l 
o f a Sn02 g e n e r a t o r system i s b e i n g a s s e s s e d (The Squibb I n s t , 
f o r M e d i c a l Research, New B r u n s w i c k , NJ, USA). 
There remains however one v i t a l p o i n t , t h i s i s t h e l o n g - t e r m 
8 2 
s u p p l y o f Sr and t h e o n l y f a c i l i t y t h a t has t h e p o t e n t i a l t o 
e n s u r e t h i s a t t h e p r e s e n t t i m e i s t h e one a t Los Alamos. 
Ge^^ (271d)/Ga^® (68m) 
The f i r s t d e s c r i p t i o n o f a c h e m i c a l system t o s e p a r a t e Ga 
6 8 
f r o m i t s p a r e n t Ge a p p e a r e d i n 1960 ( 2 ) . What was t h e n termed 
a " P o s i t r o n Cow" because i t c o u l d be " m i l k e d " would now o f 
c o u r s e be r e f e r r e d t o as a r a d i o n u c l i d e g e n e r a t o r . The separa-
t i o n employed a s o l v e n t e x t r a c t i o n p r o c e d u r e . Ga was e x t r a c t e d 
6 8 
i n t o a 25% s o l u t i o n o f a c e t y l a c e t o n e i n c y c l o h e x a n e f r o m a Ge 
s o l u t i o n a t pH 4.5. Back e x t r a c t i o n i n t o 0.1 NHCl r e s u l t e d i n a 
68 68 Ga C l ^ s o l u t i o n e s s e n t i a l l y r e a d y f o r c o n v e r s i o n t o t h e Ga 
(EDTA) complex. 
T h i s l a s t f e a t u r e r a i s e d some i r o n y as r a d i o p h a r m a c e u t i c a l 
c h e m i s t s have, f o r t h e l a s t t e n y e a r s , been a t t e m p t i n g t o p e r f e c t 
6 8 
a c h r o m a t o g r a p h i c g e n e r a t o r t o p r o d u c e i o n i c Ga ( I I I ) , more 
a b o u t w h i c h below. 
A b o u t a y e a r a f t e r Gleason's r e p o r t was p u b l i s h e d a c h r o m a t o -
6 8 
g r a p h i c Ga "Cow" was d e s c r i b e d by Greene and Tucker ( 2 5 ) . 
T h e i r s u c c e s s f u l use o f ^^2^3 c h r o m a t o g r a p h i c T e ^ ^ ^ / I ^ 
c t 
75 
9 9 99m 
and Mo /Tc g e n e r a t o r s (26) l e d t o a t t e m p t s t o make a chroma-
6 8 
g r a p h i c Ge g e n e r a t o r . The r e s u l t i n g system was q u i t e r e v o l -
6 8 
u t i o n a r y . The Al^O^ column l o a d e d w i t h Ge c o u l d be e l u t e d 
w i t h 0.005 M EDTA pH 7 t o produce t h e Ga^^ EDTA complex d i r e c t l y 
f o r use i n " p o s i t r o n b r a i n s c a n n i n g " . A g e n e r a t o r (New England 
N u c l e a r , N o r t h B i l l e r i c a , USA) based on t h i s system i s s t i l l 
6 8 
a v a i l a b l e c o m m e r c i a l l y . However, i n o r d e r t o u t i l i z e Ga i n 
6 8 
more s u b t l e r a d i o p h a r m a c e u t i c a l p r e p a r a t i o n s , i o n i c Ga ( I I I ) i s 
6 8 
an e s s e n t i a l p r e r e q u i s i t e . I t i s p o s s i b l e t o r i d t h e Ga o f i t s 
EDTA " c l o a k " b u t i t i s a t a s k b e s t a v o i d e d due t o s i g n i f i c a n t 
decay l o s e s and i n c r e a s e d p r e l a b e l l i n g c h e m i c a l m a n i p u l a t o r s t o 
en s u r e t o t a l removal o f EDTA ( 2 7 , 2 8 ) . A g a i n t h e a d v e n t o f the 
new g e n e r a t i o n o f p o s i t r o n tomographs (14,15) s p u r r e d on t h e 
r a d i o p h a r m a c e u t i c a l c h e m i s t t o p e r f e c t a g e n e r a t o r f o r i o n i c 
G a ^ ^ I I I ) . 
6 8 
The l i t e r a t u r e has many r e p o r t s o f i o n i c Ga g e n e r a t o r s i n 
dev e l o p m e n t (29-32) b u t t h e one w h i c h now i s g e n e r a l l y a c c e p t e d 
as t h e " s t a t e o f t h e a r t " was f i r s t d e s c r i b e d by Loc'h e t a l i n 
1980 (33) . 
S e v e r a l g r oups have d u p l i c a t e d t h e work and a c o m m e r c i a l 
g e n e r a t o r based on Loc'h's c h e m i s t r y i s now a v a i l a b l e (New Eng-
l a n d N u c l e a r , N o r t h B i l l e r i c a , USA) The c h r o m a t o g r a p h i c s e p a r a -
68 68 
t i o n o f Ga f r o m Ge i s a c c o m p l i s h e d u s i n g a Sn02 column 
e l u t e d w i t h 3-5 ml IN HCl. E l u t i o n e f f i c i e n c i e s a r e h i g h 
ft 8 
(75-80%) and Ge b r e a k t h r o u g h a c c e p t a b l y low 0.0002% t o 0.003% 
(33 , 34) . 
For t h o s e c o n t e m p l a t i n g making a g e n e r a t o r o f t h i s t y p e , t h e 
c h o i c e o f Sn02 o f t h e a c i d ' r e s i s t a n t 6 f o r m i s v i t a l and t h e a 
f o r m has been shown t o be q u i t e u n s u i t a b l e ( 2 3 ) . 
68 68 
I n a r e c e n t c o m p a r i s o n o f Ge /Ga g e n e r a t o r systems by Mc-
E l v a n y e t a l ( 3 4 ) , t h e o n l y r e s e r v a t i o n a b o u t t h e pe r f o r m a n c e 
o f t h e SnO^/HCL g e n e r a t o r was t h a t t h e i r s t u d i e s i n d i c a t e d t h a t 
even t h e s m a l l t r a c e s o f m e t a l i m p u r i t i e s , p r i n c i p a l l y t i n a t 
3 ugm i n a 5 ml e l u t i o n , c o u l d i n t e r f e r e w i t h t h e e f f i c i e n t 
l a b e l l i n g o f r a d i o p h a r m a c e u t i c a l s where l i m i t e d numbers o f 
c h e l a t i n g s i t e s would be a v a i l a b l e , e.g. a n t i b o d i e s and p r o t e i n s 
l i n k e d t o b i f u n c t i o n a l c h e l a t e s . The l e s s s o p h i s t i c a t e d r a d i o -
76 
p h a r m a c e u t i c a l s a p p a r e n t l y do n o t s u f f e r f r o m t h i s e f f e c t and 
s a t i s f a c t o r y l a b e l l i n g has been r e p o r t e d f o r human serum a l b u m i n 
m i c r o s p h e r e s ( 3 5 ) , t r a n s f e r r i n (36) r e d c e l l s ( 3 6 ) , c i t r a t e and 
p y r o p h o s p h a t e (36) DTMP ( 3 7 ) , A l i z a r i n ( 3 7 ) , Fe(OH) ( 3 7 ) , 
8 2 68 
A l i z a r i n - r e d - S ( 3 7 ) . U n l i k e Sr , Ge can be pr o d u c e d r e a s o n -
a b l y e f f e c t i v e l y by c y c l o t r o n s . However, i t s p r o d u c t i o n by 
s p a l l a t i o n a t BLIP and LAMPF s h o u l d be v e r y a t t r a c t i v e p r o v i d i n g 
t h e c o s t i n g o f i r r a d i a t i o n t i m e i s based o n l y t h e p a r a s i t i c 
beam dump c o n c e p t ! 
4 4 4 4 T i ^ (47y)/Sc^ (3.9h) 
• 5 4 — 
A Sc g e n e r a t o r was d e s c r i b e d by Greene and H i l l m a n i n 1967 
4 4 
( 3 8 ) . However, t h e p r o d u c t i o n o f t h e 46y p a r e n t T i was n o t 
4 5 4 4 
d e s c r i b e d . I t s c y c l o t r o n p r o d u c t i o n by t h e Sc (p,2n) T i 
w o u l d appear p o s s i b l e b u t r a t h e r l a b o r i o u s . P r o d u c t i o n a t one 
o f t h e h i g h e n e r g y p r o t o n a c c e l e r a t o r s (16,39,40) by s p a l l a t i o n 
w o u l d be w o r t h y o f i n v e s t i g a t i o n s h o u l d a demand a r i s e . 
The g e n e r a t o r system i s based on an i o n exchange (Dowex 1, 
4 4 
C I form) column o f some 15 ml volume and 2 cm d i a m e t e r . T i 
i s l o a d e d , a f t e r t r e a t m e n t w i t h h y d r o g e n p e r o x i d e , o n t o t h e 
r e s i n bed i n 0.1 M o x a l i c a c i d . A f t e r washing t h e column w i t h 
40 ml o f 0.1 M o x a l i c a c i d / 0 . 2 M h y d r o c h l o r i c a c i d and a l l o w i n g 
4 4 
an a p p r o p r i a t e i n g r o w t h o f Sc i t was e l u t e d w i t h 30 - 50 ml o f 
t h e same s o l u t i o n . O x a l a t e was decomposed by hydrogen p e r o x i d e 
44 
t r e a t m e n t o f t h e Sc c o n t a i n i n g o x a l i c a c i d r e s i d u e r e s u l t i n g 
f r o m b o i l i n g down t h e e l u a t e t o d r y n e s s . The e l u t i o n y i e l d 
r e p o r t e d was 60 t o 70% b u t t h e b r e a k t h r o u g h o f t h i s e a r l y system 
was 0.02 - 0.1%. W i t h ' a 44y p a r e n t t h i s c o u l d e x p l a i n why l i t t l e 
has been heard o f t h i s g e n e r a t o r system s i n c e . 
Fe^^ (8.3 h)/Mn^^'" (21.1m) 
Fe^^ has been used f o r many y e a r s i n haemopoetic s t u d i e s . 
C o n s e q u e n t l y many p o t e n t i a l human r a d i o n u c l i d e g e n e r a t o r s have 
been made! However, d e s p i t e r e p e a t e d s t u d i e s no e v i d e n c e f o r 
t h e s e p a r a t i o n o f Mn^^"* f r o m Fe^^ has been o b s e r v e d i n man. The 
c y c l o t r o n p r o d u c t i o n o f Fe f o r p r a c t i c a b l e Mn ^ g e n e r a t o r 
p r e p a r a t i o n w o u l d be p r o h i b i t i v e l y s l o w and e x p e n s i v e . However, 
i t s p r o d u c t i o n p a r a s i t i c a l l y on a l i n e a r a c c e l e r a t o r b e i n g 
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o p e r a t e d f o r o t h e r p u r p o s e s , as BLIP (39) and LA^^PF (40) a r e , 
seems p a r t i c u l a r l y p r a c t i c a b l e . U s i n g a manganese t a r g e t t h e 
Mn^^ (p,4n) Fe^^ r e a c t i o n a t Ep = 70 MeV a y i e l d o f 98 pCi yAh~^ 
i s a c h i e v e d r e s u l t i n g i n t y p i c a l p r o d u c t i o n b a t c h e s o f 60 mCi 
CO tr 9 
( 3 9 ) . W i t h a n i c k e l t a r g e t t h e N i (p,3p4n) Fe r e a c t i o n a t 
Ep = 193 MeV a y i e l d o f 50 y C i u A h ^  r e s u l t s i n a t y p i c a l 
p r o d u c t i o n o f 33 mCi ( 3 9 ) . However r e p o r t s f r o m LAMPF a t Los 
Alamos where i r r a d i a t i o n o f n i c k e l t a r g e t s can be c a r r i e d o u t 
a t Ep = 800 MeV r e c o v e r e d y i e l d s o f o v e r 1 C i o f Fe^^ have been 
r e p o r t e d (40) . 
A c h e m i c a l g e n e r a t o r system was d e s c r i b e d by A t c h e r e t a l i n 
1978 (41) and by Ku e t a l i n 1979 ( 4 2 ) . The g e n e r a t o r column 
c o n s i s t s o f a 0.6 ml bed o f a n o i n exchange r e s i n ( B i o Rad AG1 x 
8, 200 - 400 mesh) c o n t a i n e d i n a 1 ml p l a s t i c t u b e r c u l i n 
52 
s y r i n g e b a r r e l . Fe i s l o a d e d o n t o t h e column i n 8N h y d r o -
c h l o r i c a c i d and s t r o n g l y a b s o r b e d as t h e FeC l ^ - complex. A f t e r 
a f u r t h e r 5 ml wash w i t h 8N HCl t h e g e n e r a t o r i s ready f o r 
e l u t i o n . A p p r o x i m a t e l y 90% o f t h e Mn^^'^ a v a i l a b l e i s e l u t e d i n 
2 ml o f 8N HCl. The e l u a t e i s q u i c k l y e v a p o r a t e d t o d r y n e s s and 
t h e Mn r e s i d u e t a k e n up i n 3 ml o f sodium a c e t a t e b u f f e r 
(pH 5.6) . 
T e r m i n a l s t e r i l i z a t i o n by a 0.45 ym b a c t e r i a l f i l t e r i s 
r e p o r t e d . W i t h an e l u a n t o f 8N HCl pro b l e m s w i t h b a c t e r i a l endo-
t o x i n s s h o u l d be no p r o b l e m . However c a r e s h o u l d be t a k e n t o 
e l i m i n a t e any i o n exchange r e s i n d e c o m p o s i t i o n p r o d u c t s t h a t 
c o u l d g i v e r i s e t o adv e r s e p y r o g e n i c r e a c t i o n s i n t h e proposed 
c l i n i c a l use o f Mn ^ f o r m y o c a r d i a l i m a g i n g . No Fe b r e a k -
based on t h e 
52g 
t h r o u g h as d e t e c t e d a t an upper l i m i t o f 1 x 10 
minimum d e t e c t a b l e Fe^^ a c t i v i t y o f 0.001 y C i . However Mn 
52m (5.67 d) w i l l i n e v i t a b l y r e m a i n i n t h e decayed Mn e l u a t e as 
2.2% o f i t s decays r e s u l t i n Mn^^^ however i f c a r e i s e x e r c i s e d 
i n t h e s e l e c t i o n o f t h e p o s t e l u t i o n r e g r o w t h p e r i o d i t s h o u l d 
/ c n „ 
) s s i t 
52m 
be p o s s i b l e t o m a i n t a i n a f i g u r e o f 3.2 x 10 ^% o f Mn^^^ r e l a t i v e 
t o Mn' (39) 
he 
i 
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Zn^^ (9.2h)/^^Cu (9.7 m) 
A r a d i o n u c l i d e g e n e r a t o r based on t h i s n u c l e a r r e l a t i o n s h i p 
was d e s c r i b e d by Robinson i n 1976 ( 4 3 ) . The p a r e n t Zn^^ i s most 
e f f e c t i v e l y p r o d u c e d by t h e Cu^"^ (p,2n) Zn^^ r e a c t i o n . A t h i n 
c o p p er t a r g e t i s bombarded w i t h 22 MeV p r o t o n s . The Zn^^ i s 
r e c o v e r e d f r o m t h e t a r g e t by a c h l o r i d e complex a n i o n exchange 
p r o c e d u r e . T h e g e n e r a t o r column 1 cm d i a m e t e r 2 cm l o n g f i l l e d 
w i t h Dowex 1 x 8 200 - 400 mesh i s l o a d e d w i t h Zn^^ i n 2N HCl. 
E l u t i o n s a r e c a r r i e d o u t u s i n g 0.1N HCl c o n t a i n i n g 100 mgm/ml 
NaCl and 1 ygm/ml C u ( I I ) c a r r i e r . Over 85% o f t h e a v a i l a b l e 
: e] 
62 
Cu^^ was r e c o v e r e d i n 3 ml o f l u a t e and t h e Zn^^ b r e a k t h r o u g h 
was l e s s t h a n 1 yCi/mCi o f Cu 
Robinson a l s o r e p o r t e d t h e r a p i d p r e p a r a t i o n o f some p o t e n t - ! 
i a l Cu r a d i o p h a r m a c e u t i c a l s ( 4 3 , 4 4 ) . These i n c l u d e d c o l l o i d a l 
CuS^^ and CuO^^ b o t h o f w h i c h were shown i n r a t and dog s t u d i e s 
t o be h i g h l y e x t r a c t e d by t h e l i v e r . CuS was i n c o r p o r a t e d 
i n t o macro a g g r e g a t e d a l b u m i n (MAA) u s i n g t h e h e a t d e n a t u r i n g 
p r o c e d u r e . T i n ( I I ) c o a t e d human serum a l b u m i n m i c r o s p h e r e s 
(HAM) were l a b e l l e d by t h e a d j u s t m e n t o f t h e g e n e r a t o r e l u a t e 
t o pH3, a d d i n g t h e " i n s t a n t " HAM and h e a t i n g t o 121° C f o r 10 
6 2 6 2 
min . Both Cu MAA and Cu HAM were shown t o be over 8 5% ) 
e x t r a c t e d by t h e l u n g i n r a t s a t 5 min. P e r f u s i o n images o f t h e 
dog l u n g were r e p o r t e d t o be o f good q u a l i t y . F i n a l l y a s e r i e s 
o f Cu " c h e l a t e s " were s t u d i e d and a l t h o u g h w h i l e n o t e x h a u s t -
i v e l y assessed showed some i n t e r e s t i n g r a d i o p h a r m a c e u t i c a l ; 
p r o p e r t i e s . 
Se^^ (8.4 d) /As^^ (26-- h) 
The r a d i o n u c l i d e g e n e r a t o r s e p a r a t i o n o f t h i s p a i r was b e i n g 
s t u d i e d a t Brookhaven i n 1958 ( 4 5 ) . S e v e r a l o t h e r g r oups have 
s t u d i e d t h e p r o b l e m s i n v o l v e d . A l l came t o t h e c o n c l u s i o n t h a t 
due t o t h e wide range o f o x i d a t i o n s t a t e s t h a t b o t h t h e p a r e n t • 
and t h e d a u g h t e r can a d o p t i n s o l u t i o n a p r a c t i c a b l e c h r o m a t o -
g r a p h i c g e n e r a t o r was e x t r e m e l y d i f f i c u l t t o p e r f e c t . R e p o r t s 
o f t h i s work have a p p a r e n t l y n o t a p p e a r e d i n t h e l i t e r a t u r e . 
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Te''^^ (6.0 d)/ S b ^ ^ ^ (3.5 m) 
118 and i t s Only p r e l i m i n a r y r e p o r t s o f t h e p r o d u c t i o n o f Te 
118 
p o t e n t i a l as a p a r e n t f o r Sb have appeared ( 3 9 ) . No g e n e r a t o r 
s y stem has y e t been d e s c r i b e d . I t w o u l d be a n t i c i p a t e d t h a t a l l 
72 72 
t h e p r o b l e m s o f t h e Se /As system w i l l have t o be overcome. 
T h i s t o g e t h e r w i t h t h e 3.5 m d a u g h t e r h a l f - l i f e l e a d s one t o 
s u s p e c t t h a t a p r a c t i c a l system i s a l o n g way o f f . 
12 2 12 2 Xe'^^ (20.1 h ) / l ' ^ ^ (3.6 m) 
Over t h e y e a r s r a d i o i o d i n e s have c o n t i n u e d t o f i l l t h e gap 
between s i m p l e i n o r g a n i c r a d i o n u c l i d e s and t h e c l a s s i c l a b e l l e d 
m o l e c u l e where no p o t e n t i a l p e r t u r b i n g atoms a r e i n t r o d u c e d . 
1 23 
For s i n g l e p h o t o n e m i s s i o n tomography I (13.2h) has v e r y good 
p h o t o n e m i s s i o n c h a r a c t e r i s t i c s and f o r p o s i t r o n e m i s s i o n tomo-
1 21 
g r a p h y c y c l o t r o n p r o d u c e d I (2.12h) c o u l d be u s e f u l . Away 
f r o m a c y c l o t r o n a g e n e r a t o r produced p o s i t r o n e m i t t i n g i o d i n e 
1 22 
r a d i o n u c l i d e c o u l d have some a t t r a c t i o n . Xe i s produced as a 
by p r o d u c t o f Xe^^"^ p r o d u c t i o n f o r i ^ ^ - ^ g e n e r a t i o n . A r a d i o -
1 2 1 
n u c l i d e g e n e r a t o r f o r t h e r e c o v e r y o f I has been d e s c r i b e d 
by R i c h a r d s and Ku i n 1979 ( 4 6 ) . U n l i k e most o t h e r r a d i o n u c l i d e 
g e n e r a t o r s w h i c h o p e r a t e i n t h e s o l i d / l i q u i d phases t h i s gene-
12 2 
r a t o r o p e r a t e s i n t h e g a s / s o l i d phase. The Xe 
i s t r a n s f e r r e d 
back and f o r t h between a m e t a l r e s e r v o i r and a g l a s s g r o w t h 
1 22 
chamber c r y o g e n i c a l l y . The Xe i s h e l d i n t h e g r o w t h chamber 
a t -196° C (LN2) f o r a 5 t o 10 min. i n g r o w t h p e r i o d . I t i s t h e n 
t r a n s f e r r e d t o t h e m e t a l r e s e r v o i r by c o o l i n g i t t o -196° C 
w h i l s t warming t h e g l a s s g r o w t h v e s s e l . A f t e r o p e r a t i n g t h e 
a p p r o p r i a t e v a l v e s 1.4% sodium b i c a r b o n a t e i s i n t r o d u c e d t o t h e 
g r o w t h v e s s e l v i a a septum and t h e I s o l u t i o n r e c o v e r e d by 
vacuum t r a n s f e r . E l u t i o n e f f i c i e n c y i s q u o t e d t o be about 40% 
b u t i t i s n o t c l e a r how t h i s f i g u r e i s a r r i v e d a t . Radioxenon 
b r e a k t h r o u g h i s r e p o r t e d t o be l e s s t h a n 0.1%. Rapid i o d i n a t i o n s , 
some u s i n g l a c t o p e r o x i d a s e and c h l o r a m i n e - T , have been r e p o r t e d 
(39,47,48) t o a c h i e v e 85 - 90% y i e l d s i n 1 t o 3 min. F u r t h e r 
e x p l o i t a t i o n o f t h i s r a t h e r u n u s u a l g e n e r a t o r system w i l l 
p r o b a b l y pose many q u a l i t y c o n t r o l headaches' 
80 
Ba^^^ (2.43 d)/Cs^^^ (3.6 m) 
8 2 8 2 
T h i s r a d i o n u c l i d e g e n e r a t o r i s a n a l o g o u s t o t h e Sr /Rb 
128 
system. The p r o d u c t i o n o f Ba has been d e s c r i b e d by Lagunas-
S o l a r e t a l i n 1982 (49,50) by t h e p r o t o n i r r a d i a t i o n o f CsCl 
128 
w i t h 67 MeV p r o t o n s . A l t h o u g h t h e p o s i t r o n e m i s s i o n % o f Cs 
8 2 
i s n o t as good as Rb (see t a b l e 1) and t h e m y o c a r d i a l e x t r a c -
t i o n o f Cs i s a b o u t h a l f t h a t o f Rb. The 3.6 min. h a l f - l i f e may 
o f f e r some a d v a n t a g e s . 
CONCLUDING DISCUSSIONS 
W i t h o u t d oubt t h e m a j or f a c t o r t h a t s t i m u l a t e d a r e v i v a l o f 
i n t e r e s t i n " P o s i t r o n G e n e r a t o r s " was t h e a d v e n t o f P o s i t r o n 
E m i s s i o n T r a n s a x i a l Computed Tomography PETT ( 1 4 , 1 5 ) . 
We now have t h e two h i g h l y d e v e l o p e d g e n e r a t o r systems f o r 
8 2 68 
Rb and Ge w h i c h f u l f i l c o mplementary r o l e s i n t h e c l i n i c a l 
a p p l i c a t i o n o f PETT. The r a d i o p h a r m a c e u t i c a l l a b e l l i n g p o t e n t i a l 
6 8 ' o f Ga has been d e m o n s t r a t e d and more developments s h o u l d be 
a n t i c i p a t e d . I 
One p r o b l e m a r e a w i t h t h e s e g e n e r a t o r s w i t h a l o n g p a r e n t 
h a l f - l i f e w h i c h has r e c e i v e d l i t t l e a t t e n t i o n i s t h a t o f l o n g -
t e r m maintenance o f s t e r i l i t y ( 2 8 , 3 7 , 5 1 ) . The c o l l a b o r a t i o n o f 
t h e r a d i o p h a r m a c i s t w i t h t h e g e n e r a t o r r a d i o c h e m i s t t o h e l p 
r e s o l v e t h i s p r o b l e m w o u l d seem most a p p r o p r i a t e . J 
What o f t h e r e s t o f t h e p o s i t r o n g e n e r a t o r f a m i l y l i s t e d i n I 
t a b l e 1? I t i s f a i r t o say t h a t we do n o t a n t i c i p a t e h e a r i n g f 
much more a b o u t some o f them f o r a v a r i e t y o f r e a s o n s . 
6 2 '62 
However t h e Zn /Cii g e n e r a t o r w o u l d appear t o have more 
p o t e n t i a l f o r e x p l o i t a t i o n . The p a r e n t h a l f - l i f e i s n o t i m p r a c -
81 
t i c a l l y s h o r t a t 9.2 h. I n f a c t i t i s j u s t t w i c e t h a t o f Rb 
w h i c h we and o t h e r s a r e d i s t r i b u t i n g t o d i a g n o s t i c c l i n i c s as 
81 81 in 
t h e Rb /Kr g e n e r a t o r ( 5 2 ) . There would seem t o be scope f o r 
i n v e s t i g a t i o n t h e p o t e n t i a l f o r r a d i o p h a r m a c e u t i c a l l a b e l l i n g 
w i t h Cu^^, a t l e a s t as d e v e l o p m e n t a l r a d i o p h a r m a c e u t i c a l p r o j e c t s , 
a t c e n t r e s remote f r o m t h e p r o d u c i n g c y c l o t r o n . 
j r . , 1 „ 52 •, „ 122 ,, , c , . 52m , ^122 U n f o r t u n a t e l y Fe and Xe t h e p a r e n t s o f Mn and I 
r e s p e c t i v e l y , can o n l y be made i n s u f f i c i e n t q u a n t i t i e s a t t h e 
p r e s e n t t i m e on t h e g i a n t a c c e l e r a t o r s i n t h e USA. The l o g i s t i c s 
a l 
81 
o f t r a n s p o r t a t i o n t o E u r o p e w i t h t h e 8 . 3 h . a n d 2 0 . 1 h . h a l f -
l i v e s w o u l d p r e c l u d e t h e m f o r a l l p r a c t i c a l p u r p o s e s . However 
some t h o u g h t s h o u l d be p u t i n t o t h e p r o d u c t i o n p o t e n t i a l o f t h e 
v e r y l a r g e a c c e l e r a t o r s i n E u r o p e , f o r e x a m p l e S w i s s I n s t i t u t e 
o f N u c l e a r R e s e a r c h ( S I N ) , V i l l i g e n , S w i t z e r l a n d a n d S p a l l a t i o n 
N e u t r o n S o u r c e ( S N S ) , S c i e n c e a n d E n g i n e e r i n g R e s e a r c h C o u n c i l , 
R u t h e r f o r d a n d A p p l e t o n L a b o r a t o r i e s , C h i l t o n , D i d c o t , O x o n , 
b e f o r e we t o t a l l y d i s m i s s t h e s e two g e n e r a t o r s y s t e m s . 
I n c o n c l u s i o n i t i s c l e a r t h a t p o s i t r o n g e n e r a t o r s h a v e b e e n 
d e m o n s t r a t e d t o c o m p l e m e n t t h e i n h o u s e c y c l o t r o n i n R E T T s t u d i e s 
a n d i t i s n o t t o t a l l y u n r e a l i s t i c t o e x p e c t t o s e e some c l i n i c a l 
R E T T d i a g n o s t i c t e s t s b a s e d on g e n e r a t o r p r o d u c e d p o s i t r o n r a d i o -
p h a r m a c e u t i c a l s . 
c t s , 
c s 
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The radionuclide oxygcn-15, half-life 2.05 min. is used in simple chemical forms to study oxygen 
metabolism, blood flow and blood volume in man,'" using the technique of positron emission tomography 
(PET)."' 
The production of '*0 and the preparation of |"010,, ['*0]COj, ('^ OICO and ('>0)H,0 is now well 
established in several PET centres in Europe, North America and Japan. In order to provide a practical 
design and operational data base for others intending to make use of these techniques an EEC task group 
representing four European laboratories routinely using '*0 in PET studies was set up to review the 
current practice of '*0 production purification and quality control of the clinically useful products. 
Radionuclide Production 
Choice of nuclear reaction 
Oxygen-15 may be produced by the "'N(d, n)'^0,'^' 
( Q > 0 ) , "OCp, d ) ' W - " (threshold energy = 
14MeV) and " N ( p , n ) ' W - " (threshold energy = 
3.7 MeV) nuclear reactions. 
The '' 'N(d, n)'^0 reaction is most widely used. The 
" 0 ( p , d)'^0 reaction is used when only high energy 
protons are available (E^ > 20 MeV). At least three 
centres in North America are now using this reaction 
to produce '^O, and HJ'O but due to the high oxygen 
content of the target the production of C'^ O^ by 
combustion of carbon is difficult to control. The 
production of C " 0 by combustion is avoided due to 
the hazardous amounts of carbon monoxide that 
would be produced. 
The '*N(p, n) ' '0 reaction must be used when only 
low energy protons are available (£p < 15 MeV). The 
use of enriched '^Nj to produce "Oj for both bolus 
and steady state metabolic studies has been 
demonstrated'*' using 4mL volume gas target irra-
diated with a very well regulated 8-11 MeV proton 
beam. The running cost, at a flow rate of 4 mL/min, 
of U.S. $ 1.00 per minute may not represent an unrea-
sonable fraction of the total cost of a PET clinical 
study. 
The "'N(d, n)"0 reaction will be of principal con-
cern in this report, as the experience with the other 
• A report from an EEC task group. 
reactions is currently limited to only a few centres, 
none of which are in Europe. 
Selection of charged panicle energy 
The energy of the deuterons incident on the nitro-
gen target gas should be adjusted to about 7 MeV 
either by adjustment of the accelerator output, de-
grader foil thickness of both. This energy should 
minimise the production of the longer lived radio-
nuclidic impurities " N (half-life = 10.0 min) and "C 
(half-life = 20.4 min) by the "N(d , t ) "N (threshold 
energy 4.9 MeV) and '''N(d, an)"C (threshold energy 
5.8 MeV) reactions. 
Target design and gas delivery tubes 
The target vessel used to contain the nitrogen 
during irradiation is usually made of aluminium 
alloy. The cross sectional dimensions of the target 
will depend on the size and shape of the deuteron 
beam and the length dependant on the chosen oper-
ating pressure. 
The pressure is usually determined by the dimen-
sions (diameter and length) of the radioactive gas 
delivery pipe. The choice of these parameters may be 
aided using the computer programme GASLIN. '" 
Typically tubes with internal diameters from 1.5 to 
4 mm and up to a few hundred metres length have 
been found to be practicable. Stainless steel, PTFE 
and polypropylene tubes have been used satis-
factorily. Nylon should be avoided due to its lack of 
chemical and radiation resistance. A titanium beam 
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entry window 0.025-O.050 mm thick and 25-30 mm 
diameter is fitted with a nitrile, viton or metal sealing 
ring to a 30-50 mm diameter cylindrical vessel some 
200-250 mm long, filled with nitrogen gas between 3 
and 1.5 bar (abs) respectively. As with all gas target 
and accelerator beam windows, provision must be 
made for their cooling. This is achieved with air or 
preferably helium jets with flow rates of 
10-20 L min" ' at 1-1.5 bar (abs) with recirculation in 
the case of helium. 
Target gases 
" O j production 
In-larget production of "Oj is achieved by irra-
diating nitrogen containing 0.2-4% (vol) oxygen. The 
lower level is quite critical as the recovered yield of 
'^Oj falls dramatically when lower concentrations are 
used but may be necessary when higher specific 
activities are required as e.g. in some C'^0 labelling 
procedures. Hl^O may also be prepared from '^Oj. 
'^O, production yields of 0.2-0.3 GBq m i n ; i A " ' 
(5-8 mCi m i n " ' / J A " ' ) using a nitrogen/2% oxygen 
target gas can be achieved at flow rales of 
500 mL min- ' . 
C '^O, production 
In-target production of C'^O, is generally preferred 
to the less efficient chemical conversion of '^O, using 
hot activated charcoal. The target gas is nitrogen 
containing 2-2.5% carbon dioxide. CO, production 
yields of 0.2-0.3 GBq m i n " ' A " ' (S-SmCimin"' 
/ J A " ' ) using nitrogen/2.5% carbon dioxide target gas 
can be achieved at flow rates of 500 mL min"' . 
Target gas supply 
Target gas mixtures are generally purchased from 
commercial gas suppliers and are either certified 
mixtures made from medical grade gases of the 
mixtures of N45 (99.995%) gases depending on the 
requirements of the local regulating authorities. 
Whichever type of mixture is used it must be ade-
quately labelled to avoid accidental misuse. 
Target Operating Criteria 
Deuteron beam currents of up to 50 / i A have been 
found to be practicable. The target windows being 
the principal limitation. It is possible to use the same 
target vessel for '^Oj and C'^Oj production provided 
that adequate evacuation or flushing of the target and 
its supply pipes is achieved between irradiations. For 
C o production the risk of accidental inclusion of 
oxygen or carbon dioxide with the inherrant risk of 
producing high levels of carbon monoxide precludes 
the use of a common target in this case. 
Processing and Purification . 
"O2, C"0, and H'/O 
The main chemical and radiochemical impurities 
ozone, nitrogen oxides and C"0; , N^O are removed 
using two absorber columns in series. The first 25 mm 
dia X 120mm long is filled with soda lime and a 
second similarly dimensioned column is filled with 
1.5 mm granules of activated charcoal. 
When C'^0 is produced by the oxidation of a 
250 X 15 mm column of 60 mesh dried activated 
charcoal at IOOO°C with previously purified "O,, the 
presence of "O; carrier inevitably leads to Ihe prod-
uction of potentially hazardous quantities of carbon 
monoxide. For example if a nitrogen target contain-
ing 0.25% oxygen is used, stable carbon monoxide at 
levels of at least 0.5% are produced. Under these 
conditions a yield of C'^0 of 37 MBq m i n " ' / l A " ' 
(1 mCi min"' / J A " ' ) can be achieved and by using a 
20:1 dilution a carbon monoxide concentration of 
0.025% can be administered safely for periods of up 
to 15 min. Carboxyhaemoglobin measurements in ihe 
blood samples taken from subjects exposed in this 
way al SHFJ, Orsay, have been found to exhibit 
acceptable levels of carbon monoxide. 
Alternative methods using no added oxygen have 
been proposed'"*"' but no data is available for the 
stable carbon monoxide produced. At present there is 
no experience with these systems in Europe. The in 
target production of C"0 at high specific activity"" 
should be studied in more detail 
HJ^ O is readily prepared by the palladium caia-
lysed reaction of '^Oj with hydrogen.'^ ' ' ' A flow of 
purified "O2 in nitrogen is mixed with hydrogen and 
passed over a few pellets of palladium/alumina cata-
lyst (Engelhard Deoxo Model D) the resulting water 
vapour is trapped by bubbling the nitrogen carrier 
through sterile isotonic saline. 
The catalyst also generates a small amount of 
ammonia which causes the pH of the saline to rise to 
9. Consequently the use of a physiological bufler may 
be desirable for some applications. Batches of over 
3.7 GBq (100 mCi) can be readily be prepared with 
deuteron beam currents of 20/iA. Two alternative 
methods for the preparation of H!*0 have been 
described on involving the exchange reaction between 
C O j and water""' and the other employing in-target 
reaction of '^ O atoms with hydrogen using a 
nitrogen/5% hydrogen target gas."" However no 
experience of these techniques exist in Europe. 
During the irradiation of nitrogen/2-2.5% carbon 
dioxide the chemical and radiochemical impurities 
carbon monoxide and '^O, are observed. Earlier 
attempts to reduce these have now been shown to be 
unreliable. The use of an oxidising column composed 
of a mixture of copper and iron oxides supported on 
kaolin reduces the ''O2 and carbon monoxide to 
<0.02% and < I O / J L / L respectively.'"' Nitrogen-13 
will inevitable be present in all systems employing 
carbon dioxide in the target gas because of the 
'^C(d, n)"N reaction (threshold energy 0.4 MeV). 
For applications where >0.5% " N j cannot be toler-
Methodology for ''O production 599 
ated the less efficient low temperature combustion of 
activated charcoal with '^ O^ must be employed. The 
use of the copper/iron oxide column after the carbon 
furnace being recommended. 
Quality Control 
Radiogas chromatography 
A radiogas chromatograph is employed to analyse 
for the chemical and radiochemical atmospheric gas 
impurities:'^'*' typically a dual column chro-
matograph equipped with a thermal conductivity 
detector for the stable gas analysis and a small 
sensitive volume flow-cell beta particle detector, a 
well shielded gamma ray scintillation or 
Geiger-Mueller counter for the radioactive gas anal-
ysis. The two colurhns most commonly used are 
(a) 1500 X 4 mm Porapak-Q 80-100 mesh (precon-
ditioned at 250°C); 
(b) 3000 X 4 mm Molecular Sieve 5A 80-100 mesh 
(preconditioned at 350°C). 
These columns when operated at between 25 and 
80°C with helium carrier gas flow rate of approx 
lOmLmin" ' provide adequate separation of the 
gases '*Oj, " N j , C'^Oj, NJ^O and '^ N^O when used 
in combination. Recently the use of a concentric dual 
column, containing the above packings (CTRI 
Alltech Assoc.) has been proposed and some 
simplification of the analytical procedures may be 
possible.'"" 
Decay curve analysis 
Radionuclidic purity can be controlled by decay 
curve analysis of a gas sample. A gas sample can be 
measured repeatedly, e.g. with a coincidence set-up, 
consisting of two Nal(Tl) detectors in a 180° geom-
etry and the decay curve obtained can be analysed 
according to Gumming.'"' Using 7.5 MeV deuterons 
and " N activity is 0.5% and the "C is 0.004% of the 
activity. 
Chemical analysis 
The chemical analysis of the noxious gases, ozone, 
nitrogen dioxide, and carbon monoxide down to the 
levels necessary for safety prior to the administration 
of a radioactive gas to man cannot be carried out 
satisfactorily by gas chromatography. 
Instrumental methods, employing chemi-
luminescence, of high sensitivity are available for the 
estimation of ozone down to /<L/L levels. Un-
fortunately the detectors are also radiation sensitive 
especially to the high energy positrons emitted by the 
radionuclides under review. Post radioactive decay 
measurement of ozone is not recommended due to 
the difficulty in storing ozone samples reliably. The 
classical iodometic analysis for zone is recommen-
ded.'"' The only likely interference in the systems 
under present discussions being due to nitrogen diox-
ide. 
Ozone will be potentially present in all irradiated 
mixtures containing oxygen. Particularly large 
amounts will be present in the irradiations of 100% 
oxygen as used with the "'0(p, d)'*0 reaction.""' In-
strumental methods of analysis for nitrogen dioxide 
are available but are not appropriate for the same 
reasons as above for ozone. A colorimetric estimation 
is available with adequate sensitivity for the present 
purposes based on an azo dye forming reagent."" 
Ozone interferes to a small extent. Nitrogen dioxide 
will always be present in irradiated nitrogen/oxygen 
mixtures used for '^0, production. Therefore the 
proof of absence of this noxious gas following the 
purification processes is essential. 
The sensitivity of the thermal conductivity doctors 
in the gas chromatograph can be considered mar-
ginally adequate for routine carbon monoxide anal-
ysis. More sensitive methods such as non dispersive 
i.r. photometry using a large folded path gas cell""' or 
the use of an electrochemical detector specific for CO 
e.g. "Ecolyser" (Energetic Science Inc., New York), 
should be considered especially for checking the 
status of the copper/iron oxide column. 
Radiochemical purity of '*0j and C'^O, 
products 
C"0, 
100 <0.03"-0.2'' 
"N, 0.5 0.5 
c"o <0.3 <0.09 
c"o, <0.3 100 
0.5 <0.6 
"N,0 <0.3 — 
'For an oxidising column used for several 
hours. 
*'For a freshly oxidised oxidising column. 
Levels of chemical impurities found in '^ O^ and C'^O; 
purified products / i L / L and threshold limit values (TLV) 
in / i L / L 
C"0 T L V 
0.01 0.01 — 0.1 
NO, 0.01 0.02 — 5 
CO <1 2-9 5000 50 
Recommended Good Manufacturing 
Procedures in Oxygen-15 Production 
for Clinical Use 
(1) Incoming gas supplies should be checked for 
correct contents and labelling especially if uncertified 
mixtures are used. The cylinders should be stored in 
an area where they cannot be tampered with. 
(2) The energy of the accelerator beam if variable 
should be checked with the normal operating param-
eters of the cyclotron. 
(3) Where the target window is used to significantly 
degrade the deuteron energy, regular checks on its 
condition, and a preventative maintenance schedule 
designed, based on these checks instituted. 
(4) The reagents used in the purification systems 
should be checked and changed (or reoxidised for the 
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copper/iron oxide column) according to a regular 
schedule. The frequency of these checks will depend 
on the number of hours the systems are in use. 
However, a good starting point would be to carry 
out weekly inspections of furnace tubes and changing 
of the room temperature reagents. Whilst checking 
the furnaces an inspection of the thermal regulation 
system should be carried out. 
(5) The heart of the routine quality control pro-
cedure is the radiogaschromatograph. This should be 
maintained in accordance with the manufacturers 
recommendations and the performance of the col-
umns checked using a calibration gas mixture of all 
the expected inactive gases. 
(6) Where C " 0 must be used the usual quality 
control checks should be followed by strictly regu-
lated dispensing procedure to enable the chemical 
dose of carbon monoxide to be prescribed. 
(7) Where Hi^O samples arc prepared for injection 
the system used should be shown to be capable of 
providing samples which are sterile and pyrogen free. 
One of the best ways of achieving this is to use 
disposable sterile components for those parts of the 
system that come into contact with the infusate and 
sterilise the incoming gases by filtration. As only 
restrospective testing of these samples is possible, 
random batches should be taken for biological 
testing. 
(8) It is recommended that an operating manual 
should be provided for the production systems. This 
should be accompanied by an operations log book so 
that records of patient administration can be kept 
together with QC data and any information on the 
system's malfunctions and the operator's rectifying 
actions. 
(9) Finally it should be stressed that as with all 
short half-life preparations ultimately destined for 
human use, the staff responsible for the preparations 
should be adequately trained in the procedures both 
technically, and emotionally, thus being able to de-
liver high quality samples often under the pressures 
of both rapid radioactive decay and urgent clinical 
need! 
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ABSTRACT 
Positron emission tomography (PET) requires the use of compounds labelled with short-lived, pos-
itron-emitting isotopes (['.,!,'.. /, , of " C ~ 120 min). As the coiiccniraiion of unbound, non-mciabolised 
drug is required as the iiipui ftiiiciion for modeling, this prcsenis pai ticular problems for ihe study of ihe 
kinetics and metabolism of such compounds. We have now developed a rapid exiraclioii procedure, 
followed by high-performance liquid chromatography using a short analytical column coupled to an 
on-line y-detector to determine the metabolism and kinetics of a non-sclcciive /i-adrenergic antagonisi of 
high afFinity, S-4-('/(?(7.-butylamiiio-2-hydroxypropoxy)benziniidazol-2-one. This antagonist is poicmially 
well suited to the non-invasive localisation of/J-receptors in vivo. The ligand was rapidly taken up inlo the 
/J-receptor pool or excreted in urine, with less than 5% of the drug converted to metabolites. Plasma 
protein binding was only 16%. No significant metabolism of the ligand was observed in the anaesthetised 
dog, and, therefore, no correction for blood metabolite concentration is required for kinetic analysis of the 
"C-labclled ligand during PET studies in this species. The analytical meiliod reported here should be 
widely applicable: quantification of metabolites enables accurate estimation of the input function and is 
critical to the interpretation of PET data. 
0378-4347/91/503.50 © 1991 Elsevier Science Publishers B.V. Ai l rights reserved 
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I N T R O D U C T I O N 
Positron emission tomography (PET) is a powerful inclliocl for determining 
the distribution and kinetics of radiolabelled hgands //; vivo [1,2]. Positron-emit-
ting isotopes (such as '^C and '^F) are chemically incorporated into a suitable 
Hgand. Following administration, the ligand will distribute between tissue com-
partments including the plasma and tissue receptor pool. The regional concentra-
tions o f radioligand are determined f rom the PET signal, which arises f rom radio-
active decay o f the positron-emitting isotope. The PET signal in plasma or tissue 
wil l represent both the parent radioligand and any labelled metabolites formed in 
vivo, either free or bound. However, it is the concentration o f unbound ligand in 
plasma which is required as the input function for modeling receptor ligand 
kinetics [3,4]. Thus, any metabolites (or impurities f rom the original synthesis) 
must be measured and a suitable correction made to the input function. 
5-4-(/t'r/.-Butylamino-2-hydroxypropo.xy)benzimidazol-2-one (5-1) (Fig. I) is 
a non-selective ^-adrenergic antagonist of high affinity [5]. Because of its low 
lipophilicity, it exhibits low non-specific binding and does not accumulate in cells. 
The racemic fo rm of the ligand {RS-\) has been proposed as a specific antagonist 
of surface /i(-receptors [6]. It has been used in competition studies to determine ihe 
binding constants of unlabelled /j-adrenergic antagonists [5]. l l has been labelled 
with the positron-emitting isotope " C [7] in order to visualise /i-receptor distri-
bution and density in the lung and heart. 
In order to determine the input function in PET studies, a knowledge of the 
clearance and metabolism of ^'C-labelled drugs is critical [8.9]. We have devel-
oped extraction and analytical techniques, based on high-performance liquid 
chromatography (HPLC) , to investigate the possible metabolism of this ligand in 
the rat and dog in vivo. Ini t ia l assessment of the metabolism of the ligand was 
carried out using both [-^Hj-S-I and ['^C]-/?^-! to enable detailed analysis o f any 
metabolites and to establish the rapid techniques required when using "C- la -
belled ligands ( /1 /2 of ~ 20 min). Subsequently, studies were performed with 
[^  ' Q - ^ - I using a short analytical H P L C column coupled to an on-line v-detector. 
o = c 
H OH 
Fig. i . Structure of 5-1. The positions o f l l i e radiolabcls arc marked: (*) ' H ; (**) " C or '"'C. 
ANALYSIS 01- ' ' C - L A I i E L L l i D D R U G METAI50I JTE -V)3 
E X P E R I M E N T A L 
Radioligands 
Isotopically labelled ligand ["C]-4-(/(?/-/.-butylamino-2-hydroxypropoxy)-
benzimidazol-2-one was synihesised in the M R C Cyclotron Unit at Hammer-
smith Hospital by reacting 1-(3-Ze/7.-butylamino-2-S-hydroxypropoxy)-2,3-dia-
minobenzene with [' 'C]phosgene as previously described [7]. The radioligand was 
purified by HPLC. The specific activity was < 10 TBq/mmol and the radiopurity 
greater than 99.98% on all occasions. The •'H-labelled ligand ([•^H]-5-l) was ob-
tained f rom Amersham International (Amersham, U K ) (specific activity 1.11-
2.22 TBq/mmol , radiochemical purity 99.1%). A racemic form of the ligand 
labelled with '*C ([ '^C]- /?5-I , 3.6 M B q / m m o l , purity 96%) was a kind gift f rom 
Ciba-Geigy (Basle, Switzerland). 
Animal sludies 
Five greyhound dogs were studied. Two females (weight 27.6 and 29.4 kg) and 
two males (weight 28.5 and 32.6 kg) were infused with [ " C j - S - l . One female 
(weight 25.5 kg) was infused with [^H]-5-I . Anaesthesia was induced wi ih thio-
pental sodium (5 mg/kg) and maintained with nitrous oxide-oxygen with 0.75'/o 
halothane (tidal volume 20 ml/kg, fifteen breaths per min). For injection o f radio-
ligand, a catheter (8F) was placed in the inferior vena cava via the femoral vein. 
Catheters were placed in the aorta (8F) via a femoral artery and in the pulmonary 
artery (6F) via an internal jugular vein for blood sampling and pressure monitor-
ing. One animal received 37 M B q [•'Hl-S'-I (223 ng/kg) in 10 ml over 20 s and the 
others 240-750 M B q o f [ ' ^Q-S- l (173-215 ng/kg). Blood samples (5 ml) were 
withdrawn simultaneously f r o m the aorta and pulmonary artery at 1-min in-
tervals up to 30 min, at 5-min intervals up to 50 min and 10-min intervals to 125 
ni in . The chest was opened 10 min before injection to obtain sequential lung 
tissue biopsies and the bladder was catherised for collection of urine (-^H study 
only). Seven male Sprague-Dawley rats (220-280 g) were anesthetised with ox-
ygen-nitrous oxide-isofluorane (BOC, London, U K ) and a catheter (0.96 mm) 
was inserted into a tail vein. The rats were allowed to recover consciousness in a 
restraining cage. The radioligand (^H, n = 3, 0.25-2500 /'g/kg; " C . // = 4. 
1.1-2.8 Mg/kg) 5-1 or ('"^C, n = 1) RS-\ (5 mg/kg) was injected into the tail vein. 
A t intervals (5, 10, 15 and 30 min) fol lowing injection animals were reanaesihe-
tised and the maximum possible amount o f blood (5-8 ml) was withdrawn by 
cardiac punture at this time. Urine samples were collected through a needle in-
serted into the bladder. 
E.xlraction of^H- and ^'^C-labelled compounds 
A l l solvents were o f H P L C grade and obtained f rom Rathburn (Walkerburn. 
U K ) . Other chemicals were o f AnalaR grade ( B D H , Poole, U K ) . A l l blood sam-
ples containing [• 'H]-5-I or [^*C]-7?5-I were cooled in ice immediately on collec-
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l ion and cenlrifuged (3 min, 3000 g^ , 4°C) lo obtain ihe plasma, which was Ihen 
frozen al -" 80°C for subsequent analysis. Following thawing. 20% trichloroacet-
ic acid was added to each sample in a ratio of 1:2 to precipilaie the protein, and 
the supernatant, after centrifuging, was passed through a solid-phase C i s ad-
sorption cartridge (Sep-Pak, Waters Assoc., Chester, U K ) and sequentially 
washed with 5 ml each of water, water-methanol (1:1, v/v) and methanol. Each 
wash was collected separately and the solvent was removed unde r^ vacuum. Lung 
samples (between 0.5 and 1.1 g) were homogenised in 2 ml o f 0.2 M hydrochloric 
acid, centrifuged (10 min, 1000 g) and the supernatant removed and treated as 
above. Urine (10 ml) was extracted directly onto a C i g Sep-Pak cartridge as for 
plasma. 
High-perfoiinance liquid chromatography 
Samples were reconstituted in the mobile phase (1 ml) and HPLC was carried 
out on a Waters gradient elution system, eluting at I ml/niin on a /tBondapak C i 8 
column (30 cm x 0.8 cm, 10/<m particle size. Waters Assoc.) with aqueous acetic 
acid (5%, v/v) isocratically at ambient temperature for 5 min followed by a 
20-n3in linear gradient to 40% propan-2-ol in aqueous acetic acid. The radio-
active H P L C fractions ( f rom blood samples collected at 5. 10. 60 and 120 min) 
were further purified. HPLC solvent was removed under vacuum and then the 
samples were reconstituted in 500 /d of aqueous trifluoroacetic acid (0.04%). 
These samples were then chromatographed on a Nova-Pak ODS column (15 cm 
X 0.4 cm, 4 / im particle size. Waters Assoc.) eluting at ambient temperature at 1 
ml/min wi th water-trifluoroacetic acid (100:0.04, v/v) isocratically for 5 min fol-
lowed by a 20-min linear gradient to acetonitrile-water-trifluoroacetic acid 
(15:85:0.04, v/v). The HPLC eluent was monitored at 254 nm and by scintillation 
counting in lO-ml Instagei (Packard Instrument, Meriden, CT, USA) per 100 
Extraction and HPLC yields were determined by adding [-^HJ-S-I to blood and 
lung tissue and extracting as above. 
Rapid analysis of '' C-labelled compounds 
Untreated plasma (2-3 ml) was passed through a Sep-Pak solid-phase C i 8 
cartridge, washing with 5 ml water and eluting with 5 ml o f methanol. The metha-
nol fraction was reduced to 0.3 ml by rotary evaporation and made up to 1.5 ml 
wi th water containing unlabelled S-\ as a carrier. The sample was then cen-
trifuged (1000 g, 2 min) before injection of 1.4 ml onto a Brownlee cartridge 
containing M C H I O packing (Varian Assoc.). Radioligand was eluted al 2 ml/min 
wi th a 5-min linear gradient f r o m 20 to 50%) methanol in 5 mM aqueous sodium 
octanesulphonate (pH 6). The eluent was passed through a 1.2-ml PTFE coil 
inserted into the well of a N a l (Tl) well-type y-ray detector ( N E Technology, 
Edinburgh, U K ) linked to a rate meter. 
A N A L Y S I S o r ' 'C - L A H L L L E D D R U G Ml .n ABOLITE 36.S 
Ovei -pressurcd ihin-layer chromatography (OPTLC) 
Samples o f ral urine and plasma which had been partially purified through a 
Sep-Pak were also analysed by O P T L C (Clirompress, Newman-Howell Assoc., 
Winchester, U K ) by Dr. David Saynor at Glaxo (Ware, U K ) using the method of 
the Orsay PET group [10]. Samples were dissolved in 100 p\ of OPTLC bufler and 
duplicate 20-jul aliquots were chromatographed on a plastic backed silica TEC 
plate (Merck, Darmstadt, Germany), developing in acelonitrile-ethylamine-wa-
ter (100:4:396) buflfered to pH 4 with 125 mM sodium acetate-acetic acid. Radio-
activity on the TEC plate was quantified on a multi-wire proportional counter 
(Autograph, Oxford Positron Systems, Oxford , U K ) . 
Plasma protein binding 
Plasma protein binding was measured by introducing paired aliquots (1 ml) of 
dog plasma containing 0.125-32 /.tg/l [^H]-S-I into one side of the cells of a 
multiple equilibrium dialysis system (Dianorm, Berne, Switzerland). Samples 
were dialysed against phosphate-buffered saline through 0.025-mm Visking tub-
ing for 24 h. Each side o f a cell was sampled and the ^H activity measured by 
liquid scintillation counting. 
RESULTS 
A simple extraction protocol was developed for 5-1 (using the ''H-labelled 
ligand) based on Cis solid-phase extraction and reversed-phase H P L C on a semi-
preparative /.zBondapak column. The ligand eluted f rom the Sep-Pak cartridge in 
methanol-water (1:1, v/v) and eluted on HPLC as a single peak with a retention 
time o f 29 min (^Bondapak column) or 25 min (Nova-Pak column). The extrac-
tion yields for this ligand throughout the procedure were over 70% for both 
plasma and lung homogenates and over 80% for urine. Protein binding in plasma 
was approximately 16% at all concentrations o f 5-1 studied. There was no evi-
dence for ex vivo metabolism, when 5-1 was incubated with plasma or lung ho-
mogenate: a single peak o f radioactivity post H P L C was always obtained using 
both the pfBondapak and Nova-Pak H P L C system. 
When [•'H]-5-I was infused into an anaesthetised dog, the plasma radioactivity 
fell rapidly (Fig. 2). A t all time points up to 2 h, > 9 5 % of the radioactivity 
recovered in the plasma was found in the methanol-water (1:1, v/v) Sep-Pak wash 
and chromatographed on H P L C as a single peak with a retention time of 29 min 
on the ;uBondapak column (Fig. 3). When this purified substance was chroma-
tographed further on a Nova-Pak column, a single peak of radioactivity was 
observed, eluting at 25 min. These data show that plasma radioactivity consisted 
almost entirely of unmetabolised 5-1. From 60 min, there was evidence for the 
presence of a more polar species than 5-1; a radioactive peak appeared in the 
Sep-Pak water wash and eluted on H P L C (^Bondapak) at 19 min. This repre-
sented < 2 . 5 % of the unmetabolised 5-1 present in plasma at this time (c/. Fig. 2) 
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Fig. 2. Radioactivity-time curve for plasma, following infusion of l"*H]-S-l inlo a single dog. 
and could arise either f r o m a metabolite or f rom trace impurity in the injected 
drug. The plasma radioactivity declined bi-exponentially. The initial phase repre-
sents distribution o f the ligand mainly onto /^-receptors (particularly in the lung). 
The terminal elimination phase was very prolonged. This was due largely to 
urinary excretion, as > 7 0 % of the dose was recovered unchanged in the urine. 
Al though only 6% o f the dose was recovered in the urine over 2 h, this was due 
presumably to the very slow elimination caused by the long oflf-time f rom the 
^-receptors, as the renal clearance o f S-l in the greyhound (calculated f rom the 
ratio o f amount o f unchanged S-l excreted in the urine to the area under the 
I 
S 
300 
250 
200 
150 
100 
(a) 
Time (min) 
15000 
(b) 
10000 
5000 
25000 
20000 
15000 
10000 
5000 
(c) 
25 
Time (min) 
50 25 
Time (min) 
50 
Fig 3 HPLC radioprofile (^Bondapak column) for dog plasma (a) and homogenised lung tissue (b) taken 
at 60 min following infusion of [ 'H] -5 - I . The radioprofile of 60-90 min urine from the same dog is also 
shown (c) The time for the dead volume to be voided was 11 min. In each case, the radioactivity was 
contained in only one fraction corresponding to authentic 5-4-(/err.-butylamino-2-hydroxypropoxy)benz-
imidazol-2-one. 
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plasma concentration-lime curve of radiolabel over the same interval) w a s s i m i -
lar to creatinine clearance. When uptake to the receptors was blocked, the elim-
ination rate constant of 5-1 increased considerably (data not shown), showing 
that at the tracer dose used in this study, elimination was distribution limited. 
Serial lung biopsies contained only unchanged 5-1. Similarly, > 9 5 % of the 
urinary radioactivity chromatographed as unchanged S-l on HPLC. There was 
some evidence for small amounts of more polar radiolabelled compounds in the 
urine, but these accounted for < 1 % of unmetabolised ^ - I al any lime. The 
overall recovery o f radiolabel in each case was >70%o, which was similar lo 
recoveries obtained in control studies, making it unlikely that any metabolites 
had been .selectively lost on extraction. 
Similar data were obtained f r o m four rats infused with [-^Hl-S-l. Unchanged 
ligand accounted for > 9 5 % of the radioactivity recovered in plasma and lung 
homogenates at all times. Because of the small plasma volumes (and the conse-
quent low counts) available, it is possible that small amounts of metabolites 
( < 2 % ) would not have been observed. To determine whether the position of 
radiolabelling or the use of a racemic mixture could affect the results, a single rat 
was infused with ['""^Cj-Z^S-I and a sample of blood and urine obtained after 5 
min. There was no difierence in the recovery of radiolabel during the extraction, 
and, again, there was no evidence for metabolism at this time. 
Samples o f plasma (taken at 5 inin) and urine (post Sep-Pak) from the rat 
study were also analysed by normal phase using the technique of OPTLC. A 
single radioactive spot was present for each sample eluting in the same position as 
authentic S-l {Rf = 0.7). There was no evidence for the presence of metabolites. 
The extraction protocol used for [^Hj-S-I and [^'^C]-/?S-1 was modified for use 
with the short-lived "C-labelled ligand. Plasma was extracted directly with a Cis 
Sep-Pak, and a short reversed-phase Brownlee H P L C cartridge (packed with 
M C H I O ) was used for analysis. S-l eluted with a retention time of 7 min. The 
elution system was buffered to p H 6 to overcome any possibility of acid-catalysed 
degradation. Unlabeled ^ - I was included as a carrier, and also to act as a UV-
absorbing marker. A n on-line y'-detector was set up to monitor " C radioactivity. 
The extract ion-HPLC is rapid, taking only 25 min ( ~ one half-life) f rom collec-
tion o f blood to H P L C quantification o f the ligand. The system was evaluated 
wi th plasma samples obtained f rom the dog studied with [•'HJ-S-I; a single peak 
was observed on H P L C (7 min), wi th a recovery of >80%o. 
Samples f r o m four dogs infused with [ '^C]-5- I were analysed with this tech-
nique. In each case, only unchanged 5-1 was detected in plasma (Fig, 4). Recov-
eries in excess o f 90% were obtained, indicating that any putative metabolites had 
not been lost on extraction. In two experiments in the rat, using either " C -
labelled RS-l or 5-1 and analysing plasma by the rapid technique, no metabolites 
were observed at 5 min; however, small amounts ( < 5%) of a polar material were 
observed at 15 min post infusion. 
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Fig. 4. HPLC radioprofile for dog plasma taken at 10 mm (a) and 60 min (b) following infusion of 
["C]-S-L A short HPLC column was used and " C radioactivity was inoniioied on-line with a Nal (Tl) 
well-type 7-ray detector linked to a rate meter. The void volume was 3 ml. A single radioactive peak was 
detected eluting al the same position as the authentic material. The sensitivity of ihe detector was decreased 
by 30-fold immediately before the elution position of S-\ for the 10-min sample. 
DISCUSSION 
The interpretation o f data obtained in vivo f r om the PET scanner is based on 
mathematical models which allow the determination of receptor density and k i -
netics [3,11]. This modelling depends critically on the accurate estimation of the 
input function, which, in the case of the lung, is the free 5-1 present in the mixed 
venous blood, and for the heart, that present in the arterial blood. Although 
protein binding wil l reduce the proportion o f free ligand as a fraction of the total 
radioactivity in the plasma, in the case o f 5-1 such binding is minimal. Radio-
activity which is present in plasma, either as an impurity co-injected with ligand 
or as metabolites produced in vivo, w i l l , however, lead to inaccuracies in the 
measured input function. This is particularly important wi th a ligand such as 5-1 
which is thought to be taken up into the j^-receptor pool within minutes of admin-
istration. Metabolites (or impurities) which are not as avidly sequestered may 
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consequently be cleared iVom the circulation more slowly than the parent ligand. 
The input function for 5-1 would therefore need to be corrected for a progres-
sively decreasmg proportion of the parent ligand to other radiolabeled species in 
plasma. 
It is well known that receptor binding, metabolism and clearance of 
enantiomers can difler [12,13], Thus, infusion of a racemic mixture may lead to 
different plasma concentrations of each enantiomer. This is a particularly impor-
tant consideration for PET studies, because of the dependence on mathematical 
modelling which requires an accurate input function for the ligand. In this study, 
we have used the biologically active S-\, which has an 80-fold greater aflinity for 
/^-receptors than its /?-enantiomer [6]. 
No metabolism of 5-1 was observed in the dog during the 2 h of these studies. 
The high extraction yields excluded the possibility that metabolites had been lost 
on extraction. No diflerences were observed when three different isotopically 
labelled forms of the ligand (-^H, " C and '*C) were used, showing that the 
position of the radiolabel does not affect the metabolism of the ligand i^e.g. 
through an isotope effect on the C-'^H bonds). To determine whether our re-
versed-phase HPLC systems (three used overall) could have failed to resolve 
metabolites from the parent ligand. an additional study using normal-phase chro-
matography was carried out on samples of rat plasma and urine using OPTLC: 
only unchanged 5-1 was observed. In our preliminary extraction procedures, 
there was a possibility that the acid extractions (using trichloroacetic acid) and 
HPLC conditions could have resulted in the hydrolysis of a labile metabolite, 
such as an N-glucuronide, back to the parent compound. Our final rapid extrac-
tion procedure (used for the "C-labelled ligand) was carried out without acid 
precipitation and using neutral solution. Using this method no metabolites were 
observed in the dog. 
In contrast to our data on 5-1, Delforge ei al. [14] using OPTLC to analyse for 
metabolites, found that infusion of racemic [' 'C]-/?5-l into the dog rapidly led to 
a high metabolite-to-parent drug ratio in blood; at 5 min, less than 12% of the 
total radioactivity in blood was unchanged RS-l. In a single experiment in the rat. 
also using ['*C]-/?5-I and with analysis by OPTLC, we still did not observe any 
significant metabolism at 5 min. However, using our rapid HPLC procedure 
(under neutral extraction conditions), small amounts (<5%) of ' 'C-labelled 5-1 
polar substances were detected in rat plasma after I 5 min. The presence of radio-
labelled impurities in the ^'C preparation would, if the plasma elimination rate 
constant of the impurity were greater than that of /?5-l, give results consistent 
with the formation of metabolites. Quality control of the ["C]-5-l used in our 
study showed that the ligand was essentially pure. 
In summary, we have developed a rapid extraction and purification protocol 
suitable for the analysis of [' ^C]-5-L This ligand is not metabolised to any signif-
icant extent //; vivo in the dog. Such information is essential in the use of ["C]-5-l 
to investigate the behaviour of the different fi-adrenergic receptor subtypes and 
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the kinetics of unlabelled /i-receptor antagonists in this species //; vivo. The analyt-
ical procedures described here should be generally applicable for a number of 
drugs (and their possible metabolites) labelled with short-lived radioisotopes. 
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S U . M . M . A R Y 
L Positron emission tomogtaphic imaging of brain blood How w as usctl [<> idri i l i fy 
areas of motor activation associated with volitional inspiration in si.\ I K H I I U I I maii' 
subjects. 
2. Scans were performed using intravenous infusion of t l . , ' ' ( ) during x u l i m l a r x 
targeted breathing and positive pressure passive ventilation at the same I c v c T 
3. Regional increases in brain blood How, due to active inspiration, wciv dci ixcd 
using a pixel by pixel comparison of images obtained during the volimtaiy and 
passive ventilation phases. 
4. Pooling data from all subjects revealed statistically significant incii'a.ses in 
blood flow bilaterally in the primary motor cortex (left, 5-4%: right. 4 8 "'..)• in ' I" ." ' 
right pre-motor cortex (7-6%), in the supplementary motor area (8MA; 3 l "At) and 
in the cerebellum (4-9%). 
5. The site of increased neural activation in the inotor cort.ex. associated with 
volitional inspiration, is consistent with an area which when stimulated, either 
directly during neurosurgery or transcranially with a magnetic stimulus, results in 
activation of the diaphragm. 
6. The presence of additional sites of neural activation in the pre-motor cortex and 
SMA appears analogous to the results of studies on voluntary limb movement. The 
site of the increase in the SMA was posterior to that previously reported for arm 
movements. These areas are believed to have a role 'upstream' of the motor cortex 
in the planning and organization of movement. 
7. This technique provides a means of studying the volitional motor contiol of 
respiratory related tasks in man. 
I N T R O D U C T I O N 
The automatic generation of a respiratory rhythm within pontoinedullary 
structures and its projection to spinal motoneurones via the bulbospinal tract has 
t To whom correspondence should be addres.sed. 
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been extensively investigated and reviewed (von iMiler, I98(); Feldman, 1986). I t is 
also recognized that the same spinal motoneurones can bo activated from higher 
centres in the central nervous system (AminofF &. Sears, 1971; Hugclin, 1986) 
allowing modulation of breathing for beha\ iouial purposes. In man, such non-
automatic control of breathing is crucial for the performance of respiratory motor 
acts such as breath-holding as well as the production of speech. Even during quiet 
breathing, thei'e is evidence that the level of arousal forms an important component 
of the overall respiratory drive (Fink, Katz, Pvheinhold & Schoolman, 1962; Shea, 
Walter, Pelley, Murphy & Guz, 1987) and it has been suggested that some 
ventilatory i-esponses, hitherto thought to be reflex in nature, may depend in part on 
a neural drive originating from above the brain stem (Eldridge, Milhorn & VValdrop, 
1981; Murphy, Mier, Adams & Guz, 1990). 
Studies in anaesthetized animals allow efferent projections from midbrain or 
forebrain areas to respiratory spinal motoneurones to be identified (CoUe & Massion, 
1958; Bassal & Bianchi, 1982; Lipski, Bcktas & Porter, 1986) but tell us little about 
their role in the conscious state. Studies in conscious animals to addi'ess this question 
have only recently been attempted (Orem & Xettick, 1986) and are difficult to design 
and interpret. Consequently, much of what is known about the neurophysiological 
basis foi' respiratory control related to consciousness eomes from obsei'vations in 
patients with defined neurological abnormalities (Plum & Leigh, 1981). 
Despite the fact that humans clearly possess highly developed motor skills for 
volitional control of respirator}' muscles, relatively little is known about the 
presumed areas in the cerebral cortex associated with this function. Foerster (1936) 
found an area in the primary motor cortex which, when stimulated electrically in 
conscious man during neurosui'gery, resulted in contraction of the diaphragm 
(hiccough). More I'ecently, Gandevia & Rothwell (1987) identified a short-latency 
electromyogram (EMG) response in the diaphragm following fci-anscranial electrical 
stimulation at the vertex. Maskill, Murphy, Mier, Owen & Guz (1991), who used focal 
transcranial magnetic stimulation, reported the best site for activating the 
contralateral diaphragm to lie approximately 3 cm lateral to the vertex. Such studies 
support the existence of an .oligosynaptic (probably corticospinal) excitatory 
projection between the cortex and the main inspiratory muscle in humans, but as in 
animal studies the}' permit only a limited interpretation in terms of the voluntai-y 
control of breathing. 
Positron emission tomography (PET) allows the non-invasive measurement of 
regional cerebral blood flow (rCBF) and has been used to define areas of increased 
neural activity associated with specific motor or cognitive tasks in conscious man 
(Raichle, 1987). The aim of the present study was to use PET to identify those areas 
of the brain showing an increased blood flow (and hence neural activity) associated 
with volitional inspiration in normal subjects. The objective was to perform scans 
during 'active' inspiration and matched 'passive' inspiration with intermittent 
positive pressure ventilation (IPPV) against relaxed respiratory muscles. The reason 
for this,approach was to control for, as far as possible, afferent feedback from the 
lungs and chest wall occurring during inspiration, thus only identifying sites 
dominated by 'centrally generated' neural activity. 
This study has been presented in a preliminary form (Colebatch, Adams, Murphy, 
Martin, Lammertsma, Tochon-Danguy, Clark, Friston & Guz, 1991a). 
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Si.x l ight-handed male siil)|c< t.s aged 24-00 years with no kiiou n lespii aldi y or neurological 
abnormalities were studied. Local ethical committee a]j]3ioval was obtained and (.'ach subject gave 
infoi ined consent. Thiee of the siil)jects were co-authors ( L . A., Iv. M. and X.G.) and the remainder 
w-ei-e respiratofv ]jhysiologist colleagues not involved with this study. 
Trcdning 
All the subjects weie trained to perform the required tasks |)i'iar to scanning. 'IVpicaily tiiis 
required fouf to si.x sessions but no subject was unable to ac;hieve satisfactory peiTormance. For the 
'act ive' respiratory task the subjects practised adopting a target respiratory volume and 
frequency, initially with auditory cues, and then maintaining this pattern without any external 
cues. F o r the 'passive' task, the subjects were taught to remain rela.xed during t P P V . The 
adequacy of relaxation u'as judged from recordings of upper airway pressure (Datta. Shea. Horner 
& Guz, 1991) and initially this was displayed to the subjects on an oscillosco|)e. 
Exjterimenlnl protocol 
VenliluLion. T h e experimental arrangement is shown schematically in l<"ig. I . The subjects 
inspired through a tightly-litting nasal mask to a v^olume of l o-2 1 with a frequency of 
10-12 min~'; e.xpiration was passive. Inspiratory and expiratory airflow-s and volmnes were 
measured with an ultrasonic flowmeter (Branta, U K ) and tidal P^^^^ was monitored using an 'in-
line' infra-red analyser (Hewlett Packard 47210.A, US.A). Sufficient additional deadspace, in the 
form of 2 5 cm i d. anaesthetic tuljing (approx. 1-.5 m), w^ as added to maintain end-tidal 
{/'\i-.co.) about .'38 mniHg despite the voluntary over-ventilation. The |5ressure within the nasai 
mask was measured (Statham P2,'51.5. USA) as an index of upper airway pressure. Initially, subjects 
targeted their inspiratoiy and ex|Mratoiy durations to the audible cycling of a mechanical 
ventilator and were given verbal feedback about the adequacy of their acliieved tidal volume 
relative to the desired level. Subjects then maintained this pattern without any cues for the 4 min 
duration of each P E T scan. For the 'pa.ssive' task, an intermittent positive pressure ventilator 
(Pneupac, U K ) was connected to the terminal end of the dead space and set to deliver a similar 
inspiratory volume and frequency. While in the relaxed state, subjects were ventilated for the 
duration of the scan and were instructed not to sleep. 
I n order to assess the possible in\'oivement of accessorv muscles of respiration during voiuntar\'' 
breathing, three subjects performed the 'active' task, at a separate time (under exactly the same 
experimental conditions as described above), with E M G surface electrodes jjlaced over the 
sternomastoid muscle; L.MCi signals were processed through an isolated differential amplifier of 
local design (bandwidth 10-1000 Hz). 
PET scanning. Subjects were scanned six times consecutively in each session. Radiolabelled 
water (Hj'^O) was used as a tracer of cerebral blood flow. Hj '^O was produced continuously by the 
catalytic reaction of '^Oj and hydrogen and was infused intravenously in a concentration of 
approximately 8 mCi ml"'. Preparation for scanning included insertion of camnilae into the left 
radial artery (under local anaesthesia; bupivacaine 1% S C . ) and also into the right antecubital 
vein. A polyurethane head mould was fitted to minimize head movement. Subjects lay supine in 
a quiet darkened rooin with eyes closed and ears unplugged and with the head placed in the scanner 
so that the lowermost plane was approximately parallel to, and 20 mm above, the orbitomeatal 
line. 
Scanning was performed with an E C A T 931-08/12 ( C T I Inc. , Knoxville, U S A ) the physical 
characteristics of which have been described previously (Spinks, Jones, Gilardi & Heather, 1988). 
The scanner collects data in fifteen contiguous transverse planes, with a total axial field of view of 
10-4 cm. Transmission data were collected first, over a period of 20 min, using an external 
^*Ge ring source generating positrons. These data are required to correct subsequent emission 
scans for the effects of radiation attenuation by the tissues of the head. This period also served to 
accustom subjects to the environment. 
F o r each measurement of r C B F , scans were collected sequentially over 3 o min, with a 0 5 min 
background scan followed by twelve scans of 5 s duration and twelve of tO s. The Hj '^O infusion, 
at a rate of 10 ml min""', began immediately after the background scan and continued for 1 min. 
The scans collected in the 110 s following the start of the tracer infusion w-ere added for calculation 
of the r C B F images. Arterial blood was drawn continuously during scanning at a rate of 5 ml min"' 
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and radioactivity was inea.surcd every second. Corrections to the arterial radioaci ivii v (in|iiii) 
curve Cor delay and dispersion in the brachial vessels and tubing- wviv made and an a\cra.i:e 
[lartilion coefficient of Oi);") lor the relative vokniie of distribution of betucen brain li.ssiic' 
and blood was assumed, 'i'he |)rotocol and calculations were modified from those describrd bv 
Lainmertsnia , Cunningham. Deiber. Heather, Bloomfield, Nutt. Frackowiak & .tones (KHIO) Ib r 
C'-'^O., inhalation. 
Airflow 
and volume 
IPPV 
Arterial sample 
H2'^0 I.V. 
infusion 
Fig. i . Sciiematic representation of tiie experimental arrangement lor r i i e a s u r e m i ' i i l of 
changes in r C B F by Pl^T scanning resulting from voluntary breathing. Subjects remained 
still, with the head positioned in the scanner and eyes and mouth closefl. and Ijieathed 
through a nasal mask via a deads|)ace (to maintain normocajinia). either volitionally from 
room air ('active' inspiration), or with relaxed respiratory muscles Cpa.ssi\-e' inspiration) 
using 'matched' intermittent positive pressure ventilation ( I P P \ ' ) : e.\]iirarion was 
always passive. Respiratoiy airflow (integrated to volume) and /',.,, were measured 
continuously with appropriate 'in line' transducers. Pressure within the nasal mask 
(^ n.i.sai) provided an index of relaxation during I P P V . Radiolabelled water ( H j ' H ) ) was 
infu.sed over I min via the right antecubetal vein and blood was sampled continuously 
from the left radial artery to allow C|uantification of rCI3F. 
Six scans were collected for each subject, with rest periods of t 0 - i 2 min l)etween scans to allow 
for deca}' of i-adioactivity from the previous measurement {TL for ' '0 = 21 min). The scans were 
performed under 'act ive' and 'passive' conditions alternately and with the order rever.sed in half 
the subjects. A stable ventilatory pattern was established during the background scan of s and 
maintained for a further 3-5 min until the last blood sample was collected. .Scans were reconstructed 
using a Manning filter with a cut-off frequenc\- of O o maximum resulting in an image resolution of 
8 5 X 8 5 mm (at full width half maximum) and a slice thickness of 6 75 mm. The reconstructed 
images contained 128 x 128 picture elements (pixels) each 2-05 x 2-05 mm in size. 
T h e images of C B F were automatically reorientated and resized in height, length and width to 
match best a reference set of images. This set of images had been aligned jjieviously with respect 
to the intercommissural plane using the method of Friston, Passingham, Nutt. Heather. Sawie & 
Frackowiak (1989) and rescaled to correspond to the standard brain dimensions usefl by Talairach 
&. Tournoux (1988) in their stereotaxic atlas. The final image consisted of twenty-six slices at 4 mm 
intervals with plane 8 being the intercommissural plane. E a c h image was smoothed with a 
Gaussian filter 10 pixels wide, to accommodate variations in functional and g\'ral anatomy. 
Subjects differ in the level of overall C B F , but activation results in an additional component 
which is independent of the global How. Differences in global flow were therefore accounted for pixel 
by pixel in each scan by normalizing to a standard mean C B F of 50 ml (100 ml brain volume)""' min"', 
using a method based on analysis of covariance with global flow as covariant (Periston, Frith, Liddle, 
Dolan, Lammert sma , & Frackowiak, 1990). For every pixel, this analysis generated an adjusted 
CORTICAL COXTROL OF RREATHINO 95 
mean rCMF lor each of the two conditions (•a(tive' and 'pa.ssive') and the ei-ror variance was us(;d 
to compa.re ihc t«^o conditions in a manner (!(|ui\ alent to a ))aircd /. test. In each ol'three subjects, 
one pair of scans was technically unsavisfaclory and hence only fifteen indi\ idual |)airs of scans 
(•out ribut.ed to each condition nK;an. The method of Friston. Fi ith, Liddle &• I'^racUowiak (1991) was 
used to |)roduce 'statistical images' of r C H F change w ith signiHcanc:e (;ritc.ria set at / ' < 0 0 5 and 
/ ' < O O l . Only significant increases in rClBF in the active' compared to 'passive' condition were 
consideied ftirtlier. The most significant pi.xel within such regions oi inc;ieased fiow uas used to 
determine anatomical location bv reference to the corresponding locus in the atlas of 1'ala.irach & 
Tfuirnoiix (19SS). Where foci occurred witliin the same anatomical structure; (e.g. within tht; motor 
cortex) on multiple planes, 'weighted mean' co-ordinat(.'s were calculated (C'olebatch. Deiber. 
Passingham. Friston & Frackowiak, 1991 ii). Average fiow increases were C|uantified at the site of 
the most significant pixel using the images of normalized blood flow. 
R I 5 . S I : L T S 
eels'' comments 
The subjects confir-med that during the scans thc\' had remained awake with eyes 
closed and had experienced little or no discomfort. All subjects were confident that 
the\" had been able to maintain a fairl}- uniform pattern of breathing duiing the 
'active' task and that they had ke|)t their respiratory muscles relaxed during 
Insp 
Volume 
Exp 
Active Passive 
C O , 
n n 
40 
mmHg 
n n n n n 
20 
cmHsO 
/I f\ 
VJ 
5 s 
Fig . 2. Examples of original records of respiratory variables from one subject over 1 min 
infusion of H^'^O during volitional breathing (active) and 'matched' positive pressure 
ventilation (passive). Note similarity of: inspired volumes (Insp), respiratory frequency, 
expiratory volume profiles (E.xp) and end-tidal P^^ levels in the two conditions. I n 
Passive, smooth and repeatable piessure profiles witfiin the nasal mask IP ,) indicate 
I 1 . > [|<lSill ' 
relaxed respiratoiy muscles. 
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positive pressure ventilation. Subjects did not report any particular concentration on 
their breathing during the 'passive' task other than being aware that they were 
being ventilated: by contrast, the 'active' task did require coiitiiuunis a.tte.ntioii Id 
the rate and depth of breathing. 
Rallern of breathing 
A record of the breathing pattern, tidal /^ co.. pressure recorded within the 
nasal mask {R,y,^^.^^) during the 'active'' and matched 'passive' breathing task.s is 
T . A H L i c 1. Mean ventilatory \'ariables during P F / f scans 
Subject 
T (s) i) /Vr.co., (mmHg) 
(scan no.) Act Pas Act Pas Act l \ is Act Pas 
A G (1) 21 1-7 4 0 3-4 1-83 1-60 34-9 36-5 
A G (2) 21 I S 3!) 3-7 1-62 1-70 35-5 3 7 0 
R L (1) 2 0 16 3-3 34 1-72 1-63 370 38-1 
37-8 R L (2) 1!) 1-8 3-6 3 5 1-41 1 42 36() 
K.M(1) I S 1-6 2-9 2-9 1-32 1 -50 39-4 37-1 
K.M(2) 2 2 2 0 3-9 3-3 181 1 -65 37-3 38-3 
L A (1) 1-9 1 0 3-4 3 0 1-72 I S 2 38(1 39() 
L A (2) 1-9 Lo 3o 3-2 1 74 1-70 37-2 38-1 
L A (:i) l b 1-5 31 3-2 1-51 1 -55 4()(i 39-4 
A i d ) 1-4 1-4 3-2 31 1-32 1-40 430 410 
A l (2) 1-4 1-4 3-2 3-1 1 -45 1-45 38-5 380 
A I (3) 16 1-6 3-6 31 1-71 1-70 35-5 36-5 
R H ( 1 ) 1-6 1-6 4-8 3-4 1-60 1-45 35-0 36-5 
33-5 R H (2) 2o 1-6 4-7 3-4 1-83 1 54 33-0 
R H (3) 16 1-6 3-9 4-2 1-70 1 55 32-2 33-2 
X 1-84 1-61 3-67 3-33 .1-62 1-58 30-9 37-3 
S.D. 0-31 016 0o.5 0-32 018 012 2-8 2 0 
P 0004 002 016 0-23 
Mean values, for each of six subjects, of inspiratory lime (T,), ex))iratoiy time (7',..), tidal \'oluiiic 
(P .^) and end-tidal /^o^ E T . C O J o^ '<3r the 1 min of H,'"0 infusion (9-14 breaths) during a PICT scan. 
E a c h subject underwent two or three pairs of scans during 'active' voluntary inspiration (Act) and 
'passive' positive pressure ventilation (Pas). The mean (.f) and standard deviation (s.D.) ofthe.se 
average values for the fifteen paired scans comprising the r C B F analysis are shown. P gi \es the 
level of statistical significance for differences in the means of each variable for Active us. Passive 
(paired I test). 
shown for one subject in Fig. 2. A breath by breath analysis of inspiratory time 
(TJ), expiratory time (T^), tidal volume {V•^f and RET.CO., corresponding to the I min of 
Hg'^O infusion (taken as representative of the scan period), was performed for each 
of the 'active' and 'passive' runs; the number of breaths taken during this period 
ranged from nine to fourteen between subjects but never differed by more than three 
between a matched pair of runs. The tnean values of these ventilator}' variables are 
given in Table 1. Paired t test anah'sis on each variable for the 'active' vs. 'passive' 
conditions in the fifteen matched runs rev^ealed significantly lower values for both 
Ti (1-61 vs. 1-84 s) and 7^ (3'33 vs. 3-67 s) in 'passive' compared with 'active' 
breathing but Kj. and P^^ were not significantly different between the two 
conditions. 
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All subjects showed a smooth and repeatabic /;,^,,, ti'ace during 'passive' 
inspiration (Fig. 2) for virtually all l)rc.aths occurring during scanning. Over the 
1 min of li2''''0 infusion, the mean peak ranged between 14-1 and 30-8cinH.,O 
for difl'erent subjects, and for individual scans the coefficient of variation of /•'„.,j.,i| m 
Fig . 3. Diagram summarizing the sites of significantly increa.sed rCMf'' occuri-ing with 
active inspiration in pooled data from G subjects. .Medial (left-hand) and lateral (right-
hand) views of the right (upper-half) and left (lower-half) hemispheres are shown. The 
horizontal lines indicate the position of the intercommissural (.AC-l^C) plane and the 
vertical line the location of V'ca. a line jiassing thi'ough the anterioi- commissure (Talairach 
& Tournoux, 1988). The shaded areas indicate the regions, projected onto these views, at 
which significant (P < 0-05) increases in r C B F occurred during the ' active ' task. The right 
medial view shows two regions (comprising four foci) and the left medial view two regions 
(three foci) of increased flow within the SMA, which, due to their ] i r o . \ i m i t y to the mid-
line, could not be allocated to either hemisphere with certainly. I'lie medial view of the 
left hemisphere also shows, below the A C - P C plane, the focus of increa.sed r C B F occurring 
within the cerebellum which overlay the cerebral cortex at this level. The lateral 
projections, show, on the right, a focus within the motor cortex and. anteriorly, one 
within the pre-motor cortex. On the lateral view of the left hemisphere are 2 foci of 
increased flow within the motor cortex. The brain outlines were copied from a drawing by 
R . Passingham taken from the atlas of Talairach & Tournoux (1988). 
nine to fourteen successive breaths ranged between 0 9% and 6 5% (median 1-9%). 
During 'active' inspiration, peak P^ s^^ , never exceeded —2-5 cmHjO, consistent with 
the relatively low resistance of the external breathing circuit (Fig. 1). 
Minimal or no EMG activity was recorded in the sternomastoid muscles in the 
three subjects studied. 
Regional cerebral blood fiow 
The brain volume successfully imaged in all subjects extended from the vertex to 
the upper cerebellum. Global cerebral blood flow was not significantly different (P = 
0-4, paired t test) between the 'active' and 'passive' conditions. Significantly 
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increased flows (/'* < 0-05) in association with the 'active' state occurred within live 
brain regions: the right pre-motor cortex, the supplementally motor area (S.M.A). I lie 
cerebellum and both the right and left motor cortices (i*"ig. 3). (.'iveii that the peri-
Rolandic foci were located anterior to the fissure and that our experiinenl was 
designed to subtract out any change due to afferent activity, we felt justified in tising 
T . ' V K L K 2. Sites of significantly increased blood flow in active inspiration 
Region .-\verage flow increa.se (%) Co-ordinates (mm) 
Left Motor (2) 5 4 - 1 8 . - 2 3 . 65 
Right Motor 4-3 -t-18. - 18. 60 
Right Pre-motor 7-6 - I - I S . - 2 . 64 
SMA (4) 31 +4, - 2 ! ) . 48 
Cerel)ellum 4-9 - 6 , - 5 2 . - S 
Degree of flow increase and co-ordinates for sites of significantiv (I' < (1(15) incicascil blood flow 
in the 'active' cr)mpared to the passive' task. The flow changes represent the a \ i - i a g c values li-Min 
the SIX subjects. (!-'o-oidi nates are given in order of sagittal, coronal and vert ica l locat ions and i v f r r 
to the stereotaxic atlas of Talairach & Tournoux (1988). The sagittal reference is the mid-lim-
(displacements to the right are positive), the coronal reference is a plane v i T i i c a l i n ilu-
intercommissural plane, passing through the anterior commissure wilh di,-,iaii(c.-< a n i r r i n r bi-ini; 
positive; the vertical is the distance above the intercommissural plane The figiiics g i \ c n in 
brackets indicate the number of foci (on different transverse |)lanes) lying within the s.imi-
anatomical region. .All the regions except the cerebellum included some foci u h i c h were also 
significant at the /•" < 0 01 level. 
the term 'motor' rather than 'sensorimotor' cortex. All but the cerel.icllar regiun 
included foci which remained significant at the P < 0 01 level. Foci of significant l \ ' 
increased flow occurred in four transverse planes within the SMA (two at the 
P < 0-01 level). Within the left inotor cortex, foci of significantly increased How 
occurred in two transverse planes (one at the P < 0 01 level). Average flow increa.ses 
ranged from 3T to 7-6% within the different regions and are gi\'eii with their 
co-ordinates in Table 2. The laterality of the cerebellar and S!\'l.-\ sites of'activat ion is 
uncertain because of the proximity of the sagittal coordinates to the mid-line. 
D I S C U S S I O N 
R,espiratory motor control is characterized by the presence of rhythmical motor 
outflow that proceeds in the absence of conscious awareness, as well as by the 
capacity for a high degree of volitional modification of this basic rhythm. 
PhN'siological observations, as well as the effects of disease in man in which the 
automatic and 'voluntary' aspects of breathing can sometimes be dissociated (Plum 
& Leigh, 1981), suggest that these two functions reflect diffeicnces in the relative 
contribution from cortical and brain stem structures. 
The present study was designed to examine the neural contiol of breathing in its 
'most voluntary' form. The subjects were required to generate accurately a specific 
inspiratory volume and respiratory frequency, a task that could not be achieved 
without training. Anxiety, a potential influence on breathing (Howell, 1990) was 
minimized by training sessions, and by explanation and reassurance during the 
study. The target tidal volume was roughly three times normal and end-tidal P^ ;,-, 
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was kept at low normal levels to ensure that chemical drives to breathe were 
minimized. The level of /^ <;;o.,; however, was not low enough to cause a significant 
alteration in overall cerebral blood fiow (Ivct}- Schmidt, 1948). 
The 'passive' t^ ask was used as a conti'ol for the afferent activity evoked in the 
'active' task. Inflation of the lungs excites atferents within the lung and airways, as 
well as in the skin and muscles of the chest wall, and there is direct evidence that 
alferents within intercostal nerves at least, project to the cerebral cortex (Gandevia 
& Macefield, 1989). In order that any cortical activation resulting from the 'passive' 
task reflect only the effects of peripheral afferent dischai'ge, it was clearly necessary 
that the subjects' inspiratory muscles did indeed remain relaxed during this control 
condition ; the recordings of pressure from within the nasal mask indicated that this 
was so. Although end-tidal PpQ_ levels showed that the overall levels of ventilation 
were well matched, there were small differences in the duration of the inspiratory and 
expiratory phases in the 'active' and ' passive' tasks. Furthermore, although afferent 
activit}' from all sources should have been very similar in the expiratory phases of 
both tasks, the afferent discharge generated during the inspiratory phases would not 
have been perfectl}- matched. While intrathoracic, cutaneous and joint receptor 
discharge should have been similar in the two conditions throughout the respiratory 
cycle, extrathoracic aii'way pressure receptors, facial afferenfs innervating skin 
within the mask and respiratory muscle aff'crents would have been expected to 
discharge differently during the inspiratory phase of the two tasks. Indeed perfect 
matching of afferent activity is probably impossible for this and most motor tasks. 
Previous measurements of rCBF during movements of the eyes and limbs (Roland. 
Larsen, Lassen & Skinhoj, 1980; Fox, Fox, Raichle & Burde, 1985a; Colebatch elal. 
19916) have measured increases against a resting state. Due to the limited temporal 
resolution possible with PET, the problem arises of whether the increases seen are the 
cause, or the result of the movement. I t has been shown, for example, that both 
muscle and cutaneous afferents project to the pre- and post-central gyri, the SMA 
and the pre-motor cortex (Powell & Mountcastle, 1959; Lemon &, Porter, 1976; 
Hummelsheim, Bianchetti, Wiesendanger & VViesendanger, 1988) and could have 
contributed towards the increased blood flow recorded for these regions. By 
subtracting out the effects of a 'passive' control state, it is likely that the sites 
identified represent cortical areas dominated by ' centrally generated ' neui'al activity 
in association with the volitional inspiratory task. 
The size of the flow increases reported here are modest in comparison with 
increases seen in association with limb movements. Repetitive contraction of a single 
digit, for example, has been reported to result in a 13% increase in I'CBF within the 
sensorimotor cortex (Colebatch et al. 19916). Several factors could have contributed 
towards the modest blood flow increases found in the present study. Firstly, the 
experiment was designed to remove flow increases associated with the 'passive' task. 
Such peripheral afferent activity may have contributed significantly to increases in 
rCBF seen with limb movements; Colebatch, Findley, Frackowiak, Marsden ct 
Brooks (1990) reported increases of 15 %o in sensorimotor cortex blood flow in 
response to passive wrist movements. Secondly, only about one-third of the 'active' 
task scan time was actually spent in generating inspiratory airflow, the remainder 
being spent in expiration which occurred passively in both tasks. Finally, the 
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repetition rate u.sed here (12 breaths min~') was much slower than that tiscd in .some 
studies of limb movement (e.g. 40 movements min"', Col(4)atch et al. 1991/>). 
Althougli the dynamic sensitivity of rCBF to different rates of movement is nol 
known. Fox & i^,aichle (1984. 1985), who studied occipital cortex i C B F responses to 
visual stimuli, found a linear increa,se in flow with increasing repetition rates between 
1 s"^  and 8 s"'. 
The motor cortex, SMA, pre-motor cortex and cerebellum, activated m this study, 
have also been reported to be active in association with simple, i-epetitive arm and 
hand movements (Fox el al. 1985a; Fox, Fvaichle &• Thach, 19856; Colcbatch et al. 
19916). This suggests that these regions participate in the generation of all voluntary 
movements with clearly defined targets and disagrees with the claim by Roland el al. 
(1980) that only complex motor tasks require SMA and pre-motor activation. 
Furthermore, there would appear to be a fundamental similaril-y in the mechanism 
by which voluntary movements of both the limbs and respiratory muscles are 
generated. Anatomically, the n-iotor and non-primary motor areas are closely inter-
related (e.g. Ghosh, Brinkman & Porter, 1987) and, for different movements of the 
arm, the activation within sensorimotor cortex, SMxA and premotor cortex change 
roughly in parallel (Colebatch el al. 19916). In unilateral movement, increa.ses in flow 
in the pre-motor cortex may occur either bilaterally or just contralateral to the limli 
moved (Roland, Meyer, Shibasaki, Y^amamoto & Thompson, 1982). in the present 
study, where a S3''mmetrical bilateral movement was performed, the unilateral pi'c-
motor activation seen raises the possibility' of hemispheric specialization for the 
' active ' task; this may be related to a greater degree of attention associated with this 
manoeuvre (Pardo, Fox & i-v.aichle, 1991). 
The present study outlines the motor cortical areas involved in the inspiratory 
'active' task but cannot define exactly which inspirator}' muscles are 'represented ' 
b}' these areas. Although inspiratory intercostal muscles could certainly have been 
activated during the 'active' task, the diaphragm would have been the principal 
muscle of inspiration. The locations in the motor cortical foci in each hemisphere 
correspond well to an earlier report of an optimal site for direct stimulation of the 
cortex to activate the diaphragtn in man (Foerster, 1936). The use of transcranial 
magnetic stimulation in man (Maskill et al. 1991) has indicated an optimal site for 
activating the contralateral diaphragm, approximately 3 cm lateral to the vertex. 
V\^ith the assumption of a skull thickness of 0-8 mm, it is possible to calculate that 
the motor cortical sites identified in the present study correspond to locations 
approximately 2-5 cm lateral to the vertex. 
The SMA, which in monkeys has been shown to have its own projection to the 
spinal cord (Macpherson, Marangoz, Miles & Wiesendanger, 1982) is nevertheless 
generall}' believed to have a role in planning movement 'upstream' of the motor 
cortex (Roland et al. 1980). Our results indicate a role for the SMA in voluntary 
respiratory movements and complement recent evidence for the presence of a 
Bereitschaftspotential (Deecke, 1987) preceding similar respiratory manoeuvres 
(Macefield & Gandevia, 1991). The location of the SMA focus in the present study lay 
at a similar vertical height above the intercommissural plane as reported in 
association with shoulder movements (Colebatch et al. 19916) but 15 mm more 
posterior. Rostrocaudal somatotopy within the SMA has been reported for man, with 
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areas active in vocalization and eye mo\ements lying progressively more rostral to 
that for arm movement (Talaiiach, Szlika, Tournoiix, Prossalentis. Bordas-Fei'rer, 
Corello, lacob & Men-ipcl, 1967; Fox el ai I985r/). Our data suggest that the S.MA 
region, active in association with the inspirat;or\- task used here, lies posterior to that 
for arm movement and is thus sepai'ated by it from the region involved in 
vocalization. 
This study, using rCBF as an indicator of local neural activation (Raichle, 1987), 
has provided, for the first time, direct evidence for a functional role of specific cortical 
structures in the generation of a. voluntary inspiratory task. The present 
methodology is potentially capable of enabling the study of respiratory motor 
control under a variety of different behavioural conditions in both normal volunteers 
and patients with defined deficits. Caieful choice of experimental paradigms should 
allow conclusions to be drawn about the control of breathing not only in other 
overtly volitional tasks but also, for example, during speech and in states of anxiety. 
Such everyday examples of behavioural influences on breathing have, in the past, 
been extremely difficult to study in a rigorous fashion. 
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and Professor R . Frackowiak for their suppoit. advice and encouragement. We greatly a|)preciate 
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Data for the production of fluorine-IS (/,; = 109.6 min;/?* = I00%)are reviewed. The experience of some 
well-cslablishcd European centres for positron emission tomography (PET), in the rouiine production of 
fluorine-18 for the purpose of labellmg radiopharmaceuticals, is described. This experience is evaiuali;d, 
along with published data, to give practical and technical recommendations to new P E T groups entering 
this kev area. 
Introduction 
The labelling of radiopharmaceuticals with fluorine-
18 (;,;,= 109.6 min; / J+ = 100%) will continue to 
play a major role in the development of positron 
emission tomography (PET) as a modality for clinical 
research, or even clinical diagnosis, in future years. 
For fluorine-18, perhaps for more than any other 
radionuclide, the ultimate success of any labelling 
reaction hinges on factors that are determined up-
siream by the conditions of radionuclide production. 
The challenge of fluorine-18 production for P E T is to 
generate fluorine-18 in a well-characterized chemical 
fomt, that proves useful for subsequent labelling 
chemistry, ideally with minimal carrier, without con-
taminants thai may bind the fluorine-18 into inert 
compounds and with sufficient activity to prepare 
useful activities (e.g. ca lOmCi) of labelled radio-
pharmaceuticals for P E T studies in vivo. These cri-
leria are not always easily satisfied. 
Several European centres have now gained exten-
sive experience in the production of fluorine-18, 
specifically for labelling radiopharmaceuticals for 
PET. The aim of this report is to share this know-how 
^ifh the increasing number of P E T centres that are 
now being established. It includes a review of data on 
fluorine-18 production, a discussion of production 
'^ chniques now developing in our own laboratories 
fsport from a task group organized within the frame-
work of the E E C concerted action on "PET investi-
gations of cellular regeneration and degeneration". 
and elsewhere, and recommendations, drawn from 
broad experience, that should be helpful to new P E T 
groups entering this key area. 
Main Sources of Fluorine-18 
Fluorine-18 can be reached by a wide variety of 
production channels (Table I). The approach taken 
by a particular laboratory is mainly shaped by the 
facilities at hand. High activities are available from 
such diverse machines as cyclotrons. Van de Graaff 
generators and nuclear reactors. Cyclotrons classed 
(Wolf and Jones, 1983) as Level I ( < 10 MeV p or d) 
and Level 2 ( < 2 0 M e V p, plus perhaps other par-
ticles) have become the favoured machines for pro-
duction at new P E T centres. 
Table 1 displays experimental data reported for the 
main reactions producing fluorine-18 on thick 
targets. Nuclear data for these reactions have been 
reviewed (Qaim, 1982) and recently compiled (Gan-
darias-Cruz and Okamoto, 1988). Of these reactions 
the ^''Ne(d,a)'*F and "'0(p, n)"F reactions are of 
major practical interest, in view of their requirement 
for only a moderate projectile energy and a moderate 
beam current to give a useful yield. The ^ Ne(d, a)"F 
and "0(p, n)"F reactions are mainly applied to 
prepare carrier-added (CA) molecular ["F]fluorine 
and no-carrier-added (NCA) ["FJfluoride, respKt-
ively. Nearly all fluorine-18 radiochemistryVnow 
stems from these products. These processes;and 
their variations are therefore the main focus of the-
749 
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Tabic 1. Lilcraiurc data for ihc production of fluorine-18 for medical use from different nuclear reactions on thick largcis 
Reaction Target 
E 
(MeV) 
Thick 
target yield' 
Main 
form Reference 
"0 (p ,n )"F " 0 , 
" 0 , 
14-0 
10-0 
16-0 
2 l6mCi / ; iA ' ' ' 
150mCi//;A' 
l l O m C i / / j A ' 
( " F ) F , 
[ " F ] F -
Ruth and Wolf (1979) 
Nickles ei al. (1984) 
Kilbourn el al. (1985) 
*'i . 
' °Ne (d ,a )"F '"Ne 
0.1% F j / N e 
0.18% F; /Ne 
15% Hj /Ne 
6.7% Hj /Ne 
14 
14-2 
11.2-0 
11.2-0 
11.2-0 
91.9mCi/AiA''' 
12.2mCi//jAh'' 
10mCi/;iAh 
IOmCi / / jAh 
8 mCi/;j Ah 
l " F ) F , 
("FIF.-
["F]HF 
( ' •F )F-
Casella ei al. (1980) 
Casella el al. (1980) 
Blessing ei al. (1986) 
Blessing el al. (1986) 
Blessing ei al. (1986) 
"Ne(d.x)"Ne' 10% H,/Ne 6.3-0 11 mCi/;<A' ( " F ] H F Dahl ei al. (1983) 
"0(ot,d)"F HjO 30 
48 
1.1 mCi/ ; jAh 
7.0 mCi / / iAh 
1"F]F-
( " F ] F -
Clark and Silvester (1966) 
Lindner et al. (1973) 
"0(cr.2n)'«Ne' 0 , 40 14 mOltiAh ( " F I H F Noraki ei al. (1968) 
" 0 ( ' H e . p ) " F H , 0 41-14 7 mCi//j Ah ( " F I F - Fitschcn ei al. (1977) 
"0('He,n)"Ne'' H.,0 36 7.6 mCi/; iAh ( " F I F - Knust and Machulla (1983) 
' ° N e ( ' H c . i n ) ' " N e ' 2% H, /Ne 27.5 
n Flux 
( c m - ' s - ' ) 
5 -7mCi / / jAh 
Yield 
["F]HF Crouzel and Comar (I97S) 
"0( 'H.n) '"F L i . C O , 
' L i O H . H . O 
3 X 10" 
3 X 10" 
200 mCi/3 h 
250 mCi/h 
I"F1F 
I " F i F 
Vera Ruiz (I9S8) 
Vera Ruiz (1988) 
' F o r I h experimental irradiation unless otherwise indicated by superscript. 
•"Theoretical yield. 
'Saturation yield. 
''Yield per 2 h irradiation. 
""Ne decays to fluorine-IX wiih a half-life of 1.67 s. 
remainder of this report. Some other processes arc 
considered for comparison or to indicate their future 
potential. 
Production of C A |"F|fluorine by the 
^''Ne(d,!x)"F Rcacrion 
The bombardment of high pressure neon (up to 
25 bar) containing a low percentage (0.1-0.2%) o f 
molecular fluorine with moderate energy deuterons 
(Lambrecht ct a/., 1978; Casclta ei ai, 1980) is now 
a common and well-established method for produc-
ing CA molecular ('*F]fluorine (Table 1). Table 2 
shows experimental conditions and typical dau fo.-
the production of ('-'Flfluorinc via the •°Ne(c. ;) '-F 
reaction at three European centres. Data reported 
(Casiella ci al.. 19S0) f rom Brookhavcn Nauonai 
Laboratory (BNL) are also shown for companson. 
These centres use essentially the same method 'Ai i l i 
small variations'in some phs-sical parameters. Sntnl-
factors must be taken into account to achieve satis-
factory routine production, as follows. 
/. Target design and construction 
Target bodies and the necessary ancillary tz'^ip-
ment (including air or electrically operated belows 
Table 2. Typical experimental conditions and production parameters for the production of ("Flfluonne by the Ne(d.!i) reaction at dtferesi 
centres . .-' 
Centre 
B N L M R C C U Jiilich Liege 
Target body (type; m L ) 
(internal size, cm) 
Target gas (% F ; in Ne)' 
Pressure (beam off. atm) 
(beam on, atm) 
Window (material, ftm) 
(seals) 
E (incident (MeV) 
Irradiation (pA X h) 
Recovery of (mCi) 
" F at E O B (% of theoretical)'' 
Yield (mCi / / jAh at E O B ) 
Specific (mCi//jmol at E O B ) 
.activity 
Reference 
'Nominal value. 
Honed Ni; 50 
2.5 i.d. X 10 
0.1 
50-60 
25.8 
32.5 
A l . 810-Ni. 25 
Metal 0-ring 
14-9.4 
1 5 x 2 
367 
55 
12.5 
7-10 
Polished Ni-201; 100 Ni: 38 
2.5 i.d. X 20 
0.12-0.15 
88' 
13.5 
23 
Havar, 50-Ni. 25 
Lead 
13.8 
15 X 1.67 
250 
43 
9-10 
1.1 
: 10 2.2 i.d. 
0.18 
60 
18 
30 
Nb. 25-Havar, 50 
Meul joints 
11.25 
40 X 1 
500 
50 
12 
3.5 
Ni; 206 
Casella f( g/. (1980) Clark ei al. (1990) Blessing a/. (1986) 
•"Calculated from target volume and nominal filling parameten. 
^^perimentally determined as 194-242/imo! recovered, under conditions in which the fill-line contributes fluorine 
Theoretical yields were calculated according to Casella ei al. (1980). 
Al. 80-Ni. 20 
Indium 0-nngs 
10 X 1 
0.8-1.2 
GuiUaume ei 
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valves, pressure transducers and manometers) have 
been described formerly by various authors [e.g. 
Casella et al. (1980); Blessing et al. (1986)]. 
Nickel and Monel , machined or welded, appear to 
be the optimal metals for the target body. Stainless 
steel (316) is also convenient but needs longer passi-
vation with fluorine (vide infra). Inconel also requires 
longer passivation and gives lower recovei7 o f 
fluonne-18 (Casella et a!., 1980; Blessing et al., 1986). 
Nickel plating on stainless steel deteriorates after a 
few runs (Blessing et al., 1986). Generally, target 
bodies are 10-20 cm long and are fabricated f rom 1.5 
to 2.5 cm i.d. tube with gas connections through 
stainless steel weld fittings. Swagelok fittings are 
recommended for this purpose. Experience now 
shows that honing of the target is unnecessary, but 
the target must be chemically clean. 
The window is preferably made f rom 25 or 50 / i m 
Havar™ foi l (Hamilton Precision Metals). Nickel, 
niobium and titanium foils have also been used. 
.Mummium or Haver, having a thick layer (e.g. 
20-25 /(m) of nickel on the side exposed to fluorine, 
has been used in some centres. A i r , or preferably 
helium, cooling of the foi l is recommended. 
Seseral methods may be used to seal the beam 
entry window to the target body. Those that are 
saiisfactory include the use of a copper ring (Leybold) 
a gold crush seal, an indium wire or a flat washer 
made f rom thick (0.5 mm) lead sheet. 
//. Target gas 
• The neon should be 99.998%--pure as- obtain-
able f rom A i r Liquide or Messer Griesheim. In 
particular, it should be as free as possible f rom 
carbon oxides, nitrogen and fluorocarbons which can 
have a drastic eff'ect on the chemical form of recov-
ered radioactivity (Casella et al., 1980; Bida et al., 
1980; Dahl and Schyler, 1985). These effects are 
discussed below. The pressure regulator should be o f 
all metal construction and designed for use with high 
purity gases. 
In the absence o f added fluorine, nucleogenic fluor-
ine-18 diffuses to the target wall and is chemically 
adsorbed (as nickel fluoride). In the presence of 
carrier fluorine, exchange of nucleogenic fluorine-18 
competes with surface adsorption and recovery o f 
radioactivity f rom the target becomes possible 
(Lambrecht et al., 1978; Casclla el al., 1980, Bida et 
1980). Corrosion o f target and ancillary com-
ponents is not a significant problem if only dilute 
(e g. < 2%) mixtures of fluorine in neon are used. A 
mixture of 2% fluorine in neon (with certificate o f 
analysis) is supplied by Union Carbide, Air Liquide 
or Matheson. The pressure regulator is specially 
prepared for use with fluorine mixtures by the gas 
. supplier. A mixture of 2% fluorine in helium, as 
& prepared for lasers, can also be used as the source of 
lifluorine gas. This is supplied by Matheson or Air 
gLiquide w i th a full Moncl delivery s>^tem. 
/ / / . Target gas handling 
Given the highly hazardous nature of fluorine, it is 
emphasized that a safe faciity is required to dilute the 
stock fluorine mixture with further neon to achieve 
the composition desired within the target and to 
retrieve the fluorine-18 after irradiation. 
Stainless steel and Swagelok fittings are recom-
mended for transport lines, since surface fluorination 
(passivation) lasts longer at room temperature than 
for the alternatives o f nickel and Monel. Teflon 
tubing, though chemically resistant, is unsuitable as 
it becomes permeable to fluorine with use (Casella 
et al., 1980). Stainless steel bellows (Hoke, Nupro) 
valves have been found to be reliable in service. A 
piezoresistive, low dead-volume pressure transducer 
(Kistler) is recommended to monitor target pressure 
before and during irradiation. Great care should be 
taken to avoid any ingress of air into the gas handling 
facility and target. Flow purging rather than evacua-
tion of air is preferred. 
The use of the same line lo load and unload the 
target with fiuormc poses the risk that the amouni of 
fluorine reaching the largci before irradiation and 
that which is eventually rcco\ered u i i l depend criti-
cally on the fili/empiy procedure (see fooinoie c. 
Table 2). In turn, control of the sioichiometry of 
radiofluorination reactions may be diflicult. with an 
adverse efl'eci on the reproducibility of yields. It is 
preferable to use a dedicated line for the filling of the 
target and also a low volume dedicated line for 
the recovery of radioactivity. The fill/empty stoichi-
ometry of this arrangcmcn! can be highly repro-
ducible. 
/K. Target operating conditions 
The main factor that determines ['^FJfluorine 
recovery is the chemical state of the target surface 
(Casella et al.. 1980; Bida ei al.. 1980). Passivation 
(prefluorination) of the surface is necessary before 
bombardment to avoid a significant loss of fluorine-
18 along with fluorine carrier. Two passivation 
methods have been proposed, namely "thermal" pas-
sivation and "beam-induced plasma" passivation. 
Thermal passivation requires the target to be heated 
for 1-3 h to between 100 and 200'C, when filled to a 
low pressure (a few bar) with dilute fluorine in neon. 
Beam-induced plasma passivation is achieved by 
deuteron bombardment of the target when filled to at 
least the same partial pressure o f fluorine as used in 
production. Two or three irradiations, using ca 10 / i A 
of deuterons for 30 min, are carried out successively, 
with the contents o f the target discarded after each"-
irradiation. Beam-induced passivation is most easy to 
operate routinely. The frequency with which passiva-
tion is carried out varies between centres. Some 
centres, such as Liege, regard passivation as necessary 
before each bombardment. Others, such as the M R C 
Cyclotron Unit , find passivation to be necessary only, 
after a target system has been opened and thereafter 
752 M A R C E L G U I L L A U M E ei al. 
only infrequently, i f the target is in regular use for 
production. In general, passivation is more likely to 
be required the longer a target is not in use. It is 
considered that a good passivation is achieved when 
75-80% of the fluorine-18 can be recovered in a 
production run. 
Cooling o f the target during irradiation may not be 
necessary; metal targets can often be run under 
non-cooled conditions and are easier to build for air 
cooling. 
Nickel targetry and the associated gas handling 
systems are still problematical to maintain in routine 
use. Small volume gold-plated targets seem to show 
promise for high yield and recovery of ['*F]fluorine 
f rom the proton irradiation o f ["OJoxygen (Wieland 
et al., 1989), and might also offer advantages for neon 
targets. However, experience has shown that, where 
beam strikes cause local heating, gold plating of less 
than 50 fim thickness, progressively peels off", deterio-
rates after a few runs, or diffuses into a copper 
backing. More experimental data arc needed to assess 
the potential o f gold-plated targets. 
[''. Chemical forms of the recovered fluorine -1S 
The chemical form of the recovered fluorine-18 
depends critically on contaminants in the target gas 
(Casclla et al., 1980; Bida et at., 1980; Dahl and 
Schlycr, 1985). The target neon gas should be as free 
as possible f rom nitrogen and carbon oxides, as these 
incorporate fluorine-18 into inert substances namely, 
nitrogen ("Fl t r i f luoride and carbon ['"Fltetrafluoride, 
respectively. Contamination by fluorocarbons should 
also be avoided (Table 3). Under such conditions, 
the fluorine-18 is mainly obtained as molecular 
[ ' 'Flfluorine (Bida et al.. 1980; Dahl and Schlyer, 
1985). 
The fol lowing reaction is useful to monitor the 
chemical activity of the available fluorine-18, as well 
as its specific activity (Blessing et al.. 1986): 
Me,SnPh 
C K C I ) . - 7 8 C 
Ph'^F-f McjSn '^F. 
The amount o f ('"Flfluorobenzene in the freon sol-
ution of labelled products is determined by gas 
chromatography, and its activity by y-counting. 
From measurement o f total recovered activity the 
reactive fraction of recovered fluorine-18 (presumed 
to be molecular ["F]fluorine), and its specific activity 
can be calculated. Blessing et al. (1986) found the 
Table 3. Relative importance of impurities in neon gas on fluorine-18 
recovery (according to Dahl and Schlyer (1985)] 
% Impurity in the % " F 
J. starling neon gas appearing as 
r , 
(%) O , C F , C O , F , N F , C F , 
1,00 0.49 0.60 N D 0.13 29 54.1 
0 62 0.30 0.037 . N D 0.008 29 50.7 
0,047 0.002 N D N D 0.001 98 — 
0.076 0.0002 0.009 0.008 N D 15 — 
16.9 
20.3 
85.0 
N D , not detected. 
total organic radiochemical yield to be 51 + 2% and 
the fluorobenzene yield 36 + 2% over 30 runs under 
the conditions described in Table 2. 
I t should be noted that deuteron irradiation of 
neon containing a low percentage ( < 15%) o f hydro-
gen has been used by several groups to produce NCA 
fluorine-18 (Clark et al., 1973; Winchell et al., 1976; 
Straatman and Welch, 1977; Lambrecht et al., 1978; 
Helus et al., 1979; Clark and Oberdorfer, 1982; 
Dahl et al., 1983; Ehrenkaufer et al., 1983; Blessing 
et al., 1986). Various means have been used to 
recover the radioactivity, including removal from 
the heated target with a stream of hydrogen 
(Winchell ei al., 1976; Clark and Oberdorfer, 1982; 
Dahl et al., 1983; Blessing el al.', 1986), recirculation 
o f the irradiated neon over a basic trap (Clark et al., 
1973) and water-washing o f the target after irradi-
ation (Helus et al., 1979; Blessing et al., 1986). 
Removal from the heated target in a stream of 
hydrogen is invariably described as giving NC.^ 
hydrogen [ 'T]fluoride, though it has been argued that 
the true chemical form might be NCA ammonium 
("F)fluonne [see Tewson (1989)). Water washing of 
the Inconel target recovers a high proportion (90%) 
of the radioactivity as aqueous (""Flfluoridc with hieh 
specific actisiiy (10 Ci/'/tmol). as dcicrmincd by an 
ion sclectix e electrode, and free of contamination by 
Co. Cr. Fe. Mo and M n , as measured by optical 
emission spectroscopy in conjunction with induc-
tively coupled plasma ( < 0 . I p p m . detection limit) 
(Blessing et al.. 1986). Only 0.1 ppm levels o f Ni and 
Cu were found (Blessing et al., 1986). However, these 
neon/hydrogen targets are relatively inconvenient to 
- operate and difficult to maintain-and so are no; in-
widespread use. 
VI. Specific aciiviiy 
The specific activity of molecular ("Fjfluorine can 
be measured via titration of the iodine liberated on 
passing the target output into potassium iodide sol-
ution (Casella et al., 1980). However, in principle, ibis 
method does not distinguish between the several 
oxidizing chemical forms of fluorine-18, such as 
["F]-labelled OF, , H O F , N F H , or N F , H , that might 
arise in the target i f there is any contamination by air.-
A misleading result might therefore be obtained. 
Preferably, specific activity is measured via the reac-
tion with irimethylphenyl tin, which is expected to be 
more specific for fluorine-18 in the form of molecular 
fluorine (Blessing et al., 1986), 
The effect of systematically varying fluorine con-i; 
tent between 0,006 and 0.18% (2-60/imol F,) onT 
activity recovery and specific activity has been exam-
ined (Blessing el al., 1986). Between 0.10 and O-lSV^i 
of fluorine carrier, ["F]fluorine recovery i n c r e a s ^ 
but specific activity did not change. The optima 
composition for recovery yield and specific activit 
seems to be 0.18% fluorine. There appears to b ^ 
trend in that the ibwer the incident energy^ 
deuterons, the higher the fluorine concentrationiK 
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is necessary for maximal recovery (Blessing et al., 
1986). 
The volume of the target is an important factor. 
The smaller the size o f the target, the more irrepro-
ducible are the results, both in terms of yield and 
specific activity. Plasma/wall interactions play an 
increasing role with decreasing diameter of the target 
body. The Julich group have found that, for a 
collimated (1 cm <^ )), defocussed and wobbled beam, 
the optimal target size is 2.2 cm t^ ) x 10 cm giving a 
total fluorine content o f 60; /mol for the target, 
leading to a specific activity of 1.5-3.0 Ci/mmol in 
production (Blessing et al., 1986). 
Production of N C A ['^FlFluoride by the 
'*0(p ,n)"F Reaction on "O-enriched Water 
The use of the " 0 ( p , n ) " F reaction on '^O-enriched 
water is now the most effective method for the 
production of NCA ['"Flfluoride (Table 1). 
/. Calculated Production Yields 
The excitation function for the " 0 ( p . n ) " F reaction 
has been determined for proton energies f rom 2.3 to 
14.7 MeV on molecular ["OJoxygcn (Ruth and Wolf, 
1979). Saturation activities for fluonnc-18 production 
arc available and serve as reference data for the 
evaluation and extrapolation of experimental pro-
duction capabilities using a low energy (Level I or II) 
cyclotron and "0-enrichcd water targets. From 
these data, the thick target rate of production of 
fluorine-18 f rom 100% "O-enriched water targets 
can be easily calculated as a function of proton 
" eiiefgy (Table'4). ' 
Under optimal conditions, several hundreds of 
millicuries of aqueous ['*F]fluoride are easily avail-
able f rom a low energy cyclotron, in a bombardment 
time of less than 1 h. Table 5 summarizes typical 
experimental data on the production of ['*F]fluoride 
Table 4. Proton range in water and production 
rate of fluorine-18 from a target of 100% " O -
enriched water as a function of proton energy 
Range in Production 
water rate 
(MeV) (mg/cm-) (mCi/ / jAh) 
4 23.3 2 2 
5 34.5 6.4 
6 47.6 16.2 
7 62.7 23.2 
8 79.6 28.9 
9 98.3 33.8 
10 119 39.1 
11 140 43.8 
12 165 48.4 
13 190 52.2 
14 216 54.5 
15 246 56.4 
16 277 58.0 
17 312 59.5 
18 345 60.5 
19 378 61.4 
20 415 62.1 
21 445 62.5 
22 4S0 62.7 
(/) o 
F 2 I 
< o 
*j -
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f rom "O-cnriched water targets, taken f rom the 
literature and our own experience. 
/ / . Target Systems 
Many different ["OJwater targets have been exper-
imentally tested and described (Wieland and Wolf , 
1983; Kilbourn et al., 1984, 1985; Huszar and Wein-
reich. 1985; De Jesus et al., 1986; Keinonen et al., 
1987; Vogt et al., 1986; Berridge and Tewson, 1986; 
Berridge and Kjellstrom, 1989; Iwata et al., 1987; 
Mulholland et al., 1989). The primary consideration 
in design has been to consume as little of the costly 
"0-enriched water as possible during productiofi . 
The requirement for small target volume in turn 
means that target thickness has to be selected care-
ful ly for effective use of the beam. Also radiolysis and 
boiling of the water [sec Stcinbach et al. (1990)] 
become important considerations. These can cause 
significant loss of target water in open targets 
(Ki lbourn ci al.. 1984; Borridacand Tewson 1986a, b; 
Iwata CI al.. 19X7) or unacceptable pressure build up 
or bubble Ibrmation in closed targets, with adverse 
effect on yield. Cavitation and even complete voiding 
o f the largoi can occur during high current irradi-
ations To reduce these effects, the proton beam 
should be uniformly dcfocusscd over ihc whole area 
o f the large! (Iwala <•/ al.. 1987). Effective target 
cooling is mandatory. 
The decision to operate a low pressure or high 
pressure target is fundamental, since it bears on target 
construction and the strategy for coping with the 
adverse effects of radiolysis and heat. Experience 
has shown that the most efficient water target is 
simply composed of a cavity for the target water, 
bounded by two rigid metallic foils, the back one 
being efficiently cooled by a suitable fluid. Targets 
requiring only 0.4-2.5 mL of water can be con-
structed on this basis. Other parameters of import-
ance are the type of target seals, the chemical nature 
of the metallic insert and foils- the type of transfer 
tubing (Iwata et al.. 1987) and the facility for recovery 
of the "O-enrichcd water, as these potentially bear on 
the reactivity and the specific activity of the generated 
['"Flfluondc. 
Below we describe and discuss examples o f reliable 
target assemblies designed for low and high pressure 
operation. 
(A) An example of a reliable low pressure target 
system 
In the low pressurt mode or operation, without 
suitable precautions, radiolysis and boiling can cause 
a significant loss of "O-enriched water, and render 
the use of high beam currents impractical for high 
yields. Provision for effective Venting (Wieland and 
Wolf, 1983; Berridge and Tetvson, 1986a, b; Iwata 
et al., 1987) or for the catalytic recombination of 
radiolytically generated oxygen and hydrogen (Iwata 
et al., 1987) must therefore be considered. Recircu-
lation of the water during irradiation has also been 
found to offer some advantage for some targets 
(Keinonen et al., 1987; Iwata et al., 1987), but results 
are not necessarily consistent (Iwata et a!., 1987). A 
low pressure target in use at the M R C Cyclotron 
Unit, is described here as an example o f a reliable 
system. 
/. Target hard\<-are. The target (Fig. 1) is fabricated 
f rom 25 mm dia stainless steel (316) and titanium for 
the proton irradiation o f 20% "O-enriched water. 
The front window is aluminium (155.mg/cm', 
0.57 mm thick) backed on the water side by a 
titanium foi l (12.4 mg/cm^ 25 nm thick). This main-
tains a flat front surface to the target and degrades 
the 19 MeV beam to 16 MeV. The water thickness is 
determined by a 3 mm thick stainless steel spacer. The 
back of the target is made f rom 125 /tm thick stainless 
steel (316) foil which is water-cooled. The foils and 
spacer are clamped together metal to metal. Hence, 
there are no 0 nngs in the target water cell. The 
target cell has three j-^' stainless steel tubes inserted 
through the spacer, fixed and scaled with Locktite 
retainer 601. the joints having been pretreated with 
Locktite Activator T. A small pellet of pallacium 
catalyst (Engelhard Model D) is supported in an 
external gas space lo recombinc any radiolyticalK-
gcncratcd hydrogen and oxygen thai might oiher.vise 
cause excessive iniernal pressure. 
2. Target ivaicr. '"O-cnrichcd water (97°o. Isotec. 
I S diluted to 20% enrichment with sterile HPLC grade 
water, and used as target material. 
Target operation. The target is normally oper-
ated with an incident beam of 19 "MeV protbrii" 
(20 / i A , 20 mm dia. spun at 45-50 Hz). Table 5 gives 
performance data. 
4. Liquid transfer system. The target is 45 n: f ro . -
the nearest hot cell in which the fluorine-18 can fc« 
used. Several types and sizes of tube have been trieJ 
to effect this transfer. Some (e.g. polythene) ha\'e 
eventually developed restriction to liquid flo-. 
present Teflon lines {j^" o.d., 0.030" bore) are used 
with a neon drive pressure of 2 bar and flow regtilator 
(Fig. 2). The transfer yield for 1-2 mL target water is 
currently > 9 5 % while the recovery o f fluorine-18 
is typically between 95 and 98%. within 5 mia 
f rom EOB. At EOB ca 65% of the radioactivity is 
nitrogen-13 (r, ; = 9.96 min). 
5. Recovery of .MCA ["Fjfluoride and recyding of 
"O-enriched water. A procedure, based on that 6:-
scnbed by Schlyer ei al. (1987, 1990) aad by 
Hamacher et al. (1990) has been adopted for tht 
recovery of ["F]fluoride and for the recyc£ng o! 
'*0-enriched water. A 90 mg bed of carb>onais foc3i 
ion exchange resin (100-200 mesh A G I X 8) is niaiJ< 
into a column (28 x 3 mm), "0-Enriched «^ter i 
forced f rom the target through the column by ^ 
neon pressure (2 bar). Finally, neon is blown t h r o i ^ 
the column to extract the last traces o f l i q « « ^ ^ ^ 
recovered water is pooled into 10-20 n iL b a | S 
and distilled under reduced pressure using a j o D ^ 
rotary evaporator. The degree of "O-enric^g 
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Helium cooling jet 
19 MeV 
Proton beam 
Helium cooling jet ^ 
O-ring 
Water cooling 0-r lng 
Helium cooling O-ring 
0.025 mm Titanium 
\ 
S T " 
Cooling water 
inlet. 4 I . 
y (S 90 psi. 
m z z m . 
0.57 mm Aluminium 
window for support 
and energy dropping. 
Cooling water 
outlet 
0.125 mm Stainless 
steel exit window. 
Fixing bolts 
and washers 
3 mm Stainless 
steel spacer with 
water cavity. 
Vent port 
Fill/recycle port 
(> 50 mm 
25 mm 
Empty port 
Fig 1 An exploded schematic view of the target (internal volume, 2mL) in use at the MRC Cyclotroti 
Unit (London) for ["F]fl"oride production via the '*0(p,n)-F reaction on '«0-enr>ched water. Operauonal 
parameters are described in Table 5. See also the text. 
is measured by mass spectrometry (Waters, 1990). 
Bacterial contamination of the "O-enriched water 
must be avoided by Miliipore filtration into clean 
sterile glass vials (Pierce). The ["F]fluoride is recov-
ered from the anion exchange column by elution with 
potassium carbonate solution. : 
The procedure is highly efficient-with respect to 
recovery of ["F]fluonde and to |recychng of the 
''O-enriched water.;Qrcat care mustjl^^^ in the 
preparation of thc.idtf exchange:re'sinlto ensure that 
• it is obtained jfuUy.'iriito^^^ 
«^rbonate soiu&nlfDffier^^ 
chloride form, residual chlonde can-c°ompete with 
["FJfluoride in subsequent labelling chemistry [see, 
for example, AIexoff"ef al. (1990)]. 
6. Reactivity of the NCA ["Fjfluoride. The 
("Fjfluoride is used routinely for the production 
of 2-['*F]fluoro-2-deoxy-D-glucose, according to 
Hamacher et al. (1986). Generally, over 90% of the 
radioactivity reacts in the first stage of the radiosyn-
thesis, the displacement of the triflyl group, if per-
forined .in a glassy carbon vessel. If the reaction is 
performed in a glass vessel, incorporation is typically 
60%:;^.. 
. cZ?.%C(/k;;:flcrn«/^>ipe: spedfic;^ 
the ["pjfluoride has. not been measured.'directly. 
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Catalyst vesse l contains 
Engelhard D E O X O D palladium catalyst 
20 psi neon 
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Peristaltic Peristaltic 
pump pump 
K , C O 
Target Target 
Empty 
port 
Empty 
H '"o 
Target area Hoi lab 
Recovered 
90mg AGl x 8 
resin. 
Carbonate 
lorm. 
1 I S u m X 28mm. 
' F " 10 F O G rig 
Fig. 2. SchcHKiiic representation of the unit lor remotely filling the '*0-onrichcd uaicr laryci ;ii llic .VIRC 
Cyclotron Unit. The principles of its operation are described in the ic.\i 
However, the amounts of carrier arising from single 
irradiations arc < l i i m o l as assessed indirectly by 
specific activity nicastirements on derived radiophar-
maceuticals, such as ["F]PK 14105 (Pascali et al., 
.1590). This corrcspond.s to n specific activity at EOB 
of 300mCi//imol at EOB. Currently the target and 
recovery system arc used to produce ['"F]fluoride 
for applications that do not demand high specific 
activity. It is expected that much higher specific 
activity could be achieved by avoiding Teflon lines for 
recovery (sec Part B4, below), by producing higher 
activity from 98% "0-enriched water, and by rigor-
ously excluding work with CA molecular ["F]fluorine 
from the production area. 
(B) An e.xamplc of a reliable high pressure target 
system 
High pressure targets are operable at beam cur-
rents up to 30 /<A, due to the higher boiling point of 
the water under a higher pressure (Wieland et al., 
1986) which, as a diagnostic, can be monitored during 
irradiation. A target (Fig. 3) in use at Julich is 
described here as an example of a system, which has 
functioned reliably, even after reaching an intergrated 
beam current of 3000/t Ah. 
1. Target hardware. The target consists of a tita-
nium body electron beam-welded to two titanium 
foils (75 pim thick), which act as front and back 
window. (Generally, depending on the target material 
used, electron beam welding or diffusion welding of 
the target foils is preferred to sealing by Viton or 
silver 0-rings). It is a modified form of the targets 
described earlier (Well' <-/ al.. 1985: Qaim tn al., 
1987). The inner diameter of the present target 
is 21mm with a water thickness of 3.5 mm. The 
target takes 1.3 mL of '^0-enriched water with no , -
-expansion space. Two ,7," stainless steel-tubes. leading --- -"' 
to a multi-port valve (Fig. 4) are connected via 
screws that are sealed with silver washers. During 
irradiation, the back window is water-cooled, typi-
cally to 10-12-C, and the from window is helium-
cooled to - 5 ' C . 
2. Purity of "0-enriched niiier. The purity of the 
'"O-enriched water used in high pressure targets is of | 
major concern. It is found that high chemical purity .' 
is needed to avoid excessive pressure build-up. i 
For large-scale production, >90% "O-enrichment j 
is needed to avoid the generation of excessive J 
("Njnitrogen by the "0(p,-3)'^N reaction, which may ; 
pose radiation protection problems. Organic impuri- <-• ] 
ties must be absent as these can prevent recombina-:y "j 
tion of radiolytically generated oxygen and hydrogenjvfr-J 
atoms, causing the target to burst. The "0-enriched',^^ 
water is purified by treatment with active charcoal, 
followed by refluxing with potassium permanganate V;?H 
and potassium hydroxide, and finally triple dislilla-j";";] 
tion. Purity is assessed by capillary gas chromatog-.<£^-, j 
raphy with an FID detector operating at hJgbest^^. 
sensitivity. ''^P-^ 
3. Target operating conditions. The target is " o r ^ 
mally operated with a 25 / iA beam of nMeV.pr i^ 
tons. Performance data are given in Table 3 . ' ' 
maximum current tested was 35/JA. The pressur^ 
a routine production run is between 5 and 7'-.te 
Silver sealing 
tf- foil 75 um 
K. ^ \ \ \ \ \ J \ 
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Fig. 3. Sectional view of the electron-welded titanium target 
(inicrnal volume l . 3 m L i in use at -KFA- (Julich) . for-
("FJfluoride production via the "0(p,n)"F reaction on 
'^ 0-enriched water. Operalional parameters are described in 
Table 5. See also the text. 
(Fig. 5). Figure 6 shows ihc dependence of aqueous 
["Fjfluoride yield on txam intensity and irradiation 
lime. 
4. Liquid handling and transfer system. The target 
can be remotely loaded with '*0-enriched water 
using the filling unit depicted in Fig. 4. Filling of 
the target with "0-enriched water is achieved with 
a motor-driven syringe through 3-way valves 
(Asco 368) and 6-way valves (Valco AC6W), which 
are connected by polyethylene-polypropylene tube. 
The target is locked by the 6-way valve and the 
pressure is monitored by a piezoresistive pressure 
transducer with very low dead volume. A custom' 
made polyethylene-polypropylene copolymer tube 
with an i.d. of 0.8 mm and helium drive pressure of 
1.3 bar is considered a reliable transfer system. Trans-
fer over 40 m through this tubing from the target to 
the nearest hot-cell by a helium drive pressure of 1.3 
bar takes only 2 min. Teflon tubes are not rec-
ommended for the recovery of the ("F]fluoride if high 
specific activity is required, since radiolysis and rad-
ical stripping can give rise to fluorine carrier. 
5. Recovery of .\-.-tC f'^F]fluoride am! recycling of 
'^0-enriched waier. The '"O-enriched water is recov-
ered by retrievini; the ('•''F]nuoride on a carbonate 
form ion exchange resin (Hamacher ei uL. 1990). 
The water can be recycled 4 or 5 times, unless the 
enrichment of water falls below 90%. as measured by 
mass spectromelry and by measuring ihc amount of 
nitrogen-1 3 from a production run. 
6. Reaciiviiy of ilie NCA ["Fjfliiuride. Cation 
and anion coniaminanis (Solin ei al.. 1988) have 
generally been considered to influence the reactivity 
of NCA ["Fjfluoride. If Havar foils are used for 
the target the conlaminants arc mainly Fe. Cr and Co 
ions inconccntrations ranging "from 0.2 to'3ppm'as" 
assessed by atomic absorption spectroscopy. Use 
of titanium foils results in a greater than 10-fold 
decrease in these ions and therefore can be 
recommended as ihe least conlamining metal to use 
as insert and window foil. Contamination of the 
"0-enriched water wiih vanadium-48 was found to 
Helium 
Motor 
Syringe 
Helium 
Pressure 
0 Overflow l7MeVp 
Inject-
block 
foFDG . 
Fig. 4. Schematic representation of. the unit for remotely filling the "O-enriched water target at K F A 
(Julich). The principles of its operation are described in the text. 
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Fig. 5. Tiic dependence ol i;irgei prcsiiure in a ckfSed largel 
(see Fig. 3) on beam inlcnsiiy. JS measured al K F A (Jiilichl. 
See Table 5 ior laruel operalional paraniclers. 
be 0.1X7//Ci after irrLidiaiion for lOniin wilh a 
20/(."V beam producing 270 mCi of lUiorinc-18. .An 
advantage of the ('Tllluoride' iccovcrv system is that 
cationic species arc not co-rccovercd. 
Over 9 0 % ol" ihc rcco\crcd ['-^FjHuoridc reacts 
in the first siagc of the synthesis of 2-|'^Flfluoro-2-
dco.xy-D-glucosc described by Haniaelior cr al. (19.S6), 
when a glassy carbon vessel is used. 
7. Specific aciiviiy. The largci delivers ["Fjfluoridc 
-with-high specific activities (up lo-200 Ci/;i mol) as 
measured by a fluoride selective electrode. 
al.. 1980) and has been converted into acetyl 
["F]hypoffuorite, which was then used for the syn-
thesis of L-6-['*F]fluoro-Dopa (Sunderland et al., 
1990). Solin and Bergman (1986) used a similar .t\ 
process, but substituted fluorine in neon for fluorine 
in krypton. They recovered up to 25% of the total - I . , 
radioactivity. Half of the radioactivity was recovered 
in the "O-enriched oxygen. Given the experience with 
nickel targets, such variations in recovered activity 
are not unexpected. 
Wieland el at. (1989) described a one step proton 
irradiation of a mixture of helium, fluorine and "Q. 
. enriched oxygen. A gold-plated copper body with a 
conical bore was used as target and no attempt was 
made to recover the "O-enriched oxygen. Also, no 
aggressive passivation was used to precondition the 
target. Preliminary results are very encouraging. For 
example. Wicland ei al. (1989) were able lo produce 
more than 1 Ci of fluorine-18 radioactivity from a I h 
irradiation with 30 / l A beam of 10.4 MeV protons on 
a largei containing only 19/(mol of carrier fluorine. 
The achieved specific activity is close to 50 mCi/;j mol. 
much higher than that usually achieved via the 
dcuieron irradiation of neon/fluorine mixture 
(Table 2). 
These results have to be reproduced routinely, and 
especially the radioactive product has lo be tested 
regularly for its suitability in, for example, the prep-
aration of acetyl ['"Fjhypofluorilc. and in turn of a 
radiopharmaceutical such as L-6-['"F|nuoro-Dopa, 
before either a one or a two step process with the •• 
"0(p.n)'*F reaction can be recommended for the _ 
production'of ("Fjfluorinc. 
2000 
Fluorine-18 from the '"0(p,n)'*F Reaction on 
| "0 |Oxygen Gas 
The "Ofp.nj^F reaction is of considerable interest 
for producing ["FJfluorinc in centres having a pro-
ton-only cyclotron. Nicklcs ci al. (1984) first de-
scribed the production of this important precursor 
from an oxygen-18 gas target -, using a two-step 
irradiation process. Nickel is used as material for the 
target body, and nickel and Havar foils for the 
windows. The target is conically shaped and has a 
volume of 15mL. After irradiating pressurized 
"O-enriched (98%) oxygen gas, fluorine-18 becomes 
deposited on the target walls, and the oxygen-18 
is recovered cryogenically. A second and short 
irradiation of 1% fluorine (75pmol) in krypton is 
needed for isoiopic exchange of the adsorbed 
fluorine-18 and the recovery of more than 50% of the 
total fluorine-18 activity (Sunderland et at., 1989). 
Target performance is determined by the level of 
fluorine passivation. Passivation with n.olecular 
fluorine at 200°C for several hours gives the best 
results. Up to 50% of the total radioactivity has 
been recovered as ["F]fluorine. The ["Fjfluorine 
can be titrated by well known methods (Casella et 
o 
E 
1000 h 
500 
10 15 20 
Current (pA) 
Fig. 6. Yield of ("F)fiuorid£ from the " 0 ( p , n ) " F r e a c t i M | 
on 97.5% "O-enriched water (1.3 mL) in a titaiiium t a i ? ^ 
(Fig. 3), under various conditions of beam current 
irradiation time, as measured a l K F A (Julich),' yi* 
measurements were taken after transport of the^irradia 
water through 40 m of polyethylene-polyproijylene'*^" 
• (0.8 mm i.d.). ' '••'^••'f: 
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Other Reactions for the 
Production of Fluorine-18 
/ . 'He- and 'He-induced reactions 
Large-scale production of fluorine-18 in high 
specific activity is possible with helion-induced reac-
tions on oxygen, using water as target material (Clark 
and Silvester, 1966; Tilbury et al., 1970; Lindner et 
al., 1973; Fitschen et al., 1977; Knust and Machulla, 
1983; Solin et al., 1988), or neon, using a neon 
hydrogen mixture (Crouzel and Comar, 1978) 
(Table 1). A critical comparison of these production 
routes, with an exhaustive bibliography, is given by 
Qaim and Stocklin (1983). Due to the high energy 
needed (E > 40 MeV) for substantial yield (Table 2) 
these routes are not widely used. They are not 
recommended for fluorine-18 production, unless 
compelled by lack of facility for the '"0(p,n)'*F 
process. 
/ / . Reacwr-inducedfluorine-IS 
The production of fluorine-18 in nuclear reactors 
via the "'0{t.n)'''F reaction has been extensively re-
viewed by an IAEA consultants meeting (Vera Ruiz. 
1988). The consultants concluded that reactors with 
neutron thermal fluxes of 1.0 x 10"cm"'s" ' can 
produce sufficient fluorinc-IS (30-100 mCi) for the 
preparation of useful quantities (3-10 mCi) of fluor-
ine-IS labelled radiopharmaceuticals by nuclcophilic 
substitution reactions. Generally, a lithium salt con-
taining an oxy anion, such as hydroxide or carbonate, 
is irradiated with neutrons to enact the''.Li(n,^.H)''.He. 
reaction. The emitted trilons then perform the 
'°0('H,n)"'F reaction. The practical diflScullies are 
significant, not least because of the need to isolate the 
product from tritium and lithium. 
I 'TlPrecursors for Labelling Procedures 
Routes for the introduction of fluorine-18 into an 
organic structure mainly fall into the following cat-
egories: 
(a) aliphatic electrophilic addition to double 
bonds; 
(b) aromatic electrophilic substitution; 
(c) aliphatic nucleophilic substitution; 
(d) aromatic nucleophilic substitution. 
For electrophilic processes (a and b) the fluorine-18 
has to be in a suitable chemical form. CA molecular 
("FJfluorine has found some useful application as a 
routine labelling agent, notably for L-6-['*F]fluoro-
Dopa (Fimau el al., 1984). However, molecular 
fluorine-18 is invariably non-selective as a fluorinat-
' ig agent, because of its high reactivity and because 
of its panicipation not only in electrophilic processes 
but also in oxidation and free radical reactions. 
Hence, 
there is considerable interest in developing 
•"ilder and more regioselective agents for "electro-
philic" ["F]fluorination. 
Xenon ['^Fjdifluoride is a somewhat milder re-
agent, but is not always rcgioselective and can also 
fluorinatc non-activated rings. So far, two procedures 
have been adapted to the routine synthesis of xenon 
["F]difluoride. The first involves isotopic exchange 
between xenon difluoride and hydrogen ("F]fluoride. 
The radiochemical yield reaches 30% with a final 
specific activity of several tens of mCi/mmol (Schro-
bilgen et al., 1981). The second procedure (Chirakal 
el al., 1984) leads to ten-fold higher specific activities 
and is based on the reaction of xenon with 
['*F]fluorine. 
['*F1F,-F Xe- l ' ' F )XeF , 
A chemical yield of 65+15% is obtained within 
40 min giving access to a final production yield (EOB) 
of 11 niCi//iAh and a sp. act. of 450 mCi.'mmol. 
Acetyl ['*F]hypofluoritc possesses a number of 
advantages over molecular ["Fjfluorinc as an elcciro-
philic labelling agcni. Compared lo ["FJfluorine it is 
considerably less \ioleni. and has a much greater 
solubility in a wider range of solvents. Its regio-
.selcctivity is noi necessarily beiier than that of 
['"Flfluorine. but dilfcrs according lo reaction circum-
stances [see, for example. Cocnen ci al. (1988)]. It can 
be prepared according lo a niicrochemical method 
(Jcwett (•/ al.. l9S4a. b) by passing dilute |'"F]fluorine 
through columns containing a complex of alkali 
metal acetate uith acetic acid. 
("FIF, - f AcOH .AcOK 
-r»FlAcOF-f['^FJHF-.AcOK 
Among the various acetates which have been 
tested, the ammonium, potassium and caesium salts 
give better yields than the corresponding sodium salt 
(Fowler ci al.. 1982). However, commercially avail-
able sodium acetate irihydraie gives similar results to 
acetic acid complexes (Bida ei al.. 1984). The practi-
cal radiochemical yield of acetyl ["Flhypofluorite 
from ['*F]fluorine is near theoretical (50%). 
These few examples serve to show the scope for 
converting CA ["Fjfluorine into more manageable 
and more useful 'electrophilic' labelling agents. Many 
other agents are in development (e.g. Satyamurthy et 
al. (1990b, c)l. Useful NCA electrophilic agents, par-
ticularly ["FJfluoroalkylating agents, can be prepared 
from NCA ("FJfluoride by, for example, nucleophilic 
substitution on alkyl dihalides (Coenen ei ai, 1986; 
Block et at., 1987) or alkyl ditosylates (Block ei al., 
1987). 
For nucleophilic processes the fluorine-18 is re-
quired as 'naked' NCA ['*F]fluoride (i.e. in the ab-
sence of water). Several procedures have been 
described for the recovery of NCA ["FJfluoride in a 
reactive form from "O-enriched water (e.g. Brodack 
et al. (1986); Schlyer et al. (1987, 1990); Jewett et dl. 
(1988, 1990); AlexofT « al. (1989); Hamacher et al. 
(1990)j. These deliver the ("FJfluoride in natural 
enrichment water or organic solvent. The strategy for 
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generation of reactive ["F]fluonde, is generally dis-
solution of the ("F]fluoride with a large counterion 
(e.g. K \ Cs\ Rb*, B U 4 N * or K^/Kryplofix) in a 
polar aprolic solvent. Where required, water (or 
other solvent) is removed by distillation from an 
added base (e.g. KOH, K X O j , R b X O j , 
E t . N ^ O H " , B u . N ^ O H - or KXOj-Kryptof ix) 
and the ["FJfluoride salt dried by, for example, 
azeotropic distillation with acetonitrile or even by 
microwaves. This salt is then solubilized in the 
solvent containing the substrate for nucleophilic 
attack. Resolubilization efficiency is affected by 
the reaction vessel, solvent and perhaps other factors 
such as metal ion contamination (Brodack ei at., 
1986). The intrinsic reactivity of the ["FJfluoride is 
affected by several factors, including cation and 
anion contaminants whose level are largely deter-
mined by the materials of target construction and 
operation (Nickles ci a!.. 1986). Cations, especially 
•Al'*, and Ca"', are probably most detrimental to 
successful chemistry. These contaminants can be 
avoided, if necessary, by purifying the ['~F-']lluoride 
by conversion into ('•Tjfiuorotrin-iethylsikinc. evapor-
ation and hydrolysis (Gatlcy. 1989). However, it 
is not usually necessary to adopi ihis procedure 
roiuinely. 
Fluorinc-18 as hydrogen ['"Flfluoride can be used 
for labelling arom.itic systems by the Schiemann or 
triazene decomposition reactions (Dc Rleijn. 1977; 
Ng CI al.. 1981; Barrio ci al.. 1983; Berridgc <-/ at.. 
1985; Satyamurthy ('( at.. 1990a). These methods are 
now seldom used because the Schicmann reaction 
requires carrier and the triazene decomposition 
reaction is generally low yielding. Reviews of fluor-
ine-18 chemistry have been published recently 
(Berridgc and Tewson. 1986a, b; Coencn. 1989; 
Kilbourn, 1990). 
Conclusion 
Satisfactory routine production of CA ('"FJfluorine 
is attainable with a suitably constructed, operated 
and maintained nickel target. The scope for improv-
ing recovery yield by, for example, the use of gold-
plated targets needs to be addressed. Also the 
scope for exploiting the '*0(p,n)'*F reaction for pro-
ducing CA ("FJfluorine in higher activity and specific 
activity is worthy of further attention. Careful atten-
tion to target design and operation now allows high 
activities of NCA ["FJfluoride to be produced in high 
activity, high specific activity and with excellent reac-
tivity from (he "0(p,n)"F reaction on '*0-enriched 
water. This is now clearly the method of choice for 
routine production. The recommended methods de-
pend greatly on the purity of the target substances for 
success. Industry should be stimulated to ensure that 
these materials, particularly "O-enriched oxygen gas 
and water, fluorine and inert gases, can continue to 
be available in adequate purity and at reasonable 
cost. 
References 
Alexoff D. . Schylcr D . J . and Wolf A. P. (1989) Recovery 
or["F]fluoride from ["0)waler in an electrochemical cell 
Appl. Radial, hoi. 40, I . ' , 
Alexoff D. L . , Casati R. , Fowler J . , Wolf A. P., Shea C fe' 
Schlyer D . and Shiue C . - Y . (1990) Ion chromatographic ' 
analysis of " F D G produced by ["F)fluoride displace- J'?-^  ' 
menl: production of 2-chloro-2-deoxy-D-glucose as an •• ' 
impurity in the presence of chloride ion. Proceedings of 
the Sih International Symposium on Radiopharmaceutical 
Chemisiry (In Press). 
Barrio J . R. . Satymurthy N. , K u H . and Phelps M. E . (1983) 
The acid decomposition of l-aryl-3,3-dialkyl-triazencs. 
Mechanistic changes as a function of aromatic subsli-
lution. nucleophilic strength and' solvent. J. Chem. Soc 
Chenj. Conmiun. 443. 
Berridge M. S. and Kicllslrom R. (1989) Fluorinc-18 pro-
duction: new designs for 0-18 water largeis. J. Label. 
Compd Radiopharm. 26, 188. 
Bcrridge M. S. and Tewson T . (1986a) Effects of target 
design on the production and utilization of |F-l8)-lluoride 
from (O-lSJ-ualer. J. Label. Coiiipd Radiopliann. 23 
1177. 
Berridge M. S. and Tewscn T . J . (l9S6b) Chemisiry of " F 
radiopharmaceulicals. .Appl. Radial, hot. 37, 685. 
Berridge .M, S.. Crouzel C and Coniar D. (I9S5) Aromatic 
lluorinaiion with N C A F-18 fluoride: a comparative 
study. 7, Label. Citiiipd Rudiiiphnrm. 22, 6X7. 
Bida G . T. , Ehrcnkauler R. E . . Wolf A. P.. Fowler J . S.. 
MacGregor R. R. and Ruih T . J . II9S0) The effect ot 
largci-^a> purity on the chemical form of F-18 during 
' " F - F . production using the neon/fluorine largci. J. Nucl. 
Med.'l\. :>-s. 
Bida G . T . . Satyamurlhy N. and Uarrio G . R. (I9S-1| The 
syniliesis of 1X)lluoro---deo.<.y.u-glucose using gly-
cais: a re-e.taniinalion. J. S'ucl. Med. 25, 1.127. 
Blessing G . Cocnen H . H . , Franken K. and Qaim S. M. 
(1986) Production of ( ' " F | F , . H'"F and " F , ^ using the 
•"'Netd.ai'T process. .Appl. Radial, hot. 37, 1135. 
Block D.. Coencn H . H . and Stockhn G . 11987) The N.C.A. 
nucleophilic 'T-duorinal ion of I .n-disubsiilutcd alkancs 
as fluoroalkvlaiion agents. J. Label. Compd Radiopharm. 
24. 1029. 
Brodack J . W.. Kilbourn M . R, . Welch M. J . and Katzenel-
Icnbogcn J. A. (I9,S6) N C A l6j-("Finuorocdsiradiol-
the elVecl of reaction vessel on fluorine-IS 
resolubilizaiion. product yield, and elfeciive specific 
activilv. .Appl. Radial. Isol. 37, 217, 
Cascila v.. Ido T . . Wolf A . P.. Fowler J . S.. MacGregor 
R. R. and Ruth T . J. (1980) Anhydrous F-18 labeled • 
elemental fluorine for radiopharmaceutical preparation. 
J. Nucl. Med. 21, 750. 
Chirakal R.. Firnau G . . Schrobilgen G . J . . McKay J. and 
Garnett E . S. (1984) The synthesis of ("F|xenon difluoride 
from ['"F]fluorinc gas. /nr. J. Appl. Radial, hoi. 35, 401. , 
Clark J . C . and Oberdorfer F . (1982) Thermal character-
istics of the release of fluorine-18 from an lnconei-600gas / 
target. / Label. Compd Radiopharm. 19, 1337. . 
Clark 1. C and Silvester D . J . (1966) A cyclotron method j . 
for the production of fluorine-18. Ini. J. Appl. Radial, x 
hot. 17. 151. 
Clark J . C , Goulding R. W. , Roman R. and Palmer A. J-
(1973) The preparation of fluorine-18 labelled compounds J^ ' 
using a recirculalory neon target. Radiochem. Radiodrtal.^>^ 
Lett. 14, 101. { i l S l 
Clark J . C . ei al. (1990) Unpublished results. . ••.W^; 
Coenen H . H . (1989) No-carricr-added " F chemistry .ok 
radiopharmaceuticals. In Synthesis and Applications ok 
hoiopically Labelled Compounds (Eds Baillie T . A . ' ^ a * 
Jones J . R . , pp. 443-448. Elsevier, Amsterdam, - ij*^ 
Coenen H . H . , Colosimo M . , SchuUcr M. and Slocklin 
(1986) Preparation of N . C . A . ( " F l - C H j B r F via ami,?' 
Recommendations for fluorine-IS production 761 
polycthcr supported nucleophilic substitution. J. Label. 
Compd Radiopharm. 23, 587. 
Coenen H . H . , Franken K . , Kling P. and Stocklin G . (1988) 
Direct eleclrophilic radiolluorination of phenylalanine, 
tyrosine and dopa. Appl. Radial. Isoi. 39, 1243. 
Crouzel C . and Comar D. (1978) Production of carrier-free 
i»F-hydrofluoric acid. /nr. J. Appl. Radial. Isol. 29, 407. 
Dahl J . R. and Schlyer D . (1985) Proceedings of hi Work-
shop on Targelry, Heidelberg, Germany. 
Dahl J . R. , Lee R., Bigler R. E . , Schmall B. and Aber J . E . 
(1983) A new target system for the preparation of no-
carrier-added "F-fiuorinating compounds. Ini. J. Appl. 
Radial. Isol. 34, 693. 
De Jesus O. T . , Martin J . A . , Yasillo N. J . . Gatley S. J . and 
Cooper M . D. (1986) ("FJFIuoride from a small cyclotron 
for the routine synthesis of ["F)2-fluoro-2-deoxy-glucose. 
Appl. Radial. Isol. 37, 397. 
De Kleijn J . P. (1977) Organic synthesis with fluorinc-18. A 
concise survey. J. Fluorine Chem. 10, 5341. 
Ehrenkaufer R. E . , MacGregor R. R. , Wolf A. P., Fowler 
J, S., Ruth T . J . . Schlyer D . J . and Wicland B. W. (1983) 
Production of M " F by dcutcron irradiation of a neon 
hydrogen larger Radiochiin. Ada 33, 49. 
Firnau G . . Chirakal R . and Garncit E . S. (1984) Aromatic 
radiofluorinaiion with ('"F]fluorine gas: 6-l"F]lluoro-
Dopa. J. .\-ucl. Med. 25, 1228. 
Fiischcn J. . Bcckmann R . Holm U . and Neuerl H. (1977) 
Yield and produciion of " F by 'He irradiation of water. 
hu. J. Appl. Radun. I.sol. 28, 781. 
Fowler J . S.. Shiuc C . Y . Wolf A. P.. Salvadori P. A. and 
MacGrcgor R . R . 11982) Synthesis of "F-labclled acetyl 
hypolluoriic for radiotracer synthesis. J. Label. Coinpd 
Rddiiipluirni. 19, 1634. 
Gaiidarias-Cru:' D. and Okamolo K . (19SS) Stalus on the 
compiiaiion ot nuclear daUi for medical radioisotopes 
produced by acceleraiors, I N D C (NDS)-209 /GZ. 
Galley S. J . (1989) Rapid production and trapping of 
['•*F]nuorolrimcihylsilane, and its use in nucleophilic 
fluorine-18 labeling wiihoul an aqueous evaporation step. 
Appl. Rcdiui. i.uii. 40, 541. 
Guillaume M. ei ol. (1990) Unpublished experimental 
results. 
Hamacher K . . Coenen H. H . and Stocklin G . (1986) 
Eflicient stercospecific synthesis of no-carrier-added 
2-|"F)fluoro-2-deoxy-i)-glucosc using aminopolyethcr 
supported iiucleophiiic substitution. J. Nucl. Med. 27, 
235. 
Hamacher K . . Blessing G . and Ncbeling B. (1990) C o m -
puter-aided synthesis ( C A S ) of no-carrier-added 
2-|'*F]nuoro-2-deoxy-D-glucosc: an efficient automated 
system for the aminopolyelhcr-supporled nucleophilic 
fluorination. Appl. Radial. Isoi. 41, 49. 
Helus F . . Maier-Borsi W., Sahm U . and .Wiebe L . (1979) 
F-18 cyclotron produciion methods. Radiochem. Radio-
anal. Lii. 38, 395. . 
Huszar I. and Weinrcich R, (1985) Production of '"F with 
an "O-enriched water target. J. Radioanal. Nucl. Chem. 
Leu. 93, 349. 
Iwata R., Ido T . . Brady F . , Takahashi T . and Ujice A. 
(1987) ("FJFIuoride production with a circulating 
["Olwater target. Appl. Radial. Isol. 38, 979. 
Jewell D . M . , Potocki J . F . and Ehrenkaufer R. E . (1984a) 
A preparative gas-solid-phase synthesis of acetyl hypo-
fiuorite. Synlh. Commun. 14, 45. 
Jeweti D . M . . Potocki J . F . and Ehrenkaufer R. (1984b) A 
gas-solid phase mjcrochemical method for the synthesis of 
acetyl hypofiuoritc. J. Fluorine Chem.. 24, 477. 
•lewett D . M . , Toorongian S. A . , Mulholland G . K . Watkins 
G . L . and Ki lboum M . R . (1988) Multi-phase extraction: 
rapid phase-tratisfer of ("FJfluoride ion for nucleophilic 
radiolabelling reactions. Appt. Radiat. Isot. 39, 1109. 
Jewett D . M . , Toorongian S. A . , Bachelor M . A . and 
Ki lboum M . R. (1990) Extraction of ["FJfluoride from 
("Ojwater by a fast fibrous anion exchange resin. Appl. 
Radial. Isol. 41, 583. 
Keinonen J . , Fonlell A. and Kaireto A . - L . (1987) EfTective 
small volume ["0|water target for the production of 
("FJAuoride. Appl. Radial. Isoi. 37, 631. 
Kilboum M . R. (1990) Fluorine-18 labelling of radio-
pharmaceuticals. Nuclear Science Scries NAS-NS3203, 
National Academy Press. Washington D C . 
Kilbourn M . R., Hood J . T . and Welch M . J . (1984) A 
simple " 0 water target for " F production. Ini. J. Appl. 
Radial. Isol. 35, 599. 
Kilboum M. R., Jerabek P. A. and Welch M . J . (19S5) An 
improved ("OJwaler target for ("FJ production. Ini. J. 
Appl. Radial. Isoi. 36, 327. 
Knust E . J . and Machulla H. -J . (1983) High yield pro-
duction of " F in a water target via the " 0 ( ' H e . p ) " F 
reaction. Ini. J. Appl. Radial. Isoi. 34, 1627. 
Lambrecht R. M . , Neirinckx R. and Wolf A. P. (1978) 
Cyclotron isotopes and radiopharmaceuticals X X l l l . 
Novel anhydrous 18F-fluorinaling intermediates. Ini. J. 
Appl. Radial. Isol. 29, 175. 
Lindner L . , Suer T . H . G . A., Brinknian G . A. and Veen 
Boer J .Th . (1973) A dynamic 'loop'-targel for ihc in-
cycloiron produciion of " F by ihe l60(a!.d)"F reaction 
on water. Ini. J. Appt. Radial. Isol. 24, 124. 
Mulholland G . K . . Hichwa R D. . Kilbourn . \ l . R. and 
.Vioskwa J, (I9S9) A rcliabie water largei for F - I S pro-
duction ai high beam currenis. J. Label. Compd Radio-
pharm. 26, 19"^ .^ 
Nebeling B. el al. (1990) Unpublished results. 
Nickles"R. J . . Daube M. E . and Ruth T. J. (1984) An ' ' O . 
large! for the production of [ " F J F . . Ini. J. Appl. Radial 
ISOI. 35, I 17. 
Nicklcs R. J . . Galley S. J , . Vouiw J . R. and Kornauih M. L . 
(1986) Produciion of reaciive fluorine-IS. Appl. Rndiai 
Isiu. 37, 649. 
Ng J. S., Kalzenellenbogen J . A. and Kilbourn M . R . ( I 9 S 1 ) 
Aromatic fluorinalions suitable for fluorine-IS labeling of 
estrogens. / , Org. Chem. 46, 2520. 
Nozaki T. , Iwamolo M. and Ido T. (1974) Yield of '*F for 
various reactions from oxygen and neon. Ini. J. Appl. 
Radial. Isol. 25, 393. 
Nozaki T . , Tanaka Y . . Shimamura A. and Karasawa T. 
(1968) The preparalion of anhydrous H F " . Ini. J. Appl. 
Radial, /.to/. 19, 27. 
Pascali C . Lulhra S. K . . Pike V. W., Price G . W.. Ahier 
R. G . . Hume S. P.. Myers R.. Manjil L . and Cremer J . E . 
(1990) The radiosynlhesis of | ' *FJPK 14105 as an alterna-
tive radioligand for peripheral type tienzodiazepine bind-
ing sites. Appl. Radial. Isol. 41, 477. 
Qaim S. M. (1982) Nuclear data rclevani to cycloiron 
produced short-lived medical isotopes. Radiochim. Aiia 
30, 147. 
Qaim S. M. (1986) Recent developments in the produciion 
of " F . '- ' ' -"Br and Appl. Radial. Isoi. 37, 803. 
Qaim S. M . and Stocklin G . (1983) Production of some 
medically important short-lived neulron-deficienl radio-
isotopes of halogens. Radiochim. Acta 34, 25. 
Qaim S. M. , Blessing G . and Stocklin G . (1987) Routinely 
used cyclotron targets for radioisotope production at 
K F A Julich, Proc. Second Workshop on Targeis and 
Targei Chemislry. Heidelberg, Germany, p. 50. 
Rozen S., Lernian 0 . and Kol M. (1981) Acetyl hypofluor-
ite, the first member of a new family of organic com-
pounds. J. Chem. Soc. Chem. Commun. 443. 
Ruth T . and Wolf A. P. (1979) Absolute cross sections 
for the production of " F via the " 0 ( p , n ) " F reaction. 
Radiochim. Acia 26, 21. 
Satyamurthy N . , Barrio J . R. , Schmidt D . G . , Kammerer 
C , Bida G . T . and Phelps M . E . (1990a) A d d -
catalysed thermal decomposition of l-aryl-3,3-dia]kyl-
triazenes in the presence of nucleophilcs. J. Org. Chem. 
55, 4560. 
Saiyaniuriliy N. . Bida G . T . , Phelps M . E. and Barrio J. R . 
(1990b) /V-l"F)Fluoro-/V-alkylsuironamides: novel re-
agents for mild and regiosclective radiofluorinalion. Appl. 
Radial, hoi. 41, 733. 
Satyamurthy N . , Bida G . T . , Phelps M . E . and Barrio J . R. 
(1990c) A'-Fluorolactams: rapid mild and regiospecific 
fluorinating agents. J. Org. Chem. 55, 3373. 
Schlyer D . J . , Bastos M . and Wolf A . P. (1987) A rapid 
quantitative separation of fluorine-18 fluoride from oxy-
gen-18 water. / . Nucl. Med. 28, 764. 
Schlyer D . J . , Bastos M . A. V. , Alexoff D . and Wolf A. P. 
(1990) Separation of ("FJfluoride from l'"0|water using 
anion exchange resin. Appl. Radial, hoi. 41, 531. 
Schrobilgen G . , Firnau G . , Chirakal R. and Garnel l E . S. 
(1981) Synthesis of ( " F l X e F , , a novel agent for the 
preparation of "F-radiopharmaceuticals. J. Chem. Soc. 
Chem. Commun. 198. 
Solin O . and Bergman J . (1986) Production of " F - F , from 
" O , . J. Label. Compd Radiopharm. 23, 1202. 
Solin O . , Bergman J . , Haaparanta M. and Reisscll A. (1988) 
Production of " F from water targets. Specific radio-
activity and anionic contaminants. Appl. Radial. I.wi. 39, 
1065. 
Steinbach J.. Gucnther K . . Loesel E . , Grunwald G , Mikccz 
P., Ando L . , Szelecscnyi F . and Beyer G . J . (1990) 
Temperature course in small volume |"Oiwatcr targets 
for ('"FlF-producllon. Appl. Radial, hoi. 41, 753. 
Straalmaan M. G . and Welch M. J. (1977) Fluorine-
18 labelled diethyl aminosulphur irifluoride (D.AST): 
an F - f o r - O H fluorinallng ageni. J. i\'ucl. Med. 18, 
151. 
Sunderland J . J . . De Jesus O. T . . Martin C . G . and Nickles 
R. J . (1939) Eleclrophilic F-18 from a small proton 
cyclotron. J. Nucl. Med. 30 (Supplement). 972. 
Sunderland J . J . , De Jesus O. T . . Solin O. and Nicklcs 
R. J . (1990) Radiolabelling of pre-synaplic dopaminergic 
tracers wiih eleclrophilic F-18 from a I I MeV proton 
cyclotron. J. Nucl. Med 31. 901. 
Tewson T. J . (19S9) Procedures, pitfalls and solutions in the 
production of (''F|2-deoxy-2-nuoro-D-glucose: a para- ' 
digm In the routine synthesis of fluorine-IS radiopharma-
ceuticals. Nucl. Med. Biol. 16, 533. 
Tilbury R. S., Dahl J. R., Mamacos J , P. and Laughlin J. s 'i 
(1970) Fluorine-18 production for medical use by helium^S 
3 bombardment of water. Int. J. Appl. Radial, hot n'^'i 
277. m 
Vera Ruiz H . (1988) Report of an International Atomic'-'"^ 
Energy Agency's Consultants' Meeting on fluorine-lj- •' 
reactor production and ulilizalion. Appl. Radiat. tsat 
39, 31. 
Vogt M . , Huszar 1.. Argenlini M . , Oehningcr H. and 
Weinrecih R. (1986) Improved production of l"F]fluoride 
via the |"01H;0(p .n)"F reaction for no-carrier-added 
nucleophilic syntheses. Appl. Radiat. hoi. 37, 448. 
Waters S. L . (1990) Determination of H , " 0 enrichment 
for " F targelry using a quadrupole mass spectrometer. 
Appl. Radiat. hot. 41, 686, 
Wieland B. W. and Wolf A . P. (1983) Large-scale pro. 
duciion and recoverv- of aqueous [F-18|nuoride using 
proton bombardment of a small-volume [0-18|u-aier 
target. Society of Suclear Medicine. St Louis, Missouri, 
7-10 June, 1983. 
Wieland B. W., Hendrv G . 0 . . Schmidt D. G . Bida G.and 
Ruth T . J . (I9S6I Elficient small volume 0-18 water 
targets for producing F-18 fluoride with low energy 
protons. J. Label. Compd Radiopharm. 23, 1205. 
Wieland B. W,. Bida G T.. Padgett H . C . and Hendry G. 0. 
(I9,S9) Current status of C T l target systems for the 
production of P E T radiochemicals. Proceedings of 3rd 
H'orkshop on Targeirv. Vancouver, Canada. 
Winchell H, S,. Well's D. K . . Lamb J . F . and Bcaudry S. B. 
(1976) Process lor preparing fluorine-18. U.S. Pat. 
3.981.769 
Wolf A. P. and Jones W. B. (1983) Cyclotrons for bio-
medical radioisoiope production. Rudiocliim. Ada 34, 1. 
Wolf A. P. et al. (19S51 Unpublished results. 
, K. T A T I M X W Q i 08S3-28S9/9I $3.00-f 0.00 ^ C Appl. Radial. Isol. Vol. 42, No. 7. pp. 621-628, 1991 . ^^ ^^  p^ ^^ ^ | | 
Ini. J. Radial. Appl. Insirum. Pan A i ) . v 
Printed in Greal Britain. All rights reserved 
Asymmetric Synthesis of a Precursor 
for the Automated Radiosynthesis of 
5'-(3'-r-Butylamino-2'-hydroxypropoxy)-
benzimidazol-2-[''C]one (^'-[••qCGP 12177) 
as a Preferred RadioHgand for -Adrenergic 
Receptors 
F R A N K B R A D Y ' , S A J I N D E R K. L U T H R A ' , H E N R I - J . T O C H O N - D A N G U Y ' 
C O L I N J. S T E E L ' , S T E P H E N L. W A T E R S ' , M A L C O L M J. K E N S E T T ' , 
P A T R I C I A LANDAIS'* , F A R A H SHAH' , K N U T A. J A E G G I ^ 
A L E X D R A K E \ JOHN C. C L A R K ' and V I C T O R W. P l K E ' f 
'MRC Cyclotron Unit, Hammersmith Hospital, Ducane Road, London W12 OHS, England. 
^Ciba Geigy AG, R-1058.5.52, 4002 Basel, Switzeriand and 
'Department of Chemistry, Birkbeck College, University of London, Gordon Street, 
London WCIH OAJ, England 
(Received 24 November 1990) 
5-[l-(2,3-Diaminophenoxy)J-3'-(A'-f-butylamino)propan-2'-ol has been synthesized in three steps from 
2,3-dinitro-phenol and the chiral auxiliary, S-glycidyl-3-nitrobenzenesulphonate, to provide a precursor 
for labelling S-(3'-/-butylamino-2'-hydroxypropoxy)-benzimidazol-2-one (S-CGP 12177) with the short-
lived positron-emitting radionuclide, carbon-11 (r|,2 = 20.4 min; =99.8%). Reaction of the diamine 
with ["CJphosgene, itself derived from no-carrier-added cyclotron-produced ["CJmethane, provides 
radiochemically and chemically pure S-{carbonyl-^^C\CG? 12177 in >95% enantiomeric excess 
after HPLC. Automated apparatus is described for safely producing up to 5.9 GBq (160 mCi) of 
5-["CJCGP 12177 with high sp. act. (20-40 GBq/;rmol or 0.54-1.08 Ci//tmol) in a form suitable for human 
intravenous injection at only 30 min from the end of radionuclide production. 5-["ClCGP 12177 is 
preferred to the formerly described ra'cemate as a radioligand for the study of ^-adrenergic receptors 
m vivo by positron emission tomography. 
In t roduct ion et al. (1986)], octanol-water partition coefficient (P) 
[see Main and Tucker (1985)] and fl-adrenergic 
Several antagonists have been labelled with carbon- . , , , . •. r o ; / m o ^ M 
/ -.r, . r,^ ^r.r.n,-, r , , r rcccDtor sub-typc selcctivity [scc Brcc fl/. (1986) . 11 (;|o = 20.4 min; j8+ = 99.8%) for the study of o c r i i / - iD i i • u- ui r w\ n 
„ , ' • • , . . , . /R,5-["C Propranolol is highly lipophilic (Log,o 
«-adrenergic receptors in heart in vivo by positron „ -, - .u u- i . a : . r t - i i x^is u . 
• . T u / D ^ - ^ ^ r c . r . n o o M = 3.65) With high affinity (A^p, 1,1 nM) but very 
emission tomography (PET) [see Syrota (1988), , , . i .• •. c n • . • . 
1 r, o 1 w t . ; ir ,o-i\ n e- low sub-typc Selectivity. FoUowing i.v. injcciion into 
namely ^,5-propranolol (Berger 198^ R,S. ^^^^ radioligand ts almost completely (98%) 
practolol (Berger et a/ 1983 S-pindolo (Prenant ^ ^ i ^ et al., 1986) and R,S-CG? 12177 (Boullais et al., . ui c- .u . u A-' . ' ,. ,. , • £c •. r n '5 non-saturable. Furthermore, the myocardium 
1985).I These radioligands differ in affinity [see Bree . i- j u m-r- , i< • r. ' * ^ •' ' cannot be visualized by PET, even at 75 min after 
injection o f the radioligand (Syrota, 1988). 
•Present address: CERMEP, Cyclotron Biomedical de /?,S-["C]Practolol is much more hydrophilic 
Lyon, 59 Bd Pinel, 69003 Lyon, France. (Log,o P = 0.79) with selectivity for the ^ , sub-type, 
tAuthor for correspondence. ^h ich predominates in myocardium. Following i.v. 
ISeveral racemic fluoroalkyl derivatives of the high affinity . . . . .u- A- y A \, A ^ 
^-adrenergic receptor antagonist, carazalol, have also '"J^'^t'"" '"^o man this radioligand shows rapid up-
been labelled recently with fluorine-18 (r.^, = 109.6 min; take into myocardium enabling its visualization by 
=96.9%) (Kinsey and Tewson, 1991). PET. However, clearance of radioactivity f rom the 
621 
622 F R A N K B R A D Y ei al. 
myocardium is fast and bound radioligand cannot be 
displaced by large saturating doses of any of a range 
of ^-receptor antagonists (Dormont et al., 1983). 
On a simple theoretical basis the maximal binding 
potential of a radioligand for its receptors is given by 
^max/^D vitro, whcrc is the receptor concen-
tration, and should exceed 10 for a real possibility of 
using the radioligand to measure receptors in vivo 
(Eckelman, 1982). Hence the failure to observe 
specific receptor binding is consistent with the rela-
tively low affinity (K^, 110 nM) of /?,5-practolol for 
^-receptors. 
^ - ["CjPindolo l has a high receptor affinity {K^, 
1.3 n M ) , similar to that of /?,5'-propranolol, but is 
much less lipophilic (Logio P = 1.75) and again has 
very low sub-type selectivity. However, an evaluation 
of its behaviour as a PET radioligand has been 
reported only briefly and not in man. Uptake in dog 
myocardium and displacement by excess pindolol has 
been reported but not in detail (Seto et al., 1986). 
R,S-CGP 12177 (Fig. 1) is a potent (Ko, 0.3 n M ) , 
hydrophilic (Log,o = 181) antagonist for both ^ | -
and ^2-adrenergic receptors. It shows low non-specific 
binding to membranes and low cellular uptake 
(Staehelin and Hertel, 1983; Staehelin ei at.. 1983) 
and does not bind lo internalized receptors (Staehelin 
and Hertel, 1983). /?,S-["C]CGP 12177 has been 
reported as a promising radioligand for PET studies 
of ^-receptors in heart (Seto et at., 1986). On this 
basis, ^^.^-["CICGP 12177 appears best suited of the 
known radioligands to specific measurements of cell-
surface 'functionally active' ^-adrenergic receptors 
in vivo. 
However, studies in vitro with R,S- and 
/?-[ 'H]CGP 12177 show that the S'-enantiomer has 
approximately 80-fold greater affinity than the 
7?-enantiomer for /?-adrenergic receptors (Affolter 
et at., 1985). Also studies of 5-, R-and /?,5-['H]CGP 
12177, injected i.v. into rats, have-shown that 
the S-enantiomer gives approximately two-fold 
greater specific signal as represented by the ratio of 
)S-receptor-bound radioligand to non-specifically 
bound radioligand, both in heart and in lung (Law 
and Burgin, 1989). I t is well known that relatively 
inactive enantiomers of stereospecific receptor ligands 
may exhibit differential metabolism [see Testa 
(1986)], protein binding [see Simonyi et al. (1986)], 
biodistribution [see Testa et al. (1986)], toxicity [see 
(CH3)3C 
Ariens el al. (1986)], pharmacokinetics [see Wallc 
and Walle (1986)] and pharmacological effect (see 
Lehmann (1986); Ariens (1986)]. Such differences are 
particularly well documented for ^-receptor radio-
ligands [see, for example. Lennard et at. (1983); Walle 
et al. (1983); Gut et al. (1984); Wilson and Thompson 
(1984) ; Sager et al. (1985); Richards and Tattersfield 
(1985) ]. On this basis, it would clearly be preferable 
to use the S'-enantiomer of ["C]CGP 12177, rather 
than the racemate, for PET studies of ^-adrenergic 
receptors in both the heart and lung. One approach 
to obtaining the S-isomer is to replace the racemic 
diamine, [l-(2,3-diaminophenoxy)]-3'-(A'-f-butyl-
amino)propan-2'-ol, with the S-isomer (V) in the 
radiosynthesis from nca ["C]phosgene described by 
Boullais et al. (1985). 
A 12-step synthesis of 5-CGP 12177 from 2,3-di-
aminophenol is known, but does not proceed through 
the diamine enantiomer V (Affolter ei at., 1985) and 
is inapplicable to the preparation of "C-labelled 
^-CGP 12177. We have previously described one 
approach to the synthesis of the diamine enantiomer 
V (Brady et at., 1991). based on the known ability 
of enantiomerically pure S-glycidyl-3-nitroben2ene-
sulphonate (II) to react rapidly and efiiciently with 
phenoxide ions (Klunder ei at., 1986, 1989) and of the 
epoxide rings of the resultant epoxy ethers to open by 
reaction with amines, giving products in which the 
configuration of the original glycidyl ester is retained 
(Klunder et at., 1986). Problems with deprotection, 
due to the instability of the diamine V in basic media, 
led to very low yields ( < l . 5 % ) . Here we report 
an alternative and more efficient approach to the 
asymmetric synthesis of the diamine V and describe 
its use in a safe automated radiosynthesis o f 
5-["C]CGP 12177 (VI) from nca ["C]phosgene (Fig. 2). 
Experimental 
Materials 
F i g . I . Structure of C G P 12177 showing numbering system 
used in nomenclature and in assigning its " C - N M R data . 
7? ,5 - [ l - (2 ,3 -d iaminophenoxy) ] -3 ' - (A ' - / -bu ty l -
amino)propan-2'-ol and 2,3-dinitrophenol (I) were 
donated by Dr K. A. Jaeggi of Ciba-Geigy, Basel 
(Switzerland). Reference R-and S-(3'-;-butylamino-2'-
hydroxypropoxy)benzimidazol-2-one (CGP 12177), 
that had been synthesized by routes independent 
to that described in this paper, were also donated by 
D r K . A. Jaeggi. Other chemicals and solvents were 
purchased as follows: II , sodium hydride, A'.A'-
dimethylformamide (DMF) , f-butylamine, 5% pal-
ladium on carbon (Aldrich Chemical Co. Ltd); 
chloroform, ethanol, ethyl acetate and propan-2-ol 
were H P L C grade (Fisons); chlorine gas, research 
purity (Union Carbide). Other reagents were o f 
'Analar' quality. 
Methods 
Mass spectrometry, with a quadrupole mass spec-
trometer (Nermag RlO/lOC), was used to investigate 
the content of crude reaction mixtures and partially 
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Fig. 2. Synthesis of S-diamino precursor V and its reaction with ["CJphosgene to give V I . 
isolated products, as well as the structures of purified 
products. Samples were introduced into the ioniz-
ation source of the spectrometer using the probe 
facility and vaporized by passing a current through 
the probe filament. The spectrometer was calibrated 
conventionally using FC-43 (perfluorotributylamine) 
and run in the electron impact (EI) mode or tuned for 
positive or negative ions in the chemical ionization 
(CI +ve or - v e ) mode, using ammonia as reactant 
gas. Spectral data were collected using a PDP 11/23 
(Digital Computers) and analysed using the Sidar 
software programme (Nermag). 
Proton-decoupled '^C-NMR spectroscopy was 
performed on a Bruker W M 250 spectrometer at 
62.9 MHz, with D E F T editing for multiplicity at 
King's College N M R Service, University of London. 
Circular dichroism was performed on a Jasco J-600 
spectrophotometer at the National C D Service 
( S E R C ) , Birkbeck College, University of London. 
Preparation ofS-[l-(2,3-dinitrophenoxy)]-2',3'-epo.xy-
propane (III) 
2,3-Dinitrophenol (I) (1.5 g, 8 mmol), containing 
20% water, was dissolved in dry D M F (5 mL). 
Anhydrous magnesium sulphate {ca 3 g) was added 
and the suspension was allowed to stand for 1 h. The 
magnesium sulphate was removed by filtration and 
washed with dry D M F (3 mL). The orange solution 
of 2,3-dinitrophenol was cooled to ca - 5 ° C . A 
suspension of sodium hydride (0.2 g, 8 mmol) in dry 
D M F (2mL) was then added under nitrogen. The 
reaction mixture was stirred for 15 min. A solution of 
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I I (1.75 g, Vmmol) in dry D M F (3 mL) was then 
added dropwise and the reaction mixture stirred at 
room temperature for ca 4 h. Reaction progress was 
monitored by T L C on silica layers using ethyl acet-
ate/ethanol (80/20, v/v) (;?r values: I = 0.87; I I = 0.91; 
I I I = 0.17) and also by mass spectrometry (CI mode). 
The reaction mixture was cooled in ice and a 
saturated aqueous solution of ammonium chloride 
(1 m L ) was added slowly. The mixture was then 
extracted with chloroform (3 x 20 mL) . The chloro-
form extracts were combined, washed successively 
with saturated sodium bicarbonate solution 
(2 X 40 mL) and water (2 x 40 mL) , dried over mag-
nesium sulphate, filtered and evaporated under re-
duced pressure to give a pale orange solid. This was 
washed with pentane and dried under vacuum giving 
the pale yellow epoxypropane ( I I I ) (0.7 g, 43%). 
Characterization: '^C-NMR (DMSO-dJ : 5 (ppm), 
C , 151.8(C); C 2 , 130.6 (C); C3, 141.3(C); C,, 117.8 
(CH); C 5 , 132.8 (CH); C^, 122.1 (CH); C , , 72.2 
{CHj)\ Cr, 50.2 (CH); C3., 44.2 (epoxide-CH^). Small 
peaks were also observed at 125.0 and 121.4 ppm. 
For comparison I in CD3OD gave: 6 (ppm), C,, 152.2 
(C); C„ 134.5 (C), C3, 142.4 (C); C„ 116.3 (CH); 
C5, 132.5 (CH); C^, 124.7 (CH) and the glycidyl 
compound I I in DMSO-d j gave S (ppm) C,, 138.5 
(C), Cj, 123.6 (CH); C3, 149.3 (C); C 4 , 129.5 (CH); 
C5, 132.4 (CH); C,, 134.4 (CH); C, , 79.7 (CH^); C^., 
49.5 (CH); C,., 44.6 (epoxide-CHj). 
Mass spectrometry: in CI -t-ve mode, m/z =258 
[ M + N H 4 ] % 275 ' [ M + N H 3 + NH4]-' and 292 
[M- t -2NH3- f -NH4] + , and in EI mode, m/z =240 
[My (12%), 184 (27%), 167 (4%), 164 (5%), 121 
(4%), 107 (3%), 93 (13%) and 57 (100%). For 
comparison I gave: in CI +ve mode, m/z =202 
[M + 'NH.y, 219 [ M - F N H 3 - h N H 4 ] + and 236 
[ M + 2NH3 + NH4] + , and in E I mode, w/z = 184 
[ M ] ^ (56%), 126 (12%), 121 (5%), 109 (38%), 107 
(4%), 96 (6%), 93 (36%) and 63 (100%). The glycidyl 
compound I I gave in CI -l-ve mode, mjz =211 
[ M - I - NH4]+ and 294 [ M - I - N H 3 + NH4]+, and in E I 
mode, mjz = 204 (15%), 186 (100%), 11 (14%), 170 
(10%), 122 (59%), 92 (40%) and 76 (85%). A 
molecular ion at m/z = 259 was not observed in E I 
mode. 
Preparation of S-[l-(2,3-dinitrophenoxy)]-3'-(N-t-
butylamino)propan-2'-ol (VI) 
A suspension of 5-[l-(2,3-dinitrophenoxy)]-2',3'-
epoxypropane ( I I I ) (0.38 g, 1.6 mmol) in propan-2-ol 
(5 m L ) was added to freshly prepared r-butylammo-
nium /-butylcarbamate. The latter was prepared by 
passing carbon dioxide through a solution of f-buty-
lamine (0.3 g, 4 mmol) in diethyl ether (2 mL) at O X 
until only a white solid remained. The reaction 
mixture was stirred under nitrogen and heated on 
an oi l bath at 80°C for ca 2 h . Reaction progress 
was monitored by T L C on silica layers using ethyl 
acetate/chloroform (70/30 v/v) (/?f values, H I = 0.57; 
I V = 0.07) and also by mass spectrometry (CI mode). 
Upon completion of ihe reaction the solvent was 
removed under reduced pressure giving the amine IV 
as an orange oil (0.4 g, 80%). 
Characterization: ' X - N M R (CD3OD) d (ppm), C, , 
152.6 (C); C j , signal not observed; C j , 142.0 (C); C 4 , 
1I7.7(CH); C5, 132.8 (CH); C^, 121.8 (CH); C, , 74.1 
( C H 2 ) ; C j . , 69.9 (CH); C3., 46.0 (amino-CHj); C4-, 
51.3 (C); C5., 28.8 (CH3) . 
Mass spectrometry: in CI -t-ve mode, mjz =314 
[ M - l - H ] * and m EI mode, m/z = 298 (100%), 269 
(5%), 116 (4%), 114 (5%), 100 (4%), 93 (5%) and 
86 (3%). A molecular ion at / H / Z = 313 was not 
observed in El mode. 
Preparation of S-[l-(2.3-diaminophenoxy)]-3'-(N-i-
butylamino)propan-2'-ol (V) 
To a solution of 5-( l-(2,3-dinitrophenoxy)]-3'-(A'-
^-butylamino)propan-2'-ol (IV) (0.4 g, 1.3 mmol) in 
ethanol (15 mL) was added 5% palladium/carbon 
(0.5 g) under nitrogen. Hydrogen was passed through 
the reaction mixture for ca 4 h al room temperature. 
Reaction progress was monitored by T L C on RP-C|g 
layers (Merck) using eihanol as mobile phase (R; 
values; IV = 0.55; V = 0.47) and also by mass spec-
trometry (CI mode). The catalyst was removed by 
filtration and washed with hot ethanol. The ethanol 
was removed under reduced pressure giving a brown 
oil (0.25 g, 77%). Portions of this crude product were 
purified by HPLC on a silica gel column (/i-Porasil, 
30 cm X 7.8 mm i d.. Waters Associates Inc.) eluted at 
3.0mL/min with a mobile phase of ethanol/ethyl 
acetate (80/20, v/v) giving the diamine V with a 
retention time of ca 20 min. 
Characterization: '^C-NMR (CD3OD) S (ppm) C, , 
149.0 (C); C j , 124.6 (C); C3, 136.8 (C); C4, 104.5 
(CH); C5, 120.1 (CH); C^, 111.3 (CH); C,-, 72.7 
( C H 2 ) ; C^., 70.6 (CH); C3. 46.1 (amino-CH,); C4-, 
51.4 (C); C5., 28.7 (CH3) . 
Mass spectrometry: in CI -l-ve mode, mjz =254 
( M - I - H ] ^ and in E I mode, m/z = 253 (M]+ (22%), 
238 (8%), 166 (5%), 163 (5%), 130 (10%), 124 
(100%), 112 (27%) and 95 (41%). 
Radiochemistry 
(a) Production of nca ("Cjmethane 
nca ["Cjmethane was produced using a Scandi-
tronix M C 4 0 (Mark I I ) cyclotron by the "'N(p, a ) " C 
nuclear reaction on nitrogen containing hydrogen 
(5%) at a total initial pressure of 1400 kN/m (210 psi) 
in an aluminium gas target. Typically, bombardment 
was carried out for 20 min with a 30 / iA beam of 
19 MeV protons. A t the end of bombardment (EOB), 
the radioactivity {ca 74 GBq or 2 Ci) was transferred 
to the "hot-cell" (Fig. 3) through a pressure regulator 
set at 100 k N / m (15 psi) at 1.5-2 L/min and then a 
dual trap containing soda lime and phosphorous 
pentoxide to remove all traces of carbon dioxide and 
water. A l l subsequent radiochemistry was performed 
within this hot-cell with automatic external control 
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Fig. 3. Scheme for the automated radiosynthesis of VI. The apparatus is contained in a 'hot-cell' (85 mm 
thick lead shielding) and all operations are controlled externally. Cooling baths are raised and lowered 
from Porapak Q traps 1 and 2 by means of mechanized iab jacks (using pneumatically actuated valves). 
Valves 1-12 are of the following types: I and 2, stainless steel, solenoid; 3-8, 11 and 12, P F T E , solenoid; 
9, four-port teflon rotary, pneumatic, Rheodyne; and 10, six-port stainless steel rotary, pneumatic. 
Rheodyne. In a typical procedure, the labelled ["CJmethane is delivered to Porapak Q trap 1 and then 
concentrated mlo trap 2, by actuating valves 1 and 2, Valves 4 and 5 control the transfer of ("CJmethane 
to the homogenization cell that has previously been filled with chlorine. At this stage, valve 6 controls 
the flow of oxygen which carried the mixture of ["Qmethane and chlorine through the first furnace for 
conversion into ["C]carbon tetrachloride and then through the second furnace for conversion into 
["C]phosgene. ["C]Phosgene is passed into a solution of the diamine V by opening valve 9 and the solvents 
are then removed using a hot air blower. Rotary valves 9 and 10 are used to recover the crude radioactive 
product and to inject onto the H P L C column. Valves 11 and 12 are used to collect the fraction containing 
pure product (VI). 
for safety, as further described in the legend to Fig. 3. 
The ["Qmethane was trapped in a stainless steel 
U-tube (140 x 4 mm i.d.) filled with Porapak Q 
(80-100 mesh, Water Associates Inc.) immersed in 
l iquid nitrogen ( - 196°C). This trap was then flushed 
with helium (15 mL/min) to discard any nitrogen and 
hydrogen, originating f rom the target, to waste. The 
["qmethane was then transferred to a second smaller 
stainless steel U-tube (55 x 1.5 mm i.d.), also filled 
with Porapak Q, and immersed in liquid nitrogen to 
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concentrate the nca ["CJmethane into a small volume 
{ca 1 mL) . 
(b) Radiosynlhesis of nca ["CJphosgene 
The second Porapak Q trap was allowed to warm 
to room temperature and the ["Cjmethane was trans-
ferred by helium flow (5 mL/min) to the homogeniz-
ation cell, which had previously been loaded with 
chlorine (50 m L at 1 aim). The transfer of radio-
activity was monitored by a radioactivity detector. 
When optimal transfer had been reached, a stream of 
oxygen (ca 15 mL/min) was used to carry the mixture 
of ["Qmethane and chlorine out of the homogeniz-
ation cell through a 1:5 mixture (3 g) of pumice stone 
impregnated with cupric chloride and neutral pumice 
stone, heated by an oven (Carbolyte, 150 mm length) 
set at 390°C. The generated ["C]carbon tetrachloride 
was then carried by the oxygen stream through iron 
filings (1.5 g), heated by a second identical oven set at 
290°C. The generated nca ["C]phosgene was then 
passed through a glass tube (100 x 5 mm i.d.) filled 
with a mixture of antimony powder (400 mg) and 
glass beads (1 mm dia) in order to remove any 
residual chlorine or chlorinated compounds. 
(c) Radiosynthesis of nca Sf'CJCGP 12177 (VI) 
["C]Phosgene in oxygen was gently bubbled into 
an open conical glass vial containing a solution o f V 
(0.2 mg, 0.8/ imol) in dichloromethane (100/ iL) di -
luted with toluene (100/^L). ["C]Phosgene was led 
into the reaction vial by the stream of oxygen. The 
accumulation of radioactivity was monitored and 
continued until maximal (generally for ca 5 min). 
Solvents were then removed from the reaction mix-
ture by heating the vial with a hot air blower, set to 
give temperatures o f 95°C for 1 min followed by 
125°C for 2 min. The radioactive residue was cooled 
to room temperature with cold air and taken up into 
1.2 m L of the H P L C mobile phase [a mixture of 
disodium hydrogen phosphate solution (0.03 M , 
p H 6.0) and ethanol (85:15, v/v)]; and loaded 
onto a divinylbenzene column (RPl , Hamilton, 
30.5 X 0.7 cm i.d.), e;luted at 2 mL/min. The eluate 
was monitored continuously for radioactivity and 
for absorbance at 254 nm. The radioactive fraction 
{ca 4 m L ) containing the nca 5-["C]CGP 12177 (VI) , 
having a retention time of 9.2 min, was collected and 
ethanol removed by heating i f required. The solution 
was sterilized by millipore filtration (Milex GS, 
0.22 / i m , Mill ipore) . This solution was diluted to 
B m L wi th saline (1.8% w/v) and was ready for i.v. 
injection subject to satisfactory quahty control. The 
final p H of this solution was 6.0. The radiosynthesis 
takes 30 min f rom BOB and typically provides 
3.7-5.9 GBq (100-160 mCi) of V I ready for clinical 
use. The retention time of the 5-diamino precursor V 
was 4.5 min. A stable impurity also eluted at 7 min. 
Characterization and analysis. A sample o f the 
formulated product (100/^L) was analysed on a 
column (Nucleosil-5 C,,, 25 x 0.46 cm) eluted at 
0.7 mL/min with a mixture of dipotassium hydrogen 
phosphate solution (0.07 M , pH 4.5) and methanol 
(70/30, v/v). A single radioactive peak with the same 
retention time (7.8 min) as authentic COP 12177 was 
observed. Radiochemical and chemical purity were 
greater than 99%. The specific activity of V I was 
found to be in the range 55-111 GBq//(mol 
(1.5-3 Ci///mol) decay-corrected to EOB, corre-
sponding to the presence of 3-6/;g of stable 
CGP 12177 (carrier) in the injected dose. 
A sample for formulated V I was analysed during 
and after radioactive decay by mass spectrometry (El 
and CI -l-ve mode). The spectra obtained were 
identical to those of reference CGP 12177. 
Further validation of the radiosynthesis. The appar-
atus and procedure described for the radiosynthesis 
of V I were applied to prepare non-radioactive 
S-CGP 12177 from the 5-diamino precursor V 
(0.2 mg, 0.8/(mol) and target gas in an identical 
manner, except that no proton irradiation was per-
formed. It is known from the specific activity 
measurement on radioactive product that the radio-
synthetic procedure also gives carrier {vide supra). 
The collected fraction was analysed by HPLC as 
described above and the chemical purity was found lo 
be > 9 9 % . Solvent was removed from the collected 
HPLC fraction under reduced pressure. 
Mass spectrometry of the residue gave spectra 
identical to authentic R.S-CG? 12177, i.e. in CI -t-ve 
mode, / ) i / z = 280 [ M - h H ] * and 297 [ M - i - N H , ] ^ 
and in EI mode ml- =219 [My (20%), 264 
[ M - C H j ] ^ (12%), 189 (8%), 150 (13%), 149 (8%), 
121 (12%), 86 (100%) and 71 (27%). 
" C - N M R of authentic R,S-CGP 12177 in DMSO-
d j gave 5 (ppm) Q , 143.9 (C); C;3, 119.7 (C); C, , . 
131.7 (C); C, , 106.1 (CH); C^, 122.7 (CH); C,, 104.1 
(CH); C,., 71.3 (CH,) ; Cv, 66.9 (CH); C^., 45.3 
( C H j ) ; C,.. 58.0 (C); C^., 25.7 (CH,) ; C,, 157.1 
( C = 0 ) . Numbering which differs from components 
I - V is shown in Fig. 1. 
Determination of enantiomeric e.Kcess. The circular 
dichroism of the residue (ca 2/ig) was measured in 
methanol and gave a value of -f 0.6 mdeg/absorbance 
unit at 270 nm. Authentic samples of S-CGP 12177 
( [a]D= - 1 3 + 1 ° , [ a ] 3 , 3 = - 4 8 ° ) and R-CG? 12177 
( [ a ] p = - 1 - 1 4 + 1 ° , [ a ] , „ = + 4 9 ° ) were measured 
under identical conditions and gave CD values of 
+ 0.68 and —0.68 mdeg/absorbance unit, respect-
ively. The compound synthesized by the above 
procedure f rom the precursor V is unequivocally 
identified as containing > 9 5 % 5'(-)-enantiomer and 
< 5 % /?( + )-enantiomer, corresponding to an e.e. 
(enantiomeric excess) of >90%. 
Discussion 
Our aim was to radiolabel the 5-enanliomer of 
CGP 12177 with the positron-emitting radionuclide, 
ca rbon- l l , for evaluation as a radioligand for PET 
studies of ^-adrenergic receptors in lung and heart. 
Asymmetric synthesis of S-["C]CGP 12177 627 
^,S-CGP 12177 has previously been labelled with 
carbon-11 by reaction of ["CJphosgene with /?,S-[1-
(2,3-diaminophenoxy)]-3'-(/V-/-butylamino)propan-
2'-ol. We were unable to resolve this precursor, or its 
progenitors, by H P L C (Brady et al., 1991) using any 
of a number o f different chiral columns, including 
Chiralcel O D and Cyclobond I . These columns also 
failed to resolve racemic CGP 12177. We therefore 
sought a convenient synthetic route to the S'-enan-
tiomer of the precursor V for use in the radiosynthesis 
of 5- ["C]CGP 12177. 
That 5-propranolol has been synthesized by 
the reaction o f (25)-glycidyl tosylate with sodium 
1-napthoxide, followed by ring opening with iso-
propylamine (Klunder et al., 1986), led us to consider 
the use of (25')-glycidyl tosylate for the synthesis of 
the 5-diamino precursor V. However, a recent report 
shows that the asymmetric synthesis of 5-^-receptor 
ligands is greatly improved by the use of S'-glycidyl-
3-nitrobenzenesulphonate in place of 5-glycidyl 
tosylate (Klunder et al., 1989). Under appropriate 
conditions the reactions of aryl oxides with the 
latter chiral auxiliary proceed not only faster than 
with 5-glycidyl tosylate but also in some cases with 
almost complete retention of configuration. This rate 
enhancement is advantageous since the aryl epoxy 
ether is exposed to nucleophilic aryl oxide for a 
shorter period leading to higher yields. These con-
siderations prompted us to use 5'-glycidyl-3-nitroben-
zenesulphonate ( I I ) in the synthesis of the S-diamino 
precursor V as a precursor to V I . 
Our initial approach (Brady ei al., 1991) proceeded 
with the reduction of I to 2,3-diaminophenol fol -
lowed by acetylation of the sensitive amino groups 
to give 2,3-diacetylaminophenol. Treatment of the 
latter with sodium hydride generated the phenoxide 
ion which was allowed to react with 5'-glycidyl-3-
nitrobenzenesulphonate I I to give 5'-[l-(2,3-diacetyl-
aminophenoxy)]-2',3'-epoxypropane. Refluxing the 
latter epoxide wi th /-butylamine gave 5'-[l-(2,3-di-
acetylaminophenoxy)]-3'-(A'-/-butylamino)-propane-
2'-ol. The acetyl protecting groups were removed by 
refluxing wi th potassium hydroxide to give the di-
amino precursor V. However, the instability o f V in 
the basic media used for deprotection led to very low 
yields ( < 1.5%) [e.g. 3 g of I gave only 50 mg of V). 
We sought therefore to circumvent these problems by 
building the side chain onto the di-nitro compound I 
first, and reducing the nitro groups in the last stage 
go give the di-amino precursor V, thus reducing the 
synthesis to three steps. 
In our second approach, described here (Fig. 2), 
the phenoxide ion of I was generated by reaction of 
I wi th sodium hydride in D M F under nitrogen and 
is allowed to react, in the same pot with I I , to give 
I I I . The epoxide ring o f I I I opens by reaction with 
refluxing /-butylamine giving crude IV as an orange 
oi l . The latter hydrogenates at room temperature 
over palladium on carbon in ethanol giving crude 
di-amino precursor V as a brown oil in an overall 
yield of 24% f rom I . Final purification of V is 
achieved by preparative HPLC on a normal phase 
column (Lichrosorb Si-60) using methanol as elueni. 
Compounds I to V I were characterized by mass 
spectrometry and " C - N M R spectroscopy. Mass 
spectroscopy (CI mode) was also used to monitor the 
progress o f all reactions (Waters et al., 1990). The 
radiosynthesis o f carbon-11 labelled S-CGP 12177 
f rom V was performed in a fully automated system 
(Fig. 3) using nca ["C]phosgene, itself prepared ac-
cording.to Landais and Crouzel (1987). Typically, 
this system delivers ca 5 GBq of radiochemically and 
chemically pure V I with a sp. act. up to 50 GBq//imol 
at 40 min after EOB. By operating this system in a 
non-radioactive mode it was directly demonstrated 
that the enantiomeric excess of product is greater 
than 90%. ^- ["CICGP 12177, prepared in this appar-
atus f rom the precursor V, is now being applied to the 
study of ^-receptors in heart and in lung with PET. 
and also in biological experiments. Results will be 
pubHshed elsewhere. 
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Summary 
A robust, highly sensitive system is described for monitoring the concentration of positron emitiini: 
radioisotopes contained within arterial blood continuously withdrawn dring PET studies of the brain. 
Ut i l iz ing a specially designed flow-through bismuth germanate detector, gammas arc more efrcctivel;. 
counted, replacing the less efficient method of positron detection with plastic detectors. A polvtcirafluo-
roethylene f low path system has been developed to overcome the problem of highly cohesive tracers 
adhering to the tubing material. 
Blood is drawn through the system f rom the radial artery by a medically approved peristaltic pump. 
Syringe samples of blood are extracted periodically downstream of the detector, for calibrations, plasm; 
assays, metabolic analysis and physiological measurements. 
The complete system, including efficient heavy lead shielding is contained on a bedside trolley. 
Blood activity is continuously recorded throughout the PET uivestigaiions, and stored dirccily by the 
scanning computer, and additionally backed up on disc by a P.C. 
Introduction 
A f low-through detector has been developed which 
consists of 2 bismuth germanate ( B G O ) crystals 
mounted on a single photomultiplier tube. This 
affords the opportunity for measuring either the 
summed (coincidence) 1022 keV peak or, for maxi-
mum sensitivity, the combined 511 keV and 
1022 keV peaks. The length of tubing monitored 
traverses a hair-pin pathway through the detector. 
This maximises the volume of blood detected with-
out having to increase the internal diameter of the 
tubing and hence the need for connectors whic. 
cause additional dispersion. Although background 
counts can be minimised by counting only the 
1022 keV coincidence peak, in practice, through 
the use of heavy lead shielding, both the 511 ke\ ' 
and 1022 keV peaks are recorded to maximise sen-
sitivity. The detection of annihilation photons b 
preferred to counting emitted positrons, using a 
beta counter, since larger volumes of blood can b: 
monitored, and more reproducible calibrations ca.-
be realised. The count rate performance of the 
B G O assembly is found to be adequate for cl inici l 
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r/s;. /. Schematic diagram of on-line whole blood deieciion 
system. 
PET studies. When counting the combined 511 and 
1022 keV peaks, the deadtime at 10,000 counts per 
second is of the order of 1%. 
Particular consideration has been given to the 
material f r om which the withdrawal tubing is 
made. Experience has shown that sterile polythene 
tubing, commercially available for blood with-
drawal, results in certain radiotracers sticking to 
the wall of the tubing. This causes incorrect con-
centrations being monitored due to pick up of the 
tracer between the patient and the detector and 
retention of the tracer within the length of tubing 
contained within the detector itself. To minimise 
these effects, polytetrafluoroethylene (PTFE) has 
been found to be the optimal material for the with-
drawal tubing. This has resulted in the commercial 
manufacture of sterile lengths of PTFE tubing f i l -
led with luer connectors specifically for PET stud-
ies. 
A peristaltic roller pump has been used down-
stream f rom the detector for withdrawal. Experi-
ence has shown that most high grade pumps, as 
used in chemical laboratories, are not considered 
electrically safe for direct connection to patients. 
Hence care needs to be taken when selecting ihc 
pump to ensure that it has approved safety specifi-
cations for human use. 
The blood withdrawal circuit includes a point 
f rom which samples may be withdrawn for; a) cali-
brating the B G O detector against a laboratory well 
counter, b) plasma assays f rom centrifuge samples, 
c) plasma metabolite analysis and d) physiological 
Table 1. SUMMARY O F PHYSICAL C H A R A C T E R I S T I C S 
B G O crystal assembly Number of BGO 
crystals 
2 
Number of PM 
lubes 
1 
Crystal dimensions (mm) 
length width height depth 
30 30 60 6 
Energy resolution of B G O Isotope Energy kcV % FWHM 68Ge - measured as 1 mm ID 
detector 68 Ge 511 17.7 tubing source located in ihc 
68 Ge 1022 11.9 'hairpin' shaped pathway 
137 Cs 661.8 15.3 bcuvcen the crystals. 137 C s -
measured as 'point source' 
located midway between 
crystals 
Sensitivity and deadtime keV energy cps /iCi"' mi"' cps jiCi"' usec/pulse 
sum peak ( ± 3 % ) ( ± 3 % ) dcadlime 
797-^ 1290 787 10225 3.86 
511-1- sum pk 
318^ 1290 2401 31187 1.88 
PTFE mm mm mm ml ml/min ml/min 
Blood withdrawal ID OD ID batch vol in FOV flow rate for flow rale 
variation ± batch var U C , 18F tracers for H,'^0 
Tubing 1 2 ±0.05 0.077 + 9% 2.5 5.0 
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measurements for blood gases, haemoglobin and 
other parameters. This withdrawal point is placed 
downstream f rom the detector to avoid additional 
delay and dispersion being irnposed on the blood 
f lowing within the monitored length of tubing. 
The system described has been integrated and 
assembled on a bedside trolley, the signal output of 
which feeds directly into the computer used for 
collecting the PET data. 
Method - general description 
During clinical PET investigations, blood is contin-
uously sampled f rom the radial artery cannula 
( R A C ) through external tubing to enable contin-
uous monitoring of the radiotracer content of 
whole blood. The arterial whole blood is pumped 
through tubing 1 mm I D , 2 mm O D , which passes 
through a B G O detector (see Fig. 1). The flow rate 
is set at 5 ml per minute for brain blood flow mea-
surements using H i '-'O. This rate is also used for 
the first 10 min of "C and '"F-labelled tracer studies 
and then reduced to 2.5 ml per minute. This en-
sures that the total volume of blood extracted f rom 
the patient does not exceed 300 ml during long 
(90min) scans. 
The 1 mm bore tubing passes between the two 
parallel blocks of B G O 6 mm apart. A special Te-
flon j i g (see Fig. 2) has been designed into which 
the tubing is placed to describe an exposed hair-pin 
shaped f lowpath, 98 mm in length, between the 
opposing crystal faces. This configuration provides 
increased exposure and minimum impedence to 
f low. In order to minimise delay and dispersion, 
the B G O detector is installed first in line within the 
withdrawal circuit. The distance f rom the patient's 
R A C to the mid point of the detector is 65 cm. Ten 
centimetres of lead shielding surrounds the detec-
tor allowing blood concentration levels less than 
G.OI microcuries per ml to be accurately detected. 
The effective volume in the f ield of view of the 
B G O is approximately 0.08 ml . 
To enable blood samples to be taken at pre-
determined times during scanning, a 3 way tap is 
installed 35 cm downstream f r o m the B G O detec-
tor (1 M f r o m the R A C ) . These samples are taken 
DIMENSIONS IN mm 
D E T E C T E D FtOW PATH 
LENGTH IS 9Sram 
Fig. 2. Drawing of BGO dcicclor assembly & jig. 
into heparinised syringes and counted in a sodium 
iodide well counter to provide values of whole 
blood and plasma from which to calibrate the re-
sponse o f the B G O counter. Similarly, samples are 
extracted for metabolite analysis. Flushing is peri-
odically carried out with heparinised saline intro-
duced via the 3 way tap. This prevents the forma-
tion of clots which are especially susceptible within 
the R A C during the latter stages of the 90 min scans 
at the slower f low rate of 2.5 ml per min. At a point 
50cm further downstream of the tap is the blood 
pump [Watson Marlow W M 501H]. This eight roll-
er, peristaltic pump, provides a smooth constant 
output utilising silicon manifold tubing. It has been 
approved for use with human subjects by The U K 
Department of Health. The waste blood and saline 
is pumped into a 300 ml 'transfer' bag, completing 
the closed system. Each component is sterile within 
this system. Fig. 1 shows diagrammatically the 
withdrawal and monitoring system. 
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Fig. 3a. '*F spectrum (ungated) of activity filled tubing in the 
B G O detector, b. "*F spectrum gated sum-peak 797-1290 keV. 
c. " F spectrum gated total (511-H t sum-peak) 318 keV-
1290 keV. 
Instrumentation and electronics 
The detection system is set up to measure the 
511 keV and 1022 keV sum peak. The detector 
comprises two B G O crystals ( 3 0 m m x 30 mm x 
60 mm) assembled on to a single photomultiplier 
(PM) tube. A light-guide connects the blocks of 
B G O to the P M tube. The assembly is sealed within 
an aluminium can presenting a neat, light-tight 
rectangular module 190 x 65 x 39 m m , the geom-
etry of which is efficiently shielded. This detector 
NM2 I lC-(>;picnyl-Scan 
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I'C - nibitig 
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Timc[sccl 
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D o « injected- 3 . 9 m C i 
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5 150:- I 
OGD; t 
rine[i«i 
fig. 4a. b. BGO whole blood curve (511 keV + sum) N12 shows 
"C-deprcnyl sticking to polyethylene tubing. No reduction of 
counts during flushing. 
was constructed as a prototype by C T I Inc, Knox-
vil le, L/SA. 
The signal and high voltage are carried on sep-
arate leads brought out f rom the base of the as-
sembly. The signal is fed into an EG & G Ortec 
preamp-amp single channel analyser mod. 4890 
and the analogue pulse split into a second single 
channel analyser to enable 2 energy windows to be 
gated simultaneously (Fig. 3b and 3c). The digital 
outputs of both these analysers are fed into a quad 
scaler timer E G & G Ortec mod. 974. This acquires 
data continuously in one second integrated units 
throughout the scan and transmits them directly 
into a pre-defined count file in the PET scanner 
(CTI/Siemens E C A T 953B) system's ' S U N ' com-
puter. A separate PC is also used as an independent 
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Fig. 5a, b. BGO whole blood curve (511 keV + sum) N9 shows 
reduced sticking of "C-deprenyl to polyethylene tubing coated 
with silicon. During flushing, the count rate is still significantly 
above background. 
back-up for data logging, using a Blue Chip DPC10 
counter-timer card. This acquires data which is 
continuously written to a S'// f loppy disc. Each 
computer has its own internal clock. Hence all 
clocks have to be synchronised daily in order that 
data f r o m any of the count files can be directly 
compared and related to absolute time. This is 
done to Greenwich Mean T ime ( G M T ) using a 
radio receiver clock. 
On-line whole blood data collected during scans 
can be formatted, and quantitatively analysed f r o m 
calibrations supplied f r o m accurately timed aliquot 
samples taken during emission data acquisition. 
Plasma and whole blood samples are counted in a 
well counter ( W C ) , which is routinely cross-cali-
Dosc mjeftcd" T O S m C i 
= 2500 
Tiraclsct 
N77 l lC.Depicnyl-Scan 
2001 
ISO^ 
160 
140 
120 
loo: 
SO 
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"°i 
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Dose injecied. T O S m C i 
I T R t - lub:3? 
I ( j I ' 
Fig. 6a, b. BGO whole blood curve (511 keV + sum) N77 PTFE 
tubing shows no Slicking of "C-dcprenyl in the tubing. During 
flushing, the count rate drops to almost background level, 
brated against the PET scanner's pixel element 
response. Since there is the possibility of ± 9% 
variation in detected volumes, due to batch varia-
nce in the manufacture of the PTFE withdrawal 
tubing (see below), cross calibrations for each scan 
are carried out (WC v BGO) , However within 
production batches, variations of less than 3% are 
expected. 
The selection of withdrawal tubing 
Certain positron labelled compounds, (in partic-
ular "C-deprenyl, "C-PK11I95 and "C-raclopride; 
have been found to adhere very strongly to many 
types of commercially produced plastic medical 
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Fig 7(1. rhc on-line B ( i ( ) detector trolley beside Ihc CTI/Sienicns ECAr' )53B neuro PET scanner showingihe shielded deicclor. blood 
pump, nucleonics, and back-up PC system. The ihree way sampling tap is mounted directly above the shielded dclcclor on the lrolle> 
lop which is maniitacturetl from slorilizable 'Trespa" material, h. To minimise deieciion >^f exiranctius gammas Irtiin lube conlaining 
radioaclno bkHKl outsule the field ot view, special lead inserts have been designed lo surround the jig and lubing which extends Iroin ihe 
uip ot the cr\'slal assemblv 
cannulae and catheters. In an attempt to overcome 
this prtiblem, a variety of tubing types were in-
\cstigatcd. Those included polypropylene, poly-
ethylene (PE) and PE tubing coated with silicon. 
However, only one product has been proved to 
have a near zero cohesion for all substrates in-
vestigated so far - namely PTFE. Previously, no 
sterile medical grade PTFE tubing of the desired 
dimensions with luer fittings has been available. 
The nearest acceptable tubing to this was 'chrom-
line" - chromatt)graphic grade tubing from PTFE 
Fabricators L t d . This had to be connected to poly-
ethylene luer connectors with silicon tubing and 
sterilised in house. Routine tests had to be fre-
quently carried out lor pyrogens and sterility. Be-
cause of the problems encountered in cleaning and 
sterilising PTFE tubing to create a pyrogen and 
' P T F E Fabricators L t d . . Port Va le . Hertford. Herts SG14 
3 A B . U K 
bacteria free system. Tony Davis Avon Medical 
Limited has produced a sterile PTFE extension 
tube with luer connectors specifically ftir PE T stud-
ies. Prototypes f rom Axon have been successfully 
tested at Hammersmith. Commercial batches of 
this product in ,50 cm and 100 cm lengths are now 
available. Figures 4-6 show examples when using 
withdrawal tubing of different materials for assay-
ing "C-deprenyl. a typical highly adhesive com-
pound. 
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PRODUCTION AND APPLICATION OF OXYGEN-15; RADIOPHARMACY ASPECTS 
J C CLARK BSc. 
ABSTRACT 
Pioneering c l i n i c a l r e s e a r c h i n the l a t e '50s and e a r l y '50s 
e s t a b l i s h e d the value of Oxygen-15 s t u d i e s i n medicine ( 1 - 8 ) . 
Imaging with a h e a v i l y c o l l i m a t e d gamma camera i n the mid '70s 
enabled estimates of blood flow and oxygen u t i l i z a t i o n to be made in 
b r a i n and b r a i n tumours (9,10). The a p p l i c a t i o n of PET technology 
soon enabled dramatic progress to provide q u a n t i t a t i v e measures of 
b r a i n blood flow, blood volume and oxygen e x t r a c t i o n (11,12) a l l 
u s i n g oxygen-15 l a b e l l e d gaseous t r a c e r s administered by i n h a l a t i o n . 
PET s t u d i e s of organ blood flow have a l s o been c a r r i e d out using 
bolus i n j e c t i o n s of HjO water (12) and more r e c e n t l y butanol (13) 
l a b e l l e d with oxygen-15. 
C l i n i c a l l y u s e f u l and often unique data (40) continue to be generated 
u s i n g PET-oxygen-15 methodology as a r e s u l t of s i g n i f i c a n t investment 
i n s c i e n t i f i c r e s e a r c h i n t h i s area. Commercial e x p l o i t a t i o n of t h i s 
r e s e a r c h may soon enable a wider access to 0-15 c l i n i c a l diagnostic 
techniques when small simple oxygen-15 generators (41) become 
a v a i l a b l e and PET scanners can be made simpler and hopefully cheaper 
(42) ! 
The radiopharmaceutical aspects of t h i s work w i l l require some 
r e g u l a t i o n for i t s ongoing safe a p p l i c a t i o n and e f f i c a c y but one 
hopes that the r e g u l a t o r y bodies w i l l f i n d ways of s a t i s f a c t o r i l y 
embodying the wide knowledge and e x p e r t i s e i n t o manageable guidelines 
by c l o s e c o n s u l t a t i o n and c o l l a b o r a t i o n with the r e l e v a n t experts in 
t h i s f i e l d . 
PRODUCTION OF OXYGEN-15 
Oxygen-15 may be produced with charged p a r t i c l e a c c e l e r a t o r s v i a 
s e v e r a l nuclear r e a c t i o n s ( 1 4 ) . The long e s t a b l i s h e d "N(d,n) '^0 
r e a c t i o n i s undoubtedly the most convenient (15,16,17), but s p e c i a l 
circumstances r e l a t i n g to s p e c i f i c types of p a r t i c l e a c c e l e r a t o r s 
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have l e d to the use of the '^N(p,n)"0 (18) and "0(p,pn)'^0 r e a c t i o n s 
(19,20,21). 
Oxygen-15 v i a the "Nfd.n^'^O r e a c t i o n 
Oxygen-15 has been produced using t h i s r e a c t i o n for many years 
(15,16,17). Providing the deuteron energy i s not g r e a t e r than 6 MeV 
no s i g n i f i c a n t r a d i o n u c l i d i c i m p u r i t i e s are produced. I f the 
n i t r o g e n t a r g e t gas contains some oxygen (= 1%) (16,22) oxygen-15 i s 
recovered a t the target output mainly as '^Oj. However, to ensure 
t h a t the product i s s u i t a b l e for c l i n i c a l a p p l i c a t i o n a flow-through 
p u r i f i e r c o n t a i n i n g a c t i v e carbon and soda lime i s used to remove 
ni t r o g e n oxides and carbon dioxide. I f the nitrogen ta r g e t gas 
con t a i n s carbon dioxide (= 1%) (16,22), oxygen-15 i s recovered from 
the t a r g e t output mainly as C'^ Oj here the main i m p u r i t i e s are '^ Oj and 
carbon monoxide generated by the r a d i o l y s i s of the carbon dioxide in 
the t a r g e t gas. Both are r e a d i l y removed usi n g a heated (400°C) 
o x i d i s i n g reagent composed of a mixture of i r o n and copper oxides 
supported on k a o l i n . (22) 
Another approach to the production of C'^ Oj and '^ 0; from a conunon 
t a r g e t source i s to c a r r y out c a t a l y t i c i n t e r c o n v e r s i o n of C'^ Oj to '^ 0^  
i n a flow system using metal oxide c a t a l y s t s (eg Hopcalite-11) (23). 
Carbon monoxide l a b e l l e d with oxygen-15 (C'^0) may be produced from 
e i t h e r '^ 0^  or C'^ Oj by passing the primary product, produced and 
p u r i f i e d as described above, through a column of a c t i v e carbon heated 
to = 900''C (16,17,22,23). Any C'^ O^  that remains a f t e r t h i s r e a c t i o n 
i s removed by a soda lime trap. The outstanding problem r e l a t i n g to 
the c l i n i c a l use of i s the presence of s t a b l e carbon monoxide in 
the f i n a l product (24). 
Methods are being developed which are d i r e c t e d towards reducing the 
s t a b l e carbon monoxide content i n and hence ensuring p a t i e n t s ' 
s a f e t y ( 2 5 ) . 
There are s e v e r a l ways by which oxygen-15 l a b e l l e d water (H^ '^ O) can 
be prepared u s i n g the "'N(d,n)"0 r e a c t i o n . The chemical s y n t h e s i s of 
water by the p a l l a d i u m - c a t a l i s e d r e a c t i o n of oxygen ('^ 0^ ) with 
hydrogen i s widely applied (16,26). Using t h i s system i t i s possible 
t h a t some ammonia i s made due to the r e a c t i o n of N, and H, over the 
; I 
I I I! 
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c a t a l y s t . Oxygen-15 l a b e l l e d water can a l s o be made from C'^ O^  e i t h e r 
by exchange l a b e l l i n g d i r e c t l y with water (8,17) or by i t s r e a c t i o n 
with d i l u t e sodium hydroxide and subsequent n e u t r a l i s a t i o n with 
d i l u t e h y d r o c h l o r i c a c i d to y i e l d an i s o t o n i c sodium c h l o r i d e 
s o l u t i o n (27) . A f u r t h e r method of production of Hj'^ O i s to c a r r y 
out an i r r a d i a t i o n of nitrogen/hydrogen mixtures. Here the 
predominant product i s H^'^O vapour (28,29,30). Ammonia i s als o 
produced during the i r r a d i a t i o n but the l e v e l s found i n the infusion 
samples can be adequately c o n t r o l l e d ( 3 1 ) . With care i t i s possible 
to transport t h i s vapour to a s i t e remote from the t a r g e t , u s u a l l y Ln 
"Teflon" tubing, where the vapour may be e x t r a c t e d into a s a l i n e 
i n f u s i o n medium. (29,30,31) (See below. "Oxygen-15 l a b e l l e d water 
generators. " 
Oxygen-15 v i a the '^N(p.n)'^0 r e a c t i o n 
This r e a c t i o n i s used where an a c c e l e r a t o r can only d e l i v e r protons 
of 8-10 MeV. A t a r g e t gas of h i g h l y enriched '^ Nj c o n t a i n i n g e i t h e r 
1% Oj or 1% COj i s used and due to i t s expense care i s taken to 
optimise t a r g e t gas consumption ( 1 8 ) . A l l the chemical processing 
techniques described for the '''N (d,n)'^0 production route are employed 
to prepare and p u r i f y a l l the u s u a l '^ 0 l a b e l l e d products. 
Oxvgen-15 v i a the '^0(p.pn)"0 r e a c t i o n 
T h i s r e a c t i o n has a threshold energy of 16.6 MeV and consequently can 
only be employed u s i n g r a t h e r l a r g e c y c l o t r o n s . The tendency i s only 
to use t h i s method of production when other ones are not a c c e s s i b l e 
(19,20,21). Pure oxygen i s used as the t a r g e t gas and copious 
amounts of ozone are produced during i r r a d i a t i o n which are removed 
together with small amounts of oxides and "CO^  using a c t i v e carbon 
and soda lime flow-through p u r i f i e r s . Use of the p u r i f i e d produce as 
'^ Oj s u i t a b l y d i l u t e d to s a f e p h y s i o l o g i c a l l e v e l s i s s t r a i g h t 
forward. However, the conversion of pure oxygen to water by reaction 
with hydrogen although f e a s i b l e r e q u i r e s great care to c o n t r o l the 
highly exothermic r e a c t i o n ! A much more a t t r a c t i v e route to H^'^O 
u s i n g t h i s r e a c t i o n i s to employ a Hj"*0 water t a r g e t (32) . Here when 
pure water i s i r r a d i a t e d the predominant "0 product i s H^ '^ O. Some 
nitrogen-13 i s produced v i a the "0 (p, o)'^N r e a c t i o n together with 
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t r a c e s of '*F from the "0 (p,n)"F r e a c t i o n on n a t u r a l abundance Hj"0. 
These i m p u r i t i e s may be removed usin g mixed-bed ion-exchange columns 
( 3 2 ) . 
The production of C'^ O^  (19) and i n p a r t i c u l a r C'^ 0 u s i n g pure oxygen 
t a r g e t s poses many p r a c t i c a l problems and i n the case of carbon 
monoxide insurmountable problems r e l a t i n g to t o x i c l e v e l s (21). 
P r e l i m i n a r y s t u d i e s with water t a r g e t s to produce high s p e c i f i c 
a c t i v i t y '^ Oj and hence C"0 are encouraging (33) 
OXYGEN-15 LABELLED WATER GENERATORS 
As d e s c r i b e d above H^'^O may be r e a d i l y prepared by a v a r i e t y of 
rout e s . However, s e v e r a l problems need to be addressed i f safe and 
e f f e c t i v e i n j e c t i o n s or i n f u s i o n s are to be prepared. Of primary 
concern i s that the product should be f r e e from any harmful 
i m p u r i t i e s both chemical and r a d i o a c t i v e and be s t e r i l e and pyrogen-
f r e e . Due to the short h a l f - l i f e of Oxygen-15 q u a l i t y c o n t r o l of 
each sample or batch would be i m p r a c t i c a l . However, most groups (17, 
26, 27, 30, 31, 32, 36) c a r r y i n g out work i n t h i s a r ea have evolved 
sa f e operating procedures (SOPS see appendix 1) which have been shown 
to be capable of maintaining the req u i r e d standards. The measurement 
and d e l i v e r y of the prepared doses of Hj'^ O a l s o r e q u i r e s c a r e f u l 
a t t e n t i o n both for the ad m i n i s t r a t o r and the r e c i p i e n t . As a t y p i c a l 
I n j e c t e d bolus of H^'^O would be 80-100 mCi the dose to the 
a d m i n i s t r a t o r i s of great concern. Automated i n j e c t o r s and i n f u s e r s 
are a t an advanced stage of development i n s e v e r a l l a b o r a t o r i e s and 
the commercial e x p l o i t a t i o n of these d e v i c e s i s a n t i c i p a t e d . This 
t r a n s f e r of technology w i l l not of course be without some s i g n i f i c a n t 
r e g u l a t o r y i m p l i c a t i o n s but i t i s hoped that c l o s e c o l l a b o r a t i o n 
between the innovators, the commercial p a r t n e r s and the regulators 
w i l l enable c o s t e f f e c t i v e , s o l u t i o n s to t h i s c h a l l e n g e to be found. 
OXYGEN-15 LABELLED BUTANOL GENERATORS 
The production of Bu'^ OH introduces another l e v e l of s y n t h e t i c 
complexity i n t o oxygen-15 c l i n i c a l a p p l i c a t i o n s . 
S e v e r a l groups are a c t i v e l y developing d e v i c e s to produce Bu'^ OH based 
on organoborane chemistry (34,13,35,36,37). The e s s e n t i a l features 
of the procedure are as foll o w s . T ri-n-Butylborane i s immobilised on 
alumina SEP PAK (Waters) c a r t r i d g e s . Oxygen-15 l a b e l l e d '^ 0^  i s 
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r e a c t e d w i t h t h e t r i - n - b u t y l b o r a n e , t h e o x i d i s e d i n t e r m e d i a t e i s 
h y d r o l y s e d w i t h water and the crude p r o d u c t i s e l u t e d onto C-18 SEP 
PAKS which r e t a i n t h e Bu"OH. F u r t h e r washing o f t h i s SEP PAK w i t h 
w a t e r removes the water s o l u b l e i m p u r i t i e s i n c l u d i n g b o r i c a c i d and 
F i n a l l y t h e Bu'^ OH i s e l u t e d f r o m t h e C-18 SEP PAK w i t h 10% 
e t h a n o l / s a l i n e . HPLC a n a l y s i s o f the p r o d u c t shows < 0.5% H^'^O and 
4-5% sec Bu'^ OH. B o r i c a c i d d e r i v a t i v e s r e s u l t i n g from the chemical 
p r o c e s s i n g o f the p r i m a r y t r i - n - b u t y l borane are a d d i t i o n a l l y 
c o n t r o l l e d u s i n g a n i o n exchange t e c h n i q u e s ( 3 7 ) . As w i t h the H^'^O 
g e n e r a t o r systems, SOPS (see appendix 2) are b e i n g e v o l v e d f o r the 
r o u t i n e p r o d u c t i o n o f t h i s f l o w t r a c e r f o r PET and i t would seem 
l i k e l y t h a t commercial Bu"OH g e n e r a t o r s a r e b e i n g c o n s i d e r e d . 
QUALITY CONTROL TECHNIQUES AND PROCEDURES 
The gas phase p r o d u c t s l a b e l l e d w i t h oxygen-15 are most r e a d i l y 
a n a l y s e d r o u t i n e l y u s i n g r a d i o gas chromatography. The permanent 
gases are r e a d i l y s e p a r a t e d u s i n g columns o f m o l e c u l a r s e i v e 5A and 
PORAPAK-Q. S p e c i a l l y designed c o n c e n t r i c columns o f these m a t e r i a l s 
( A l l t e c h CTRl) (17,38) a l l o w a s i g n i f i c a n t s i m p l i f i c a t i o n o f the 
a n a l y t i c a l procedure and automated r o u t i n e s a m p l i n g can be a p p l i e d 
( 3 8 ) . Chemical p u r i t y o f the gas p r o d u c t s i s assessed u s i n g 
a d d i t i o n a l c h e m i c a l gas a n a l y s i s t e c h n i q u e s f o r ozone, n i t r o g e n 
o x i d e s and carbon monoxide ( 2 2 ) . 
The oxygen-15 l a b e l l e d i n f u s i o n p r o d u c t s undergo the u s u a l s c r e e n i n g 
t e s t f o r s t e r i l i t y and a p y r o g e n i c i t y . Chromatographic a n a l y s i s o f 
Bu"OH t y p i c a l l y u s i n g a C-18 r e v e r s e phase HPLC column e l u t e d w i t h 
a c e t o n i t r i l e / w a t e r NH^ OAC (10 mMol) 10:90 (35) enables adequate r a p i d 
a n a l y t i c a l s e p a r a t i o n o f nBu'^OH, sec Bu'^OH, H^'^O and borane r e s i d u e s . 
As i n a l l s h o r t h a l f - l i f e r a d i o p h a r m a c e u t i c a l endeavour, much 
d e t a i l e d a n a l y t i c a l i n f o r m a t i o n i s c o l l e c t e d i n the R & D phase o f 
th e work and i t i s w i d e l y acknowledged t h a t f o r the d e s i g n o f 
p r a c t i c a b l e r o u t i n e q u a l i t y c o n t r o l p r o c e d u r e s t h i s d a t a base i s 
i n v a l u a b l e . 
DISPENSING OF OXYGEN-15 PRODUCTS 
D i s p e n s i n g o f the gas phase 0-15 l a b e l l e d p r o d u c t s e i t h e r as batches 
o r f o r c o n t i n u o u s i n h a l a t i o n can be r e a d i l y r e g u l a t e d . With batch or 
b o l u s i n h a l a t i o n s i g n i f i c a n t p e r s o n a l r a d i a t i o n exposure can be a 
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problem. With conCinuous i n h a l a t i o n p e r s o n a l exposure i s r e a d i l y 
m i n i m i s e d as the d i s p e n s i n g can be c a r r i e d o u t on l i n e u s i n g f l o w 
t h r o u g h r a d i o a c t i v e c o n c e n t r a t i o n m o n i t o r s and e l e c t r o n i c f l o w 
m e t ers. Systems f o r a u t o m a t i c a l l y r e g u l a t i n g t h e r a d i o a c t i v e dose 
l e v e l and d u r a t i o n f o r c o n t i n u o u s a d m i n i s t r a t i o n f o r steady s t a t e PET 
s t u d i e s have been developed ( 3 8 , 3 9 ) . For t h e 0-15 l a b e l l e d i n f u s a t e s 
s a f e d i s p e n s i n g procedures are s t i l l e v o l v i n g b u t remote dose 
m o n i t o r i n g and a d m i n i s t r a t i o n i s i m p e r a t i v e f o r the r a d i a t i o n s a f e t y 
o f o p e r a t i n g p e r s o n n e l . 
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P R O D U C T : 
B A T C H NO.: 
N U C L E A R M E D I C I N E D I V I S I O N 
T h « U n l v o r t l l y of M i c h i g a n 
M A S T E R F O R M U L A C A R D 
xHZOynl X . D a w ; Y = L w no. 
|A I l A U I L A I l L l . n i . l U I 
L O T N O . I N G R E D I E N T S P E C I F I C A T I O N S A M T S P E C I F I E D A M T U S E D I H i r i A L S 
1 Mixed bed restn column -
7nifn ID 
UM Cyclot ion - P E T 
F a c i l i t y 
1 
2 Detonized water S l e r i l e , p y r o g e n - t r e e 7 • 9 m L 
3 2 0 % Sod ium chloride soln S t e r i l e , p y r o g e n - t r e e 0.3 • 0.4 m L 
4 0 .22 Jim vented syr inge filler Millipore v e n i e d - G S 1 
T to c c mull idose vial S i e r i l e . p y r o g e n - l r e e 
H o l l i s l e r - S l i e r 
I 
C Y C L O T R O N 
C U R R H f ^ : 
D U R A T I O N : 
P R O D U C T (mCi | : 
Q.C. S A M P L E 
O . C S A M P L E ( m C i | ; | |(ai 
0 . 0 . S A M P L E (mCi) : | |@>p 
J m i n pos l E O B (dmin) 
"Imin p o s t - E O B (20 min) 
QUALITY C O N T R O L 
T E S T M E T H O D R E S U L T S D A T E I N I T i a L S 
1 ( lod ionucHdic purlly O C sample @ 20 min should be < 0 .8% ol the 
acllvi ly ol the s a m p l e @ 4 min (Capintec) 
2 CH pHion test paper • pH 4.5 • 8.0 
3 V i s u a l C l e a r , c o l o r l e s s 
4 P y f o g e n test Limutus lysa ie a s s a y 
5 Ster i l i ty test F T M . T S B media incubaiion 
6 
7 
P r o d u c t A p p r o v e d (or H u m a n U s e b y : 
O r i g i n a l M a s t e r F o r m u l a C a r d A p p r o v e d b y : D a t e : 
D a l e 
T h i s b a t c h r e c o r d s h e e l is a n a c c u t a l e r e p r o d u c t i o n o l the m a s t e r f o r m u l a c a r d . 
APPENDIX l A 
T h i s document r e l a t e s t o the SOP used f o r the Oxygen-15 water 
p r o d u c t i o n procedure d e s c r i b e d i n Ref 32. 
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N U C L E A R M E D I C I N E D I V I S I O N 
T h « U n l v e r t l t y ot M I c h l g i i n 
M A S T E R F O R M U L A C A R D lA i iAai i Aiiri. ni.ni:| 
P R O D U C T : 
B A T C H NO.: 
R o s i n C o l u m n s lor 0 - 1 5 W a t e r 
( X X X X X X H 2 0 C 0 L Y Y Y I ; X . O a l e : Y . L o l no. 
L O T N O . I N G R E D I E N T S P E C I F I C A T I O N S A M I S P E C I F I E D A M T U S E D INI I A L S 
1 A G 1 - X 2 Anion otch. resin -
2 0 0 - 4 0 0 m e s h . C I - lorm 
Biotechnology grade 
B io fad 140-1251 
30 g 
2 A G 5 0 W - X 2 Cat ion exch 
f e s i n , 2 0 0 - 4 0 0 m e s h , H t l o r m 
Biotechnology grade 
B iorad 142 1251 
10 g 
3 C h e t B * 100 ( e s i n . 2 0 0 - 4 0 0 
m e s h , N a t form 
Biotechnology g iado 
B io tad 1 4 2 - 2 8 4 2 
10 g 
4 Absolute eihanol U S P e n . 300 mL 
5 Milli-O water S te r i l e , p y r o g e n - t r e e c a . 400 mL 
~ G l a s s columns 
7mm ID X 10 c m 
S t e r i l e , p y r o g e n - t r e e 6 
D I R E C T I O N S (Use asept ic techn iques . P e r l o i m all nonradioact ive p r o c e d u r e s in a laminar How tiood ) 
] l . S lur ry t o g e t h e r in 1 5 0 m L o( 5 0 % e l h a n o i 3 0 g o l A G 1 - X 2 . l O g of A G 5 0 W - X 2 a n d l O g o l 
C h e l e x l O O . Fi l iGf ihe r e s i n m i x i u r e a n d w a s h w i i h a n a d d i l i o n a l 3 0 0 m L o l 5 0 % e i h a n o l 
R e s u s p e n d the r e s i n in 3 0 % e t h a n o l a n d s lur ry p a c k in lo 7 m m ID c o l u m n s to a d e p t h o) 5 - 7 c n 
S i o r e r e f r i g e r a i e d in 3 0 % e i h a n o l . L a b e l the c o l u m n s w i ih loi n u m b e r . 
I?. B e f o r e u s i n g a c o l u m n , d r a i n i h e 3 0 % e l h a n o l a n d oqur l ib ra ie i h e c o l u m n w i i h Miili O v-/aior 
Q U A L I T Y C O N T R O L 
T E S T M E T H O D R E S U L T S D A T E I N I T I A L S 
t 
2 
3 
4 
S 
6 
7 
P f o d u c i A p p r o v e d for H u m a n U s e b y : 
O r i g i n a l M a s t e r F o r m u l a C a r d A p p r o v e d b y : D a t e : 
D a t e : 
T h i s b a t c h r e c o r d s h e e l is a n a c c u t a l e r e p r o d u c l i o n of the m a s t e r f o r m u l a c a r d . 
APPENDIX IB 
T h i s document: r e l a t e s t o the SOP used f o r the Oxygen-15 water 
p r o d u c t i o n procedure d e s c r i b e d i n Ref 32. 
0 - 1 5 W a l o r 
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D I R E C T I O N S (Use asept ic l e c h n i q u e s . P e r l o r m all non iad ioac i ive p r o c e d u r e s in a laminar Haw h o o d ) 
1. A d d 0.3 - 0.4 m L o l s te r i l e 2 0 % s a l i n e \o l O c c i n u l l i d o s e v i a l . 
2. C o n n e c t t a i g e l e m p t y i n g l ine to l o p of m i x e d b o d c o l u m n . C o n n o c t s io f i lo mii l iporo lilior to 
c o l u m n o u l l o L A s i a r i l e n e e d l e o n tfie mi l l iporo (il lnr p i o r c c s iMo r . c p t u m q( tho ( n u ' u d o ' . o vi . i l 
w h i c h a l s o h a s a s le r i l e n e e d l e p u n c t u r i n g it. 
3. F i l l the target with 7 - 9 m L of s tor i lo d o i o n i z e d w a t n i . t h e n p r o s s u r i ^ o i h n l.^(QOl v/uh 100 pr-i d 
h e l i u m o v e r p r e s s u r e . 
•4. I r radiate target for 2 • 6 m in with p r o t o n s . 
5 . C l o s e off h e l i u m o v e r p r e s s u r e at e n d of i r r a d i a i i o n . E m p i y the target c o n t o n i s i h r o u g h iho m i ^ c d 
bed c o l u m n , mi l l ipore filter a n d into the m u l l i d o s o v in i c o n t a i n i n g s tor i lo 20"/a s a l i n e s o l u t i o n 
u s i n g the r e s i d u a l h e l i u m o v e r p r e s s u r e in the s y s t e m a s l l ie p u s h g a s . 
6- N o t e (he a m o u n t of p r o d u c i in i h e v i a l a n d w i t h d r a w a s m a l l por t ion (0. i 0 3 m l ) v i a s l e n i e 
s y r i n g e lor q u a l i t y c o n t r o l t e s t s . 
0 - 1 5 W a l e r . M a s t e r F o r m u l a C a r d D a i e d 11-09-89. p g 2 of 2. 
APPENDIX IC 
T h i s docLinient r e l a t e s t o the GMP used f o r the Oxygen-15 water 
p r o d u c t i o n procedure d e s c r i b e d i n Ref 32. 
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APPENDIX I I A 
UNIVERSITY HOSPITALS OF CLEVELAND PET FACILITY 
SAFE OPERATING PROCEDURE FOR 0-15 BUTANOL PRODUCTION 
P r e p a r a t i o n 
1. AlLimina SEP-PAK (No 1) 
I f p r e v i o u s l y used, wash w i t h EtOH, a c e t o n i t r i l e , f l u s h w i t 
a i r , s u c k d r y w i t h vacuum. Dry i n vacuum oven a t 80°C a t l e a s t 
h o u r s . Flush w i t h Argon, and p u t s l e e v e s t o p p e r s on b o t h ends 
S t o r e i n glove box. I n j e c t 0.1 ml pure BUjB ( f o r 0.2% Oxygen i 
N i t r o g e n t a r g e t g a s ) . The p r e p a r e d SEP-PAK i s be s t used 5-
hours a f t e r i n j e c t i o n . I n d e f i n i t e l i f e span. 
For new Alumina SEP-PAK, f l u s h w i t h Argon and proceed as above 
2. C-18 SEP PAK (No 2) 
Wash 2 C-18 SEP-PAKS w i t h 3 ral pure EtOH, a i r b o l u s , f o l l o w e d b 
6 ml M i l l i p o r e water. Connect w i t h s h o r t g l a s s t u b i n g . Thes 
may be reused many t i m e s . 
P r e p a r a t i o n 
1. F l u s h l i n e s w i t h Helium (V13 open). He f l o w - 40-50. 
2. For p a t i e n t runs: s t e r i l i s e a l l l i n e s w i t h EtOH, M i l l i p o r e water 
He f l u s h . 
For add l i n e 1: V2 open, V7 c l o s e d , V8 open 
For add l i n e 2: V7 open, V8 open 
For c o l l e c t l i n e : V8 c l o s e d . 
3. Beam on: 10 m amp/10 min f o r 50-70 mCi Bu'^ OH dose 
V7, V8, V13 open 
4. A t EOB-1 min: I n s e r t Alumina SEP-PAK. Helivim f l o w on. 
5. Empty t a r g e t : Close V13, Open 17, V5. 
A f t e r 15 seconds, open V18. 
At 25 seconds, c l o s e V17, w a i t f o r p r e s s u r e t o drop 
below 1. 
Close V5. V7, V18, open V2. 
6. 4ml wash o f b o t h SEP-PAKS t h r o u g h add l i n e No 1 (2 p o r t i o n s ) 
Add 1 ml raillipore water and 2 ml a i r b o l u s . Then push 3n 
t h r o u g h s l o w l y , f o l l o w e d by a l a r g e a i r b o l u s . Watch c l 
a c t i v i t y t r a n s f e r t o the lower C-18 SEP-PAK on the F r a n c i s meter 
7. Three 1/2 ml washes o f SEP-PAK No 2 ( M i l l i p o r e w a t e r ) throug 
add l i n e No 2. Open Valve 7. 
8. 5ml e t h a n o l i n s t e r i l e s a l i n e t h r o u g h SEP PAK No 2. 
( t h r o u g h add l i n e No 2 ) . V8 c l o s e d . C o l l e c t i n s y r i n g e . 
9. Measure on HPLC 15% A c e t o n i t r i l e / O . O I M NH.OAc 
A l l t e c h ECONOSIL Column 
Flow '- 2 ml min"' 
Scale - 2000 KCPM 
Re t e n t i o n times H^ O 1.45 min 
sec BuOH 4.4 min 
nBuOH 5.7 min 
10. Remove SEP-PAKS and f l u s h d r y system a f t e r a l l runs. 
Leave dry. 
T h i s document r e l a t e s t o the SOP used f o r the Oxygen-15 Butane 
p r o d u c t i o n procedure d e s c r i b e d i n Ref 13. ( V a l v e numbers r e f e r t o 
s p e c i f i c system and can be i g n o r e d f o r t h e p r e s e n t p u r p o s e s ) . 
107 
APPENDIX I I B 
Raw M a t e r i a l s 
: S u p p l i e r 
Nj/0.2%0j L i n d e 
Helium Linde 
SEP-PAK-C18 Waters 
SEP-PAK-Alumina Waters 
S y r i n g e 10ml 
Beckton-Dickson 
Needle 
25G5/8 
B e e t o n - D i c k i n s o n 
T r i B u t y l 
Borane Alpha 
Normal S a l i n e 
S t e r i l e B a xter 
F i l t e r 0.22;i 
S t e r i l e 
M i l l i p o r e 
Batch No. 
T44852 
UN1046 
P9324A1 
P8148A2 
OB530 
9L023 
E29G 
ZP033241 
H8Jk-
85499 
E x p i r y Date 
month/year 
1/95 
1/95 
1/95 
1/92 
9/93 
1/95 
1/91 
12/91 
1/92 
1. Open v a l v e s on compressed N2-02 and He. 
2. Open V13. 
3. Rinse a l l l i n e s w i t h e t h a n o l , M i l l i p o r e Water, a i r and He. 
4. Prepare 2 C-18 SEP-PAKs. 
5. Prepare alumina SEP-PAK w i t h .1ml t r i b u t y l b o r a n e under Ar. 
6. Assemble lOcc r e c e i v i n g s y r i n g e , cap and f i l t e r . 
7. Load T a r g e t (V18) . 
8. Bombard f o r p r e d e t e r m i n e d c u r r e n t and t i m e . 
9. A t EOB-1 min, i n s e r t alumina SEP-PAK 
10. A t EOB, c l o s e V13, open V5, V17, V18. 
11. A t maximum a c t i v i t y c l o s e V17, V18 open V2, V8 c l o s e V7. 
12. Two washes o f b o t h SEP-PAKS w i t h w a t e r . ( 1 m l , 3ml) 
13. Three washes o f SEP-PAK No 2 ( . 5ml/. 5ml/. 5nil) open V7 . 
14. Close V8. Add 5ml 10% e t h a n o l i n s t e r i l e s a l i n e . 
15. C o l l e c t p r o d u c t . 
16. Measure and send d e s i r e d amount t o c l i n i c . 
Procedure was f o l l o w e d as d e s c r i b e d above. 
Signed Approved 
T h i s document r e l a t e s t o the GMP used f o r t h e Oxygen-15 Butanol 
p r o d u c t i o n procedure d e s c r i b e d i n Ref 13. ( V a l v e numbers r e f e r t o a 
s p e c i f i c system and can be i g n o r e d f o r t he p r e s e n t p u r p o s e s ) . 
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Production of radiopharmaceuticals for PET 
S8 
J . C . C l a r k 
Medical Research Council Cvcloiron Uiiii. Ilaininersiniili Hnspiial. London \VI2 OHS. United Kin'^dom 
Abstract 
A range of radionuclides .suitable for use in PET is available for incorpdrai ion inlo Radiopliarmaceulieal.s. 'r i ie ones of nriiiLTpal 
interest are (half l ife shown in brackets). ' "O (2.05 n i in ) , ''N (10 niin) " C (21) n i in) . '"^F ( I 1(1 nun) aiul those d c i u e d i i u m the 
radionuclide cenerator systems " 'Sr (25 dayj /^-Rb (75 s). ' % e (271 dayir'^Ga (6,S ni in) , " "Z i i (9.. ' htnii l "-'C ii ('».,S m in i . 
'^O, '-'N. ' t and "*F have to be produced using a dedicated accelerator close to the PIV l i n s l a l l a i i o n . U I K T C I S ihe r a d i o m i c l i L l e 
generators can be made using remote accelerator locations. In all cases, however, the svn thcs i - . o i the la t l ioph. i ru iaceu i ica l . ii--
pur i f icat ion and qual i ty control must of necessity take place at the PEiT facil ity. 
These syntheses may range f rom a simple clut ion of a radionuclide generator, the eluted p r o d i i c l being iinnieili. i ielv s i i i l . i b le l o i 
administrat ion to man for PET imaging, to a niult i step rapid organic chemical radiosyntliesis wnl i high speeti p n n f K M i i o n o f ihc 
product to provide a highly selective marker for a specific biological process which can then be q iMiUiKi lueK ^ l i u l i c i l i i s i n ; ; I'l- 1' 
The paper wi l l in no way attempt to be comprehensive in its coverage of this f ie ld, rather it per l i : ips e iuoniaue ilie i i K | u i s i h \ e 
reader to delve into the l i terature ci ted. 
1. Nuclear reactions for the production of P E T 
radionuclides. 
Oxygen-13 
Three nuclear reactions are currently in use for the 
production of '"'O for medical use they are: 
" 'N(d,n) ' - '0 
'-"^N(p,n)'-'0 
16 ' 0 ( p , p n ) ' ^ 0 
E j 6-10 M e V (1-4) 
E,, 10 M c V |5 | 
E,, 17 MeV -h |61 
T h e "'O(-^He.a) ''^O reaction with 8 M e V ^He is 
proposed for use with a new type of linear accelera-
tor which is under development (23), 
Nitrogen-13 
Nitrogen 13 is principally produced for medical use 
by the following reactions 
' ' O (p ,a ) '-'N 
" C (p,n) '-^ N 
Carbon-11 
Ep 10-16 M e V [7 
Ep 10-11 M e V [8 
Carbon-11 production for use in PET organic 
radiosynthesis is almost exclusively produced using 
the reaction '"N ( p , a ) " C EplO-20 M e V [9]. 
Other possible reactions which are not without sig-
nificant problems include: 
'"B (d,n) " C 
" B (p,n) " C 
" B (d,2n) " C 
' ^ C CHe,a) " C 
Ed 5-15 MeV [1,10] 
Ep 10-20 MeV 
Ed 15 MeV [10] 
Fluorine-IS 
Several nuclear rcaclioiis h ; i \ c b e e n u,--cd M p i M -
ducc "^F for PET b u t t h e I'lisl i w n arc i i o u u n c J 
almost e.xclusivclv. 
-"Ne (d.o) " ' F E | 1(1 M c \ - -- 111, 1.^ 1 
(P,n) ''^ F^ Ep 1(1 Me\ - -
"'O f H e , pn) " F E,, , 1> M c \ ' - |1.^| 
'"O (^He. p) " F E, , , S M c V - jl.^.j 
Strontium 821 Rubidiuni ,S2 
The production of large anuuiiiis o\ "~-Sr relics on 
the high energy spallalinn of Molslulcinim: 
Mo (p,x)'^-Sr Ep 6(H) M c V | I4 | 
However practical quantities have been |iroiliicccl 
using the reaction 
^ ' R b ( p , 4 n f - S r Ep 6(1 M e V -l- |1.^| 
A commercial '"""Rb radionuclide generator is 
manufactured by Bristol-Myers-Squibb and i.s used 
principally in PET cardiac studies |16|. 
Germanium-68/Galliunt-6S 
Large scale production of'""^Ge is based on the high 
energy proton spallation of Bromine containing 
targets: 
B r ( p , x ) ^ « G e ' Ep 600 M e V ( I7.18| 
For lower energy accelerators the less productive 
reaction has been employed. 
- H e 8 MeV [23] 
69--G a (p,2n) ^«Ge Ep 20 M e V + . 
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A commercial '''"^Ga radionuclide generator is 
manufactured by Nen-Dupoi i t which yields a pro-
duct of use in radiopharmaceutical preparations 
[19]. A further and important use of '•'^ Ge PET is 
it's use as "Transmission sources" which are built 
into P E T scanners to allow for attenuation correc-
tion of the emission data collected after the admi-
nistration of the P E T radiopharmaceutical. 
Zinc-621 Copper 62 
This radionuclide is most commonly produced us-
ing the reaction 
63, C u (p,2n)^-Zn E, , 20 M e V + [2(1] 
Radionucl ide generators which can provide ' ' -Cu 
suitable for incorporation into radiopharmaceutic-
als have been described [21 j but none have as yet 
been produced on a commercial basis. 
2. Particle accelerators for PF/I radionuclide pro-
duction 
Consideration will be given here only lo the dedi-
cated machines that are mtendcd solclv lo provide 
for the P E T installation. 
Although some P E T facilities h a \ c made use of 
pre existing tandem Van Der Graaf accelerators 
the majority now make use of small cyclotrons. 
These are usually isochronous machines with pro-
ton energies of 10 to 17 N'leV. They are commer-
cially produced and in most cases arc also able to 
accelerate deuterium ions, typically ui the range .'i 
to 8 M e V . No provision is usually made for the 
heavier helium ions on these accelerators. The 
reader is recommended to refer to the suppliers 
data sheets for full information about these 
accelerators. The principal suppliers being listed in 
Table I. 
3. Recent developments in V\L V accelerators 
Ear ly isochronous cyclotrons accelerated positiv'c 
ions and relied on an electrostatic deflector to ex-
tract a useful beam. This component can be quite 
heavily stressed and many manufacturers are look-
ing towards accelerating negative ions and achiev-
ing high efficiency extraction by ""stripping" the 
particle's electrons to form a positive ion which will 
escape the accelerators magnetic field as the orbit 
curvature is instantly reversed. This advance ma\ 
lead to cheaper and simpler to operate devices. 
There is an upsurge in interest in two tyjies o! 
linear accelerators. One is based on the Tandem 
Cascade Accelerator ( T C A ) [22[ which is effective-
ly a tandem Van Der Graaf powered by a l.S M \ 
electronic power supplv. The resulting pr tHon nr 
deuteron energy can be as high as .^ i.7 MeV. 
Another is based on device called a Radio l-'ie-
quency Quadrupole ( R F O ) . Here the chargcc 
particles '"ride" a radiofrequcnc\ u-a\'C set up W-
tween the quadrant vanes of a Rl- c a v i l \ . / \ device 
which is capable of accelerating "I le to 8 .MeV ha-
been described [23|. Finally the demonstration m 
the use of a very small deuteron cyclotron of .v" 
M e V solely to produce o.xygen-1,"^ has introducctl 
further possible wav to support a P E T operation 
[24|. 
4. Target systems for PET radionuclide production 
A n essential interface between the accelerator 
charged particle beam and the radiopharmaceutical 
Table I - List of accelerator suppliers 
Ion Beam Applications. B1348. Louvaine - La Ncuve. Belgium, F A X 32 10 47 58 10. 
Models: C Y C L O N E - 3 (O.xygen-15 generator). CYCLON-To/.S. C Y C L O N - l S / 9 . 
Japan Steelwork, Konigsallec V2a. 4000 Dusscldorf 1. Germany. F A X 49 211 32 8199. 
Models: B C 126, BC-1710. 
Oxford Instruments/NKK, Osney Mead, Oxford 0 X 2 O D X U,K. . F A X 44 865 269690. 
Model: " O S C A R " (Super conducting magnet). 
Scanditronix/GE Medical Systems, Husbyborg, S 75229 Uppsala. Sweden. F A X 46 185 37276. 
Model: S MC-17, " P E T trace 200". 
Siemens/CTI Medical Engineering Group Henkestrasse 127, D8520 Erlangen, Germany. 
Models: RDS-112 (Protons only). 
Sumitomo/CGR, 1 Kand Mitoshiro-Cho, Chiyoda-Ku, Tokyo 101, Japan. F A X 3296 5391. 
Models: 325, 370. 
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synthesis is the Target . Th is is where the nuclear 
reactions outlined above are carried out in a con-
trolled way in order to produce the desired 
radionunclide in an appropriate chemical form for 
the synthetic work which follows. 
P E T radionuclide targets operate predominantly 
in the gas or liquid phase and their geometry is de-
termined principally by this. Both types of target 
have a beam entry window system that provides an 
essentially transparent aperture through which the 
high energy charged particles exit the accelerator 
vacuum and enter the target material containment 
vessel. These windows are invariably made of thin 
(10-50 fxm) heat resistant metals or alloys and are 
cooled with He l ium. T h e window is often under 
considerable stress especially in the case of high 
pressure gas targets. G a s targets are commonly 
used to produce Oxygen-15 from Nitrogen [1,2,5], 
C a r b o n - f l from Nitrogen [9] and Fluorine-18 
C^F,) from Neon [11]. L iqu id targets are used for 
the production of Flourine-18 (''"^F-fluoride) from 
enriched water F1T'''^ 0 [25] and Nitro^en-Ll from 
natural water (H2'"'''0) [7]. 
By control of the chemical conditions under 
which the irradiation takes place the chemical form 
of the product nuclide can be manipulated to 
achieve the form most appropriate for the next 
stage in the radiosynthesis. Th is is usually referred 
to as "in target chemistry". Examples include the 
production "'in tars^et" of '=0. , C^'^O,, [2] H. '^O 
3] , C'-^O [26], " C O , . "CH4 [27]. [ l l ]^and 
^NHj [28]. 
Where expensive enriched target materials are 
used, eg H , O , it is usual to recover them by in-
corporating a chemical retrieval step in the 
radiosynthesis [29]. 
5. Radiolabelled precursor preparation 
In some cases the radionuclide is produced in'the 
target in a chemical form suitable for direct use. 
Fiowever, for organic radiosyntheses where fast 
reactions are essential to achieve useful end pro-
duct specifications of radioactivity and specific 
radioactivity (Ci/| j .M) it is usual to generate highly 
reactive radiolabelled intermediates or precursors. 
Examples for carbon-11 would include the con-
version of "CO2 to " C H 3 O H , H " C H O , " C H 3 I 
[30] and "CH4 to "COCI2 [31]. Fluorine-18 ' * *F , is 
converted to C H p C O O ' ^ ^ F (Acety l hypofluoride) 
[32] and "^F-fluoride is prepared in "naked" form, 
all hydration water being removed, making the '**F 
of value in nucleophil ic substitution reactions, eg 
the synthesis of ' ^ F D G [33]. 
6. Radiopharmaceutical production for P E T 
D u e to the short half-life of the most useful PET 
radionuclides the aim is to carry out the synthesis. 
purification and formulation of the product as fast 
as possible. Typical ly a Carbon-11 product may be 
made available for injection soine 30-40 minutes af-
ter the end of radionuclide production [35j. In the 
case of Fluorine-18, 90-120 mins would be typical, 
eg "^FDG [29]. 
However, it is often the case that the price one 
has to pay for speed is efficiency of incorporation 
of the radionuclide and the efficiency of the man-" • 
ipulative steps. T h u s one typically will start a Car -
bon-11 synthesis with 2-3 Curies of "CO2 and de-
liver 50-100 millicuries of formulated radiophar-
maceutical. E v e n under these apparently adverse 
conditions many carbon-11 labelled radiophar-
maceutical tracers of metabolic substrates and re-
ceptor ligands are now available to the P E T clinical 
research with specifications that meet current 
needs. [34| The variety of synthetic techniques 
available in this field is still growing to meet the 
demand for new radiolabclled molecules to probe 
specific pathways using P E T techniques. [35|. 
7. Hot cells and automated radiopharmaceutical 
production 
The high levels of starling ladioaciivity make it 
mandatory that all the cliemical [iroccsses be car-
ried out in a lead shielded enclosure { H O T C E L L ) 
and that all manipulations are at least by remote 
control. Typically a Hot cell will have lead walls 
50-100 mm thick and lead glass viewing windows of 
equivalent shielding performance for the positron 
annihilation radiations of 0.511 MeV. 
The environment inside the hot cell should be 
controlled to avoid accidental escape of radioactiv-
ity and often it is also necessary to provide an en-
vironment within the cell suitable for radiophar-
maceutical formulation. There is potential for con-
flict between these two requirements and no satis-
factory solution has yet been demonstrated. 
Although remote control achieves the required 
safety for the synthetic chemist, it is usually felt 
necessary to provide some degree of automation to 
the remote control devices [36]. This approach has 
led to faster more reliable procedures capable in 
some cases of repetitive operation. A variety of 
automation techniques are being employed ranging 
from dedicated compact synthetic units designed 
with one end product in mind to potentially flexible 
systems which make use of a Robotic arm device to 
"work" between an array of discrete workstations 
which when linked together function as a complete 
synthetic system [37]. Examples can now be found 
from commercial suppliers of both the dedicated 
unit, e.g. to make ' ^ F D G and the Robot arm based 
system. 
8. Quality assurance of P E T radiopharmaceuticals 
Before any radiopharmaceutical preparation for 
PET is administered it should be subjected to a 
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quality control procedure which has been designed 
to ensure that the product will not only be safe but 
also meet a specification that would enable valid 
interpretable data to be acquired in the PET studv 
[38]. 
A vital part of these procedures is the establish-
ment of a safe operating procedure (SOP) and a 
compliance to an established good manufacturing 
practice ( G M P ) . This is essential as due to the 
short time available for analysis of PET radiophar-
maceuticals. Some of the standard pharmaceutical 
tests e.g. sterility, cannot normally be carried out. 
The special consideration relating to the quantita-
tive determination of purity and specific radioactiv-
ity for receptor radioligands in all cases is crucial to 
the ultimate goal of " in vivo" receptor density map-
ping [34, 35]. 
S u m m a r y 
The production of radiopharmaceuticals for PET 
has many challenges and involves several disci-
plines. Their use in applying the PET technique in 
aiding the understanding of in vivo metabolic and 
pharmacological processes is probably unrivalled in 
Its picomolar sensitivity. Some clinical diagnostic 
exploitation of PET is now evolving using relatively 
simple Radiopharmaceuticals, e.g. H2 '^0 , ' 'NH; , 
and "^FDG. It would seem that due to complexities 
in the application Carbon-11 ligand Radiophar-
maceuticals they wi l l remain in the realm of re-
search tools for some time to come. 
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An Oxygen-15 Generator: Early Experience 
with the IBA CYCLONE-3 
69 
John C . Clark 
MRC Cyclotron Unit 
Hammersmith Hospital 
London W12 0HS 
United Kingdom 
Jean -Luc Morel le 
Ion Beam Applications, S.A. 
Louvain-la-Neuve 
Belgium 
Clinical Requirement 
Oxygen-15 is widely acknowledged to pertorm a vital 
role in PET clinical applications, for example measure-
ments of 
• Blood volume by ['^0]C0 
• Blood flow by r^OJCO,, ['^OJHp, ['=0]BuOH 
• Metabolic rate by [ '*0]0,. 
The Hammersmith PET programme exploits "Otracer 
techniques extensively and it was appropriate to inves-
tigate potential dedicated " O generator systems to 
allow the more flexible mutti-particle 40 MeV cyclotron 
to be applied more efficiently to " C and " F PET 
radiopharmaceutical production. 
The Project 
A collaborative programme drawn up with IBA, Louvain-
la-Neuve. A performance specification was agreed 
that would meet the cun-ent demands for '^O products 
to support the Hammersmith PET programme. Thus, 
MRC propose to purchase the prototype CYCLONE-3. 
Acceptance tests 
All products were produced at rates in excess ol 
specification. CYCLONE-3 was shipped to Hammer-
smith in February 1991. 
Current status 
Mechanical difficulties relating to insulators supporting 
dees have not yet allowed Hammersmith acceptance 
tests to be carried out. Corrective action is in progress. 
A research phase has been initiated at Hammersmith 
with 50 nA maximum to assess chemical processing, 
gastransferlossesandC^OJHjOgenerator integration. 
Radiochemical purity of ['^OJCO and ['^OJCOj meets 
clinical requirements, however, the contamination o! 
[ ' ^ j O j with 7.5 % C^OjNjO remains to be resolved. Jn 
target" production of ['*0]HjO using N/H^ target gas 
mixtures gives very encouraging results. 
Transport of f *0]HjO vapour with no added earner has 
been achieved over 100 m of 1.5 mm inside diameter 
PTFE tube. Atout 50 % losses overall were found. 
Table 1: Acceptance test data 8/9 January 1991 
Beam Flow 
(ml/min) 
Activity 
(mCl/min) 
Specific 
Activity 
(mCi/mln/tiA) 
Performance 
specification 
(mCl/mIn)' 
r = 0 ] 0 , 
r^OJCO, 
r^ojco 
58 
83 
79 
430 
435 
475 
140 
85 
115 
2.41 
1.02 
1.4 
30 
80 
40 
* All data were measured 80 m distant from the target at a 
flow of 4 - 500 ml/min (to simulate transport to the most 
distant PET scanner). 
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Figure 1: The IBA CYCLONE-3 
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Status Report from Hammersmith 
70 
J o h n C . C l a r k 
MRC Cyclotron Unit 
Hammersmith Hospital 
Ducane Road 
London W 1 2 OHS.United Kingdom 
Hardware 
• SCANDITRONIX MC 40-Operated 24 hrs per day. 
PET in daytime. Isotope production overnight e.g. 
"Rb/='"'Kr, "Br , ' "K, ^ ' P b , " F e 
• IBA CYCLONE-3 '^O generator 
• PET Scanner I: SIEMENS/GTI Model 931. Whole 
body machine used for Cardiology, Oncology and 
Neurology 
• PET Scanner II: SIEMENS/CTI Model 953B. Brain 
machine used for Neurology. Retractable septa 
gives approximately 5 fold increase in sensitivity. 
H j ' ^0 infusion unit installed underthe patient couch. 
Radiopharmaceuticals for P E T 
Carbon-rt .-Raclopride (RAC), Deprenyl (DEP), PK-
11195. Diprenoiphine (DPR), CGP-12177 (CGP), SCH-
23390 (SCH), Flumazenil (FLU), Thymidine (develop-
ing), all automated. 
F/uor/ne-rS.-C'FlFDG automated, ["F]DOPA remote, 
['»F]Fluorouracil remote (FU). 
Oxygen-15: ["0]C0^. ['^OjO,, [ '=0]C0 and l''0]Hfl 
infusions automated (plus cyclotron schedule and PET 
schedule). 
Metabolite Analysis: Many PET studies require 
plasma metabolite analysis to facilitate kinetic model-
ling. Analysis is mainly carried out using semiautomated 
radio-HPLC and RAYTEST PC integrator. 
Scheduling 
See Cyclotron Schedule (Table 1) and associated PET 
Scanner Schedules (Table 2). 20 - 25 clinical studies 
per week. 
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Table 1: MC 40 Cyclotron Operations Schedule, Week 4, 19-24 January 1992. 
D a t e / t i m e 
S u n d a y 19 J a n u a r y 
22:00 - Z3:30 
23:30 - 24:00 
Monday 20 J a n u a r y 
Beam/Posn P a r t i c l e / E n e r g y T a r g e t / N u c l i d e 
0 0 : 0 0 
00:30 
01:00 
01:15 
0 6 : 3 0 
10:00 
10:30 
12:00 
12:30 
12:45 
13:15 
13:30 
14:00 
14:30 
15:00 
15:30 
16:30 
18:45 
19:15 
0 0 : 3 0 
0 1 : 0 0 
01:15 
0 6 : 3 0 
10:00 
10:30 
12:00 
12:30 
12:45 
13:I5+++ 
13:30 
14:00o» 
14:30 
15:00o* 
15:30 
16:30 
18:45 
19: 15 
24:00 
M a i n t e n a n c e , s e l e c t 25.5 MeV He4 
5/11 He4/25.5 
S e l e c t 33 MeV He4 
5/12 He4/33 
Change t a r g e t s 
5/12 He4/33 
M a i n t e n a n c e / E n g i n e e r i n g 
S e l e c t 16.5 MeV d 
1 
A/K4 3 
AS203/Br77 
NaBr/Rb81 
U s e r E r i c o m 
JM/150 
SAC/150 
HRK/MJH/150 
S e l e c t 
5/8 
5/4 
19 MeV 
T u e s d a y 21 J a n u a r y 
5/10 
S e l e c t 9.5 MeV d 
5/6 
S e l e c t 16.5 MeV d 
5/1/2 
PET N e u r o l o g y s t u d 
S t u d y o v e r r u n 
E n g i n e e r i n g / m a i n t e n a n c e 
d/16.5 N e u t r o n a c t i v a t i o n BCP/130 
p/19 H j O / F l S I F ' j P E T 11 TJS/.»iS/150 
p/19 N ; / C 1 1 I F L U ) P E T 11 DRT/168 
p/19 N ; / C n ( C G P ) PET 1 D J B / C J S / i 6 8 
d/9.5 N j / O l S t C O P F T i NS/170 
d/16.5 Ne/F18 ( c o n d t n ) NS/150 
PET i CF/XX.X 00:00 = 17:30 NS/170 
00:00 
00:30 
05:15 
0 5 : 4 5 
0 6 : 3 0 
07:00 
0 9 : 0 0 
11:00 
11:30 
12:00 
12:30 
13:00 
13:30 
14:00 
14:30 
15:30 
17:15 
19:00 
19:30 
0 0 : 3 0 
05:15 
0 5:45 
0 6 : 3 0 * * * 
0 7 : 0 0 
S e l e c t 
5/12 
S e l e c t 
5/9 
S e l e c t 
09:00»*OKbc5/l 
1 1 : 0 0 * * 
11:30 
1 2 : 0 0 * * 0 
12:30 
13:00 
13:30+ 
14:00 
14:30+ 
15:30 
17:15 
19:00 
19:30 
2 4 : 0 0 
5/2 
S e l e c t 
5/6 
S e l e c t 
5/4 
S e l e c t 
5/6 
33 MeV He4 
19 MeV p 
15.5 MeV d 
9.5 MeV d 
19 MeV p 
9.5 MeV d 
He4/33 
p/19 
d/16. 5 
d/16.5 
d/9.5 
p/19 
d/9.5 
NaBr/Rb81 JM/HJM/150 
H20/F18(FIX;)PET l i SAC/151 
N e / F 1 8 ( 5 F U j P E T 
Ne/F18(D0PA)PET 
N,/015(C0,)PET I 
N,/C11(PK)PET I I 
CB/151 
HJM/151 
JM/170 
DJB/168 
N,/015(H,'^0)PET I I NS/HRK/170/190 
PET C a r d i o l o g y s t u d y PET I NU/XXX 
PET N e u r o l o g y s t u d y PET 1 HR/XXXX 
S t u d y o v e r r u n 
E n g i n e e r i n g / m a i n t e n a n c e 
00:00 = 
00:00 = 
16: 15 
17:45 
Wednesday 22 J a n u a r y 
0 0 : 0 0 
0 0 : 3 0 
0 1 : 0 0 
06:30 
0 7 : 0 0 
0 9 : 0 0 
12:30 
13:00 
13:15 
13:30 
14:00 
14:30 
15:00 
16:00 
18:30 
19:00 
19:30 
00:30 
01:00 
0 6 : 3 0 
0 7 : 0 0 
0 9 : 0 0 * * 
12:30 
13:00 
13:15 
1 3:30 
1 4 : 0 0 * 
14:30 
1 5 : 0 0 * 
16:00 
18:30 
19:00 
19:30 
24:00 
S e l e c t 33 MeV He4 
5/12 
S e l e c t 16.5 MeV d 
5/1 • d/16.5 
PET N e u r o l o g y Hj'^O s t u d y PET I I 
S e l e c t 19 MeV p 
5/4 
5/8 
5/4 
S e l e c t 9.5 MeV d 
5/6 d/9. 
He4/33 
p/19 
p/19 
p/19 
NaBr/Rb81 
Ne/F18 (DOPA)PET I 
JW/XXX 00:00 = 10:00 
N'z/CIKNSC) 
H 2 0 / F 1 8 ( F - ) P E T I I 
HRK/170 
HRK/170 
SAC/NS/150 
MJM/151 
JM/170 
GB/DRT/168 
TJS/NS/150 
N,/C11(RCP)PET I & B i o l H R K / 1 6 8 
N2/015(CO2)PET 1 
PET N e u r o l o g y s t u d y 
S e l e c t 16.5 MeV d 
5/12 
PET I AK/XXX 00:00 = 17:00 
d/16.5 Fe/Co56 
DJB/170 
DJB/170 
HRK/CSJr/150 
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Table 1 (continued) 
T h u r s d a y 23 J a n u a r y 
00:00 - 00 :30 S e l e c t 33 MeV He4 
00:30 - 06 :30 5/12 He4/33 NaBr/Rb81 HRK/HJH/150 
06:30 - 07 :00 S e l e c t 16.5 MeV d 
07:00 - 09 :00** 5/2 d/16.5 Ne/F18(D0PA)PET I NS/151 
09:00 - 12 :30 PET Neurology H j ^ O s t u d y PET 11 SR/XXX 00:00 = 10:00 SAC/170/190 
12:30 - 13 :00 S e l e c t 19 MeV p 
13:00 - 13 30+++ 5/4 p/19 N j / C 1 1 ( F L U ) P E T 1 1 OUT/158 
13:30 - 14 :00 S e l e c t 9.5 HeV d 
14:00 - 14 30+++ 5/6 d/9.5 N 2 / 0 1 5 ( h / ^ 0 ) P E T 11 JM/170/190 
14:30 - 15 00 S e l e c t 19 MeV p 
15:00 - 15 30o* 5/10 p/19 N j / C I U C G P I P E T 1 DJB/168 
15:30 - 16 00 S e l e c t 9.5 MeV d 
16:00 - 17 4 5 o t 5/6 d/9.5 N 2 / 0 1 5 ( C O j , C O ) P E T 1 JM/170 
17:45 - 18 30 S e l e c t 52 MeV He3 
18:30 - 19 30 5/7 He3/52 C r / F e 5 2 MLS/HRK/120 
19:30 - 22 00 
22:00 - 24 00 No s h i f t 
F r i d a y 24 J a n u a r y 
00:00 - 05 00 No s h i f t 
05:00 - 05 30 S e l e c t 33 MeV He4 
05:30 - 07 30 5/12 He4/33 Na8r/Rb81 SAC/JM/150 
07:30 - 08 00 S e l e c t 19 MeV p 
08:00 - 08 3 0 * * * 5/9 p/19 H , 0 / F 1 8 ( F D C ) P E T 11 NS/150 
08:30 - 10 15 PET Neurology s t u d y PET I CB/XXX 00:00 = 09:15 S.AC/170 
10:15 - 12 15 PET C a r d i o l o g y s t u d y PET I NU/XXX 00:00 = 1 1 : 1 5 S.^C/i70 
12:15 - 12 45 S e l e c t 19 MeV p 
12:45 - 13 00 5/4 p/19 N 2 / C l U > i S C ) GB/DRT/168 
13:00 - 13 30o 5/4 p/19 N ^ / C l U D P R j P E T 1 JM/168 
13:30 - 14 00 S e l e c t 9.5 MeV d 
14:00 - 14 30o 5/6 d/9.5 N 2 / 0 1 5 ( C O j ) P E T I MJM/170 
14:30 - 15- 45 
15:45 - 18; 00 PET Neurology s t u d y PET I H J/XXX 00:00 = 16:45 M J M / n O 
18:00 - 18- 30 S t u d y o v e r r u n 
18:30 - 19. 45 
19:45 - 24: 00 No s h i f t 
Duty E n g i n e e r : MLR O p e r a t o r s N i g h t : GCT/JG E a r l y : NWM/JP L a t e : RGH/JC 
t O i l t o r PET R a c l o p r i d e s t u d y Wed PET I NT/XXX and B i o l o g y 
00: 00 = 14:45 ( C O j ) 15: OO(RCP) [Met a n a l ) 
* t F I B f o r PET 6F DOPA S t u d i e s PET I T u e s DBn, Wed NT, T h u r s GS 
[ m e t a b o l i t e s Wed & T h u r s ) 00:00 = EOB + 2 i h o u r s 
PLEASE NOTE CHANGE OF TIMING TUESDAY, 5 FU PRECEDES DOPA 
F18 t o r PET FOG s t u d i e s T u e s 4 F r i 
T u e s PET I I AK s t u d y 00:00 = 10:30 a p p r o x FDaG {no g a s e s ) 
RMS & GYS d e s p a t c h t i m e 10:30 a p p r o x . 
F r i PET I I AK s t u d y 00:00 = 11:00 a p p r o x . FDG (no g a s e s ) 
PET I NU s t u d y 00:00 = 11:15 ( g a s e s ) 1 2:15(FDG) 
C l l f o r PET PK 11195 s t u d y T u e s PET 11 SR/XXX 
00:00 = 14:15 (H^'^O) 14:30 ( P K ) [ M e t a n a l ] 
C l l t o r PET F l u m a z e n i l s t u d i e s Mon & T h u r s PET I I MP/XXX 
Monday 00:00 = 14:15 ( F L U ) o n l y [Met a n a l ) 
T h u r s d a y 00:00 = 14:15 ( H / ' O ) 14:30 ( F L U ) [Met a n a l ) 
C l l f o r PET D i p r e n o r p h i n e s t u d y F r i . AKPJ 
F r i d a y 00:00 = 14:15 ( C O 2 ) 14:30 ( D P R ) l M e t a n a l ) 
C l l f o r PET CGP s t u d i e s PET 1 Hon JMBH/XXX and T h u r s PC/XXX 
Monday 00:00 = 14:45 (CO) 15:10 and 15:40 (CGP) 
T h u r s 00:00 = 16:15 ( C O 2 ) 16:35 and 1 7 : 0 0 ( C G P ) 17:30(C01 
F18 t o r PET 5 FU s t u d y T u e s PET I , OT/XXX 
00:00 = 11:45 ( C O j ) 12:00 ( 5 F U ) (met a n a l ) 
F18 f o r 5 FU s t u d y on u h o l e body c o u n t e r T u e s OT/XXX 
00:00 = 12:00 approx. o r l a t e r . 
C i r c u l a t i o n : K I G , CJP, J E C , RSJF, T J , AAL, T J S , NU, CGR, OT, CAJF, Sun Rra, 
CJVT, GCL, ADW, ASOR, 112M, KRB, C J P , PJNA, DBM, ENG NB, MLR, MLS, C ROOM, 
KGPP, 244, Chen NB, KD, C J S , DJS, SLK, FB, VWP, SKL, DRT, Annex N B 
*»o 
wbc 
:14 N B , P E T S B , 
15 X 2, JCC, SO 
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Table 2: PET Schedule. Week 4, 19-24 January, 1992 
W e e k 
4 
S C A N N E R O N E Zero 
t i m e 
C h m D r S C A N N E R T W O Zero 
l i m e 
C h m D r 
MON 
2ettl 
JRN 
C Y C L O T ] 
Pulmonary. 
"C-CCP 
Neuro(schizo)..C'^02 * 
R O N 
1 5 : 4 5 
1 6 : 1 0 
1 8 : 3 0 
M A 
NS 
DJB 
NS 
I N T 
MH 
CF 
E N A N C E 
Neuro(epilepsy)."C-Flumaienil M 1 4 : 1 5 DRT M P 
TUE 
21st 
JRN 
Oncology €^^02 
ISF-SFU M 
Neuro(mve dis)..'^F Dopa * 
Cardiac C^^O.C'^Ol 
Neuroidep PD.).C^02 
1 1 : 4 5 
1 2 : 0 0 
1 3 : 3 0 
1 6 : 1 5 
1 7 : 4 5 
J M 
CB 
M J M 
HRK 
HRK 
o r 
CB 
NU 
m 
Neuro(demeniia)..'^F F.D.C-
Neuro(M.S.).M2'^0 
IK-PKI1195 A/ 
1 0 : 3 0 
1 4 : 1 5 
1 4 : 3 0 
SAC 
NS 
DJB 
AK 
SR 
IVEO 
22nd 
JRN 
Neuro(mve dis)..'^F Dopa * 
Neuro(mve dis)..C'^02 
^ 'C-Raclopride M 
Neuro(dementia)..C'i02>^02C!iO 
1 1 : 3 0 
1 4 : 4 5 
1 5 : 0 0 
1 7 : 0 0 
M J M 
DJB 
HRK 
DJB 
NT 
NT 
A K 
Neuroinormal) .H2'^0 * 
Biology.." C-Raclopride 
1 0 : 0 0 
1 5 : 0 0 
JM 
HRK 
JW 
A A L 
THUR 
23rd 
JRN 
Neuro(mve dis)..'^F Dopa M 
Cardiac.C'^O 2 
"C-CGP 
1 1 : 3 0 
1 6 : 1 5 
1 6 : 3 5 
1 7 : 0 0 
NS 
J M 
DJB 
J M 
GS 
PC 
Neuro(normal)..H2'^0 * 
Ncuro(epilepsy)..H2'^0 
i'C-Flumaieni! M 
1 0 : 0 0 
1 4 : 1 5 
1 4 : 3 0 
SAC 
I M 
DRT 
SR 
M P 
FRI 
2 4 fh 
JRN 
Neuro(normal)..C'^0 * 
Cardiac.C'^O 2 dO 
ISPD.G. 
Neurolpain) ..O^02 
1 !C-Diprenorphine M 
Neuro(nonruil)..C'^02 
0 9 : 1 5 
1 1 : 1 5 
1 2 : 1 5 
1 4 : 1 5 
1 4 : 3 0 
1 6 : 4 5 
SAC 
SAC 
NS 
M J M 
J M 
M J M 
PG 
NXl 
AJ 
HJ 
Neuro(demeniia)..'^F F.D.C 1 1 : 0 0 NS AK 
Paul Scherrer Institut 241 
T A R G E T R Y - 9 1 
••R2D2", A Bedside [Oxygen-15]Water Infuser 
/ 1 
J o h n C . C l a r k 
MRC Cyclotron Unit 
Hammersmith Hospital 
London W 1 2 OHS, United Kingdom 
Henri T o c h o n - D a n g u y 
Hopital Cantonal Universitaire 
1211 Geneve 4, Switzerland 
Clinical Requirement 
• "Hands off" infuser for flow studies in brain and 
heart. 
• Must be user-friendly. 
• Must be safe and effective for patient use. 
A Practical Solution 
• Produce p^OJHjO vapour at the bedside. 
• Introduce [ '^0]HjO into normal saline infusate us-
ing semi-permeable membrane exchanger (VIS-
KING regenerated cellulose*). 
• Deliver nonnal saline using medically approved 
pump IVAC 560. 
Two fluid handling valves for control of infusion 
parameters 24 Volt ANGAR/ASCO 368 3-pof1 mem-
brane valves. 
On-line radioactivity detector based on a loop of 
1/16" PTFE around PHILIPS 2P-1300 GM tube. 
Counts acquired into MINI-INSTRUMENTS 6-90 
scaler ratemeter modified with adjustable pre-scaler 
to allow direct calibration in "mCi infused". 
All controls and power supplies designed and built 
to comply with electromedical safety standards. 
Non-used product allowed to decay within the unit 
before discharge into sterile bag. 
S a l i n e 
Vented 
Millipore 
5% H y d r o g e n 
95% N i t r o g e n 
Act ive G a s 
1% Oxygen 
99% N i t r o g e n 
T U B E 
Lead p lug 
C a U l y s t 
Oven 
a t 200-C 
Waste d e c a y 
co i l 
O u l p i i l 
Lo p a U e n t 
O x v g e n - 1 D 
Water 
G e n e r a t o r . 
Waste gas 
K. Dowset l 
J a n u a r y 1992 
^ D e c a y e d waste 
S a l i n e 
Figure 1: Schematic Drawing of the R2D2 Infusor. 
• V ISKING - Medicen International, Fax 071 700 4156, U.K. 
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1 orr H5 
1 orr 5.10 
10-32 u»<r 
5C000O • 
85.00—6* — 6 6 
CHAMFER <5 X 25KK 
L 
iSi SLOT viiH eamh xisc cuiirii 
I orr 250 KCP 
1 orr l i s DECP 
Fgure 2: Membrane Exchanger in the R2D2 Infuser Material: Perspex DWG No. 15. 
Typical Operating Parameters 
Infusion for 2 minutes at flow rate of 10 ml/min. Infused 
radioactivity determined by PET scanner mode, typi-
cally: 
SEPTA O U T - 1 5 mCi 
SEPTA IN - 80 mCi 
GM counter calibration checked against standard ioni-
zation chamber routinely. 
Pharmaceutical Maintenance 
Membrane exchanger cleaned and sterilised prior to 
assembly. Fluid system washed with 0.9 % NaCI 
solution with Millipore filters in place. Pyrogen tests 
(LAL) and sterility tests carried out to validate assem-
bly techniques. Routine operation involves replace-
ment of disposables - pump tube - saline bag -
Millipore filters and infusion catheters. Followed by 
LAL test. 
Current Status 
R2D2 is in routine use in PET Brain Activation Studies 
and has tjeen well received by the users. 
Figure 3: Photographic View of the ["0]Hp Bedside Figure 4: Further Automation Trends at Hammersmith 
Infuser R2D2. in the Planning Phase. 
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Automated Carbon-11 Radiopharmaceutical Production 
J o h n C . C l a r k and K e i t h D o w s e t t 
MRC Cyclotron Unit 
Hammersmith Hospital 
London W12 0 H S 
United Kingdom 
/ ^ 
Control System 
The Hammersmith methylation systems are controlled 
by a TOSHIBA EX40+ programmable controller with 
an EX40E expansion unit. This provides 48 inputs and 
32 relay outputs. These devices have been programmed 
using ladder logic, a system based on relay type logic 
with open and closed contacts and relay coils. There is 
also a bi-directional shitt register which sequences the 
operations. Programmable controllers were selected 
tor reliability which at present is very good. 
Sequence of Operations (Fig. 1) 
„Set-up" procedure. 
• Purge apparatus with nitrogen, load lithium alu-
miniumhydride,hydriodicacid, and precursor. Load 
syringes 17 and 26. 
• Nitrogen flows through valves 2 ,3 , 4, 6 and 7 and 
also through 11 and 12. 200 ul of LiAIH, in THE is 
placed in the methyl iodide pot, and 200 nl of HI 
loaded into the loop controlled by valve 10. 
• Approximately 2 mg of precursor in 500 |il of DMSG 
+ base is loaded into the methylation vial. Load 
syringe 17 with 9 ml of water and load syringe 26 
with 10 ml of isotonic saline. 
^Run" procedure. 
• Trap activity. Trap is lowered into liquid.argon, then 
valves 1 and 4 actuate to empty the target. Nitrogen 
flow continues through valves 2,3,6 and 7 and also 
through 11 and 12. 
• Dispense activity. The trap is raised and nitrogen 
passed through it from valve 2. The cartxjn dioxide 
is carried through valve 6 and into the LiAIH^. The 
nitrogen is vented through valve 7. 
• Make methyl iodide. The THE is removed by heat-
ing, nitrogen flows through valves 2, 3, 4, 6 and 7. 
When the evaporation is finished the pot is cooled 
by air through valve 9. After cooling the HI is added 
through valve 10 under nitrogen pressure. The pot 
Needl 
V«|re Nitrogen 
Coolm< Air 
^ Needle raWe 
o -
Loop c o n t A i n i n f 
SOOui ot HI 
SUrrer 
" C O j T r a p "CH^I production Methylation 
HPLC elucnl 
!<:-,'» * . . i e V X 
column 
^ Nitrocc; 
roUry 
cvaporftior 
Product (or lojecuow 
HPLC purification Formulat ion 
Figure 1: Schematic diagram of the automated radiopharmaceutical production. 
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is then sealed and heated to 165''C for 2 minutes to 
convert any remaining methanol into methyl iodide. 
Methylate the precursor. Switch off nitrogen ftow 
through valve 11 and distil methyl iodide through 
valves 11 and 12 into the precursor. AfterS seconds 
switch on nitrogen through valves 2,4 and 6. After 
1 minute lower vial into oil bath and heat to 90°C for 
5 minutes. During this heating cool the methyl 
iodide pot with air through valve 9. 
Purify precursor by HPLC. Raise the methylation 
vial and wittxJraw the contents through valves 12 
and 16 into syringe 17. Wash the via! with water 
from syringe 17, then load the contents into the loop 
on valve 18. Switch valve 18totransferthe contents 
on the loop onto the short C-18 column. Wash with 
water for 5 minutes. Switch valve 19 to wash the 
organic products onto a semi-prep C-18 column. 
The effluent from the C-18 column is monitored by 
UV and radioactivity detectors and valve 20 actu-
ated by the operator to select the product. 
Fomiulate the product. The eluent from the column 
is transferred through valves 20 and 21 into the 
rotary evaporator where the HPLC eluent is re-
moved. 10 ml of isotonic saline is then added from 
syringe 26. This is sucked out, then passed out of 
the cell and through a Millipore 0.22 ^UT^ filter into a 
sterile vial. 
Labelled Compounds 
This type of system has been used to methylate the 
following compounds: 
• S C H 23390 
• Deprenyl 
• Racfopride 
• PK 11195 
• Flumazenil 
A similar system with an additional deprotection stage 
(hydrolysis) has tieen used to label Diprenorphine. 
Yield 
Atypical preparation will start with > 50 GBq of ("C]COj. 
45 minutes later this will yiekJ around 2.7 GBq of 
labelled product. This typically has a specific activity in 
the region of 7-10 GBq/nmol @ 60 minutes EOB. 
J 
Figure 2: Caibon dioxide trap. This trap is constnjcted 
from 600 mm of 1/16" stainless steel tubing. This is 
cooled in liquid argon to prevent nitrogen condensa-
tion. Efficiency is > 99%. 
Figure 3. Methyl iodide reaction pot. This pot contains 
200 \U of a saturated solution of lithium aluminium 
hydridein THF. This is prepared in a nitrogen glove box 
on a weekly basis. The complex formed by reaction 
with carbon dioxide is hydrolysed by addition of200\d 
of 55% hydriodic acid which is transferred under gas 
pressure from a loop above the pot. 
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Figure 4: The methyl iodide pot is shown here life size. 
The lid is made ofKel-Fwith five 1/4-28 ports machined 
into it. It is sealed to the glass reaction pot by a teflon 
coated silicone rubber seal ring. Attached to the outlet 
is a trap which holds sodium hydroxide. This is used to 
prevent hydriodic acid distilling into the precursor with 
the methyl iodide. 
Figure 5: Methylation vial. The vial is sealed with a 
teflon faced septum which is pierced by two round 
nosed needles. Methyl iodide is distilled from the 
reaction pot into a vial containing the precursor m 
strong base. This is then lowered into the oil bath, and 
the needles withdrawn from the septum. The sealed 
vial is then heated to complete the reaction. 
Figure 6: HPLC system. The reaction mixture is first 
loaded into a 10 ml loop then transferred to a short C-
18 column. This retains organic compounds but ionic 
materials are washed to waste. The organic materials 
are then removed with a different solvent and trans-
ferred to an HPLC column. 
Figure 7: Formulation hardware. This is based on a 
modified rotary evaporator with a dip lube to allow 
liquids to be sucked out. It is mounted on an air cylinder 
with an oval piston to prevent rotation. 
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Introduction: State of the Art in Automated Syntheses of Short-Lived 
Radiopharmaceuticals 
73 
J e a n n e M. L i n k 
University of Washington 
Seattle. WA, USA 
J o h n 0 . C l a r k 
Hammersmith Hospital 
London W12 0HS 
United Kingdom 
T h o m a s J . R u t h 
UBC/TRIUMF PET Facility 
4004 Wesbrook Mail 
Vancouver, B.C., Canada 
The goal of this session was to discuss automation as 
it currently exists in the field of radionuclide and radio-
chemical synthesis. Emphasis was placed on the prob-
lems participants have encountered in implementation 
of automation. Group participation was encouraged 
both to define the problems which require solutions 
and to present alternative solutions to those problems. 
In order to focus these efforts, the session began with 
a presentation of varying philosophies regarding argu-
ments for and against automation. The session then 
wori<ed through specific areas of radionuclide produc-
tion and synthesis which are worth automating. These 
included target filling, transfer of materials to and from 
targets, additions, mixing, transfers into and out of 
reaction vessels , evapwrations, incubations, andsepa-
ratons. The latter part of the session dealt with auto-
mation of quality control methods including formula-
tons, set-up and clean-up. 
A p p r o a c h e s to Automation 
John C L A R K (Hammersmith Hospital, London) began 
the discussion by presenting his views of „What is 
automation, and why do we automate?" He defined 
automation, very broadly, as anything that gets our 
hands out of the system. First and foremost, an auto-
mated system should be reliable. This includes txith 
the mechanical system and the synthesis itself. S e c -
ond, automation involves significant time and expense. 
It is not economically sensible to automate any 
radiosynthesis which wont be performed many times. 
One must decide if the clinical demands will be suffi-
cient to justify the effort. 
Jeanne LINK (Univ. of Washington, Seattle) catego-
rized radiosyntheses in four ways: 
• Manual syntheses where the chemist's hands per-
fonn transfers and additions; 
• Remote syntheses where valves or manipulators 
are used to effect the transfers and additions; 
• Remote automated syntheses where a computer is 
used to control the switching of valves of a remote 
process. The computer may be as simple as a 
sequence timer or as complex as a decision making 
computer. These systems can be dedicated to one 
synthesis or modular. 
• Robotic syntheses which uses a mechanical arm to 
move the reaction vessel rather than just moving 
chemicals in and out of the reaction vessel. There 
can be significant complementarity between ro-
botic and remote automated systems. 
Manual radiosynthesis is undesirable, exposure to 
radiation should be avoided when possible. Yet alrrrast 
all of our facilities still include some manual synthesis 
wori<. Why? It is a matter of resources; i.e. personnel 
time and skills, and equipment and supply costs. 
Manual synthesis is the fastest and least expensive 
method for implementing a radiosynthesis. If for exam-
ple, a manual synthesis required $15,000 in equipment 
and supply costs and a half-year of a chemist's time to 
develop the synthesis, the costs for remote systems 
would be at least as numbered in Table 1. 
These are only baseline costs. The costs for remote 
systems typically are valves and tubing. Robert DAHL 
(North Shore Hospital, Manhasset) said one remote 
manipulator arm costs $15,000. For a renxjte auto-
mated system or a rotx)tic system more typical costs 
are $70,000 to $100,000. There are a few automated 
systems on the market (CT l , SCANDITRONIX , 
DANATEC, J S W , NKK, SUMITOMO efc.) and their 
costs are similar. However, there is more to be consid-
ered than initial capital costs. Each approach to syn-
thesis has definite advantages and disadvantages. 
LINK uses both a ZYM ARK robotic system for " C and 
^°F syntheses and dedicated remote systems for pro-
duction of F D G and '^O compounds. She argued that 
the decision as to type of system to be used for a 
174 Paul Scherrer Institut 
TARGETRY '91 
Table 1: Comparison of Costs Between Different Levels of Automation 
Remote Remote 
Automated 
Robotic 
Initial Supplies 
Equipment 
>$20,000 >$21,000 >$30,000 
Personnel (PTE years) 
Initial Development 
0.6 1.0 1.0 
Personnel (PTE years) 
Annual Support 
0.1-0.2 0.25 0.25 
Table 2: Advantages and Disadvantages of the Different Levels of Automation 
Advantages Disadvantages 
Manual Flexibility is high 
Cost is low 
Cost to maintain is low 
High radiation exposure to 
chemists 
Reliability can be low 
Remote Lower radiation exposure to 
chemists 
Cost to maintain is still low 
Cost to develop is greater than 
for manual 
Requires more space than a 
manual synthesis 
Remote 
Automated 
Low radiation exposure to the 
chemists 
High reliability 
Often useful for more than one 
synthesis 
Initial cost to develop is greater 
than for manual or remote 
Requires more space than a 
manual synthesis 
Robotic Low radiation exposure to the 
chemist 
High reliability 
Useful for more than one 
synthesis 
Initial costs to develop are high 
Requires more space than other 
systems 
synthesis has to be matched to the resources and 
needs of an individual group and no single method is 
optimal for every situation. 
DAHL offered additional views on automation: He 
defined an automated system as an „apparatus which, 
after a signal to perform a complex series of opera-
tions, does so with no further human intervention". He 
gave two reasons to automate: 
• to reduce personnel exposure to radioactivity and 
• to reduce the time requirement for personnel to 
perform radiosynthesis. 
In that light he felt that the only syntheses worth 
automating are high dose, well-defined procedures. 
You automate a synthesis by defining the process, 
selecting the appropriate apparatus and then develop-
irtg the computer program and testing it. Automated 
systems should be simple to use and reduce exposure 
to radiation. DAHL uses a remote non-automated 
system for production of F D G . It takes no more or less 
time to do F D G by their system than by others; two 
hours. They use a plywood board with the synthesis 
vessels and tubing mounted on the front. They use 
stopcocks for valves and turn the stopcocks with re-
mote manipulators. After the synthesis, they let the " F 
decay and clean it out. With regard to the remote F D G 
synthesis used by DAHL, C L A R K asked how many 
people are skilled enough to use manipulators? DAHL 
acknowledged that could be a disadvantage, many 
people do not have the experience or dexterity to 
operate them efficiently and reliably. 
C L A R K summarized his approach to automation. First, 
he figures out how to do the synthesis. Then he adds 
switches. He then programs the sequence of events, 
time, temperature and critical steps. He likes to use 
programmable logic controllers (PLC's) as controllers. 
His systems are built to be as space efficient as 
possible. For example, he packs at least two complete 
methylation systems in one hot cell; the only common 
point being the CO^ trap. He has independent P L C 
controlled set-up procedures for each synthesis. An 
operator stays close by to oversee HPLC product peak 
collection. His limitation is that he can't prepare the hot 
cell quickly for the next synthesis, due to radiation 
dose. Setting up an automated clean-up is an impor-
tant future goal. 
Greg G A E H L E {Washington University, St. Louis) pre-
sented some comparisons between two rotxitic sys-
tems, HUDSON and ZYMARK, for radiosynthesis [1,2]. 
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G A E H L E prefers the HUDSON system, primarily for 
two reasons: 
• The H U D S O N robot software runs in a Windows 
environment and allows parallel syntheses. This is 
more convenient than the ZYMARK programming 
system. While the ZYMARK commands must be 
programmed in a linear fashion, programming of 
the H U D S O N can follow branching paths. 
• The HUDSON rotx)t is roof mounted, thus saving 
floor space. They use their robot in a hot cell with 
lOft^of floor space. 
He set up F D G automation in 1 month, although they 
had previous experience automating the synthesis of 
F D G using a ZYMARK robot He learned the program-
ming language in three days. He showed pictures of 
the robot in a mobile (on wheels) hot ceil. G A E H L E also 
described the 18 stations which comprise the St. Lou is 
rotxjtic system: a robot arm, homing station, pipette 
unit, three dual liquid dispensing units (HAMILTON), 
balance ( M E T T L E R ) , capping station (HUDSON RO-
B O T I C S ) , Vortex mixer (F ISHER SCIENTIF IC) , liquid/ 
solid extraction station (ZYMARK), two H P L C s (SSI) 
with automated injectors, UV detectors, and two radia-
tion detectors (BECKMAN), dose calibrator (ATOMIC 
P R O D U C T S ) , two heating stations, a nitrogen purge 
device, fraction collection station (GILSON), filtration 
station, pipette shucker, waste receptacle, three ves-
sel racks, cold bath, and shielded receiving and collec-
tion vessels . 
Christian C R O U Z E L (Hopital F. Joliot, Orsay) pre-
sented the Orsay philosophy regarding automation. 
They consider three situations when they automate 
systems: 
• Routine hospital syntheses, 
• Research syntheses, and 
• Mixed routine / research syntheses. 
A remote control system is used to produce CH3I. They 
have designed their system to be flexible so that other 
precursors, including acetone and acid chlorides, are 
made using one single remote system. They handle 
many mCi of F D G each day and they also use a remote 
automated system for this synthesis. They use a 
Z Y M A R K robot for production of other ' ' F compounds, 
including fluorospiperone. C R O U Z E L stated that it is 
difficult to produce CH3I, because it is necessary to 
work with liquids. He recommended that if we are 
going to continue to rely on CH3I as a major precursor 
in ^'C synthesis then we should devise a method to 
make it directly from ["Cjmethane and then automate 
that synthesis a s a gas. 
Regin W E I N R E I C H (PSl Villigen) gives priority to prac-
tical questions in automation, namely the frequency of 
expected production runs, and the finger doses to the 
personnel (The regulatory authorities also like auto-
mation as a kind of guarantee for unchanged produc-
tion oins, but there is no fixed rule in Switzeriand). 
From this consideration, the PSl group automated 3 
processes: 
• ['«F]2-FDG. It is believed that 2-FDG will be the 
main P E T compound for the next decade. Further, 
they have delivery commitments to external F D G 
users. Thus, the philosophy was to construct a 
simple reliable compact apparatus for 2-FDG as a 
„wori<ing-horse" with the option to change the reac-
tion process by simple rean-angementof the valves • 
and simple re-programming. 
• ["CjCHjI . Methylation is the main process for intro-
ducing " C into biomolecules. Thus, it was decided 
to constmct a synthesis apparatus with similar 
specifications as for 2-FDG, but with the option to 
extend to further labelling steps. This has been 
realized for ["Cjraclopride. 
• " F e . The reason for constmction of an automated 
apparatus for separation of longer-lived " F e from 
irradiated Ni targets is the handling of very high 
activities of ^ F e in order to increase its specific 
activity for some labelling purposes. 
For realization of its ideas, the PSl group cooperates 
with DANATEC AG. PSl follows consequently the 
guideline that technical improvement must go along 
with a continuous improvement of quality control pro-
cedures. 
There was considerable audience discussion regard-
ing these approaches to automation and costs in-
volved in different levels of automation. Bruno 
NEBELING (KFA Julich) objected to generalizing the 
costs for automation; he felt that they were unneces-
sary and inaccurate. Jean-Luc M O R E L L E (IBA, 
Louvain-la-Neuve) thought that the cost estimates 
were reasonable. Kari ERDMAN ( E B C O , Vancouver) 
suggested that one could use industrial robots which 
are less expensive than the ZYMARK, HUDSON or 
SCANDITRONIX robot systems. Kenneth KROHN 
(Univ. of Washington, Seattle) countered that while 
industrial robots cost less to purchase than the com-
mercial latx)ratory robotic systems, their research group 
has both a ZYMARK system and an industrial robot 
( S C O R B O T ) , and the latter has required much more 
wori<, i.e. time and money, to program and set up for 
radiopharmaceutical syntheses. CLARK concuned and 
recalled how much trouble SCANDITRONIX has had 
adopting the industrial ANATECH robot for radio-
pharmaceutical use. Johan ULIN (SCANDITRONIX, 
Uppsala) concurred. M O R E L L E had experience using 
robots early on in industrial electronics assembly and 
said usingrotx)ticsforradiochemistryisquitedifferent. 
There is much more than moving things involved in 
automation of a radiosynthesis. Industrial rot»ts have 
been used at Karolinska Hospital in Stockholm [3]. 
Volker B E C H T O L D (KfK Karismhe) and LINK stated 
that the cost of developing an individual synthesis 
would decrease when automation was devetoped a s 
an assemblage of modules. In that situation, a single 
module operation such as liquid transferorsolid phase 
extraction could be used for multiple syntheses. 
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CLARK commented further on the advantages and 
disadvantages of different types of automation: „Many 
people have a wrong expectation of robots, if you want 
to do something lots of times then go to a dedicated 
system, if not go to a robot. Robots can in principle do 
anything, but they are very hard to automate." He 
agreed that the advantage of a robot is versatility, but 
asked if there wasn't a cross-contamination problem. 
Do you run the risk of cross-contaminating samples 
from one synthesis to another by using shared sta-
tions, hands, etc.? LINK agreed that the potential for 
contamination is real, but one should always be careful 
to never use the same transfer material, pipet tips, 
tubing, needles, etc. from one synthesis to another. 
Marc BERRIDGE (Univ. Hosp. of Cleveland) also felt 
that the flexibility available from robots is an advantage 
over dedicated systems. 
Andrei SEBYAKIN (KURCHATOV Inst., Moscow) ar-
gued that one of the advantages of automated systems 
is that they require less sophisticated people to mn 
them. An automated system should be „fool proof", it 
should not require the same skill to operate as would a 
manual synthesis, or it is a waste of money. He was 
also concerned that it is difficult to standardize compu-
ter instnjction from different sources. There are lots of 
costs in connecting to different source units (manufac-
turers). One should put intellect into a „really good" 
system. Automation systems will not be cost effective 
if there is not a big demand and this will require 
standards in hardware and software. GAEHLE thought 
standardization was an unobtainable goal, manufac-
turers will be continually upgrading and changing their 
own products and are in competition with others. He 
felt that uniform hardware and software standards 
weren't necessary to meet SEBYAKIN's goals. He has 
set up and oversees a synthesis that he taught to a 
technician with no experience in chemistry for a cost 
of $50,000 plus personnel time. SEBYAKIN countered 
with the argument that you pay now, then the proce-
dure changes and you pay again. He restated the need 
to set standards for the industry. LINK said that this 
applied to both robots and automated txDxes. One 
needs to pick a system which is the best fit to the 
number and type of syntheses and the resources 
available for the individual lab. Attempting to get eve-
ryone to use a single computer standard is akin to 
arguing religion. MORELLE agreed. A significant com-
ment was offered by RainerWAGNER (MAX-PLANCK 
Institute, Koln) who objected to referring to technicians 
in the laboratory as Jnexperienced" personnel. We 
need to hire and train people who know what they are 
doing in the laboratory; the personnel who wor1< in his 
lab are competent to work with their syntheses. 
BERRIDGE feels that a good system for performing 
the FDG synthesis by the Julich method should also be 
useful for synthesizing other compounds made with 
fluoride using standard nucleophilic substitution reac-
tions. Such a system under computer control could be 
programmed for the variations between such synthe-
ses with at least as much ease as a robotic system: 
Therefore, multi-synthesis use alone is not necessarily 
a factor which should riKive one to a robotic system. A 
similar „black box" synthetic system has been con-
stmcted for the preparation and use of methyl iodide. 
It has been used not only to perform several methyl 
iodide methylations, but also GRIGNARD based pro-
cedures using labeled acetone. It might be used for 
other " C syntheses. It seems that a general system 
could be designed for synthesis of several different 
preparations. 
A general use system can be designed and built as 
long as the basic steps for the syntheses under consid-
eration are the same, i.e. the reagents added, 
evaporations, and purifications via chromatography 
require the same number of reaction vessels. This had 
been demonstrated by the multiple syntheses per-
formed with the CTI Chemistry Process Control Unit. 
However, there will always be trade-offs between 
efficiency, cost and general utility. One must always 
assess the function for which an automated system will 
be used and decide whether flexibility or routine use is 
the requirement. 
The discussion returned to the comparison of two robot 
systems presented by GAEHLE. KROHN objected to 
his argument about the space advantage of the HUD-
SON rotx»t. He commented that one can pack lots in a 
hot cell with either Tobo\ if you consider the full three-
dimensional space. John SUNDERLAND (Univ. of 
Nebraska, Omaha) was curious about the mobile hot 
cell and asked if they bolted down the robot to maintain 
positioning. GAEHLE said not yet, but they would in 
the future. SUNDERLAND also asked how they did 
liquid transfers. They used pipets. GAEHLE was also 
asked how they maintain sterility? He said that they use 
sterile filtration for all of their products. 
Tom RUTH (TRIUMF, Vancouver) asked; how many 
syntheses could be performed per hot cell „door open-
ing" using a robot? LINK said that they only pro-
grammed the ZYMARK to oin one synthesis at a time, 
but more could be programmed. Two syntheses can be 
run concurrently using the ZYMARK robot at St. Louis 
and GAEHLE said they are working to automate clean-
up after a synthesis and set-up for sequential synthe-
ses so that the door doesn't need to be opened except 
to occasionally replenish supplies. DAHL was con-
cemed that only one synthesis in one enclosure will be 
allowed by the FDA. There was a big protest from the 
audience that this didn't make sense. Michael HAKA 
(SUNY, Buffalo) said „the FDA doesn't think logically". 
People agreed that it was more important to reduce 
exposure. 
Transfer In and Out of Targets 
Richard FERRIERI (Brookhaven Natl. Lab) presented 
the automation work they have done with regard to 
making and delivering ['"Flfluoride reliably to the \abo-
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ratory. In order to accomplish this they have auto-
mated filling of the fluoride target in a system which 
they presented as a poster as well as described in this 
meeting [4]. The system includes: 
• A R wire conductivity sensor in the top target outlet 
which has direct feedback through conductivity 
response to Insure that the target is filled. 
• An automated resin / recovery system, located in 
the vault. This insures reliable p^F]fluoride produc-
tion and delivery. The system maintains the chemi-
cal and isotopic integrity of ("0]water. It eliminates 
thetransferof in-adiatedrO]watertotheHotlab. In 
the area of radiation safety, long-lived radionuclides 
residing in the irradiated target water, remain con-
tained in the vault. 
The conductivity sensor remains on during the filling 
and emptying of the target, but is turned off during 
irradiation. The sensor is a detector they had in the lab, 
platinum wire in polyethylene tubing, with a 25 VAC 
supply. FERRIERI preferred small wires that would fit 
within a 1/16 inch tube. The wire is kept out of the path 
of the beam. He also suggested that the conductivity 
detector could be used to show the degree of fullness 
of the target if the sensor were in a >< configuration. 
There was considerable difference of opinion as to the 
usefulness of the conductivity detector. Jorg 
STEINBACH (FZ Rossendorf, Dresden) uses a con-
ductivity detector similar to that of FERRIERI, but also 
has an HPLC type valve attached to his target inlet 
which he closes during irradiation to hold the water in 
the target. CLARK argued that the fullness of the target 
was not difficult to ensure. One should just load the 
desired volume from a syringe and close the target 
when ready for irradiation. NEBELING agreed that a 
conductivity sensor isn't necessary. He monitors pres-
sure on target to show that beam is on target and the 
target is full. There is 7 bar of resistance in his capillary 
tubing when water is going into the targetrwhen the 
target is full this resistance decreases. On the other 
hand, several participants acknowledged that they 
had run beam on their ['*F]fluoride targets when they 
were not full or dry, at least once. It is apparent that 
while some laboratories have avoided or solved the 
problem of keeping a water target full, simple feed-
back sensors, e.g. conductivity or pressure, are useful 
in the water target systems of many laboratories. 
James fwlOSKWA (Univ. of Michigan, Ann Arbor) has 
had two unsuccessful experiences in using optical 
level sensors in the vault to monitor target fullness. 
Both detectors „died" because they were neutron 
sensitive. He now uses a small ultrasound transducer 
and over fills the target intentionally. The sensor is 
clamp-mounted and works well, it is manufactured by 
MAGNETROL {120-C Jeffryn Blvd. East, Deer Park, 
New York). 
Radiation Detectors 
Radiation detectors have been discussed at previous 
targetry meetings [5]. However there is still a need for 
inexpensive radiation detectors which have small sen-
sors, at least 3 decades of response, can be located in 
many positions around the hot cell and wrth low sensi-
tivity to background.This maybe usefulforfeedbackin 
automation of syntheses. What types of detectors 
have people found for this purpose? 
SUNDERLAND stated that NUCLEAR ASSOCIATES 
(PO Box 349, Carle Place, NY 11514-0349) has a 
radiation therapy monitoring device called „PC Rain-
bow" which meets all of those requirements but cost: 
It's price is approximately $10,000. The unit now han-
dles 6 to 7 detectors which can be 10 to 20 meters 
away. He is trying to persuade the corrpany to modify 
the unit to handle up to 12 detectors. The cost is 
~ $150 per semiconductor detector and they are about 
the size of the end of a 0-tip. They have a serial tie to 
the PC through an optical cable. SUNDERLAND is 
wori<ing with NUCLEAR ASSOCIATES and SIEMENS 
to get these commercialized for PET radiochemistry. 
The detectors are sensitive with reasonable accuracy 
from 5 mCi up to „lots more than you will ever make". 
LINK asked what detector to use for a lower range of 
activity, for example 0.5 mCi to 2 mCi in 1 ml? 
Jerry NICKLES (Univ. of Wisconsin, Madison) sug-
gested that one of his students had solved this by 
mounting a BGO detector to a photo amplifier or photo 
resistors which then could either be read into a 
KEITHLEY electrometer or an acoustical transducer. 
BERRIDGE uses a semiconductor detector called „the 
Posimeter. The detector head is about the size of a 
film can, in aluminum from POLYTECH LAB, Houston 
(9407 Rowan, Houston, TX 77036, ask for Francis 
LING). The cost is around $ 800 each. The detector 
head is connected by coaxial cable to a meter unit 
which mounts on the hot cell exterior in his lab. The u nit 
is about 10x15x5 cm. The readout is a standard meter, 
wrth an associated scale adjustment wheel. It runs on 
12 VDC, and comes with a calculator-type power 
supply which plugs into an ordinary outlet, and a small 
jumper cable to allow a series of meters to be run from 
one power supply. The lower detection limit is around 
1 mCi, depending on geometry and the response is 
linear from 1 mCi to 5 Curies of There is ananatog 
output which can be used to drive a chart recorder or 
computer input. He has used the devices as detectors 
in the hot cells with up to three of them per apparatus 
for the last four years. He also uses them successfully 
as chromatography detectors on the hot cell prepara-
tive LC's, and in a shielded syringe holder for dose 
dispensing, tt is nothing fancy, but does the job while 
requiring no attention, little space, and offering no 
hazards. He has been satisfied wrth them. 
178 Paul Scherrer Institut 
T A R G E T R Y '91 
FERRIERI uses probes similar to those described by 
SUNDERLAND. They come from THERADOS. He 
cautioned that these detectors are temperature-sensi-
tive, but SUNDERLAND disagreed. The detectors he 
uses vary about 0 .1% per °C. DAHL has also used 
small detectors from LND (3230 Lawson Blvd., 
Oceanside, NY 11572). LND has both small GM and 
ion chambers, called peanut detectors. These are for 
detecting y-rays and so require shielding against back-
ground. 
SUNDERLAND said that if people would be willing to 
pay $3,000 to $4,000 for a system like he described, 
he'd like to discuss A with the manufacturer. The 
concensus was yes. DAHL predicted that there will be 
several companies wrth useful, small radiation detec-
tion systems on the martlet in the next one ortwo years. 
Synthesis 
Transferring Materials To and From Reactions. 
LINK has found that small volume, less than 100 ^1, 
water and air-sensrtive transfers can be difficult to 
automate and described a few of the transfer methods 
they use at the Univ. of Washington. For example, the 
synthesis of ["Cjthymidine requires transfer of 100 jil 
of oleum and 7 ^il diethyl malate as water free liquids 
into a reaction vessel. Both transfers are difficult be-
cause the liquids are viscous. In addition, rt is neces-
sary to set up these reagents in the hot cell between 1 
and 2 hours before they are used. The oleum is placed 
in a Reactiware vessel under argon. A1 /16" teflon tube 
at the bottom of the oleum vessel connects to a 
dispense posrtion to which the rotxDt arm brings the 
reaction vessel. The oleum is transferred by pressuriz-
ing the vessel wrth argon. It is necessary to have 130 
p.1 of oleum in the vial to transfer 100 iii to the reaction 
vessel. The diethyl malate is transferred using a 7 ii,l 
HAMILTON syringe which their group built onto a 
robotic hand. They tried and abandoned .using a 
micropump which can deliver 1-2 \^i aliquots. These 
pumps reliably deliver small volumes, but they have 
dead volumes of several hundreds of microlrters be-
cause they are built wrth large pipe f rttings on the inlet 
and outlet ports. The diethyl malate is made in limited 
quantrties and cannot be wasted. A peristartic pump 
also has a large dead volume. 
For transfers, Ulrich SCHERER (Ludwigshafen, for-
meriy PSl Villigen) uses 12-posrtion rotary valves. The 
single rotary valve sequences through vials to deliver 
reagents to a common center port. He can use vacuum 
in between. He uses spring cap vials wrth TFE / rubber 
septa. 
WAGNER usesa HAMILTON microlabdispensercon-
nected to two six-way valves for the synthesis of 
DOPA. Organic reagents pass through one of the 
valves; aqueous reagents through the other. They are 
somewhat programmable and workfine. The system is 
reliable. He also uses stopcock style OMNIFIT valves 
wrth home-made actuators from model airplanes, as 
do the researchers at Li6ge. 
CLARK and NEBELING also use multiport valves. 
CLARK suggested that we should make a list of valves. 
A sign-up sheet for anyone who was interested was 
circulated. He has had trouble wrth membrane valves 
for phosgene synthesis. The valves were wrecked rt 
chlorine got into them. He uses a loop that is filled wrth 
HI during set-up and then liquids are pushed wrth N .^ 
He doesn't need to change HI loop even rt rt looks 
brown. He worries about getting LiAIH^ and it's hydroly-
sis debris into valve seats. 
MORELLE likes stainless steel double 3-way 
RHEODYNE valves for his H^O targets. He uses his 
own air-operated rotary actuator which allows for an all 
closed posrtion. These valves have operated near a 
target for a long time. CLARK cautioned that the 
RHEODYNE valves have either Vespel or Tefzel ro-
tors. The Vespel rotors fall apart wrth strong base. 
DAHL uses two 3-way valves with a loop between for 
microlrter injections. He pressurizes the loop to transfer 
the liquids. 
Ren IWATA (CYRIC, Sendai) doesn't use a mass flow 
meter anymore. He likes pinch valves on TFE tube so 
that there is no valve to clean after the synthesis. Bmce 
WIELAND (CTI West, Berkeley) alsouses pinch valves, 
both double and single headed. He commented that 
tubing compatibilrty wrth the reagents is crrtical. 
Heating and Cooling. SCHERER uses halogen lights 
for his syntheses and described his raclopride appara-
tus. He has found that when these lamps have quartz 
windows they can induce photoreactions. For produc-
tion of methyl iodide, the "C activity stuck to the vessel 
walls. He put a metallic cap on the heater and the 
problem disappeared. KROHN asked what the spec-
tnjm of the halogen lamp was. SCHERER said the 
lamps were 250 Watts but he didn't know the spectmm 
of light output. FERRIERI asked how long rt took to 
cycle between hot and cold and what was the to ngevrty 
of the lamp? SCHERER responded that the cycle was 
fast, he could go from -5 to +l 50°C in 30 seconds. He 
has never had a lamp to break in 1.5 years of use. 
FERRIERI was curious why SCHERER's yields of 
["CJraclopride (45%) were higher than others (25% in 
the literature; 15% for DANNALS), he wondered rf the 
halogen lights might have something to do wrth rt. He 
asked rt SCHERER had used these lights for other 
synthesis? Yes, methionine. KROHN suggested that 
they wrap the light wrth Al toil to see rt photochemistry 
is contributing to their exceptionally high raclopride 
yields. 
CROUZELuses WOOD'S metal baths for heating in his 
syntheses. It provides excellent heat transfer and is 
very simple to use. 
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NICKLES thinks that ultrasound has a role in heating 
syntheses and also likes WOOD'S metaloroiltocouple 
the reaction vessel to the heat bath for efficient heat 
transfer. 
BERRIDGE commented that he has used WOOD'S 
metal very successfully for heat transfer without the 
mess of oil. It is important to maintain constant heat 
transfer in processes which rely on heating for control-
led times. Also, you must remove the vessel from the 
bath before cooling the WOOD'S metal or it will break 
vessels! He drills out his heat blocks and then uses only 
a thin film of WOOD'S metal to gain better heat conduc-
tivity. He feels that a machined aluminum block with a 
heating cartridge, thenrocouple, temperature control-
ler, and cooling channel works very well. The block is 
kept small for rapid heating, and water, CO^, and 
nitrogen can be used to cool it. Evaporations of 
solvents can be done conveniently under vacuum and 
with a gas stream, tuning the gas flow and temperatu re 
to meet the needs. Didier LeBARS (CERMEP. Lyon) 
uses WOOD'S metal to 200°C. 
NEBELING has a system for heating / cooling com-
bined that operates from -200 to +200°C using 300 
Watts. He uses a 1 mm thick film of oil to couple the 
reaction vessels to the heating block. If the Al block is 
already at the desired temperature, it takes only 1 1/2 
min to change temperature in the reaction vessel. At 
Michigan they also combine heating and cooling. HAKA 
said that they had used an Al block to transfer heat. 
They blow CO^ on the block to cool it and use a resistive 
cartridge to heat the block. The Michigan group has 
also used Vortex cooling on their reaction vessels. 
WAGNER asked what people use for FDG heating? 
Does anyone use non-liquid cooling and/or heating? 
MORELLE uses glass reactor vials with Cu sheath 
heaters. NICKLES uses microwaves. He has not used 
it for heating but it is great for shaking things off the 
vessel walls. MartinORBE(SCANDITRONIX, Uppsala) 
stated that Sharon STONE-ELANDER (Karolinska 
Hospital, Stockholm) uses microwaves for a lot of 
syntheses. The Liege group uses microwaves to syn-
thesize altanserin. The group at Washington Univer-
sity, St. Louis also uses microwaves in syntheses. 
CLARK asked if anyone measured temperature inside 
reaction vessels? No. LINK commented that tempera-
ture measurements of the heating bath are not ideal, 
particularly with short heating times. For example, she 
has found that 4 ml Reactiware vessels can vary 
significantly in wall thicknesses, enough to cause heat 
transfer into the reaction vessels to vary from one 
synthesis to another. MORELLE said that we shouldn't 
demand accurate temperature measurements for our 
reactions, we just need to make our (automated) 
syntheses reproducible. 
David SCHLYER (Brookhaven Natl. Lab) uses themiai 
grease between a surface mounted thermocouple and 
the reaction vessel to more accurately monitor the 
reaction temperature. David ALEXOFF calibrates the 
thermocouple before each mn. 
FERRIERI would like to see chemical sensors devel-
oped which would be in the reaction vessel to track 
starting reagents or tell something aboui the progress 
of a reaction. This is a tough goal with which they have 
no progress yet. The trouble is often competing reap-, 
tions occur and interfere with the signals. It would be 
ideal to have specific sensors which monitor the reac-
tion rate rather than the reaction conditions. While this 
is not yet feasible, the area of chemical microsensors 
is an emerging research area for analytical chemistry 
that we should watch carefully and we should be 
prepared to take advantage of new findings. See for 
example, Ref. [6]. 
Evaporations. WAGNER asked if anyone had tried 
Vortex evaporators. Specifically, he felt the „Turtxi-
Vap" of ZYMARK was intriguing but too big, and he 
knew that there was another system on the mari<et. He 
thought that Vortex mixing with convection to vacuum 
would have a big martlet for multi-vial wor1<. LINK had 
lx»rrowed a Vortex drying system from HNU Corp. and 
tried it. The maximum temperature of the instnjment 
was 90°C and it took ove r 20 minutes to evaporate 5 ml 
of water. She said both the HNU and ZYMARK sys-
tems were too big and too slow. She also likes the 
concept but suggested that a home-made system 
which operated at higher temperature was worth fur-
ther investigation. WAGNER thought that you should 
heat the system with light, hot air. FERRIERI com-
mented that drying systems require considerable flex-
ibility in mounting to the reaction system. This is 
particulariy tme for automated but not robotic systems. 
BERRIDGE asked why are evaporations a problem? 
Isn't it a simple matter of gas in and vacuum out? He 
uses an Al block with WOOD'S metal, a thermocouple 
probe, heat fast and then flows H^O through to cool the 
block. LeBARS replied it's not that easy, sometimes 
that approach just isn't fast enough for "C syntheses. 
The approach described by BERRIDGE can evapo-
rate ~ 5 ml of water in 5 minutes without vacuum. 
Rotary evaporators or systems such as that described 
by BERRIDGE are currently used for radiochemical 
syntheses, but often aren't optimal. Rotary evapora-
tors have a large surface area, but it is difficult to 
quantitatively recover small volumes remotely. This 
has been accomplished to a certain degree by the 
chemists at TRIUMF [7]. 
Solid Phase Chemistry. IWATA described his sys-
tem for solid phase methylation similar to that de-
scribed by the University of Michigan group which he 
has incorporated into an automated system. He has 
subm'rtted the full description of this system for publica-
tion to Applied Radiation and Isotopes. Basically 
["CJmethyl iodide is trapped in a short column, 55 
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containing Poropak Q or another appropriate adsortD-
ent material at -42°C, then solvent, base & substrate 
(precursor) introduced. The column is closed with 
valves and then heated to 80°C for the reaction. After 
the reaction is complete, the reaction mixture is washed 
off of the column, through a six-port valve and onto an 
HPLC column for separation of the product from the 
reactants. They are pleased with this system. They can 
reduce the amount of substrate which is used and yet 
get a greater concentration of substrate as well as an 
increase in radiochemical yield. There is some dead 
volume, but it is small. If he decreases the volume of 
adsortDer used he obtains the same chemical yield but 
decreases his radiochemical trapping efficiency. 
HAKA described the Michigan experience: Their phi-
losophy is to do everything as simply as posssible. 
Simple heating and evaporations. Solid phase has 
been a big focus at Michigan and solid phase systems 
are easily automated. A good example is their use of 
the trimethylammonium triflate for synthesis of FDG. 
ORBE stated that SCANDITRONIX had two auto-
mated systems; one for production of methyl iodide 
and one for FDG. He went on to discuss the automated 
system for production of FDG, which utilizes the solid 
phase synthesis developed at Michigan [8]. The unit 
consists of a mechanical box which uses pinch valves 
and is controlled using a personal computer. The 
control unit has no user-adjustable variables. There is 
a disposable process kit used for each synthesis which 
consists of a panel which is ~ 30 cm x 30 cm in area with 
holes for pinch valves. The system comes with the 
resin for FDG synthesis in a column. They do not use 
resin to remove acid at the end of the synthesis but use 
a neutralizing buffer. The box contains a heater. Greater 
than 70% of the ['^Ojwater is recovered. 
SUNDERLAND asked if the SCANDITRONIX chem-
ists had experienced any pressure problems with the 
synthesis. HAKA said that they had experienced pres-
sure problems at Michigan with the solid phase synthe-
sis and asked what resin that ORBE used. ORBE said 
that they used the resin that Michigan had reported and 
that they did have some back-pressure problems. 
HAKA said they should have high back-pressure prob-
lems because that resin will decompose after a few 
minutes. It is necessary to push through the resin fast, 
i.e. within 1.5 minutes. The chemists at Michigan had 
found that the displacement was instantaneous and 
had found that dilution of the resin with high density 
polyethylene (Primax) from AIR PRODUCTS, 17 mg 
resin and 8 mg Primax, solved the back pressure 
problems and they controlled the flow rate of precursor 
through the column. SUNDERLAND asked how they 
put the tubing onto the pinch valves, and ORBE answ-
ered that the pinch valves fit nicely overthe tubing in the 
process kit and the control system held the pinch 
valves open for placement during set-up. CLARK com-
mented that the system looked heavy, and asked if it 
was self-shielding? ORBE replied that the full dimen-
sions were 55 cm high x 25 cm in diameter x 36 cm wide 
and it was not self-shielding. There is a lead container 
for shielding the product vial. CLARK also asked how 
they moved the syringes. ORBE replied that they used 
a stepper motor. NEBELING asked if the reagent vials 
came filled and ORBE replied that they were empty in 
the kit and had to be filled at synthesis time to a line 
mari<ed on the vessel. ORBE stated that the tubing in 
the kit was polyethylene and the vessels were made of -
Tefzel. WIELAND commented that one needed the 
proper polyethylene history for a successful pinch 
valve controlled radiochemical synthesis. MOSKWA 
asked what happens if you have an error, what kind of 
quality control is done to determine if there is 
unhydrolyzed material in the product and what radio-
chemical yields they obtained. ORBE replied that any 
error was a catastrophic failure which stopped the 
synthesis and the hard copy printout would tell one how 
far in the synthesis the error occurred. They did not 
worry about unhydrolyzed product because Sep-Paks 
were in the system to rerrxive this material and the 
yields were 40± 10 %, not decay-corrected. BECHTOLD 
asked how many runs they had done and ORBE 
refused to reply, which was severely criticized by the 
participants as not in keeping with the spirit and pur-
pose of the wort<shop. NEBELING asked what the 
radiochemical purity was and what quality control 
method was used to determine this? ORBE replied 
98% radiochemical purity as measured by TLC. 
NEBELING stated that was impossible because the 
accuracy of TLC is + 5%. MORELLE asked if 
SCANDITRONIX intended to design other similar syn-
thesis units and ORBE replied that it should be possi-
ble. 
Separations. LINK asked IWATA if they were still 
using the glass col extractor-phase separators for 
automation in their lab, IWATA replied that the product 
had been commercialized (HAMAMATSU, Inc.) and 
he had nothing further to add. 
Feedback of HPLC Loading/Injection. RUTH auto-
matically loads samples onto an HPLC by the system 
illustrated in Fig. 1. The system has worthed well for 
him. 
A similar system is used at the University of Washing-
ton. WAGNER works in the reverse direction to pull the 
sample ratherthan push it into the injector loop. CLARK 
injects his material first onto a short of high pressure C-
18 concentration column which is then water-washed 
to get rid of unwanted aqueous, soluble materials and 
then eluted onto the preparative column with HPLC 
mobile phase. 
Assaying of Product Dose. MOSKWA described the 
system he is currently testing for automating dose 
assayof product senjm vials. He uses 3" long 1 1/4 dia 
„rabbits" which contain the product multidose vial up-
side down. The rabbit, which has a hole drilled in the 
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vented Millipore filter 
HPLC valve with 
injection loop 
t 
Source 
Overflow with 
optical density 
sensor 
Figure 1: System for Loading Solutions into tfie HPLC 
(T.J. RUTH, Vancouver). 
bottom, falls into a cup and a jig is used to push rt into 
the dose calibrator. The rabbrt ends up in the dose 
calibrator upside down, i.e. the hole and the murtidose 
vial are right side up. The dose is recorded and a 
needle set is dropped directly into the multidose vial / 
rabbrt combo for infusion into the patient. 
BERRIDGE uses a small detector next to the dose 
syringe which he has calibrated for radiation dose 
units. 
RUTH has home-made ion chambers similar to those 
developed by SOLIN and HESELIUS at Turku which 
have loops of 1/8" teflon tubing wound around be-
tween the anode and cathode and the sample flows 
through the tubing and is detected. These also have to 
be calibrated in dose units. 
Quality Control 
Formulations and Purity (radiochemical, chemi-
cal, sterility and apyrogenicity). CLARK has an 
unique system for infusion of pOjH^O which he pre-
sented as a poster and in discussion [9]. He produces 
the water at the bedside in a shielded unrt and uses a 
membrane to transfer the wafer vapor into saline. For 
qualrty control, he sterilizes the membrane pack and 
puts a sterile filter at both ends. Routine tests of the 
infusate are carried out for sterilrty and apyrogenicrty 
using LAL test kits. 
CLARK asked how others keep their HPLC systems 
sterile and apyrogenic? NEBELING sterilizes his 
columns wrth acetonrtrile and stores them in ethanol. 
LINK stores the columns in erther 20% acetonrtrile / 
80% water or 50% ethanol / 50% water. She uses 
sterile apyrogenic 0.22 nm firters on all openings and 
then changes to the correct mobile phase shortly prior 
to synthesis. DAHL warned that rt is necessary to wash 
the column In H^O before putting in organic, i.e. to 
remove all sarts, if one has been using a buffer such as 
phosphate. 
NICKLES uses Nyton-66 fitters to remove pyrogens. 
While this may work, It Is not obvious what the mecha-
nism Is for this removal. This certainly should be 
investigated in detail before rt Is used. PIERCE CHEMI-
CAL Co. (PO Box 117, Rockford, IL 61105 U.S.A. or 
PO Box 1512.3260 BA Oud-Beijerland, Netherlands) 
sells „Detoxigel" for removal of pyrogens. For any 
methods of pyrogen removal, the chemists need to be 
certain that the federal and local regulatory agendes-
approve of these agents for pyrogen removal. 
GAEHLE is evaluating the use of a pressure trans-
ducer on his robotic system to check for ruptured 
sterilization filters .This technique Is not yet completely 
Implemented but Jooks promising." The SCAND-
ITRONIX system also checks filter integrity using a 
pressure transducer. 
BERRIDGE described his system for production of 
['=0]butanol. He has found that for his system the 
quantrties of solutions added and the total time of 
synthesis are Important. Control of solvent volumes is 
achieved using a single, controlled-pressure, gas sup-
ply as the driving force on solvent resen/oirs and by 
adjusting the tubing length and diameter to provide 
convenient flow rates. Flow volumes are then meas-
ured by timing the opening of the valve for each 
solvent. It is a simple method which wori<s well in this 
synthesis even though the yield and purity of the 
product are very sensrtive to the solvent volumes used. 
Too great a volume of H^O in the washes towers the 
butanol yield from 60% down to 20%. The system is 
automatable wrthout the use of feedback sensors, or 
wrth only one POLYTECH LAB radiatton detector. At 
the moment rt is run without a computer interface, using 
a „stopwatch-driven programmable bio-organic con-
troller" (human). WAGNER asked rt he used an air 
bolus between each wash of his system, and 
BERRIDGE answered yes. GAEHLE menttoned that 
they have set up a system at St. Louis for delivery of 
sequential doses of P'Ojbutanol whtoh uses a HAMIL-
TON MICROLAB dual syringe injection station and a 
distribution valves to ten drtferent set-ups for sequen-
tial syntheses of the P^Ojbutanol wrthout clean-up [10]. 
LINK briefly discussed the poster on qualrty control to 
measure cryptand in FDG product by Ronald FINN 
(SLOAN-KETTERING, New Yori<). She stated that the 
data appear to show that wrth the special resin column 
[11] there was Irttle tritiated cryptand in the product. 
However, since a tritiated compound was used, the 
researchers still needed to show that the tritium label 
was not exchanged off of the molecule during the FDG 
synthesis and more wort< was needed. 
Clean-up. FERRIERI presented some of the prob-
lems and automation solutions which they have imple-
mented at Brookhaven regarding batch vs. serial syn-
theses. A single batch synthesis can satisfy PET needs 
for p*F]fluoride labelling of FDG. However for short-
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lived radionuclides like " C , single batch synthesis is 
not practical. There is usually not enough activrty and 
the specrtic activrty for later injections is a big concern. 
Specrtically he worries aboui serial "C syntheses. 
Tfiey do six cocaine runs per day and can't do batch 
syntheses. Their systems don't deal wrth failure mode 
and can't recover from errors. They need duplicate or 
replacement systems. How does one deal wrth things 
like contaminated reaction vessels {etc.) in serial syn-
theses? One can strip and clean vessels or use dispos-
able components and replace them. If this is performed 
manually, these increase the radiation dose to the 
operator. One solution is to use robotics or manipula-
tors, but then the costs in money and space are high vs. 
in-place self-cleaning. One of the solutions to these 
problems that is used at Brookhaven is to do in-place 
sert-cleaning of the methyl Iodide / HI vessel. The 
vessel is washed wrth acetone, then 2N HCI, then a 
series of cycles of acetone and vacuum + heat using an 
air bath reactor. By using this method, the specrtic 
activity is maintained. In fact specific activrty increases 
wrth each procedure. They have buirt a muHiport glass 
cow 1 port in with 4 ports out for synthesis of methyl 
iodide. WAGNER asked what happened to the PjO^? 
FERRIERI replied that they don't use P^O ,^ they use a 
NaOH trap which they change every 1-2 weeks. The 
target gas and He pass through a tube of MgCIO^to dry 
the target gas. Other aspects of this problem are that 
they can't sett-clean the alkylation vessel used for 
synthesis of raclopride at Brookhaven. 
BERRIDGE had the following to add. Often, the clean-
ing of the apparatus is a minor variation on the syn-
thetic manipulations. It generally requires that addi-
tional solvent reservoirs be attached and that the 
number of valves in the system be increased by a small 
percentage. Since cleaning does not generally require 
as strict control of temperatures, pressures etc. as a 
synthesis, rt is really easier to automate in many 
respects than the synthesis. One must decide which 
parts of the apparatus should not be changed, but 
cleaned. Strategic locatton and shielding of waste 
reservoirs allow certain drtficutt components (resins, 
alumina) to be changed quickly after the system has 
been cleaned. This helps to reduce radiation exposure. 
NEBELING was asked to comment on the Julich 
automated FDG system which was presented at the 
last targetry meeting [12] which is sett-cleaning. 
NEBELING Stated that the system was wort<ing well 
but that the key to this success was the use of glassy 
carbon for their reaction vessel. LINK asked who 
supplies the glassy carton and the list of suppliers is 
summarized as an Annex to these proceedings. 
GAEHLE Is using the robot for set-up and clean-up of 
supplies and vessels for the reactions. The Karolinska 
methyl iodide system uses valves to clean the compo-
nents. They flush rt several times wrth acetone then 
flush wrth ethanol 4-5 times, heat rt, pass carrier gas 
through rt, and evaporate rt dry. The cleaning takes 5 
minutes per reactor and there are six methyl iodide 
syntheses done per set-up. 
Regulatory Issues Regarding Radiation Safety 
MOSKWA raised one final issue. At the Universrty of 
Michigan they produce "C as a gas and have had 
radiation safety problems due to gaseous radionuclide 
emissions. Several hundred mCi of T^NjN^ and [ " 0 ]0 j 
go into their ducts from the "N(p,a)"C reaction. They 
have a 5 Ci release limrt per year and a 10 mCi limrt per 
irradiation. That value is easily exceeded, and has 
been very drtficutt for their group to achieve. They are 
concerned about methods to reduce emissions so that 
they can keep their laboratory working, and cautioned 
that others are likely to face similar problems as regu-
lations on radionuclide emissions become more re-
strictive. WEINREICH said that the PSl group has 
installed two evacuated 60 I vessels to delay the 
emission of target gases into the air. Irradiation can 
start only after a good enough vacuum has been 
reached. The resutts in order to minimize the emrtted 
radioactivity are excellent. It was agreed that we all 
begin thinking and worthing toward solutions now. It 
might be useful to use shielded delay / decay tanks of 
a surtable volume. 
Closing Comments 
A distillation of the discussions on automation shows a 
remari<able amount of concurrence anwng such a 
diverse group of participants. While not all participants 
have automated their syntheses, there was a general 
posrtive attrtude toward automation. The reasons given 
to automate were to reduce dose to personnel and to 
reduce personnel cost per synthesis. The reason not to 
automate was inrtial cost in time and personnel when 
resources are limited. There seem to be two principal 
categoriesofcompoundswhich have been automated. 
First, precursors, particularly ["Cjmethyl iodide and 
[''F]fluoride recovery and drying. They are relatively 
simple to automate and have the greatest amounts of 
activrty, therefore pose the greatest radiation hazard to 
personnel, during a synthesis. Second, the compounds 
most frequently synthesized by a group. This primarily 
means ['=F]PDG, but also ["Cjcocaine, ["Cjraclopride 
and ["CJthymidine, ['^Olbutano! and ['^Ojwater. Sev-
eral of the participants (Julich, BNL, Sendai, St. Louis, 
Hammersmrth) have also set up these syntheses for 
erther multiple syntheses or automated sett-cleaning 
before one has to open the „hot cell" to set up for 
another synthesis. 
With regard to transfer to and from targets, most 
participants are using systems which are erther auto-
mated or remote and which function well. It was appar-
ent that feedback sensors could improve the reliabilrty 
of water target radiochemical yields for many groups 
and possibly other targets as well. While, none of the 
radiation detectors proposed as radiation sensors for 
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target yields and synthesis transfers met all of the 
proposed criteria, there appear to be many detectors 
available if one is able to afford several thousand 
dollars, othenwise it appears that building one's own 
ion chambers is a viable alternative. 
Very few participants described any problems with 
transfers into and out of reaction vessels and many 
alternative methods were presented. A remarkable 
number of people use multi-port, small volume distri-
bution valves for their syntheses and are happy with 
the way they work. Maybe those of us who haven't 
usedthemshouldconsidertheiruseforoursyntheses. 
With regard to heating and cooling, there was no 
concensus. There are many solutions, but none ap-
pears to be best for all situations at this time. The 
halogen heating introduced by DANATEC was intrigu-
ing . Their chemistry yields were very good and the idea 
that these lamps could improve or worsen the chemis-
try needs to be examined further. Evaporations are 
being performed the same way they have foryears, but 
there is room for improvement with no obvious solution 
at this time. Separations are beingcarried out primarily 
using low or high pressure solid / liquid phases and the 
automation of these remains single but in need of 
better feedback, such as the overflow level sensor of 
RUTH. 
HAKA complained that PET chemists are unwilling to 
try new synthetic techniques when he discussed Michi-
gan's commitment to develop soFid phase chemistry. 
This is unfair, an unwillingness to try new synthetic 
methods was not in evidence at this meeting. It re-
quires time and resources to develop a new synthesis 
and if one has a worthing synthesis, for example for 
FDG, it is difficult to justify the effort to make the 
change. Despite this, two groups in addition to Michi-
gan presented their wori< with solid phase synthesis at 
this meeting. ORBE presented the SCANDITRONIX 
FDG system which uses the Michigan FDG method. 
IWATA presented a small volume column system for 
" C methylations. Solid phase synthesis is much easier 
to automate than multiple liquid vial transfers, and with 
time it is likely that more solid-liquid phase syntheses 
will be introduced. The easiest to automate though, is 
gas transfers through solid catalysts and reactants. As 
CROUZEL stated, we should try to find a way to 
produce ["CjCHjl without liquids if we are going to 
continue to do methylations. 
In general, it was good to see manufacturers coming 
forth with more automated radiochemistry synthesis 
units, interacting with the group, and for the most part 
freely exchanging information. CTI / SIEMENS has 
had their Jblack box" synthesis unit out for several 
years and published the details of the system fairfy 
completely. It was disappointing that no one from that 
division of the company was available to participate in 
this session. The companies who did attend appear to 
be taking different approaches to the syntheses and it 
will be interesting to see how successful they are. 
SCANDITRONIX has opted for two types of systems: 
They are continuing with the .ANATECH" robot for ^'C 
syntheses; raclopride and methyl iodide, which are in 
use in St. Petersburg, and a black box with a com-
pletely disposable synthesis module for synthesis of 
[''FjFDG. Both are operated using a personal compu-
ter. DANATEC, in conjunction with PSI. have devel-
oped relatively simple systems for production of 
["F]FDG and ["Cjmethyl iodide and ["C]raclopride-
using different heating technology and very simple 
microprocessor controls, which are easily accessible 
and reprogrammable by the user. EBCO is wori<ing 
with TRIUMF to commercially develop his dedicated 
automated rf=lFDG and ['=F]F-DOPAsyntheses, which 
emphasizes feedback sensors and whose personal 
software concept was presented at the last targetry 
meeting by David MORRIS [13j. 
The greatest strength of this session was the tremen-
dous group participation and discussion which will 
hopefully continue among the participants until the 
next meeting. One weakness was that all of the active 
participants were involved in PET radiosyntheses. 
There is a need for automation in other areas of 
radiosynthesis, particulariy in high activity iodine pro-
duction and syntheses. Some of these people were at 
the meeting and had participated before, perhaps we 
can better include them in the future. 
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P E T R A D I O N U C L I D E PRODUCTION 
Syed M. Qaim, John C. Clark, Christian Crouzel, Marcel Guillaume, 
Hans J. Helmeke, Bruno Nebeling, Victor W. Pike and Gerhard StOcklin 
ABSTRACT. Several short-lived positron-emitters are routinely used in PET studies while a few others 
are of potential interest. A brief review of the decay data and production methods for several of these 
positron-emitters is given. Special attention is paid to the production of the four major positron-emitters, 
namely carbon-11, nitrogen-13, oxygen-15 and fluorine-18, which are widely applied in several European 
PET centres. 
1. Introduction 
The number of positron-emitting radionuclides is large (c/. Lederer and Shiriey, 1978; 
Browne and Firestone, 1986). Some medically relevant short-lived positron-emitters and 
their decay data are listed in Table 1. Most of the PET studies to date are carried out with 
organic positron-emitters ( " C , I ^ N , I S Q and i^p). Several other radionuclides, for example 
potassium-38, selenium-73, bromine-75 and bromine-76, also find some applications. There 
is also considerable interest in copper-62, gallium-68 and rubidium-82, which are obtained 
via longer-lived generator systems. 
The production of useful and potentially useful positron-emitters has been the 
subject of several review articles and books (Lambrecht, 1971; Claric and Buckingham, 1975; 
Welch, 1977; Stdcklin and Wolf, 1982, 1983; Vaalburg and Paans, 1983; Qaim, 1986a). 
Development of a production process involves a study of several aspects such as nuclear data, 
high current targetry, chemical processing, automation and quality control. A knowledge of 
nuclear data is essential for calculating thick target yields, estimating levels of radionuclidic 
impurities and designing suitable target systems. High current targets are needed to produce 
radionuclides in sufficient quantities. Due to the short half-lives of the useful 
positron-emitters the chemical separation and subsequent labelling procedures have to be 
fasL The high level of radioactivity calls for remotely controlled and, sometimes necessarily, 
automated methods. Quality control must be concerned with the radionuclidic, 
radiochemical, chemical and pharmaceutical quality of the products. This chapter deals 
mainly with the routine methods of production of commonly used positron-emitters. A brief 
discussion of less commonly used and generator-produced positron-emitters is also given. 
The important production routes, the suitable energy ranges and the theoretically 
expected thick target yields over these energy ranges are given in Table 1. The yields are in 
1 
C . Stocklin and V. W. Pike (eds.), Radiopharmaceuticals for Positron Emission Tomography, 1-43. 
© 1993 Kluwer Academic Publishers. Printed in the Netherlands. 
o 
c 
o 
o 
-o 
o 
c 
(0 
cu 
E 
CD 
> 
o 
c 
ro 
> 
CD 
_>< 
15 
u 
CD 
E 
E 
o 
CO 
i -
c 
O 
3 
o 
ro 
u 
Q. 
O 
O 
t/> 
O 
ro 
1 
ro :2 •-
.y ^ (J 
cU E 
' — 
O CD O" 
cn 
c 
s 
> > „ 
I - J> 
CD a) 
c S 5 
ro 
o 
3 
z: 
(J — 
.5 > 
^1 
ro 
0) 
CD 
- a 
O 
!-
r o _ _ „ O ~ 
o cs) C O c\i L O 
— vo L D ^ 
o o o o — 
v O v D ^ 00 00.— r-cvjLDLn 
_ vO 00 r-' -^ J; 
CO ^ ro 
O O ON o in 00 o o o o ^ r~-C M L D ^ 
osj o vD ^ ^ vO C M O 00 L O o un uD C M 00 ^  ^ O -d- vD 00 C M •— \ i - C S J C M .—• 00 ro c\J — ^ 3- C M C M ro ^ C M 
00 O O O O r-- o o ^ O ro ^ C M O O ro oo 00 
' — 00 00 oo — — 
T T T T T T T T T T T 1 T I I T T i l l 
ro O O 00 O vO 00 O 'JD ^ o — C M \D C\J C M O U-) ro C O ro ^ -cr C M C M 
u ' u u z z z : O O O 
o <= c c cs_ 
^ d. -d . 3 
z; oa cQ u o O 
c a . 
d._Q. 
Z.O 
I k 
Z O O 
o a: o 
CSJ — — 
00 
o 
o ON 
CM 
— — 
L O 
o O o 
\0 CM 
o '—' 
O 
o cK 
• — 
+ o + + c a LL) c a CO. 
c c c 
m
i 
m
i 
m
i 
o in 
o 
CM ' — Cvi 
o 
O 
•X 
L O ro 
+ O cn.uj 
E 
O 
CD OJ 
CO CO 
U < U < 
c 
5 ^ 
O CT> 
CM 
— CO 
. - vD 
L O — 
CM 
O 
O 
O 
C 
E 
CD 
un 
'cD 
" c CO 
CMR 
ro ^  X • 
< < O O 
o -
ro 
o 
CM ro 
JZ 
U O 
CD 
CO 
ro 
0) 
ro 
E 
5 ai v_ 
ro 
in 
ro 
O 
O 
-o 
CD 
'v_ S! d 
CD 
" T O 
JZ c 
a> CD 
JZ £ 
cn 
in 
3 
• — 
3 
o 
C L 
-D 
Ci). 
3 
C 
C 
o 
U 
J O 
( -
10 
10 
o 
<D 
Q 
(o : g . -
o o) cr 
CD 
C 
JO 
CD CD 
>- c 
lO o 
3 (O 
2: 
u 
i" (O 
o •—• 
E > 
UJ 
CD 
lO 
o 
CD 
-o 
CD 
O : 
f -
CD 
D . 
O 
o 
g 
lO 
§ iD un 0 0 „ „ 
d ' ^ ' S E l i o c o r -
O v£> 
o C O ,— . ON L O 
C M O C M C M C M 
C O C O 
CM in O N •<a- o o 
CM CM CM L O — ^ — 
t T T t T T T 
O L O L D 00 'VO L D 
C O C O C O V D ^ CM 
(T) CO 
CO C3 
" i^- CO 
C M — 
r T 
o 
C M C O 
. C Q . 
W. i D J - V -
C Q ' X . C Q CQ 
C M .^i! CO 
c i ^ - D " a 
CO . 
CQ 
^^c5 c CsJ 
CO < ; CO < < CO CO 
vO i f l vD iT) i n 
3 : 
L O CM 
— 00 
iD CM 
o 
^ 2 
C O - U J 
.rz 
C M 
,~ ^ \£l ^ CO uD 
. — O N ^ . — • — 
^ L D L O L O r—cy^ — 
L D L O v£) 00 in in in 
o o 
O N 
C O 
o 
vD 
o 
C O 
O N 
CM 
CM O o o o o 
^ in 
o ci 
o 
T in 
CM O 
CM O 00 
CD 
o 
•XI — 
^ (O 
+ U 
CQ.UJ 
CQ CQ 
CO r . ^ 
O N ! — 
+ u 
CCLLlJ 
- C 
CM 
cK 
o 
C 
+ U U 
C Q . L U L U 
e 
O N CNI 
3 
o 
10 
c 
in ^  X. — CO in ^ ^  o o o o o o 
C O CO O N 
ro — 
CM CM 
T 1 T 
O O O O 
O l O ON CvJ 00 — 
CO CO 
C O ' L e o 
o 
L O O 
o o 
O N 
O N CO 
in r-^  
o in ro ro 
- o 
5 2 2 
a N - _ ^ 
4 U U 
C2.LU LU 
C 
e 
CO 00 i£) 
s 
in 
CM 
o 
CD 
c 
LO — 
- u 
c a u J 
E. 
CO 
X I 
ro 
ro 
e 
cn 
ro 
i/i 
ro &) 
O 
o 
-o 
CD 
c
h
 
' \ _ c CD 
" T O 
X 
cn CD jr £ 
cn 
c in •y. Z) LlJ 
a few cases experimental yields (Lambrecht et al., 1978; Helus et al.. 1980; Pao et al., 1981; 
Loc'h et al., 1982; Robertson et al., 1982; Thomas, 1987), since the excitation functions arc 
either unknown or uncertain. In general, however, the yields were calculated from the 
reported excitation functions, as follows: carbon-11 (compilation by Keller et al., 1973; Bida 
et al., 1980b); nitrogen-13 (compilation by KeUer et at., 1973; Bair et al., 1981; Sajjad et al.. 
1986); oxygen-15 (Vera Ruiz and Wolf. 1977; Sajjad et al.. 1984, 1985); fluorine-18 
(Nozaki et al., 1974; Ruth and Wolf, 1979); potassium-38 (Qaim et al., 1988; Tiriclnyi et al-:, 
1992); selenium-73 (Mushtaq et al., 1988; Mushtaq and Qaim, 1990); bromine-75 (Paans et 
al., 1980; Alfassi and Weinreich, 1982; Kov^cs et al.. 1985); bromine-76 (Janssen et al., 
1980; Alfassi and Weinreich, 1982; Kov^cs e/a/. , 1985); zinc-62 (Neirinckx, 1977; 
Kopecky, 1985); strontium-82 (Horiguchi et al., 1980; Tdrk^yi et ai, 1988, 1990). Several 
other details of production methods are described below. 
2. Commonly used Positron-emitters 
The positron-emitters best suited to PET studies are the 'organic' radionuclides, carbon-11, 
nitrogen-13, oxygen-15 and fluorine-18. Whereas the former three radionuclides can be 
used only on site, fluorine-18 is suitable for longer lasting studies and for transport to PET 
centres without a cyclotron ('satellite' centres). 
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Figure 1. Integrated thick target yields of some commonly used positron-emitters expected 
from the most common production routes, plotted as a function of incident particle energy. 
Data were calculated using the measured excitation functions (for reference see text). 
The thick target yields of the most common production routes, calculated from the 
measured excitation functions (Nozaki et al., 1974; Vera Ruiz and Wolf, 1977; Ruth and 
Wolf. 1979; Bida et aL, 1980b; Sajjad ei al.. 1984, 1985, 1986) are shown in Figure 1 as a 
function of incident particle energy. The values for nitrogen-13 and oxygen-15 give 
saturation yields; however, for carbon-11 and fluorine-18 an irradiation time of 1 h was 
assumed. It is emphasised that the curves should be regarded as approximations since the . 
calculation of the thick target yield from an excitation function showing large fluctuations, as 
for the light mass nuclei discussed here, is rather uncertain. In Figure 1 no data are shown 
for the i3C(p,n)i3N reaction. Due to the very large uncertainty in the excitation function for 
this process, only the integrated thick target yield for the whole energy range is given in 
Table 1. 
From the data presented in Figure 1 it is evident that, in principle, all four 
positron-emitters can be produced at a small cyclotron. In practice, however, several 
important considerations need to be addressed when embarking on a production scheme. 
State of the art information is summarised below. 
2.1. CARBON-11 
Over the last two decades a large number of compounds labelled with carbon-11 
(t = 20.4 min; Ip-e = 100%; Ep->- = 0.96 MeV) have found application in biomedical and 
pharmacological studies using PET. With the increasing interest in investigations of 
receptor-ligand interactions it has become mandatory for radioligands to be prepared in high 
specific radioactivity. Generally, the starting precursor for radiosyntheses is high specific 
radioactivity ["Cjcarbon dioxide. For some radiosyntheses [I'Cjmethane is prepared 'in 
target' as a precursor to the off-target synthesis of other labelling agents. 
Several nuclear reactions can be used to produce carbon-11 (for reviews see Wolf and 
Redvanly, 1977; Ferrieri and Wolf, 1983). The common reactions are summarised in 
Table 1. Out of these processes the most convenient and commonly used is the '''N(p,a)"C 
nuclear reaction on a target of nitrogen gas (Blaser et al., 1952; Nozaki et al., 1966; Epherre 
and Seide, 1971; Jacobs et al., 1974; Casella et al., 1978; Bida et a!., 1980b). The 
experimental production yields are of the order of 3.7-5.2 GBq/p.A (100-140 mCi/|iA) for 
proton energies of 16 MeV. Useful activities (0.7-1.2 GBq/p,A, 25-31 mC\/\iA) can also be 
produced using lower energies (8 MeV) (of. Wolf and Jones, 1983). 
Technical details with regard to achieving an efficient production of ["Cjcarbon 
dioxide of high specific radioactivity have been discussed in an E E C Task Group report 
(Crouzel et al., 1987). Here we give an updated version of that report. 
2.1.1. Target construction. Pure aluminium or aluminium alloy is a satisfactory material for 
target construction. Havar™, titanium or stainless steel foils are suitable materials for target 
windows. Metal gaskets are preferable to rubber ' 0 ' rings. The target should be made as 
small as possible with respect to beam profile and penetration, in order to achieve high 
specific radioactivity and fast emptying. For good recoveries of [iiCjcarbon dioxide, it is 
recommended that newly constructed targets be carefully washed with O.lM-phosphoric acid 
followed by water, and dried under vacuum. It is advised that this process be carried out al 
each subsequent target maintenance. 
2.1.2. Target material. The target gas should be of high purity and especially as free as 
possible from carbon-containing impurities. 'Nitrogen N60' (99.9999% pure, from Air 
Liquide), 'white spot' nitrogen (nominally 99% from BOC Ltd) and 'CO-free' nitrogen 
(with < 20 ppb CO and < 50 ppb CO2, from Linde) are known to be suitable. As a 
precaution against carbon dioxide contamination, a trap (3 mm x 2 cm) of supported lithium 
hydroxide, Ascarite^, molecular sieve (4 A or 5 A) or Porapak™ (P or Q) can be inserted 
into the line that leads from the nitrogen supply to the target. Great care must be taken to 
prevent any contamination of the target by trap contents. To restrict the entry of carbon 
dioxide by diffusion, metal (stainless steel or copper) is preferred to nylon or other polymers 
as the material for the tubing between the gas supply and target. The intemal diameter of the 
tubing should be kept as small as practicable with regard to achieving acceptable flow rates 
and minimising gas volume. 
2.1.3. Target operation. Targets are operated only in the batch mode. Both cylindrical and 
conical targets are used, though the latter is preferred. A conical target is more difncult to 
construct but gives somewhat higher yields and much higher specific radioactivity, mainly 
due to the contairmient of the beam within the gas volume and the smaller volume of Uie 
target gas used. 
A typical conical target used at the Baby Cyclotron (BC1710) at Jiiiich (Blessing ei 
al., 1988) is shown in Figure 2. It is 144 mm long, with front and rear parts having diameters 
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Figure 2. Batch target system used for production of high specific radioactivity ['iC]carbon 
dioxide at KFA Julich (after Blessing et al.. 1988) 
of 18 and 44 mm, respectively. The target body is made of aluminium-magnesium alloy 
containing 3% magnesium (AlMg3). The double window in front of the target consists of a 
0.6 mm thick aluminium sheet (closing the target) and a 50 urn thick aluminium foil 
(separating the cyclotron vacuum). A helium stream (0.8 bar, - 70C) flows through the two 
foils and cools the window. The target body is cooled by flowing water. The target is filled 
with 'CO-free' nitrogen gas to a pressure of 12 bar. At a beam current of 45 nA (in a 
typical production run) the pressure rises to 16 bar. The proton energy range within the gas 
corresponds to Ep = 13^3 MeV. 
2.1.4. Dose dependence of precursors. The recoiling carbon-11 atoms undergo hot 
chemical and radiation chemical reactions in the gas phase, depending on the target fill and 
the radiation dose (Ache and Wolf, 1968). While using "pure" nitrogen containing traces of 
oxygen as target gas both [iiC]carbon monoxide and [I'Cjcarbon dioxide are formed; the 
former is favoured at very low doses and the latter at medium and high doses. 
From the excitation functions of the competing nuclear reactions on nitrogen, 
namely '''N(p,a)nC and '''N(p,pn)i3N, it is expected that over the optimal energy range for 
carbon-11 production (Ep = 13->3 MeV) the amount of nitrogen-13 impurity will be small. 
Experience has shown that the relative amount of ['3N]nitrogen is strongly dose-dependent. 
Results of a radio-GC analysis are shown in Figure 3 (Nebeling et al., 1990). Evidently, ver>' 
short irradiations lead to relatively high amounts of [i3N]nitrogen. Suitable irradiation times 
for [iiCjcarbon dioxide production appear to be 30 min or more. 
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Figure 3. Relative radiochemical yields of some precursors produced by the proton 
irradiation of nitrogen in a batch target as a function of irradiation time. The proton energy 
range in the target was Ep = 13-^3 MeV and the beam current 30 \ik (Nebeling et al., 1990). 
2.1.5. I'lCJCarbon dioxide recovery. [nCJCarbon dioxide should be led from the target to 
a hot-cell in metal tubing (stainless steel, small diameter) and passed through a column of 
magnesium perchlorate (MgC104.H20) or granular phosphorus pentoxide to trap out any 
water from the nitrogen gas. To maintain high specific radioactivity, the [HC]carbon dioxide 
should be recovered from the target as quickly as possible. Generally, 2 min are required for 
releasing the target with a flow of 1-2 L/min. Two methods are recommended for '• 
[•'CJcarbon dioxide separation, namely the use of a cryogenic trap or the use of a molecular 
sieve trap. 
a. Use of a cryogenic trap. 
["CJCarbon dioxide is trapped in a small stainless steel tube (40 cm i d. x 0.2 mm) immersed 
in liquid nitrogen (b.p., -196^0 or preferably liquid argon (b.p.. -186C>C), the temperature 
being maintained using a temperature controller. The [HCjcarbon dioxide is recovered 
simply by passing a slow stream of helium through the trap while it is warmed to room 
temperature. If liquid nitrogen is used care must be taken to avoid the entrapment of a large 
quantity of nitrogen which is released vigorously in only a few seconds during delivery. The 
efficiency of trapping is > 98% and recovery is quantitative. An alternative method uses a 
cryogenic trap which can be cooled down to -1960C and heated up to 200OC, each 
temperature in this range being set by a temperature controller. 
b. Use of a molecular sieve trap. 
['iC]Carbon dioxide is collected in a pre-activated column (6 cm x 9 mm i.d.) of molecular 
sieve (4 A, 60-80 mesh). The column is pre-activated by heating to 400OC under vacuum, 
followed by cooling with a through flow of nitrogen. Entrapment of [nCJcarbon dioxide is 
> 98% efficient. The ["C]carbon dioxide may be recovered in a small volume of nitrogen 
within 2-3 min by heating the trap to > 230OC, with a through flow of nitrogen (20 mL/min). 
The recovery of ['iCJcarbon dioxide is about 90%. 
2.1.6. Yield and purity. For the target system shown in Figure 2 an irradiation at 45 | iA for 
0.7 h leads typically to a ['iQcarbon dioxide batch yield of > 2 Ci (> 74 GBq). Analysis of 
the decay curve showed that the activity is more than 99.9% carbon-11 for Ep = 13^3 MeV. 
The specific radioactivity of [HCJcarbon dioxide was found to be about 1100 GBq/[imol 
(30 Ci/nmol). 
2.1.7. Considerations for the production of [^^C] methane. [I'CJMethane can be produced in 
targetry identical to that used for ['iCjcarbon dioxide and under similar irradiation 
conditions except that the target is filled with 5% hydrogen in high purity nitrogen. The 
yield and specific radiaoctivity are also similar. The [HCJmethane may be trapped from the 
target gas in a Porapak™ Q trap cooled with liquid argon. [ "C]Methane is recovered by 
passing helium or nitrogen at about 100 mL/min through the trap while warmed to room 
temperature. This process may be repeated to obtain the [nC]methane in a small volume (co 
2 ml) of inert gas (see Landais and Crouzel, 1987). 
2.2. NITROGEN-13 
Nitrogen-13 (t ja = 10 min; Ip-f- = 100%; Ep+ = 1.19 MeV) has found limited application in 
biological studies (for an earlier comprehensive review see Cooper et a/., 1985). The most 
commonly used i3N-labelled tracer in P E T is [i3N]ammonia; however, [ i3N]nitrate, for 
example, has also found application in plant physiology (e.g. Wieneke and Nebeling, 1990). 
Both these chemical species can be produced easily using a water target. 
Out of several nuclear processes which lead to the formation of nitrogen-13 (see 
Ferrieri and Wolf, 1983; Table 1), the i3C(p,n)i3N and i60(p.a )i3N reactions are most useful. 
The optimal energy range for the i60(p, a)J3N reaction is ^ = 16->7 MeV, and this process 
is thus ideally suited to a 'baby' cyclotron. This route offers the advantage of the use of a 
water target, though the yield is the lowest of the three reactions listed in Table 1. At a small 
cyclotron (with Ep = 11 MeV) the nitrogen-13 yield from the i60(p,a)'3N reaction is rather 
low; the alternative at such a low energy cyclotron is the '3C(p,n)i3N process (Bida et ai, 
1986) using highly i3C-enriched powder saturated with natural water {i.e. a slurry target). 
Since a natural water target constitutes the standard method for nitrogen-13 production (c/. 
Vaalburg et a/., 1975; Parks and Krohn, 1978; Lindner et a/., 1979; Siegers et ai. 1980), we 
describe it below in detail. 
2.2.1. Target hardware. Target bodies made of nickel or titanium have been used. A 
typical target, as used at Jiilich, is shown in Figure 4. It is exactly the same as that employed 
in [i8F]fluoride production via the i80(p,n)i8F reaction on i^O-enriched water (see below). 
Silver sea l ing He-cool ing 
T i - fo i l 75 um 
wate r jet 
0 21 mm 
cooling 
7 MeV p 
beam 
Titanium body 
Figure 4. Sectional view of the electron-welded titanium target (internal volume, 1.3 mL) in 
use at KFA Julich for nitrogen-13 production via the i60(p ,a)i3N reaction on natural water. 
An identical target is used for fluorine-18 production via the '80(p,n)i8F reaction using 
180-enriched water. 
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The target consists of a titanium body, electron beam-welded to two titanium foils (75 |im 
thick), which act as front and back window. The inner diameter of the target is 21 mm witli a 
water thickness of 3.5 mm. The target takes 1.3 mL of water with no expansion space. Two 
1/16" stainless steel tubes, leading to a multi-port valve are connected via screws that are 
sealed with silver washers. During irradiation, the back window is water-cooled, typically to 
8-lOOC, and the front window is helium-cooled to -f>C. 
2.2.2. Target operating conditions. The target is norinally operated with a 30 f iA beam of 
17 MeV protons. The pressure in a routine production run is between 10 and 15 bar. 
2.2.3. Liquid handling and transfer system. The target can be remotely loaded with water 
using the f i l l i n g unit described below for [ '8F ] f l uo r ide production. A 
polyethylene-polypropylene copolymer tube with an i.d. of 0.8 mm and a helium drive 
pressure of 1.3 bar is considered a reliable transfer system. Transfer over 40 m through this 
tubing from the target to the nearest hot-cell by a helium drive pressure of 1.3 bar takes only 
2 min. 
2.2.4. Dose-dependence of ^^N-labelled precursors. The major chemical species observed in 
the irradiated water are [i3N]nitrate, [ i3N]ni t r i t e , [i3N]ammonium ion and 
[i3N]hydroxylamine. Dose effects were observed in several studies (Parks and Krohn, 1978; 
Tilbury and Dahl, 1979; Root and Krohn, 1981). In general, with increasing dose, the 
proportion of the higher oxidation state increases at the expense of the lower oxidation states. 
A typical result is shown in Figure 5 (( / . Patt et al., 1991). Effects of dose rate are observed 
only in the low dose region. The highest [i3N]nitrate yield in pure water is 85 ± 5% in the 
high dose region. 
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Figure 5. Dose dependence of iSN-labelled precursors in a natural water target. The proton 
energy range in the target was Ep = 16^3 MeV and the beam current 15 ^ A (Patt et al., 
1991). 
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2.2.5. Production of ['^Njnitrate. The irradiated water (1.3 mL, 99.99% '60-enriched to 
avoid '^F impurity) is passed through an ion exchange column containing 200 mg of Dowex 
50W-X8 (50-80 mesh) and connected to the end of the polyethylene-polypropylene tube. 
The by-products, [i3N]ammonium ion and vanadium-48 (from the activation of titanium), 
are adsorbed on the column. Sulphuric acid (30%; 100 |J.L) is then added to the eluted target 
water and the mixture boiled to decompose nitrous acid and to expel it as nitrogen oxides. 
Quality control on the residual ['3N]nitrate solution is performed by radio-HPLC on a 
Nucleosil™ 5SB column (250 X 4 mm) eluted with 50mM-perchloric acid adjusted to pH 3.8 
with potassium hydroxide (Wieneke and Nebeling, 1990). 
A 10 min irradiation with 17 MeV protons at 30 ^ A leads to about 20.4 GBq 
(550 mCi) of [i3N]nitrate. The radiochemical purity of the ['3N]nitraie is > 99.8%. An 
alternative procedure consists of separation of the ['3N]nitratc by preparative 
chromatography using a Nucleosil™ 10 SB column (250 X 10 mm) and the aforementioned 
eluent. The same results can be achieved by this method. 
2.2.6. Production of ['^Njammonia. 
[i3N]ammonia (Figure 6). 
There are two methods for the production of 
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Figure 6. Schemes for the synthesis of [i3N]ammonia (A) via classical reduction with 
DeVarda's alloy and (B) via on-line reduction in situ. 
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In the first method, which is the more classical, the irradiated water is transferred to a vessel 
containing DeVarda's alloy (c/. Vaalburg et al.. 1975; Siegers et al., 1980). On reduction of 
the [i3N]nitrate and ['3N]nitrite to [i3N]ammonia, the gaseous ['3N]ammonia is swept by a 
stream of helium into saline solution. After sterile filtration the product is ready for use. In 
a new method oxidation is prevented in situ (Wieland et al., 1991). Ethanol is added, as 
scavenger for oxidising radicals, to the distilled and degassed water to give a ImM-solution.: 
After an irradiation for 10 min at 20 \iA, the target volume is transferred to a cation 
exchange cartridge connected to the end of the transfer line to trap [i3N]ammonium ion. 
The [i3N]ammonia is then eluted with an isotonic solution of sodium chloride solution. 
After final sterile filtration the product is ready for use. 
2.3. OXYGEN-15 
Oxygen-15 (t],2 = 2.05 min; Ip+ = 99.9%; Ejj-t- = 1.72 MeV) is extensively used in simple 
chemical forms to study oxygen metabolism, blood flow and blood volume in man with PET. 
Methods for the production of oxygen-15 and the preparation of [iSQjoxygen, [i50]carbon 
dioxide, [i^OJcarbon monoxide, ['^Olwater and Ai-[i50]butanol are well established. Most of 
the producUon aspects were described earlier (Clark et al.. 1987). Here we give only a 
summary of the important features and discuss some of the recent developments regarding 
this radionuclide. 
Methods for the production of oxygen-15 are summarised in Table 1 (c/. Clark and 
Buckingham, 1975; Beaver et al., 1976; Vera Ruiz and Wolf, 1977; Sajjad et al., 1984. 1985; 
Ruth, 1985; Strijckmans et al., 1985; Welch and Kilboum, 1985; Krohn et al., 1986; 
Berridge et al., 1990). The i5N(p,n)'50 reaction on highly enriched nitrogen-15 is used only 
when low energy protons are available (Ep = 11 MeV). The use of i5N-enriched nitrogen gas 
to produce [i50]oxygen for both bolus and steady state metabolic studies has been 
demonstrated using a 4 mL gas target irradiated with a very well regulated 8-11 MeV proton 
beam (Wieland et al., 1986b). 
The i60(p,pn)i50 process has a threshold energy of 16.6 MeV and is applied when a 
medium-sized proton only cyclotron is available. The tendency is to use this method of 
production only when others are inaccessible (Beaver et al., 1976; Ruth, 1985; Krohn er a!.. 
1986). Pure oxygen is used as the target gas and copious amounts of ozone are produced 
during irradiation. This ozone is removed together with small amounts of [i3N]nitrogen 
oxides and [HCJcarbon dioxide using active carbon and soda lime flow-through purifiers. 
Use of the purified product as [i50]oxygen, suitably diluted to safe physiological levels, is 
straightforward. However, the conversion of pure oxygen into water by reaction with 
hydrogen, although feasible, requires great care to control the highly exothermic reaction! A 
much more attractive route to [i50]water, using this reaction, is to employ an [i60]water 
target (Mulholland et al., 1990). Here, when pure water is irradiated, the predominant 
'50-labelled product is [i50]water. Some nitrogen-13 is produced via the •60(p,a)i3N 
reaction together with traces of fluorine-18 from the i80 (p ,n ) 'SF reaction on natural 
abundance [i^oiwater. These impurities may be removed using mixed-bed ion exchange 
columns (Mulholland et al.. 1990). 
The producfion of ['SOJcarbon dioxide (Beaver et al.. 1976) and in particular 
[i50]carbon monoxide using pure oxygen targets poses many practical problems and, in the 
case of carbon monoxide, insurmountable problems relating to toxic levels (Krohn et al., 
1986). Preliminary studies with water targets to produce high specific radioactivity 
I 
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[i50]oxygen and hence [i50]carbon monoxide arc encouraging (Link et a!., 1991). 
The i ' 'N(d,n)i50 reaction is the most widely used process. The energy of the 
deuterons incident on the nitrogen target gas should be adjusted to about 8-10 McV. This 
energy should minimise the production of the longer lived radionuclidic impurities, 
nitrogen-13 (tj,2 = 10.0 min) and carbon-11 (ti/2 = 20.4 min) generated by the i4N(d,t)i3N 
(threshold energy, 4.9 MeV) and i '»N(d,an)"C (threshold energy, 5.8 MeV) reactions, 
respectively. 
2.3.1. Target design and gas delivery tubes. The target vessel used to contain the nitrogen 
during irradiation is usually made of aluminium alloy. The pressure is usually determined 
by the diameter and length of the radioactive gas delivery pipe. Typically tubes with internal 
diameters from 1.5 to 2 mm and 50 m length are used; in exceptional cases tubes of a few 
hundred metres length have also been found to be practicable. Stainless steel, PTFE™ and 
polypropylene tubes have been used satisfactorily. A titanium beam entry window 
25-50 [im thick and 25-30 mm in diameter is fitted with a nitrile, Viton™ or metal sealing 
ring to a 30-50 mm diameter cylindrical vessel some 100-50 mm long, filled with nitrogen 
gas between 5 and 6 bar, respectively. As with all gas target and accelerator beam windows, 
provision must be made for their cooling. This is achieved with air or preferably helium jets 
with flow rates of 10- 20 L/min at 1-1.5 bar, with recirculation in the case of helium. 
In recent years conically shaped targets used in batch mode have found increasing 
application. The target system shown in Figure 2, for example, was adapted at Jiilich to 
irradiations with 10 MeV deuterons. 
2.3.2. Target gases. 
a. [i^OJOxygen production. 
In-target production of [i^Ojoxygen is achieved by irradiating nitrogen containing 0.2-0.5% 
(vol) oxygen. The lower level is quite critical as the recovered yield of [i^Qjoxygen falls 
dramatically when lower concentrations are used, but may be necessary when higher specific 
radioactivities are required as, for example, in some ['^Ojcarbon monoxide labelling 
procedures. ['SQ]Water may also be prepared from ['^QJoxygen. [i^OjOxygen production 
yields of 0.2-0.3 GBq/)iAmin (5-8 mCi/^iA min) using nitrogen-oxygen (0.5%) as target gas 
can be achieved at flow rates of 500 mL/min. 
b. [i^OjCarbon dioxide production. 
In-target production of [isQJcarbon dioxide is generally preferred to the less efficient 
chemical conversion of [i50]oxygen using hot activated charcoal. The target gas is nitrogen 
containing 2-2.5% carbon dioxide. ['^OjCarbon dioxide production yields of 0.2-0.3 
GBq/^JAmin (5-8 mCi/nAmiii) using nitrogen-carbon dioxide (2.5%) as target gas can be 
achieved at flow rates of 5(X) mL/min. 
2.3.3. Target gas supply. Target gas mixtures are generally purchased and are either 
certified mixtures, such as 0.2% oxygen in nitrogen 6.0, or made from medical grade gases 
[mixtures of N45 (99.995%)], depending on the requirements of the local regulating 
authorities. 
2.3.4. Target operation. Deuteron beam currents of up to 50 |j,A have been found to be 
practicable, the target windows being the principal limitation. It is possible to use the same 
target vessel for [i50]oxygen and [i50]carbon dioxide production provided that adequate 
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evacuation or flushing of the target and its supply pipes is achieved between irradiations. For 
[i50]carbon monoxide production, the risk of accidental inclusion of oxygen or carbon 
dioxide with the inherent risk of producing high levels of carbon monoxide precludes the 
use of a common target in this case. 
The batch targets are more suitable for bolus studies with ['^OJwater and . 
«-[i50]butanol. 
2.3.5. Processing and purification. 
a. P^OJOxygen, [^^OJcarbon monoxide and ['^OJwater. 
The main chemical and radiochemical impurities ozone, nitrogen oxides and ['^Olcarbon 
dioxide are removed using two adsorber columns in series. The first (25 mm diameter x 
120 mm) is filled with sodalime and a second similarly dimensioned column is filled with 
granules (1.5 mm) of activated charcoal. 
When [i50]carbon monoxide is produced by passing previously purified 
[i50]oxygen into a column of dried activated charcoal (60 mesh; 250 x 15 mm) at lOOOOC 
the presence of oxygen carrier inevitably leads to the production of potentially hazardous 
quantities of carbon monoxide. For example i f a nitrogen target containing 0.25% oxygen 
is used, stable carbon monoxide at levels of at least 0.5% are produced. Under these 
conditions a yield of [i^OJcarbon monoxide of 37 MBq/|j.A min (1 mCi/p.A min) can be 
achieved and by 20-fold dilufion a carbon monoxide concentration of 0.025% can be 
administered safely for periods of up to 15 min. On the other hand methods are being 
developed which are directed towards reducing the stable carbon monoxide content in 
['50]carbon monoxide and hence ensuring patients' safety (c/. Votaw et al., 1986). 
[150]Water is readily prepared by the palladium-catalysed reaction of ['^OJoxygen 
with hydrogen (c/. Clark and Buckingham, 1975; Meyer et al., 1984; Clark and Tochon 
Danguy, 1992). A flow of purified [i50]oxygen in nitrogen is mixed with hydrogen and 
passed over a few pellets of palladium-alumina catalyst, the resulting water vapour is trapped 
by bubbling the nitrogen carrier through sterile isotonic saline. 
The catalyst also generates a small amount of ammonia which causes the pH of the 
saline to rise to 9. ConsequenUy, the use of a physiological buffer may be desirable for some 
apphcaUons. Batches of over 3.7 GBq (100 mCi) can be readily prepared with deuteron 
beam currents of 20 nA. Two altemaUve methods for the preparation of [i50]water have 
been described, one involving the exchange reaction between ['^OJcarbon dioxide and water 
(Welch and Kilboum, 1985) and the other employing in-target reaction of oxygen-15 atoms 
with hydrogen in a nitrogen-5% hydrogen target gas (Vera Ruiz and Wolf, 1978). However, 
very little experience of these techniques exists. 
b. SO]Carbon dioxide. 
During the irradiation of nitrogen-carbon dioxide (2-2.5%) the chemical and radiochemical 
impurities, carbon monoxide and [i50]oxygen, are observed. Earlier attempts to reduce 
these have now been shown to be unreliable. The use of an oxidising column composed of a 
mixture of copper and iron oxides supported on kaolin reduces the [i^OJoxygen and carbon 
monoxide to < 0.02% and < 10 [ iL/L respectively (Strijckmans et al., 1985). Nitrogen-13 
wi l l inevitably be present in all systems that employ carbon dioxide in the target gas because 
of the i2C(d,n)'3N reaction (threshold energy, 0.4 MeV). For applications where > 0.5% 
[i3N]nitrogen carmot be tolerated the less efficient low temperature combustion of activated 
charcoal with [i^Ojoxygen must be employed. The use of the copper-iron oxide column 
after the carbon furnace is recommended. Another approach to the production of 
[•50]carbon dioxide and ['SOJoxygcn from a common target source is to carry out catalytic 
interconversion of ['SOjcarbon dioxide and [i50]oxygen in a flow system using metal oxide 
catalysts {e.g. HopcaliteTM-H) (Iwata et ai, 1988). 
c. n-['^0]Butanol. 
This appears to be a very promising agent for regional cerebral blood flow studies. Its 
production and quality control are described in the chapter on Automation (Crouzel et al., 
this volume). 
2.3.6. Analysis of gaseous products. A radio-GC is employed to analyse the chemical and 
radiochemical 'atmospheric gas' impurities (see Clark and Buckingham, 1975; Meyer, 
1982). Typically a dual column instrument, equipped with a thermal conductivity detector 
for stable gas analysis plus a small sensitive volume flow-cell radioactivity detector for 
radioactive gas analysis, is used. The two columns most commonly used are: 
(a) Porapak™-Q (80-100 mesh, 1500 x 4 mm, pre-conditioned at 250OC) 
(b) Molecular sieve SA (80-100 mesh 3000 x 4 mm, pre-conditioned at 350OC). 
These columns when operated in combination between 25 and 8(PC with a helium carrier 
gas flow rate of about 10 mL/min provide adequate separation of ['50]oxygen [i3N]nitrogen, 
['50]carbon dioxide, ['^Olnitrous oxide and [i3N]nitrous oxide. 
The chemical analysis of the noxious gases, ozone, nitrogen dioxide, and carbon 
monoxide, down to the levels necessary for safety prior to the administration of a radioactive 
gas to man, cannot be carried out satisfactorily by GC. In the case of ozone classical 
iodometric analysis is recommended. For nitrogen dioxide colorimetric estimation is 
acceptable. 
More details on the quality control of radioactive gases are given in the chapter on 
Quality Assurance and Quality Control (Meyer et al., this volume). 
2.4. FLUORINE-18 
For fluorine-18 (t la = 109.6 min, lp+ = 97%; Ep-i- = 0.64 MeV), perhaps for more than any 
other radionuclide, success in labelling depends on factors that are determined by 
radionuclide production. The following section of this chapter is mainly based on a report 
of a recently sponsored EEC Task Group (Guillaume et al., 1991) and specifically discusses 
production. 
2 .4 .1 . Main sources of fluorine-18. Fluorine-18 can be reached by a variety of 
well-documented (Qaim 1982, 1986a; Qaim and Stocklin, 1983; Gandarias-Cruz and 
Okamoto, 1988) routes (for a recent summary see Guillaume et al., 1991). Of these, the 
20Ne (d , a ) i 8F and i80(p,n)i8F reactions are of major practical interest, in view of their 
requirement for only a moderate projectile energy and a moderate beam current to give a 
useful yield (Figure 1). Hence, even simple cyclotrons, such as those classified by Wolf and 
Jones (1983) as Level I (< 10 MeV p or d) and Level II (< 20 MeV p, plus perhaps other 
particles), are capable of useful fluorine-18 production. The 20Ne(d,a y^¥ and'80(p,n)i8F 
reactions are mainly applied to prepare c.a. molecular ['^FJfluorine and n.c.a. ['^FJfluoride, 
respectively. Currently, nearly all fluorine-18 radiochemistry stems from these cyclotron 
products, either through their direct use as labelling agents or via their conversion into others 
(for reviews see Berridge and Tewson, 1986b; Coenen, 1989; Kilboum, 1990). 
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The •60(3He,p)i8F reaction is also occasionally used for [i8F]fluoride production. 
The yield is low (Table 1 and Figure 1); the only advantage is that natural water rather than 
180-enriched water is used. However, the cost of the required helium-3 is also significant. 
2.4.2. Production of c.a. [^^FJfluorine by the 20Ne(d,a)^^F reaction. The bombardment of 
high pressure neon (up to 25 bar) containing a low percentage (0.1-0.2%) of molecular 
fluorine with moderate energy deuterons (Lambrecht et al., 1978a; Casella etal., 1980) is a 
well-established method for producing c.a. molecular [i^Fjfluorine. Table 2 shows 
experimental conditions and typical data for the production of [iSFjfluorine via the 
20Ne(d,a)i8F reaction at a few centres. Several factors must be taken into account to achieve 
satisfactory routine production, as follows. 
a. Target design and construction. 
Target bodies have been described formeriy (e.g. Casella et al., 1980; Blessing et al., 1986). 
Nickel and Monel™, machined or welded, appear to be the optimal metals for the target 
body. Stainless steel (316) is also convenient but needs longer passivation with fluorine (vide 
infra). Inconel™ also requires longer passivation and gives lower recovery of fluorine-18 
(Casella et al., 1980; Blessing et al., 1986). Nickel plating on stainless steel deteriorates after 
a few runs (Blessing et al., 1986). Generally, target bodies are 10 to 20 cm long and are 
fabricated from 1.5 to 2.5 cm i.d. tube with gas connections through stainless steel weld 
fittings. SwagelokTM fittings are recommended for this purpose. The target must be 
chemically clean before installation. 
The window is preferably made from 25 or 50 ^.m Havar™ foil (Hamilton Precision 
Metals). Aluminium or Havar™, having a thick layer (e.g. 20- 25 pim) of nickel on the side 
exposed to fluorine, nickel, niobium and titanium have also been used. Several methods may 
be used to seal the beam-entry window to the target body. Those that are satisfactory include 
the use of a copper ring (Leybold) a gold crush seal, an indium wire or a flat washer made 
from thick (0.5 mm) lead sheet. Cooling of the fo i l , preferably with helium is 
recommended. 
b. Target gas. 
The neon should be 99.998% pure as obtainable from Air Liquide or Messer Griesheim, in 
order to recover the radioactivity mainly as molecular [i^Fjfluorine (vide infra) (Bida et al., 
1980a; CaseUa et al., 1980; Dahl and Schlyer, 1985). The pressure regulator should be aU 
metal and designed for use with high purity gases. 
In pure neon, nucleogenic fluorine-18 diffuses to the target wall and is chemically 
adsorbed. When a low (0.1-0.2%) proportion of carrier fluorine is present, exchange of 
nucleogenic fluorine-18 can compete with surface adsorption and recovery of most of the 
radioactivity from the target becomes possible (Lambrecht et al., 1978a; Bida et al., 1980a; 
Casella et al., 1980). Corrosion of target and ancillary components is not a significant 
problem i f only dilute (e.g. < 2%) mixtures of fluorine in neon are used. A mixture of 
2% fluorine in neon, with certificate of analysis, can be obtained from Union Carbide, Air 
Liquide or Matheson. The pressure regulator is specially prepared for use with fluorine 
mixtures by the gas supplier. Alternatively, a mixture of 2% fluorine in helium, as prepared 
for lasers, can also be used as the source of fluorine gas. This is supplied by Matheson or Air 
Liquide with a ful l Monel™ delivery system. 
c. Target gas handling. 
Given the highly hazardous nature of fluorine, it is emphasised that a safe facility is required 
to dilute the stock fluorine mixture with further neon to achieve the composiuon desired 
within the target. 
Stainless steel and SwagelokTM fittings are recommended for transport lines, since 
surface fluorination (passivation) lasts longer at room temperature than for the alternatives of 
nickel and Monel™. Teflon tubing, though chemically resistant, is unsuitable as it becomes 
permeable to fluorine with use (Casella et al., 1980). Stainless steel bellows (Hoke, Nupro) 
valves are reliable in service. A piezoresistive, low dead-volume pressure transducer (Kistler) 
is recommended to monitor target pressure before and during irradiation. Great care should 
be taken to avoid any ingress of air into the gas handling facility and target. Flow purging 
rather than evacuafion of air is thus preferred. It is preferable to dedicate a line for filling the 
target and to dedicate another low volume line for recovering radioactivity. The fill/empty 
stoichiometry of this arrangement can be highly reproducible. 
d. Target operating conditions. 
The main factor that determines [iSFjfluorine recovery is the chemical state of the target 
surface (Bida et al., 1980a; Casella et al., 1980). Passivafion (prefluorination) of the surface 
is necessary before bombardment to avoid a significant loss of fluorine-18 along with 
fluorine carrier. Two passivation methods have been proposed, namely 'thermal' passivation 
and 'beam-induced plasma' passivation. Thermal passivafion requires the target to be heated 
for 1-3 h to between 100 and 200OC, when filled to a low pressure (a few bar) with dilute 
fluorine in neon. Beam-induced plasma passivafion is achieved by deuteron bombardment 
of the target when filled to at least the same partial pressure of fluorine as used in production. 
Two or three irradiafions, using about 10 \iA of deuterons for 30 min. are carried out 
successively, with the contents of the target discarded after each irradiation. Recoil 
passivafion is most easy to operate roufinely. In general, the requirement to repeat 
passivafion is more likely the longer a target has not been in use. It is considered that a good 
passivafion is achieved when 75 to 80% of the fluorine-18 can be recovered in a production 
run. Water-cooling of the target during irradiation is not usually necessary, so simplifying 
target construcfion. 
e. Chemical forms of the recovered fluorine-18. 
The chemical form of the recovered fluorine-18 depends criUcally on the purity of the target 
gas (Bida etal., 1980a; Casella etal., 1980; Dahl and Schlyer, 1985). The neon should be as 
free as possible from nitrogen and carbon oxides, as these incorporate substantial proportions 
of the fluorine-18 into inert substances namely, nitrogen [i8F]trifluoride and carbon 
[i8F]tetrafluoride, respecfively. Contamination by fluorocarbons should also be avoided. 
Under such condifions the fluorine-18 is mainly obtained as molecular ['SFjfluorine (Bida et 
al., 1980a; Dahl and Schlyer, 1985). 
The following reacfion is useful to monitor the chemical activity of the available 
fluorine-18, as well as its specific radioacfivity (Blessing et al.. 1986): 
18F2-I-MesSnPh Phi^F-t-MesSn'SF 
CFQs, -78°C 
The amount of [i8F]fluorobenzene in the freon solufion of labelled products is determined 
by radio-GC. From measurement of the total recovered activity the reactive fraction of 
recovered fluorine-18 (presumed to be molecular [i^Fjfluorine), and its specific radioactivity 
can be calculated. Blessing et al. (1986) found the total organic radiochemical yield to be 
51 ± 2 % and the fluorobenzene yield to be 36 ± 2% over 30 runs under the production 
conditions described in Table 2. 
It should be noted that deuteron irradiation of neon containing a low percentage 
(< 15%) of hydrogen has been used by several groups to produce n.c.a. fluorine-18 (Clark et 
al., 1973; Winchell era/., 1976; Straatman and Welch, 1977; Lambrecht et al., 1978a; Helus 
et al., 1979; Clark and Oberdorfer, 1982; Dahl et al., 1983; Ehrenkaufer et al., 1983; 
Blessing et al., 1986). Various means have been used to recover the radioactivity, including 
removal from the heated target with a stream of hydrogen (Winchell et al., 1976; Clark and 
Oberdorfer, 1982; Dahl et al., 1983; Blessing et al., 1986), recirculation of the irradiated 
neon-hydrogen mixture over a basic trap (Clark et al., 1973) and water-washing of the target 
after irradiafion (Helus et al.. 1979; Blessing et al., 1986). Removal from the heated target in 
a stream of hydrogen is invariably described as giving n.c.a. hydrogen [iSFJfluoride. Water 
washing of the target recovers a high proportion (90%) of the radioactivity as aqueous 
[i8F]fluoride with a high specific radioactivity of 370 GBq/p.mol (10 Ci/|imol) (Blessing et 
al., 1986). However, these neon-hydrogen targets are relatively inconvenient to operate and 
difficult to maintain and so are not widely used. 
/ . Specific radioactivity. 
The effect of systematically varying fluorine content on activity recovery and specific 
radioactivity has been examined (Blessing et al, 1986). Between 0.10 and 0.18% 
(60 )imol F2) of fluorine carrier, [i^FJfluorine recovery increased but specific radioactivity 
did not change. The optimal composition for recovery yield and specific radioactivity seems 
to be 0.18% fluorine. 
The volume of the target is an important factor. It was found that for a collimated 
(1 cm diameter), defocussed and wobbled beam, the optimal target size is 2.2 cm diameter x 
10 cm length giving a total fluorine content of 60 jxmol for the target, leading to a specific 
radioactivity of 55.5-111 GBq/mmol (1.5-3.0 Ci/mmol) in production (Blessing et al., 
1986). 
The specific radioacUvity of molecular [i8F]fluorine can be measured via titration of 
the iodine liberated on passing the target output into potassium iodide solution (Casella et al., 
1980). However, in principle, this method does not distinguish between the several oxidising 
chemical forms of fluorine-18 (such as i^F-labeUed OF2, HOF, NFH2 or NFjH) that might 
arise in the target i f there is any contamination by air. A misleading result might therefore 
be obtained. Preferably, specific radioacfivity is measured via the reaction with 
trimethylphenyl tin {vide supra), which is expected to be more selective for fluorine-18 in the 
form of molecular fluorine (Blessing et al.. 1986). 
2.4.3. Production of n.c.a. ['^FJfluoride by the '^0(p,n)'^F reaction on i^O-enriched water. 
The proton irradiation of i^O-enriched water is now the most effective method for the 
producfion of n.c.a. [i^FJfluoride. Under optimal condiuons, greater than 20 GBq (several 
hundreds of mCi) of aqueous [i8F]fluoride are easily available from an 11 MeV proton 
cyclotron, in a bombardment Ume of less than 1 h. At a 'baby' cyclotron with Ep= 17 MeV, 
batch yields of about 74 GBq (2 Ci) are available. Table 3 summarises typical experimental 
data on the production of ['8F]fluoride from i^O-enriched water targets, as developed in 
several laboratories. 
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a. Target systems. 
Many different [i80]water targets have been described (Wieland and Wolf. 1983; Kilboum et 
al., 1984, 1985; Huszir and Weinreich, 1985; Berridge and Tewson, 1986a; De Jesus et al., 
1986; Keinonen et al., 1986; Vogt et al., 1986; Wieland et al., 1986a; Iwata et al., 1987; 
Qaim et al., 1987; Solin et al., 1988; Benridge and KjeUstrom, 1989; Muiholland et ai. 1989; 
Steinbach et al., 1990). The primary consideration in design has been to consume as little of 
the costly i^O-enriched water as possible during production. The requirement for small 
target volume in turn means that target thickness has to be selected carefully for effective use 
of the beam. Also radiolysis and boiling of the water become important considerations, i f 
impure water is used for irradiation. These can cause significant loss of target water in open 
targets (Kilboum et al., 1984; Berridge and Tewson, 1986; Iwata et al., 1987) or 
unacceptable pressure build up in closed targets, with adverse effect on yield. Effective target 
cooling of the front window by helium and the back side with water is mandatory. 
The decision to operate a low pressure or high pressure target is fundamental, since it 
bears on target construction and the strategy for coping with the adverse effects of radiolysis 
and heat. Experience has shown that the most efficient water target is simply composed of a 
cavity for the target water, bounded by two rigid metallic foils, the rear foil being efficiently 
cooled by a suitable fluid. Targets requiring only 0.4-2.5 mL of water can be constmcted 
on this basis. Other parameters of importance are the type of target seals, the chemical nature 
of the metallic insert and foils, the type of transfer tubing (Iwata et al., 1987) and the facility 
for recovery of the i^O-enriched water, as these potentially bear on the reactivity and the 
specific radioactivity of the generated [i8F]fluoride. 
For labelling by nucleophilic subsfitutions the ['^Flfluoride is required to be 
essentially free of water, i.e. to be 'naked' n.c.a. [i^Fjfluoride. Several procedures have been 
described for the recovery of n.c.a. [i8F]fluoride in a reactive form from '^O-enriched water 
{e.g. Brodack et al., 1986; Schlyer tt al., 1987, 1990; Jewett et al., 1988, 1990, 1991a,b; 
Alexoff et al., 1989; Hamacher et al., 1990). These dehver the [i8F]fluoride in natural 
enrichment water or organic solvent. Generally, the strategy for generating reactive 
[i8F]fluoride is dissolution of the [i^Fjfluoride with a large counter-ion {e.g. K + , Cs+, Rb+. 
B U 4 N + or K+-Kryptofix™) in a polar aprotic solvent. Where required, water (or other 
solvent) is removed by distillation from an added base {e.g. KOH, K2CO3, Rb2C03, Et4N0H, 
B U 4 N O H or K2C03-Kryp to f ix™) and the [ i8F]fluoride salt dried by, for example, azeotropic 
disdllation with acetonitrile, or even by microwaves. This salt is then resolubilised in the 
solvent containing the substrate for nucleophilic attack. Resolubilisation efficiency is 
affected by the reaction vessel, solvent and perhaps other factors such as metal ion 
contaminafion (Brodack et al., 1986). The intrinsic reacfivity of the [isFJfluoride is affected 
by several factors, including cafion and anion contaminants whose level are largely 
determined by the materials of target construcfion and operation (Nickles et al., 1986). 
Below we describe and discuss examples of reliable target assemblies designed for low and 
high pressure operafion. 
b. Example of a reliable low pressure target system. 
In the low pressure mode of operation, without taking appropriate precautions, radiolysis and 
boiling can cause a significant loss of i^O-enriched water, and render the use of high beam 
currents impractical for high yield. Provision for effective venting (Wieland and Wolf, 1983; 
Berridge and Tewson, 1986a; Iwata et al., 1987) or for the catalytic recombination of 
radiolytically generated oxygen and hydrogen (Iwata etai, 1987) must always therefore be 
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considered. Recirculation of the water during irradiation is also advantageous for some 
targets (Iwata et al., 1987; Keinonen et al., 1987), but results are not necessarily consistent 
(Iwata et al., 1987). A low pressure target, in use at the MRC Cyclotron Unit at 
Hammersmith Hospital, is described here as an example of a reliable system. 
Hel ium coo l ing jet 
19 MeV 
Proton b e a m 
He l ium coo l ing jet 
0 - r i n g 
Water coo l ing O-nng 
He l i um coo l ing 0 - r i ng 
0 025 m m T i tan ium 
\ 
0.57 m m A lum in ium 
w indow lor support 
and energy d ropp ing . 
Cool ing waier 
out le i 
Cool ing water 
in let . 4 I. 
/ @ 90 ps i . 
0.125 mm Stainless 
steel exit window 
Fixing Polls 
and wasners 
3 mm Sta in less 
steel spacer wi th 
water cav i ty . 
Vent port 
0 50 m 
0 25 mm 
Fil l /recvcie porl 
Empty por i 
Figure 7. An exploded schematic view of the target (internal volume, 2 mL) in use at the 
MRC Cyclotron Unit (Hammersmith Hospital) for [i8F]fluoride production via the 
i80(p,n)i8F reacfion on isQ-enriched water. 
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The target (Figure 7) is fabricated from 25 mm diameter stainless steel (316) and 
titanium for the proton irradiation of 20% i^O-enriched water (97% i^O-enrichcd water from 
Isotec diluted with sterile HPLC grade water). The front window is aluminium (155 mg/cm2, 
0.57 mm thick) backed on the water side by a titanium foil (12.4 mg/cm2, 25 \im thick). 
This maintains a flat front surface to the target and degrades the 19 MeV beam to 16 MeV. 
The water thickness is determined by a 3 mm thick stainless steel spacer. The back of the 
target is made from 125 |im thick stainless steel (316) foil which is water-cooled. The foils 
and spacer are clamped together metal to metal. Hence, no ' O ' rings are in the target-water 
cell. The target cell has three 1/16" stainless steel tubes inserted through the spacer, fixed 
and sealed with Locktite retainer 601, the joints having been pretreated with LockUte 
Acfivator T (Cat. No 74736). A small pellet of palladium catalyst (Engelhard Model D) is 
supported in an extemal gas space to recombine any radiolytically-generated hydrogen and 
oxygen that might otherwise cause excessive intemal pressure. 
The target is normally operated with an incident beam of 19 MeV protons (20 [lA, 
20 mm diameter, spun at 45-50 Hz). The target is 45 m from the nearest hot cell in which 
the fluorine-18 can be used. Teflon™ lines (1/16" o.d., 0.030" bore) are used with a neon 
drive pressure of 2 bar and flow regulator. The transfer yield for 1-2 mL target water is 
currenfly > 95% while the recovery of ['^F]fluoride is typically between 95 and 98%, within 
5 min from FOB. Though, at the end of inradiation approximately 65% of the radioactivity 
is nitrogen-13 (r 7/2 = 9.96 min) from the i60(p,a)'3N reaction, this is not a problem for 
radiosyntheses with the ['8F]fluoride which generally take more than one hour. Final 
products are devoid of nitrogen-13. 
A procedure, based on those described by Schlyer et al. (1987, 1990) and Hamacher 
et al. (1990), has been adopted for the recovery of ['^F]fluoride and for the recycling of 
180-enriched water. Carbonate form ion exchange resin (100-200 mesh AG 1X8; 90 mg) is 
made into a column (28 mm x 3 mm). i^O-Eruiched water is forced from the target through 
the column by low neon pressure (2 bar). Finally, neon is blown through the column to 
extract the last traces of liquid. The recovered water is pooled into 10 to 20 mL batches and 
distilled under reduced pressure using a microrotary evaporator. The degree of 
180-enrichment is measured with mass spectrometry (Waters, 1990). Bacterial contamination 
of the '80-enriched water must be avoided by sterile millipore filtration into clean sterile 
glass vials (Pierce). The [i8F]fluoride is recovered from the anion exchange column by 
elution with potassiimi carbonate solution. The procedure is highly efficient with respect to 
recovery of [isFjfluoride and to recycling of the '^O-enriched water. 
The [ i8F]fiuoride is used routinely for the production of 2 -18FDG 
(2-['8F]fluoro-2-deoxy-D-gIucose), according to Hamacher et al. (1986). Generally, over 
90% of the radioactivity reacts in the first stage of the radiosynthesis, the displacement of the 
tr i f lyl group, i f performed in a glassy carbon vessel. If the reaction is performed in a glass 
vessel, incorporadon is typically 60%. 
c. Example of a reliable high pressure target system. 
Targets without an expansion volume are operable at beam currents up to 30 | iA. due to the 
pressure build up in the target by radiolysis, depending on the purity of the water (Wieland et 
al., 1986a) which, as a diagnostic, can be monitored during irradiation. A target (Figure 4) 
in use at Jiilich is described here as an example of a system which has functioned reliably, 
even after reaching an integrated beam current of 3000 nAh. 
The target consists of a titanium body electron beam-welded to two titanium foils 
(75 \im thick), which act as front and back window. The dimensions of the target are exactly 
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the same as those described above for nitrogen-13 production. The target lakes 1.3 mL of 
180-enriched water with no expansion space. Two 1/16" stainless steel njbcs lead from each 
end of the target to a multi-port valve (Figure 8) and are connected via screws that are sealed 
with silver washers. 
Helium 
Pressure 
Overflow 17MeVp 
Target 
In ject 
block 
to FDG 
Figure 8. Scheme of the remotely loaded filling unit for the '^O-enriched water target used 
at KFA Julich. 
The purity of the 'SQ-enriched water used in high pressure targets is of major 
concern. It is found that high chemical purity is needed to avoid excessive pressure 
build-up. For large-scale production, greater than 90% '^O-enrichment is needed to avoid 
the generation of excessive [i3N]nitrogen, which may pose radiation protection problems. 
Organic impurities must be absent as these can prevent recombination of radiolytically 
generated oxygen and hydrogen atoms, causing the target to burst. In order to eliminate 
traces of organic solvents after use, the i^O-enriched water is purified by reflux with 
potassium permanganate and potassiimi hydroxide, and finally double distillation. Purity is 
assessed by capillary GC with an FID detector operating at highest sensitivity. 
The target is normally operated at a beam current of 20-30 ^ A of 17 MeV protons, 
depending on the purity of water. The maximum current tested was 35 |J.A. The pressure in 
a routine production run is in the range 15-25 bar. The yield of aqueous [i8F]fluoride is 
linear with beam current up to 30 nA and irradiation times up to 1 h. 
Filling of the target with iSQ-enriched water is achieved with a motor-driven syringe 
through 3-way valves (Asco 368) and 6-way valves (Valco AC6W), which are connected by 
polyethylene-polypropylene tube. The target is locked by the 6-way valve and the pressure 
is monitored by a piezoresistive pressure transducer with very low dead volume. A 
polyethylene-polypropylene copolymer tube with an inner diameter of 0.8 mm and helium 
drive pressure of 1.3 bar is considered a reliable transfer system. Transfer over 30 m 
through this tubing from the target to the nearest hot-cell takes only 2 min. 
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The 180-enriched water is recovered by retrieving the [i8F]fluoride on a carbonate 
form ion exchange resin (Hamacher et al, 1990). The water can be recycled 4 or 5 times, 
unless the enrichment of water falls below 90%, as measured by mass spectrometry and by 
measuring the amount of nitrogen-13 from a production run. 
Cation and anion contaminants (Solin et al., 1988) have generally been considered to 
influence the reactivity of n.c.a. ['^FJAuoride. I f Havar™ foils are used for the target the . 
contaminants are mainly Fe, Cr and Co ions in concentrations ranging from 0.2 to 3 ppm as 
assessed by atomic absorption spectroscopy. Use of titanium foils results in a decrease in 
these ions and therefore can be recommended as the least contaminating metal to use as 
insert and window foi l . Contamination of the i^O-enriched water with vanadium-48 was 
found to be 6.9 kBq (0.187 p,Ci) after irradiation for 10 min with a 20 tiA beam producing 
10 GBq (270 mCi) of fluorine-18. An advantage of the ['^FJfluoride recovery system is that 
cationic species are not co-recovered. Over 90% of the recovered ['^FJfluoride reacts in the 
first stage of the synthesis of 2-18FDG described by Hamacher et al. (1986), when a glassy 
carbon vessel is used. The target delivers [i8F]fluoride with specific radioactivities up to 
7400 GBq/p.mol (200 Ci/nmol) as measured by a fluoride selective electrode. 
2.4.4. Fluorine-18 from the i^O(p,n)'^F reaction on P^O]oxygen gas. The '80(p,n)i8F 
reaction is of considerable interest for producing [i8F]fluorine in centres having a 
proton-only cyclotron. Nickles et al. (1984) first described the production of 
[i8F]fluorine-18 from an oxygen-18 gas target using a two-step irradiation process. Nickel is 
used as material for the target body, and nickel and Havar^M foils for the windows. The 
target is conically shaped and has a volume of 15 mL. After irradiating pressurised 
i^O-enriched (98%) oxygen gas, fluorine-18 gets deposited on the target walls, and the 
oxygen-18 is recovered cryogenically. A second and short irradiation of 1% fluorine 
(75 nmol) in krypton is needed for isotopic exchange of the adsorbed fluorine-18 and tlie 
recovery of more than 50% of the total fluorine-18 activity (Sunderiand et al., 1989). Target 
performance is determined by the level of fluorine passivation. Passivation with molecular 
fluorine at 200OC for several hours gives the best results. The ['^F] fluorine can be titrated by 
well known methods (Casella et al., 1980) and has been converted into acetyl 
[i8F]hypofluorite, which was then used for the synthesis of L-6-[i^F]fluoro-DOPA 
(Sunderland et al., 1990). Chirakal et al. (1992) have also produced fluorine-18 in this 
manner for the direct radiofluoririarion of dopamine. Solin and Bergman (1986) used a 
similar process, but substituted fluorine in neon for fluorine in krypton. They recovered up 
to 25% of the total radioactivity. Half of the radioactivity was recovered in the 'SO-enriched 
oxygen. Given the experience with nickel targets, such variations in recovered activity are 
not unexpected. 
Wieland et al. (1989) described a one step proton irradiation of a mixture of helium, 
fluorine and i^O-enriched oxygen. A gold-plated copper body with a conical bore was used 
as target and no attempt was made to recover the i^O-enriched oxygen. Also, no aggressive 
passivation was used to precondition the target. Preliminary results appeared encouraging. 
For example, Wieland et al. (1989) were able to produce more than 37 GBq (1 Ci) of 
fluorine-18 radioactivity from a 1 h irradiation with 30 | iA beam of 10.4 MeV protons on a 
target containing only 19 \imo\ of carrier fluorine. The achieved specific radioactivity is 
close to 1.85 GBq/|imol (50 mCi/|imol), and thus much higher than that usually achieved via 
the deuteron irradiation of a neon-fluorine mixture (Table 2). 
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These results have to be reproduced routinely. Especially the radioactive product has 
to be tested regularly for its suitability in, for example, the preparation of acetyl 
(i8F]hypofluorite, and in turn of a radiopharmaceutical such as L-6-['8F]nuoro-DOPA, 
before either a one or a two step process with the i80(p,n)i8F reaction on [i^OJoxyen can be 
recommended for the production of fluorine-18. 
3. Production Limits of Short-lived Organic Positron-Emitters at Low Energy 
Accelerators 
In recent years considerable effort has been devoted to developing very high intensity small 
accelerators for the production of common positron-emitters, mainly on hospital sites [cf. the 
detailed presentations at Targetry Workshops in Vancouver (1989) and Villigen (1991)]. 
The major stipulated advantages of such accelerators include small size, a low activation of 
components, a low neutron background, and hence almost no requirement for shielding. In 
general three concepts and designs have been projected: 
— Deuteron acceleraUng cyclotron, 3.6 MeV d+, 70 ^.A, for producing exclusively 
oxygen-15 via the '''N(d,n)'50 reaction on nitrogen gas 
— Tandem cascade accelerator, 3.7 MeV p- or d-, 1 mA, for producing oxygen-15 via the 
i''N(d,n)i50 reaction and fluorine-18 via the '80(p,n)i8F reaction 
— 3He Radiofrequency quadrupole accelerator, 8 MeV 3He, 15 mA, for producing 
nitrogen-13 via i2C(3He,d)i3N, oxygen-15 via i60(3He,a )i50 and fluorine-18 via 
i60(3He,p)i8F reactions 
In principle all three concepts appear to be promising, although the use of the helium-3 
beam may be associated with more difficulties. In practice, however, only technology that 
withstands the stringent test of reliability and simphcity will be acceptable, especially in a 
hospital environment. 
We consider the production of the two major PET radioisotopes oxygen-15 and 
fluorine-18 at a low energy accelerator in more detail (cf. Qaim, 1992). The excitation 
functions of the commonly used reactions, i ' 'N(d,n)i50 and '80(p,n)'8F, are shown in 
Figure 9 (reproduced from Vera'Ruiz and Wolf, 1977; Ruth and Wolf, 1979; Sajjad et o/., 
1984, 1985). A calculation of the integral oxygen-15 yield for an 'on-gas' deuteron energy 
of 3.2 MeV leads to a value of 222 MBq/^iA, (6 mCi/p-A) which is 6.7% of the yield with 
10 MeV deuterons. Evidently, to obtain an initial oxygen-15 activity of about 11 GBq 
(300 mCi), a beam current of about 50 \iA on the nitrogen gas target is mandatory. This is 
achievable with the present day technology; indeed the routine production of oxygen-15 
with a smaU accelerator has now been demonstrated at Hammersmith Hospital. In the case of 
fluorine-18, on the other hand, the integral yield at Ep = 3.7 MeV amounts to 33 MBq/|iAh 
(0.9 mCi/|xAh) and corresponds to only 1.15% of the yield at 15 MeV. Beam currents of 
about 500 \iA are needed to obtain a batch of about 10 GBq (270 mCi) of fluorine-18. The 
producUon of intense beams is not a great problem; however, the construction of a target 
system capable of withstanding such intense beams involves a new dimension in targetry. A 
thin film of i^O-enriched water cooled at the back by liquid nitrogen, as suggested in one 
concept, may be promising but practical utility and cost-effective economics have yet to be 
demonstrated. 
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Figure 9. Production limits for fluorine-18 and oxygen-15 at low energy accelerators. 
4. Less Commonly used Positron-Emitters 
The less commonly used positron-emitters for PET studies include potassium-38, 
selenium-73, bromine-75 and bromine-76. Furthermore, the positron-emitters, 
phosphorous-30, manganese-52'", iron-52, copper-64, krypton-77, rubidium-81 and 
rubidium-82'" have also found limited apphcations. Rubidium-82'" (r 1,2 = 6.2 h) may be of 
special interest as a longer-lived substitute for generator-produced rubidium-82 
{ti/2 = 1.3 min), although the radiation dose is somewhat high (see Kovics ei al., 1991). In 
this section we limit ourselves to a description of the production methods of the first four of 
the aforementioned positron-emitters (Table 1). 
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4.1. POTASSIUM-38 
Potassium-38 (0/2 = 7.6 min; IB+ = 100%; E B + = 2.7 MeV) has found application in 
myocardial blood flow studies using PET, although three other competing agents, 
[i3N]ammonia, [i^OJwater and 82R5+^ are more widely used because they are easier to 
produce with low energy cyclotrons or via a generator system. Among the various methods 
suggested for the production of potassium-38 (Meyers, 1973; Lambrecht et al., 1978b; Helus 
et al., 1980; Tilbury et al., 1980; Vandecasteele et al., 1981; Yagi and Amano, 1981; Daube 
and Nickles, 1985; Guillaume etal., 1988; Qaim et al., 1988; Blessing and Qaim, 1990) the 
35Cl(a,n)-process at a medium energy cyclotron is most convenient, the optimal energy 
range being (£„ = 2 2 ^ 7 MeV). Irradiation of a sodium chloride pellet with a-particles at 
beam currents of about 10 | i A leads to sufficient quantities (500 MBq; 14 mCi) for one 
patient study. The irradiated pellet has simply to be dissolved in water and, after sterile 
filtrauon, is ready for human application. The level of long-lived radioactive impurities like 
sodium-22 (ti,2 = 2.6 a) is very small (< 10-4%). 
In an attempt to produce potassium-38 at a small cyclotron, T^rkdnyi et al. (1992) 
recenfly invesUgated the 38Ar(p,n)-process using 95.7% enriched gas as target material. 
Determination of the excitation function and the measurement of production yields under 
high current irradiation condifions revealed that, in die optimal energy range of Ep = 16^12 
MeV, the yield from this reaction is an order of magnitude higher than that from the 
35Cl(a,n)38K process. The 38Ar(p,n)-process, however, has two drawbacks. Firstly, the highly 
enriched argon-38 is expensive (one target fill is approximately US $10,000) and secondly, 
the recovery of argon-38 is more problematic as compared to krypton-82 or xenon-124 
(used for producing of ^iRb/^imKr generators and i23i, respectively). 
4.2. SELENIUM-73 
Selenium-73 (r y/2 = 7.1 h; Ip+ = 65%; Ep+ = 1.32 MeV) is a potentially interesting sulphur 
analogue for applicafion in PET. It can be produced via several nuclear processes 
(Guillaume etal., 1978; Nozaki etal., 1979; Mushtaq a/., 1988; Mushtaq and Qaim, 1990: 
Plenevaux etal., 1990). Detailed comparative studies (Mushtaq et al., 1988; Mushtaq and 
Qaim, 1990) have, however, revealed that only the ''5As(p,3n)73Se and 70Ge(a,n)73Se reactions 
(the latter using highly enriched target material) are of practical interest. In the latter case a 
CUT^KJC alloy was developed for irradiations with internal beams of 28 MeV a-panicles and 
selenium-73 was separated by thermo-chromatography (Blessing et al., 1992). However, the 
need for very high beam currents, the necessity of recovering the expensive target material, 
and the low batch yield of selenium-73 make this process rather unattractive. The method of 
choice is therefore the •'5As(p,3n)73Se process. 
The excitation functions of''5As(p,xn)72.73,75Se reactions are shown in Figure 10 (o'-
Mushtaq et al., 1988). EvidenUy the energy range Ep = 40->30 MeV is optimal for the 
production of selenium-73. The expected thick target yield of selenium-73 over this energy 
range is 1406 MBq/| iAh (38 mCi/^iAh) and the level of selenium-72/75 impurities < 0.1%. 
The major drawback of the process is the requirement of relatively high energy protons. 
Only low current target materials like arsenic(III) oxide have been used so far for 
producing selenium-73 via the •'5As(p,3n)-process (Mushtaq et al., 1988; Plenevaux et al.. 
1990). The radioselenium is either separated by anion exchange chromatography or 
extracted directly into benzene. In the latter case the radioselenium is presumably in the 
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Figure 10. Excitation functions of 75As(p,xn)72.73,75Se reactions. The optimal energy range 
for the production of selenium-73 is Ep = 40->30 MeV (after Mushtaq et al, 1988). 
elemental form and is very suitable for subsequent labelling work (Plenevaux et ai, 1990). 
Attempts to produce large quantities of selenium-73 via development of high current target 
materials and efficient chemical separation methods are presenUy underway in several 
laboratories. 
4.3. BROMINE-75 
Bromine-75 {tja = 1.6 h; Ip+ = 75.5%; Ep-i- = 1.74 MeV) is the most useful radionuclide of 
bromine for PET studies. For its production several nuclear reactions have been suggested 
(for reviews see Qaim and Stocklin, 1983; Qaim, 1986b), out of which two processes, namely 
75As(3He,3n)75Br and 76Se(p,2n)75Br, have proved to be most suitable. The thick target yields 
of bromine-75 expected from those reactions are given in Figure 11 as a function of incident 
particle energy. The major impurity associated with both the processes is bromine-76; its 
contributions under the optimal energy ranges are also given in Figure 11. Evidently, the 
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•'6Se(p,2n)75Br reaction is more advantageous provided that Ep > 25 MeV and highly 
enriched target material are used. The 75As(3He,3n)''5Br reaction, on the other hand, makes 
use of natural arsenic. In both the cases solid targets are used. 
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Figure 11. Thick target yields of bromine-75 calculated from the excitation functions (after 
Qaim et al., 1986b). 
In the case of 76Se(p,2n)75Br process, a few selenides (like Ag2Se and Cu2Se) were 
found to be suitable for irradiations with beam currents < 7 M.A (Paans et al., 1980; Vaalburg 
et al., 1985). In another approach an external rotating target system was developed (Kov^cs 
et al., 1985) where it is possible to irradiate low melting elemental selenium-76 with proton 
beam currents up to 20 |xA. The loss of selenium-76 after a 1 h irradiation amounts to < 1%. 
The separation of radiobromine from irradiated selenium-76 is effected by 
thermo-chromatography at 300OC. Radiobromine is taken up in a small volume of hoi 
water. The loss of selenium-76 during the process is about 1% and the target can be reused. 
The radiochemical yield of bromine-75, however, is only 40%. Due to this reason the 
process has not found wide application. 
The more widely used method for the production of bromine-75 is the 
''5As(3He,3n)-reaction. A Cu3As-alloy layer on a copper-backing is inradiated in the internal 
target system of a compact cyclotron with 36 MeV 3He-particles at beam currents of about 
100 | iA (Blessing et al., 1982; Blessing and Qaim, 1984). A sketch of the system is shown in 
Figure 12. The beam falls at an angle of 6.2° and only the back of the target holder is 
cooled. Radiobromine is separated from the irradiated target material via 
thermo-chromatography (at 950^0) and is taken up in 1 mL of hot water {cf. Blessing et ai. 
1982). The radiochemical yield of bromine-75 is > 90%. Radiochromatographic analysis 
shows that bromine-75 is present only as [75Br]bromide. The batch yield of bromine-75 is 
about 7 GBq (190 mCi). The main disadvantage of the process is the rather high level of 
bromine-76 impurity (6-8% at EOB). 
Thermocouple vol tage 
Torget tiolder 
67° ^ 
Bom angle 
Cu; As-a l loy loyer (-.lOiim) 
Cavity for thermoelement 
Cu-bocking (wedged) 
Beam current 
Figure 12. Sketch of the target and target holder used for irradiation with internal beams. 
The target consists of a thin layer of CusAs-alloy on a wedged copper backing. A 
thermoelement in a cavity in the middle of the target allows the adjustment of the beam (after 
Blessing and Qaim, 1984). 
4.4. BROMINE-76 
Bromine-76 {tia = 16.1 h; I 3 + = 57%; Ep-i- = 3.9 MeV) has found very limited application 
because it causes a relatively high radiation dose. Nevertheless, this radioisotope seems to be 
suitable for longer-lasting PET studies, especially on animals (for a review see Mazidre and 
Loc'h, 1986). Its production methods have been reviewed (Qaim, 1986b). The 
75As(3He,2n)76Br, ''6Se(p,n)76Br and ''7Se(p,2n)''6Br processes have been suggested, although 
the latter two methods have not been used practically, mainly due to the difficulty in targetry 
with highly enriched selenium-76 and selenium-77. The method of choice is the 
''5As(3He,2n)76Br reaction over the energy range of E3He = 18->10 MeV, although the yield 
is low. The production procedure for bromine-76 is the same as for bromine-75 (except for 
change in the energy range), and quantities up to 1 GBq (27 mCi) have been produced. 
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Somewhat lesser quanfities have been produced via irradiation of elemental arsenic at 
medium currents, followed by separaUon of radiobromine via a wet chemical method 
(Mazi^re and Loc'h, 1986). The major impurity is bromine-77 (r 1,2 = 56 h) at a level of 
< 2 % . 
5. Generator-produced Positron-emitters 
Several generator produced short-lived positron-emitters find application in PET studies at 
centres without a cyclotron. Their production methods have been reviewed (Lambrechi, 
1983; Knapp and Butler, 1984; Qark, 1986; GuiUaume and Brihaye, 1986; Qaim, 1987). Of 
aU the systems suggested the 62Zn(62Cu), 68Ge(68Ga) and 82Sr(82Rb) systems are widely used. 
The decay characteristics of the six radionuclides concerned are summarised in Table 1. 
Considerable effort has been devoted in recent years to the investigation of chemical aspects 
of generator preparafion. Based on ion-exchange chromatography a large number of 
generators have been developed for each system. A consideration of all those generators is 
beyond the scope of this chapter. Here the discussion wil l be limited to the production of the 
three parent radionuclides concerned. 
5.1. ZINC-62 
Copper-62 (r j/2 = 9.7 min; \ ^ = 98%; Ep-i- = 2.93 MeV) has found application in blood flow 
studies in heart and brain using PET (Green et ai, 1990), especially in chelated form. The 
parent zinc-62 (tnz = 9.2 h) is generally produced via the 63Cu(p,2n)-process at a 
medium-sized cyclotron (see Robinson, 1976; Robinson et al., 1980; Fujibayashi et al.. 
1989; Green et al., 1990). The optimal energy range for production is Ep = 26->21 MeV. 
A copper disc or copper-electroplated aluminium sheet is irradiated with protons at high 
beam currents. After the decay of short-lived radionuclides, copper is dissolved in 
hydrochloric acid and the solution transferred to an anion-exchange resin column (AG 1X8. 
100-200 mesh, CI- form). Copper is eluted with 3M-hydrochloric acid, followed by zinc-62 
with distilled water. The product is of high radionuclidic purity. The copper concentration 
in the zinc-62 eluate is < 2 p.g/mL (Fujibayashi et al., 1989). The eluate is generally 
evaporated to dryness and the'residue containing zinc-62 is dissolved in 2M-hydrochloric 
acid. This solufion is then loaded onto an anion-exchange generator column for periodic 
'milking o f f ' of the copper-62. 
The 63Cu(p,2n)62Zn reaction is a high yield process and 15 GBq (400 mCi) quantities 
of zinc-62 are easily produced (Green et al., 1990). The 60Ni (a,2n)62Zn (Neirinckx, 1977) 
and 64Zn(Y,2n)62Zn (Yagi and Kondo, 1979) processes give relatively low yields and have 
therefore not been used for routine production of zinc-62. A direct production route for 
copper-62 via the 62Ni(p,n)-reaction has also been suggested (Piel et al., 1992). However, i; 
could be of only limited application. 
5.2. GERMANIUM-68 
GalIium-68 (O/2 = 68.3 min; Ip+ = 90%; Ep+ - 1.9 MeV) is applied for measuring 
blood-brain barrier integrity as well as for tumour localisation. Furthemiore, it is widely usee 
for the attenuation correction of positron tomographs. The parent germanium-68 (/ m -
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271 d) is long-lived and rather difficult to produce. The 69Ga(p,2n)68Ge reaction has a high 
cross section but due to the long half-life of the product radioisotope the yield is low (Pao et 
al., 1981; Loc'h et al., 1982). Although a high current Ga4Ni target capable of withstanding 
proton beams of up to 45 \iA was developed (Loc'h et al., 1982), the method has not found 
wide applicaUon due to the very long irradiation times needed. The method of choice is thus 
the spallafion process. This radionuclide is therefore exclusively produced at large 
accelerators where long irradiations in parasitic positions are possible (see Grant et al., 1982; 
Robertson et al., 1982). The purification of the product involves several multi-step wet 
chemical processes. The main impurity is germanium-71 (tji2 = 11.2 d) at a level of 3% at 
60 d after EOB. 
5.3. STRONTIUM-82 
Rubidium-82 (tj,2 = 1.3 min; Ip+ = 96%; Ep+ = 3.35 MeV) is mainly used for myocardial 
blood flow studies and has found rather wide application. The production methods for the 
parent stromium-82 (tj/2 = 25 d) have been reviewed (Waters and Coursey, 1987; Tlrk^nyi et 
al., 1988, 1990). In principle several processes can be used, for example helium-3- and 
a-particle-induced reactions on natural krypton (TSrkSnyi et al., 1988, 1990), (p,4n) 
reacUon on rubidium-85 (Horiguchi et al., 1980; Mausner et al., 1987; Husz^r et al., 1989) 
and, above all, the spallation of molybdenum with high energy protons. In practice, however, 
the spallation process is the method of choice. The yields in 3He- and a-particle-induced 
reacfions are low and very long irradiations are needed. The (p,4n) reaction is a high yield 
process but targetry is rather difficult. The major quantities of strontium-82 are therefore 
presently produced via spallation of molybdenum at high energy accelerators where, similar 
to germanium-68 production, long parasitic irradiations are possible (see Robertson et al., 
1982; Thomas, 1987). Product is purified via multi-step wet chemical separations. The main 
impurity is strontium-85 (tj,2 = 65 d) at a level of about 50% (EOS). On the other hand, the 
(p,4n) reaction has a great potential, both with regard to strontium-82 yield and strontium-85 
impurity. 
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RADIOCHEMISTRY AUTOMATION FOR PET 
Christian Crouzel, John C. Clark, Claude Brihaye, Bengt Langstrom, 
Christian Lemaire, Geerd J. Meyer, Bruno Nebeling and Sharon Stone-Elander 
ABSTRACT. Methodological approaches to automation for PET radiochemistry are discussed. Detailed 
examples of automation using i) simple remote control, ii) PLC-operated devices and iii) 
computer-controlled devices are described for the syntheses of "C- , '^O- and '^F-labelled 
radiopharmaceuticals. Approaches to robot-based automation are also discussed and exempUfied. 
1. Introduction 
PET requires compounds labelled with short-lived positron-emitting radioisotopes, such as 
oxygen-15, nitrogen-13, carbon-11 and fluorine-18 that have half-lives of 2, 10, 20 and 110 
minutes, respectively. In order to label the compounds, several steps must often be carried out, 
ranging from production of the radioisotof)e as a primary in-target precursor, sequentially 
through to synthesis of a secondary labelling agent by an on-line or batch procedure, 
radiolabelling, purification and quality control. This chapter aims to discuss the need to automate 
these processes and to describe the approaches and methodologies that have been applied. 
2. Why Automate? 
Only i f radiopharmaceutical production is safe, reliable and efficient can PET become a routine 
clinical tool. In radiopharmaceutical production the short half-lives of the radioisotopes render 
the total time taken by all the processes a fundamental consideration; it is therefore essential for 
all steps in each radiosynthesis to be as fast and efficient as possible. The short half-lives also 
mean that many radiosyntheses are required repetitively. These radio syntheses must be reliable 
and easily repeatable for the efficient use of costly PET facilities. Radiosyntheses must usually 
start from high initial radioactivity but must also be safe to personnel. Automation, within a 
shielded environment, is increasingly seen as a solution to these key logistical and safely 
requirements. Furthermore, it must be emphasised that each radiopharmaceutical batch must 
also meet appropriate quality assurance standards (see Meyer etal., this volume). Significantly, 
automation can also assist in establishing and complying with all aspects of necessary 'good 
manufacturing practice' (GMP). 
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3. What to Automate? 
In some cases it is preferable to have a simple remotely controlled system rather than a 
completely automated system, as for example when the radiosynthesis is not very often required 
or when the radiosynthesis is expected to undergo large modification to increase radiochemical 
yield. Put simply, full automation should only be applied to radiosyntheses that have reached an 
adequate degree of refinement and understanding. 
For these radiosyntheses all the following processes should be automated or at least 
remotely controlled: 
— Radionuclide production i.e. 
- positioning of the target-holder, target cooling and filling with target 
material. 
I I — Intermediate chemistry i.e. 
- production of precursor in-targel 
- production of a gaseous labelling agent 'on-line' or of a batch labelling agent. 
— Labelling chemistry 
— Radiopharmaceutical purification 
— Formulation and dispensing. 
The following may also be considered for automation: 
— Quality control 
— Metabolite analysis. 
What types of functions can be automated? In order to perform radiosyntheses, Uie 
control of reaction temperatures, reaction times, gas flows and pressures is especially important. 
Furthermore, the automation of all operations, such as radioactivity measurement, reagent 
additions and extractions, must be considered. These are all amenable to automation of various 
kinds. 
4. How to Automate? 
When the radiosynthesis of a certain radiopharmaceutical is selected for automation all tlie 
chemical procedures have to.be carefully defined with respect to reagents, catalysts, 
temperatures, feedback parameters, volumes, concentrations, materials and chemicals. This 
process should take into account the requirement for specific radioactivity. These are the 
chemical criteria. Two further requirements of automation are ease of operation and ease of 
maintenance. The setting up of an automated radiosynthesis for operation will involve cleaning 
and drying and also the changing of reagents, flasks and purification materials. It is particulariy 
important for the system to be easily maintainable to allow a repeat radiosynthesis after a 
relatively short period. 
The process of automation starts by selecting the types of woricstation required and their 
combination. There are four main approaches to automation: 
— Remote-control, which may be at various levels of sophistication 
— Progranunable logic control (PLC) with timed steps, pertiaps with feedback control 
— Computer-aided automation 
— Robotics. 
In order to automate, means must be found to measure and control temperatures, to measure 
radioactivity, to dispense solvents, reagents and to perfonm purifications, whether by extraction 
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(liquid-liquid, liquid-membrane or solid phase), selective affinity adsorption or chromatography, 
(such as HPLC). Furthermore, the materials constituting reactors or reaction flasks must be 
selected taking into account that most radiosyntheses need to be performed with large amounts of 
radioactivity at high specific radioactivity. Therefore, in any automation, attention must 
especially focus on: 
— Materials in reactors, reaction flasks, tubings, transducers and valves 
— Temperature controllers and regulators for reactors, reaction flasks and ovens 
— Flow rate controllers and regulators 
— Transducers 
— Heaters, whether band heaters, heating wires, cartridge heaters (for use in block 
heaters), heating baths or air heaters (heat guns) 
— Dispensing systems for reactors (reaction flasks) 
— Extraction hardware (for solid-phase, liquid-liquid, liquid-membrane or 
gas-membrane extraction) 
— Radioactivity detectors. 
Specific radiosyntheses, which have been automated by the various non-robotic approaches 
mentioned above, will be presented. These wiU give an insight into the solutions that have been 
found to particular automation problems. This is followed by a general discussion of the robotic 
approach to automation, with a specific example of a multi-step syndiesis. Finally, appendices 
deal with practical aspects of radioactivity detection (Appendix 1), valve selection (Appendix 2) 
and sources of glassy carbon reaction vessels (Appendix 3). 
5. Examples of Remotely Controlled and Automated Radiosyntheses 
5.1. THE REMOTE PRODUCTION OF [1-iiC]ACETATE (AS AT HANNOVER) 
[1-"C] Acetate is prepared by carboxylation of a Grignard reagent (methylmagnesium bromide) 
with cyclotron-produced [HCJcarbon dioxide (Pike et ai, 1982, 1984; Brown ei ai. 1987; Walsh 
et al., 1989; Westera, 1991; Meyer etal., 1993). In order to set up [l-i'C]acetate production for 
routine clinical application in heart studies (Pike et al., 1982, 1984; Buxton et al., 1988, 1989; 
Walsh et a/., 1989; Kotzerke et al., 1990), a system must be developed which allows repeated 
synthesis by an easy and remote assenibly. The main obstacle to complete automation in the 
early published procedures (e.g. Pike et al., 1982, 1984) is the liquid extraction step that is used 
to separate [l-^C]acetate from inorganic salts arising from the Grignard reagent. The 
modification described here is installed at Hannover and avoids this liquid extraction step. It was 
therefore easy to automate. 
5.1.1. Precursor handling. After irradiation of nitrogen with protons the target gas is released 
into a vacuum system, and [HCJcarbon dioxide is collected from the target gas in a trap Uiat is 
cooled in liquid nitrogen. ['iCJCarbon dioxide is then distilled into a special glass vessel, to 
which methylmagnesium bromide (0.1 mmol) in diethyl ether (1 mL) is added. 
5.1.2. Synthetic procedure. The reaction vessel is connected to the synthesis apparatus shown in 
Figure 1. When in place the reaction mixture is warmed to 3CMCPC for 5 min with a remotely 
controlled hot-air gun. The radioactive adduct is then hydrolysed by adding water (100 p-L) from 
a pressure-driven dispenser. Organic solvents and decomposition products are removed by 
48 
» 
Mv 8 mv 7 MV 9 
MV 4 
Vakuum 
(MV 10 ) 
Dionex 
AG 5 0 V - X 8 
1 0 0 - 2 0 0 SL<)X 
H o l - A i r - G u n 
Stenlf i l ter 
S&S 
^ Sterilfi lter 
Braun 
H e l i u m 
Figure 1. Apparatus for the production of [l-iiC]acetate (as at Hannover). MV signifies a 
solenoid valve. 
warming the reaction mixture to 120OC under vacuum. The dry residue is redissolved in dilute 
phosphoric acid, added from another dispenser. Any free [I'CJcarbon dioxide is then removed 
with a stream of helium and by wanning to 60OC for 3 min. [ l-"C]Acetic acid, in dilute 
phosphoric acid, is then withdrawn from the reaction vessel into a motor-driven disposable 
syringe. Bromide and Mg2+ ions are removed from the product mixture by passage through a 
cartridge of silver oxide and cation exchange resin. Washing the purification line with water is 
performed to improve the radiochemical yield. The solution of purified product is passed 
through a sterile 0.22 \im filter and enters a sterile vessel containing sufficient sodium hydroxide 
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to neutralise the phosphoric acid. The preparation takes 20 min from EOB. The overall 
radiochemical yield of [l-'iC]acetate is 60%. The radiochemical purity of (l-i'Cjacetate is 
found to be > 98% by HPLC. 
5.2. REMOTELY CONTROLLED SYNTHESIS WITH CARBON-11 (AS AT ORSAY) 
At Orsay remote-control is preferred to fuU automation for synthesis with carbon-11. This 
approach is used in several hot-cells and the main advantage is great flexibility. It can be used 
for many types of synthesis from different labefling agents, including ['iC]iodomethane, 
["dformaldehyde, [2-iiC]acetone and [l-iiC]acid chlorides. The system is based on the use of 
smaU pneumaticaUy-powered jacks to move reaction flasks in two dimensions, horizontal and 
vertical. The jacks are controlled by the operator from a panel located on the front of the 
hot-ceU. The different vials are connected by catheters and can be isolated by remotely operated 
valves. 
5.2.1. [i'C]Carbon dioxide production. ["ClCarbon dioxide is produced by the i' 'N(p,a)"C 
reaction on nitrogen (99.9999% purity) and collected in a stainless steel trap immersed in liquid 
argon. The end of trapping is read from an ionisation chamber. The valves and the cryotrap 
movements are controlled by the operator. 
5.2.2. Production of labelling agents. The synthesis of ["Cliodomelhane is based on the 
classical method (Comar ef a/., 1974; Lingstrdm and Lundqvist, 1976), as recommended by 
Crouzel et al. (1987). A two-pot synthesis is used. The syntheses of ["C]formaldehyde, 
[2-i'C)acetone and [ l-"C]acid chlorides are based on the methods of Marazano et al. (1977), 
Berger et al. (1980) and Luthra et al. (1985, 1990), respectively. Hearing, cooling and 
valve-switching are controlled by the operator. 
5.2.3. Labelling. The labelling agent is distilled into the cold precursor solution with a flow of 
nitrogen. Maximal transfer of radioactivity is read from an ionisation chamber. For the labelling 
reaction, the vial is isolated by remotely controlled valves. Al l stages are controlled by the 
operator. 
5.2.4. HPLC purification. The radiopharmaceutical is purified by HPLC. The loop of the 
injector is filled via a dip-tube from the diluted reaction mixture by applying gas overpressure 
within the reacfion flask. The HPLC eluate containing the labelled product is identified by the 
operator by monitoring radioactivity and UV absorbance. The labelled product is collected in a 
flask by manual and remote switching of the fraction collect/waste valve and then heated to 
evaporate solvent. 
5.2.5. Components of the system. Al l the used components are commercially available. The 
whole unit consists of five sub-units: 
— Heating unit: 4 furnaces with fingers resistances (50-25(PC) 
— Power units and numerical temperature regulators (3 each, all ex Vulcanic Co.). 
— Pneumatic unit: 7 jacks (6 for vertical displacement, 1 for horizontal 
displacement) operated by 7 electro-pneumatic units {ex Td6m6canique Co.). 
— Chemistry unit: 2 mL Reacti-vials™ each with a Teflon™-faced silicon septum 
(3 mm thick) retained by a Quickfit™ cap. The needles are by Becton 
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Dickinson. The 7 valves with pneumatic actuator are by Rheodyne. They are 
conUolled by 4 electro-pneumatic units. Gas flows are measured by flow meters 
(Brooks). Radioactivities are monitored by ionisation chambers from Service 
Development Scientifique (SDS). 
— HPLC unit: injection into the HPLC loop is carried out by pressure through a 
Rheodyne™ valve operated by an electro-pneumatic unit. The HPLC 
detectors are an ionisation chamber (SDS) for radioactivity and a UV 
absorbance detector for mass. After evaporation of the solvent, the 
radiopharmaceutical is dissolved in a physiologically acceptable medium 
(2-3 mL). This is then transferred into a small evacuated sterile vial using a 
recovery vial penetrator. 
5.2.6. Performance of the system. The system is used for the routine production of 
[S-zwer/zy-iiOmethionine {Corner et al., 1976). [N-methyl-^^C]UQm (Mazi^re etal., 1982), 
[A^-m^^Z-UClflumazenil (Mazidre etal., 1984) and [N-methyl-'^^CyPK 11195 (Camsonne et al., 
1984) from [iiC]iodomethane, and several other labelled compounds from other precursors in 
noh-roufine production. 3.7-7.4 GBq (l(X)-200 mCi) of each radiopharmaceutical is produced 
with a specific radioactivity of about 37 GBq/pjnol (1 Ci/p.mol) at EOS. 
5.3. AUTOMATION OF HC-METHYLATIONS USING A PLC (AS AT HAMMERSMITH 
HOSPITAL) 
Many I'C-labelled compounds of great interest to PET clinical science have now been prepared 
by the methylafion of suitable precursors using ["CJiodometfiane and the number continues to 
grow. At Hammersmith Hospital, in order to respond to the varied needs of a busy clinical 
research programme, a hot-ceU has been successfully equipped with a I'C-methylation facility 
that can be quickly set up and operated to produce radiopharmaceutical batches for clinical use. 
The sequence of operations that is needed to achieve each radiosynthesis is controlled in timed 
steps by a Programmable Logic Controller (PLC). This incorporates a 'plug-in' module that can 
be programmed to suit each individual radiosynthesis (Clark and Dowsett, 1992). 
5 .3 .1 . ['iC]Carbon dioxide production. [nCJCarbon dioxide is produced by the proton 
irradiation of high purity nitrogen gas via the i4N(p,a)iiC reaction. For labelling operations it is 
advantageous to concentrate the [HCJcarbon dioxide into a few millilitres from a volume of 
several litres of target gas. An automated cryotrap fabricated from a small coil of stainless steel 
tubing (20 cm X 1/16" o.d.) cooled in liquid argon is used. The use of liquid argon avoids the 
problematical co-trapping of significant volumes of nitrogen which occurs if liquid nitrogen is 
used as the coolant. The valves and cryotrap movement are controlled by the PLC's programme. 
5.3.2. Production of ["CJiodomethane. The synthesis of [iiC]iodomethane using the reaction of 
["C]carbon dioxide with lithium aluminium hydride (LAH) and subsequent reaction with 
hydriodic acid is now widely applied (for a review see Crouzel et al., 1987). The major problem 
in this radiosynthesis is maintenance of the high specific radioactivity required for "C-labelled 
receptor ligands. This can principally be achieved by the use of high quality LAH in small 
quantities under carefully controlled carbon dioxide-free atmospheres and by working quickly 
(for a review see Crouzel et al., 1987). The heating, cooling and sequencing of the valves for 
[iiC]iodomethane production are controlled by PLC programme. 
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5.3.3. "C-Methylation of precursor. The conditions under which the precursor is methylated 
depend critically on the class of compound of interest and the subsequent work-up and 
purification procedures. An automated reaction vial penetrator is used (see Figure 2). This 
device allows the relevant precursor to be introduced together with the reaction solvent and base 
in a septum-sealed vial. ["Cjlodomethane can then be disfilled into the precursor solution via a 
round-tipped side-hole needle, which can be motor-driven through the septum under programme 
control. The needles can then be withdrawn and the vial lowered into the heating bath. The 
"C-methylafion takes place for a pre-programmed time. The reaction mixture is extracted by 
re-inserting the needles and transferred to the loop of an HPLC injection valve. Again this 
sequence of events is controlled by the PLC. 
5.3.4. HPLC purification. For some compounds, where the base and/or solvent are detrimental 
to the perfonmance of the HPLC, sample-enrichment can be included in the programme of 
operauons (see Figure 2). Here an injection loop (10 mL) is loaded with an aqueous wash of the 
reaction vial and the contents of this loop are then loaded onto a silica C-18 cartridge. This 
cartridge is washed with water and then back-eluted onto the main silica C-18 column for 
purificafion using the chosen eluent. The PLC controls the sequence of operations for the 
muUi-port valves necessary to accompUsh diese steps. The HPLC eluate that contains the 
labelled product is identified by the operator by monitoring radioactivity and UV absorbance, and 
collected in the flask of a rotary evaporator by manual remote operation of the fraction 
collect/waste valve (see Figure 2). 
5.3.5. Product formulation. Solvent is removed from the product by evaporation under reduced 
pressure using a micro-rotary evaporator, modified to allow it to be raised or lowered under the 
control of the PLC. Finally, under programme control, the formulation solvent is introduced into 
the flask and the resultant radioactive solution transferred via a millipore filter into a shielded 
shipping vial outside the hot-cell. 
5.3.6. Components of the system. Wherever possible commercial components are used with little 
or no modification. A Toshiba EX40 industrial programmable logic controller, which uses 
ladder logic was chosen. The programme infonmafion is stored on a plug in Electronically 
Erasable Programmable Read Only Memory (EEPROM) module which can be interchanged 
readily. The controller contains relays that are suitable for low power (100-240 V a.c; 2 A) and 
low voltage (24 V d.c; 2 A) operaUons. Most of the valves and motorised drives are controlled 
direcfly oy these relay outputs. The 240 V operated devices, such as heaters and pumps, are 
operated via isolating solid state relays. The two- and three-port Teflon™ diaphragm valves for 
liquid and vapour handling are by Angar Scientific [part nos 3682NC2430 and 368232430 for 24 
V and up to 2 bar (30 psi) operation]. They have 1/4" x 28 threads in flat-bonomed ports suitable 
for use with low pressure chromatography fittings (e.g. 'Altex™', 'Omnifit™'). For gas handling 
the two- and three-port stainless steel valves are by Skinner [Honeywell Lucifer, part nos B2 RX 
127 DC-2 and B14 DK 1075 DC-2 operated at 24 V for pressures up to 12 bar (330 psi) and 
5.3 bar (80 psi), respectively]. The mulfi-port rotary valves are by Rheodyne. The low pressure 
Teflon™/Kel-F™ valve with 1/4" X 28 fitungs is a six-port distribuuon valve with pneumatic 
actuator (part no 501 IP). The HPLC valves are also by Rheodyne and are 
pneumaficaUy-actuated stainless steel and Vespel™ (Dupont polyimide) rotary valves (part no 
7010P). The rotary evaporator is a UV Micro (Heidolph) and has been modified to be raised and 
lowered pneumatically. The reaction vial for meUiylafion is a Reacti-vial™ (Pierce, 1 mL) witti a 
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Teflon™-faced silicon septum 3 mm thick retained by a Quickfit™ (Coming) SQ 13 cap. The 
penetration needles are by Hamilton with rounded tips and side holes (part no 1(X).090.218). The 
syringe drives and septum penetrator drives are of ' in house' design and manufacture and are 
'screw and nut' devices driven by electric motor. The HPLC detectors are by Mini Instruments 
for radioactivity detection (model 7-lOC with a MClO G-M tube) and by Severn Analytical for 
UV absorbance detection (model SA 6506). 
5.3.7. Performance of the system. The system has been used roufinely (see Pike et al., 1990) to 
produce clinical batches of 5-[A^-/ner/jy/-iiC]nomifensine (Ulin et al., 1989) and 
[0-me%/-iiC]raclopride (Ehrin et al., 1987). It was also set up to make [A'-/ner/2>'/-"iC]SCH 
23990 (HaUdin et al., 1986) for a short period. The producfion of [0-mer/jy/-"C]raclopride in 
particular benefitted from the sample-enrichment facility. The production parameters for diese 
radiosyntheses are listed below. 
a. S-fN-methyl-'iC I Nomifensine. 
[iiC]lodomethane is trapped in a solution of desmethyl-S-nom'iiens'me (5 mg) in ethanol 
(400 | iL ) . Then the reaction pot is sealed and heated at 90^0 for 5 min. The reaction mixture is 
purified by HPLC on a fi-Porasil™ column (30 X 0.8 cm i.d.; Waters Associates Inc.) eluted with 
chloroform-methanol (90:10 v/v) at a flow rate of 3 mL/min. The product is formulated in 
isotonic sahne which is sterilised by miUipore filtration. A decay-corrected radiochemical yield 
of 23% from [ i iCJiodomethane provides 370-555 MBq (10-15 mCi) of 
S-[N-methyl-i^C]mtnifcnsine ready for injection with a specific radioactivity of 15 GBq/pmol 
(405 mCi/pmol at EOS). 
b. [0-me\hy\-"CIRaclopride. 
["C]Iodomethane is trapped in DMSO (400 pL) containing desmethyl-Taclopnde (2 mg) and 
sodium hydroxide solution (5M; 10 pL). The reaction pot is sealed and heated at 90OC for 5 min. 
The reacfion mixture is purified by sample enrichment followed by reverse phase HPLC using a 
p-Bondapak™ C-18 column (30 X 0.8 cm i.d.; Waters Associates Inc.) eluted with 
methanol-lOmM ammonium dihydrogen phosphate solution (60:40 v/v) at 3 mL/min. The 
product is formulated in isotonic saline which is sterilised by millipore filtration. A 
decay-corrected radiochemical yield of 25% from [iiC]iodomethane provides 370-555 MBq 
(10-15 mCi) of [0-methyl-^^C]Taclopn6e: ready for injection with a specific radioactivity of 
10 GBq/pmol (370 mCi/pmol at EOS). 
c. p<l-me\hy\-iiC]SCH 23390. 
[iiC]Iodomethane is trapped in acetone (900 pL) containing desmethyl-SCH 23390 (1 mg). The 
reacfion pot is sealed and heated at 9(PC for 10 min. The acetone is then evaporated o f f The 
reaction mixture is purified by HPLC on p-Porasil™ column (30 X 0.8 cm i.d.; Waters Associates 
Inc.) eluted with chloroform-methanol-a<7. ammonia (90:1:0.1 by vol.) at 3 mL/min. The product 
is formulated in isotonic saline which is sterilised by millipore filtration. A decay-corrected 
radiochemical yield of 40% from [HCJiodomethane provides 0.37-1.11 GBq (10-30 mCi) of 
[N-methyl-^^C]SCH 23390 ready for injection. 
Subsequently a second hot-cell has been equipped with a very similar system to extend 
the range of roufinely available "C-labelled compounds within each working day, for example, 
to [N-methyl-iiC]PK 11195 (Camsonne et al., 1984; Cremer et al., 1992), 
[A'-mef/2>'/-i'C]flumazenil (MaziSre etal., 1984) and L-LA^-wef/iyZ-i'Cjdeprenyl (Fowler ei 
al.,mi). 
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Figure 2. Scheme of PLC-controUed apparatus for labelling radiopharmaceuticals by 
methylation with [i'C]iodomethane (as at Hammersmith Hospital). 
54 . ON-LINE PREPARATION OF ["CjlODOMETHANE AND [HCJMETHYL TRD^ATE 
(AS AT KFA JULICH). 
5.4.1. Introduction. The reliable preparation of [•iC]iodomethane with high specific 
radioacfivity and with a significantly reduced requirement for maintenance of the synthesis unit, 
by avoiding concentrated hydroidic acid as an iodination agent, are major objecfives in the 
construcfion of a general methylation unit. A very important improvement in the synthesis of 
[iiC]iodomethane is the use of a column of triphenyphosphine di-iodide adsorbed on y-alumina 
as the iodinafion agent (see Holschbach and Schiiller, 1993a). An additional on-line column 
technique, the passage of [nCjiodomethane through an alumina column which is charged with 
silver triflate, gives n.c.a. ["Cjmethyl triflate as a highly reactive methylation agent (see 
Holschbach and Schuller, 1993b). Based on these column techniques, a fully automated unit for 
methylations with [iiC]iodomethane or ["Cjmethyl triflate, incorporating feedback control and 
radiochromatography, has been developed in compliance with GMP. The set-up of the system is 
shown in Figure 3. 
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Figure 3. Scheme of the automated on-line preparafion of ["C]iodomethane and ["C]melhyl 
triflate (as at KFA Juhch). 
5.4.2. System operation. The proton-irradiated nitrogen target gas (see Qaim et al., this volume) 
is passed through a capillary tube at -1930C to -1850C, where the [nC]carbon dioxide is trapped. 
The trap is temperature controlled from -1960C to 200OC. The [HCJcarbon dioxide is then 
transferred by a flow of helium into reacfion vessel 1 and reduced by Uthium aluminum hydride. 
Subsequent addition of a mixture of diethyleneglycol monobutyl ether and water releases 
[I'Cjmethanol, which is then converted into [iiC]iodomethane or into [I'CJmethyl triflate by a 
column technique, as described above. I'C-Methylafion is performed in reaction vessel 2 by 
transferring the methylating agent into the precursor solution. Both vessels are temperature 
controlled from -196^0 to 200<^C. Also both reacfion vessels have pneumatic drives to move the 
PEEK™ tubings in the vessels. 
5.4.3. System performance. The preparation of ["Cjiodomethane takes 12 min from the end of 
bombardment and has a radiochemical yield of 90% based on ["CJcarbon dioxide. The mean 
specific radioacfivity of the [HCJiodomethane is > 222 GBq/pmol (6 Ci/pmol). HPLC 
purificafion of labelled products is perfonmed on-Une, including formulation to give an injectable 
solution. 
5.5. A N ADVANCED SYSTEM FOR THE ADMINISTRATION OF [150]WATER (AS AT 
HAMMERSMITH HOSPITAL) 
5.5.1. Introduction. The important blood flow tracer, ['^Ojwater, may be readily prepared by a 
variety of routes. However, several problems need to be addressed i f safe and effective 
injecfions or infusions are to be prepared. Of primary concern is that the product should be free 
from any harmful impurities, both chemical and radioacfive, and be sterile and apyrogenic. Due 
to the short half-life of oxygen-15, quality control of each sample or batch would be impractical. 
However, most groups carrying out work in this area have evolved safe operating procedures 
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(SOPs) which have been shown to be capable of maintaining the required standards (for 
recommendations on QA and QC see Meyer etal., this volume). The measurement and delivery 
of the prepared doses of ['50]water also requires careful attention both for the administrator and 
for the recipient. As a typical injected bolus of [i50]water would be 3-3.7 GBq (80-100 mCi) 
the radiation dose to the administrator is of great concern. Automated injectors and infusers are 
at advanced stage of development in several laboratories and the commercial exploitation of 
these devices is anficipated. 
5.5.2. Design and operation of ['^0]water infuser. Figure 4 schematically describes a 'bedside' 
[i50]water infuser (dubbed 'R2D2') recenfly developed at the MRC Cyclotron Unit 
(Hammersmith Hospital) (Clark and Tochon Danguy, 1992). ['50]Water is synthesised in the 
lead-shielded bedside device by mixing cyclotron-produced ['^OJoxygen (in 99% nitrogen-1% 
oxygen) with 5% hydrogen in nitrogen over a palladium catalyst in an oven at 200OC. The 
gaseous output is led to a semi-penmeable membrane interface (Visking-MediceU International, 
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Figure 4. Schematic representafion of the bedside [iSQjwater synthesis apparatus (as at 
Hammersmith Hospital). 
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U.K.) sandwiched between Perspex (DWG No 15) blocks. The other side of the interface is 
flushed with sterile saline. [i50]Water diffuses rapidly across the membrane and is taken up into 
the sterile saline. This is then infused into the subject for study via a shielded G-M tube and 
sterile millipore filter, using a pump (IVAC 560) approved for medical applicafion. The fluid 
handling valves, for control of the infusion parameters, are three-port membrane valves 
(Angar/Asco, 368, 24 V). 'On-line' radioacfivity detecfion is based on passing the radioacfiye. 
saline through a loop of Teflon™ tubing (1/16" o.d.) wound around the G-M tube (Philips 
ZP-1300). The counts are taken into a scaler-ratemeter (Mini Instmments 6-90) modified with 
adjustable pre-scaler to allow direct calibrafion as 'mCi infused'. This calibration is routinely 
checked against a standard ionisation chamber. Al l controls and power supplies are designed and 
built to comply with electromedical safety standards. Non-used product is allowed to decay 
within the unit before discharge into a sterile bag. The device is typically operated to give an 
infusion for 2 min at a flow rate of 10 mL/min. The amount of radioactivity infused is 
determined by the mode of operafion of the PET scaimer (CTl-Siemens Neuro-PET) and is 
typically 560 MBq (15 mCi) for 'septa out' and 3 GBq (80 mCi) for 'septa in' . 
5.5.3. Infuser maintenance. Pharmaceutical maintenance involves cleaning and sterilising the 
membrane exchanger prior to assembly and washing the fluid system with isotonic saline 
solution while the millipore filters are in place. Pyrogen tests (LAL) and steriUty tests are carried 
out to vaUdate the assembly techniques. Routine operation requires replacement of the 
disposable components, such as the pump tube, saline bag, millipore filters and infusion 
catheters, followed by pyrogen tests (LAL). 
5.6. A N ADVANCED SYSTEM FOR THE ADMINISTRATION OF [150]WATER (AS AT 
HANNOVER) 
5.6.1. Introduction. Depending upon the clinical question, [i50]water for blood flow studies 
may be administered by different protocols: 
— Bolus injecfion of up to 4 GBq (108 mCi) with strictly defined and repeatable input 
function. 
— Steady state infusion in the range of 50-300 MBq/min (1.35-8.1 mCi/min) at a flow 
rate of 2.5 mL/min for 30 min. 
— Ramp infusion with increasing or decreasing specific radioacfivity in the range of 
0.2-1 GBq (5.4-27 mCi) for 5-10 min. 
In order to minimise radiafion dose to personnel, a system for the fully automated 
production of [i50]water (Meyer et al., 1986; Matzke et al., 1993) and its infusion or injection by 
remote control has been installed at Hannover and this is now described. 
5.6.2. f'^OJOxygen production. [i^ojOxygen is produced by tlie i''N(d,n)'50 reaction in a 
nitrogen gas target. The target gas contains 0.5% oxygen as carrier and its mean transit time 
from the target is 2.2 min. The maximal acfivity at the input of the ['^Qjwater system is 
6 GBq/min (160 mCi/min) at a target pressure of 14 bar (210 psi) and a beam current of 30 pA. 
5.6.3. [JWJWater production. The ['^Ojwater producfion and infusion system is mounted on a 
laboratory trolley standing beside the PET camera. Al l radioacfive parts of this system, except 
the calibrafion devices, are shielded within a lead box of 20 x 30 x 20 cm inner shape with a 
15 x 13 cm lead glass window. The wall thickness of the box is 5 cm. The window has an 
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equivalent shielding factor (see Figure 5). Within the lead box the target gas enters a flow meter. 
Hydrogen (2 mL/min) is added downstream. The gas mixture passes through a tube oven, filled 
with about 0.2 g palladium (1%) catalyst on a charcoal support (4-8 mesh) which is held at a 
reaction temperature of 150-160OC. The resulting [I50]water vapour is trapped in a four-necked 
flask filled with isotonic saline solution. The level of the saline in the flask is monitored by a set 
of ten light barriers. With a small gear pump, the ['50]water is pumped out and into the 
calibration and infusion system. Al l devices within the lead box are fixed to a mounting plate, 
which can easily be lifted out of the box for maintenance. Outside the box is a flow meter with a 
needle valve for the control of the hydrogen gas flow, and also a second gear pump, which 
withdraws isotonic saline solution from an infusion botfle to fill the absorpfion flask inside the 
lead box. The radioactivity levels inside the absorption flask and in the waste line are monitored 
by two G-M counters and are registered by a pen-recorder. 
The whole apparatus is operated under the command of an automatic system, which 
includes interlock devices in order to prevent mis-operations. For safety reasons all electrical 
parts which are in contact with the infusion system are driven by 12 V only. 
Under maximal radioacfivity load (bolus injecfion), the radiation dose at a distance of 
one metre from the apparatus is less then 30 |iSv/h. 
5.6.4. Bolus injection. The system for the bolus injection consists of a pneumatically-driven 
syringe (10 mL), placed in an ionisafion chamber and a solenoid valve for switching flow 
direcfion. The connecfion to the pafient is by an infusion tube and a sterile filter with a total void 
volume of 1.7 mL. The amount of ['50]water inside the syringe is monitored by a set of ten pilot 
lamps at the control unit. 
The system is operated in the following manner. The absorption flask is filled to a level 
of 11 mL. Then [i50]oxygen production is started. When sufficient radioactivity (at least 
1.7 times the desired injection radioactivity) is sampled, the labelled water is pumped into the 
injection syringe. This takes 15 s and gives approximately 1.3 times Uie injection dose within the 
syringe. Interlock circuits in the control unit prevent air from pumping into the syringe 
(minimum level in the absorption flask, 1 mL) and from mistakes in handling the system. 
Injection is started by pressing a push-button switch when the radioactivity has decayed to 
1.2 times the injection dose. It may be stopped immediately at any time. The injection of 10 mL 
is completed within 7 s. 
The whole procedure from start of bombardment to end of injection takes about 10 min, 
and the next run may be started immediately. 
5.6.5. Constant infusion and ramp infusion. The radioactivity control unit for tiie constant 
infusion and ramp infusion methods is a G-M detector with a calibration loop (0.2 mL). It is 
connected to the patient by an infusion tube, a three-way valve and a sterilisation filter (void 
volume, 1.9 mL). In all cases a constant flow rate of 2.5 mL/min is maintained by pump 2. 
For steady state infusion the saline volume in the absorption flask is kept constant to 
13 mL by pump 1, which is under command of the level control system. The saline flow is 
started 4 min after the start of [isojoxygen production. An equilibrium is reached about 10 min 
later, when the infusion may be started. The radioactivity level of the infusion solution is 
pre-defined by the beam current and the flow rate of the target gas. The relatively large volume 
in the absorption flask buffers short deviations in beam current, so that an additional control 
mechanism for the radioactivity level is unnecessary. A deviation from the saline level in the 
absorption flask causes an alarm to signal, and both pumps will be switched off by tiie control 
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unit at differences greater than 15%. 
For the ramp infusion, the start procedure is the same as for constant infusion, except that 
the saline level is low (2 mL) for decreasing, and high (13 mL) for increasing specific 
radioactivities. When equilibrium is reached, the flow rate of pump 1 is set to a value grater or 
smaller than 2.5 mL/min. This will result in e-function shaped gradients. Linear gradients are 
realised by continuous variation of the flow rate of pump 1 under the control of an external ramp 
generator or a computer. 
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Figure 5. [i^O] Water production system and infusion system, as at Hannover. 
5.7. PRODUCTION AND QUALITY CONTROL OF «-[i50]BUTAN0L USING A PLC (AS 
AT KFA JULICH) 
5.7.1. Introduction. «-[i50]Butanol, because of its optimal lipophilicity (Berridge a/., 1991; 
Walter et al., 1993), is of great interest for measuring regional cerebral blood flow (rCBF) by 
PET. Labelled /i-butanol, compared to ['SOlwater, is a freely diffusible tracer over a wider range 
of rCBF (Herscovitch et ai, 1987); the use of [i50]water rather than /i-[i50]bulanol may 
underestimate cerebral blood flow in regions with high flow rate (Herscovitch et a/., 1983). The 
efficient and reliable production of «-[i50]butanol, by an automated device that can provide 
several batches in sterile vials from only one set-up, is a prerequisite for the use of this perfusion 
tracer in PET. 
The synthesis of /i-[i50]butanol by reaction of molecular oxygen with tri-zz-butylborane 
in tetrahydrofuran was first reported by Kabalka (1984) and by reaction with tri-«-butylborane 
loaded onto an alumina Sep-Pak™ by Kabalka et al. (1985) and Takahashi et al, (1986). A 
procedure to synthesise «-[i50]butanol rapidly and sequentially in sufficient activity and purity 
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for clinical use was soon developed (Berridge et al., 1986). Remotely operated production 
systems have since been reported (Berridge et ai, 1990; Bauer and Wagner. 1991; Goodman et 
ai, 1991; Moerlein etal., 1993). 
5.7.2. Design features. At Jiilich, in order to meet the clinical demand, there was a need for a 
device operated by a PLC that would be capable of producing up to eight batches of 
«-[i50]butanol, each in four minutes, with built-in quality control (for QA/QC recommendations 
see Meyer et al., this volume). The schematic form of the device that was built to meet this 
demand is shown in Figure 6. It was assembled from two 2-position-8-way valves, two 
pneumatic syringe pumps, two flow controllers, four 2-way diaphragm and six 3-way diaphragm 
valves. The system contains eight alumina and C-18 cartridges. The ['50]oxygen activity 
trapped on the alumina cartridge and the activity of the final isotonic solution of the 
«-[i50]butanol are monitored with calibrated G-M tubes. A pneumatic device for dispensing the 
filtered solution of /j-[i50]butanol into a shielded sterile and evacuated vial is also used. The 
system is controlled by a PLC with start, stop and delay push buttons. Up to eight productions of 
/j-[i50]butanol in isotonic saline containing 5% ethanol can be performed within a turn-around 
time of 15 min. For a second set-up of the system, easy replacement of the alumina and the C-18 
cartridges is all that is required. 
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Figure 6. Schematic of the set-up for automated «-[i50]butanol synthesis with built-in quality 
control by HPLC, as at KFA Jiilich. VI-VII are diaphragm valves. Ml and M2 are pneumatic 
syringe pumps. 
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5.7.3. System operation. The production of oxygen-15 via the i4N(d,n)i50 reaction is carried out 
at either of two cyclotrons, the JSW BC1710 or the CV28 in the Institute of Nuclear Chemistry in 
Julich. The high current targets are constructed from aluminum and have a conical shape and a 
volume of 1(X) mL; they have as front window, a 50 ]xm Havar™ foil in the case of the JSW 1710 
and a 330 |xm aluminum plate to degrade the beam energy from 14 to 10 MeV in the case of the 
CV 28. The irradiated target gas (0.2% oxygen in nitrogen at a pressure of 5 bar, 75 psi), is 
typically bombarded with a 22 nA beam of 10 MeV deuterons for 10 min. After irradiation, the 
target gas is transported over a distance of 40 m through a stainless steel tube of 2 mm inner 
diameter at a flow rate of 1 L/min and passed for 55 s through an alumina cartridge, pre-loaded 
with tri-/2-butyl-borane (80 | iL) . 
['50]02 
B(/i-Bu)3 —> B(/i-Bu)(i50-/!-Bu)(0-/i-Bu) 
The hydrolysis of the '^O-labelled /i-butyl-borane complex with 3 mL of sterile endotoxin-free 
water takes about 56 s. 
H 2 O 
B(n-Bu)-i50-(/i-Bu)-0-(/i-Bu) —> n-Bui^OH + «-BuOH + B ( « - B m ) ( 0 H ) 2 
The hydrolysed «-butyl-borane mixUire is then passed into a C-18 cartridge for extraction of the 
«-[i50]butanol from boron compounds. The /i-['50]butanol is eluted from the C-18 cartridge 
with 5 mL of isotonic sodium chloride solution containing 5% ethanol. This procedure takes 
73 s. In 45-50 s the eluted volume is mixed and filtered through a 0.2 ^m sterile filter into an 
evacuated vial, shielded by lead (3.5 cm thick). An average activity of 5.5 GBq (150 mCi) of 
/j-[i50]butanol is obtained under these irradiation and synthesis conditions. 
5.7.4. Quality control. Quality control by HPLC is performed automatically by analyzing 20 | iL 
of the solution taken just in front of the sterile filter (Figure 6). The analysis of the 
n-[i50]butanol by radio-HPLC is performed on a C-18 column (Hypersil™, 5 \im, 60 mm x 
4 mm) eluted with 15% acetonitrile in water. A sodium iodide [Nal(Tl)] detector and a refractive 
index detector are coupled in series. Using the short C-18 column, the analysis time is only 
1.25 min, just 25 s longer than the time needed for sterile filtration. 
Table 1. Retention times and content of the n-['50]butanol solution 
determined by radio-HPLC, as at KFA Julich. 
RT(s) % Carrier (mg/mL) 
[150] Water 25 0.05 ± 0.02 -
sec-[i50]Butanol 40 0.70 ±0.2 0.2 ±0.08 
n-[i50]Butanol 49 98.5 ±0.7 4.8 ± 1.6 
Table 1 gives the radioactive components present in n-[i50]butanol solution, their HPLC 
retention Umes (RT), relative proportions and associated carrier. The radiochemical purity of 
«-[i50]butanol obtained by radio-HPLC is 98.5 ± 0.7%. Only [i50]water and 5ec-[i50]butanol 
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are detected as radioactive impurities. The amount of n-butanol carrier varies in the range of 
22-28 mg per batch, which represents a chemical yield of about 34 ± 4% based on the starting 
tri-/j-butyl-borane. The average specific radioactivity of «-['50]butanol is therefore about 
13 GBq/mmol (350 mCi/mmol). The boron impurities, which cannot be determined by HPLC, 
are analyzed by atomic absorption spectroscopy. The average value is 2.7 ± 1.3 |i.g/mL. Figure 7 
shows chromatograms for eight successive analyses, and their consistency. 
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Figure 7. 3-D plot of the radioactivity channel of chromatograms from the quality control of 
eight successive productions of «-[i50]butanol, as at KFA Julich. 
5.8. REMOTELY CONTROLLED SYNTHESIS OF L-6-[i8F]FLUORO-DOPA (AS AT 
HAMMERSMITH HOSPITAL) 
5.8.1. Introduction. L-6-[i8F]Fluoro-DOPA is produced routinely as a marker for central 
dopaminergic neurons for clinical PET studies at the MRC Cyclotron Unit (Hammersmith 
Hospital). The radiochemistry used (see Pike et al., 1990) is based on that originally described 
by Adam et al. (1986), as recommended by Luxen et al. (1992), namely electrophilic fluorination 
of a protected L-DOPA derivative [L-ethyl-A^-acetyl-((i-3-methoxy-4-acetoxyphenyl)-alaninate] 
with [i^FJacetyl hypofluorite, followed by deprotection with hydriodic acid and HPLC separation 
of the 2- and 6-[i8F]fluoro-derivatives of L-DOPA. 
62 
5.8.2. ['SFJFluorine production. ['SFJFluorine is produced by the dcuteron (16.5 MeV; 
13-16 p.A) irradiation of neon (research grade, BOC Ltd) containing 0.2% v/v fluorine (research 
grade, BOC Ltd), initially at 200 psi. Target parameters and operating conditions are described 
in Guillaume et al. (1991). At the end of irradiaUon (90-120 min; 20-32 nAh) the [i8F]fluorine 
is introduced by stainless steel tubing (1/8" o.d.) into a lead-shielded hot-cell through a 
controllable needle valve (Nupro). 
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Figure 8. A schematic representation of apparatus for the remote production of 
L-6-[i8F]fluoro-DOPA, as at Hammersmith Hospital. 
5.8.3. Radiochemistry. The set up of the cell is shown schematically in Figure 8. A stainless 
steel gauge (Budenberg) is used to monitor gas pressure between the target and needle valve. 
The fluorine-18 is led in Teflon™ (l/8"o.d.) tubing through a stainless steel cartridge containing 
sodium-acetate 'cake' and then into a glass bubbler containing a solution of precursor 
(70-100 mg) in glacial acetic acid (12-15 mL). This sits in a well-counter, thereby enabling the 
accumulation of radioactivity to be monitored. The outlet of the bubbler is a Teflon™ tube 
leading the gas to waste through a soda lime trap and flow meter (Meterate OPE RSI, ruby float). 
Swagelok™ stainless steel fittings are used to connect the tubing to the needle valve and to the 
cartridge. Altex™ fittings are used to connect the hibing to the bubbler and to the flow meter. 
The eight three-way switching valves that are used in the system are Rheodyne™ slider valves 
(model 5301 or 5302) with remotely controlled pneumatic actuators (model 5300). The bubbler 
is connected to a mini rotary evaporator (Buchi) which has its flask in a silicone oil bath 
(Heidolph HB140-0) at 1650C. The rotary evaporator is modified to have a liquid nitrogen 
cooled trap. The oil bath is mounted on a motorised lab-jack which can be raised or lowered by 
remote control. The acetic acid is taken into the rotary evaporator under reduced pressure 
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through a Teflon™ dip-tube which for most of its length is held straight by a glass tube before 
finally terminating at the lowest part of the evaporation flask. Acetic acid is then removed from 
the radiofluorinated product by rotary evaporafion. Then hydriodic acid (BDH, 'MAR', 1.5 mL 
plus hypophosphorous acid, 0.5 mL) is introduced into the rotary evaporator from a plastic 
syringe on the outside of the cell via Teflon™ tubing (1/16" o.d.). Hydrolysis is performed at 
165'X^ for 20 min. Then the hydriodic acid is rotary evaporated off. Water {ca 3 mL) is three 
Umes added to the flask and evaporated. Finally 'neutralisaUon buffer' (KJi2P04, 71 g/L plus 
Na2HP04, 69 g/L; pH 4; 1.5 mL) is added to the flask to dissolve the radioactive product. This is 
withdrawn into a plastic syringe mounted in a homemade syringe-drive (based on a remotely 
controlled motorised lead-screw). 
5.8.4. HPLC purification. The contents of the syringe are injected into a remotely controlled 
pneumatically-operated HPLC injection valve (Rheodyne 7030, with 5701 actuator) through a 
vented millipore filter (Sterile Acrodisc, 0.2 |i,m; Gelman Sciences). The sample is remotely 
injected onto a preparative HPLC column (Nucleosil™ 5 C 18, 5 p.m particle size, 25 cm x 
20 mm i.d.) eluted at 6 mL/min with 70 mM-potassium dihydrogen phosphate solution. The 
eluate is monitored for absorbance at 280 nm and for radioactivity. The peak eluting after 
L-2-[i8F]fluoro-DOPA and with the same retenfion time as reference L-6-nuoro-DOPA is 
collected by remote operation of a waste/collect valve and diluted to 10 mL with the same buffer. 
Finally, this soluUon is sterilised by millipore filtration (0.22 |im pore size, Millex GS). 
5.8.5. System performance. The collected product (190-560 MBq; 5-15 mCi) has an average 
radiochemical purity of 93.8% and an average specific radioactivity of 4-8 MBq/|imol 
(110-220 mCi/|imol) corrected to EOS. The preparation takes about two hours from BOB. 
5.9. COMPUTER-AIDED AUTOMATION OF NUCLEOPHILIC RADIOFLUORINATION 
(AS AT KFA JULICH) 
5.9.1. Introduction. 2-[i8F]Fluoro-2-deoxy-D-glucose (2-18FDG) is currently one of the most 
important radiopharmaceuticals (see Fowler and Wolf, 1986; Coenen etal., 1987). The 
increasing demand for 2-18FDG has accelerated the design and construction of remotely 
controlled or automated procedures as well as laboratory robotic systems for its synthesis. In 
order to prepare routinely at Julich by the favoured method (Coenen et al., 1987) based 
on Kryptofix™ 2.2.2. (A.P.E. 2.2.2.)-mediated nucleophilic fluorination (Hamacher et al., 1986), 
a computer-controlled modular apparatus was built. This includes a module for the rapid 
separation of [i^FJAuoride from [i80]water for other nucleophilic fluorinations (Hamacher et al., 
1990). 
5.9.2. Computer control unit. All processes in the synthesis of 2-'8FDG are electronically 
controlled by an IBM PC/AT clone equipped with standard peripherals. The microcomputer is 
allowed to communicate with an Optomux™ networic via an RS 422/485 adapter card, which is 
plugged in direcfly and provides up to 4000 V isolation between the PC and the communication 
link. For standard input/output signals, three Optomux™ digital and one analog brain board with 
up to 16 I/O channels are used. Six lines are programmed to read status information from the 
system, such as temperature, pressure, the level of liquid in the purification unit, and the actual 
scale of three radioactivity detectors. The temperature is controUed by a 12-bit digital-to-analog 
converter. A total number of 28 solenoid valves can be operated direcUy. In the Optomux™ unit 
64 
an optical coupling is used to prevent any electrical feedback of the valves as they can induce 
high voltages when they are switched. As a programming language we have chosen 
Turbo-Pascal™. The run-down in a time-command sequence in the programme and the feedback 
of intensity factors, such as temperature and pressure, control the procedure of the radiosynthesis. 
The actual process carried out is described in a menu. Interruption and continuation of the 
automated process is possible at any time. A report, comprising the date, start and end .of 
radiosynthesis, and the calculation of the radiochemical yield of 2-18FDG, is automatically 
provided. 
i 
1: , 
5.9.3. Apparatus design. In accordance with GMP the apparatus is a closed system with helium 
overpressure. A schematic of the automated system is shown in Figure 9. The modules of the 
system are combined to achieve the shortest connections and smallest dead-volumes. The tubes 
are Teflon™ and the valves are air-actuated and Teflon™ membrane valves from Angai 
Scientific Co. Ltd (Rheodyne™ 7010, type 368 or 190, 24 V d.c). 
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Figure 9. Schematic set-up of the automated system for 2-'8FDG synthesis including the 
[i8F]fluoride-[i«0]water separation unit, as at KFA Julich. The adjacent solvent reservoirs 
containing water, ethanol and acetone are only used for the automated cleaning of the apparatus. 
5.9.4. [i^FJFluoride separation. The fluoride separation unit is connected on-line to the 
[i80]water target via a polypropylene tube. Before the [i^Fjfluoride and the [i80]water are 
separated, the water phase (1.5 mL) is collected in a degassing vessel and the total radioactivity 
monitored by a System 414 Monitor (Genitron Instruments). This vessel is connected to an air-
actuated six-way valve (Valco, AC6W) that is combined with a small ion exchange column (20 x 
2 mm) having a G l Pyrex™ frit and a loop containing potassium carbonate solution. The outlet 
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valve at the column connects to two vials: vial a) to coUect the [i^O] water after fixation of tlie 
fluoride and vial b) to mix, using a motor-driven syringe, the [ispjfluoride containing potassium 
carbonate solufion with the appropriate amount of Kryptofix™ 2.2.2. solubilised in acetonitrile. 
The transport of the solution through the resin is accelerated by reducing the pressure to about 
20 mbar at the end of the column using a vacuum pump. 
5.9.5. Reaction vessel. The central part of the apparatus is a single unit reactor (Figure 10), for a 
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Figure 10. Sectional view of the single unit reactor with a cylindrical reaction vessel (17 x 
70 mm) made of glassy carbon, as at KFA Julich. 
one-pot reaction system that contains a single heated reaction vessel combined with a rectangular 
arrangement of Teflon™ membrane valves and up to nine reagent reservoirs above the reactor. 
(For the 2-18FDG synthesis only five reservoirs are used). The closed system allows reactions in 
isothermal and isometric condifions, in the range of ~ 0-2 bar (0-30 psi) as limited by the 
Teflon™ membrane valves. The cylindrical reacfion vessel is made of glassy carbon 
(Sigradur™, 17 mm in diameter, 2 mm wall thickness and approximately 70 mm in height) 
surrounded by a copper cylinder with an integrated electric filament (Thermocoax™). The 
advantage of glassy carbon in comparison with glass is its extreme chemical resistance, low 
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capacity for adsorption and more efficient heat conduction. The top of the glassy carbon vessel 
is closed by a stainless steel cover which is connected to the cylinder by a 'quick-stretch ring'. 
The small space between the glassy carbon and the copper cylinder is filled with silicone oil (ca 
1 mL). Accordingly, the heat capacity is relatively low. The cylinder is surtounded by a steel 
coat with an inlet for liquid nitrogen at the bottom. (The injection of liquid nitrogen in a closed 
cooling jacket allows a temperature to be set in the range from 77-50(PK, which is of interest in 
syntheses with [HCJiodomethane). 
5.9.6. Purification unit. The purification unit consists of a special glass column containing the 
AG 11-AS resin (Biorad) with a built in liquid level sensor (Honeywell, Dusseldorf) and an eluent 
reservoir at the top of the resin. The solenoid valves at the top and bottom of the purification 
column arc switched automatically, depending on the signal of the liquid level sensor. 
5.9.7. Filling unit. A l l the 2-18FDG produced is collected in a glass vessel with lead shielding 
and measured by the System 414 Monitor in order to get the radioactivity concentration in MBq 
or mCi per mL via the computer. After sterile filtration through a miUipore filter (0.22 |im) the 
isotonic 2-'8FDG solution is apportioned into evacuated ampoules via pneumatic piloting of a 
sterile tube cannula. The filling unit is installed below the synthesis device in a separate small 
lead-shielded box (40 x 40 cm). 
5.9.8. Performance of the system. The routine producfion of has been accomplished 
several hundred times with excellent reliability. The integrated automatic cleaning programme at 
the end of radiosynthesis makes it possible to reuse the apparatus within one hour. Nevertheless, 
it is necessary after each third radiosynthesis to open the reactor and to clean the glassy carbon 
vessel with a soft fissue. In the course of several radiosyntheses, polymeric side products 
accumulate which are insoluble in the solvents used for the purification sequence, such as boiling 
water, ethanol and acetone. Besides the manual purificafion step, the only manual procedure 
which has to be performed before running a new radiosynthesis is to fiU up the reservoirs and to 
change the column and the Sep-Pak™ cartridges. 
Although some minor problems exist with respect to the decreasing reliability of some 
membrane valves, especially the three-way valves after 40 radiosyntheses, the automated system 
is a convenient apparatus for the routine production of high amounts of 2-18FDG. The 
preparation takes 58 min and- gives 2-18FDG in 50 ± 10% radiochemical yield with a 
radiochemical purity of 98.5 ± 0.5% and a specific radioactivity of > 370 GBq/pmol 
(10 Ci/nmol). The same device, without any appreciable modification, has been used for the 
roufine production of 2-[i8F]fluoro-D-mannose from the epimeric form of the 2-18FDG precursor, 
and also for the production of 3-A'-[i8F]methylspiperone. 
6. Robot-based Automation 
6.1. INTRODUCTION 
A l l automaUon requires standardisafion of repefitive procedures. The equipment used is chosen 
for its compatibility with other components of the system. Personal computers are used to time 
the execution of pre-programmed operations. The one major feature distinguishing a robot-based 
system from a dedicated automatic system is that the mechanical operations are performed by a 
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multi-functional manipulator - the robot arm - instead of a series of mono-functional devices. 
There are pros and cons to using robots in radiochemical procedures. Once the initial 
components are chosen and the operator is familiar with the system, a large degree of inherent 
flexibility is retained since the arm can be re-programmed to perform new operafions. As in a 
dedicated system, the robot-based system can be used to execute a weU-optimised procedure in 
exactly the same way every time. In contrast to dedicated systems, the robot can be programmed 
to remove contaminated vessels to a shielded waste area, thereby lowering the level of 
background radiation and increasing accessibiUty to a shielded work area in a given period. The 
robot may be used as a developmental tool to optimise the sequences of mechanical operations in 
a new procedure before building a dedicated system. The same manipulator can potentially 
perform several different procedures within the same set-up. In high-volume analytical 
procedures, such as in the analysis of biological samples, the robot always performs the analyses 
in the same manner, thereby eliminating errors from variations in laboratory techniques. No 
transcription errors are made since the data are automatically recorded and personnel are freed 
from time-consuming worL 
On the other hand, the cost of the robot alone is often substantially higher than the 
combined costs of the equipment used in dedicated automated systems. Most glassware and 
disposable items must be redesigned to a more robot-friendly construction for optimal reliability. 
Either the shielded work area must be custom-designed to fit the operating and service 
requirements of the robot or the choice of robot must take into account the limitations of the 
available work area. Even for commercial robots, custom-made to perform specific tasks, 
considerable time is usually needed for set up and one or several persons needs to be completely 
familiar with the function and coding of the control system. 
Once die decision has been made that investment in robotics is justified for present 
and/or future applications, the time required for implementation wiU depend on the expertise of 
the personnel working on the project and whether or not the system being considered has 
previously been optimised for the particular application. Some examples of this developmental 
procedure are surveyed below, following a specific example of robotic radiosynthesis from the 
group at Li^ge. Other laboratories in Europe have experience with robotics, as follows: France: 
Caen and Orsay; Netherlands: Groningen; Russia: St. Petersburg: Sweden: Stockholm and 
Uppsala. The three main robotic systems to be discussed are summarised in Table 2. 
Table 2. Comparison of technical data for the main robots discussed. 
Zymark Scanditronix Karolinska 
Robot type Zymate (RB-86)Anatech AB RTX (UMI) 
Coordinate system Cylindrical Cartesian -i- linear Cylindrical 
Number of axes 4-1-2 5 7 
Operation range 360O 180O-6 m linear 180O 
Programmable speeds yes yes yes 
Multiple hands yes yes no 
Reach 64 cm 68 cm 
Li f t capacity 2 kg 10 kg 2 kg 
Positioning accuracy 1 mm 0.1 mm 0.5 mm 
System controller Easylab™ IBM PC IBM PC 
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6.2. A SPECIFIC EXAMPLE OF ROBOT-ASSISTED RADIOSYNTHESIS — 
6-[i8F]FLUORO-L-DOPA (AS AT LEEGE) 
6.2.1. Introduction. Although, the labeUing of radiopharmaceuticals with fluorine-18 by 
remote-control is feasible, automatic robotic radiosynthesis is more desirable since it appears to 
be more versatile and therefore more useful for research. In order to demonstrate the potential of 
such an approach, which avoids excessive radiation exposure to operatives, a robotic system has 
been developed in the Cyclotron Research Centre of the University of Lifege based on the 
Zymate™ Laboratory Automation System (Zymaiic Coip.) (Table 2). This was the first robotic 
system to be used in PET-related procedures and is probably still the most widely used. The 
robot arm has an operational range of 360°. Easylab™ software and a variety of woricstations are 
available for performing operations often used in laboratory procedures. These may be used as 
they are, or modified to fit die special vessels and techniques used in PET radiochemistry. It is 
configured and programmed to prepare a variety of radiopharmaceuticals, such as 
6-[i8F]fluoro-L-dopa, 2-[i8F]fluoro-L-tyrosine, [i^Fjaltanserin and 4-[i8F]fluoro-tropapride, all 
by n.c.a. nucleophilic radiofluorination. 
6-[i8F]Fluoro-L-dopa and 2-['8F]fluoro-L-tyrosine are produced as tracers of presynaptic 
dopamine neurons and of cerebral protein synthesis rate, respectively. The n.c.a. enantioselective 
labeUingof 6-[i8F]fluoro-L-dopa is based on nucleophilic substitution in 2-trimethylammonium-
3,4-dimethoxy benzaldehyde triflate (Lemaire etal., 1992, Lemaire, 1993) and the labelling of 
2-[i8F]fluoro-L-tyrosine is similariy based on nucleophilic substitution in tiie corresponding 
4-methoxy benzaldehyde. The remaining steps in these multi-step syntheses require conversion 
of the radiofluorinated aldehydes into the corresponding benzyl iodide [by treatment with 
di-iodosilane (DIS)], alkylation of S-Boc-BMI with Uiis electrophilic agent, hydrolysis and 
finally HPLC purification (Lemaire et al., 1993). ['^FlAltanserin is labelled by nucleophilic 
substitution in the corresponding nitro compound and purified by HPLC (Lemaire et al., 1991). 
Its suitability for mapping 5 H T 2 receptors in vivo with PET has been demonstrated (Sadzot et al., 
1993). Tropapride has been labelled with fluorine-18 at the 4 position of its benzylic group by 
reductive amination in the presence of 4-[i8F]fluorobenzaldehyde and norbenzyl precursor 
(Damhaut et al., 1992). This molecule exhibits high selectivity and specificity for D2 receptor 
sites and appears to be a potential radioligand for the study of the dopaminergic system witii 
PET. 
6.2.2. Components of the system. The robot used for these radiosyntiieses is a Zymate™ I I 
Laboratory Robot (Zymark Corp.), as specified in Table 2. The software control is Easylab 
Plus™, and routines for several modules were written using tiiis language. Several components 
were acquired from Zymark, and others modules, more specific to the particular radiosynthesis 
were designed and fabricated ' in house'. The components were arranged in a 36CP arc around 
the robot arm and were mounted on sectors positioned around the Zymate™ II Core System. All 
the system was set up on a shielded bench top (150 x 175 cm). Located beneath the robot are the 
Power and Event Controller as well as the multiplexer, also developed ' in house', which allows 
the control of 64 outputs for tiie control of valves and otiiers modules. The controller and the 
HPLC system are also located beneath the bench top. A block diagram of the Zymate™ system 
is shown in Figure 11. In the legend tiie modules marked Zymark were purchased from Zymark 
Corporation while the modules developed in LiSge are marked CRC. Figure 12 shows a 
photograph of the configured system. 
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Figure 11. Description of the different sectors (S1-S12) around the Zymate I I Core System. 
SI—Rack containing disposable glass tubes (Zymaiic). S2—Pipetting Hand and tips (Zymark). 
S3—General Purpose Seizing Hand (Zymark). S4—Lead pig (CRC). S5—Column for the 
separafion of [i^Fjfluoride from irradiated water, a rack with capped reagent vials, two ovens, 
one equipped with an optical level probe (CRQ. S6—C-18 Sep-Pak chromatography system 
(CRC). S7—Sector for formulating the injectable solution (CRC). S8—Homemade silica 
chromatography system and rack for the preparafion of DIS (L-6-['8F]nuoro-Dopa and 
L-2-[i8F]fluoro-tyrosine) (CRC). S9—HPLC injector and fraction collector (CRC). 
SIO—Microwave oven (CTRC). SlI—Oven for the hydrolysis step (L-6-[i8F]fluoro-Dopa and 
L-2-[i8F]fluoro-tyrosine) (CRC). S12—Clapping pysection providing capping and uncapping of 
round, screw cap containers (Zymark). 
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Figure 12. Zymate™ Laboratory System used for the routine production of four isp-labeiled 
radiopharmaceuticals. 
6.2.3. Labelling of L-6-[i^F]fluoro-Dopa as an example. The radiosynthesis of 
L-6-[ '^Fjf luoro-Dopa requires many steps in common with the labelling of other 
radiopharmaceuticals, including production of ['^FJfluoride, recovery of i^O-enriched water, 
evaporation of natural abundance water, resolubilisation of the radioactivity in an aprotic dipolar 
solvent, labelling in a microwave oven or in an aluminium heafing block, Sep-Pak™ 
pre-purification, HPLC injection and separation, and finally preparation of an injectable solution. 
a. Initialisation. 
During radionucUde production, the robot initialisation program is loaded into the robot 
controller and executed. It allows the modules of the robotic system to be loaded with all 
components (e.g. vials, tips, tubes), solvent and reagents necessary for tlie radiosyntliesis. To 
conunue, manual validation of each step of the program with the keyboard, is required. Al the 
end of bombardment, the main program is loaded. 
b. Production of P^FJfluoride ion. 
No-carrier-added ['^Fjfluoride is produced in a nickel target by the '80(p,n)i8F nuclear reaction 
on i80-enriched water (45%). The target is remotely loaded using a syringe pump thniugh a fill 
entrance at the bottom of the target. A second port at the top of the target is used for venting 
during loading and irradiation. At the end of bombardment (1 h, 10 | i A ) , the radioacUvity 
(11-13 GBq; 300-350 mCi) is transferred under nitrogen gas pressure (0.67 bar; 10 psi) through 
Teflon™ tubing (30 m) to the robot room (sector 5, Figure 11). 
c. Recovery of n.c.a. ['^FJfluoride and '^0-enriched water. 
The radioactivity is trapped on a Dowex™ 1X8 anion exchange resin and the i^O-enriched water 
recovered in a receiving vial placed in sector 5. The end of transfer is detected manually and the 
command is then entered by keyboard into the robot controller to continue tiie synthesis. A 
conical glass vessel containing Kryptofix™ 2.2.2. (22 mg) and potassium carbonate (4.2 mg) is 
tiien substituted for tiie i^O-enriched vial, which is capped in tiie capping station (sector 12). 
After distillation, this water is used again for further production. [i8F]Fluoride is then eluted 
from the resin by potassium carbonate solution (7 mg/mL; 400 ^ L ) . 
d. Labelling reaction. 
Conversion of the [i8F]fluoride into its potassium-Kryptofix 2.2.2. salt in an anhydrous organic 
solvent (DMSO) is achieved in tiie oven in sector 5. The water is evaporated to dryness under 
nitrogen in an aluminium heating block (I20OC). The end of evaporation is detected 
automatically with an optical probe and a feedback signal is sent to the robot's computer which 
then allows the synthesis to continue. Therefore, this critical evaporation step can be achieved 
reproducibly and is highly independent of parameters such as water volume, temperature and 
nitrogen flow. 
The Pipetting Hand, equipped witii a tip, is then selected and tiie [K-Kryptofix 
2.2.2.]+[i8F]- salt dried by three successive additions and evaporations of acetonitrile (3 x 
100 |xL). The precursor (15 mg) in DMSO (900 | iL) , previously placed in the rack of sector 5, is 
aspirated in the tip and added to the dry residue. The probe is tiien moved up. The vial is capped 
in the capping pysection with the General Purpose Hand and introduced into tiie second oven in 
sector 5. After the labelling reaction (10 min, 140^0, tiie vial is placed eitiier in a lead pig 
(sector 4, for assessment of radioactivity), or uncapped for subsequent Sep-Pak™ 
pre-purification. 
e. Sep-Pak™pre-purification. 
By using the Pipetting Hand, the DMSO solution is diluted in glass tube number 1 in tiie rack in 
sector 1, which contains 20 mL of 0.5M-hydrochloric acid. The labelling vial is rinsed witii this 
solution. With tiie General Purpose Hand tiie tube containing tiie radioactivity is moved from the 
rack on sector 1, and the solution poured into a pneumatically actuated 50 mL syringe 
(previously filled with 5 ml of 0.5M-hydrochloric acid). The solution is then pushed through tiie 
C-18 Sep-Pak™ cartridge with a slight flow of nitrogen. The level of liquid is detected 
automatically by measuring the conductivity between two platinum electrodes. Before dryness, 
the lid is moved up and the support waished witii water. The [iSFlfluorobenzaldehyde is finally 
eluted with dichloromethane and dried by passing tiirough a magnesium sulphate column which 
is rinsed with additional dichlorometiiane. The final solution is collected in a conical vial and 
moved from sector 5 into tiie rack in sector 8. 
/ . Preparation of DIS and reductive iodination. 
In a conical vial containing iodine, phenylsilane is added with the Pipetting Hand. With tiie 
General Purpose Hand a Teflon™ lid is placed on the vial and removed after 2 min. The 
Pipetting hand is selected again and tiie radiofluorinated aldehyde transferred to tiie DiS reagent. 
With the General Purpose Hand the vial containing the ['8F]fluorobenzyl iodide is displaced so 
that the solution is poured onto a silica gel column and eluted witii dichlorometiiane. The 
purified [i8F]fluorobenzyl iodide is collected in another vial and tiie dichloromethane evaporated. 
g. Alkylation and hydrolysis reactions. 
After alkylation, which is not presentiy conducted witii the robotic system (under development), 
tiie [i8F]fluoroalkylated derivative is hydrolysed in tiie oven in sector 11. 
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h. HPLC purification. 
A homemade fraction collector has been developed (sector 9). Presently robotic controlled 
injection onto the HPLC is underdevelopment The robotic preparation of L-6-[i8F]fluoro-Dopa 
takes a similar time (120 min) to a remotely controlled preparation and gives a similar 
radiochemical yield (25 % decay corrected to E.O.B.). 
6.2.4. Other radiopharmaceuticals. The software written for the L-6-[i8F]fluoro-Dopa 
radiosynthesis can be used for labelling other radiopharmaceuticals with only minor 
modification. Indeed, the flexibility of the Easilab Plus™ programming language easily allows 
any modification needed. For the radiosynthesis of L-2-['8F]fluoro-tyrosine all the same 
homemade workstations are used. For the radiosynthesis of ['^Fjaltanserin the HPLC system is 
modified to accept an additional C-18 column. The application of robotics is not limited to the 
routine preparation of these four i^F-IabeUed radiopharmaceuticals for PET studies. Set up for 
die labelling and purification of several new radiopharmaceuticals is easily performed the same 
day with all the hardware presently available on our robotic system. 
6.3. A SURVEY OF OTHER APPLICATIONS OF ROBOTICS IN RADIOSYNTHESIS 
6.3.1. At the University of Washington (St. Louis). The PET group at the University of 
Washington (St. Louis), first reported the use of the Zymate system in the radiosynthesis of 
16a-[i8F]fluoroestradiol-17p (Brodack a/., 1985, 1986). This particular radiosynthesis was 
chosen because the half-life of the radioisotope is adequately long, the operations are compatible 
with robotic procedures and the long synthesis time and low radiochemical yield require large 
amounts of starting radioactivity. The procedures performed included conversion of 
[18F]fluoride into the tetra-/i-butylammonium salt in anhydrous solvents, handling of air-sensitive 
solvents, evaporation of solvents to dryness, heating and cooling, liquid-liquid separations and 
HPLC purification. In addition to the commercially available equipment incorporated in the 
procedure a number of modifications were introduced by the St. Louis group. These included the 
use of radiosynthesis-specific reagent and vessel racks, methods for the reproducible placement 
of the reaction vessels in heating or cooling baths and of specially constructed nitrogen purge 
lines that allowed the robot to perform other tasks during the evaporation of solvents. The 
General Purpose Hand was modified for Luer™ adapters to accommodate disposable needles, 
injections onto the HPLC system', monitoring of the eluate and the collection of fractions. The 
robotic procedure requires less time than the manual procedure (80 vs 90 min) but the 
radiochemical yields are lower (5-6 vs 22%). The major problems reportedly encountered were 
control of the evaporation time needed for resolubilisation of the ['^FJfluoride, lower efficiency 
in sample extractions than when performed manually and inefficient transfer for injection onto 
the HPLC system. 
Based on their experiences with this first apphcation, the St. Louis group subsequently 
modified the system to include smaller custom-made workstations and standardised the addition 
of reagents and the reaction vessels (Brodack et al., 1988b). The robot workspace is more 
efficiently used. They demonstrated the flexibility of the procedure by performing several 
radiosyntheses within the same set-up, namely those of 16a-['8F]fluoroestradiol-17p with 
improved yields, 3-/^-(a)-[i8F]fluoropropyl)spiperone and / j - [ l - i iC]butanol . In the new 
radiolabelling with [ispjfluoride, a rack is simply added for the reagents and for vessels specific 
to 3-N-(co-['8F]fluoropropyI)spiperone synthesis and the HPLC system is modified to accept an 
additional silica column. The radiochemical yields of 3-A/-((0-[i8F]fluoropropyl)spiperone are 
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slightiy lower tiian for the manual procedure (15-18% 20-28%, EOS) due to tiie longer 
S3Tithesis time required (70 40 min). A third reagent rack in tiie same robotic set-up allowed 
two preparations of /i-[l-iiC]butanoI within 25 min of each other without operator intervention 
(compared to at least 60 min in manual preparations). The time required for the robotic 
preparation is slightiy longer than for tiie manual-remote preparation (25 17 min), but the 
radioactivity yields are essentially the same. 
Using the same reagent and vessel racks already implemented in the previous 
radiofluorinations, only minor modifications were necessary for the production of 2-'8FDG in 
sufficient activities for clinical PET shidies (Brodack et al., 1988a). The resolubilisation station 
was modified to include a platinum crucible. A new lab-station allowed attachment of a refiux 
column to a Reacti-vial™. Extraction procedures were performed as previously with columns 
packed with the appropriate material (sihca C-18 and A G l l A8 ion retardation resin). The 
radiochemical yields and time of preparation are comparable to the manual-remote results: 
12-17% vs 12-23% and 70 vs 60 min, respectively. Since sub-routines already generated in tiie 
previous robotic procedures can be used, this new robotic synthesis reportedly requires about 
one week for implementation. 
The St Louis group have recentiy described tiie use of an articulated anm produced by 
CRS PLUS (Hudson Robotics) for 2-18FDG syntiiesis (Gaehle and Welch, 1992). Total Control 
Software™ controls the system through an IBM or compatible PC. The system is a space-saving 
alternative to tine Zymaric™ system. 
6.3.2. At the University of Washington (Seattle). Since robotic procedures are normaUy slower 
than manual procedures, their primary application has been in labelling witii fluorine-18 rather 
tiian carbon-U. One additional application of tiie Zymaric system in "C-labelling has, however, 
been reported by tiie PET group at the University of Washington in Seattie (Link et al., 1989), 
namely the syntiiesis of the tracer [l-UCjD-glucose. This requires large activities of the labelling 
agent, [nCJcyanide, to be handled. In addition to manipulations and reagent additions, a 
sensitive titration of the pH of the reaction mixture is performed by the robot. The total lime 
required for the robot-assisted radiosyntiiesis is less than 5 min more than the manual-remote 
procedure and the quantities of radiotracer produced are sufficient for PET sttidies. The same 
group has recently reported the use of Zymark robotics for the multi-stage synthesis of 
[2-iiC]tiiymidine from hydrogen ["Clcyanide (Courierera/., 1992). 
6.3.3. At Brookhaven National Laboratory. The Zymark system has recentiy been used by tiie 
Brookhaven PET group for measuring the plasma kinetics of total radioactivity and fraction of 
unmetabolised tracer (Alexoff etal., 1991, 1992), an oUierwise time- and personnel-demanding 
procedure. As demonstrated with blood samples from a PET study with 
3-N-[i8F]methylspiperone, the robot centrifuged, counted and pipetted different samples 
simultaneously to determine tiie discrete time-input function. The throughput of tiie robot is half 
that of a highly trained technician. Metabolite assays for 3-/^-['8F]melhylspiperone, 
[/^-/ner/ij/-iiC]cocaine and [O-mer/iyZ-iiCJraclopride, based on solid-phase extractions, can also 
be performed with excellent reproducibility for replicate samples. Not only might the total 
throughput be increased by tiiis use of robots, but human exposure to radiation and potentially 
infectious biological materials are minimised. Possible errors due to variations in laboratory 
techniques are also reduced. 
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6.3.4. At Stockholm University-Karolinska Hospital. For a number of reasons, a PET group may 
wish to design and implement its own robotics. The reasons may include space limitations, 
economy, the flexibility of tailoring the system to fit its own needs, and the desire to do basic 
research in the technique as a whole. In this case, a manipulator with the best performance 
characteristics (reproducibility, flexibility, strength) is chosen to use the planned work area 
effectively. If the group of scientists designing the system are competent in computer 
programming and interfaces, mechanical and electrical engineering and chemistry, a versatile 
system can be developed. 
The system designed by the Stockhohn University-Karolinska PET group (Appelquist et 
ai, 1989, 1991, 1993) illustrates such a development. The chosen robot ami is an RTX from 
Universal Machine Intelligence (Table 2). It is vertically mounted on a rail and can be installed 
I on the back wall of a hot-cell for operation in the semi-circle in front of it. A Multi-Function 
j Editor (MFE) was developed for building and interpreting control sequences for the system. The 
1 computer program recognises commands for moving the robot and for operating the equipment 
I used in the syntheses (electrovalves, flow regulators, heating elements, event waits, etc). The 
user-interface of the MFE is based on mouse-activated pull-down menus to provide a 
user-friendly mode of operation. The robot can be guided through motions in the desired 
j directions by moving the mouse or by coordinates entered from the keyboard. Since simple 
' editing commands and mouse-driven input are used in building the command sequences, the lime 
j required for a new user to learn how to program the system is minimised. 
Radiosynthesis-specific equipment is fixed on a removable Plexiglas™ tray connected to 
the base plate of the robot, allowing easy access for service or cleaning but still ensuring 
reproducible re-positioning. Supporting equipment is installed separately in or around the 
hot-ceU. The glassware is, where possible, selected from common reaction vessels such as 
Reacti-vials™ or, for special applications, is designed to be robot-friendly and standardised. 
Flow-line connections via needle stations, heating units, electrovalves, radioactivity monitors, as 
well as storage stations for reacfion vessels have been specifically designed for optimal reliability 
of the total system. The use of the system as a developmental tool has been demonstrated in the 
production and applications of [iiC]iodomethane and in nucleophilic substitution reactions with 
[i8F]fluoride and [HC]cyanide. 
6.3.5. At Uppsala. Installation and the time required for the first successful use of robotics may 
be reduced by choosing a complete commercial radiosynthesis system. One such system, based 
on the Anatech RB-86 robot (Table 2), has been adapted for PET radiochemical procedures by 
Scanditronix AB (Kjellstrom and Lindback, 1988). For radiosyntheses, the robot arm is installed 
on a rail on the back wall of the shielded area. Since it can be moved lineariy up to a distance of 
six metres, it can be used to service separate but adjacent hot-cells. However, to utilise this 
feature maximally, the working space must be custom-designed for installation of the rail through 
all the cells from the back side. The robot system is delivered with lab-stations for performing 
common operations (pipetting, liquid dispensing, solid phase extractions, vortexing, vial capping, 
heating, cooling, evaporafions and miUipore filtrafions). Additional equipment specific to the 
radiosyndieses of 2-18FDG and [HCjiodomethane is also available, thereby enabling application 
of the robotics soon after installation. However, as with all robotic systems, routine operation 
requires that at least one person is well-versed in the control characteristics of both the robot and 
the supporting equipment. The system is extendable to alkylations with [I'Cliodomethane, other 
types of syntheses or even analyUcal procedures associated with PET. The vendor supplies a tool 
for performing such operations but the applications wiU require user-design. 
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6.3.6. At St Petersburg. The group at St. Petersburg, in collaboration with Scandilronix AB, 
have recently reported the use of the RB-86 robot (Anatech AB) with workstations from 
Scanditronix AB for the synthesis of [l-i'CJacetate (Korsakov et al., 1992a) and also for 
[S-methyl-i^C]me\hionme from ['iC]iodomethane (Korsakov etal., 1992b). 
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SUMMARY 
1. The primary objective of this study was to examine in man, how induced 
changes in global cerebral blood flow (gCBF) affected a regional cerebral blood flow 
(rCBF) increase resulting from a neural activation task (opening of eyes). A 
secondary objective was to quantify how such induced changes in gCBF were 
distributed between representative regions of either predominantly grey matter or 
white matter. 
2. Positron emission tomography with intravenous infusion of H^'*0, was used 
to measure gCBF in six normal males. Concomitant measures of rCBF were 
obtained in three different regions of interest (RGI): a representative area of 
predominantly grey matter, a representative area of predominantly white matter 
and an area of visual cortex. 
3. Cerebral blood flow was altered by establishing steady-state changes in Pco^&t 
a near constant ventilation of approximately 30 1 min"'. The mean PET.CO, ( i ^ D.) 
levels (mmHg) that resulted were: low, 21-8+ 1-8; normal, 39 8 ± 1-0, and high, 
54-8 ±1*2 . The normal and high levels were obtained by adding appropriate 
amounts of CO, to the inspirate. The corresponding mean gCBF levels across all six 
subjects with eyes closed were: low, 24-2 ± 4 - 6 ; normal, 37 2 + 3-9 and high, 
66-8 ± 7-6 ml min"' dl"'. 
4. Blood flow in grey matter (insular cortex) and white matter (centrum 
semiovale) at normal levels of P(>Q^  averaged 56-8 + 10-1 and 20 3 + 3-4 ml min dl"' 
respectively. As Pco, ^os^ . the increase in r C B F to grey matter was approximately 
three times greater than that to white matter. 
5. An activation state of eyes open in a brightly lit room was compared to a 
baseline state of eyes closed in a darkened room at the three levels of (and 
hence at three levels of gCBF). Over the whole gCBF range a significant {P= 0-028) 
effect of increasing r C B F in the visual cortex ROI was found in response to opening 
t To whom correspondence should be addressed. 
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the eyes; the effect of this activation on rCBF was not significantly dependent 
(P = 0-34) on the Pco, (and hence gCBF) level. The effect of the activation on the 
r C B F was apparently 'additive' to the rise of rCBF associated with Pco^-related 
g C B F increase. 
6. The results confirm the need to normalize for changes in gCBF during studies 
of r C B F in response to an activation protocol. They also provide support for the use 
of an 'additive' model to achieve such normalization provided that other cortical 
areas behave in a similar manner to that of the visual cortex. 
INTRODUCrroN 
Regional blood flow in the brain is tightly coupled to local metabolic demand 
(Kuschinsky & V '^'ahl, 1978; Siesjo, 1984) and hence is sensitive to regional neuronal 
activation; this was first shown in conscious man by Olesen (1971). Global cerebral 
blood flow (gCBF) does not, in general, reflect changes in regional cerebral blood 
flow (rCBF) unless the region activated is very large. The major factors that control 
g C B F are the perfusion pressure and the autoregulation mechanism, together with 
chemical and metabolic factors such as the in the capillaries, the H'^  ion 
concentration and P^Q, in the perivascular space and the cerebral tissue PQ^ 
(Witzleb, 1987;Guyton, 1991). 
To our knowledge, the dependency of an rCBF increase resulting from a neural 
activation upon the prevailing gCBF has not been studied previously. However, 
this has been noted as a problem by workers using positron emission tomography 
(PET) to study regional brain functions (Horowitz, Duara & Rapoport, 1984; 
Metter, Reige, K u h l & Phelps, 1984; Ford, 1986; Moeller, Strother, Sidtis & 
Rottenberg, 1987). I n the absence of experimental data and with the need to take 
account of within- and between-subject variation in gCBF (with the particular 
requirement to identify sites of cerebral activation using intersubjecl averaging), 
statistical models have been developed to normalize for the possible confounding 
effects of changes in gCBF. A proportional model (i.e. r C B F change is linearly 
dependent on g C B F and the relationship goes through zero) has been used by some 
workers (Fox, Mintun, Reimen & Raichle, 1988). Alternatively, an additive model 
has been proposed (Fris.ton, Frith, Liddle, Dolan, Lammertsma & Frackowiak, 
1990) based on the concept that changes in rCBF resulting from activation are 
independent of g C B F . In a study of neural activation resulting from differing 
verbal fluency tasks in four subjects, Friston el al. (1990) concluded that activated 
brain regions were more sensitive to global changes than would have been predicted 
by a simple proportional model and furthermore that the findings were consist-ent 
with an independence of regional and global change. 
The present study therefore seeks to clarify the relationship between the 
prevaihng level of g C B F and the increase in rCBF in specific sites resulting from 
local regional activation. We chose to change baseline g C B F over a wide range 
using controlled steady-state alterations in arterial Ppo, iK.co,) three levels. We 
designed our study such that breathing was kept constant. At each level we 
examined the r C B F response to a well-established activation protocol, visual 
cortical activation (opening of the eyes); this is know n^ to produce a large increase in 
r C B F . During the course of these studies we also wished to compare the results of 
changing Paco, levels on the cerebral circulation and its distribution to 
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representative areas of grey and white matter, as elucidated by PIST, with those 
obtained previously in animals and man using more invasive techniques. 
Depending on the outcome of this study, we planned to further investigate 
whether hypercapnic stimulation of breathing activates any cerebral regions 
(Murphy, Meir, Adams & Guz, 1990) independently of the overall increase in gCBF, 
an inevitable consequence of an increase in P^ co,-
METHODS 
Subjects 
Six normal right handed males (mean age 32; range 26-42 years) were studied; informed 
consent was obtained. The study was approved by the local ethical committee and approval to 
administer radioactive isotopes was given by the Administration of Radioactive Substance 
Approval Committee ( A R S A C ) U K . Two of the subjects were co-authors and the others were 
scientific colleagues. 
Erperimenlal protocols and mtasunmenU 
Induclion of changes in global cerebral blood flow (gCBF) 
Changes in global cerebral blood flow in each individual were produced by establishing 
different levels of arterial PQ^^ at rest. To establish hypocapnia, subjects voIitionaUy 
hyperventilated, with a constant respiratory rate of 10-12 breaths min"' and a tidal volume of 
1-5-2 0 1, to produce a stable end-tidal Pco, ( ^ E T C O J of approximately 20 mraHg. To achieve 
normocapnia, this pattern of ventilation was maintained and dead space (corrugated plastic 
tubing; i.d. 3 5 cm) was added to establish a / C T O O , of around 40 mmHg. Hj-percapnia ( / ' C T O O , of 
around 55 mmHg) was established with the same ventilatory pattern but with additional dead 
space and supplementary inspired CO, . I n the presence of any dead space, normosia was ensured 
by supplementary inspired oxygen sufficient to keep arterial oxygen saturation (finger probe 
oximetry; Ohmeda, Biox 3700e, Louisville, USA) at the subject's resting level ( > 95%). In all 
conditions, subjects breathed through a nasal mask connected to an ultrasonic flowmeter (Branta, 
Birmingham, U K ) and C O , analyser (Hewlett Packard 47210A, USA). 
Subjects required training to produce the 'standard breathing pattern' prior to P E T scarming. 
Init ial ly , they were provided with external cues by listening to a cycling ventilator, set at the 
desired respiratory frequency ( / j j and inspiratory time (Tj); the targeted tidal volume ( w a s 
learnt by providing verbal feedback. Training was given over a number of sessions until subjects 
could maintain a constant breathing pattern for periods of 6 min without external cues and 
irrespective of different P^^ levels. 
Visual aciimtion protocol 
The visual cortex was activated by the siibjects keeping their eyes open with the room brightly 
Ut; the control state was with the room darkened and the ej-es closed. 
PET scans 
P E T studies were performed using an E C A T 953B (CTI/Sieraens, Knoxvil le, USA) dedicated 
head scanner; the performance cliaracteristics have been described elsewhere (Spinks et al. 1992). 
The scanner was used in 2-dimensional mode with interplane tungsten septa in place (Townsend, 
1991). RadiolabeUed water (H,"0) , produced continuously by the catalytic reaction of '*0, and 
hj'drogen, was used as a tracer of cerebral blood flow. A venous line was inserted in the 
antecubital fossa on the left side to allow administration of the tracer. An arterial line was 
inserted into the left radial artery to allow monitoring of radiactive levels (for subsequent 
quantification of g C B F and r C B F values) and for analysis of blood gas levels. A polyurethane 
head mould was fitted to minimize head movement and the head was placed in the scanner so 
that the lowermost plane of scan acquisition was approximately parallel to and 15-18 mm above 
the orbito-meatal line. Subjects lay supine in the quiet darkened room with eyes closed while a 
transmission scan (using orbiting **Ge/**Ga rods) was collected prior to tracer administration for 
the purpose of individual attenuation correction of emission data. 
Cerebral blood flow studies were performed using a previously described method (Lammertsma 
et al. 1990; Colebatch et al. 1991). Briefly, between 1-8 and 2 9 GBq of H,'*© was administered 
intravenously at a constant rate infusion of 10 ml min"' over 1 rain; this was followed by a 30 s 
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saline fiu.sh. A multi-frame dynamic scan was acquired over a 4 min period starting 30 s prior to 
the start of the intravenous infusion. Arterial levels of radioactivity were monitored 
continuously' using an on-line detection system as described previously (Colebatch ei al. 1991). 
Global and regional cerebral blood flow could then be calculated over the period of each scan. 
Protocol 
Six scans were collected for each subject with periods of at least 10-12 min between scans to 
allow for both decaj- of radioactivity and any required re-establishment of normocapnia from the 
previous measurement. T w o scans were performed at each level of /'jn-.co,. P^'r was in 
the rest condition with eyes closed while the other was in the neural activation condition of eyes 
open. T h e ordering of conditions was balanced within a study and across subjects. The stable 
ventilatory pattern and the P^ required were established for at least 2 5 min before the 
beginning of the scan and then maintained during the scanning period. A 2 ml sample of arterial 
blood was taken immediately- at the end of the scanning period for analysis of p H , and P^^ 
(Novastat Profile 5, Nova Biomedical. Waltham, MA, USA) . 
Blood pressure measurement 
O n a separate occasion, blood pressure was measured (Sphygraomanometry with Korotkov 
sounds) during identical experimental conditions, but without P E T scanning, Ln five of the six 
subjects. 
Image analysis 
Image analysis was performed on a S P . \ R C l computer (Sun Microsystems Europe Inc., Surrey, 
U K ) using an interactive image analysis software package ( A N A L Y Z E , Biodynamic Research 
Uni t , Mayo Clinic, Rochester, MN, USA). Calculations and image matrix manipulations relating 
to the identification of sites of activation were performed in P R O - M A T L A B (The Mathworks Inc., 
Sherbon, M A , USA). To Increase the validity and precision of the 'regions of interest' (ROT) 
placement, all the images were stereotactically normalized as previously described (Priston, Prith, 
Liddle & Prackowiak, 1991). Following normalization, the data correspond to the standard brain 
dimensions used by Talairach & Toumoux (1988) in their stereotactic atlas. The resulting images 
consisted of twenty-sLx planes of voxels (i.e. slices) measuring 2 mm by 2 mm by 4 mm in the i 
(right and left of midline), y (rostral and caudal to the anterior commissural line) and 2 (dorsal and 
ventral to the intercommissural plane) directions respectively. 
Measuremenl of global cerebral blood flow 
A whole brain ROT was drawn directly on the raw data of the d^j-namic images; the scalp was 
excluded. T h i s region was drawn in the middle third of the brain and global flows were then 
calculated using the technique of Lammertsma el al. (1990). 
Identification of regions of interest and calculation of their rCBF 
Without activation - grey and white matter. Grey and white matter R O I s were chosen from one 
of the cerebral hemispheres; The grey- matter R O I was sited in the insula and its operculae from 
the frontal and temporal lobes (see inset of Fig . 2); this region was positioned on a number of 
planes (3-6) which varied between subjects to allow the same gyral anatomy to be included from 
brains of different size. The volume of brain identified was 10-15 ml with the central plane 4 mm 
below the intercommissural line. The white matter R O I was sited in the centrum semiovale 
region (see inset of Fig . 2) using three planes; the volume of brain identified was approximately 
5 ml with the central plane 28 mm above the intercommissural line. 
T o obtain the highest possible degree of accuracy, these ROIs were projected on the original 
dynamic frames in order to obtain grey and white matter time-activity curves. These curves 
were then fitted to give both r C B F and the volume of distribution of water, taking into account 
delay and dispersion of the arterial input function as described previously (Lammertsma et al. 
1990); this allowed the computation of absolute blood flow. 
With visual activation task. The sites of neuronal activation with these tasks were defined 
during normocapnia using the functional C B F data from all subjects (obtained with a fixed 
volume of distribution of water of 0 95) as described previously (Lammertsma et al. 1990); t ie 
anatomical variation between subjects was reduced by convolving the data with a Gaussian filter 
(fuU-w'idth half-maximum 20 mm). Any physiological variation resulting from differences in 
g C B F was corrected for by treating global counts as a confounding variable using an analysis of 
covariance ( A N C O V A ; Friston et al 1990). Adjusted condition means and variances were 
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compared using linear contrasts and the resultant three dimensional maps of / statistical values 
(corrected for multiple non-independent comparisons) for the F < 0 05 level of significance were 
then displayed (Friston et al. 1991). The visual activation task produced large r C B F increases 
bilaterally in the regions around and just superior to the calcarine fissure (see Results), and ROIs 
were defined on the three planes with the highest values. On each of these planes the voxel with 
the highest / value was defined as the centre of a circular region with a volume of thirty-two 
voxels (i.e. each region approximately 0 5 ml). These regions were then applied to anatomically 
normalized unsmoothed images which had not been subjected to an A N C O V A correction for 
global flow. T h e mean voxel value was then determined for these regions and this was used to 
determine the r C B F within the visual R O I for each subject in each of the six experimental scans. 
Statistical analysis 
To test the constancy of breathing at different levels of P^co, "'''^ visual neural 
activation, mean values (over each scan) of inspired minute ventilation (F,), F^, and i'pr.oo, 
were compared between conditions using a two-factor analysis of variance (BMDP) w t h CO, level 
(low:normal:high) and activation state (rest:activation) as factors. Differences in r C B F between 
grey and white matter and the dependency of any such differences on the level of g C B F were 
examined using a two-factor analysis of variance with CO, level (low:normal:high) and 
anatomical site (grey:white) as factors. Differences in g C B F and in r C B F in response to visual 
neural activation and the dependence of any differences on the level of g C B F were examined 
using a two-factor analysis of variance with C O , level (low:normal:high) and activation state 
(rest:activation) as factors; for all comparisons P < 0 05 in a two-tailed test was taken as 
indicating a statistically significant difference. The least significant difference of Fisher (1935) was 
calculated from the analysis of variance to show the smallest difference between any two means 
which is statistically significant. 
RESULTS 
Subjects' comments 
The subjects confirmed that during the scans they had remained awake and had 
kept their eyes open or closed as requested. All subjects were confident that they 
had been, able to maintain a fairly uniform pattern of breathing during the tasks 
although they all commented that this had been more difficult in the hypercapnic 
condition due to an uncomfortable feeling of needing to breathe more. Subjects also 
reported feeling hot and flushed during hypercapnia; by contrast most felt cool or 
even cold during hypocapnia. There were no reports of any other symptoms during 
hypocapnia and there was no evidence of tetany. Subjects did not report any 
difference in the attention required,to execute the breathing task either at different 
COj levels or during neural activation runs. 
Pattern of breathing 
Individual values for breathing pattern and end-tidal Pco, (PET.CO)' ^^ e three 
levels of COj and during the rest and activation states are shown in Fig. 1. The 
results of the analysis of variance indicated the expected statistically significant 
differences in mean PETCO, 'evels between hypocapnia (21-0 mmHg), normocapnia 
(40-0 mmHg) and hypercapnia (54-6 mmHg). Mean was significantly greater at the 
high (X) , level (mean = 34-9 1 min"') compared with the low (29 8 1 min"') and normal 
(29-7 1 min"') levels although there were no significant differences for mean (low, 
16-9; normal, 16-9; high, 18-5 breaths min"') or (low, 176; normal, 174; high, 
1'84 1). Comparison between rest and activation states over the range of CO, levels 
showed that mean was significantly greater with activation (18 2 min"') compared 
^'ith rest (16-7 min"'); there were no .signiHear.t difference? for Pf:,v.>,. ^'i. ' V 
526 S C. RAMSAY AND OTHERS 
c 
E 
E 
50-
45-
40-
35-
30-
25-
20-
15-
25-
2 0 -
1 5 -
10-
2-5-
2 0 -
1-5-
1 0 -
6 0 -
5 0 -
4 0 -
3 0 -
2 0 -
1 0 -
Low Norma] High 
=• 
o 
X 
l « 8 
R A R A R A 
Fig. 1. Average values (over 1 min of H , " 0 infusion) of inspired minute ventilation 
respiratory frequency (J-^, tidal volume (F^) and end-tidal Pco, (^ ET.COI) for each of 6 
subjects (®, subject 1; V , subject 2 ; B , subject 3; A., subject 4; O , subject 5; • , subject 6) 
in each of the experimental conditions. Low, normal and high represent the three Pco, 
levels at which the scans were performed during resting (R) and visual activation (A) 
conditions. Note the close matching of ventilatory variables across the experimental 
conditions and between rest and activation states despite clear differences in P^ co,-
Blood pressure and arterial blood gas levels 
In five subjects, tested at a different time, the average blood pressures during the 
steady-state periods of were: 120/75 during hypocapnia, 122/78 during 
normocapnia and 143/86 mmHg during hj'percapnia. Analj-sis of variance showed 
that the mean blood pressure (±S.D.) was significantly higher (P = 0 018) during 
hypercapnia (105+10) compared with hypocapnia (90 ± 8) or normocapnia 
(92+ 8 mmHg). In general, there was close agreement in individuals between 
GLOBAL AND REGIONAL CEREBRAL BLOOD FLOW IN MAN 527 
arterial P<-.o^  measured at the completion of a scan and end-tidal Pco, averaged over 
the period of scanning (+ 2 mmHg); however in a few instances there were 
discrepancies between the two measurements (+ 5 mmHg). In view of this, P^ co^ 
measurements were utilised in subsequent analyses since they relate better to the 
period of scanning and do not depend on a single measurement. The average 
arterial PQ, measurements (rest and activation runs combined) were; 128+11 
during hypocapnia; 118+16 during normocapnia and 129 + 15 mmHg during 
hypercapnia. Analysis of variance showed that there were no statistically 
significant differences between these levels (P — 0-158). 
Effect of P(^ on global cerebral blood flow 
The values for PEXCO, *nd corresponding measurements of gCBFat rest with eyes 
closed are given for each subject in Table 1. The mean gCBF during normocapnia 
was 37-2 + 3-9; during hypocapnia it was 24-2 + 4-6; and during h37)ereapnia it 
was 66-8 + 7-6 ml min"'dl"'. The average ratio (from individual values) of 
AgCBF:APco, for the low to normal P^o, change was 0-72 ± 0 1 5 (range 0-44-0-85); 
and for the normal to high P^o, change it was 2-00 + 0-32 (range 1 •40-2-26) 
ml min"' dl"' mmHg"'. 
Effect o/Pco, 071 blood flow in grey and white matter 
For each individual, the measurement of gCBF obtained in each of the three 
scans (i.e. low, normal and high Pco,) in the rest (eyes closed) condition was paired 
with the r C B F measurement for the grey matter region of interest (ROI) and 
separately with the r C B F for the white matter ROI . These data have been plotted 
for each of the six subjects in Fig. 2. The mean values with normocapnia for grey 
and white matter were 56-8 + 10-1 and 20-3 + 3 4 ml min"'dl"'respectively. In 
eaeh subject, when related to Pgr co, (Fig- 2/4), the increase in rCBF for grey matter 
is greater than for white matter, particularly in the normal to high P^^ range. 
Thus in the low to normal Pco, range, the mean changes in blood flow for grey and 
white matter are 0 99 + 0-60 and 0-39 ± 0'14 ml min"' dl"' mmHg"' respectively; 
these changes are significantly different (paired t test; P = 0-01). For the normal to 
high Pco, range, the mean change in blood flow for grey matter is 2-97 + 1-07 and 
for white matter this ratio is MO + 0-34 ml min"'dl"'mmHg"'; these ratios are 
significantly different (paired t test; P = 0-001). Figure 2Pshows the same grey and 
white matter r C B F values for each subject, but in this case plotted against the 
prevailing g C B F value at each of the Pco, levels. For each subject there is a nearly 
hnear increase in r C B F as gCBF rises, with intercepts close to zero. The mean ratio 
over the entire range of gCBF (i.e. ArCBF/AgCBF) is 1-53+ 0-24 for grey and 
0-52 + 0-18 for white matter. 
Analysis of variance on the pooled data confirms the obvious effect on rCBF for 
both grey and white matter ROIs when the gCBF is increased by Poo,iP < O-OOOl); 
furthermore the r C B F within grey matter was significantly different from that 
within white matter over the range of Pco, ( P < 0-0001). The presence of a 
significant interaction term (P < 0-0001) between the Pco, factor and the R O I 
factor confirms that the pattern of increase in rCBF within grey matter was 
significantly different from that within white matter as gCBF increased. 
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Effect of visual activation on rCBF 
Opening the eyes activated the primary visual cortex bilaterally (see Methods); 
the three dimensional map of the / statistical values at normocapnia showed 
significance at the P < 0 05 level. The rCBF as-sociated with visual activation was 
determined from the mean voxel values in the visual ROIs (see Methods). These 
TABLE 1. Individual and mean values for end-tidal Pco,('" mmHg), regional cerebral blood 
flow ( r C B F ; in ml min"' dl"') in a visual region of interest and global cerebral blood flow 
(gCBF; in ml min"' dl"'). 
Condition 
Subject 
number 
1 
Mean 
Low P„ Normal P^ High Feo, 
Eyes closed Open Eyes closed Open Eyes closed 
Open 
g C B F 
r C B F 
24 
29 
32 
21 
28 
37 
39 
39 
41 
44 
48 
67 
55 
72 
84 
53 
68 
79 
Poo, 
g C B F 
r C B F 
22 
23 
27 
21 
23 
26 
39 
37 
37 
40 
39 
40 
55 
68 
76 
54 
72 
74 
^ F 
r C B F 
24 
18 
38» 
20 
19 
26 
41 
31 
32 
38 
32 
38 
53 
58 
62 
56 
57 
70 
^ F 
r C B F 
20 
26 
27 
16 
26 
34 
40 
43 
48 
40 
45 
57 
56 
75 
78 
55 
74 
87 
g C B F 
r O B F 
20 
20 
27 
21 
21 
33 
41 
36 
41 
39 
31 
42 
56 
57 
66 
54 
60 
73 
g C B F 
r C B F 
21 
29 
37 
22 
29 
40 
39 
37 
44 
40 
38 
57 
54 
71 
80 
54 
76 
89 
g C B F 
r C B F 
21-8 
-• 24-2 
31-4 
20-2 
24-3 
32-7 
39- 8 
37-2 
40- 5 
40-3 
38-3 
50-1 
54-8 
66-8 
74-2 
54-4 
67-8 
78-7 
Values are given for each of the three P^ conditions (low, normal and high) and for the rest 
(eyes closed) and activation (eyes open) states. * indicates a presumed invalid measurement due 
to undefined error (see text). 
values are given for each condition for each subject, together with the gCBF and 
PET CO,, in Table 1; the mean values for PETCO,' g^^-^ rCBF are also given. 
Examination of the data shows one point (subject 3, low P^, eyes closed) with a 
high r C B F which reduces markedl}' in response to a visual activation; it was 
thought likely that this point was a result of undefined experimental error. 
Figure 3 presents the mean data of the group of five subjects (i.e. excluding subject 
3) of the effect of visual activation on rCBF at the different gCBFs resulting from 
changes in Pco,- Analysis of variance on the data from these five subjects shows an 
overall (i.e. across the range of PQC studied) significant effect of visual activation 
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Fig. 2. Values of regional cerebral blood flow (rCBF) in standard cerebral regions 
comprising predominantly grey matter (®) and white matter (O) for each of six subjects in 
the absence of visual activation (eyes closed). The inset sho^-s diagramaticaily the areas 
chosen for the grey matter region of interest (GROI; the insula and its operculae from the 
frontal and temporal lobes) and the white matter region of interest (WHOI; the centrum 
semiovale region). The same r C B F data are plotted separately against the end-tidal Ppo, 
(^CT.co,; Fig- 2/4) and global cerebral blood flow (gCBF; Fig. 2B). With respect to PCT.CO, the 
changes in r C B F are greater for grey matter than for white matter particularly with 
hypercapnia. With respect to g C B F , r C B F in each subject increased linearly for both grey 
and white matter; for each subject, regression equations have intercepts close to the origin 
but slopes are invariably greater for grey matter, y is r C B F , x is gCBF and r is the 
correlation coefficient. 
(P = 0-028) on r C B F ; the same activation produces a minor, non-significant 
(P = 0-083) increase in gCBF. There was no significant interaction term between 
the Pco, factor and the activation factor (P = 0-340) on rCBF implying that the 
effect of activation on r C B F was not dependent on the Pco, level and hence on 
gCBF. Similarly, there was no significant interaction term between the Pco, factor 
and the activation factor (P = 0-787) on gCBF. 
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Analysis of variance on the data from all six subjects (i.e. including subject 3) still 
shows an overall significant increase in rCBF of visual activation {P = 0-031) and a 
non-significant interaetion term between the Pco, factor and the activation factor 
{P = 0-233) on r C B F . The only apparent effect of including the data from subject 3 
was to minimize the difference in rCBF due to visual activation at a low Ppo, (Table 
l .cf . Fig. 3). 
p 80 
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gCBF (ml min"' dr^ 
Fig. 3. Mean values ( + S.D. bars) of regional cerebral blood flow (rCBF) in the visual 
cortical R O I with eyes closed (O) and eyes open (®) plotted against global cerebral blood 
flow (gCBF) resulting from the change in P^^ in 5 of the 6 subjects (see text). Fisher's (1935) 
least significant difference (LSD) is presented geometrically to indicate the difference 
between r C B F values necessary to achieve statistical significance At P < 0-05 (see text). At 
each Pco, level, visual activation (opening eyes) is associated with greater increases In r C B F 
compared with the change in gCBF. 
DISCUSSION 
The most crucial finding in the present study is the demonstration that neural 
activation of the visual cortex causes an increase in regional cerebral blood flow 
(rCBF) which is independent of the prevailing level of global cerebral blood flow 
(gCBF). I t has considerable practical relevance for the normalization of rCBF 
measurements to take account of variations in gCBF which occur during neural 
activation studies. A further significant aspect of the present study is that we have 
been able to use P E T to confirm and extend previous observations in man (using 
'inert gas'techniques) on the effect of increased arterial P^o, C B F and its relative 
distribution to representative areEis of grey and white matter. 
We have documented a mean range in gCBF from 24-67 ml min"' dl"' as end-
tidal P^ was experimentally adjusted between 22 and 55 mmHg. By achieving 
this at a relatively constant ventilation for each P^^ level, we were able to control 
for any possible confounding influence that the act of breathing itself might have 
on gCBF. The average level of gCBF recorded in the present study under resting 
normocapnic conditions was 37 ml min"' dl"' . This is somewhat lower than the 
range of 45-55 ml min"' dl"' identified by Lassen (1985) as the 'Gold Standard' in a 
critical review of the literature. The fact that we obtained a value for gCBF below 
this range, strongly suggests a systematic error probably arising in the present 
study from the choice of the middle third of the brain (see Methods) to obtain data 
for subsequent normalization by a geometrical estimate of total intracranial 
volume; this would include the ventricles and cisternae even though radioactive 
'counts' relate essentially to the vascularized regions. 
I n the present study, we have confirmed previous observations in man that Poo, 
alterations cause substantially greater changes in C B F above the normocapnic level 
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than in the hypocapnic range (see Fig. 2). Between 40 and 55 mmHg P^^, the mean 
AgCBF/APco, the present study was 2-0 ml min'' dl"' mrnHg"'; between 40 and 
21 mmHg Pgo, t'he mean A g C B F / A f , ^ was 0-7 ml min~' dl"' mmHg"'; these values 
are similar to those derived using inert gas techniques (Kety &, Schmidt, 1948a; 
Novack, Shenkin, Bortin, Guloboff & Soffe, 1953). Thus the present findings, taken 
together with the previous observations cited, lend no support to the view that it is 
permissible to ca,lculate the slope of the best fitting straight line through gCBF data 
in the range of Pco, between 20-60 mmHg (Reivich, 1964), or to use such a slope to 
normalize values of g C B F to a of 40 mmHg as suggested by Purves (1972). 
The average rise in mean arterial blood pressure with hypercapnia in the present 
study of 13 mmHg for an average elevation of Pco, of 15 mmHg compares well with 
previous observations (Kety & Schmidt, 19486; Novak el al. 1953). During normo-
capnia, g C B F in man is independent of arterial blood pressure (Lassen, 1959). 
However, with cerebrovascular dilatation consequent upon the rise in Pco,. such 
autoregulation may well be impaired and if this is so, the small elevations in blood 
pressure documented with hypercapnia may contribute to the increasing A C B F / 
AP^Qj in the hypercapnic compared to the hypocapnic range. 
Since C B F is insensitive to changes in arterial Pq^ above 60-80 mmHg 
(Lambertsen, 1961; Borgstrom, Johannson & Siesjo, 1975) it is unlikely that the 
small range of mean arterial P^^ noted between the different conditions of this 
study (i.e. 118-129 mmHg) could have had any significant influence on the C B F 
levels recorded. 
The mean values for grey and white matter r C B F found with normocapnia were 
similar to those reported by Lammertsma et al. (1990) using a similar technique. 
The present study indicates a disproportionate increase in rCBF in grey compared 
with white matter as P(^ rises above the normocapnic range suggesting that the 
cerebrovascular resistance falls much more in grey than in white matter under 
these conditions. The reason for this phenomenon is unclear but it has been 
reported previously in anaesthetized animals (Hansen, Sultzer, Freygang &. 
Sokoloff, 1957; James, Millar & Purves, 1969). 
The nature of the relationship between focal C B F changes associated with 
activation and levels of global C B F is unclear. Since many activation protocols 
induce only relatively small changes in r C B F compared to the absolute value of 
gCBF, interpretation of such studies requires that changes in gCBF be carefully 
considered. Clearly, if there is a non-specific change in gCBF, it is important to be 
sure that any r C B F change in a ROI is not a mere reflection of the altered gCBF. 
Changes in g C B F could occur in a single subject over time, and also between 
individual subjects, as well as resulting from factors, such as exercise, anxiety or 
changes in acid-base status (as in the present study). In such cases, one would need 
to normalize for changes in gCBF in order that small changes in rCBF due to 
activation could be more readily identified. On the other hand, it is possible that 
the activation task itself may significantly alter global C B F directly through large 
focal changes; normalization for differences in gCBF in this case might be expected 
to downgrade or eliminate the effect in which one was interested (Chadwick & 
Whelan, 1991). 
A number of methods have been proposed to take account of global, region-
independent, inter- and intra-subject variation during regional neural activation 
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studies (Horowitz el al. 1984; Metter el at. 1984; Moeller el al. 1987). Fox el al. 
(1988) have proposed a normalization method for gCBF variation which simply 
involves dividing r C B F by the estimated average gCBF; this proportional model 
necessarily assumes a relationship between rCBF and gCBF which is both linear 
and passes through the origin. Friston et al. (1990) have compared this proportional 
model with an additive model in which neural activation in a ROI would result in a 
similar increase in r C B F over a range of gCBF and have concluded, using- a 
physiological activation protocol (verbal fluency task) that their additive model fits 
the observed data better than the proportional model. Their conclusion was arrived 
at through the use of an analysis of covariance which treats gCBF as a confounding 
'nuisance' oovariate which combines with the 'effect of interest' (rCBF changes 
solely due to neural activation) to produce variance in what is measured (rCBF 
changes in the ROI). However, their conclusion may be limited by the relatively 
narrow variations in gCBF which is likely to have accompanied their activation 
task. 
The present study permits a more direct analysis of the inter-relationships 
between global and regional blood flow changes encountered during P E T studies. 
By inducing changes in gCBF over a wide physiological range it was possible to 
examine the effects on r C B F , firstly, in representative areas of grey and white 
matter in the absence of activation and secondly, in response to a well-defined 
visual activation task. In this way, the appropriateness of normalization, based on 
clear-cut changes in gCBF could be judged. Our study confirms that across a wide 
range of gCBF, the relationship between gCBF and rCBF without activation is well 
described by a simple linear model for the defined areas of grey and white matter 
(see Fig. 2B) and also in the visual cortex (Fig. 3). Moreover, this study highlights 
the fact that the ratio of A r C B F / A g C B F is much higher for grey matter and clearly 
demonstrates the need for normalization of even small non-specific changes in 
g C B F during activation studies. With respect to changes in gCBF in response to 
visual activation, the present study indicates that at a normal arterial P^, there is 
a 23% increase in r C B F in a visual cortical ROI in the face of only a 3 % non-
significant increase in gCBF (Table 1; Fig. 3). Hence, with this activation, any 
normalization for changes in g C B F (which may have been induced by the 
activation) would not have greatly limited the ability to identify an increase in 
r C B F in response to neuronal activation. A different activation, producing much 
smaller increases in r C B F with a similar increase in gCBF would not have been so 
easily detected. Since in practice, it is impossible to know to what extent any 
changes in gCBF reflect non-specific as opposed to activation-related mechanisms, 
the present results point to the fact that normalization for changes in gCBF is 
indeed necessary. 
The present study demonstrates that the increase in rCBF in the visual cortex, 
which accompanies opening of the eyes, shows no systematic dependence on the 
level of gCBFover a wide physiological range. Thus, although the increase in rCBF 
in response to visual activation was apparently greatest at a normal arterial Pcot-
there were significant increases in r C B F associated with the same visual activation 
at both low and high levels of and hence gCBF (Fig. 3). One might hypothesize 
that the activation-related increase in rCBF at low is reduced because of the 
intense prevailing vasoconstriction, while at a high P^ there is such an excess of 
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blood flow that the degree of vasodilatation present may be approaching a 
maximum. In the range of P^^^ studied, and allowing for the relatively small data 
set, both the presentation of the results shown in Fig. 3 and the non-significant 
interaction term ( P = 0-340) between P^Q, (gCBF) factor and the activation (rCBF) 
factor does not provide any basis for rejecting the hypothesis that the plots of r C B F 
against g C B F with eyes closed or opened are parallel to each other. Hence there is 
no support for a proportional relationship between r C B F increases with activation 
and the prevailing level of gCBF. The data support an approximation to an 
additive model as described by Friston et al. (1990) but it must be acknowledged 
that our limited data set do not allow us to reject the proportional hypothesis. 
The results from the present study have a practical significance to those workers 
measuring r C B F to investigate activation of regional cerebral areas under 
conditions where global cerebral blood flow could change in a systematic way. Any 
change in gCBF would necessarily be associated with non-specific changes in r C B F 
in a region of interest. However, the fact that a more specific neural activation was 
still detectable over such a wide range of gCBF implies that normalization, on the 
basis of an 'additive model', should not Umit the ability to study focal changes in 
the face of even substantial changes in total blood flow. I f our results with resjject 
to visual activation are representative of other cortical areas, then studies on areas 
in the brain activated by COj inhalation (e.g. any cerebral areas associated with 
respiratory control) should be possible. 
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Detection of Thirty-Second Cognitive Activations in Single 
Subjects with Positron Emission Tomography: A New 
Low-Dose H2 O Regional Cerebral Blood Flow 
Three-Dimensional Imaging Technique 
ntDavid A. Silbersweig, *§Emily Stern, *Christopher D. Frith. *Connie Cahill, 
*Leonard Schnorr, *Sylke Grooloonk, *Terry Spinks, *John Clark, 
*Richard Frackowiak, and *Terry Jones 
*MRC Cyclotron Unit. Hammersmith Hospital. London. Enf;land: and Departments of ^Psychiairy (Payne Whitney 
Clinic), tNei/rology and Neurosciences. and §Radiology. New Yorii Hospilal-Coniell Medical Center. 
New York. New York. U.S.A. 
Summary: Positron emission tomography regional C B F 
( r C B F ) studies of cognitive processes have traditionally 
required 30-60 mCi of H2''0 per scan and intersubject 
averaging to achieve statistical significance. However, in-
lersubject anatomical, functional, and disease variability 
can make such an approach problematic. A new method 
that produces significant results in single subjects is pre-
sented . It is based upon h igh-sens i t iv i ty three-
dimensional imaging and a "slow" bolus administration 
of < 15 mCi of H2"O per scan. The method is validated in 
four normal volunteers using control and auditory-
language activation tasks with four scans per condition 
and statistical parametric mapping analysis. It is demon-
strated that the r C B F distribution associated with the 
cognitive state is detected during the arrival of radiotracer 
in the brain. This occurs over 30 s and constitutes a crit-
ical temporal window during which stimulation should be 
performed. A 90-s acquisition time is found to produce 
results of greater significance than a 60-s acquisition time. 
The implications of the results and the functional neuro-
anatomical findings are discussed. This method is suitable 
for the study of individual functional neuroanatomy in 
many neuropsychological, pharmacologic, and symptom 
states in normal subjects and in patients with psychiatric 
and neurologic disorders. Key Words: Functional brain 
imaging—'^O-labeled water—Positron emission tomog-
raphy—Regional cerebral blood flow—Single-subject 
analysis—Slow bolus technique. 
Functional brain imaging of regional CBF (rCBF) 
with positron emission tomography (PET) provides 
an in vivo index of localized synaptic activity asso-
ciated with cognitive and behavioral states in hu-
mans (Raichle, 1987). "O-labeled water, despite 
some limitation in diffusion (Eichling et al., 1974), is 
currently the preferred CBF tracer because of its 
short half-life (2.05 min), ease of production and 
use, and low toxicity (Lammertsma and Mazoyer, 
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Abbreviations used: B A , Brodmann's area; 3-D, three-
dimensional; N E C , noise equivalent count rate; PET, positron 
emission tomography; r C B F , regional C B F ; SMA, supplemen-
tary motor area; SPM, statistical parametric map. 
1990). Qualitative subtraction studies utilizing 30-
60 mCi of Hj'^O per scan and a two-dimensional 
scanning technique (with interplane septa) have 
provided valuable information concerning func-
tional neuroanatomy (Posner et al., 1988; Zeki et 
al., 1991). However, limitations on acceptable 
doses of administered radioactivity and limitations 
of scanner sensitivity have necessitated the use of 
multiple subjects to obtain results of statistical sig-
nificance. While intersubject averaging may in-
crease the generalizability of results, it introduces 
additional problems associated with intersubject an-
atomical, functional, and disease variability (Fris-
ton and Frackowiak, 1991; Raichle et al., 1991; 
Watson et a!., 1993). It is therefore desirable to be 
able to perform within-subject analyses of activa-
tion studies. The possibility of single-subject stud-
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ies also raises the issue of examining transient or 
randomly occurring brain or mental states that con-
stitute signs or symptoms in individual patients. An 
ideal single-subject technique should therefore have 
a well-defined temporal window and permit signal 
averaging to allow the study of events not under 
direct experimental control. 
Recent technical and methodologic developments 
in PET have made it possible to scan with inter-
plane septa retracted, enabling three-dimensional 
(3-D) acquisitions of all possible lines of response 
within and across planes (Townsend et al., 1989). 
This results in greater detection of true events and 
permits scanning at lower administered activities 
where random coincidence rales and dead time are 
less problematic. A fully 3-D reconstruction algo-
rithm takes maximal advantage of the increased sig-
nal, providing increased sensitivity without a signif-
icant decrement in resolution (Townsend et al., 
1991). Hj '^O can therefore be given in lower doses, 
producing significant gains (of four- to fivefold) in 
noise equivalent count rates (NECs; a signal-to-
noise measure) and allowing a greater number of 
scans to be performed on each subject (Bailey et al., 
1991a). The combination of these factors results in 
increased statistical power. 
The aim of this study was to determine whether 
the increased sensitivity of a 3-D technique would 
enable the detection of statistically significant 
changes in rCBF associated with a cognitive acti-
vation task in single subjects. To validate the tech-
nique and to characterize its temporal window, a 
single-subject activation paradigm was designed 
with several considerations in mind. Hj'^O was ad-
ministered as a "slow" bolus to avoid some of the 
timing and statistical errors (Dhawan et al., 1986; 
lida et al., 1986; Lammertsma et al., 1989) and in-
creased dead time associated with the rapid "auto-
radiographic" bolus method (Herscovitch et al., 
1983; Raichle et al., 1983) while minimizing the de-
cay, CBF nonlinearity (lida et al., 1991), and task 
habituation problems associated with the longer 
stimulation and scanning times of a ramp infusion 
method (Colebatch et al., 1991). The slow bolus re-
sulted in the delivery of tracer to the brain over a 
period of 30 s. It was reasoned that this input phase 
would constitute a critical period during which the 
rCBF distribution would be detected. Therefore, in 
the activation condition, 30 s of auditory stimula-
tion was timed to coincide with this 30-s interval. 
Stimulation before and after the rising interval was 
also performed to define the boundaries of the tem-
poral window during which brain activity was being 
measured. Hz'^O was delivered serially in low 
doses to allow signal averaging within conditions 
for a single subject. A range of doses, from 5 to 21 
mCi per scan, was used to determine the lowest 
practical dose that provides sufficient NECs for the 
detection of a focal rCBF activation in a single sub-
ject and to determine the relationship between 
NECs and administered radioactivity with this tech-
nique. Double-frame data acquisition (60 s -(- 30 s) 
was used to allow for a comparison of different ac-' 
quisition times. Acquisition time is known to have 
significant effects on counting statistics, linearity lo 
flow, intravascular signal, and errors due to disper-
sion, time mismatch, tissue heterogeneity, and par-
tition coefficient (Koeppe el al., 1987; Kanno et al,, 
1991), Sixty-second and ninety-second acquisition 
times were chosen based upon the trade-off be-
tween f low information and error sensitiviiy 
(Kanno et al,, 1987) to determine the parameters of 
an optimal clinical functional brain-imaging para-
digm, 
METHODS 
Subjects 
The subjects were four normal male volunteers aged 
26-30 years who gave informed consent. All were right-
handed and had no history of psychiatric or neurologic 
illness, 
H2"0 administration 
Five to 21 mCi of H , " 0 in 3 ml of normal saline was 
loaded into intravenous tubing over 20 s and flushed into 
the subject over 20 s at a rate of 10 ml/min by an auto-
matic pump. After a delay of 35 s, a rise in counts was 
detected in the head, which peaked 30-40 s later (depend-
ing on individual circulalion time). The interval between 
successive Hj'^O administrations was 10 min. The pro-
cedure for administering radioactivity was covered under 
an approval by the local ethical committee and ihe Ad-
ministration of Radioactive Substances Advisor\' Com-
mittee ( U . K . ) . 
NEC determination 
The global N E C , a measure of signal-to-noise, was cal-
culated for the background- and dead time-corrected im-
age data of subjects 1, 2. and 4 using the following equa-
tion: 
N E C = 
[Td - SF)? 
T+2fR 
where 7 is unscattered + scattered true counts, R is ran-
dom counts, SF is scatter fraction ( = 0,31, based upon 
phantom line sources, assuming an average head diame-
ter of 18 cm) (Spinks et al, , 1992), a n d / i s fraction of field 
of view subtended by the head ( = 18 cm/50 cm = 0,36) 
(Strother et a l . , 1990). 
Control and activation tasks 
All four subjects were scanned in two conditions, and 
in addition, two of the subjects were scanned in a third 
condition. Four scans were obtained in each condition. 
Each session therefore consisted of 8 or 12 scans accord-
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incly The order of the conditions was balanced to avoid 
systematic time and order effects. In all conditions the 
subjects were in a supine position with their heads in 
customized head molds. An intravenous line was placed 
in the right antecubital vein. Their eyes were closed, ear-
phones were inserted, and a button-pressing device was 
held in their right hand. The button was linked to a pulse 
generator that produced a signal (logged every second by 
a Sun computer) that could be superimposed upon the 
simultaneously recorded total head counts. The room was 
dark with only low-level background noise. The experi-
mental paradigm is illustrated in Fig. 1 and the conditions 
were as follows: 
Condition I ; control (all four subjects). The subjects 
were instructed to relax and to press the button with their 
right thumb if, and for as long as, they heard sentences 
spoken through the earphones. No sentences were pre-
sented in this condition. This task represents auditory 
attention and preparatory set. Condition 2: auditory sen-
tence presentation during the rising phase of the head 
curve (all four subjects). The instructions were the same 
as for condition 1, but this time prerecorded single words 
or short sentences (mean length 3.7 words, range 1-12 
words) of random content were presented binaurally with 
normal prosody at an average rate of 2.1 words/s. The 
auditory stimulation was 30 s in duration, coinciding with 
the rising phase of the head curve. This task represents 
auditory sentence monitoring and sustained button press-
ing. Condition 3a: auditory senience presentation before 
the rising phase of the head curve (one subject). The in-
structions were the same as for condition I and the stimuli 
were the same as for condition 2. However, in this con-
dition the 30 s of auditory stiinulaiion preceded, and fin-
ished 2 s before, the rising phase of the head curve. Con-
dition 3b: auditory sentence presentation after the rising 
phase of the head curve (one subject). Again, the instruc-
tions were the same as for condition 1 and the stimuli 
were the same as for condition 2. However, in this con-
dition, the 30 s of auditory stimulation immediately fol-
lowed the peak of the head curve. 
Data acquisition and image reconstruction 
Scans were obtained with a P E T scanner (953B; Sie-
mens-CTl , Knoxville, T N , U . S . A . ) with the interplane 
septa retracted (Spinks et al . , 1992). This scanner utilizes 
block technology detectors and contains 16 individual 
rings, each 6.5 mm thick axially, which results in a total of 
31 measured planes (direct and cross). In 3-D mode, the 
scanner is able to acquire 256 oblique sinograms, one 
between any pair of opposing detectors. This is unlike the 
normal two-dimensional mode with septa, which limits 
sinograms to small (typically fewer than three) ring dif-
ferences and results in projections orthogonal to the a.xial 
plane of the scanner (Bailey et al . , I991fl). 
A 20-min transmission scan using rotating rods of'^Ge/ 
''"Ga was performed for attenuation correction. A 30-s 
frame for background activity correction was obtained 
before each administration of H,'-'^0. After a 35-s delay, 
data were acquired in two consecutive frames of 60 and 
30 s, beginning 0-5 s before the rising phase of the head 
curve. Data from the two frames were summed to gener-
ate a 90-s image that could then be compared with the 
single-frame data of the 60-s image. 
The images were reconstructed into 31 slices with a 3-D 
FIG. 1. The slow bolus tech-
nique. The timing of H2'*0 ad-
ministration, cognitive stimula-
tion, and data acquisition are 
shown with respect to each 
other and with respect to the 
head curve (counts per second 
detected over lime). On the 
X-axis, time = 0 corresponds to 
the initiation of the scanning 
(acquisition) protocol, which in-
cludes a background frame, de-
lay interval, and two data collec-
tion frames. The Hj'^O adminis-
tration protocol begins 90 s 
earlier with the buildup of ra-
diotracer that is subsequently 
loaded into the intravenous line 
and flushed into the patient. In 
this study, auditory stimulation 
was performed before, during, 
or after the rising phase of the 
head curve. 
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algorithm ( T o w n s e n d et a l . , 1991) in which back-
projection was performed at nonorthogonal angles to the 
axis of the scanner. A Manning filter with a culoff fre-
quency of 0.5 cycle/s was used at this stage, giving a 
transaxial resolution of 8.5 mm full width al half-
maximum. The reconstructed images contained 128 X 128 
pixels, each measuring 2.006 x 2.006 mm. 
Image analysis 
Image analysis was performed on a S P A R C 2 Worksta-
tion (Sun Microsystems, Europe, Surrey) using statistical 
parametric mapping ( S P M ; S P M Software, M R C Cyclo-
tron Unit, London, U . K . ) and an interactive image dis-
play software package (Analyze; Biodynamic Research 
Unit, Mayo Clinic) . Calculations and image matrix ma-
nipulation were performed in P R O M A T L A B (Math-
works, New York) . 
The 31 original contiguous 3.5-mm scan slices were in-
terpolated to 43 planes lo render the voxels approxi-
mately cubic. All images were aligned on a voxel-by-
voxel basis using a 3-D automated algorithm (AIR Soft-
ware) (Woods et a l . . 1992). The intercommissural 
(anterior commissural-posterior commissural) line was 
identified according to a previously described method 
(Frision et a l . , 1989) and the volume transformed into the 
standard stereotaxic space utilized in the atlas of Talai-
rach and Tournoux (1988). The stereotactically normal-
ized images contained 26 planes of 2 x 2 x 4-mm voxels 
corresponding to the horizontal sections in the atlas. 
Each image was smoothed with a Gaussian filter 10 mm 
wide to increase the signal-to-noise ratio and to accom-
modate normal variability in functional and gyral anat-
omy for group analysis. 
Differences in global activity were removed following 
an analysis of covariance (Friston et al . , 1990) with global 
counts as covariate and control or activation condition as 
treatment. This analysis was performed for every pixel 
and generated a mean pixel value with associated error 
variance for each condition. Differences in the adjusted 
condition means were assessed for single subjects and for 
the group as a whole using the / statistic. For each com-
parison between control and activation conditions, foci of 
significant increases and decreases of activity were iden-l 
tified and images of the pixel / values were created (Fris-
ton et a l . , 1991). The omnibus significance of these SPMs 
was assessed by comparing the expected and observed 
number of pixels above a significance threshold of p <; 
0.01 or p < 0.001 using the x^-statistic. The SPM {() val-
ues were also transformed to the unit Gaussian distribu-
tion using a probability integral transform so that changes 
could be reported as Z scores. The SPMs were displayed 
as volume images of the highest / values in three orthog-
onal projections. To indicate the change in cerebral ac-
. tivity between conditions, the r C B F equivalenis were cal-
culated for brain locations of special interest identified as 
significance maxima on the SPMs and then normalized to 
50 ml/dl/min (Mintun et al. . 1989). The adjusted r C B F 
represents a Gaussian-weighted condition mean r C B F 
over a 12-mm full width at half-maximum sphere centered 
on a local statistical maximum. 
H 
RESULTS 
,'^0 doses and NECs 
Peak head counts ranged from 114,000 to 250.0CK3 
counts/s, with 60-81% true events and a l-\4% 
dead time. Highly significant results (p < 0.001. om-
nibus) were obtained in all subjects, including sub-
ject 4, who received 5-10 mCi of H, ' ' '0 per scan. 
Global NEC values rose with increasing dose. 
NECs per millicurie were plotted against adminis-
tered dose of radioactivity in the three subjects (1. 
2, and 4) for whom data were available (Fig. 2). .A 
linear relationship with a negative slope was ob-
served. Lower doses provided more NECs per mil-
licurie, with a two- to threefold gain at 5 mCi com-
pared with 20 mCi. Over the range of doses, the %-i 
acquisition time provided an average gain of 1.6-
fold in NECs per millicurie compared with the 6f>s 
acquisition time. 
A 9 0 second acquisition lime 
• 6 0 second acquisition time 
FIG. 2. Noise equivalent count rates (NECsi 
per millicurie for the range of administe-ec 
Hj '^O doses in subjects 1, 2. and 4. Lo<»er 
doses and the 90-s acquisition time produce 
greater gains in signal-to-noise ratio per - i l -
licurie. Linear regression performed on ; ie 
90-s acquisition time data reveals the rela-
tionship Y = -0.25x + 8.17; R = 0.97. p = 
0.0001. Linear regression performed on aie 
60-s acquisition time data reveals the relc-
tionship Y = -0.16x + 5.19; R = 0.93. : = 
0.0001. 
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Slcnificance levels 
SVIicii (he control and activation conditions were 
contrasted, profiles of significant relative increases 
and decreases in cerebral activity were obtained. 
7hc main comparison was between condition 2 
(stimulation during the rising phase of the head 
curve) and condition 1 (control). In single subjects 
with four s c a n s in each condition, the profiles of 
increases (at a threshold of p < 0.001) and de-
creases (at a threshold of p < 0.01) demonstrated 
brain regions comparable with those obtained when 
intersubject averaging (at a threshold of p < 0.001) 
was performed (Fig. 3). The Z scores for the in-
creases were generally of larger magnitude than 
those for the decreases (see Tables 2-5). Changes in 
adjusted rCBF values as small as 5% were detected 
at a level of p < 0.001. 
Timing of stimulation 
Stimulation before and after the rising phase of 
the head curve (conditions 3a and 3b) did not result 
in significant profiles of increased or decreased ac-
tivity when contrasted with control condition I (Ta-
ble !) . 
G R O U P 
Subject 1 
FIG. 3. SPM {f} profiles (p < 0.001, omnibus) of increased 
activity for condit ion 2 (auditory sentence monitoring during 
the rising phase of the head curve) versus control condition 
1 (auditory attention/preparatory set) with a 90-s acquisition 
time. Sagittal, coronal, and transverse volumetric projections 
• are shown. R, right. The single-subject profiles are compa-
• ^ ^ f e W i o profile obtained with group analysis. 
Acquisition time 
The 90-s acquisition time produced whole-brain 
significance profiles with higher x"-values and (with 
one exception) more significant p values than did 
the 60-s acquisition time (Table I ) . The exact loca-
tion of local maxima within a given functional area 
varied with the acquisition time in a nonsystcmatic 
fashion. The 90-s acquisition time provided higher 
NEC values and generally produced higher Z 
scores. It also resulted in less variability among the 
subjects (and between individual subjects and the 
group) with regard to the percent change in adjusted 
rCBF for a given functional region (Tables 2-5). 
Group analysis with 90-s acquisition time 
With intersubject averaging, the main rCBF in-
creases in activation condition 2 relative to control 
condition 1 were detected in the superior and mid-
dle temporal gyri bilaterally [Brodmann's areas 
(BAs) 21, 22, 38, 41, 42] ITable 3). These areas con-
stitute auditory primary and association cortices, 
including Wernicke's area. The overall maximum 
(Z = 10.47) was located in area 22 on the right 
(Talairach coordinates x = 48, y = -20, i = 0). 
Increases were also seen in Broca's area and its 
right-sided homologue (BA 44,45). Other areas with 
smaller or less significant foci of activation included 
right supramarginal gyrus area 40, right insula, right 
supplementary motor area (SMA) 6, right prefrontal 
area 10, bilateral inferior frontal area 47, and right 
hypothalamus. 
With intersubject averaging. rCBF decreases in 
activation condition 2 relative to control condition 1 
were detected bilaterally in visual primary and as-
sociation cortices (BA 17, 18, 19), parietal and mul-
timodal association cortices (BA 5, 7, 37, 39, 40), 
prefrontal association cortices (BA 9,10), anterior 
(BA 24, 32) and posterior (BA 23, 29, 31) cingulate 
gyrus, premotor areas (BA 6, 8), and cerebellum 
(Table 5). 
Single-subject analysis with 90-s acquisition time 
In subject 1, rCBF increases in activation condi-
tion 2 relative to control condition I were detected 
bilaterally in auditory primary and association cor-
tices, insula, and SMA. Increases in Broca's area 
and left inferior frontal area 47 were also observed. 
The overall maximum (Z = 6.86) was located in 
area 22 on the right {x = 44,y = - 20, z = 0) (Table 
3). rCBF decreases were detected bilaterally in vi-
sual primary and association cortices, parietal and 
multimodal association cortices, prefrontal associ-
ation cortices, anterior and posterior cingulate gy-
rus, premotor areas, and cerebellum (Table 5). Very 
small isolated areas of less significant decrease 
were detected in the left thalamus, parahippocam-
JiCtrtSmoaOcntMttabi Vol. «. No. 4. 1993 
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T A B L E 1. Whole-brain significance profiles (aclivalion versus control). stimulation before, during. and after rising 
phase of head curve 
SPM significance 
SPM increases SPM decreases 
Acquisition . 
Subject no. lime (s) threshold X' p(HO) X" p(HO) 
Stimulation during 
1 60 p < 0.01 621 <0.0000l 58 <0.00005 
p < 0.001 491 <0.0000l 3.4 0.00396 
90 p < 0.01 1,205 <0.0000l 946 <0.0000'i 
p < 0.001 935 <0.0000l 81 <0.00001 
2 60 p < 0.01 1,207 <0.00001 389 <0.0OO0l 
p < 0.001 892 <0.0000l 13 <0.0000l 
90 p < 0.01 IJ55 <0.0000l 763 <0.0000l 
p < 0.001 917 <0.00001 6.1 <0.00001 
3 60 p < 0.01 57 0.00006 247 <0.00001 
p < 0.001 66. <0.0000l 8.9 <0.00001 
90 p < 0.01 216 <0.0000l 701 <0.00001 
p < 0.001 147 <0.0OO0l 50 <0.0000l 
4 60 p < 0.01 1,481 <0.0000l 0 1 
p < 0.001 540 <0.00001 0 1 
90 p < 0.01 2,143 <0.0000l 367 <0.0000l 
p < 0.001 983 0 5.6 0.0O030 
Group 60 p < 0.001 3,545 0 4,189 0 
90 p < 0.001 4,234 0 8,619 0 
Stimulation before 
3 60 p < 0.01 0 1 0 1 
p < 0.001 0 1 0 1 
90 p < 0.01 0 1 0 1 
p < 0.001 0 1 0 1 
Stimulation after 
4 60 p < 0.01 0 1 0 1 
p < 0.001 0 1 0 1 
90 p < 0.01 0 1 0 1 
p < 0.001 0 0 
The x"-statislic is a measure of the significance of the observed number of pixels (versus the expected number of pixels under the null 
hypothesis) that exceeded the threshold indicated. The p(HO) values indicate the probability that the observed profile may have occurred 
by chance. Stimulation during the rising phase of Ihe head curve resuked in highly significant profiles, while stimulation before or after 
the rising phase did not. 
pal gyrus, and motor cortex and in association cor-
tices bilaterally. 
In subject 2, rCBF increases were detected bilat-
erally in auditory primary and association cortices 
and insula. Increases in the right-sided homologue 
of Broca's area and left inferior frontal area 47 were 
also observed. The overall maximum (2 = 8.26) 
was located in area 22 on the right {x = 52, y = 
- 18, z = 8) (Table 3). rCBF decreases were de-
tected bilaterally in visual primary and association 
cortices, parietal and multimodal association corti-
ces, prefrontal association cortices, anterior and 
posterior cingulale gyrus, premotor areas, and cer-
ebellum (Table 5). Very small isolated areas of less 
significant decrease were detected in the right thal-
amus and in sensorimotor cortices bilaterally. 
In subject 3, rCBF increases were detected bilat-
erally in auditory primary and association cortices. 
Increases in the left insula were also observed. The 
overall maximum (Z = 5.49) was located in area 
21/22 on the right (jc = 52, y = -12 , z = - 4 ) 
(Table 3). rCBF decreases were detected bilaterally 
in visual primary and association cortices, prefron-
tal association cortices, anterior and posterior cin-
gulate gyrus, premotor areas, and cerebellum (Ta-
ble 5). Very small isolated areas of less significant 
decrease were detected in the right caudate and in 
sensorimotor and association cortices bilaterally. 
In subject 4, rCBF increases were detected bilat-
erally in auditory primary and association cortices, 
insula, supramarginal gyrus, and SMA. Increases in 
Broca's area and its right-sided homologue and in 
left inferior frontal area 47 were also obsen.ed. 
Very small isolated areas of activation were de-
tected in the anterior and posterior cingulate gyrus 
and in area 18. The overall maximum (Z = 7.15) 
was located in area 22 on the right (x = 50. y = 
- 10, z = - 4 ) (Table 3). rCBF decreases were de-
tected bilaterally in visual primary and association 
cortices, prefrontal association cortices, posterior 
cingulate gyrus, and premotor areas. Decreases in 
the left anterior cingulate gyrus and right cerebel-
lum were also observed (Table 5). Very small iso- J 
lated areas of less significant decrease were de-^ 
tected in the right parahippocampal gyrus and 
association cortices bilaterally. 
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T A B L E 2. Increases in brain activity {activation versus control). 60-s acquisition time: single-subject and group 
analyses (p < 0.001) 
Regions of 
aclivation 
Temporoparielal R 
Inferior frontal R 
Maxima 
and BAs 
Z score 
U. y. z) 
% rCBF change 
BAs 
Z score 
(x. y. i) 
% rCBF change 
BAs 
Z score 
U . .V. I ) 
% rCBF change 
BAs 
Z score 
(x. y. I ) 
% rCBF change 
BAs 
Subjecl I 
5.25 
(46, -24 , 0) 
13.5 
21, 22". 42, 
insula 
5.71 
( -52 , -26 , 0) 
11.8 
21". 22". 40. 42 
3.85 
( -46 , 
9.8 
6" 
-6 . 12) 
Subjecl 2 
8.51 
(52, -22, 8) 
17.6 
21. 22, 38, 40, 
41, 42" 
3.84 
( -48 , 0. - 12) 
13.3 
21". 22. 38. 42 
4.31 
(38. 24, 4) 
7.3 
45" 
5.12 
( -44 , 28. 
16.2 
47" 
•4) 
Subjecl 3 Subjecl 4 Group 
-6 , 0) 
5.45 
(48, 
11-3 
21, 22", 38, 41 
42 
3.80 
( - 5 2 . 
11.3 
21", 22 
8) 
6.64 
(50, - 8 , 0) 
16.7 
21, 22", 40. 42 
insula 
4.75 
( -50 . -38 . 0) 
10.5 
21". 22. 38, 
insula 
3.32 
(34, 16. 16) 
7.3 
44°, 45" 
8.48 
(44. - 14, 4) 
10.1 
21. 22°, 38. 41. 
42 
7.00 
( - 5 2 . - 16. 4) 
12.2 
21. 22°. 38, 42 
4.07 
(42. 26. 8) 
5.8 
6. 45°. 47 
5.38 
( - 4 4 . 16. - 8 ) 
8.7 
6. 45. 47° 
Values are the Z score Talairach atlas coordinales. and perceni change ,n adjusted regional CBF (rCBF) for regional maxima The 
coordma.es are ,n mm; . is .he la.eral dis.ance from .he midline (positive = righ.). v is the an.enor-pos.eno d°s,an? from ihe an,^^ 
commissure, and z is .he height above the in.ercommissural line. R, righi; L . lef.. 
° Brodmann's area (BA) in which Ihe local maximum Z score occurred. 
* Region presen. a. an SPM{(} .hreshold of p < 0.01. 
^ Region not presen. a. an SPM{/) threshold of p < 0.01. 
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DISCUSSION 
The single-subject paradigm 
Single-subject analysis avoids the confounding 
effects of anatomical, functional, and disease vari-
ability in norma! subjects and in patients with psy-
chiatric or neurologic disease. This permits a more 
rigorous correlation of specific brain states with 
particular cognitive, perceptual, affective, and be-
havioral states. In addition, the effect of individual 
task performance, strategy and laterality can be 
more easily assessed. Within-subject PET-
magnetic resonance coregistration, which provides 
a direct mapping of function onto structure, can 
T A B L E 3. Increases in brain activity {activation versus control). 90-s acquisition time: single-subject and group 
analyses {p < 0.001) 
Regions of 
ac.iva.ion 
Maxima 
and BAs Subjecl I Subject 2 Subjec. 3 
Temporoparietal R 
Subjecl 4 
Inferior fron.al R 
Z score 
U. y. z) 
% rCBF change 
BAs 
Z score 
{x. y. z) 
% rCBF change 
BAs 
Z score 
(x, y. z) 
% r C B F change 
BAs 
Z score 
{X, y. z) 
% rCBF change 
BAs 
6.86 •, 
(44. -20 . 0) 
11.4 
21, 22", insula 
6.80 
( - 5 4 . - 22. 4) 
10.2 
21. 22°. 41, 42, 
insula 
4.80 
( - 4 8 , 10, 8) 
5.2 
44°, 47 
Croup 
-18, 8) 
8.26 
(52. 
13.8 
21, 22°, 38, 41, 
42 
3.65 
( - 5 8 , -28 , 4) 
7.9 
21. 22°, 38 
3.13 
(40, 20, 8) 
8.4 
44°, 45° 
3.44 
( - 4 2 , 12, - 8 ) 
9.7 
47° 
5.49 
(52, - 12, 
13.8 
21°, 22° 
3.61 
( - 5 0 , 
12.7 
22° 
- 10, 0) 
7.15 
(50. - 10, - 4 ) 
11.6 
21. 22", 40, 42, 
insula 
4.50 
( -56 , - 4 2 , 0) 
7.3 
21°, 22, 38. 40. 
42, insula 
3.23 
(36. 20, 16) 
5.1 
45° 
3.47 
( - 4 2 , 24, 0) 
6.9 
6, 45, 47° 
10.47 
(48. -20. 0) 
10.7 
21. 22°. 38, 40. 
41. 42 
8.67 
( - 5 2 . - 22 . Ol 
9.4 
21°. 22". 38, 
41, 42 
4.91 
(44. 24. 12) 
5.9 
44, 45°, 47 
6.55 
( - 4 6 . 16. - 8 ) 
9.0 
44, 45, 47° 
^ r l w H r l ' l i ' " " ' " - '^K^'iT*' f!!"' ^ " ' i P^^""' change in adjus.ed regional CBF (rCBF) for regional maxima. The 
^mmissur / .^^ u I K u ' ^ " ' f = "S*"'' y 'he an.erior-pos.erior dis.ance from the an.enor 
° R T ' ^ h^'^h' ""^ intercommissural line. R, right; L , left 
J "rodmann's area (BA) in which the local maximum Z score occurred 
"legion present at an SPM{r} threshold of p < 0.01. 
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T A B L E 4 Decreases in brain activity (activation versus control). 60-s acquisition time: single-subject and 
group analyses 
Regions of 
activation 
v i s u a l 
Parietal/ 
associat ion 
Prefrontal 
Anterior 
cingulale 
Posterior 
cinguiate 
Cerebe l lum 
M a x i m a 
and B A s 
Subject I 
(p < 0.01) 
Subject 2 
(p < O.fl l l 
Z score 2.94 3,00 
ix. V. z) (24, - 3 8 , - 8 ) (28, - 7 4 , 201 
% r C B F change 7.7 11.4 
B A s 19", 37 18, 19" 
Z score 3,75 3.63 
(jr. .V. z) ( - 4 0 , - 4 6 . - 16) ( - 2 0 . - 7 0 . 241 
% t C B F change 13.2 10.1 
B A s 17. 18. 19. 37" 18". 19 
Z score 3.12 3.03 
(X. V. I) (34. - 6 6 , 24) (32, - 6 8 , 24) 
% r C B F change 10.5 9.5 
B A s 7, 39", 40 5. 7. 39° 
Z score 3.77 2.99 
(X. y. z) 
% t C B F change 
( - 4 . - 52. 40) ( - 4 . - 38. 441 
8.8 6.7 
B A s 7". 40 5. 7". 40 
Z score 3.45 2.64 
(.t. y. z) (24. 40 - 8 1 (14, 46, 12) 
% r C B F change 15.0 6.8 
B A s 10" 9. 10" 
Z score 3.16 3.30 
(jr. >•. 1} ( - 2 8 . 8. 401 
( - 32, 44, 24) 
% r C B F change 8.0 5.4 
B A s 9". 10 9 ° , 10° 
Z score 2.54 3.00 
(x. y. z) (10, 24 . - 8 ) (20. 38. 8) 
% r C B F change 15.3 9.3 
B A s 24. 32 24" 
Z score 2.87 3.06 
(.<. V. z) ( - 2 4 . 40. 81 ( - 4 . 14. 361 
% r C B F change 9.6 6,9 
B A s 32" 24. 32" 
Z score 2.72 2.68 
{x. y. z) (10, - 62. 8) (26. - 6 8 . 121 
% r C B F change 7.3 9.6 
B A s 31" 31" 
Z score 2.92 3.18 
(x. V. z) ( - 4 . - 5 2 . 36) ( - 10. - 30. 361 
% r C B F change 7.8 7.3 
B A s 31" 23. 31" 
Z score " 3.75 
(.t. v. z) 
(2. 12. 44) 
% r C B F change 6.6 
B A s 6" 
Z score 2.68 2.83 
(jr. y, z) ( - 1 4 14. 60) 
( - 18. - 12, 56) 
% r C B F change 5.1 9.2 
B A s 6". 8 6". 8 
Z score 2.79 2.57 
(x. y. z) 
% i C B F change 
Z score 
(j;. y. z) 
% r C B F change 
(6, - 7 6 , - 12) 
7.6 
2.64 
( - 4 2 , - 4 6 , - 2 4 ) 
12,2 
(6, 
no 
2.62 
(-34, 
10.2 
- 3 2 , - 2 4 ) 
Subject 3 
(p < 0.01) 
3.78 
(26. - 7 4 , 20) 
6.7 
17, 18", 19, 37 
2,99 
( - 1 8 , - 5 4 , - 4 
7.0 
18, 19" 
2.96 
(10. - 5 8 , 40) 
11.1 
7". 39. 40 
3.67 
( - 4 . - 28.481 
9.0 
5". 7. 39. 40 
3.08 
(34 .40 . - 4 ) 
7.5 
9. 10" 
2.62 
( - 32. 48. - 8 ) 
9.3 
10" 
2.54 
(6. 30. 24) 
8.4 
32" 
2.47 
( - 2 0 . 34. 0) 
7.4 
24° 
2.62 
(0, - 36, 40) 
6.3 
23, 31" 
2.62 
(0, - 3 6 , 40) 
6.3 
31° 
2.92 
(18. - 18. 48) 
111 
6° 
4.03 
( - 2 6 , 30, 44) 
9,4 
6, 8° 
Subject 4 
(p < 0.011 
G r o u p 
(p < 0.001) 
2.92 
( - 2 6 , 
8.0 
-46, - 1 6 ) 
121 
- 7 2 , 20) 
3.09 
(24. -
7.0 
17. 18". 19 
3.38 
( - 2 . 
6.8 
17. 18 
2.51 
(30. - 7 0 . 24) 
6.1 
39" 
2.84 
( - 2 6 . 
10.6 
7. 39° 
19 
- 4 6 . 24) 
5.44 
(24. 
6.4 
18". 19 
4.62 
( - 2 8 . 
6.0 
17. 18. 
4.82 
(14 
6.2 
7". .19. 40 
4.49 
( - 1 4 . - 5 8 
7.4 
5. 7". 40 
3.44 
-84 , 12) 
. 37 
- 8 6 , 8) 
19", 37 
-58, 40) 
(22. 54. 121 
4.8 
10" 
3.28 5.49 
( - 2 4 . 50. 201 ( - 32. 54. 161 
8.6 7.6 
9. 10" 10" 
2.54 „ 
( - 2 . 42. 41 
9.8 
32" 
2.80 4.50 
(4. - 6 4 , 12) (2. - 36. 36) 
8,3 5.0 
31° 31" 
2.63 4.58 
( - 16. - 6 8 . 12) ( - 14. - 6 0 . 121 
8.3 5.9 
31° 29. 31" 
2.38 4.29 
(18. 0. 561 (24. 12. 55i 
6.5 4.6 
6° 6" 
2.79 4.20 
( - 32. 20. 40) ( - 2 2 . 0. 521 
4.7 6.2 
6. 8 ° 6 ° . 8 
2.33 3.93 
(34. - 5 6 . - 161 (36. - 6 0 . - 161 
5.3 4.8 
b 3.45 
( - 42. - 4 4 . - 20 
5.2 
Va lues are the Z score T a l a i r a c h atlas coordinates , and percent change in adjusted regional C B F ( r C B F ) for regional maxima. T h e coordinates are in mm, 
X ^ stLTMuZdX^ midline (positive = nght), y is the antenor-postenor distance from the antenor commissure , and z ,s the height above the 
intercommissural l ine, R . right; L , left, 
° Brodmann-s area ( B A ) in which the local maximum Z score occurred. 
» Region not present at an S P M { r } threshold of p < 0.01. 
also be performed. Case studies of the same patient 
in different symptom and treatment states are pos-
sible as well. Group analysis is not precluded. In-
deed, a combined within-subject and group analysis 
is easily performed and can help to clarify the rela-
tionship between subject-specific and relatively in-
variant modes of processing. 
The single-isubject paradigm described in this ar-
ticle relies ftiiad^ehtally on 3-D acquisition and re-
J cer.b BtooctF^iS^^^^^^mr^^mmf^^- ^ 
construction techniques that provide more statisti-
cal information for a given administered dose of ra-
dioactivity imaged for a given period of time. Using 
a scanner with retractable septa (now commercial!; 
available), it is therefore possible to use one-half to 
one-quarter of the conventional dose per scan and 
perform more scans without increasing the risk lo 
the subject. In fact, with this technique, the lowest 
doses were found to result in the greatest gain in 
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T A B L E 5. Decreases in brain activity {activation versus control). 90-s acquisition time: single-subject and 
group analyses 
Regions of M a x i m a Subjec l 1 Subject 2 Subject 3 Subject 4 G r o u p 
acHva l ion and B A s (p < O.Oi) (p < 0.01) (p < 0.01) (p < 0.01) (p < 0.001) 
V i s u a l R Z score .1.85 3.48 3.67 3.44 5.45 
U. y. I) (22, - 8 0 . - 4 1 (10. - 7 6 . 12) (30. - 7 2 . 12) (2. - 7 4 . 201 (36. - 7 8 . 20) 
% r C B F change 8.0 8.9 6.3 4.9 6.0 
B A s 18". 19. 37 17". 18. 19 18. 19". 37 17. 18". 19 17. 18, 19". 37 
L Z score 3.46 3.60 2.87 3.48 5.57 
(x. y. z) ( - 3 8 . - 6 2 . - 121 ( - 2 4 . - 7 2 . 20) ( - 3 4 . - 7 8 . 16) ( - 4 0 . - 7 2 . 4 | ( - 3 6 . - 7 2 . 0 ) 
% r C B F change 9.0 6.4 4.9 8.1 5.8 
B A s 18. 19. 37" 17. 18". 19 19" 18. 19". 37" 18. 19". 37 
Par i c la l / R Z score 3.55 3.04 3.60 2.85 6.07 
assoc ia . ion ix. y. i ) (30. - 5 4 . 28) (0. - 16. 44) (12. - 6 4 . 36) (16. - 7 0 . 401 (10. - 6 0 . 40) 
% r C B F change 6.6 6.1 8.9 7.5 6.0 
B A s 5. 7. W . 40 5. 7". 39. 40 5. 7 ° . 40 7° 5. 7". 39. 40 
L Z score 3.84 3.04 3.37 2.94 5.36 
(jr. .V. I) ( - 3 2 . - 5 0 . 321 (0. - 16. 44) ( - 4 4 , - 3 6 . 40) 1 - 2 0 . - 6 0 . 441 ( - 26. - 54. 401 
% r C B F change 6.3 6.1 6.3 8.6 4.6 
B A s 7. 39". 40" 7" 7. 39. 40" 7". 39. 40 7. 39. 40" 
Prefrontal R Z score 2.72 2.36 3.77 2.89 4.13 
(.r. y. z) (26. 16. 32) (24. 18. 32) (34. 24. 36) (12. 44. - 8 1 (26. 56. 16) 
% r C B F change 4.9 5.8 6 5 8.8 4.9 
B A s 9° 9" 9". 10 10° 9. 10" 
L Z score .V22 2.95 2.70 3.51 5.36 
(X. y. z) 1 - 22. 56. 121 ( - 2 6 . 50. 24) ( - 3 2 . 52. 0) ( - 34. 42. 81 ( - 28. 48. 161 
% r C B F change 5.5 6.5 8.2 6.8 5.4 
B A s 9. 10" 9. 10" 10" 9. 10" 9. 10" 
A n l e r i o r R Z score 2.86 3.20 2.48 b 4.47 
cingulale (.f. >•. z) (16. 18. 401 (20. 40. 12) (16. 0. 44) (16. 18. 40) 
% r C B F change 6.8 8.8 5.4 5.1 
B A s 32" 24. 32" 24" 32" 
L Z score 3.30 3.29 2.91 2.52 4.50 
U. y. z) ( - 18. 34. 16) ( - 24. 16. 281 ( - 1 0 , - 2 . 36) 1 - 2 . 40. 41 ( - 2 0 . 14. 40) 
% r C B F change 9.2 10.6 8.6 8.4 5.0 
B A s 24. 32" 24". 32 2 4 ° . 32 24° 32" 
Posterior R Z score 3.34 3.31 3.44 3.19 5.87 
cingulale (x. y. z) (22. - 5 4 . 201 ( 1 2 . - 3 2 . .16) (28. - 4 6 . 36) (10. - 6 2 . 161 (4. - 3 8 . 40) 
% r C B F change 6.8 6.6 11.4 8.9 5.1 
B A s 31" 31° 23. 31° 23. 29. 31° 23. 31" 
L Z score 3.22 2.67 2.51 2.68 5.54 
(x. y. z} ( - 10. - 5 6 . 121 ( - 4 . - 4 0 . 40) ( - 1 8 . - 1 6 . 4 0 ) ( - 1 6 . - 6 2 . 16) ( - 14. - 6 2 . 16) 
% r C B F change 7.0 5.7 8.6 6.3 5.2 
B A s 23". 31" 31" 31° 23. 29. 31" 29. 31" 
Premotor R Z score 3.15 3.23 3.33 2.37 4.73 
(x. y. z) (20. 30. 48i 110. - 24. 56) (36. 10. 44) (24. 30. 44) (22. 16, 48) 
% r C B F change 5.8 8.3 5.9 6.6 4.4 
B A s 6, 8" 6". 8 6". 8 8° 6". 8 
L Z score 2.93 2.98 3.25 3.30 4.93 
(Jr, y. I) ( - 1 2 . - 24. 641 ( - 1 2 . - 12. 54) ( - 1 0 . 24. 52) ( - 3 0 . 18. 4 4 ) ( - 2 2 . 0, 52) 
% r C B F change 7.7 7.7 6.7 4.6 5.8 
B A s 6 ° . 8 6 ° . 8 6. 8° 6. 8" 5". 8 
C e r e b e l l u m R Z score 2.64 2.46 2.95 3.03 4.53 
(Jf. y, z) (6, - 7 6 . - 16) (4. - 6 0 . - 12) (32. - 5 0 , - 2 0 ) (22. - 7 2 . - 16) (20. - 7 6 , - 1 6 ) 
% r C B F change 5.2 4.9 4.7 7.3 4 .7 
L Z score 2.45 2.52 2.95 b 4.02 
U. y. I ) ( - 2 6 . - 7 6 . - 2 0 ) ( - 1 6 . - 3 6 . - 2 0 ) ( - 3 8 , - 4 2 . - 2 0 ) ( - 4 0 . - 4 4 . - 2 0 ) 
% r C B F change 6.6 5.0 6.2 4.3 
Va lues are the Z score , T a l a i r a c h atlas coordinates, and perceni change in adjusted regional C B F ( r C B F ) for regional maxima. T h e coordinates are in m m ; 
X is the lateral distance from the midline (positive = rightl. y is the anterior-posterior distance from Ihe anterior commissure , and i is the height above the 
intercommissural line. R , right; L , left. 
° B r o d m a n n ' s area ( B A ) in w h i c h the local maximum Z score occurred. 
' Region not present at an S P M ( / l threshold of p < 0.01. 
signal per millicurie, and significant results were 
obtained in subject 4 with only 5-10 mCi of H t ' ^ O 
per scan. A dose range of 10-15 mCi can be re-
commended as this amount balances the gains 
achieved at lower doses with the increased counting 
statistics obtained at higher doses. Even with the 
low doses used in this study, activations as small as 
5% were detected when two conditions were com-
pared using just four scans for each condition. Four 
scans per condition minimizes the effects of varia-
tions in response magnitude and permits signal av-
eraging, while allowing several conditions to be 
contrasted in a single study session for an individual 
subjecl. I f more sampling of each condition is de-
sired, five or six scans per condition can be per-
formed. 
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Temporal window 
The 3-D slow bolus technique, as described, has 
a temporal window of 30 s. This is long enough to 
provide adequate sampling while brief enough to 
minimize patient distraction and task habituation. 
To our knowledge, this is the shortest discrete ac-
tivation to be demonstrated with PET to date, and 
the first time tracer arrival time has been used to 
define the temporal window in a clinical activation 
paradigm. The results for conditions 3a and 3b dem-
onstrated that stimulation before and after the rise 
of the head curve did not contribute significantly to 
the resultant image, regardless of acquisition time. 
This underscores the tight temporal coupling be-
tween rCBF and localized neuronal activity as well 
as the primacy of the radioactivity input phase. 
Such information can be of help in the design of 
stimulation studies and in the analysis of images of 
transient or fluctuating conditions. For routine 
studies 45 s of stimulation can be recommended, as 
this duration allows the subject to become engaged 
in the task a few seconds before the head curve 
rises and ensures that stimulation occurs through-
out the rising phase in subjects with slightly differ-
ent circulation times. The shorter stimulation time 
of 30 s may be used if the head curve is monitored 
during the scan and the delivery of stimulation is 
timed precisely to correspond to the rising phase. In 
addition, the contribution to an image of a brief, 
variable sign or symptom may be determined using 
a correlational analysis relating the timing and du-
ration of the measured event to the timing and du-
ration of the rising phase. 
Acquisition time 
The similarity in the SFM profiles obtained with 
60- and 90-s acquisition times is consistent with the 
demonstration that the image is predominantly 
determined during the 30-s critical phase. There 
was, however, some variation in the location of 
significance maxima within a given region of acti-
vation. The data for the two acquisition times indi-
cate that the 90-s acquisition time provided better 
counting statistics with a greater signal-to-noise ra-
tio and resulted in higher Z scores. The 90-s acqui-
sition time also resulted in less variability among 
adjusted rCBF change measurements. These find-
ings are in keeping with the observation of im-
proved signal-to-noise ratios with 90- to 120-s ac-
quisition times for the autoradiographic method 
(Kanno et al., 1981). They also suggest that ra-
diotracer diffusion and washout do not pose a sig-
nificant problem over this time scale. Therefore, a 
single 90-s frame is recommended for use in this 
paradigm. 
Single-subject versus group analysis 
In the main comparison between condiii,>:i •> 
(stimulation during the 30-s rising phase of the hc.-.d 
curve) and condition 1 (control), the single-subject 
analysis for rCBF increases produced highly signif-
icant results comparable with those obtained uiih 
the group analysis (p < 0.001, omnibus). This level 
of significance has been shown to protect against 
false-positives (Bailey et al,, 1991/?), Results m a v 
also be viewed at the p < 0,01 level to ideniii\ 
statistical trends or areas of slightly lesser, but 
nonetheless genuine, activation. 
The rCBF decreases were more widespread and 
variable and tended to be of lesser significance. 
With single-subject analysis, areas of maximal de-
crease were significant at the p < 0,001 level: ho^v-
ever, a p < 0,01 threshold produced a profile thai 
was more like that of the group analysis (which v'-as 
performed at the p < 0,001 level). While normaliza-
tion for global activity may necessarily result m 
small, widely distributed decreases, statistically sig-
nificant negative peaks are thought to be of impon, 
particularly when more complex behavioral siaie-
are compared (Fox, in Chadwick and Whelan, un-
published observation. 1991), Such decreases mav 
reflect inhibition due to system connectivity (Fn;h 
et al.. 1991), selective attention with depression of 
modalities not being attended to (H. Jenkins el c!.. 
personal communication), or relative increases ;n 
activity during a nonrest control task. 
While there was good concordance overall b-e-
tween the SPM profiles for the single-subject and 
group analyses, not every area observed in i . - ic 
group SPM was observed in each of the single-
subject SPMs, and not every area observed in each 
single-subject SPM was observed in the grojp 
SPM. In other words, the single-subject profiles 
were similar, but were not all identical. For exa.Ti-
ple, subject 2 had a greater degree of lateralization 
in superior temporal response, and subject 3 had 
less inferior frontal activity (present at the p < 0,-)l 
level), associated with the activation task. This miv 
be due to individual functional-anatomical variabil-
ity in organization or strategy regarding language 
functions (Mazziotta et al,, 1982; Ojemann, 1983). 
To the extent that this is the case, any discordance 
may be informative and may provide further e i 
dence for the value of single-subject studies. .Alter-
natively, the degree of intersubject variability niay 
not always be so great (Fox and Pardo, 1991). '•^'^ 
discordance may reflect a lack of specificity m ^ 
tasks employed or a lack of sensitivity of the tec^ 
nique. In either event, it should be noted ^ ^ ^ ^ 
most cases, areas of discordance were ' h o s « ^ ^ g 
lower Z scores that were present on only o n | ^ ^ ^ 
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Areas of cerebral activation 
The main areas of increased activity associated 
ith the activation task (representing auditory sen-
tence monitoring and sustained button pressing) 
constitute a bilateral auditory language network. Bi-
lateral superior and middle temporal (BA 21, 22, 38, 
41, 42) and even left inferior frontal (BA 45, 47) 
activations have been observed when subjects sim-
ply listen to words (Nishizawa et al., 1982; Petersen 
et al., 1988; Frith et al., 1991; Zatorre el al., 1992). 
When lexical, phonological, pitch, semantic, or (si-
lent or vocal) arliculalory processes are involved, 
unilateral or bilateral insula, parietotemporal (in-
cluding BA 40), and inferior frontal (BA 44, 45, 47) 
areas may be seen as well (Roland et al., 1981; 
Mazziottaetal., 1982; Frith et al., 1991; Wise et al., 
1991; Zatorre et al., 1992; Demonet et al., 1992). 
These areas, which were observed in this study, 
function as components of neurocognitive networks 
(Mesulam, 1990) and may be activated automati-
cally with the presentation of meaningful stimuli 
(McClelland and Rumelhart, 1981). 
Right-sided superior temporal maxima, as ob-
served in this study, have been found in many of the 
studies of verbal listening tasks cited above. This 
may reflect a lateralized difference in resting and 
activation rCBF values and their variability, a lat-
eralized attentional component, or, with stimuli of 
random content such as employed in this study, a 
lateralized affective component (Heilman et al., 
1975). The minimal SMA activity detected and lack 
of primary motor region activity reflect the fact that 
there was essentially no finger movement or voli-
tional planning during the activation task; the but-
ton remained depressed in response to an external 
stimulus throughout the entire rising phase of the 
head curve. 
The areas of decreased activity associated with 
the activation task/increased activity associated 
with the control task (representing auditory atten-
tion and preparatory set) include visual, prefrontal, 
multimodal association, premotor, cerebellar, and 
cingulate regions. I f these findings are due to re-
gionally specific phenomena, one reasonable inter-
pretation is that visual and high-order association 
cortices are inhibited or less active during the audi-
tory sentence monitoring/button-pressing task, 
while the parietal, cingulate, and SMA areas that 
constitute the posterior and anterior attentional sys-
tems (Posner and Rothbart, 1991) are more active 
during the auditory attention/preparatory set con-
trol task. I t is unclear whether the cerebellar signal 
is the result of cerebellar involvement in motor pre-
paratory set or the result of an inaccuracy in the 
mapping of inferior occipital signal at the bottom of 
the scan onto the Talairach atlas. This raises two 
relevant points. First, SPM analysis docs not re-
quire a priori determination of regions of interest. It 
is therefore more likely that new findings will occur, 
which can be tested and explored in subsequent 
studies. Second, the Talairach atlas represents one 
person's postmortem brain. The resultant problems 
associated with atlas mapping can be avoided by 
using single-subject techniques, such as this one, 
that permit intrasubject PET-magnetic resonance 
coregistration. 
CONCLUSION 
We have described a PET paradigm utilizing 
high-sensitivity 3-D scanning with low doses of 
Hj'^O that allows the detection of small, statisti-
cally significant changes in rCBF associated with 
cognitive/behavioral states in single subjects. It 
consists of four scans per condition with each scan 
characterized by a slow bolus of 10-15 mCi of 
Hj'^O, a 30-s critical period (corresponding to the 
arrival of radiotracer in the brain) during which the 
rCBF distribution is detected, 30-45 s of cognitive 
stimulation, and a 90-s acquisition time. This 
method was investigated and validated in normal 
volunteers using control and activation tasks and 
SPM analysis. It is a potentially valuable tool for 
the study of functional neuroanatomy in various 
neuropsychological, pharmacologic, and disease 
states. In addition, its well-defined temporal win-
dow provides a means of recording the maximum 
response associated with an experimental task and 
may allow the imaging of transient or randomly oc-
curring mental/brain states that are not under direct 
experimental control. 
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"THE HAMMERSMITH PHILOSOPHY FOR PET CHEMISTRY AUTOMATION" 
John C Clark, MRC Cyclotron Unit.Hammersmith Hospital.London W1 2 OHS.UK. 
We have only automated production of robust chemical syntheses for routine use on a weekly scheduled 
basis; iSpDG, nC-methyiations & H2I50. We use programmable logic controllers (PLC's) to control temp, 
time and flow. "Set up" and "run" programmes are assembled in "ladder logic" and stored on an "EPROM". 
During "set up" clean dry reaction vessels, product reception vials & reagents are installed. HPLC product 
peak is "cut" by remote control valve operation. For 1 iC methylations an automated product formulation 
system is integrated with the HPLC "cut peak" and delivers the product via a membrane filter to the 
delivery vial. A PLC controlled iSpDG unit, incorporating a closed glassy carbon reactor in a one pot system 
for fluorination and hydrolytic deprotection has been built. Enriched Hz^^O is recovered and the product is 
purified by HPLC. H2^50 is infused from a unit housed under the PET scanner couch. It is supplied with 
15O2 .5% H2 & saline for infusion Solution & gas are separated by a sterile, pyrogen free water permeable 
membrane. Infusions are controlled from the scanner console where infused doses are displayed using an 
"on board" radiation detector. These systems are operated by a small team of trained technicians within a 
Good Manufacturing Practice framework. Independent Quality Assurance is provided, to qualify for a 
"specials" Radiopharmaceutical Manufacturing Licence. 
THE H A M M E R S M I T H PHILOSOPHY FOR PET CHEMISTRY 
AUTOMATION 
John C Clark, Keith Dowsett, CoUn J Steel and David R Turton 
Medical Research Council Cyclotron Unit, Hammersmith Hospital 
London W12 DBS, England. 
INTRODUCTION 
Clinical scientific research using PET requires access to a wide variety of 
radio-pharmaceuticals. We have chosen only to automate the 
production of those accessible via robust chemical syntheses. Three types 
of system are in routine use on a weekly scheduled basis. They are for 
[i8F]-2 fluoro-2 deoxy-D-glucose([^8F]FDG) production, [nc]-methylations 
and infusions. As most PET Radiopharmaceutical syntheses 
generally require only control of valves, temperature, time and flow, we 
have chosen to use industrial programmable logic controllers (PLC's) 
wi th sensing and feedback of temperature and multiport valve position 
where essential."Set up" and "run" programmes are assembled in 
"ladder logic" and stored on an erasable programmable read only 
memory (EPROM). During the "set up" procedure clean dry reaction 
vessels, SEP- PAC®s, precursors, reagents, filters and product reception 
vials are installed. During the "run" sequence the processing proceeds 
automatically the operator intervenes only to"cut" the preparative HPLC 
product peak by remote , control valve operation. For [ i C ] 
methylations an automated product formulation system is integrated 
with the HPLC "cut peak" and delivers the product via a membrane filter 
to the delivery vial.A PLC controlled [18F]FDG unit, incorporating a 
closed glassy carbon reactor in a one pot system for fluorination and 
hydrolytic deprotection has been built. Enriched H2^80 is recovered and 
the product is terminally purified by HPLC. . Bedside infusions of H i ^ S Q 
are carried out using a unit which is housed under the PET scanner 
couch which is supplied with [ i S Q ] oxygen in 1%02/N2, 5% H 2 / N 2 and 
saline for infusion. The gas and solution phases are permanently 
separated by a water permeable membrane which is maintained sterile 
and pyrogen free. Infusions are controlled from the scanner control 
room and infused doses are displayed there using an on board radiation 
detector.These systems are in routine use operated by a small team of 
trained technicians within a Good Manufacturing Practice (GMP) 
framework. Quality Assurance (QA) is provided by an independent 
person in order to qualify for our "specials Radiopharmaceuticals" 
Manufacturing Licence. 
AUTOMATION OF p8F]FDG PRODUCTION 
The nucleophilic fluorination of methyl 4,6-0-benzylidine-3-0-methyl-2-
O-trifluoromethanesulfonyl-P-D-mannopyranoside using Kryptofix® -
222(K-222) and [18F] fluoride (Hamacher et al 1986) has become the 
synthetic route of choice for the preparation of l i8F]FDG.Having 
reviewed the available commercial devices on offer at the time we chose 
to assemble our own system based on a single glassy carbon reaction 
vesseUsee Figure 1). The processing sequence is controlled by a Toshiba 
EX-40+ programmable controller. This is used to reproduce the various 
timed steps in the[i8F]FDG synthesis reliably without any intervention 
from the operator. Thus, once the system is set up, [18F]FDG can be 
produced automatically. The system consists of two parts: the reaction 
and primary purification system, and the HPLC final purification system. 
The reaction and the HPLC systems are designed to be easily removed 
from the hot- cell should either need to be repaired or replaced. Most of 
the liquid transfers on the system are achieved by helium overpressure. 
In the final stages, however syringe drives are used in order to achieve 
greater control over the transfer rates. 
[i8F]Fluoride Production. 
[i8F]fluoride is produced by the proton irradiation of 80 % oxygen-18 
enriched water via the i80(p,n)i8F reaction. The target is closed with a 2 
Bar imposed overpressure,, any spray or condensed steam produced 
during the irradiation is recondensed and pumped back into the target 
chamber. In addition any radiolytic gases (H2 and O2) are recombined 
using a single pellet of palladium on alumina catalyst to avoid excessive 
pressure rises. After irradiation, the solution containing the [i8F]fluoride 
is transferred using the 2 Bar overpressure via a 40 m of teflon tube (i.d. 
0.87 mm) to the[^8F]FDG synthesis system. The recirculation pump and 
the target f i l l syringe drive and fil l /empty valves are remotely controlled 
by a PLC. 
[i8F]Fluoride Recovery. 
Due to the expense of enriched water, it is desirable to recover it for 
reuse. This is achieved by trapping the [i8F]fluoride on an anion 
exchange resin column (3mm x 20mm, BioRad AG 1-X8 carbonate form) 
and allowing the enriched water to pass into a collection vial. The water 
can then be distilled and reused. The [i8F]fluoride is then eluted using 
potassium carbonate (1ml 4.6 mg/ml) which is transferred into the 
reaction vessel. 
[18F] Fluorination of the Precursor. 
Before the [i8F]fluoride can be incorporated into the triflate precursor, 
the dry complex [K-222][i8F] must be formed by adding a solution of K-222 
in acetonitrile to the reaction vessel. The reaction mixture is then dried 
in a single stage evaporation. The main reaction vessel is made of glassy 
carbon which is both chemically inert and has good thermal 
conductivity. The evaporation and drying is achieved by heating the 
reaction vessel whilst blowing a stream of helium onto the liquid 
surface. The vapours are removed using a vacuum pump. The flow 
rates are set to provide a positive pressure in the reaction vessel to stop 
the liquid bumping during evaporation. If this were to occur, then 
[i8F]fluoride would be lost to the vacuum pump and the vessel walls! 
When dry, the precursor in acetonitrile is added to the to the reaction 
vessel and [i8F]fluoride is incorporated by nucleophilic substitution of 
the triflate. The reaction vessel can be heated at one of two temperatures 
by a CAL 9000 controller using one or two band heaters as desired.It can 
be cooled with a compressed air jet. Two heaters are used for drying and 
one is used for refluxing. The heating, cooling and liquid transfer 
processes are all controlled by the PLC program (see Table 1 for program 
sequence). 
Hydrolysis. 
Before hydrolysis, the protected ispDG is transferred onto a C-18 SEP-
PAC® which is then washed with Hydrochloric acid (O.IM) to remove 
K2.2.2. The product is then eluted into the reaction vessel with ethanol 
which is subsequently removed by evaporation. The Hydrochloric acid 
(lml.2M) is then added and heated. Again the sequence of events is 
controlled by the PLC. 
Purification. 
Before HPLC purification the solution is transferred through a C-18 
SEP-PAC® and a resin column 8mmx40mm (BioRad AG 11 A8) to 
remove organic by-products and to neutralise the acid. A syringe drive 
with pulse control is used to provide an accurate flow rate of 0.5 ml /min 
to ensure effective neutralisation. If this is not achieved then the 
product w i l l be acidic and damage to the HPLC column will result. The 
product is then drawn up using the second syringe drive and transferred 
to the loop of the HPLC injector valve.A BioRad HPX-87P column is 
eluted with water at 0.5ml/min.The purified product "peak" is "cut" by 
manual remote control of valve 20 while observing the radioactivity 
trace. 
Performance of the System 
The labelling efficiency corrected to start of synthesis and before HPLC is 
50%.Losses incurred during HPLC result in an overall efficiency of 30%. 
Figure 1 Scheme of PLC-controlled apparatus for the preparation of 
18FDG. 
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Table 1 Program sequence for the PLC used for the preparation of [ISFJFDG 
SETUP MODE 
Step No, Description 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
Empty Vial 4 
Empty Reaction Vessel to Waste 
Empty Vial 5 
Empty Reaction Vessel to Waste 
Empty Vial 6 
Empty Reaction Vessel to Waste 
Empty Vial 7 
Synnge Out Reaction Vessel to 
waste (1) 
Syringe Out Reaction Vessel to 
waste(2) 
Syringe Out Reaction Vessel to 
waste(3) 
Syringe Out Reaction Vessel to 
waste(4) 
Empty Vial 8 
Empty Reaction vessel to Waste 
Empty Vial 1 
Empty Vial 2 
Empty Vial 3 
Empty Reaction Vessel to Waste 
Blow Out Lines 
Step 17+Vacuum 
Step 17-HDry Pot (Heat) 
20 Cooling-i-Vent 
RUN M O D E 
Step No, Description 
0 Elute 18F with K 2 C O 3 (Vial 1) 
1 Add K222 (Vial 2) 
2 Dry off solvents 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
Cool-nVent reaction vessel 
Add precursor(Vial 3) 
React precursor 
Add 0,1M HCl (Vial 4) 
Pass through SEP-PAC® 
Add O.lMHCl (Vial 5) 
Pass through SEP-PAC® 
Elute SEP-PAC® with EtOH (Vial 6) 
Evaporate solvents 
Vent reaction vessel 
Add 2M HCl 
Hydrolyse 
(Vial 7) 
Pass solution through columns 
Add water (Vial 8) 
Pass solution through columns 
Pass solution through columns 
Fill HPLC syringe 
Load HPLC Loop 
Inject loop onto column 
Cut Peak 
Outputs 
11 (Posn, 4),16,25 
11,13,16,25,26 
16,22,25 
13,16,25,26 
16,23,25 
13,16,25,26 
11 (Posn. 5),16,25 
11 (Posn, 6),2S,Syringe drive up 60 sec,24. 
Syringe drive down 60 sec 
Syringe drive up 60 sec,24,Syringe drive 
down 60 sec 
Syringe drive up 60 sec,24,Syringe drive 
down 60 sec 
Syringe drive up 60 sec,24,SyTinge drive 
down 60 sec 
11 (Posn. 4),16,27 
13,16,25,26 
10,11 (Posn, 1),16,25 
16,21,25 
11 (Posn, 2),16,25 
11 (Posn, 4),13,16,25,26 
16,23,25,26,27 
13,14,16, 23,25,26,27,33 Vacuum Pump on 
13,14,16,23,25,30 Heater 2 on, 31 Heater on 
32Temperature Controller on (100°C) 
33Vacuum Pump on 
12,14,15,23,25 Note; Output 11 is to a 6 port 
rotary valve with position 
feedback to the PLC.Outpuis 
3(),31 and 32 are connected via 
Outputs the PLC to allow for set point 
and temperature feedback 
10,16,25 
16,21,25 
13,14,16,25,26,30 Heater 1 on,31 Heater 2on,32 
Temperature controller on(l(X)°C),33 Vacuum Pump on 
12,14,15,30 Heater 1 on,32 
Teniperature controller on (85°C) 
11 (Posn, 2),16,25,30 Heater Ion, 
32 Temperature controller on(85''C) 
30 heater 1 on,32 Temperature 
controller on (85°C) 
11 (Posn, 3),12,16,25 
11 (Posn, 4),13,16,25,26 
16,22,25 
13,16,25,26 
16,23,25 
13,14,16,25,26,30 Heater lon,31 Heater 2 on 
32Temperature controller on(100°C),33Vacuum Pump on 
14,15,30 Heater 1 on,32 
Temperature controller on (100°C) 
11 (Posn, 5),16,25,30Heater 1 on,31 Heater 2 on 
,32Temperature controller on(100°C) 
30 Heater 1 on,31 Heater 2 on,32 
Temperature controller on(100°C) 
11 (Posn. 6),12,16,Syringe drive up 60secs 
25,Syringe drive down 60secs,24,27 
Syringe drive up 60 secs,25. 
Syringe drive down 60 secs,24 
Syringe drive up 60 secs,25, 
Synnge drive down 60 secs,24 
HPLC syringe drive up 
Syringe drive down (manual control) 
Manual control 
20 (Manual control) 
AUTOMATION OF nC-METHYLATIONS 
Many ^^C-labelled compounds of great interest to PET clinical science 
have now been prepared by the methylation of suitable precursors using 
[i^CJiodomethane and the number continues to grow. At Hammersmith 
Hospital, in order to respond to the varied needs of a busy clinical 
research programme, a hot-cell has been successfully equipped with a 
i^C-methylation facility that can be quickly set up and operated to 
produce radiopharmaceutical batches for clinical use (see Figure 2). The 
sequence of operations that is needed to achieve each radiosynthesis is 
controlled in timed steps by a Programmable Logic Controller (PLC) . 
This incorporates a 'plug-in' module that can be programmed to suit 
each individual radiosynthesis (Clark and Dowsett, 1992). (see Table 2 for 
program sequence for [O-methyl-iiC] Diprenorphine ) 
[iiClCarbon Dioxide Production. 
[iiC]Carbon dioxide is produced by the proton irradiation of high purity 
nitrogen gas via the i ' 'N(p,a)iiC reaction. For labelling operations it is 
advantageous to concentrate the [^^C]carbon dioxide into a few millilitres 
f rom a volume of several litres of target gas. An automated cryotrap 
fabricated from a small coil of stainless steel tubing (20 cm x 1/16" o.d.) 
cooled in liquid argon is used. The use of liquid argon avoids the 
problematical co-trapping of significant volumes of nitrogen which 
occurs i f liquid nitrogen is used as the coolant. The valves and cryotrap 
movement are controlled by the PLC's programme. 
Production of [nCJIodomethane. 
The synthesis of [nCJiodomethane using the reaction of [nC]carbon 
dioxide wi th l i thium aluminium hydride (LAH) and subsequent 
reaction wi th hydriodic acid is now widely applied (for a review see 
Crouzel et al., 1987). The major problem in this radiosynthesis is 
maintenance of the high specific radioactivity required for nC-labelled 
receptor ligands. This can principally be achieved by the use of high 
quality L A H in small quantities under carefully controlled carbon 
dioxide free atmospheres and by working quickly . The heating, cooling 
and sequencing of the valves for [^CJiodomethane production are 
controlled by PLC programme. 
[iiC]-Methylation of Precursor. 
The conditions under which the precursor is methylated depend 
critically on the class of compound of interest and the subsequent 
work-up and purification procedures. An automated reaction vial 
penetrator is used. This device allows the relevant precursor to be 
introduced together wi th the reaction solvent and base in a 
septum-sealed vial. [^Cjlodomethane can then be distilled into the 
precursor solution via a round-tipped side-hole needle, which can be 
motor-driven through the septum under programme control. The 
needles can then be withdrawn and the vial lowered into the heating 
bath. The nC-methylation takes place for a pre-programmed time. ^The 
reaction mixture is extracted by re-inserting the needles and transferred 
to the loop of an HPLC injection valve. Again this sequence of eventVis 
controlled by the PLC. \ 
HPLC Purification. 
For some compounds, where the base and/or solvent are detrimental to 
the performance of the HPLC, sample-enrichment can be included in the 
programme of operations . Here an injection loop (10 mL) is loaded 
wi th an aqueous wash of the reaction vial and the contents of this loop 
are then loaded onto a silica C-18 cartridge(30mmX4mm). This cartridge 
is washed with water and then back-eluted onto the main silica C-18 
column for purification using the chosen eluent. The PLC controls the 
sequence of operations for the multi-port valves necessary to accomplish 
these steps. The HPLC eluate that contains the required labelled product 
is identified by the operator by monitoring radioactivity and UV 
absorbance, and collected in the flask of a rotary evaporator by manual 
remote operation of the fraction collect/waste valve 
Product Formulation. 
Solvent is removed from the product by evaporation under reduced 
pressure using a micro-rotary evaporator, modified to allow it to be 
raised or lowered under the control of the PLC. Finally, under 
programme control, the formulation solvent is introduced into the flask 
and the resultant radioactive solution transferred via a Millipore® filter 
into a shielded shipping vial outside the hot-cell. 
7 
Performance of the System. 
The system has been used routinely to produce clinical batches of 
S - [ N - m e t h y l - i i C ] n o m i f e n s i n e (U l in et a l . , 1989) and 
[0-methyl-iiC]raclopride (Ehrin et al., 1987), [N-methyl-nC]SCH 23990 
(Halldin et al., 1986) and [O-methyl-HC] Diprenorphine (Luthra et al 
1991). The production of [0-methyl-iiC]raclopride in particular 
benefitted f rom the sample-enrichment facility. The production 
parameters for these radiosyntheses are listed below. 
a. S-[N-methyl-iiC]Nomifensine. 
[llC]Iodomethane is trapped in a solution of desmethyl-S-nomifensine 
(5 mg) in ethanol (400 |iL). Then the reaction pot is sealed and heated at 
90°C for 5 min. The reaction mixture is purified by HPLC on a 
IJ.-PorasiF'^ column (30 x 0.8 cm i.d.; Waters Associates Inc.) eluted with 
chloroform-methanol (90:10 v / v ) at a flow rate of 3 mL/min , The 
product is formulated in isotonic saline which is sterilised by Millipore® 
f i l t ra t ion . A decay-corrected radiochemical yield of 23% from 
[ 1 1 C J i o d o m e t h a n e p r o v i d e s 370-555 M B q of 
S-[N-methyl- i iC]nomifensine ready for injection wi th a specific 
radioactivity of 15000MBq/|j,mol. (product no longer required routinely). 
b. [0-methyl-iiC]Raclopride. 
[ l lC]Iodomethane is trapped in DMSG (400 |J.L) containing 
desmethyl-raclopride (2.5 mg) and sodium hydroxide solution (5M; 10 
| iL). The reaction pot is sealed and heated at 90°C for 5 min. The reaction 
mixture is purified by sample enrichment followed by reverse phase 
HPLC using a ^i-BondapakT" C-18 column (30 x 0.8 cm i.d.; Waters 
Associates Inc.) eluted with methanol-lOmM ammonium dihydrogen 
phosphate solution (60:40 v /v ) at 3 mL/min. The product is formulated 
in isotonic saline which is sterilised by Millipore® filtration. A 
decay-corrected radiocherriical yield of 25% from [iiC]iodomethane 
provides 1019 MBq of [0-methyl-iiC]raclopride ready for injection with a 
specific radioactivity of 21100 MBq/|J,mol. (average of 10 preparations), 
c. [N-methyl-"C]SCH 23390. 
[ l lCj Iodomethane is trapped in acetone (400 |J.L) containing 
desmethyl-SCH 23390 (1 mg). The reaction pot is sealed and heated at 
90°C for 10 min. The acetone is then evaporated. The reaction mixture 
is recovered in 2ml of HPLC eluent and purified by HPLC on li-PorasiF'" 
column (30 x 0.8 cm i.d.; Waters Associates Inc.) eluted wi th 
chloroform-methanol-aq. ammonia (90:1:0.1 by vol.) at 3 mL/min, The 
product is formulated in isotonic saline which is sterilised by Millipore® 
f i l t ra t ion . A decay-corrected radiochemical yield of 40% from 
[ncjiodomethane provides MOOMBq of [N-methyl-llC]SCH 23390 ready 
for injection with a specific activity of 19600 MBq/}imol. (average of 10 
8 
preparations). 
d. [Q-methyl-iiC]Diprenorphine. 
[llCjIodomethane is trapped in DMSO (300 ^L) containing (3-0 -trityl,6-
O -desmethyl)diprenorphine (2.0 mg) and sodium hydride (4mg ). The 
reaction vial is sealed and heated at 95°C for 5 min. The reaction vial is 
then raised back onto the needles and hydrochloric acid (250 [il, 2M) is 
slowly added. The reaction vial is then lowered into the oil bath and 
heated at 95°C for a further 2 mins. to remove the protecting group. 
Af ter hydrolysis, the reaction mixture is purif ied by sample 
enrichment followed by reverse phase HPLC using a ii-Bondapak'^^ C-18 
column (30 x 0.8 cm i.d.; Waters Associates Inc.) eluted wi th 
acetonitrile-lOmM ammonium formate solution (45:55 v / v ) at 3 
m L / m i n . After evaporating the HPLC solvent, the product is formulated 
in isotonic saline which is sterilised by Millipore® filtration. A 
decay-corrected radiochemical yield of 25% from [iiC]iodomethane 
providesl051MBq of [6-0-methyl-nC]-Diprenorphine 
ready for injection with a specific radioactivity of 28600 MBq/| imol. 
(average of 10 preparations). 
A second hot-cell has been equipped with two very similar systems to 
extend the range of routinely available llC-labelled compounds within 
each working day, for example, [N-methyl-^^CjPK 11195 (Camsonne et 
al., 1984; Cremer et al., 1992), [N-methyl-nC]flumazenil (Mazi&re et al., 
1984) and L-[N-methyl-nC]deprenyl (Fowler et al.,1987). 
Figure 2. Scheme of PLC-controlled apparatus for labelling 
radiopharmaceuticals by methylation with [ncjiodomethane. 
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Table 2 Program sequence for the PLC used in the preparation of 
[ i iC] Diprenorphine. 
SETUP MODE, 
Step No. Description 
0 Start 
1 Wash HI loop,remove methylation vial, 
wash line from HCl syringe to vial, 
wash line from ammonia syringe to vial, 
2 Pump storage eluent to formulation rig, 
3, Wash line from formulation syringe to 
rotary evaporator, 
4 Wash out rotary evaporator, 
5 Load ammonia syringe, 
6 Load HCl syringe. 
7 Load formulation syringe, 
8 Purge target and apparatus for 3minutes, 
9 Pressurise pot and flush HI loop 
10 Seal pot, and pressure test 
11 Slow flush through apparatus 
1 2 Load vial 
13 Vial up, nitrogen on, 
14 Load HI loop 
Outputs 
All off 
7,8,vessel B 
manual, 
10,11,12 
16 
17,18 
Rotary evap. 
52 manual 
SI manual 
53 manual 
1,2,3,5,6,9 
2,3,6,7,8 
All off 
3,6,9 
Vessel B manual 
Vessel B up,13 
3,6,7,8,13 
RUN MODE 
Step No, Description Outputs 
0 Change over from setup 
1 Flush apparatus, load LAH into pot 
2 Trap down,wait 10secs,empty target ISOsecs 
3 Trap up, dispense 2 minutes 
4 Evaporate THF for 3 minutes 
5 skip (an unnecessary step was deleted here) 
6 Cool pot and flush line for 2,5 minutes 
7 Add HI for 2 sees 
8 Heat reaction for 2 minutes 
(optional nitrogen pulse for 0,4 s) 
9 Switch off nitrogen through vial, 
vent Mel pot for 2 seconds 
10 Distil Me for 90 seconds 
11 Lower vial, wait 5 minutes 
12 Raise vial, add HCl 
13 Lower vial, wait 2 minutes 
14 Raise vial, extract reaction mixture 
into ammonia 
15 Load sample into loop 
16 Transfer to enrichment, 3,5 minutes 
17 Load onto HPLC, 2 minutes 
18 HPLC and cut peak into rotary evaporator 
19 Vacuum on, wait 30 sees, 
20 Evap up, wait 3s, add saline 
21 Draw up saline 
22 Dispense product through millipore 
All off 
2,3,6,9,13 
Cryogenic trap down ,1,4,13 
Cryogenic trap up,3,6,9,13 
Heatir, 2,3,6,^ ,13 
Cooling air,2,3,6,9,13 
7,8,9 
Heater, 13 
(manual 2,6) 
Heater,10 
Heater,2,6,10 
Vessel B down 
Vessel B up,ll,Sl 
Vessel B down 
Vessel Bup,l 1,12 
S2 manual 
52 manual,14 
15 
15,16 manual 
Vacuum on, lower flask, rotation 
on. Rotary evap. down. 
Rotation on, 17,18,S3 
17,18,53 
53 manual 
Components of the ispDG and [nClMethylation Systems. 
Wherever possible commercial components are used with little or no 
modification. A Toshiba EX40 industrial programmable logic controller, 
which uses ladder logic was chosen. The programme information is 
stored on a plug in Electronically Erasable Programmable Read Only 
Memory (EEPROM) module which can be interchanged readily. The 
controller contains relays that are suitable for low power (240 V a.c; 2 A) 
and low voltage (24 V d.c; 2 A) operations. Most of the valves and 
motorised drives are controlled directly by these relay outputs. The 240 
V operated devices, such as heaters and pumps, are operated via isolating 
solid state relays. The two- and three-port Teflon™ diaphragm valves 
for l iquid and vapour handling are by Angar Scientific [part nos 
3682NC2430 and 368232430 for 24 V and up to 2 bar (30 psi) operation]. 
They have 1/4" x 28 threads in flat-bottomed ports suitable for use with 
low pressure chromatography fittings (e.g. 'Altex™', 'Omnifit'^'^'). For 
gas handling the two- and three-port stainless steel valves are by Skinner 
[Honeywell Lucifer, part nos B2 RX 127 DC-2 and B14 DK 1075 DC-2 
operated at 24 V for pressures up to 12 bar (330 psi) and 5.3 bar (80 psi), 
respectively]. The multi-port rotary valves are by Rheodyne. The low 
pressure Teflon™/Kel-F™ valves with 1/4" x 28 fittings are 3-port (part 
no 5301/5300 ) and six-port distribution valves with pneumatic actuators 
(part no 501 IP). The HPLC valves are also by Rheodyne and are 
pneumatically-actuated stainless steel and VespeF^ (Dupont polyimide) 
or Kel-F™ rotary valves (part no 7010P). The rotary evaporator is a UV 
Micro (Heidolph) and has been modified to be raised and lowered 
pneumatically. The glassy carbon reaction vessel (70mmxl6mm I.D) is 
made of sigradur® (HTW GmbH,D-8901 Meitingen). The reaction vial for 
methylation is a Reacti-vial™ (Pierce, 1 mL) with a Teflon™-faced 
silicon septum 3 mm thick retained by a Quickfif^" (Corning) SQ 13 cap. 
The penetration needles are by Hamilton with rounded tips and side 
holes (part no 100.090.218). The syringe drives and septum penetrator 
drives are of ' in house' design and manufacture and are 'screw and nuf 
devices driven by electric motor. The HPLC detectors are by Mini 
Instruments for radioactivity detection (model 7-lOC with a MClO G-M 
tube) and by Severn Analytical for UV absorbance detection (model SA 
6506). 
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AN AUTOMATED SYSTEM FOR THE PREPARATION AND 
INFUSION OF [150]WATER AT THE BEDSIDE. 
Introduction 
The important blood flow tracer, [^SQJwater, may be readily prepared by 
a variety of routes. However, several problems need to be addressed if 
safe and effective injections or infusions are to be prepared. Of primary 
concern is that the product should be free from any harmful impurities, 
both chemical and radioactive, and be sterile and apyrogenic. Due to the 
short half-life of oxygen-15, quality control of each sample or batch would 
be impractical. However, most groups carrying out work in this area 
have evolved safe operating procedures (SOPs) which have been shown 
to be capable of maintaining the required standards The measurement 
and delivery of the prepared doses of [iSQjwater also requires careful 
attention both for the administrator and for the recipient. As a typical 
injected bolus of [ iSQjwater would be 3-3.7 GBq (80-100 mCi) the 
radiation dose to the administrator is of great concern. Automated 
injectors and infusers are at advanced stage of development in several 
laboratories. The device we have developed at Hammersmith is 
described below. 
Design and Operation of the [150]Water Infuser. 
The 'bedside' [150]water infuser (nicknamed 'R2D2') recently developed 
at the MRC Cyclotron Unit (Hammersmith Hospital) (Clark and Tochon 
Danguy, 1992) is shown schematically in Figure 3. [ iSQjWater is 
synthesised in the 50mm thick lead-shielded bedside device by mixing 
cyclotron-produced [i50]oxygen (in 1% oxygen/ 99% nitrogen) with 5% 
hydrogen/95% nitrogen over a palladium catalyst in an low voltage(24-0-
24Vac.l00VA) oven at 200°C. The gaseous output is led to a 
semi-permeable membrane in ter face ( V i s k i n g - M e d i c e l l 
International,U.K.) sandwiched between Perspex blocks (see Figure 4), 
The other side of the interface is flushed with sterile saline using a pump 
(IVAC 560) approved for medical application. . [iSQjWater diffuses 
rapidly across the membrane and is taken up into the sterile saline. This 
is then infused into the subject for study via a shielded G-M tube and 
sterile Millipore® filter. The f luid handling valves, for control of the 
infusion parameters, are three-port membrane valves (Angar/Asco, 
368232430 24VDC operation). 'On-line' radioactivity detection is based on 
passing the radioactive saline through a loop of Teflon'^'^ tubing (1/16" 
o.d.) wound around the G-M tube (Philips ZP-1300). The counts are 
taken into a scaler-ratemeter (Mini Instruments 6-90) modified with 
adjustable pre-scaler to allow direct calibration as 'mCi infused'.This 
calibration is routinely checked against a standard ionisation chamber. 
Al l controls and power supplies are designed and built to comply with 
electromedical safety standards. Unused product is allowed to decay in a 
delay vessel consisting of a 250ml volume coil of polypropylene tubing 
housed within the unit before discharge into a sterile bag external to the 
lead shield. The device can be operated to give a constant infusion for 
any predetermined time at a flow rate of 10 mL/min . Alternatively 
bolus infusions can be prepared and administered. This is achieved by 
accumulating a "bolus" dose in the membrane exchanger whilst the 
saline f low is temporarily interupted.The amount of radioactivity 
infused is determined by the mode of operation of the PET scanner 
(CTI-Siemens Neuro-PET) and is typically 560 MBq (15 mCi) for 'septa 
out' and 3 GBq (80 mCi) for 'septa in'. 
Infuser maintenance. 
Pharmaceutical maintenance involves cleaning and sterilising the 
membrane exchanger prior to assembly and washing the fluid system 
with isotonic saHne solution while the millipore filters are in place. 
Pyrogen tests (LAL) and sterility tests are carried out to validate the 
assembly techniques. Routine operation requires replacement of the 
disposable components, such as the pump tube, saline bag, millipore 
filters and infusion catheters, followed by pyrogen tests (LAL). 
Figure 3 Schematic diagram of the bedside H2I5O infusor 
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Figure 4 Membrane exchanger design as used in the Ha'^O infusor 
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